<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Pharmacology - Combined Tests</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
</style>
  <style>
  body {
    font-family: Arial, sans-serif;
    padding: 0;
    margin: 0;
  }

  button {
    margin: 5px;
    padding: 10px 15px;
    background: #ffffff;
    border: 1px solid #2d3748;
    border-radius: 4px;
    cursor: pointer;
    color: #000000;
    position: relative;
    top: 5px;
    font-size: 14px;
    transition: background 0.2s ease, color 0.2s ease, transform 0.1s ease;
  }

  button:hover {
    background: #f3f4f6;
    color: #000000;
    transform: translateY(-1px);
  }

  body, html {
            margin: 0;
            padding: 0;
            height: 100%;
            overflow: hidden;
        }
        .iframe-container {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            overflow: auto;
            -webkit-overflow-scrolling: touch;
        }
        .iframe-container iframe {
            width: 100%;
            height: 100%;
            border: none;
            display: block;
        }
    
    /* Mobile optimization */
    

  /* Dropdown styling */
  .dropdown-wrapper {
    position: absolute;
    top: 20px;
    right: 20px;
    z-index: 1100;
  }

  .dropdown-toggle {
    background: #2c5281;
    color: white;
    border: none;
    font-size: 14px;
    padding: 10px 18px;
    border-radius: 6px;
    font-weight: bold;
    letter-spacing: 0.5px;
  }

  .dropdown-toggle:hover {
    background: #24466c;
  }

  .dropdown-menu {
  display: none;
  position: absolute;
  right: 0;              /* keep aligned to right edge of toggle */
  margin-top: 6px;
  background: white;
  border: 1px solid #cbd5e0;
  border-radius: 8px;
  max-height: 350px;
  overflow-y: auto;
  box-shadow: 0 6px 16px rgba(0, 0, 0, 0.15);
  min-width: 250px;
  max-width: 90vw;       /* prevent it from going outside screen */
  word-wrap: break-word; /* wrap long names */
  white-space: normal;   /* allow text to wrap */
  animation: fadeIn 0.2s ease-in-out;
}

.dropdown-menu button {
  display: block;
  width: 100%;
  text-align: left;
  margin: 0;
  padding: 10px 15px;
  border-radius: 0;
  background: transparent;
  color: #2d3748;
  border: none;
  border-bottom: 1px solid #edf2f7;
  font-size: 13px;
  white-space: normal;   /* allow wrapping inside button */
  word-break: break-word;
}


  img {
    max-width: 100%;
    max-height: 400px;
    width: auto;
    height: auto;
    display: block;
    margin: 10px auto;
  }

  body > section:last-child {
    margin-bottom: 0 !important;
  }
  
</style>
  <script>
  function showTest(id) {
    document.querySelectorAll('.iframe-container').forEach(div => div.style.display = 'none');
    document.getElementById(id).style.display = 'block';
    document.getElementById('dropdownMenu').style.display = 'none';
    window.scrollTo(0, 0);
  }

  function toggleDropdown() {
    const menu = document.getElementById('dropdownMenu');
    menu.style.display = menu.style.display === 'block' ? 'none' : 'block';
  }

  document.addEventListener('click', function (event) {
    const toggle = document.getElementById('dropdownToggle');
    const menu = document.getElementById('dropdownMenu');
    if (!toggle.contains(event.target) && !menu.contains(event.target)) {
      menu.style.display = 'none';
    }
  });
</script>
<script src="../../../access-control.js"></script>
  <script src="../../../block.js"></script>
  <script src="../../../error-handler/link-checker.js"></script>
  <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5920367457745298"
     crossorigin="anonymous"></script>
</head>
<body>
<script>
      // Initialize access control for protected page
      if (!accessControl.initProtectedPage()) {
        throw new Error('Access denied - redirecting to index.html');
      }
    </script>
  <button onclick="history.back()" style="position: absolute; top: 20px; left: 20px; background: transparent; color: white; border: none; padding: 10px; cursor: pointer; z-index: 1001; font-size: 20px;">
  <i class="fas fa-arrow-left"></i>
</button>

<div class="dropdown-wrapper">
  <button class="dropdown-toggle" id="dropdownToggle" onclick="toggleDropdown()">â˜° INDEX</button>
  <div class="dropdown-menu" id="dropdownMenu">
<button onclick="showTest('test1')">Pharmacology E&D (First Test) - 17-05-2023 - 2023-05-17</button>
<button onclick="showTest('test2')">Pharmacology E&D (Mission NEET PG_INICET 2.0) - 26-05-2024 - 2024-05-26</button>
<button onclick="showTest('test3')">Pharmacology E&D (Second Test) - 23-05-2023 - 2023-05-23</button>
<button onclick="showTest('test4')">Pharmacology E&D - Mission (2.0 Batch 3) - 05-12-2024 - 2024-12-05</button>
<button onclick="showTest('test5')">Pharmacology E&D - Mission 1.5 - 03-02-2024 - 2024-02-03</button>
<button onclick="showTest('test6')">Pharmacology E&D - Mission 1.5, Lap 2 - 12-06-2024 - 2024-06-11</button>
<button onclick="showTest('test7')">Pharmacology E&D - Mission 2.0 (Batch 2) - 27-09-2024 - 2024-09-27</button>
<button onclick="showTest('test8')">Pharmacology E&D - Mission 2.0 (INICET) - 08-09-2024 - 2024-09-07</button>
<button onclick="showTest('test9')">Pharmacology E&D - Mission 2.0, Lap 2 - 13-03-2025 - 2025-03-13</button>
<button onclick="showTest('test10')">Pharmacology E&D 1 (Mission NEET PG 1.0) - 27-09-2023 - 2023-09-27</button>
<button onclick="showTest('test11')">Pharmacology E&D Part-1, Mission 3.0 (Early_Intern Batch) - 12-05-2025 - 2025-05-12</button>
<button onclick="showTest('test12')">Pharmacology E&D Part-2, Mission 3.0 (Early_Intern Batch) - 17-05-2025 - 2025-05-17</button>
<button onclick="showTest('test13')">Pharmacology Revision E&D 2 (Mission NEET PG 1.0) - 17-11-2023 - 2023-11-17</button>
<button onclick="showTest('test14')">Pharmacology Test (The Champion Batch Hyderabad) - 26-09-2024 - 2024-09-26</button>
<button onclick="showTest('test15')">T-20 Pharmacology Test-1 (Pharmacokinetics) - 03-05-2023 - 2023-05-03</button>
<button onclick="showTest('test16')">T-20 Pharmacology Test-10 (Kidney, Respiratory System & Anaesthesia) - 18-09-2023 - 2023-09-18</button>
<button onclick="showTest('test17')">T-20 Pharmacology Test-2 (Pharmacodynamics) - 18-05-2023 - 2023-05-18</button>
<button onclick="showTest('test18')">T-20 Pharmacology Test-3 (ANS) - 08-06-2023 - 2023-06-08</button>
<button onclick="showTest('test19')">T-20 Pharmacology Test-4 (CVS) - 29-06-2023 - 2023-06-29</button>
<button onclick="showTest('test20')">T-20 Pharmacology Test-5 (CNS) - 10-07-2023 - 2023-07-10</button>
<button onclick="showTest('test21')">T-20 Pharmacology Test-6 (Endocrine) - 24-07-2023 - 2023-07-24</button>
<button onclick="showTest('test22')">T-20 Pharmacology Test-7 (Hematology & GIT) - 07-08-2023 - 2023-08-07</button>
<button onclick="showTest('test23')">T-20 Pharmacology Test-8 (Antimicrobials-1) - 21-08-2023 - 2023-08-21</button>
<button onclick="showTest('test24')">T-20 Pharmacology Test-9 (Antimicrobials-2) - 04-09-2023 - 2023-09-04</button>
</div>
  </div>
  
<div id="test1" class="iframe-container" style="display:block;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D (First Test)   17 05 2023   2023 05 17&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D (First Test)   17 05 2023   2023 05 17&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A young female Shagun comes to you in the gynaecology OPD and gives the history that she had intercourse with her boyfriend 4 days back. Select the drug that can act as a single dose post-coital contraceptive for her:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clomiphene citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mifepristone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ulipristal&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medroxyprogesterone acetate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ulipristal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ulipristal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the fastest urate lowering therapy in tumor lysis syndrome to prevent renal damage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Febuxostat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rasburicase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rasburicase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Rasburicase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a study involving one thousand patients, half of the participants receive a newly developed drug designed to lower cholesterol levels, while the other half receive a placebo. The physicians and subjects are unaware of the treatment assignment. Which phase of the drug development process does this scenario most closely describe?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phase IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phase III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Phase III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The scenario described corresponds to Phase III of the drug development process. Phase III trials involve large-scale studies conducted on a significant number of participants, usually in the range of hundreds to thousands. These trials are designed to assess the effectiveness of the drug in a specific patient population and compare it to a control group, often using a placebo. In Phase III, the goal is to gather additional evidence of the drug&#x27;s efficacy, safety, and potential side effects. The study in question involves one thousand patients divided into two groups, with one group receiving the newly developed drug and the other receiving a placebo. The blinding of physicians and subjects ensures that neither party knows the treatment assignment, minimizing biases and increasing the reliability of the study results. This blinding helps to maintain objectivity during data collection and analysis. Therefore, the scenario described aligns most closely with Phase III of the drug development process.&lt;/li&gt;&lt;li&gt;â€¢ The scenario described corresponds to Phase III of the drug development process. Phase III trials involve large-scale studies conducted on a significant number of participants, usually in the range of hundreds to thousands. These trials are designed to assess the effectiveness of the drug in a specific patient population and compare it to a control group, often using a placebo. In Phase III, the goal is to gather additional evidence of the drug&#x27;s efficacy, safety, and potential side effects.&lt;/li&gt;&lt;li&gt;â€¢ The study in question involves one thousand patients divided into two groups, with one group receiving the newly developed drug and the other receiving a placebo. The blinding of physicians and subjects ensures that neither party knows the treatment assignment, minimizing biases and increasing the reliability of the study results. This blinding helps to maintain objectivity during data collection and analysis.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the scenario described aligns most closely with Phase III of the drug development process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is admitted to the emergency department for treatment of a drug overdose. The identity of the drug is unknown, but it is observed that when the urine pH is acidic, the renal clearance of the drug is less than GFR and that when the urine pH is alkaline, the clearance is greater than GFR. The drug probably is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Strong acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Weak acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Weak base&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Strong base&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Weak acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Weak acid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ When the urine pH is acidic, the renal clearance of a weak acid drug is less than the glomerular filtration rate (GFR). This is because in acidic urine, weak acid drugs remain predominantly in their non-ionized form, which hinders their excretion into the urine. As a result, their renal clearance is limited.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, when the urine pH is alkaline, the renal clearance of a weak acid drug is greater than the GFR. In alkaline urine, weak acid drugs become ionized, which promotes their excretion into the urine. This leads to a higher renal clearance compared to the GFR.&lt;/li&gt;&lt;li&gt;â€¢ Strong acids (Choice A) and strong bases (Choice D) are usually fully ionized and do not undergo significant changes in their excretion based on urine pH.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, based on the observed changes in renal clearance in response to urine pH, the drug in question is most likely a weak acid (Choice B).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of epilepsy presents to the clinic for medication review. The patient is currently taking multiple medications, including isoniazid, hydralazine, procainamide, and phenytoin, for their various medical conditions. During the discussion, the patient asks about the differences in the metabolism of these drugs. The healthcare provider explains that all the drugs mentioned are metabolized by different pathways except for one. Which of the following drugs is NOT metabolized by acetylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenytoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Phenytoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation. On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects.&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body.&lt;/li&gt;&lt;li&gt;â€¢ Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following factor in PC vs time graph is a measure of extent of drug absorption of a drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Area under the curve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Half life&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tmax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Area under the curve&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Area under the curve&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Area under the curve (AUC): The area under the curve represents the total amount of drug that has been absorbed into the bloodstream over a specific period of time. It provides information about the extent of drug absorption and bioavailability. A larger AUC indicates a greater extent of drug absorption. Half-life: The half-life of a drug is the time it takes for half of the drug concentration in the bloodstream to be eliminated. It is a measure of the rate at which the drug is eliminated from the body, not directly related to drug absorption. Half-life is more relevant in assessing the rate of drug elimination rather than the extent of drug absorption. Cmax: Cmax refers to the maximum concentration of a drug in the bloodstream after administration. It represents the peak concentration achieved by the drug. While Cmax does not directly measure the extent of drug absorption, it provides information about the drug&#x27;s peak exposure, which can be related to the drug&#x27;s bioavailability and absorption characteristics. Tmax: Tmax represents the time it takes for a drug to reach its maximum concentration in the bloodstream. It indicates the rate of drug absorption rather than the extent. Tmax is useful in determining how quickly the drug reaches its peak concentration, which can have implications for the drug&#x27;s onset of action or duration of effect.&lt;/li&gt;&lt;li&gt;â€¢ Area under the curve (AUC): The area under the curve represents the total amount of drug that has been absorbed into the bloodstream over a specific period of time. It provides information about the extent of drug absorption and bioavailability. A larger AUC indicates a greater extent of drug absorption.&lt;/li&gt;&lt;li&gt;â€¢ Half-life: The half-life of a drug is the time it takes for half of the drug concentration in the bloodstream to be eliminated. It is a measure of the rate at which the drug is eliminated from the body, not directly related to drug absorption. Half-life is more relevant in assessing the rate of drug elimination rather than the extent of drug absorption.&lt;/li&gt;&lt;li&gt;â€¢ Cmax: Cmax refers to the maximum concentration of a drug in the bloodstream after administration. It represents the peak concentration achieved by the drug. While Cmax does not directly measure the extent of drug absorption, it provides information about the drug&#x27;s peak exposure, which can be related to the drug&#x27;s bioavailability and absorption characteristics.&lt;/li&gt;&lt;li&gt;â€¢ Tmax: Tmax represents the time it takes for a drug to reach its maximum concentration in the bloodstream. It indicates the rate of drug absorption rather than the extent. Tmax is useful in determining how quickly the drug reaches its peak concentration, which can have implications for the drug&#x27;s onset of action or duration of effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Anti-glaucoma drug that acts by increasing trabecular outlfow is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Netarsudil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dorzolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Netarsudil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Netarsudil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition from the given graph:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Competitive&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/17/farma-12.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Competitive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ The figure shown in the question is Lineweaver-Burk plot, also known as the double reciprocal plot. It is constructed by taking the reciprocal of both the reaction velocity (1/V) and the substrate concentration (1/[S]) and plotting them against each other. In this plot, the x-axis represents 1/[S] (the reciprocal of the substrate concentration), and the y-axis represents 1/V (the reciprocal of the reaction velocity). The slope of the Lineweaver-Burk plot is equal to Km/Vmax, and the intercept on the y-axis is equal to 1/Vmax.&lt;/li&gt;&lt;li&gt;â€¢ The figure shown in the question is Lineweaver-Burk plot, also known as the double reciprocal plot. It is constructed by taking the reciprocal of both the reaction velocity (1/V) and the substrate concentration (1/[S]) and plotting them against each other.&lt;/li&gt;&lt;li&gt;â€¢ In this plot, the x-axis represents 1/[S] (the reciprocal of the substrate concentration), and the y-axis represents 1/V (the reciprocal of the reaction velocity).&lt;/li&gt;&lt;li&gt;â€¢ The slope of the Lineweaver-Burk plot is equal to Km/Vmax, and the intercept on the y-axis is equal to 1/Vmax.&lt;/li&gt;&lt;li&gt;â€¢ How to interpret this graph?&lt;/li&gt;&lt;li&gt;â€¢ How to interpret this graph?&lt;/li&gt;&lt;li&gt;â€¢ X-axis represents Km and Y-axis represents Vmax. If the lines of two graphs (with inhibitor and without inhibitor) intersect at Y-axis, it means Vmax is same and Km is different. This is a case of competitive inhibition. If the lines of two graphs (with inhibitor and without inhibitor) intersect at X-axis, it means Km is same and Vmax is different. This is a case of non-competitive inhibition.&lt;/li&gt;&lt;li&gt;â€¢ X-axis represents Km and Y-axis represents Vmax.&lt;/li&gt;&lt;li&gt;â€¢ If the lines of two graphs (with inhibitor and without inhibitor) intersect at Y-axis, it means Vmax is same and Km is different. This is a case of competitive inhibition.&lt;/li&gt;&lt;li&gt;â€¢ If the lines of two graphs (with inhibitor and without inhibitor) intersect at X-axis, it means Km is same and Vmax is different. This is a case of non-competitive inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following table gives the data of AUC of drug A alone and AUC of drug A when combined with drug B. p value is &amp;lt;0.01. Which of the following statement regarding these drugs is most correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B decreases the first pass metabolism of drug A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B increases the systemic metabolism of drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug B decreases the intestinal absorption of drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug B increases the renal clearance of drug A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Drug B decreases the first pass metabolism of drug A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/16/7.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Drug B decreases the first pass metabolism of drug A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A continuous intravenous infusion of a drug was started at a rate of 3 mg/min. The drug has a half-life of 3 hours, a volume of distribution of 120 L, and a clearance of 0.6 L/min. If the rate of infusion remains constant, what will be the plasma concentration at steady-state?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.005 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.4 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2.0 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5.0 mg/L&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 5.0 mg/L&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male patient presents to the clinic with sudden onset of weakness and numbness on the right side of his body, difficulty speaking, and a sudden severe headache. He denies any recent trauma or significant changes in his lifestyle. On physical examination, there is evidence of right-sided hemiparesis and decreased sensation. The patient&#x27;s speech is slurred, and he exhibits mild confusion. His blood pressure is within normal limits, and the rest of the physical examination is unremarkable. He has a past medical history significant for a stroke that occurred 6 months ago. At that time, he was initiated on clopidogrel for secondary prevention. The patient has been compliant with his medications, including clopidogrel, since his initial stroke. Given this clinical scenario, the most probable cause for the patient&#x27;s recurrent stroke despite being on clopidogrel is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rapid metabolism by CYP 1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poor metabolism by CYP 2C19&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Poor metabolism by CYP 2D6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Poor metabolism by CYP 2E1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Poor metabolism by CYP 2C19&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Given this clinical scenario, the most probable cause for the patient&#x27;s recurrent stroke despite being on clopidogrel is poor metabolism by CYP 2C19. Clopidogrel is a prodrug that requires hepatic activation by cytochrome P450 enzymes, primarily CYP 2C19, to form its active metabolite. This active metabolite inhibits platelet aggregation and helps prevent further clot formation in patients at risk for stroke. However, some individuals have genetic variations that result in poor metabolism of clopidogrel by CYP 2C19, leading to reduced effectiveness of the drug. This phenomenon is known as clopidogrel resistance. Patients who are poor metabolizers of clopidogrel may have a higher risk of recurrent stroke despite taking the medication as prescribed&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Intravenous administration of norepinephrine in a patient already taking an effective dose of atropine will often?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase heart rate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease total peripheral resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decrease pupil size&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Has no effect on cardiovascular system&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increase heart rate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Increase heart rate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Sunder Lal, 28 year old farmer is found convulsing in the farm. Heart rate is 100/min and blood pressure is 180/110 mm Hg. Diarrhea, sweating and urination are apparent. Pupils are pin point. Drug poisoning is suspected. Most probable cause is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetaminophen overdose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amphetamine toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Organophosphate poisoning&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atropine poisoning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Organophosphate poisoning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Organophosphate poisoning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old, insulin-dependent diabetic patient is diagnosed with hypertension and begins therapy with an antihypertensive agent. Three days later, he measures his blood glucose at home and finds that it is 53 mg/dL. He recalibrates his glucose testing apparatus and repeats the test, only to find that the first reading was accurate. He is concerned that his hypoglycemia did not produce the normal premonitory signs and symptoms. Which of the following medications was most likely prescribed to treat his hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;IV administration of drug X to an anesthetized animal produces an increase in blood pressure. After administration of drug Y, re-administration of drug X produces a decrease in blood pressure. Which of the following pairs of drugs could produce this sequence of events?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetylcholine â€“ Neostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Epinephrine â€“ Phentolamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isoproterenol â€“ Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Norepinephrine - Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Epinephrine â€“ Phentolamine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/16/13_y6UFnc4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anticholinergic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholinomimetic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Opioid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Salicylate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anticholinergic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Anticholinergic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for treatment of anaphylactic shock is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diphenhydramine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nor-adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Adrenaline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young boy presents to the emergency department with constant crying due to pain after a history of bite from an insect. The patient complains of severe pain at the sting site, restlessness, sweating, and increased heart rate. On examination, the patient has local erythema and swelling at the site. The patient&#x27;s blood pressure is elevated. What is the most appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of prazosin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of antihistamines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administration of corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Application of ice packs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administration of prazosin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â A. Administration of prazosin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The symptoms described by the patient, including severe pain, restlessness, sweating, and increased heart rate, are consistent with scorpion envenomation. Scorpion venom can cause an excessive release of catecholamines, leading to sympathetic overactivity. Prazosin acts by blocking alpha-1 adrenergic receptors, counteracting the effects of the released catecholamines. Options B and C, administration of antihistamines and corticosteroids, respectively, are not the mainstays of treatment for scorpion stings. Antihistamines are primarily used for the management of allergic reactions, which are not the primary mechanism of scorpion envenomation. Corticosteroids may have a limited role in certain cases, but they are not the initial treatment of choice. Option D, application of ice packs, may help provide local pain relief, but it does not address the systemic symptoms associated with scorpion envenomation.Top of Form&lt;/li&gt;&lt;li&gt;â€¢ The symptoms described by the patient, including severe pain, restlessness, sweating, and increased heart rate, are consistent with scorpion envenomation. Scorpion venom can cause an excessive release of catecholamines, leading to sympathetic overactivity.&lt;/li&gt;&lt;li&gt;â€¢ Prazosin acts by blocking alpha-1 adrenergic receptors, counteracting the effects of the released catecholamines.&lt;/li&gt;&lt;li&gt;â€¢ Options B and C, administration of antihistamines and corticosteroids, respectively, are not the mainstays of treatment for scorpion stings. Antihistamines are primarily used for the management of allergic reactions, which are not the primary mechanism of scorpion envenomation. Corticosteroids may have a limited role in certain cases, but they are not the initial treatment of choice.&lt;/li&gt;&lt;li&gt;â€¢ Option D, application of ice packs, may help provide local pain relief, but it does not address the systemic symptoms associated with scorpion envenomation.Top of Form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug addict patient presented with agitation and ulceration on skin. The patient had severe itching and scratch marks on the body. On examination there is presence of tachycardia, mydriasis and hypertension. Likely substance responsible for these symptoms is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannabis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LSD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heroin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Cocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A college student is brought to emergency after taking an overdose of a non-prescription drug. The patient is confused and lethargic. He has been hyperventilating and dehydrated. Arterial blood gas analysis demonstrates metabolic acidosis. In the management of this patient, which is NOT likely to be of any therapeutic value?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkalinization of urine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Correction of metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastric lavage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment with acetyl cysteine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Treatment with acetyl cysteine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Treatment with acetyl cysteine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented with left sided severe throbbing headache associated with nausea, vomiting, photophobia and phonophobia. Which of the following is a new drug that can provide immediate relief to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rimegepant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Erenumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Rimegepant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Rimegepant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Individuals with alcoholic cirrhosis of liver may develop severe hepatotoxicity after doses of acetaminophen that are not toxic to individuals with normal liver function. This increase sensitivity to acetaminophenâ€™s toxicity is due to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decrease availability of acetaldehyde dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased hepatocellular stores of glutathione&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased activity of Cytochrome P450 enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased liver blood flow&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased hepatocellular stores of glutathione&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Decreased hepatocellular stores of glutathione&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen is primarily metabolized in the liver through a process that involves the formation of a toxic metabolite called N-acetyl-p-benzoquinone imine (NAPQI). Under normal circumstances, NAPQI is rapidly detoxified by glutathione, preventing liver damage. However, individuals with alcoholic cirrhosis often have reduced levels of glutathione in their hepatocytes (liver cells). This decreased glutathione availability impairs the detoxification of NAPQI, leading to an accumulation of the toxic metabolite in the liver. Consequently, the hepatocytes are more susceptible to damage and toxicity, even with lower doses of acetaminophen that would be well-tolerated by individuals with normal liver function. Factors such as decreased availability of acetaldehyde dehydrogenase (choice A), decreased activity of Cytochrome P450 enzymes (choice C), or increased liver blood flow (choice D) may contribute to liver damage in other contexts or with different substances, but they are not the primary reasons for the increased sensitivity to acetaminophen&#x27;s toxicity in individuals with alcoholic cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen is primarily metabolized in the liver through a process that involves the formation of a toxic metabolite called N-acetyl-p-benzoquinone imine (NAPQI). Under normal circumstances, NAPQI is rapidly detoxified by glutathione, preventing liver damage.&lt;/li&gt;&lt;li&gt;â€¢ However, individuals with alcoholic cirrhosis often have reduced levels of glutathione in their hepatocytes (liver cells). This decreased glutathione availability impairs the detoxification of NAPQI, leading to an accumulation of the toxic metabolite in the liver. Consequently, the hepatocytes are more susceptible to damage and toxicity, even with lower doses of acetaminophen that would be well-tolerated by individuals with normal liver function.&lt;/li&gt;&lt;li&gt;â€¢ Factors such as decreased availability of acetaldehyde dehydrogenase (choice A), decreased activity of Cytochrome P450 enzymes (choice C), or increased liver blood flow (choice D) may contribute to liver damage in other contexts or with different substances, but they are not the primary reasons for the increased sensitivity to acetaminophen&#x27;s toxicity in individuals with alcoholic cirrhosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of aspirin in myocardial infarction is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of thromboxane synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of cyclooxygenase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of prostacyclin synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of formation of free radicals&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of thromboxane synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of thromboxane synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new born was diagnosed as having a congenital abnormality that resulted in transposition of great vessels. While preparing the infant for surgery, the medical team needed to keep the ducts arteriosus open. They did this by infusing?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alprostadil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alprostadil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alprostadil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old pregnant woman with a past medical history significant for chronic hypertension presents with a blood pressure of 158/105 mm Hg. Which of the following antihypertensive agents would be most suitable for initial therapy in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bumetanide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fosinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Methyldopa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Methyl dopa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Methyldopa is considered a safe and effective antihypertensive agent for use during pregnancy. It has been extensively studied and has a long history of use in pregnant women without significant adverse effects on the fetus. Methyldopa acts centrally by stimulating alpha-2-adrenergic receptors in the brain, leading to decreased sympathetic outflow and a subsequent reduction in blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Choice A, bumetanide, is a loop diuretic that is not typically used as first-line therapy for hypertension in pregnancy. Loop diuretics can cause volume depletion and electrolyte imbalances, which may be harmful to both the mother and the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Choice B, fosinopril, is an angiotensin-converting enzyme (ACE) inhibitor and is contraindicated during pregnancy. ACE inhibitors are associated with fetal abnormalities, including renal malformations and impaired fetal growth. They should be avoided in pregnant women due to their potential to cause harm to the developing fetus.&lt;/li&gt;&lt;li&gt;â€¢ Choice C, hydrochlorothiazide, is a thiazide diuretic that is generally not recommended as first-line therapy for hypertension in pregnancy. Thiazide diuretics may reduce placental perfusion and have the potential to negatively affect fetal growth.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, methyldopa (Choice D) is the most appropriate antihypertensive agent for initial therapy in this pregnant patient with chronic hypertension. It provides effective blood pressure control while minimizing potential harm to the mother and fetus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not true about use of Î² blockers in CHF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;These should be started at very low dose and slowly titrated upwards&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol is most widely used Î² blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;These are drug of choice in acute decompensated heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;These can reduce mortality in CHF patient&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. These are drug of choice in acute decompensated heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. These are drug of choice in acute decompensated heart failure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old patient being treated for a recent myocardial infarction develops symptoms of arthralgia, myalgia, fever, and pleuritis, and upon examination has a high titer of antinuclear antibodies. Which of the following medications is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Procainamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Procainamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug effect that is produced by therapeutic doses of both nadolol and amiodarone is blockade of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Na channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac K channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-adrenoceptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-adrenoceptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-adrenoceptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Beta-adrenoceptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with symptoms of 3rd degree AV block and severe nausea and anorexia one week after being prescribed an antiarrhythmic drug. The patient&#x27;s history indicates that she is also currently taking digoxin 0.25 mg/day and hydrochlorothiazide 25 mg/day for treatment of congestive heart failure. Which of the following antiarrhythmic drugs is most likely the cause for the patient&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tocainide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is WRONG about amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is longest acting anti arrhythmic drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has positive ionotropic action&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It contains iodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It causes pulmonary fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It has positive ionotropic action&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It has positive ionotropic action&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of statins is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of HMG - CoA synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stimulation of HMG-CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indirect increase of LDL receptors synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of intestinal cholesterol absorption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Indirect increase of LDL receptors synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Indirect increase of LDL receptors synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these drugs DO NOT decrease angiotensin II activity:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valsartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omapatrilat&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nesiritide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Nesiritide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following hyperpolarizes AV nodal tissue, used in PSVT and has short lasting adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adenosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Adenosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of digitalis in atrial fibrillation is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;By decreasing cardiac contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Na + K + ATPase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in refractoriness of AV nodal tissue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;By causing bradycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increase in refractoriness of AV nodal tissue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Increase in refractoriness of AV nodal tissue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug can decrease bone resorption as well as increase bone formation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Romosozumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cinacalcet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Romosozumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Romosozumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;At a high altitude of 3000m, a person complains of breathlessness. All of the following can be used for management of this person except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous digoxin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen supplementation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Intravenous digoxin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Intravenous digoxin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mannitol is used in the management of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congestive Cardiac Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Congestive Glaucoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute Renal Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary edema&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute Congestive Glaucoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/17/untitled-385.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Acute Congestive Glaucoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metformin is least likely to reduce blood sugar in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obese diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non diabetics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2 diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetics not responding to sulfonylureas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non diabetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Non diabetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about dapagliflozin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Its major mode of action in diabetes mellitus is to cause glucosuria when serum glucose is above 180 mg/dL.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It acts by inhibiting SGLT2 present in collecting tubules of the nephron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urinary tract infections are common with its use&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Urinary tract infections are common with its use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Urinary tract infections are common with its use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One of the health benefits of the use of combined oral contraceptives in pre-menopausal women is that these contraceptives reduce the risk of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deep vein thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ovarian cancer&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ovarian cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ovarian cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about bisphosphonates is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bisphosphonates are drug of choice for steroid induced osteoporosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Zolendronate can be given i.v. once yearly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Person should be advised not to lie down for half an hour after administration of risedronate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of these&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. All of these&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year old obese patient with type 2 diabetes mellitus and a history of alcoholism probably should not receive metformin because it can increase the risk of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disulfiram like reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe hepatic toxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lactic acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lactic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the statements about liraglutide are FALSE except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by releasing insulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is an amylin analog useful in diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is effective orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can be used for treatment of type 1 as well as type 2 diabetes mellitus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It acts by releasing insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. It acts by releasing insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Octreotide is useful in esophageal varices. It is a synthetic analogue of somatostatin. The true statement regarding this drug is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It can be given orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is longer acting than somatostatin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Its major adverse effect is secretory diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is longer acting than somatostatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It is longer acting than somatostatin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Select the regime of corticosteroids which has the most dangerous adverse effect potential?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisolone 80 mg/day oral for 7 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisolone 40 mg/day oral for one year&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prednisolone 100 mg twice weekly for 3 months.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methyl-prednisolone 1000 mg intravenous single dose&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prednisolone 40 mg/day oral for one year&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Prednisolone 40 mg/day oral for one year&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following patients would enalapril be the best first line agent for high blood pressure control?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A 62 year old man with bilateral renal artery stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A 32 year old pregnant female&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A 41 year old woman with hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A 56 year old diabetic woman&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A 56 year old diabetic woman&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. A 56 year old diabetic woman&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patients is most likely to be treated with intravenous glucagon?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A young man who took cocaine and has a blood pressure of 190/110 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A middle aged man with type II diabetes who has not taken his regular dose of glipizide for last 4 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An old woman with lactic acidosis as a complication of severe infection and shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An old man with severe bradycardia and hypotension resulting from ingestion of overdose of atenolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. An old man with severe bradycardia and hypotension resulting from ingestion of overdose of atenolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. An old man with severe bradycardia and hypotension resulting from ingestion of overdose of atenolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A professor in medical college is teaching students about the adverse effects of a drug. Which of the following drug can cause gynaecomastia in men and menstrual irregularities in women?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxytocin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statement is correct regarding the given graph?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A represents agonist and Drug B represents inverse agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug C represents agonist and Drug D is inverse agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug A is agonist and Drug D is inverse agonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug B is partial agonist and Drug C is inverse agonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug A is agonist and Drug D is inverse agonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/17/farma-1.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/farma-13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Drug A is agonist and Drug D is inverse agonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs act through intracellular receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroxin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parathyroid hormone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroxin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/17/untitled-384.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Thyroxin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Thyroxine acts via nuclear receptors whereas all other drugs mentioned in the options act via G protein coupled receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test2" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D (Mission Neet Pg Inicet 2.0)   26 05 2024   2024 05 26&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D (Mission Neet Pg Inicet 2.0)   26 05 2024   2024 05 26&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;What of the following is true about plasma half-life?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Is the same as bioavailability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is directly proportional to clearance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is inversely proportional to volume of distribution&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is constant for the drugs eliminated by first order kinetics&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is constant for the drugs eliminated by first order kinetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It is constant for the drugs eliminated by first order kinetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Is the same as bioavailability:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Is the same as bioavailability:&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Bioavailability refers to the fraction of an administered dose of a drug that reaches the systemic circulation in its active form . In contrast, plasma half-life is the time required for the concentration of the drug in the plasma to reduce to half its original value. These are distinct pharmacokinetic properties.&lt;/li&gt;&lt;li&gt;â€¢ Bioavailability&lt;/li&gt;&lt;li&gt;â€¢ fraction of an administered dose&lt;/li&gt;&lt;li&gt;â€¢ drug that reaches the systemic circulation&lt;/li&gt;&lt;li&gt;â€¢ active form&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is directly proportional to clearance:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is directly proportional to clearance:&lt;/li&gt;&lt;li&gt;â€¢ This is incorrect. Plasma half-life is inversely related to clearance . Clearance is the rate at which a drug is removed from the body. If a drug is cleared quickly from the body (high clearance), its plasma half-life will be shorter, and vice versa.&lt;/li&gt;&lt;li&gt;â€¢ Plasma half-life is inversely related to clearance&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is inversely proportional to volume of distribution:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is inversely proportional to volume of distribution:&lt;/li&gt;&lt;li&gt;â€¢ This statement is actually a misunderstanding. Plasma half-life is not solely dependent on the volume of distribution . The relationship between half-life, volume of distribution, and clearance is given by the formula: half-life = (0.693 Ã— volume of distribution) / clearance. Thus, half-life is directly proportional to the volume of distribution and inversely proportional to clearance.&lt;/li&gt;&lt;li&gt;â€¢ Plasma half-life is not solely dependent on the volume of distribution&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For drugs eliminated via first-order kinetics , the plasma half-life remains constant because a fixed percentage of the drug is metabolized per unit time , regardless of the drug&#x27;s concentration in the plasma.&lt;/li&gt;&lt;li&gt;âž¤ drugs eliminated via first-order kinetics&lt;/li&gt;&lt;li&gt;âž¤ plasma half-life remains constant&lt;/li&gt;&lt;li&gt;âž¤ fixed percentage of the drug&lt;/li&gt;&lt;li&gt;âž¤ metabolized per unit time&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following set of drugs can be considered as physiological antagonists?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adrenaline and Isoprenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Histamine and adrenaline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isoprenaline and propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Histamine and adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Histamine and adrenaline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adrenaline and Isoprenaline : These are both sympathomimetic agents that act on adrenergic receptors , not physiological antagonists.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Adrenaline and Isoprenaline&lt;/li&gt;&lt;li&gt;â€¢ both sympathomimetic agents&lt;/li&gt;&lt;li&gt;â€¢ act on adrenergic receptors&lt;/li&gt;&lt;li&gt;â€¢ Option C. Isoprenaline and Propranolol : Isoprenaline is an agonist of Î²-adrenergic receptors , while propranolol is a Î²-adrenergic receptor antagonist. They are pharmacological antagonists because they bind to the same receptor with opposing actions.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Isoprenaline and Propranolol&lt;/li&gt;&lt;li&gt;â€¢ Isoprenaline&lt;/li&gt;&lt;li&gt;â€¢ agonist of Î²-adrenergic receptors&lt;/li&gt;&lt;li&gt;â€¢ Option D. All the above : This option is incorrect because it includes both physiological antagonists (histamine and adrenaline) and pharmacological antagonists (isoprenaline and propranolol).&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ All the above&lt;/li&gt;&lt;li&gt;â€¢ includes both physiological antagonists&lt;/li&gt;&lt;li&gt;â€¢ pharmacological antagonists&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Physiological antagonists are those that produce opposite action by acting on different receptors eg. Histamine and adrenaline&lt;/li&gt;&lt;li&gt;â€¢ Physiological antagonists&lt;/li&gt;&lt;li&gt;â€¢ produce opposite action&lt;/li&gt;&lt;li&gt;â€¢ acting on different receptors&lt;/li&gt;&lt;li&gt;â€¢ Histamine and adrenaline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pharmaceutical company is preparing an advertisement leaflet for a new medication that will be promoted to healthcare providers. As part of the regulatory compliance team, you are reviewing the content to ensure all necessary information is included and aligns with FDA guidelines for pharmaceutical advertising. Which of the following pieces of information is NOT required to be included in the drug advertisement leaflet intended for healthcare professionals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reference of research papers for the claims made by the company.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Expiry Date&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rare, but serious life-threatening adverse effects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Common, but not so serious adverse effects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Expiry Date&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Expiry Date&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ References to research papers&lt;/li&gt;&lt;li&gt;â€¢ Option C. Information on rare, but serious life-threatening adverse effects : This information is crucial and must be included to provide a complete risk assessment for the healthcare provider.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Information on rare, but serious life-threatening adverse effects&lt;/li&gt;&lt;li&gt;â€¢ provide a complete risk assessment&lt;/li&gt;&lt;li&gt;â€¢ healthcare provider.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Information on common, but less serious adverse effects : Knowing the side effect profile , including common and non-serious adverse effects , is essential for healthcare providers to make informed decisions about prescribing a drug.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Information on common, but less serious adverse effects&lt;/li&gt;&lt;li&gt;â€¢ side effect profile&lt;/li&gt;&lt;li&gt;â€¢ common and non-serious adverse effects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The expiry date is not required on promotional drug literature , as it varies by batch; instead, it is a crucial detail on the drug&#x27;s label for patient safety.&lt;/li&gt;&lt;li&gt;âž¤ expiry date&lt;/li&gt;&lt;li&gt;âž¤ not required on promotional drug literature&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new drug X is given orally to a healthy volunteer in a dose of 100 mg. Plasma concentration of the drug is measured at hourly intervals and a graph is plotted between plasma concentration and time as shown below in Fig. Which of the following statements about drug X is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Its Cmax is 20 Î¼g/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AUC from the above graph reflects the rate of absorption of the drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tmax for drug X is 7 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Instead of 100 mg drug X should be given in divided doses&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Instead of 100 mg drug X should be given in divided doses&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/24/12.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Instead of 100 mg, drug X should be given in divided doses.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Its Cmax is 20 Î¼g/dl : This is incorrect. Cmax refers to the peak plasma concentration of a drug after administration . In the graph, the Cmax appears to be higher than 20 Î¼g/dl, around 27 Î¼g/dl.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Its Cmax is 20 Î¼g/dl&lt;/li&gt;&lt;li&gt;â€¢ Cmax refers&lt;/li&gt;&lt;li&gt;â€¢ peak plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ drug after administration&lt;/li&gt;&lt;li&gt;â€¢ Option B . AUC from the above graph reflects the rate of absorption of the drug : This is incorrect. The area under the curve (AUC) is related to the extent of absorption of the drug into the systemic circulation , not the rate. The rate of absorption is typically inferred from the Tmax and the steepness of the curve leading up to Cmax.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ AUC from the above graph reflects the rate of absorption of the drug&lt;/li&gt;&lt;li&gt;â€¢ area under the curve&lt;/li&gt;&lt;li&gt;â€¢ extent of absorption of the drug&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tmax for drug X is 7 hours : This is incorrect. Tmax is the time it takes for a drug to reach its maximum concentration in plasma . In the graph, the Tmax seems to be 4 hours, not 7 hours.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Tmax for drug X is 7 hours&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ time it takes for a drug&lt;/li&gt;&lt;li&gt;â€¢ reach its maximum concentration&lt;/li&gt;&lt;li&gt;â€¢ plasma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ When a single dose of a drug results in a plasma concentration that exceeds the toxic threshold , the drug should be administered in divided doses to avoid toxicity .&lt;/li&gt;&lt;li&gt;âž¤ single dose of a drug&lt;/li&gt;&lt;li&gt;âž¤ plasma concentration&lt;/li&gt;&lt;li&gt;âž¤ exceeds the toxic threshold&lt;/li&gt;&lt;li&gt;âž¤ administered in divided doses&lt;/li&gt;&lt;li&gt;âž¤ avoid toxicity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of fungal infection is being treated with multiple medications. He is also taking a drug known to interact with several other medications by inhibiting hepatic cytochrome P450 enzymes, leading to increased concentrations of co-administered drugs. Which of the following drugs is most likely to cause such an interaction by inhibiting cytochrome P450 enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketoconazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ketoconazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-153907.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ketoconazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rifampicin : Incorrect. Rifampicin is a known inducer of cytochrome P450 enzymes , which can decrease plasma levels of drugs metabolized by these enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin&lt;/li&gt;&lt;li&gt;â€¢ inducer of cytochrome P450 enzymes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phenytoin : Incorrect. Phenytoin is also an inducer of cytochrome P450 enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Phenytoin&lt;/li&gt;&lt;li&gt;â€¢ inducer of cytochrome P450 enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenobarbitone : Incorrect. Phenobarbitone, like rifampicin and phenytoin, induces cytochrome P450 enzymes .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ induces cytochrome P450 enzymes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Ketoconazole is an inhibitor of cytochrome P450 enzymes , which can lead to increased concentrations of drugs metabolized by these enzymes when administered concomitantly .&lt;/li&gt;&lt;li&gt;âž¤ Ketoconazole&lt;/li&gt;&lt;li&gt;âž¤ inhibitor of cytochrome P450 enzymes&lt;/li&gt;&lt;li&gt;âž¤ lead to increased concentrations of drugs&lt;/li&gt;&lt;li&gt;âž¤ enzymes when administered concomitantly&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While reviewing the pharmacology of various medications, a medical student notes that drug-protein interactions can significantly influence the pharmacokinetics and effects of medications. Which of the following statements regarding drug-protein binding in the plasma is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acidic drugs bind to albumin in plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Basic drugs bind to alpha-1 acid glycoprotein in plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drugs having higher affinity for a plasma protein can displace the other drug from the same protein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sex steroid hormones do not bind to any protein in plasma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sex steroid hormones do not bind to any protein in plasma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Sex steroid hormones do not bind to any protein in plasma.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acidic drugs bind to albumin in plasma. This statement is correct . Acidic drugs often bind to albumin, which is the main protein in human blood plasma. Albumin carries a negative charge and can bind to various acidic drugs, affecting their distribution and availability in the body.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Acidic drugs bind to albumin in plasma.&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option B. Basic drugs bind to alpha-1 acid glycoprotein in plasma. This statement is also correct . Alpha-1 acid glycoprotein is a plasma protein that primarily binds to basic (positively charged) drugs. The binding affinity of drugs to this protein can influence their pharmacokinetics and pharmacodynamics.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Basic drugs bind to alpha-1 acid glycoprotein in plasma.&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option C. Drugs having higher affinity for a plasma protein can displace the other drug from the same protein. This statement is correct . If two drugs bind to the same plasma protein (like albumin) and one has a higher affinity for the protein, it can displace the other. This displacement can increase the concentration of the free (unbound) form of the displaced drug, potentially leading to increased activity or toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Drugs having higher affinity for a plasma protein can displace the other drug from the same protein.&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Sex steroid hormones do bind to plasma proteins , specifically to Sex Hormone Binding Globulin (SHBG) and albumin , which can influence their bioavailability and action in the body .&lt;/li&gt;&lt;li&gt;âž¤ Sex steroid hormones&lt;/li&gt;&lt;li&gt;âž¤ bind to plasma proteins&lt;/li&gt;&lt;li&gt;âž¤ Sex Hormone Binding Globulin&lt;/li&gt;&lt;li&gt;âž¤ albumin&lt;/li&gt;&lt;li&gt;âž¤ influence their bioavailability&lt;/li&gt;&lt;li&gt;âž¤ action in the body&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man with chronic angina is prescribed a medication that is known to undergo significant hepatic first-pass metabolism. Which of the following routes of drug administration would not bypass the hepatic first-pass effect for this medication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sublingual&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subcutaneous&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oral&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oral&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous : Incorrect. The intravenous route bypasses the hepatic first-pass effect by delivering the drug directly into the systemic circulation .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous&lt;/li&gt;&lt;li&gt;â€¢ intravenous route bypasses&lt;/li&gt;&lt;li&gt;â€¢ hepatic first-pass effect&lt;/li&gt;&lt;li&gt;â€¢ delivering the drug directly&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sublingual : Incorrect. The sublingual route bypasses the hepatic first-pass metabolism by allowing the drug to directly enter the systemic circulation via the oral mucosa.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Sublingual&lt;/li&gt;&lt;li&gt;â€¢ sublingual route bypasses&lt;/li&gt;&lt;li&gt;â€¢ hepatic first-pass metabolism&lt;/li&gt;&lt;li&gt;â€¢ Option D. Subcutaneous : Incorrect. The subcutaneous route bypasses the liver and allows the drug to slowly absorb into the systemic circulation .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Subcutaneous&lt;/li&gt;&lt;li&gt;â€¢ subcutaneous route bypasses&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ drug to slowly absorb&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The oral route of administration subjects drugs to hepatic first-pass metabolism , which can substantially reduce the bioavailability of drugs that are extensively metabolized by the liver .&lt;/li&gt;&lt;li&gt;âž¤ oral route&lt;/li&gt;&lt;li&gt;âž¤ administration subjects drugs&lt;/li&gt;&lt;li&gt;âž¤ hepatic first-pass metabolism&lt;/li&gt;&lt;li&gt;âž¤ reduce the bioavailability of drugs&lt;/li&gt;&lt;li&gt;âž¤ metabolized by the liver&lt;/li&gt;&lt;li&gt;âž¤ Drugs with high first pass metabolism include:&lt;/li&gt;&lt;li&gt;âž¤ L: Lignocaine&lt;/li&gt;&lt;li&gt;âž¤ P: Propranolol&lt;/li&gt;&lt;li&gt;âž¤ G: Glyceryl tri nitrate (nitroglycerine)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents to the clinic with symptoms of a malar rash, joint pain, and fatigue. She has no significant past medical history and reports that she started taking a medication for her recent diagnosis of tuberculosis. Additionally, she has been using an over-the-counter medication for occasional nasal congestion. She denies using any herbal supplements or illicit drugs. Her laboratory tests show positive antinuclear antibodies (ANA) and anti-histone antibodies. Which of the following drugs is not associated with causation of Drug induced lupus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphetamine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Amphetamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Amphetamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Isoniazid is an antitubercular medication that is known to cause drug-induced lupus erythematosus (DILE).&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid&lt;/li&gt;&lt;li&gt;â€¢ antitubercular medication&lt;/li&gt;&lt;li&gt;â€¢ cause drug-induced lupus erythematosus&lt;/li&gt;&lt;li&gt;â€¢ Option B: Procainamide , an antiarrhythmic agent , and hydralazine , an antihypertensive medication , are both well-documented causes of DILE.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Procainamide&lt;/li&gt;&lt;li&gt;â€¢ antiarrhythmic agent&lt;/li&gt;&lt;li&gt;â€¢ hydralazine&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive medication&lt;/li&gt;&lt;li&gt;â€¢ Option D: Amphetamines are central nervous system stimulants and are not typically associated with the induction of lupus .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Amphetamines&lt;/li&gt;&lt;li&gt;â€¢ central nervous system stimulants&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ associated with the induction of lupus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amphetamine is not associated with the causation of drug-induced lupus , in contrast to certain drugs like isoniazid, procainamide, and hydralazine , which are known to precipitate DILE.&lt;/li&gt;&lt;li&gt;âž¤ Amphetamine&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ causation of drug-induced lupus&lt;/li&gt;&lt;li&gt;âž¤ drugs like isoniazid, procainamide,&lt;/li&gt;&lt;li&gt;âž¤ hydralazine&lt;/li&gt;&lt;li&gt;âž¤ Most common drugs that precipitate a DILE or systemic lupus erythematosus like syndrome, including:&lt;/li&gt;&lt;li&gt;âž¤ Most common drugs that precipitate a DILE or systemic lupus erythematosus like syndrome, including:&lt;/li&gt;&lt;li&gt;âž¤ S: S ulfonamides&lt;/li&gt;&lt;li&gt;âž¤ S: S&lt;/li&gt;&lt;li&gt;âž¤ H: H ydralazine&lt;/li&gt;&lt;li&gt;âž¤ H: H&lt;/li&gt;&lt;li&gt;âž¤ I: I soniazid&lt;/li&gt;&lt;li&gt;âž¤ I: I&lt;/li&gt;&lt;li&gt;âž¤ P: P rocainamide&lt;/li&gt;&lt;li&gt;âž¤ P: P&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man is brought to the clinic by his wife due to concerns about the effectiveness of his medication regimen. He has been taking aspirin for his cardiovascular health, phenobarbitone for a seizure disorder, and diazepam as needed for anxiety. The patient also mentions he has been experiencing frequent bouts of diarrhea. The wife is concerned that the diarrhea may be affecting the absorption of his medications. Regarding the absorption profile of these drugs in relation to their acidic or basic nature and gastrointestinal transit time, which of the following statements is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin is present in mainly non-ionized form in the stomach, hence can be easily absorbed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam is mostly absorbed from the intestine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenobarbitone can be absorbed from the stomach but most of the absorption occurs in the small intestine due to its large surface area&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diseases decreasing the transit time of drugs like diarrhea will increase the drug absorption in the intestine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diseases decreasing the transit time of drugs like diarrhea will increase the drug absorption in the intestine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diseases decreasing the transit time of drugs like diarrhea will increase the drug absorption in the intestine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Aspirin , being an acidic drug , is non-ionized in the acidic environment of the stomach , which increases its lipid solubility and allows it to be easily absorbed through the gastric mucosa.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ non-ionized in the acidic environment&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ Option B: Diazepam , a basic drug, is more likely to be in a non-ionized, lipid-soluble form in the relatively higher pH of the intestine, facilitating its absorption there.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Diazepam&lt;/li&gt;&lt;li&gt;â€¢ non-ionized, lipid-soluble form&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phenobarbitone , although acidic, has a significant amount of absorption in the intestine due to the larger surface area and longer transit time compared to the stomach.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ amount of absorption in the intestine&lt;/li&gt;&lt;li&gt;â€¢ larger surface area&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diseases which decrease the transit time in the intestine , such as diarrhea , typically reduce the absorption of drugs .&lt;/li&gt;&lt;li&gt;âž¤ Diseases&lt;/li&gt;&lt;li&gt;âž¤ decrease the transit time&lt;/li&gt;&lt;li&gt;âž¤ intestine&lt;/li&gt;&lt;li&gt;âž¤ diarrhea&lt;/li&gt;&lt;li&gt;âž¤ reduce the absorption of drugs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does IP in the figure shown stands for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug is an instant release preparation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Meant for intra pulmonary use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The standards according to Indian Pharmacopoeia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug tested preclinically via Intraperitoneal route&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The standards according to Indian Pharmacopoeia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/24/10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The standards according to Indian Pharmacopoeia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A : \&quot;Instant release preparation\&quot; refers to the formulation of the drug that affects how quickly it is released into the bloodstream; however, \&quot;IP\&quot; does not indicate this.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Instant release preparation\&quot;&lt;/li&gt;&lt;li&gt;â€¢ formulation of the drug&lt;/li&gt;&lt;li&gt;â€¢ how quickly it is released into the bloodstream;&lt;/li&gt;&lt;li&gt;â€¢ Option B : \&quot;Intra pulmonary use\&quot; suggests that the drug is to be used within the lungs , typically inhalation drugs fall under this category, but \&quot;IP\&quot; does not denote this.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Intra pulmonary use\&quot;&lt;/li&gt;&lt;li&gt;â€¢ drug is to be used within the lungs&lt;/li&gt;&lt;li&gt;â€¢ Option D : \&quot;Intraperitoneal route \&quot; is a method of drug administration used in research, but \&quot;IP\&quot; on a drug package does not relate to this.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Intraperitoneal route&lt;/li&gt;&lt;li&gt;â€¢ method of drug administration&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;IP\&quot; on a medication package indicates that the drug conforms to the standards set by the Indian Pharmacopoeia.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;IP\&quot; on a medication package&lt;/li&gt;&lt;li&gt;âž¤ drug conforms to the standards set by the Indian Pharmacopoeia.&lt;/li&gt;&lt;li&gt;âž¤ IP stands for Indian Pharmacopoeia BP: British Pharmacopoeia USP: United Nations Pharmacopoeia BNF: British National Formulary&lt;/li&gt;&lt;li&gt;âž¤ IP stands for Indian Pharmacopoeia&lt;/li&gt;&lt;li&gt;âž¤ BP: British Pharmacopoeia&lt;/li&gt;&lt;li&gt;âž¤ USP: United Nations Pharmacopoeia&lt;/li&gt;&lt;li&gt;âž¤ BNF: British National Formulary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male is brought to the emergency department after ingesting an overdose of a medication. In order to enhance drug clearance, you consider the modification of urinary pH as a therapeutic measure. Knowing that manipulating the urinary pH can increase the excretion of certain drugs by altering their ionization state, which of the following drugs would not have its excretion increased by alkalinization of the urine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Morphine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Morphine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin : Aspirin (acetylsalicylic acid) is an acidic drug . Alkalinizing the urine with agents such as sodium bicarbonate can enhance its ionization and excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate : This is also an acidic drug , and alkalinization of the urine will increase its ionization , decreasing reabsorption and increasing elimination.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ alkalinization of the urine will increase its ionization&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenobarbitone : This is an acidic drug , and like aspirin and methotrexate , it is more ionized in alkaline urine, leading to increased excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ aspirin and methotrexate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of drug overdose , urinary alkalinization is utilized to increase the excretion of acidic drugs by enhancing their ionization , which does not apply to basic drugs like morphine that are better excreted in acidic conditions. Remember, the drugs ending with â€˜ineâ€™ are basic.&lt;/li&gt;&lt;li&gt;âž¤ drug overdose&lt;/li&gt;&lt;li&gt;âž¤ urinary alkalinization&lt;/li&gt;&lt;li&gt;âž¤ increase the excretion of acidic drugs&lt;/li&gt;&lt;li&gt;âž¤ enhancing their ionization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man with a history of chronic obstructive pulmonary disease (COPD) and hypertension is being managed in an outpatient clinic. He has been prescribed a nonselective beta-blocker to manage his hypertension. Based on the receptor shown in the figure, which of the following drugs prescribed to the patient acts through this type of receptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucocorticoids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Estrogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicotine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/24/7_ybtpG0K.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glucocorticoids: Act through cytoplasmic receptors that, upon activation , translocate to the nucleus to affect gene transcription .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Glucocorticoids:&lt;/li&gt;&lt;li&gt;â€¢ cytoplasmic receptors&lt;/li&gt;&lt;li&gt;â€¢ upon activation&lt;/li&gt;&lt;li&gt;â€¢ translocate to the nucleus&lt;/li&gt;&lt;li&gt;â€¢ affect gene transcription&lt;/li&gt;&lt;li&gt;â€¢ Option B. Estrogen: Binds to nuclear receptors which directly interact with DNA to regulate gene expression .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Estrogen: Binds to nuclear receptors&lt;/li&gt;&lt;li&gt;â€¢ directly interact with DNA to regulate gene expression&lt;/li&gt;&lt;li&gt;â€¢ Option D . Nicotine: Primarily acts through nicotinic acetylcholine receptors , which are ionotropic receptors, not GPCRs.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Nicotine:&lt;/li&gt;&lt;li&gt;â€¢ nicotinic acetylcholine receptors&lt;/li&gt;&lt;li&gt;â€¢ ionotropic receptors,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Propranolol acts via G-protein coupled receptors , which are characterized by their seven-transmembrane domain structure .&lt;/li&gt;&lt;li&gt;âž¤ Propranolol acts via G-protein coupled receptors&lt;/li&gt;&lt;li&gt;âž¤ seven-transmembrane domain structure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in mean arterial pressure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased renal perfusion and reduced urine output&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increase in mean arterial pressure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increase in mean arterial pressure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase in heart rate - Not the best indicator for the efficacy of nor-epinephrine in septic shock , as the drug may actually lead to a reflex bradycardia due to increased blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase in heart rate&lt;/li&gt;&lt;li&gt;â€¢ Not the best indicator&lt;/li&gt;&lt;li&gt;â€¢ nor-epinephrine in septic shock&lt;/li&gt;&lt;li&gt;â€¢ reflex bradycardia due to increased blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decrease in heart rate - While nor-epinephrine can cause a reflex decrease in heart rate due to increased blood pressure, it&#x27;s not the primary indicator of therapeutic response in septic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decrease in heart rate&lt;/li&gt;&lt;li&gt;â€¢ nor-epinephrine&lt;/li&gt;&lt;li&gt;â€¢ reflex decrease in heart rate&lt;/li&gt;&lt;li&gt;â€¢ increased blood pressure,&lt;/li&gt;&lt;li&gt;â€¢ not the primary indicator&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased renal perfusion and reduced urine output - These are potential adverse effects of nor-epinephrine due to its vasoconstrictive action , not indicators of a positive therapeutic response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased renal perfusion and reduced urine output&lt;/li&gt;&lt;li&gt;â€¢ potential adverse effects of nor-epinephrine&lt;/li&gt;&lt;li&gt;â€¢ vasoconstrictive action&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ positive therapeutic response.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The effectiveness of nor-epinephrine in the management of septic shock is best monitored by an increase in mean arterial pressure , aiming to maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg to ensure adequate organ perfusion .&lt;/li&gt;&lt;li&gt;â€¢ nor-epinephrine&lt;/li&gt;&lt;li&gt;â€¢ septic shock&lt;/li&gt;&lt;li&gt;â€¢ monitored&lt;/li&gt;&lt;li&gt;â€¢ increase in mean arterial pressure&lt;/li&gt;&lt;li&gt;â€¢ maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ adequate organ perfusion&lt;/li&gt;&lt;li&gt;â€¢ Ref: Harrison 19 th /1761&lt;/li&gt;&lt;li&gt;â€¢ Ref:&lt;/li&gt;&lt;li&gt;â€¢ Harrison 19 th /1761&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old farm worker is rushed to a nearby emergency department after an accidental exposure to parathion. Which of the following drugs can be given to increase the activity of his acetyl cholinesterase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dimercaprol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pralidoxime&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pralidoxime&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pralidoxime&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atropine: Atropine is drug of choice as an antidote in organophosphate poisoning , but it does not increase the activity of acetylcholinesterase. Instead, it serves to counteract the effects of excess acetylcholine on muscarinic receptors , thereby relieving symptoms such as bradycardia, salivation, and bronchoconstriction. Atropine does not affect the nicotinic receptor-mediated effects (e.g., muscle weakness, paralysis).&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Atropine:&lt;/li&gt;&lt;li&gt;â€¢ Atropine&lt;/li&gt;&lt;li&gt;â€¢ drug of choice&lt;/li&gt;&lt;li&gt;â€¢ antidote in organophosphate poisoning&lt;/li&gt;&lt;li&gt;â€¢ does not increase&lt;/li&gt;&lt;li&gt;â€¢ acetylcholinesterase.&lt;/li&gt;&lt;li&gt;â€¢ serves to counteract the effects&lt;/li&gt;&lt;li&gt;â€¢ acetylcholine on muscarinic receptors&lt;/li&gt;&lt;li&gt;â€¢ bradycardia, salivation, and bronchoconstriction. Atropine does not&lt;/li&gt;&lt;li&gt;â€¢ nicotinic receptor-mediated&lt;/li&gt;&lt;li&gt;â€¢ effects (e.g., muscle weakness, paralysis).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dimercaprol: Dimercaprol is a chelating agent used in the treatment of poisoning by heavy metals , such as arsenic, lead, and mercury . It is not used in the treatment of organophosphate poisoning and does not i ncrease acetylcholinesterase activity .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Dimercaprol:&lt;/li&gt;&lt;li&gt;â€¢ agent&lt;/li&gt;&lt;li&gt;â€¢ poisoning by heavy metals&lt;/li&gt;&lt;li&gt;â€¢ arsenic, lead, and mercury&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ organophosphate poisoning&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ ncrease acetylcholinesterase activity&lt;/li&gt;&lt;li&gt;â€¢ Option C . Physostigmine: Physostigmine is a cholinesterase inhibitor, and unlike pralidoxime, it would exacerbate the effects of organophosphate poisoning by further inhibiting acetylcholinesterase. Therefore, it is not used in the treatment of organophosphate poisoning and is contraindicated in such cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Physostigmine:&lt;/li&gt;&lt;li&gt;â€¢ cholinesterase inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ unlike pralidoxime,&lt;/li&gt;&lt;li&gt;â€¢ organophosphate poisoning&lt;/li&gt;&lt;li&gt;â€¢ inhibiting acetylcholinesterase.&lt;/li&gt;&lt;li&gt;â€¢ not used&lt;/li&gt;&lt;li&gt;â€¢ organophosphate poisoning&lt;/li&gt;&lt;li&gt;â€¢ contraindicated in such cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pralidoxime is used to reactivate acetylcholinesterase inhibited by organophosphates, thereby r educing the toxic accumulation of acetylcholine . This treatment, often used in conjunction with atropine to manage muscarinic symptoms, is critical in the management of organophosphate poisoning, highlighting the importance of specific antidotes in toxicological emergencies.&lt;/li&gt;&lt;li&gt;âž¤ Pralidoxime&lt;/li&gt;&lt;li&gt;âž¤ reactivate acetylcholinesterase&lt;/li&gt;&lt;li&gt;âž¤ educing the toxic accumulation of&lt;/li&gt;&lt;li&gt;âž¤ acetylcholine&lt;/li&gt;&lt;li&gt;âž¤ conjunction with atropine to manage muscarinic symptoms,&lt;/li&gt;&lt;li&gt;âž¤ organophosphate poisoning,&lt;/li&gt;&lt;li&gt;âž¤ specific antidotes in toxicological emergencies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child opened his fatherâ€™s drawer and ingested multiple tablets of his cardiac medication, metoprolol. The child was brought to hospital with profound hypotension and bradycardia. What is the specific antidote used in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nor-adrenaline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glucagon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glucagon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In cases of beta-blocker overdose , such as with metoprolol , the specific antidote is glucagon . It works by increasing cyclic AMP independently of the beta-adrenergic receptors , thereby improving heart rate and contractility despite the beta-blockade. Understanding the role of glucagon and its mechanism of action is crucial in managing beta-blocker toxicity effectively .&lt;/li&gt;&lt;li&gt;âž¤ beta-blocker overdose&lt;/li&gt;&lt;li&gt;âž¤ metoprolol&lt;/li&gt;&lt;li&gt;âž¤ glucagon&lt;/li&gt;&lt;li&gt;âž¤ increasing&lt;/li&gt;&lt;li&gt;âž¤ cyclic AMP independently&lt;/li&gt;&lt;li&gt;âž¤ beta-adrenergic receptors&lt;/li&gt;&lt;li&gt;âž¤ improving heart rate and contractility&lt;/li&gt;&lt;li&gt;âž¤ beta-blockade.&lt;/li&gt;&lt;li&gt;âž¤ role of glucagon&lt;/li&gt;&lt;li&gt;âž¤ managing beta-blocker toxicity effectively&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Repeated administration of a drug produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nicotinic actions of acetylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Biphasic response of adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tachyphylaxis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tachyphylaxis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nicotinic actions of acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nicotinic actions of acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ This is not the correct answer . The nicotinic actions of acetylcholine refer to the effect acetylcholine has on nicotinic acetylcholine receptors, which are ligand-gated ion channels found in the nervous system and at the neuromuscular junction . Normally acetylcholine decreases blood pressure and heart rate due to its action of muscarinic receptors. However, if we give very high dose of acetylcholine after giving atropine (to block muscarinic receptors), then it shows increase in BP and heart rate . This is due to the action of acetylcholine on nicotinic receptors present on ganglia&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ correct answer&lt;/li&gt;&lt;li&gt;â€¢ nicotinic actions&lt;/li&gt;&lt;li&gt;â€¢ acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ nicotinic acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ receptors,&lt;/li&gt;&lt;li&gt;â€¢ ligand-gated ion channels&lt;/li&gt;&lt;li&gt;â€¢ nervous system and at the neuromuscular junction&lt;/li&gt;&lt;li&gt;â€¢ acetylcholine decreases blood pressure and heart rate&lt;/li&gt;&lt;li&gt;â€¢ muscarinic receptors.&lt;/li&gt;&lt;li&gt;â€¢ very high dose of acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ atropine (to block muscarinic receptors),&lt;/li&gt;&lt;li&gt;â€¢ increase in BP and heart rate&lt;/li&gt;&lt;li&gt;â€¢ acetylcholine on nicotinic receptors&lt;/li&gt;&lt;li&gt;â€¢ ganglia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Biphasic response of adrenaline&lt;/li&gt;&lt;li&gt;â€¢ Option C. Biphasic response of adrenaline&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. A biphasic response to adrenaline would involve an initial phase in which there is increase in blood pressure (due to stimulation of alpha 1 receptors) followed by a second phase in which there is fall in blood pressure (due to action on beta 2 receptors). The tracing does not show a biphasic response; it shows a series of responses that diminish over time, consistent with tachyphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ biphasic response&lt;/li&gt;&lt;li&gt;â€¢ adrenaline&lt;/li&gt;&lt;li&gt;â€¢ initial phase&lt;/li&gt;&lt;li&gt;â€¢ increase in blood pressure (due to stimulation of alpha 1 receptors)&lt;/li&gt;&lt;li&gt;â€¢ second phase&lt;/li&gt;&lt;li&gt;â€¢ blood pressure (due to action on beta 2 receptors).&lt;/li&gt;&lt;li&gt;â€¢ tracing does not&lt;/li&gt;&lt;li&gt;â€¢ biphasic response;&lt;/li&gt;&lt;li&gt;â€¢ series of responses&lt;/li&gt;&lt;li&gt;â€¢ diminish over time, consistent&lt;/li&gt;&lt;li&gt;â€¢ tachyphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vasomotor reversal of Dale&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vasomotor reversal of Dale&lt;/li&gt;&lt;li&gt;â€¢ Vasomotor reversal of Dale is a phenomenon where adrenaline can produce a paradoxical decrease in blood pressure due to stimulation of vasodilatory beta-adrenergic receptors , especially after pre-treatment with drugs that block alpha-adrenergic receptors. This is not what is depicted in the tracing.&lt;/li&gt;&lt;li&gt;â€¢ Vasomotor reversal of Dale&lt;/li&gt;&lt;li&gt;â€¢ adrenaline&lt;/li&gt;&lt;li&gt;â€¢ paradoxical decrease in blood pressure&lt;/li&gt;&lt;li&gt;â€¢ stimulation of vasodilatory beta-adrenergic receptors&lt;/li&gt;&lt;li&gt;â€¢ pre-treatment with drugs&lt;/li&gt;&lt;li&gt;â€¢ block alpha-adrenergic receptors.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Based on the image, the correct answer is:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Tachyphylaxis is a diminishing response to repeated administrations of the same dose of a drug over a short period. This is a common pharmacological phenomenon often seen with drugs that act on receptors or other cellular targets that can become desensitized or down-regulated with frequent stimulation .&lt;/li&gt;&lt;li&gt;â€¢ Tachyphylaxis is&lt;/li&gt;&lt;li&gt;â€¢ diminishing response&lt;/li&gt;&lt;li&gt;â€¢ repeated administrations&lt;/li&gt;&lt;li&gt;â€¢ act on receptors or other cellular targets&lt;/li&gt;&lt;li&gt;â€¢ desensitized or down-regulated with frequent stimulation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patients would not benefit from the use of beta blockers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;64-year-old female with frequent attacks of migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;56-year-old male with erectile dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;74-year-old male with history of compensated heart failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 56-year-old male with erectile dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 56-year-old male with erectile dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 64-year-old female with frequent attacks of migraine:&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ prophylaxis of&lt;/li&gt;&lt;li&gt;â€¢ migraines&lt;/li&gt;&lt;li&gt;â€¢ reduce the frequency&lt;/li&gt;&lt;li&gt;â€¢ severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors:&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ useful&lt;/li&gt;&lt;li&gt;â€¢ hyperthyroidism&lt;/li&gt;&lt;li&gt;â€¢ tachycardia and tremors&lt;/li&gt;&lt;li&gt;â€¢ blocking the effects&lt;/li&gt;&lt;li&gt;â€¢ excess&lt;/li&gt;&lt;li&gt;â€¢ hyroid hormones on the heart and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 74-year-old male with history of compensated heart failure:&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ heart failure&lt;/li&gt;&lt;li&gt;â€¢ mprove survival and reduce&lt;/li&gt;&lt;li&gt;â€¢ hospitalization&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ failure,&lt;/li&gt;&lt;li&gt;â€¢ history of compensated heart failure,&lt;/li&gt;&lt;li&gt;â€¢ carefully selected and dosed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the indications and contraindications for beta-blocker therapy . While beta-blockers are versatile medications with a broad range of clinical applications , their potential side effects, such as exacerbating erectile dysfunction , must be considered when prescribing these drugs to ensure they align with the patient&#x27;s overall health status and medical needs.&lt;/li&gt;&lt;li&gt;âž¤ indications and contraindications&lt;/li&gt;&lt;li&gt;âž¤ beta-blocker therapy&lt;/li&gt;&lt;li&gt;âž¤ beta-blockers are versatile&lt;/li&gt;&lt;li&gt;âž¤ medications&lt;/li&gt;&lt;li&gt;âž¤ broad range of clinical applications&lt;/li&gt;&lt;li&gt;âž¤ potential side effects,&lt;/li&gt;&lt;li&gt;âž¤ exacerbating erectile dysfunction&lt;/li&gt;&lt;li&gt;âž¤ prescribing these drugs to ensure they align&lt;/li&gt;&lt;li&gt;âž¤ health status and medical needs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cholinomimetic drugs can be used for the treatment of all the following conditions except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Closed angle glaucoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cobra bite&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120058.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bradycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct Usage - Closed angle glaucoma : is treated with drugs like Physostigmine and Pilocarpine to increase aqueous humor outflow .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct Usage - Closed angle glaucoma&lt;/li&gt;&lt;li&gt;â€¢ Physostigmine and Pilocarpine to increase aqueous humor outflow&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct Usage - For a cobra bite: Neostigmine plus atropine is used to counteract the neuromuscular blockade caused by the venom .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct Usage - For a cobra bite:&lt;/li&gt;&lt;li&gt;â€¢ Neostigmine plus atropine&lt;/li&gt;&lt;li&gt;â€¢ counteract the neuromuscular blockade&lt;/li&gt;&lt;li&gt;â€¢ venom&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct Usage - In Myasthenia gravis: drugs such as Neostigmine are used to enhance neuromuscular transmission by preventing the breakdown of acetylcholine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct Usage - In Myasthenia gravis:&lt;/li&gt;&lt;li&gt;â€¢ Neostigmine&lt;/li&gt;&lt;li&gt;â€¢ neuromuscular transmission&lt;/li&gt;&lt;li&gt;â€¢ breakdown of acetylcholine.&lt;/li&gt;&lt;li&gt;â€¢ Additional Uses of Cholinergic Drugs:&lt;/li&gt;&lt;li&gt;â€¢ Additional Uses of Cholinergic Drugs:&lt;/li&gt;&lt;li&gt;â€¢ Alzheimerâ€™s disease treatment with Donepezil, Rivastigmine, and Galantamine to increase acetylcholine in the brain. Management of xerostomia with drugs like Cevimeline to stimulate salivary gland secretion . Postoperative urinary retention and paralytic ileus managed with drugs like Bethanechol and Neostigmine to stimulate the bladder detrusor muscle and GI motility . Antidote for anticholinergic poisoning with Physostigmine to counteract muscarinic receptor blockade.&lt;/li&gt;&lt;li&gt;â€¢ Alzheimerâ€™s disease treatment with Donepezil, Rivastigmine, and Galantamine to increase acetylcholine in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Alzheimerâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Donepezil, Rivastigmine, and Galantamine&lt;/li&gt;&lt;li&gt;â€¢ increase acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ Management of xerostomia with drugs like Cevimeline to stimulate salivary gland secretion .&lt;/li&gt;&lt;li&gt;â€¢ xerostomia&lt;/li&gt;&lt;li&gt;â€¢ Cevimeline&lt;/li&gt;&lt;li&gt;â€¢ salivary gland secretion&lt;/li&gt;&lt;li&gt;â€¢ Postoperative urinary retention and paralytic ileus managed with drugs like Bethanechol and Neostigmine to stimulate the bladder detrusor muscle and GI motility .&lt;/li&gt;&lt;li&gt;â€¢ Postoperative urinary retention&lt;/li&gt;&lt;li&gt;â€¢ paralytic ileus&lt;/li&gt;&lt;li&gt;â€¢ Bethanechol and Neostigmine&lt;/li&gt;&lt;li&gt;â€¢ bladder detrusor muscle and GI motility&lt;/li&gt;&lt;li&gt;â€¢ Antidote for anticholinergic poisoning with Physostigmine to counteract muscarinic receptor blockade.&lt;/li&gt;&lt;li&gt;â€¢ Antidote for anticholinergic poisoning&lt;/li&gt;&lt;li&gt;â€¢ Physostigmine&lt;/li&gt;&lt;li&gt;â€¢ muscarinic receptor blockade.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Cholinomimetic drugs are not used for the treatment of bradycardia due to their potential to cause a decrease in heart rate . They are, however, useful in treating various other conditions where increased cholinergic action is beneficial, such as closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimerâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Cholinomimetic drugs&lt;/li&gt;&lt;li&gt;â€¢ not used&lt;/li&gt;&lt;li&gt;â€¢ bradycardia&lt;/li&gt;&lt;li&gt;â€¢ decrease in heart rate&lt;/li&gt;&lt;li&gt;â€¢ increased cholinergic action&lt;/li&gt;&lt;li&gt;â€¢ closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimerâ€™s disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient present with diabetic macular edema with glaucoma. Which of the following drug should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prostaglandin analogues&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prostaglandin analogues&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115656.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prostaglandin analogues&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha agonists: These are not primarily associated with exacerbation of macular edema .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha agonists:&lt;/li&gt;&lt;li&gt;â€¢ not primarily&lt;/li&gt;&lt;li&gt;â€¢ exacerbation of macular edema&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetazolamide :  A carbonic anhydrase inhibitor, not typically associated with causing or worsening macular edema .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetazolamide&lt;/li&gt;&lt;li&gt;â€¢ carbonic anhydrase inhibitor, not&lt;/li&gt;&lt;li&gt;â€¢ causing or worsening macular edema&lt;/li&gt;&lt;li&gt;â€¢ Option C. Beta blockers: Commonly used in glaucoma to reduce intraocular pressure without affecting macular edema.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Beta blockers:&lt;/li&gt;&lt;li&gt;â€¢ Commonly used in glaucoma&lt;/li&gt;&lt;li&gt;â€¢ reduce intraocular pressure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandin analogues can worsen macular edema and therefore should be avoided in patients with diabetic macular edema.&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandin analogues&lt;/li&gt;&lt;li&gt;âž¤ worsen macular edema&lt;/li&gt;&lt;li&gt;âž¤ avoided in patients with diabetic macular edema.&lt;/li&gt;&lt;li&gt;âž¤ Important adverse effects of anti-glaucoma drugs&lt;/li&gt;&lt;li&gt;âž¤ adverse effects of anti-glaucoma drugs&lt;/li&gt;&lt;li&gt;âž¤ Ref : KDT 8 th /169&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : KDT 8 th /169&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pharmacological experiment was conducted to study effect of three drugs on heart rate and blood pressure. The following graphs were obtained before and after giving the drug. Which of the following statements is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A in the graph is epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The effect on heart rate in graph A can be prevented by anti-muscarinic agents&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug acting on graph B is isoprenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug acting in the graph C is nor-epinephrine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The effect on heart rate in graph A can be prevented by anti-muscarinic agents&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) The effect on heart rate in graph A can be prevented by anti-muscarinic agents&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug A in the graph can be epinephrine: This is incorrect since epinephrine usually increases heart rate due to its beta-1 stimulatory effect.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Drug A in the graph can be epinephrine:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ epinephrine&lt;/li&gt;&lt;li&gt;â€¢ increases heart rate&lt;/li&gt;&lt;li&gt;â€¢ beta-1&lt;/li&gt;&lt;li&gt;â€¢ stimulatory effect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The drug acting on graph B is isoprenaline: This statement is incorrect because isoprenaline (also known as isoproterenol) is a non-selective beta-adrenergic agonist that can increase SBP but decrease DBP and MBP. Rather the graph shown is typically present in epinephrine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The drug acting on graph B is isoprenaline:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ isoprenaline (also known as isoproterenol)&lt;/li&gt;&lt;li&gt;â€¢ non-selective beta-adrenergic agonist&lt;/li&gt;&lt;li&gt;â€¢ increase SBP&lt;/li&gt;&lt;li&gt;â€¢ decrease DBP&lt;/li&gt;&lt;li&gt;â€¢ MBP.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The drug acting in graph C is norepinephrine: This statement is incorrect because norepinephrine primarily increases SBP, DBP and MBP and cause reflex tachycardia. The graph shown is typically present in isoprenaline.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The drug acting in graph C is norepinephrine:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ norepinephrine&lt;/li&gt;&lt;li&gt;â€¢ increases SBP,&lt;/li&gt;&lt;li&gt;â€¢ DBP and MBP&lt;/li&gt;&lt;li&gt;â€¢ reflex tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ graph shown&lt;/li&gt;&lt;li&gt;â€¢ isoprenaline.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Anti-muscarinic agents can prevent the reflex bradycardia induced by vasoconstrictive drugs like norepinephrine by inhibiting the parasympathetic nervous system&#x27;s control over the heart.&lt;/li&gt;&lt;li&gt;â€¢ Anti-muscarinic agents&lt;/li&gt;&lt;li&gt;â€¢ reflex bradycardia&lt;/li&gt;&lt;li&gt;â€¢ vasoconstrictive drugs&lt;/li&gt;&lt;li&gt;â€¢ norepinephrine&lt;/li&gt;&lt;li&gt;â€¢ parasympathetic nervous system&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ over the heart.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Goodman and Gilman 12th/283&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Goodman and Gilman 12th/283&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the management of anaphylactic shock, which of the following action of adrenaline is not required?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchodilation by beta-2 receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiovascular effects of beta-1 receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Action on blood vessels by alpha-1 receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Action on presynaptic alpha-2 receptors&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Action on presynaptic alpha-2 receptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Action on presynaptic alpha-2 receptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchodilation by beta-2 receptors is vital for reversing airway constriction in anaphylaxis .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bronchodilation&lt;/li&gt;&lt;li&gt;â€¢ beta-2 receptors&lt;/li&gt;&lt;li&gt;â€¢ airway constriction&lt;/li&gt;&lt;li&gt;â€¢ anaphylaxis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiovascular effects of beta-1 receptors are crucial for supporting heart function during shock .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiovascular&lt;/li&gt;&lt;li&gt;â€¢ beta-1 receptors&lt;/li&gt;&lt;li&gt;â€¢ heart function during shock&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vasoconstriction by alpha-1 receptors is necessary to counteract the profound vasodilation and hypotension seen in anaphylactic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vasoconstriction&lt;/li&gt;&lt;li&gt;â€¢ alpha-1 receptors&lt;/li&gt;&lt;li&gt;â€¢ counteract&lt;/li&gt;&lt;li&gt;â€¢ vasodilation and hypotension&lt;/li&gt;&lt;li&gt;â€¢ anaphylactic shock.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The presynaptic alpha-2 receptor action of adrenaline, which would normally inhibit norepinephrine release and dampen sympathetic responses , is not desired in the treatment of anaphylactic shock , where a strong sympathetic response is needed to combat severe allergic reactions.&lt;/li&gt;&lt;li&gt;â€¢ presynaptic alpha-2 receptor&lt;/li&gt;&lt;li&gt;â€¢ adrenaline,&lt;/li&gt;&lt;li&gt;â€¢ inhibit norepinephrine&lt;/li&gt;&lt;li&gt;â€¢ dampen&lt;/li&gt;&lt;li&gt;â€¢ sympathetic responses&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ anaphylactic shock&lt;/li&gt;&lt;li&gt;â€¢ strong sympathetic&lt;/li&gt;&lt;li&gt;â€¢ allergic reactions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man came with urinary symptoms of increased frequency and hesitation. The patient was diagnosed with benign hyperplasia of prostate. Which of the drugs will help to prevent further growth and possibly reduces the size of the prostate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tamsulosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Finasteride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Testosterone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Finasteride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Finasteride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tamsulosin: This medication is an alpha-1A antagonist that relaxes the muscles in the prostate and bladder neck, improving urine flow, but does not affect prostate size.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tamsulosin:&lt;/li&gt;&lt;li&gt;â€¢ alpha-1A antagonist&lt;/li&gt;&lt;li&gt;â€¢ relaxes the muscles&lt;/li&gt;&lt;li&gt;â€¢ prostate and bladder neck,&lt;/li&gt;&lt;li&gt;â€¢ improving urine flow,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ prostate size.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prazosin: While this non-selective alpha-1 antagonist can improve symptoms of benign prostatic hyperplasia (BPH ) by relaxing prostate and bladder neck muscles, it doesn&#x27;t reduce prostate size and is noted for causing postural hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prazosin:&lt;/li&gt;&lt;li&gt;â€¢ non-selective alpha-1 antagonist&lt;/li&gt;&lt;li&gt;â€¢ benign prostatic hyperplasia (BPH&lt;/li&gt;&lt;li&gt;â€¢ relaxing prostate and bladder neck muscles,&lt;/li&gt;&lt;li&gt;â€¢ doesn&#x27;t reduce prostate size&lt;/li&gt;&lt;li&gt;â€¢ causing postural hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Testosterone: Administration of testosterone can actually exacerbate BPH due to its conversion to DHT within the prostate, leading to further growth.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Testosterone:&lt;/li&gt;&lt;li&gt;â€¢ exacerbate BPH&lt;/li&gt;&lt;li&gt;â€¢ conversion to DHT&lt;/li&gt;&lt;li&gt;â€¢ prostate,&lt;/li&gt;&lt;li&gt;â€¢ further growth.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a patient diagnosed with BPH, finasteride is the drug of choice to not only alleviate urinary symptoms but also potentially reduce prostate size due to its mechanism of inhibiting the enzyme 5-alpha reductase and lowering intraprostatic DHT levels.&lt;/li&gt;&lt;li&gt;âž¤ BPH, finasteride&lt;/li&gt;&lt;li&gt;âž¤ drug of choice&lt;/li&gt;&lt;li&gt;âž¤ alleviate urinary symptoms&lt;/li&gt;&lt;li&gt;âž¤ reduce prostate size&lt;/li&gt;&lt;li&gt;âž¤ inhibiting the enzyme 5-alpha reductase&lt;/li&gt;&lt;li&gt;âž¤ lowering intraprostatic DHT levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an indication of an anticholinesterase drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parkinsonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Guillain Barre syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To produce mydriasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alzheimerâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alzheimerâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Parkinsonism - Incorrect because the primary neurotransmitter affected in Parkinsonism is dopamine, not acetylcholine.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Parkinsonism&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ primary neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ Parkinsonism is dopamine,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Guillain Barre syndrome - Incorrect as this is an autoimmune condition affecting peripheral nerves , and anticholinesterase drugs are not the mainstay of treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Guillain Barre syndrome&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ autoimmune condition&lt;/li&gt;&lt;li&gt;â€¢ peripheral nerves&lt;/li&gt;&lt;li&gt;â€¢ anticholinesterase drugs&lt;/li&gt;&lt;li&gt;â€¢ Option D. To produce mydriasis - Incorrect because anticholinesterase drugs do not produce mydriasis ; they are used to treat conditions like glaucoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. To produce mydriasis&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ anticholinesterase drugs do not produce mydriasis&lt;/li&gt;&lt;li&gt;â€¢ treat&lt;/li&gt;&lt;li&gt;â€¢ glaucoma.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Anticholinesterase drugs are used in the treatment of Alzheimerâ€™s disease to increase the levels of acetylcholine in the brain, which helps in improving the cognitive symptoms of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Anticholinesterase drugs&lt;/li&gt;&lt;li&gt;â€¢ Alzheimerâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ increase the levels of acetylcholine&lt;/li&gt;&lt;li&gt;â€¢ brain,&lt;/li&gt;&lt;li&gt;â€¢ improving the cognitive symptoms&lt;/li&gt;&lt;li&gt;â€¢ disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is the new Î²3 agonist approved for overactive bladder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fesoterodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trospium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mirabegron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxybutynin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mirabegron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mirabegron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fesoterodine - Incorrect , it is an antimuscarinic agent used for overactive bladder but not a Î²3 agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fesoterodine&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic agent&lt;/li&gt;&lt;li&gt;â€¢ overactive bladder&lt;/li&gt;&lt;li&gt;â€¢ not a Î²3 agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trospium - Incorrect , also an antimuscarinic , not a Î²3 agonist .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trospium&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic&lt;/li&gt;&lt;li&gt;â€¢ not a Î²3 agonist&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxybutynin - Incorrect, this is an older antimuscarinic drug used for overactive bladder .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxybutynin&lt;/li&gt;&lt;li&gt;â€¢ - Incorrect,&lt;/li&gt;&lt;li&gt;â€¢ older antimuscarinic drug&lt;/li&gt;&lt;li&gt;â€¢ overactive bladder&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Mirabegron is the first Î²3 agonist approved for the treatment of overactive bladder, offering a mechanism of action different from antimuscarinic agents, and can be an option for patients who cannot tolerate or do not respond to anticholinergic medications.&lt;/li&gt;&lt;li&gt;â€¢ Mirabegron&lt;/li&gt;&lt;li&gt;â€¢ first Î²3 agonist&lt;/li&gt;&lt;li&gt;â€¢ overactive bladder,&lt;/li&gt;&lt;li&gt;â€¢ mechanism of action different&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic agents,&lt;/li&gt;&lt;li&gt;â€¢ cannot tolerate&lt;/li&gt;&lt;li&gt;â€¢ do not respond to anticholinergic medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following Disease modifying anti- rheumatoid drugs acts by causing extracellular accumulation of adenosine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydroxychloroquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Methotrexate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Methotrexate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leflunomide: Leflunomide is an inhibitor of dihydroorotate dehydrogenase , an enzyme involved in the de novo synthesis of pyrimidine. It does not directly affect adenosine levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leflunomide:&lt;/li&gt;&lt;li&gt;â€¢ inhibitor of dihydroorotate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azathioprine: Azathioprine is a prodrug that is converted to 6-mercaptopurine (6-MP), which inhibits purine synthesis by acting as a purine analogue . It does not directly affect adenosine levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Azathioprine:&lt;/li&gt;&lt;li&gt;â€¢ prodrug that is converted to 6-mercaptopurine&lt;/li&gt;&lt;li&gt;â€¢ inhibits purine synthesis&lt;/li&gt;&lt;li&gt;â€¢ acting as a purine analogue&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydroxychloroquine: Hydroxychloroquine exerts its effects by inhibiting lysosomal acidification , antigen presentation , and Toll-like receptor signaling . It does not directly affect adenosine levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydroxychloroquine:&lt;/li&gt;&lt;li&gt;â€¢ exerts its effects by inhibiting lysosomal acidification&lt;/li&gt;&lt;li&gt;â€¢ antigen presentation&lt;/li&gt;&lt;li&gt;â€¢ Toll-like receptor signaling&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate increases extracellular adenosine levels by inhibiting enzymes involved in de novo purine synthesis , which contributes to its anti-inflammatory effects in the treatment of Rheumatoid Arthritis .&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate increases extracellular adenosine levels&lt;/li&gt;&lt;li&gt;â€¢ inhibiting enzymes&lt;/li&gt;&lt;li&gt;â€¢ de novo purine synthesis&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory effects&lt;/li&gt;&lt;li&gt;â€¢ treatment of Rheumatoid Arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A highway truck driver has profuse rhinorrhea and sneezing. Which amongst the following drugs would you prescribe him?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pheniramine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Promethazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dimehydrinate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cetirizine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cetirizine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cetirizine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pheniramine: Pheniramine is a first-generation antihistamine that can effectively relieve allergic symptoms but is known to cause sedation as a side effect , which can impair driving ability and alertness.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pheniramine:&lt;/li&gt;&lt;li&gt;â€¢ first-generation antihistamine&lt;/li&gt;&lt;li&gt;â€¢ relieve allergic symptoms&lt;/li&gt;&lt;li&gt;â€¢ cause sedation as a side effect&lt;/li&gt;&lt;li&gt;â€¢ Option B. Promethazine: Promethazine is another first-generation antihistamine with strong sedative properties, making it unsuitable for individuals who need to remain alert, such as drivers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Promethazine:&lt;/li&gt;&lt;li&gt;â€¢ first-generation antihistamine&lt;/li&gt;&lt;li&gt;â€¢ strong sedative properties,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dimehydrinate: Dimehydrinate is primarily used to prevent and treat motion sickness rather than allergic symptoms . It also has sedative effects , making it inappropriate for someone who must stay awake and alert while driving.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dimehydrinate:&lt;/li&gt;&lt;li&gt;â€¢ primarily used to prevent and treat motion sickness&lt;/li&gt;&lt;li&gt;â€¢ allergic symptoms&lt;/li&gt;&lt;li&gt;â€¢ sedative effects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the importance of selecting appropriate medications for patients with allergic symptoms , taking into consideration their daily activities and the need for alertness. In this context, second-generation antihistamines like cetirizine are preferred for individuals who require minimal impact on their cognitive function and alertness , such as those operating vehicles or heavy machinery.&lt;/li&gt;&lt;li&gt;âž¤ selecting appropriate medications&lt;/li&gt;&lt;li&gt;âž¤ allergic symptoms&lt;/li&gt;&lt;li&gt;âž¤ daily activities&lt;/li&gt;&lt;li&gt;âž¤ need for alertness.&lt;/li&gt;&lt;li&gt;âž¤ second-generation antihistamines&lt;/li&gt;&lt;li&gt;âž¤ cetirizine&lt;/li&gt;&lt;li&gt;âž¤ require minimal impact&lt;/li&gt;&lt;li&gt;âž¤ cognitive function and alertness&lt;/li&gt;&lt;li&gt;âž¤ operating vehicles&lt;/li&gt;&lt;li&gt;âž¤ heavy machinery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug acts by stimulation of 5HT4 receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Buspirone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renzapride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Granisetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Renzapride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Renzapride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Buspirone - It is a 5-HT1A agonist and is primarily used for the treatment of anxiety .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Buspirone&lt;/li&gt;&lt;li&gt;â€¢ 5-HT1A agonist&lt;/li&gt;&lt;li&gt;â€¢ primarily used for the treatment of anxiety&lt;/li&gt;&lt;li&gt;â€¢ Option C. Granisetron - This is a 5-HT3 receptor antagonist , which is indicated for the prevention of chemotherapy-induced nausea and vomiting .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Granisetron -&lt;/li&gt;&lt;li&gt;â€¢ 5-HT3 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ indicated for the prevention of chemotherapy-induced nausea&lt;/li&gt;&lt;li&gt;â€¢ vomiting&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoclopramide - It is an antagonist at D2 receptors and is used for its anti-emetic and prokinetic properties .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoclopramide&lt;/li&gt;&lt;li&gt;â€¢ antagonist at D2 receptors&lt;/li&gt;&lt;li&gt;â€¢ anti-emetic&lt;/li&gt;&lt;li&gt;â€¢ prokinetic properties&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Renzapride is a 5-HT4 receptor agonist used to increase peristalsis in the gastrointestinal tract . Many 5-HT4 agonists , useful for GERD , end in &#x27;pride&#x27; such as cisapride , mosapride , and prucalopride . It&#x27;s important to note that Tegaserod, another 5-HT4 agonist, was withdrawn due to increased risk of myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Renzapride is a 5-HT4 receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ increase peristalsis in the gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ 5-HT4 agonists&lt;/li&gt;&lt;li&gt;â€¢ GERD&lt;/li&gt;&lt;li&gt;â€¢ end in &#x27;pride&#x27; such as cisapride&lt;/li&gt;&lt;li&gt;â€¢ mosapride&lt;/li&gt;&lt;li&gt;â€¢ prucalopride&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new biological therapy, Anakinra has been developed for treatment of Rheumatoid Arthritis. What is the mechanism of action of anakinra?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TNF antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IL-1 antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IL-2 antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IL-6 antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IL-1 antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IL-1 antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. TNF antagonist: This option is incorrect. TNF antagonists are a class of biologics that include drugs such as infliximab , etanercept , and adalimumab . They work by inhibiting the action of tumor necrosis factor-alpha (TNF-alpha), not IL-1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TNF antagonist:&lt;/li&gt;&lt;li&gt;â€¢ TNF antagonists&lt;/li&gt;&lt;li&gt;â€¢ class of biologics&lt;/li&gt;&lt;li&gt;â€¢ drugs such as infliximab&lt;/li&gt;&lt;li&gt;â€¢ etanercept&lt;/li&gt;&lt;li&gt;â€¢ adalimumab&lt;/li&gt;&lt;li&gt;â€¢ Option C. IL-2 antagonist: This option is incorrect. IL-2 antagonists , such as basiliximab and daclizumab , are used primarily to prevent rejection in organ transplantation by inhibiting the action of interleukin-2 (IL-2), which is different from the mechanism of action of anakinra.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IL-2 antagonist:&lt;/li&gt;&lt;li&gt;â€¢ IL-2 antagonists&lt;/li&gt;&lt;li&gt;â€¢ basiliximab and daclizumab&lt;/li&gt;&lt;li&gt;â€¢ prevent rejection&lt;/li&gt;&lt;li&gt;â€¢ organ transplantation&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the action of interleukin-2&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-6 antagonist: This option is incorrect. IL-6 antagonists , such as tocilizumab and sarilumab , are used in the treatment of rheumatoid arthritis by inhibiting the action of interleukin-6 (IL-6), a different pathway from that targeted by anakinra.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-6 antagonist:&lt;/li&gt;&lt;li&gt;â€¢ IL-6 antagonists&lt;/li&gt;&lt;li&gt;â€¢ tocilizumab and sarilumab&lt;/li&gt;&lt;li&gt;â€¢ treatment of rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the action of interleukin-6&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the specific mechanism of action of anakinra in the treatment of rheumatoid arthritis . Recognizing anakinra as an IL-1 antagonist is crucial for understanding its role in managing inflammation and joint damage in patients with rheumatoid arthritis, highlighting the importance of targeted biological therapies in modulating specific pathways involved in the disease process.&lt;/li&gt;&lt;li&gt;âž¤ understand the specific mechanism of action of anakinra&lt;/li&gt;&lt;li&gt;âž¤ treatment of rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ Recognizing anakinra&lt;/li&gt;&lt;li&gt;âž¤ IL-1 antagonist&lt;/li&gt;&lt;li&gt;âž¤ role in managing inflammation&lt;/li&gt;&lt;li&gt;âž¤ joint damage&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-week pregnant female with polyhydramnios presents with labour pain. She was treated with indomethacin earlier. Which of the following can be likely outcome in the baby if delivery occurs at this time?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Premature closure of ductus arteriosus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patent ductus venosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Premature closure of ductus venosus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Premature closure of ductus arteriosus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Premature closure of ductus arteriosus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patent ductus arteriosus: This condition occurs when the ductus arteriosus fails to close after birth , leading to abnormal blood flow between the aorta and pulmonary artery . It is not a direct outcome of indomethacin use during pregnancy; rather, indomethacin is used to encourage the closure of a patent ductus arteriosus in the neonatal period.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Patent ductus arteriosus:&lt;/li&gt;&lt;li&gt;â€¢ ductus arteriosus fails to close after birth&lt;/li&gt;&lt;li&gt;â€¢ abnormal blood flow&lt;/li&gt;&lt;li&gt;â€¢ aorta and pulmonary artery&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patent ductus venosus: The ductus venosus is a fetal blood vessel that diverts some blood flow directly from the umbilical vein to the inferior vena cava , bypassing the liver . A patent ductus venosus after birth is unrelated to indomethacin exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Patent ductus venosus:&lt;/li&gt;&lt;li&gt;â€¢ ductus venosus&lt;/li&gt;&lt;li&gt;â€¢ fetal blood vessel that diverts some blood flow&lt;/li&gt;&lt;li&gt;â€¢ umbilical vein&lt;/li&gt;&lt;li&gt;â€¢ inferior vena cava&lt;/li&gt;&lt;li&gt;â€¢ bypassing the liver&lt;/li&gt;&lt;li&gt;â€¢ Option D. Premature closure of ductus venosus: Like the patent ductus venosus , premature closure of this vessel is not a recognized outcome of indomethacin use in pregnancy . The ductus venosus naturally closes after birth as part of the normal transition from fetal to neonatal circulation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Premature closure of ductus venosus:&lt;/li&gt;&lt;li&gt;â€¢ patent ductus venosus&lt;/li&gt;&lt;li&gt;â€¢ premature closure&lt;/li&gt;&lt;li&gt;â€¢ vessel&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ outcome of indomethacin&lt;/li&gt;&lt;li&gt;â€¢ pregnancy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize the potential effects of indomethacin use during pregnancy on the fetal cardiovascular system , specifically the risk of premature closure of the ductus arteriosus . Understanding the pharmacological impacts of NSAIDs on fetal development is crucial for making informed decisions about drug use in pregnancy , highlighting the importance of weighing the benefits against potential risks when managing conditions like polyhydramnios&lt;/li&gt;&lt;li&gt;âž¤ recognize the potential effects of indomethacin use&lt;/li&gt;&lt;li&gt;âž¤ pregnancy on the fetal cardiovascular system&lt;/li&gt;&lt;li&gt;âž¤ risk of premature closure&lt;/li&gt;&lt;li&gt;âž¤ ductus arteriosus&lt;/li&gt;&lt;li&gt;âž¤ pharmacological impacts of NSAIDs&lt;/li&gt;&lt;li&gt;âž¤ fetal development&lt;/li&gt;&lt;li&gt;âž¤ making informed decisions&lt;/li&gt;&lt;li&gt;âž¤ drug use in pregnancy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug Y shown in figure represents:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rasburicase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Probenecid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Rasburicase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture21.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Rasburicase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Colchicine :  It is used in the treatment of gout , not as a urate-lowering agent, but to alleviate inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Colchicine&lt;/li&gt;&lt;li&gt;â€¢ used in the treatment of gout&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allopurinol: It works by inhibiting xanthine oxidase , thereby preventing the formation of uric acid from xanthine and hypoxanthine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allopurinol:&lt;/li&gt;&lt;li&gt;â€¢ inhibiting xanthine oxidase&lt;/li&gt;&lt;li&gt;â€¢ preventing the formation of uric acid from xanthine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Probenecid: This drug acts by increasing the renal excretion of uric acid but does not directly convert uric acid to allantoin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Probenecid:&lt;/li&gt;&lt;li&gt;â€¢ drug acts by increasing the renal excretion of uric acid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The goal is to understand the role of rasburicase in the management of hyperuricemia , especially in the acute setting of tumor lysis syndrome . Knowledge of rasburicaseâ€™s mechanism of action is essential for recognizing its value in lowering elevated uric acid levels quickly to prevent renal damage and other serious complications.&lt;/li&gt;&lt;li&gt;âž¤ role of rasburicase&lt;/li&gt;&lt;li&gt;âž¤ management of hyperuricemia&lt;/li&gt;&lt;li&gt;âž¤ acute setting of tumor lysis syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are used for treatment of congestive heart failure except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Trimetazidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-094413.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Trimetazidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nesiritide: Nesiritide is a recombinant B-type natriuretic peptide that has vasodilatory effects and is used in the management of acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nesiritide:&lt;/li&gt;&lt;li&gt;â€¢ recombinant B-type natriuretic peptide&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory effects&lt;/li&gt;&lt;li&gt;â€¢ acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sacubitril: When combined with valsartan (a neprilysin inhibitor and an angiotensin II receptor blocker, respectively), sacubitril is used to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sacubitril:&lt;/li&gt;&lt;li&gt;â€¢ combined with valsartan&lt;/li&gt;&lt;li&gt;â€¢ neprilysin inhibitor and an angiotensin II receptor blocker,&lt;/li&gt;&lt;li&gt;â€¢ reduce the risk of cardiovascular death&lt;/li&gt;&lt;li&gt;â€¢ hospitalization for heart failure in patients&lt;/li&gt;&lt;li&gt;â€¢ chronic heart&lt;/li&gt;&lt;li&gt;â€¢ failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol: Metoprolol is a beta-blocker that is used in the management of CHF. It reduces myocardial oxygen demand and can improve survival in patients with heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol:&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ CHF.&lt;/li&gt;&lt;li&gt;â€¢ reduces myocardial oxygen demand&lt;/li&gt;&lt;li&gt;â€¢ improve survival in patients with heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is taking atorvastatin for dyslipidemia. Which of these drugs should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxycodone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rivaroxaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Clarithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxycodone: Incorrect because oxycodone, an opioid analgesic, does not significantly interact with the CYP3A4 enzyme in a way that would affect the metabolism of atorvastatin to a clinically relevant extent.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxycodone:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ opioid analgesic,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4 enzyme&lt;/li&gt;&lt;li&gt;â€¢ metabolism of atorvastatin to a clinically relevant extent.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rivaroxaban: Incorrect as rivaroxaban, an anticoagulant , is not metabolized by CYP3A4 in a way that would interfere with atorvastatin metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rivaroxaban:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ rivaroxaban,&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant&lt;/li&gt;&lt;li&gt;â€¢ not metabolized by CYP3A4&lt;/li&gt;&lt;li&gt;â€¢ atorvastatin metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adalimumab: Incorrect because adalimumab , an immunosuppressive drug used to treat autoimmune diseases, does not interact with the CYP3A4 enzyme and thus would not affect atorvastatin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adalimumab:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ adalimumab&lt;/li&gt;&lt;li&gt;â€¢ immunosuppressive drug&lt;/li&gt;&lt;li&gt;â€¢ autoimmune diseases, does not&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4 enzyme&lt;/li&gt;&lt;li&gt;â€¢ would not&lt;/li&gt;&lt;li&gt;â€¢ atorvastatin levels.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ When prescribing statins, avoid concomitant use with drugs that inhibit CYP3A4, such as clarithromycin, to prevent an increase in their plasma levels which could lead to myopathy. Other notable CYP3A4 inhibitors to avoid include amiodarone, gemfibrozil, HIV protease inhibitors (such as saquinavir, ritonavir), and itraconazole.&lt;/li&gt;&lt;li&gt;â€¢ statins,&lt;/li&gt;&lt;li&gt;â€¢ avoid&lt;/li&gt;&lt;li&gt;â€¢ inhibit CYP3A4,&lt;/li&gt;&lt;li&gt;â€¢ clarithromycin,&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ plasma levels&lt;/li&gt;&lt;li&gt;â€¢ lead to myopathy.&lt;/li&gt;&lt;li&gt;â€¢ CYP3A4 inhibitors&lt;/li&gt;&lt;li&gt;â€¢ amiodarone, gemfibrozil, HIV&lt;/li&gt;&lt;li&gt;â€¢ protease inhibitors (such as saquinavir, ritonavir), and itraconazole.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are adverse effects of amiodarone except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corneal microdeposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Photosensitivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tachycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary fibrosis: This is a serious and well-recognized side effect of amiodarone, especially with long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pulmonary fibrosis:&lt;/li&gt;&lt;li&gt;â€¢ serious and well-recognized side effect of amiodarone,&lt;/li&gt;&lt;li&gt;â€¢ long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corneal microdeposits: Common and typically reversible upon discontinuation of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Corneal microdeposits:&lt;/li&gt;&lt;li&gt;â€¢ Common&lt;/li&gt;&lt;li&gt;â€¢ reversible upon discontinuation of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Photosensitivity: This adverse effect can occur in patients taking amiodarone , leading to increased risk of sunburn and skin pigmentation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Photosensitivity:&lt;/li&gt;&lt;li&gt;â€¢ adverse effect&lt;/li&gt;&lt;li&gt;â€¢ , leading to increased risk of sunburn and skin&lt;/li&gt;&lt;li&gt;â€¢ pigmentation.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone is a class III anti-arrhythmic drug associated with several adverse effects including pulmonary fibrosis, corneal microdeposits, and photosensitivity, but not tachycardia; in fact, it more commonly causes bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ class III anti-arrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ several adverse effects&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis, corneal&lt;/li&gt;&lt;li&gt;â€¢ microdeposits, and photosensitivity,&lt;/li&gt;&lt;li&gt;â€¢ in fact, it more commonly causes bradycardia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most like:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Quinidine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/image-2-min.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lignocaine: Lignocaine (Lidocaine) is a Class IB antiarrhythmic drug that primarily works by shortening the action potential duration by blocking sodium channels , particularly in ischemic or depolarized cells . It does not prolong the action potential plateau.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ Class IB antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ shortening the action potential&lt;/li&gt;&lt;li&gt;â€¢ blocking sodium channels&lt;/li&gt;&lt;li&gt;â€¢ ischemic or depolarized cells&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action&lt;/li&gt;&lt;li&gt;â€¢ potential plateau.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Propranolol: Propranolol is a Class II antiarrhythmic , which is a beta-blocker that reduces sympathetic nervous system activity. It does not have a direct effect on the action potential duration or plateau phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Propranolol:&lt;/li&gt;&lt;li&gt;â€¢ Class II antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ sympathetic nervous system&lt;/li&gt;&lt;li&gt;â€¢ activity.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action potential duration or plateau phase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Encainide: Encainide , which is no longer widely used, was a Class IC antiarrhythmic drug that significantly slows conduction by blocking sodium channels but does not typically prolong the action potential duration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Encainide:&lt;/li&gt;&lt;li&gt;â€¢ Encainide&lt;/li&gt;&lt;li&gt;â€¢ no longer widely used,&lt;/li&gt;&lt;li&gt;â€¢ Class IC antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ blocking sodium channels&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action potential duration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the electrophysiologic effects of antiarrhythmic drugs on the cardiac action potential. Understanding how these drugs affect the action potential can provide insights into their therapeutic uses and potential arrhythmogenic risks. Quinidine&#x27;s effect of prolonging the action potential duration is useful in the treatment of both atrial and ventricular arrhythmias, but it also carries the risk of proarrhythmia, underlining the need for careful patient selection and monitoring.&lt;/li&gt;&lt;li&gt;âž¤ electrophysiologic effects of antiarrhythmic drugs&lt;/li&gt;&lt;li&gt;âž¤ action potential&lt;/li&gt;&lt;li&gt;âž¤ therapeutic uses and potential&lt;/li&gt;&lt;li&gt;âž¤ arrhythmogenic risks. Quinidine&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ prolonging the action potential duration&lt;/li&gt;&lt;li&gt;âž¤ both atrial and&lt;/li&gt;&lt;li&gt;âž¤ ventricular arrhythmias,&lt;/li&gt;&lt;li&gt;âž¤ risk of proarrhythmia,&lt;/li&gt;&lt;li&gt;âž¤ careful patient selection&lt;/li&gt;&lt;li&gt;âž¤ monitoring.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs act as K channel opener?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nicorandil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nicorandil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nicorandil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spironolactone: Spironolactone is a potassium-sparing diuretic that works at the level of the distal convoluted tubule in the kidneys but does not act as a K channel opener in the cardiovascular system.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spironolactone:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ at the level of the distal convoluted tubule&lt;/li&gt;&lt;li&gt;â€¢ does not act&lt;/li&gt;&lt;li&gt;â€¢ K channel opener&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiloride: Amiloride is also a potassium-sparing diuretic that affects ion channels in the kidneys , but again, it does not open potassium channels in vascular smooth muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiloride:&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ ion channels in the kidneys&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ open potassium channels&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methyldopa: Methyldopa is an antihypertensive medication that acts centrally as an alpha-2 agonist to lower blood pressure . It does not have K channel opening properties.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methyldopa:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive medication&lt;/li&gt;&lt;li&gt;â€¢ acts centrally as an alpha-2 agonist&lt;/li&gt;&lt;li&gt;â€¢ lower blood&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ K channel opening properties.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nicorandil acts as a K channel opener and has nitrate-like properties, making it effective in the treatment of angina pectoris due to its ability to reduce myocardial oxygen demand and increase blood flow to the ischemic heart muscle.&lt;/li&gt;&lt;li&gt;âž¤ Nicorandil&lt;/li&gt;&lt;li&gt;âž¤ K channel opener and has nitrate-like properties,&lt;/li&gt;&lt;li&gt;âž¤ treatment of angina pectoris&lt;/li&gt;&lt;li&gt;âž¤ reduce myocardial oxygen demand&lt;/li&gt;&lt;li&gt;âž¤ increase blood flow to the ischemic heart muscle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs block late inward sodium ion channels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fasudil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ranolazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ranolazine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trimetazidine: Trimetazidine acts as a partial fatty acid oxidation inhibitor, optimizing the energy metabolism of the heart during ischemia, but it does not block sodium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trimetazidine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ivabradine: Ivabradine selectively inhibits the funny current (If) in the sinoatrial node, resulting in heart rate reduction, which can be beneficial in conditions like angina and heart failure, but it is not a sodium channel blocker.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ivabradine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fasudil: Fasudil is a Rho-kinase inhibitor with vasodilatory effects and does not block sodium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fasudil:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ranolazine is a late inward sodium channel blocker that can be used to treat chronic angina by improving myocardial relaxation and decreasing ischemia without major effects on heart rate or blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a direct renin inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aliskiren&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perindopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vernakalant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aliskiren&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Aliskiren&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Losartan: Losartan is an angiotensin II receptor blocker (ARB), which works further downstream in the RAAS pathway by blocking the angiotensin II type 1 receptors on blood vessels, leading to vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Losartan:&lt;/li&gt;&lt;li&gt;â€¢ angiotensin II receptor blocker (ARB),&lt;/li&gt;&lt;li&gt;â€¢ downstream in the RAAS pathway&lt;/li&gt;&lt;li&gt;â€¢ blocking the angiotensin II type 1 receptors on blood vessels,&lt;/li&gt;&lt;li&gt;â€¢ vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perindopril: Perindopril is an angiotensin-converting enzyme (ACE) inhibitor . It prevents the conversion of angiotensin I to angiotensin II by inhibiting the ACE enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Perindopril:&lt;/li&gt;&lt;li&gt;â€¢ angiotensin-converting enzyme (ACE) inhibitor&lt;/li&gt;&lt;li&gt;â€¢ prevents&lt;/li&gt;&lt;li&gt;â€¢ angiotensin I to&lt;/li&gt;&lt;li&gt;â€¢ angiotensin II&lt;/li&gt;&lt;li&gt;â€¢ ACE enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vernakalant: Vernakalant is not related to the RAAS pathway ; it is a class III antiarrhythmic agent that acts as a multiple ion channel blocke r, particularly affecting atrial cells, and is used to treat certain types of arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vernakalant:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ RAAS pathway&lt;/li&gt;&lt;li&gt;â€¢ class III antiarrhythmic agent&lt;/li&gt;&lt;li&gt;â€¢ multiple&lt;/li&gt;&lt;li&gt;â€¢ ion channel blocke&lt;/li&gt;&lt;li&gt;â€¢ atrial cells,&lt;/li&gt;&lt;li&gt;â€¢ types of arrhythmias.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aliskiren is the only direct renin inhibitor among the options listed, acting at the rate-limiting step of the RAAS pathway by inhibiting the conversion of angiotensinogen to angiotensin I.&lt;/li&gt;&lt;li&gt;âž¤ Aliskiren&lt;/li&gt;&lt;li&gt;âž¤ renin inhibitor&lt;/li&gt;&lt;li&gt;âž¤ rate-limiting step of the RAAS pathway&lt;/li&gt;&lt;li&gt;âž¤ inhibiting the conversion of angiotensinogen to angiotensin I.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old female came to hospital for preconception counseling. Patient is a known hypertensive compliant to drug therapy. Which of the following drugs will you advise to stop?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lisinopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lisinopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyldopa: Methyldopa is commonly used in pregnancy for hypertension and is considered safe. It is often continued during pregnancy if the patient is well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methyldopa:&lt;/li&gt;&lt;li&gt;â€¢ commonly used in pregnancy for hypertension&lt;/li&gt;&lt;li&gt;â€¢ safe.&lt;/li&gt;&lt;li&gt;â€¢ well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Labetalol: Labetalol is another antihypertensive agent commonly used during pregnancy . It has a good safety profile and is often continued if the patient is well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ antihypertensive agent&lt;/li&gt;&lt;li&gt;â€¢ during pregnancy&lt;/li&gt;&lt;li&gt;â€¢ good safety profile&lt;/li&gt;&lt;li&gt;â€¢ patient is well-controlled.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nifedipine: Nifedipine is also considered safe for use during pregnancy and is commonly prescribed for hypertension in pregnant women.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nifedipine:&lt;/li&gt;&lt;li&gt;â€¢ safe for use during pregnancy&lt;/li&gt;&lt;li&gt;â€¢ prescribed for hypertension&lt;/li&gt;&lt;li&gt;â€¢ pregnant women.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the safety profiles of antihypertensive medications during pregnancy is essential for preconception counseling. Lisinopril is contraindicated during pregnancy due to its association with fetal malformations, particularly during the second and third trimesters . It is important to discontinue potentially harmful medications before conception to minimize risks to both the mother and the developing fetus.&lt;/li&gt;&lt;li&gt;âž¤ safety profiles of antihypertensive medications&lt;/li&gt;&lt;li&gt;âž¤ pregnancy&lt;/li&gt;&lt;li&gt;âž¤ preconception counseling.&lt;/li&gt;&lt;li&gt;âž¤ Lisinopril is contraindicated during pregnancy&lt;/li&gt;&lt;li&gt;âž¤ fetal malformations,&lt;/li&gt;&lt;li&gt;âž¤ second and&lt;/li&gt;&lt;li&gt;âž¤ third trimesters&lt;/li&gt;&lt;li&gt;âž¤ discontinue&lt;/li&gt;&lt;li&gt;âž¤ harmful medications before conception&lt;/li&gt;&lt;li&gt;âž¤ minimize risks to both&lt;/li&gt;&lt;li&gt;âž¤ mother and the developing fetus.&lt;/li&gt;&lt;li&gt;âž¤ SAFE ANTI-HYPERTENSIVES IN PREGNANCY&lt;/li&gt;&lt;li&gt;âž¤ SAFE ANTI-HYPERTENSIVES IN PREGNANCY&lt;/li&gt;&lt;li&gt;âž¤ B etter              - B eta blockers (Cardio selective and Labetalol) M other            - Methyldopa C are                 - C lonidine D uring             - D ihydropyridine CCB (sustained release nifedipine, amlodipine) H ypertensive   - H ydralazine P regnancy       - P razosin (and other alpha blockers)&lt;/li&gt;&lt;li&gt;âž¤ B etter              - B eta blockers (Cardio selective and Labetalol)&lt;/li&gt;&lt;li&gt;âž¤ B&lt;/li&gt;&lt;li&gt;âž¤ B&lt;/li&gt;&lt;li&gt;âž¤ M other            - Methyldopa&lt;/li&gt;&lt;li&gt;âž¤ M&lt;/li&gt;&lt;li&gt;âž¤ Methyldopa&lt;/li&gt;&lt;li&gt;âž¤ C are                 - C lonidine&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ D uring             - D ihydropyridine CCB (sustained release nifedipine, amlodipine)&lt;/li&gt;&lt;li&gt;âž¤ D&lt;/li&gt;&lt;li&gt;âž¤ D&lt;/li&gt;&lt;li&gt;âž¤ H ypertensive   - H ydralazine&lt;/li&gt;&lt;li&gt;âž¤ H&lt;/li&gt;&lt;li&gt;âž¤ H&lt;/li&gt;&lt;li&gt;âž¤ P regnancy       - P razosin (and other alpha blockers)&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of Prinzmetalâ€™s angina is started on isosorbide mono nitrate. What is the mechanism of action of nitrates in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced cardiac contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased left ventricular end diastolic volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased diastolic perfusion pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endothelium independent coronary vasodilatation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Endothelium independent coronary vasodilatation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Endothelium independent coronary vasodilatation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced cardiac contractility: Incorrect as nitrates do not primarily act by reducing the contractility of the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced cardiac contractility:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not&lt;/li&gt;&lt;li&gt;â€¢ reducing the contractility of the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased left ventricular end diastolic volume: Incorrect because nitrates do not typically increase left ventricular end-diastolic volume; they reduce preload and afterload through vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased left ventricular end diastolic volume:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not&lt;/li&gt;&lt;li&gt;â€¢ increase left ventricular end-diastolic volume;&lt;/li&gt;&lt;li&gt;â€¢ reduce preload and afterload&lt;/li&gt;&lt;li&gt;â€¢ vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased diastolic perfusion pressure: Incorrect as nitrates do not reduce diastolic perfusion pressure; their action is aimed at reducing vasospasm and increasing perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased diastolic perfusion pressure:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not reduce diastolic perfusion pressure;&lt;/li&gt;&lt;li&gt;â€¢ reducing vasospasm and increasing perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In Prinzmetalâ€™s angina, nitrates like isosorbide mononitrate work by causing endothelium independent coronary vasodilation, acting directly on the vascular smooth muscle through NO donation, which leads to pain relief by reversing the coronary vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ Prinzmetalâ€™s angina,&lt;/li&gt;&lt;li&gt;â€¢ isosorbide mononitrate&lt;/li&gt;&lt;li&gt;â€¢ causing endothelium independent coronary vasodilation,&lt;/li&gt;&lt;li&gt;â€¢ vascular smooth muscle through NO donation,&lt;/li&gt;&lt;li&gt;â€¢ leads to pain relief&lt;/li&gt;&lt;li&gt;â€¢ reversing the coronary vasospasm.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the mechanism of action of ezetimibe for the treatment of hypercholesterolemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of HMG-CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of cholesterol absorption in the small intestine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of bile acid synthesis in the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of lipoprotein lipase activity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of cholesterol absorption in the small intestine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inhibition of cholesterol absorption in the small intestine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of HMG-CoA reductase: This is the mechanism of action for statins, not ezetimibe. Statins inhibit the rate- l imiting step in cholesterol synthesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of HMG-CoA reductase:&lt;/li&gt;&lt;li&gt;â€¢ statins, not ezetimibe. Statins inhibit the rate-&lt;/li&gt;&lt;li&gt;â€¢ imiting step in cholesterol synthesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of bile acid synthesis in the liver: Bile acid sequestrants work by this mechanism. They bind bile acids in the intestine, leading to increased excretion of cholesterol in the feces.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of bile acid synthesis in the liver:&lt;/li&gt;&lt;li&gt;â€¢ Bile acid sequestrants&lt;/li&gt;&lt;li&gt;â€¢ bile acids&lt;/li&gt;&lt;li&gt;â€¢ intestine,&lt;/li&gt;&lt;li&gt;â€¢ increased excretion of cholesterol in the feces.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of lipoprotein lipase activity: Inhibiting lipoprotein lipase would prevent the breakdown of triglycerides, not cholesterol. This is not a mechanism associated with ezetimibe.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of lipoprotein lipase activity:&lt;/li&gt;&lt;li&gt;â€¢ Inhibiting lipoprotein lipase&lt;/li&gt;&lt;li&gt;â€¢ breakdown of triglycerides,&lt;/li&gt;&lt;li&gt;â€¢ not a mechanism&lt;/li&gt;&lt;li&gt;â€¢ ezetimibe.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ezetimibe reduces LDL cholesterol by inhibiting the absorption of cholesterol in the small intestine through its action on the NPC1L1 protein.&lt;/li&gt;&lt;li&gt;âž¤ Ezetimibe&lt;/li&gt;&lt;li&gt;âž¤ reduces LDL cholesterol by inhibiting the absorption of cholesterol&lt;/li&gt;&lt;li&gt;âž¤ NPC1L1&lt;/li&gt;&lt;li&gt;âž¤ protein.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs can cause gynecomastia except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cimetidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ketoconazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Amiloride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Amiloride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: Digoxin, a cardiac glycoside, has been associated with gynecomastia as a rare adverse effect, possibly due to its estrogen-like effects and alterations in hormone metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Digoxin,&lt;/li&gt;&lt;li&gt;â€¢ cardiac glycoside,&lt;/li&gt;&lt;li&gt;â€¢ gynecomastia&lt;/li&gt;&lt;li&gt;â€¢ adverse effect,&lt;/li&gt;&lt;li&gt;â€¢ estrogen-like effects and alterations in hormone metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cimetidine: Cimetidine, a histamine H2 receptor antagonist , can cause gynecomastia by blocking androgen receptors and increasing prolactin secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cimetidine:&lt;/li&gt;&lt;li&gt;â€¢ histamine H2 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ gynecomastia&lt;/li&gt;&lt;li&gt;â€¢ blocking androgen receptors&lt;/li&gt;&lt;li&gt;â€¢ increasing prolactin secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ketoconazole: Ketoconazole, an antifungal agent, can inhibit testosterone synthesis by blocking cytochrome P450 enzymes, leading to elevated estrogen levels and resulting in gynecomastia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ketoconazole:&lt;/li&gt;&lt;li&gt;â€¢ an antifungal agent,&lt;/li&gt;&lt;li&gt;â€¢ inhibit testosterone synthesis&lt;/li&gt;&lt;li&gt;â€¢ blocking cytochrome P450&lt;/li&gt;&lt;li&gt;â€¢ elevated estrogen levels&lt;/li&gt;&lt;li&gt;â€¢ gynecomastia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize medications associated with the development of gynecomastia a s an adverse effect.&lt;/li&gt;&lt;li&gt;âž¤ recognize medications associated with the development of gynecomastia a&lt;/li&gt;&lt;li&gt;âž¤ IMPORTANT DRUGS CAUSING GYNAECOMASTIA:&lt;/li&gt;&lt;li&gt;âž¤ IMPORTANT DRUGS CAUSING GYNAECOMASTIA:&lt;/li&gt;&lt;li&gt;âž¤ DI: DI goxin&lt;/li&gt;&lt;li&gt;âž¤ DI: DI&lt;/li&gt;&lt;li&gt;âž¤ S: S pironolactone&lt;/li&gt;&lt;li&gt;âž¤ S: S&lt;/li&gt;&lt;li&gt;âž¤ C: C imetidine, K etoconazole&lt;/li&gt;&lt;li&gt;âž¤ C: C&lt;/li&gt;&lt;li&gt;âž¤ K&lt;/li&gt;&lt;li&gt;âž¤ O: O estrogens&lt;/li&gt;&lt;li&gt;âž¤ O: O&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;If a thiazide diuretic is administered for hypertension, the response seen within 24 hours on excretion of different electrolytes is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodiumâ†‘ Potassiumâ†‘ Calciumâ†‘&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sodiumâ†“ Potassiumâ†“ Calciumâ†‘&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodiumâ†‘ Potassiumâ†‘ Calciumâ†“&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodiumâ†‘ Potassiumâ†“ Calciumâ†“&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sodiumâ†‘ Potassiumâ†‘ Calciumâ†“&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-120035.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Sodiumâ†‘ Potassiumâ†‘ Calciumâ†“&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sodiumâ†‘ Potassiumâ†‘ Calciumâ†‘ : This option is incorrect because thiazides actually reduce calcium excretion , leading to hypercalcemia , while increasing the excretion of sodium and potassium.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sodiumâ†‘ Potassiumâ†‘ Calciumâ†‘&lt;/li&gt;&lt;li&gt;â€¢ thiazides&lt;/li&gt;&lt;li&gt;â€¢ reduce calcium excretion&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodiumâ†“ Potassiumâ†“ Calciumâ†‘: This option is incorrect because thiazides do not decrease sodium and potassium excretion ; instead, they increase it. They decrease calcium excretion, leading to hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodiumâ†“ Potassiumâ†“ Calciumâ†‘:&lt;/li&gt;&lt;li&gt;â€¢ thiazides do not decrease sodium&lt;/li&gt;&lt;li&gt;â€¢ potassium excretion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodiumâ†‘ Potassiumâ†“ Calciumâ†“: This option is incorrect because thiazides increase the excretion of both sodium and potassium while decreasing calcium excretion, resulting in hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodiumâ†‘ Potassiumâ†“ Calciumâ†“:&lt;/li&gt;&lt;li&gt;â€¢ thiazides increase&lt;/li&gt;&lt;li&gt;â€¢ excretion of both sodium&lt;/li&gt;&lt;li&gt;â€¢ potassium&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Thiazide diuretics increase the excretion of sodium and potassium while decreasing the excretion of calcium within 24 hours of administration .&lt;/li&gt;&lt;li&gt;â€¢ Thiazide diuretics increase&lt;/li&gt;&lt;li&gt;â€¢ excretion of sodium&lt;/li&gt;&lt;li&gt;â€¢ potassium&lt;/li&gt;&lt;li&gt;â€¢ decreasing the excretion of calcium&lt;/li&gt;&lt;li&gt;â€¢ 24 hours of administration&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A group of college students is planning to go to a trip at Leh Ladakh. Which would be appropriate for them to take to prevent mountain sickness?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A thiazide diuretic such as hydrochlorothiazide.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An anticholinergic such as atropine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A carbonic anhydrase inhibitor such as acetazolamide.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A loop diuretic such as furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A carbonic anhydrase inhibitor such as acetazolamide.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. A carbonic anhydrase inhibitor such as acetazolamide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A thiazide diuretic such as hydrochlorothiazide : Thiazide diuretics are not used for the prevention of mountain sickness. Their diuretic effect could potentially worsen dehydration , which is not desirable at high altitudes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A thiazide diuretic such as hydrochlorothiazide&lt;/li&gt;&lt;li&gt;â€¢ not used&lt;/li&gt;&lt;li&gt;â€¢ mountain sickness.&lt;/li&gt;&lt;li&gt;â€¢ worsen dehydration&lt;/li&gt;&lt;li&gt;â€¢ Option B. An anticholinergic such as atropine : Anticholinergics are not indicated for the prevention of mountain sickness. They are used to treat conditions such as bradycardia (slow heart rate) and for their drying effects on secretions in palliative care or pre-anaesthetic medication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. An anticholinergic such as atropine&lt;/li&gt;&lt;li&gt;â€¢ not indicated&lt;/li&gt;&lt;li&gt;â€¢ prevention of mountain sickness.&lt;/li&gt;&lt;li&gt;â€¢ bradycardia (slow heart rate) and for their drying effects&lt;/li&gt;&lt;li&gt;â€¢ palliative care or pre-anaesthetic medication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A loop diuretic such as furosemide : Loop diuretics, while potent diuretics, are not appropriate for preventing mountain sickness. Like thiazides, their use could lead to dehydration, complicating acclimatization to high altitude.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A loop diuretic such as furosemide&lt;/li&gt;&lt;li&gt;â€¢ potent diuretics,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ preventing mountain&lt;/li&gt;&lt;li&gt;â€¢ sickness.&lt;/li&gt;&lt;li&gt;â€¢ use&lt;/li&gt;&lt;li&gt;â€¢ dehydration,&lt;/li&gt;&lt;li&gt;â€¢ acclimatization to high altitude.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the use of acetazolamide as a prophylactic treatment for altitude sickness. Its mechanism, inducing metabolic acidosis to stimulate ventilation, highlights a strategic approach to enhance acclimatization to high altitudes. This knowledge is crucial for planning safe trips to high-altitude areas and for advising individuals on appropriate preventative measures against altitude sickness.&lt;/li&gt;&lt;li&gt;âž¤ use of acetazolamide as a prophylactic treatment&lt;/li&gt;&lt;li&gt;âž¤ altitude sickness.&lt;/li&gt;&lt;li&gt;âž¤ metabolic acidosis to stimulate ventilation,&lt;/li&gt;&lt;li&gt;âž¤ enhance acclimatization&lt;/li&gt;&lt;li&gt;âž¤ high&lt;/li&gt;&lt;li&gt;âž¤ altitudes.&lt;/li&gt;&lt;li&gt;âž¤ planning safe trips&lt;/li&gt;&lt;li&gt;âž¤ high-altitude areas&lt;/li&gt;&lt;li&gt;âž¤ preventative measures against altitude sickness.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diuretics is contraindicated in the presence of cardiac failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-120557.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Mannitol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spironolactone : Spironolactone is a potassium-sparing diuretic and aldosterone antagonist. It is often used in the treatment of heart failure to counteract the effects of aldosterone, leading to reduced fluid accumulation without causing potassium loss . It is not contraindicated in cardiac failure; in fact, it can be beneficial.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spironolactone&lt;/li&gt;&lt;li&gt;â€¢ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;â€¢ aldosterone antagonist.&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ heart failure to counteract&lt;/li&gt;&lt;li&gt;â€¢ aldosterone,&lt;/li&gt;&lt;li&gt;â€¢ reduced fluid accumulation without&lt;/li&gt;&lt;li&gt;â€¢ potassium loss&lt;/li&gt;&lt;li&gt;â€¢ not contraindicated in cardiac failure;&lt;/li&gt;&lt;li&gt;â€¢ beneficial.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Furosemide : Furosemide is a loop diuretic that is frequently used in the management of edema associated with heart failure . It helps to reduce fluid overload effectively and is a cornerstone in the management of acute and chronic heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Furosemide&lt;/li&gt;&lt;li&gt;â€¢ loop diuretic&lt;/li&gt;&lt;li&gt;â€¢ edema&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ failure&lt;/li&gt;&lt;li&gt;â€¢ reduce fluid overload effectively&lt;/li&gt;&lt;li&gt;â€¢ cornerstone&lt;/li&gt;&lt;li&gt;â€¢ acute and chronic heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrochlorothiazide : Hydrochlorothiazide is a thiazide diuretic that can be used in the management of hypertension and mild to moderate fluid retention. While it is less potent than loop diuretics like furosemide in the context of heart failure, it is not contraindicated and can be used in stable chronic heart failure patients, particularly for its blood pressure-lowering effects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrochlorothiazide&lt;/li&gt;&lt;li&gt;â€¢ thiazide diuretic&lt;/li&gt;&lt;li&gt;â€¢ hypertension&lt;/li&gt;&lt;li&gt;â€¢ mild to moderate fluid retention.&lt;/li&gt;&lt;li&gt;â€¢ less potent than loop diuretics&lt;/li&gt;&lt;li&gt;â€¢ furosemide&lt;/li&gt;&lt;li&gt;â€¢ heart failure,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ contraindicated&lt;/li&gt;&lt;li&gt;â€¢ used in stable chronic heart failure patients,&lt;/li&gt;&lt;li&gt;â€¢ blood pressure-lowering effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to know the important indications and contra-indications of mannitol , an osmotic diuretic.&lt;/li&gt;&lt;li&gt;âž¤ indications and contra-indications of mannitol&lt;/li&gt;&lt;li&gt;âž¤ osmotic diuretic.&lt;/li&gt;&lt;li&gt;âž¤ Indications and Contra-indications of Mannitol:&lt;/li&gt;&lt;li&gt;âž¤ Indications and Contra-indications of Mannitol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The given figure shows the mechanism of action of Drug Y in treatment of osteoporosis. Which of the following best represents drug Y?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bisphosphonates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Denosumab&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture16.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Denosumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Raloxifene: Incorrect for this mechanism. Raloxifene is a selective estrogen receptor modulator (SERM) that mimics estrogen&#x27;s bone-protective effect s by reducing osteoclast activity, but it does not work by targeting the RANKL-RANK interaction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Raloxifene:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Raloxifene is a selective estrogen receptor modulator (SERM)&lt;/li&gt;&lt;li&gt;â€¢ estrogen&#x27;s bone-protective effect&lt;/li&gt;&lt;li&gt;â€¢ reducing osteoclast activity,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ RANKL-RANK interaction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bisphosphonates: Also incorrect. Bisphosphonates inhibit osteoclast-mediated bone resorption by inducing osteoclast apoptosis and interfering with the mevalonate pathway , not by RANKL inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bisphosphonates:&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ inhibit&lt;/li&gt;&lt;li&gt;â€¢ osteoclast-mediated bone resorption&lt;/li&gt;&lt;li&gt;â€¢ osteoclast&lt;/li&gt;&lt;li&gt;â€¢ apoptosis&lt;/li&gt;&lt;li&gt;â€¢ mevalonate pathway&lt;/li&gt;&lt;li&gt;â€¢ Option C. Teriparatide: Incorrect for this illustration. Teriparatide, a recombinant form of parathyroid hormone , primarily works by stimulating osteoblasts to promote bone formation rather than inhibiting osteoclasts.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Teriparatide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Teriparatide,&lt;/li&gt;&lt;li&gt;â€¢ parathyroid hormone&lt;/li&gt;&lt;li&gt;â€¢ stimulating osteoblasts&lt;/li&gt;&lt;li&gt;â€¢ bone formation rather than inhibiting osteoclasts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Denosumab is used in the treatment of osteoporosis by targeting the RANKL-RANK interaction , effectively inhibiting osteoclast formation and activity, thus decreasing bone resorption.&lt;/li&gt;&lt;li&gt;âž¤ Denosumab&lt;/li&gt;&lt;li&gt;âž¤ osteoporosis by targeting the RANKL-RANK interaction&lt;/li&gt;&lt;li&gt;âž¤ inhibiting osteoclast&lt;/li&gt;&lt;li&gt;âž¤ decreasing bone resorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An obese diabetic patient was on metformin monotherapy, but his sugar levels were not well controlled. He is allergic to sulfa drugs and does not comply with injectable drugs. He has a history of pancreatitis, and family history of bladder carcinoma. In view of the raised glucose levels, you wish to add another anti-diabetic drug. Which one would you prefer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sitagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Canagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture10.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture11.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Canagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liraglutide: Not suitable as it is an injectable GLP-1 receptor agonist, and the patient has a non-compliance issue with injectable medications.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liraglutide:&lt;/li&gt;&lt;li&gt;â€¢ Not&lt;/li&gt;&lt;li&gt;â€¢ injectable GLP-1 receptor agonist,&lt;/li&gt;&lt;li&gt;â€¢ non-compliance issue&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sitagliptin: A DPP-4 inhibitor, which has been associated with cases of pancreatitis , making it a less suitable option for a patient with a history of this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sitagliptin:&lt;/li&gt;&lt;li&gt;â€¢ DPP-4 inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ cases of pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ less suitable&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pioglitazone: A thiazolidinedione that has been associated with an i ncreased risk of bladder cancer , especially in individuals with a family history of the disease , thus contraindicating its use in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pioglitazone:&lt;/li&gt;&lt;li&gt;â€¢ thiazolidinedione&lt;/li&gt;&lt;li&gt;â€¢ ncreased risk of bladder cancer&lt;/li&gt;&lt;li&gt;â€¢ family history of the disease&lt;/li&gt;&lt;li&gt;â€¢ contraindicating its use in this patient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are contraindications for the use of metformin except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypotensive state&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcoholics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypotensive state : While not a direct contraindication, caution is advised in conditions that may predispose patients to hypotension , as low perfusion may increase the risk of metformin induced lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypotensive state&lt;/li&gt;&lt;li&gt;â€¢ not a direct contraindication,&lt;/li&gt;&lt;li&gt;â€¢ predispose patients to hypotension&lt;/li&gt;&lt;li&gt;â€¢ low perfusion&lt;/li&gt;&lt;li&gt;â€¢ increase the risk of metformin&lt;/li&gt;&lt;li&gt;â€¢ lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholics : Chronic and excessive alcohol consumption is a contraindication for metformin use due to the increased risk of lactic acidosis , especially in cases of hepatic impairment and acute alcohol intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholics&lt;/li&gt;&lt;li&gt;â€¢ Chronic and excessive alcohol&lt;/li&gt;&lt;li&gt;â€¢ contraindication for metformin&lt;/li&gt;&lt;li&gt;â€¢ increased risk of lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ hepatic impairment and acute alcohol intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal failure : Renal failure or significant renal impairment is a contraindication for the use of metformin due to the increased risk of accumulating metformin and subsequent lactic acidosis . Latest guidelines regarding use of metformin in renal dysfunction include:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal failure&lt;/li&gt;&lt;li&gt;â€¢ renal impairment is a contraindication&lt;/li&gt;&lt;li&gt;â€¢ metformin&lt;/li&gt;&lt;li&gt;â€¢ increased risk of accumulating metformin&lt;/li&gt;&lt;li&gt;â€¢ lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ metformin in renal dysfunction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risk factors for metformin induced lactic acidosis :&lt;/li&gt;&lt;li&gt;âž¤ Risk factors for metformin induced lactic acidosis&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Hepatic failure Renal failure Alcoholics Metabolic acidosis Elderly Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)&lt;/li&gt;&lt;li&gt;âž¤ Hepatic failure&lt;/li&gt;&lt;li&gt;âž¤ Renal failure&lt;/li&gt;&lt;li&gt;âž¤ Alcoholics&lt;/li&gt;&lt;li&gt;âž¤ Metabolic acidosis&lt;/li&gt;&lt;li&gt;âž¤ Elderly&lt;/li&gt;&lt;li&gt;âž¤ Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)&lt;/li&gt;&lt;li&gt;âž¤ Mnemonic:&lt;/li&gt;&lt;li&gt;âž¤ Mnemonic:&lt;/li&gt;&lt;li&gt;âž¤ MET: MET abolic acidosis&lt;/li&gt;&lt;li&gt;âž¤ MET: MET&lt;/li&gt;&lt;li&gt;âž¤ F: F ailure (Liver and Renal failure)&lt;/li&gt;&lt;li&gt;âž¤ F: F&lt;/li&gt;&lt;li&gt;âž¤ O R MIN: O xygen R eaching the tissues is MIN imum (means hypoxia causing conditions)&lt;/li&gt;&lt;li&gt;âž¤ O R MIN: O&lt;/li&gt;&lt;li&gt;âž¤ R&lt;/li&gt;&lt;li&gt;âž¤ MIN&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are used in treatment of osteoporosis except.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Milnacipran&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Milnacipran&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Milnacipran&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Teriparatide : Teriparatide is a recombinant form of parathyroid hormone used in the treatment of osteoporosis. It stimulates new bone formation by acting on osteoblasts , making it effective in reducing the risk of fractures in patients with osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Teriparatide&lt;/li&gt;&lt;li&gt;â€¢ recombinant form of parathyroid hormone&lt;/li&gt;&lt;li&gt;â€¢ osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ new bone formation&lt;/li&gt;&lt;li&gt;â€¢ osteoblasts&lt;/li&gt;&lt;li&gt;â€¢ reducing the risk of fractures&lt;/li&gt;&lt;li&gt;â€¢ osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Strontium ranelate : Strontium ranelate is a medication used to treat severe osteoporosis in postmenopausal women and men at high risk of fractures . It works by simultaneously decreasing bone resorption and increasing bone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Strontium ranelate&lt;/li&gt;&lt;li&gt;â€¢ used to treat severe osteoporosis in postmenopausal women&lt;/li&gt;&lt;li&gt;â€¢ men at high risk of fractures&lt;/li&gt;&lt;li&gt;â€¢ decreasing bone resorption and increasing bone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Denosumab : Denosumab is a monoclonal antibody that inhibits RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand) , a protein that acts as the primary signal for bone removal . By inhibiting RANKL, denosumab decreases bone resorption and increases bone mass and strength in patients with osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Denosumab&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody that inhibits RANKL (Receptor Activator of Nuclear Factor Kappa-B&lt;/li&gt;&lt;li&gt;â€¢ Ligand)&lt;/li&gt;&lt;li&gt;â€¢ acts&lt;/li&gt;&lt;li&gt;â€¢ primary signal for bone removal&lt;/li&gt;&lt;li&gt;â€¢ By inhibiting RANKL,&lt;/li&gt;&lt;li&gt;â€¢ decreases bone resorption and&lt;/li&gt;&lt;li&gt;â€¢ increases bone mass and strength&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drugs Used for Osteoporosis&lt;/li&gt;&lt;li&gt;âž¤ Drugs Used for Osteoporosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is used in the treatment of hyperprolactinemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cimetidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methysergide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bromocriptine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bromocriptine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Bromocriptine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cimetidine : Cimetidine is a histamine H2 receptor antagonist used primarily to treat peptic ulcer disease and g astroesophageal reflux disease (GERD) . It is not used in the treatment of hyperprolactinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cimetidine&lt;/li&gt;&lt;li&gt;â€¢ histamine H2 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ peptic ulcer disease and&lt;/li&gt;&lt;li&gt;â€¢ astroesophageal reflux disease (GERD)&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ hyperprolactinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methysergide : Methysergide is a medication used to prevent migraine headache. It is not used for the treatment of hyperprolactinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methysergide&lt;/li&gt;&lt;li&gt;â€¢ Methysergide&lt;/li&gt;&lt;li&gt;â€¢ prevent migraine headache.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ondansetron : Ondansetron is a serotonin 5-HT3 receptor antagonist used primarily to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. It is not used in the treatment of hyperprolactinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ondansetron&lt;/li&gt;&lt;li&gt;â€¢ serotonin 5-HT3 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ prevent nausea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ chemotherapy, radiation therapy, and surgery.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ hyperprolactinemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Uses of Dopamine Agonists&lt;/li&gt;&lt;li&gt;âž¤ Uses of Dopamine Agonists&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following antidiabetic drugs act by release of insulin except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SGLT 2 inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DPP IV inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meglitinide analogues&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GLP1 agonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SGLT 2 inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. SGLT 2 inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. DPP-IV inhibitor : DPP-IV inhibitors like sitagliptin work by inhibiting the enzyme dipeptidyl peptidase-4, which is responsible for the degradation of incretin hormones. By inhibiting this enzyme, the levels of incretin hormones (such as GLP-1) are increased, which in turn stimulates the release of insulin in a glucose-dependent manner.&lt;/li&gt;&lt;li&gt;â€¢ Option B. DPP-IV inhibitor&lt;/li&gt;&lt;li&gt;â€¢ sitagliptin work by inhibiting the enzyme dipeptidyl peptidase-4,&lt;/li&gt;&lt;li&gt;â€¢ degradation of incretin hormones.&lt;/li&gt;&lt;li&gt;â€¢ inhibiting this enzyme,&lt;/li&gt;&lt;li&gt;â€¢ levels of incretin hormones (such as GLP-1) are&lt;/li&gt;&lt;li&gt;â€¢ increased,&lt;/li&gt;&lt;li&gt;â€¢ stimulates the release of insulin in a glucose-dependent manner.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meglitinide analogues : Meglitinide analogues like repaglinide stimulate the pancreas to release more insulin . They bind to specific channels on pancreatic beta cells, causing these cells to release insulin, thereby reducing blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Meglitinide analogues&lt;/li&gt;&lt;li&gt;â€¢ repaglinide stimulate the pancreas to release more insulin&lt;/li&gt;&lt;li&gt;â€¢ bind&lt;/li&gt;&lt;li&gt;â€¢ specific channels on pancreatic beta cells,&lt;/li&gt;&lt;li&gt;â€¢ cells to release insulin,&lt;/li&gt;&lt;li&gt;â€¢ reducing blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GLP-1 agonist : GLP-1 agonists like exenatide mimic the action of the incretin hormone GLP-1, which increases insulin secretion from the pancreas in a glucose-dependent manner. Additionally, GLP-1 agonists reduce glucagon secretion and slow gastric emptying.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GLP-1 agonist&lt;/li&gt;&lt;li&gt;â€¢ exenatide mimic&lt;/li&gt;&lt;li&gt;â€¢ incretin hormone GLP-1,&lt;/li&gt;&lt;li&gt;â€¢ increases insulin&lt;/li&gt;&lt;li&gt;â€¢ secretion&lt;/li&gt;&lt;li&gt;â€¢ glucose-dependent manner.&lt;/li&gt;&lt;li&gt;â€¢ GLP-1 agonists reduce glucagon secretion and slow&lt;/li&gt;&lt;li&gt;â€¢ gastric emptying.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CLASSIFICATION OF ANTI-DIABETIC DRUGS&lt;/li&gt;&lt;li&gt;âž¤ CLASSIFICATION OF ANTI-DIABETIC DRUGS&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with swelling in the neck as shown in figure. She also complained of decreased appetite, fatigue, cold intolerance, and menstrual irregularities. She gained 10 kg weight in the last 4-5 months. Thyroid function tests showed normal T4 levels but elevated TSH levels. The patient should be treated with.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liothyronine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;L-Thyroxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbimazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Steroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. L-Thyroxine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture22.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. L-Thyroxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liothyronine : Liothyronine is a synthetic form of triiodothyronine (T3) . While it can be used in certain specific situations, such as in combination therapy with levothyroxine for some patients, L-Thyroxine remains the primary treatment for hypothyroidism due to its stability, longer half-life, and more consistent serum levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liothyronine&lt;/li&gt;&lt;li&gt;â€¢ synthetic form of triiodothyronine (T3)&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ specific situations,&lt;/li&gt;&lt;li&gt;â€¢ combination therapy with levothyroxine&lt;/li&gt;&lt;li&gt;â€¢ L-Thyroxine&lt;/li&gt;&lt;li&gt;â€¢ primary treatment&lt;/li&gt;&lt;li&gt;â€¢ hypothyroidism&lt;/li&gt;&lt;li&gt;â€¢ stability, longer half-life, and more consistent serum levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carbimazole : Carbimazole is used to treat hyperthyroidism, not hypothyroidism. It works by inhibiting the synthesis of thyroid hormones, which would be contraindicated in a patient already showing signs of low thyroid hormone activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carbimazole&lt;/li&gt;&lt;li&gt;â€¢ treat hyperthyroidism,&lt;/li&gt;&lt;li&gt;â€¢ inhibiting the synthesis of&lt;/li&gt;&lt;li&gt;â€¢ thyroid hormones,&lt;/li&gt;&lt;li&gt;â€¢ contraindicated in a patient&lt;/li&gt;&lt;li&gt;â€¢ signs of low thyroid hormone activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Steroids : Steroids are not a primary treatment for primary hypothyroidism . They can be used in specific cases of t hyroiditis where inflammation is a significant component, but they would not be the first choice i n typical hypothyroidism treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Steroids&lt;/li&gt;&lt;li&gt;â€¢ not a primary treatment for primary hypothyroidism&lt;/li&gt;&lt;li&gt;â€¢ specific cases of&lt;/li&gt;&lt;li&gt;â€¢ hyroiditis&lt;/li&gt;&lt;li&gt;â€¢ inflammation is a significant&lt;/li&gt;&lt;li&gt;â€¢ not be the first choice i&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with hypothyroidism indicated by symptoms of thyroid hormone deficiency and elevated TSH levels with normal T4, L-Thyroxine is the appropriate treatment to normalize thyroid function and alleviate symptoms.&lt;/li&gt;&lt;li&gt;âž¤ hypothyroidism&lt;/li&gt;&lt;li&gt;âž¤ thyroid hormone deficiency&lt;/li&gt;&lt;li&gt;âž¤ elevated TSH levels&lt;/li&gt;&lt;li&gt;âž¤ normal T4, L-Thyroxine&lt;/li&gt;&lt;li&gt;âž¤ treatment&lt;/li&gt;&lt;li&gt;âž¤ normalize thyroid function and alleviate symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Long term steroid therapy can lead to suppression of hypothalamic pituitary-adrenal axis. It can be overcome by using alternate day therapy with corticosteroids. Which of the following steroids is unsuitable for alternate day therapy for such purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Betamethasone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrocortisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Betamethasone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Betamethasone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cortisol: Cortisol, also known as hydrocortisone when used as a medication, has a short duration of action, making it suitable for alternate day therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cortisol:&lt;/li&gt;&lt;li&gt;â€¢ Cortisol,&lt;/li&gt;&lt;li&gt;â€¢ hydrocortisone&lt;/li&gt;&lt;li&gt;â€¢ short duration of action,&lt;/li&gt;&lt;li&gt;â€¢ alternate day therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisolone: Prednisolone is an intermediate-acting corticosteroid that is commonly used in alternate day therapy to reduce HPA axis suppression.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ intermediate-acting corticosteroid&lt;/li&gt;&lt;li&gt;â€¢ alternate day therapy to&lt;/li&gt;&lt;li&gt;â€¢ reduce HPA axis suppression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrocortisone: Hydrocortisone is essentially synthetic cortisol with a short duration of action , suitable for alternate day therapy to minimize HPA axis suppression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrocortisone:&lt;/li&gt;&lt;li&gt;â€¢ essentially synthetic cortisol&lt;/li&gt;&lt;li&gt;â€¢ short duration of action&lt;/li&gt;&lt;li&gt;â€¢ alternate day&lt;/li&gt;&lt;li&gt;â€¢ minimize HPA axis suppression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Betamethasone&#x27;s long duration of action makes it inappropriate for alternate day therapy designed to mitigate HPA axis suppression, unlike shorter-acting steroids like hydrocortisone , which are better suited for such treatment schedules.&lt;/li&gt;&lt;li&gt;âž¤ Betamethasone&#x27;s long duration of action&lt;/li&gt;&lt;li&gt;âž¤ alternate day therapy&lt;/li&gt;&lt;li&gt;âž¤ mitigate HPA axis&lt;/li&gt;&lt;li&gt;âž¤ suppression,&lt;/li&gt;&lt;li&gt;âž¤ shorter-acting steroids like hydrocortisone&lt;/li&gt;&lt;li&gt;âž¤ better&lt;/li&gt;&lt;li&gt;âž¤ treatment schedules.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug is a selective progesterone receptor modulator that can be used as an emergency contraceptive even after 3 days of unprotected intercourse?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Onapristone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gestrinone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mifepristone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ulipristal&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ulipristal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Ulipristal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Onapristone: Although a selective progesterone receptor modulator , it is not indicated for emergency contraception.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Onapristone:&lt;/li&gt;&lt;li&gt;â€¢ selective progesterone receptor modulator&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ emergency contraception.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gestrinone: This SPRM is not commonly used for emergency contraception.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gestrinone:&lt;/li&gt;&lt;li&gt;â€¢ SPRM is not&lt;/li&gt;&lt;li&gt;â€¢ emergency contraception.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mifepristone: Also an SPRM used for emergency contraception but is effective if used within 72 hours of unprotected intercourse , which is a shorter window compared to ulipristal.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mifepristone:&lt;/li&gt;&lt;li&gt;â€¢ SPRM&lt;/li&gt;&lt;li&gt;â€¢ emergency contraception&lt;/li&gt;&lt;li&gt;â€¢ effective&lt;/li&gt;&lt;li&gt;â€¢ within 72 hours of unprotected intercourse&lt;/li&gt;&lt;li&gt;â€¢ shorter window compared to ulipristal.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ulipristal (30 mg) is effective as an emergency contraceptive up to 5 days after unprotected intercourse , making it a superior option for extending the window of opportunity for emergency contraception compared to other options like mifepristone and levonorgestrel.&lt;/li&gt;&lt;li&gt;âž¤ Ulipristal (30 mg)&lt;/li&gt;&lt;li&gt;âž¤ emergency contraceptive up to 5 days&lt;/li&gt;&lt;li&gt;âž¤ unprotected intercourse&lt;/li&gt;&lt;li&gt;âž¤ extending&lt;/li&gt;&lt;li&gt;âž¤ window of opportunity for emergency contraception&lt;/li&gt;&lt;li&gt;âž¤ mifepristone and levonorgestrel.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The oral contraceptives shown in the figure are.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monophasic combined OCPs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic combined OCPs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Triphasic combined OCPs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emergency pills&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Monophasic combined OCPs&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture19.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Monophasic combined OCPs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Biphasic pills will have three colors. The first 10 tablets with less content of E+P, the next 11 tablets of different color containing higher amounts of hormones and last 7 tablets of different color that contain only iron.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Biphasic pills will have three colors.&lt;/li&gt;&lt;li&gt;â€¢ first 10 tablets&lt;/li&gt;&lt;li&gt;â€¢ less content of E+P,&lt;/li&gt;&lt;li&gt;â€¢ 11 tablets of different color&lt;/li&gt;&lt;li&gt;â€¢ higher amounts of hormones&lt;/li&gt;&lt;li&gt;â€¢ 7 tablets of different color&lt;/li&gt;&lt;li&gt;â€¢ iron.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Triphasic pills will have four colors. First 6 tablets, 6-10 tablets, 11-21 tablets and last 7 tablets of different color.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Triphasic pills will have four colors.&lt;/li&gt;&lt;li&gt;â€¢ First 6 tablets, 6-10 tablets, 11-21 tablets and last 7 tablets&lt;/li&gt;&lt;li&gt;â€¢ different color.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emergency pills are incorrect because emergency contraception is not presented in a 28-day format but rather as a one-time dose or a short series of pills intended for immediate use after unprotected sex.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Emergency pills&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ emergency contraception&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ 28-day&lt;/li&gt;&lt;li&gt;â€¢ one-time dose&lt;/li&gt;&lt;li&gt;â€¢ short series of pills&lt;/li&gt;&lt;li&gt;â€¢ immediate use after unprotected sex.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Monophasic combined OCPs consist of 21 active pills with a consistent dose of estrogen and progesterone , followed by 7 non-hormonal (iron) pills, and are represented in a pack with two colorsâ€”21 of one color and 7 of another, not to be confused with biphasic or triphasic pills which have varying hormone dosages and more color variation.&lt;/li&gt;&lt;li&gt;âž¤ Monophasic combined OCPs&lt;/li&gt;&lt;li&gt;âž¤ 21 active pills&lt;/li&gt;&lt;li&gt;âž¤ estrogen and progesterone&lt;/li&gt;&lt;li&gt;âž¤ 7 non-hormonal (iron) pills,&lt;/li&gt;&lt;li&gt;âž¤ two colorsâ€”21 of one color&lt;/li&gt;&lt;li&gt;âž¤ 7 of another,&lt;/li&gt;&lt;li&gt;âž¤ biphasic or triphasic pills&lt;/li&gt;&lt;li&gt;âž¤ varying hormone dosages and more color variation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements about tamoxifen are true except.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is used as an adjuvant in the treatment of estrogen receptor positive breast cancer.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It reduces the risk of osteoporosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It has a beneficial effect on lipid profile by increasing HDL/LDL cholesterol ratio.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It reduces the risk of endometrial carcinoma.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It reduces the risk of endometrial carcinoma.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It reduces the risk of endometrial carcinoma.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adjuvant in Estrogen Receptor-Positive Breast Cancer : True, tamoxifen is commonly used as an adjuvant therapy for estrogen receptor-positive breast cancer due to its antagonistic effects on the estrogen receptor in breast tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Adjuvant in Estrogen Receptor-Positive Breast Cancer&lt;/li&gt;&lt;li&gt;â€¢ True,&lt;/li&gt;&lt;li&gt;â€¢ tamoxifen&lt;/li&gt;&lt;li&gt;â€¢ adjuvant therapy for&lt;/li&gt;&lt;li&gt;â€¢ estrogen receptor-positive breast cancer&lt;/li&gt;&lt;li&gt;â€¢ antagonistic effects&lt;/li&gt;&lt;li&gt;â€¢ estrogen receptor in breast tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Risk of Osteoporosis : True, tamoxifen has an estrogen agonistic action on bone, leading to an antiresorptive effect that can reduce the risk of osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Risk of Osteoporosis&lt;/li&gt;&lt;li&gt;â€¢ True,&lt;/li&gt;&lt;li&gt;â€¢ tamoxifen&lt;/li&gt;&lt;li&gt;â€¢ estrogen agonistic action&lt;/li&gt;&lt;li&gt;â€¢ antiresorptive effect&lt;/li&gt;&lt;li&gt;â€¢ reduce the risk of osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Effect on Lipid Profile : True, tamoxifen is associated with improvements in lipid profiles , as it decreases total and LDL cholesterol without significantly affecting HDL and triglyceride levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Effect on Lipid Profile&lt;/li&gt;&lt;li&gt;â€¢ True, tamoxifen&lt;/li&gt;&lt;li&gt;â€¢ improvements in lipid profiles&lt;/li&gt;&lt;li&gt;â€¢ decreases total and LDL&lt;/li&gt;&lt;li&gt;â€¢ cholesterol&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ HDL and triglyceride levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen is a SERM that has estrogen agonistic action on bone, blood (lipid profile) and liver whereas it acts as estrogen receptor antagonist in breast and endometrium. It is indicated as an adjuvant in the treatment of estrogen receptor positive breast cancer. It is associated with reduced risk of cancer in the contralateral breast. Tamoxifen also decreases total and LDL cholesterol without any change in HDL and triglyceride level. It thus has favorable effect on lipid profile by increasing the HDL/LDL cholesterol ratio . It also improves the bone mass due to antiresorptive effect, Tamoxifen is effective orally. It has biphasic plasma tÂ½ (10 hrs. and 7 days) and long duration of action. Hot flushes and nausea and vomiting occur in 25% of patients, and many other minor adverse effects are observed. Tamoxifen increases the risk of endometrial carcinoma and thromboembolic events. It causes retinal deposits , decreased visual acuity and cataracts in occasional patientsâ€&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen is a SERM that has estrogen agonistic action on bone, blood (lipid profile) and liver whereas it acts as estrogen receptor antagonist in breast and endometrium.&lt;/li&gt;&lt;li&gt;âž¤ SERM&lt;/li&gt;&lt;li&gt;âž¤ estrogen agonistic action on bone, blood (lipid profile) and liver&lt;/li&gt;&lt;li&gt;âž¤ acts as&lt;/li&gt;&lt;li&gt;âž¤ estrogen receptor antagonist in breast and endometrium.&lt;/li&gt;&lt;li&gt;âž¤ It is indicated as an adjuvant in the treatment of estrogen receptor positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ adjuvant in the treatment of estrogen receptor positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ It is associated with reduced risk of cancer in the contralateral breast.&lt;/li&gt;&lt;li&gt;âž¤ reduced risk of cancer in the contralateral breast.&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen also decreases total and LDL cholesterol without any change in HDL and triglyceride level. It thus has favorable effect on lipid profile by increasing the HDL/LDL cholesterol ratio .&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ decreases total and LDL cholesterol&lt;/li&gt;&lt;li&gt;âž¤ increasing the HDL/LDL cholesterol ratio&lt;/li&gt;&lt;li&gt;âž¤ It also improves the bone mass due to antiresorptive effect,&lt;/li&gt;&lt;li&gt;âž¤ improves the bone mass due to antiresorptive effect,&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen is effective orally.&lt;/li&gt;&lt;li&gt;âž¤ effective orally.&lt;/li&gt;&lt;li&gt;âž¤ It has biphasic plasma tÂ½ (10 hrs. and 7 days) and long duration of action.&lt;/li&gt;&lt;li&gt;âž¤ biphasic plasma tÂ½ (10 hrs. and 7 days)&lt;/li&gt;&lt;li&gt;âž¤ long duration of action.&lt;/li&gt;&lt;li&gt;âž¤ Hot flushes and nausea and vomiting occur in 25% of patients, and many other minor adverse effects are observed.&lt;/li&gt;&lt;li&gt;âž¤ Hot flushes&lt;/li&gt;&lt;li&gt;âž¤ nausea and vomiting&lt;/li&gt;&lt;li&gt;âž¤ 25% of patients,&lt;/li&gt;&lt;li&gt;âž¤ minor adverse effects&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen increases the risk of endometrial carcinoma and thromboembolic events.&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ risk of endometrial carcinoma and thromboembolic events.&lt;/li&gt;&lt;li&gt;âž¤ It causes retinal deposits , decreased visual acuity and cataracts in occasional patientsâ€&lt;/li&gt;&lt;li&gt;âž¤ causes retinal deposits&lt;/li&gt;&lt;li&gt;âž¤ decreased visual acuity and cataracts&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an adverse effect of dapagliflozin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Weight loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polyuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased incidence of urinary tract infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients should be cautioned not to consume alcohol when given a prescription for any of the following EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefixime&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chlorpropamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cefixime&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-175109.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cefixime&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cefoperazone: Cefoperazone, a cephalosporin antibiotic, is known to cause a disulfiram-like reaction with alcohol, which can lead to symptoms like flushing, nausea, vomiting, and tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cefoperazone:&lt;/li&gt;&lt;li&gt;â€¢ cephalosporin antibiotic,&lt;/li&gt;&lt;li&gt;â€¢ disulfiram-like reaction with alcohol,&lt;/li&gt;&lt;li&gt;â€¢ flushing, nausea, vomiting, and tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chlorpropamide: Chlorpropamide, a sulfonylurea used in the treatment of type 2 diabetes , can also cause a disulfiram-like reaction with alcohol, leading to unpleasant symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chlorpropamide:&lt;/li&gt;&lt;li&gt;â€¢ sulfonylurea&lt;/li&gt;&lt;li&gt;â€¢ type 2 diabetes&lt;/li&gt;&lt;li&gt;â€¢ disulfiram-like&lt;/li&gt;&lt;li&gt;â€¢ alcohol,&lt;/li&gt;&lt;li&gt;â€¢ unpleasant symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metronidazole: Metronidazole, an antibiotic used for various bacterial and protozoal infections , is well-known for causing severe disulfiram -like reactions with alcohol, including nausea, vomiting, headache, and flushing.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metronidazole:&lt;/li&gt;&lt;li&gt;â€¢ antibiotic&lt;/li&gt;&lt;li&gt;â€¢ bacterial and protozoal infections&lt;/li&gt;&lt;li&gt;â€¢ severe disulfiram&lt;/li&gt;&lt;li&gt;â€¢ nausea, vomiting, headache, and flushing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to know the drugs causing disulfiram like reaction with alcohol.&lt;/li&gt;&lt;li&gt;âž¤ know&lt;/li&gt;&lt;li&gt;âž¤ disulfiram like reaction with alcohol.&lt;/li&gt;&lt;li&gt;âž¤ DRUGS SHOWING DISULFIRAM LIKE REACTION WITH ALCOHOL:&lt;/li&gt;&lt;li&gt;âž¤ DRUGS SHOWING DISULFIRAM LIKE REACTION WITH ALCOHOL:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following agents is available as a patch for once-daily use and is likely to provide steady drug levels to treat Alzheimerâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rivastigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Donepezil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galantamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rivastigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rivastigmine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Rivastigmine is a newer reversible anticholinesterase indicated for the treatment of dementia and Alzheimerâ€™s disease. It has better CNS penetration than other drugs of this group. It is the only agent available as a transdermal patch for the treatment of Alzheimerâ€™s disease. It may also be used for dementia associated with Parkinsonâ€™s disease. It is applied every 24 hours to improve patient compliance.&lt;/li&gt;&lt;li&gt;â€¢ Rivastigmine is a newer reversible anticholinesterase indicated for the treatment of dementia and Alzheimerâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Rivastigmine&lt;/li&gt;&lt;li&gt;â€¢ anticholinesterase&lt;/li&gt;&lt;li&gt;â€¢ treatment of dementia and Alzheimerâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ It has better CNS penetration than other drugs of this group.&lt;/li&gt;&lt;li&gt;â€¢ better CNS penetration&lt;/li&gt;&lt;li&gt;â€¢ It is the only agent available as a transdermal patch for the treatment of Alzheimerâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ transdermal patch&lt;/li&gt;&lt;li&gt;â€¢ treatment of Alzheimerâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ It may also be used for dementia associated with Parkinsonâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ used for dementia&lt;/li&gt;&lt;li&gt;â€¢ Parkinsonâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ It is applied every 24 hours to improve patient compliance.&lt;/li&gt;&lt;li&gt;â€¢ every 24 hours&lt;/li&gt;&lt;li&gt;â€¢ improve patient compliance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of schizophrenia was prescribed haloperidol. Next day, he presented to the hospital with the features shown in the figure. What should be the treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Give propranolol.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase dose of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reassurance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Give benzhexol.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Give benzhexol.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture6.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-164806.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Give benzhexol.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This figure shows torticollis . It is an acute muscular dystonia , an extrapyramidal side effect of typical antipsychotics. This can appear within a few hours after the administration of antipsychotic drugs . Extrapyramidal side effects are seen more commonly with the use of high potency drugs like haloperidol and fluphenazine. Benzhexol is the drug of choice for acute muscular dystonia.&lt;/li&gt;&lt;li&gt;â€¢ This figure shows torticollis . It is an acute muscular dystonia , an extrapyramidal side effect of typical antipsychotics.&lt;/li&gt;&lt;li&gt;â€¢ torticollis&lt;/li&gt;&lt;li&gt;â€¢ acute muscular dystonia&lt;/li&gt;&lt;li&gt;â€¢ extrapyramidal side effect of typical antipsychotics.&lt;/li&gt;&lt;li&gt;â€¢ This can appear within a few hours after the administration of antipsychotic drugs .&lt;/li&gt;&lt;li&gt;â€¢ can&lt;/li&gt;&lt;li&gt;â€¢ within a few hours&lt;/li&gt;&lt;li&gt;â€¢ administration of antipsychotic drugs&lt;/li&gt;&lt;li&gt;â€¢ Extrapyramidal side effects are seen more commonly with the use of high potency drugs like haloperidol and fluphenazine.&lt;/li&gt;&lt;li&gt;â€¢ Extrapyramidal side effects&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ use of high potency&lt;/li&gt;&lt;li&gt;â€¢ haloperidol and fluphenazine.&lt;/li&gt;&lt;li&gt;â€¢ Benzhexol is the drug of choice for acute muscular dystonia.&lt;/li&gt;&lt;li&gt;â€¢ Benzhexol&lt;/li&gt;&lt;li&gt;â€¢ drug of choice&lt;/li&gt;&lt;li&gt;â€¢ acute muscular dystonia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient is present to the clinic with a history of seizures. The patient is diagnosed with epilepsy and started on vigabatrin therapy. Which of the following statements is true about vigabatrin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vigabatrin decreases GABA uptake at the synaptic cleft.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vigabatrin increases GABA uptake at the synaptic cleft.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vigabatrin is a GABA transaminase inhibitor.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vigabatrin is a GABA transacetylase inhibitor.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vigabatrin is a GABA transaminase inhibitor.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vigabatrin is a GABA transaminase inhibitor.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreases GABA uptake at the synaptic cleft: Incorrect , vigabatrin does not decrease GABA uptake; it increases GABA availability by inhibiting its breakdown.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreases GABA uptake at the synaptic cleft:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ increases GABA&lt;/li&gt;&lt;li&gt;â€¢ inhibiting its breakdown.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increases GABA uptake at the synaptic cleft: Incorrect , vigabatrin&#x27;s mechanism does not involve altering GABA uptake mechanisms directly.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increases GABA uptake at the synaptic cleft:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ vigabatrin&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ altering GABA uptake&lt;/li&gt;&lt;li&gt;â€¢ mechanisms directly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GABA transacetylase inhibitor: Incorrect, as there is no enzyme known as GABA transacetylase involved in GABA metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GABA transacetylase inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect,&lt;/li&gt;&lt;li&gt;â€¢ no enzyme&lt;/li&gt;&lt;li&gt;â€¢ GABA transacetylase&lt;/li&gt;&lt;li&gt;â€¢ GABA&lt;/li&gt;&lt;li&gt;â€¢ metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vigabatrin effectively treats seizures by inhibiting GABA transaminase, thereby increasing the inhibitory neurotransmitter GABA in the brain , crucial for reducing excessive neuronal firing associated with epilepsy. Additionally, it is the drug of choice for infantile spasms related to tuberous sclerosis , but potential side effects include irreversible visual field defects and behavioral changes.&lt;/li&gt;&lt;li&gt;âž¤ Vigabatrin&lt;/li&gt;&lt;li&gt;âž¤ seizures&lt;/li&gt;&lt;li&gt;âž¤ inhibiting GABA transaminase,&lt;/li&gt;&lt;li&gt;âž¤ increasing the inhibitory neurotransmitter GABA&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ reducing excessive neuronal firing&lt;/li&gt;&lt;li&gt;âž¤ with epilepsy.&lt;/li&gt;&lt;li&gt;âž¤ drug of choice&lt;/li&gt;&lt;li&gt;âž¤ infantile&lt;/li&gt;&lt;li&gt;âž¤ spasms&lt;/li&gt;&lt;li&gt;âž¤ tuberous sclerosis&lt;/li&gt;&lt;li&gt;âž¤ potential side effects&lt;/li&gt;&lt;li&gt;âž¤ irreversible visual field defects and behavioral changes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old pregnant woman with a history of bipolar disorder has been taking lithium throughout her pregnancy. Her neonate should be screened for which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac anomalies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neural defects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Facial defects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urogenital malformations&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac anomalies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cardiac anomalies.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neural defects : While important to screen for in general, neural tube defects are more closely associated with medications like valproate and carbamazepine rather than lithium.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neural defects&lt;/li&gt;&lt;li&gt;â€¢ important to screen&lt;/li&gt;&lt;li&gt;â€¢ general, neural tube defects&lt;/li&gt;&lt;li&gt;â€¢ more closely&lt;/li&gt;&lt;li&gt;â€¢ valproate and carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Facial defects : Facial defects, such as cleft lip and palate, are not specifically associated with lithium use during pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Facial defects&lt;/li&gt;&lt;li&gt;â€¢ cleft lip and palate,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lithium&lt;/li&gt;&lt;li&gt;â€¢ during pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urogenital malformations : While it&#x27;s important to screen for urogenital malformations in neonates for a variety of reasons, lithium use in pregnancy is specifically noted for its association with cardiac anomalies rather than urogenital malformations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Urogenital malformations&lt;/li&gt;&lt;li&gt;â€¢ urogenital malformations in neonates&lt;/li&gt;&lt;li&gt;â€¢ lithium use in pregnancy&lt;/li&gt;&lt;li&gt;â€¢ cardiac anomalies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the teratogenic risks associated with the use of lithium during pregnancy, particularly the increased risk of cardiac anomalies such as Ebstein&#x27;s anomaly in the neonate.&lt;/li&gt;&lt;li&gt;âž¤ teratogenic risks&lt;/li&gt;&lt;li&gt;âž¤ use of lithium&lt;/li&gt;&lt;li&gt;âž¤ pregnancy,&lt;/li&gt;&lt;li&gt;âž¤ increased risk of cardiac anomalies&lt;/li&gt;&lt;li&gt;âž¤ Ebstein&#x27;s anomaly in the neonate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs can be used in benzodiazepine toxicity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Barbiturate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ethyl alcohol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Protamine sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Flumazenil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-134937.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Flumazenil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Barbiturate : Barbiturates act on the central nervous system similarly to benzodiazepines but through different mechanisms. They would not reverse benzodiazepine toxicity and could potentially worsen central nervous system depression if used together.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Barbiturate&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;li&gt;â€¢ benzodiazepines&lt;/li&gt;&lt;li&gt;â€¢ different&lt;/li&gt;&lt;li&gt;â€¢ mechanisms.&lt;/li&gt;&lt;li&gt;â€¢ would not reverse benzodiazepine toxicity&lt;/li&gt;&lt;li&gt;â€¢ worsen central nervous system depression&lt;/li&gt;&lt;li&gt;â€¢ used together.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ethyl alcohol : Ethanol (ethyl alcohol) was used as an antidote for methanol poisoning (now the drug of choice is fomepizole) . It has no role in the treatment of benzodiazepine toxicity and could potentially lead to further central nervous system depression.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ethyl alcohol&lt;/li&gt;&lt;li&gt;â€¢ antidote for methanol poisoning&lt;/li&gt;&lt;li&gt;â€¢ drug of choice&lt;/li&gt;&lt;li&gt;â€¢ fomepizole)&lt;/li&gt;&lt;li&gt;â€¢ no role&lt;/li&gt;&lt;li&gt;â€¢ benzodiazepine toxicity&lt;/li&gt;&lt;li&gt;â€¢ lead to further central nervous system depression.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Protamine sulphate : Protamine sulphate is used to reverse the effects of heparin, an anticoagulant, and has no role in treating benzodiazepine toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Protamine sulphate&lt;/li&gt;&lt;li&gt;â€¢ reverse the effects of heparin, an anticoagulant,&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ benzodiazepine toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key educational takeaway is to recognize flumazenil as the specific antidote for benzodiazepine toxicity. Antidotes of different toxicities is very important to remember for entrance exams.&lt;/li&gt;&lt;li&gt;âž¤ educational takeaway&lt;/li&gt;&lt;li&gt;âž¤ recognize flumazenil&lt;/li&gt;&lt;li&gt;âž¤ specific antidote for benzodiazepine toxicity.&lt;/li&gt;&lt;li&gt;âž¤ different toxicities&lt;/li&gt;&lt;li&gt;âž¤ very important&lt;/li&gt;&lt;li&gt;âž¤ entrance exams.&lt;/li&gt;&lt;li&gt;âž¤ IMPORTANT ANTIDOTES&lt;/li&gt;&lt;li&gt;âž¤ IMPORTANT ANTIDOTES&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of chronic liver disease is admitted to the hospital for alcohol withdrawal management. Given his liver condition, the healthcare team needs to choose a medication that is safe and effective for managing his withdrawal symptoms while considering the potential impact on his liver function. Which of the following agents is most appropriate for managing alcohol withdrawal in this patient with liver disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlordiazepoxide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lorazepam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Flunitrazepam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lorazepam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lorazepam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chlordiazepoxide: While chlordiazepoxide is commonly used for alcohol withdrawal, its metabolism is significantly affected by liver function, making it a less ideal choice for patients with liver disease due to the risk of accumulation and increased side effects .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chlordiazepoxide:&lt;/li&gt;&lt;li&gt;â€¢ commonly used&lt;/li&gt;&lt;li&gt;â€¢ alcohol withdrawal,&lt;/li&gt;&lt;li&gt;â€¢ metabolism&lt;/li&gt;&lt;li&gt;â€¢ liver function,&lt;/li&gt;&lt;li&gt;â€¢ less ideal choice&lt;/li&gt;&lt;li&gt;â€¢ liver disease&lt;/li&gt;&lt;li&gt;â€¢ risk of accumulation and increased side effects&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diazepam: Diazepam is metabolized by the liver, and its active metabolites can accumulate in patients with liver disease, potentially leading to prolonged sedation and increased toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diazepam:&lt;/li&gt;&lt;li&gt;â€¢ metabolized by the liver,&lt;/li&gt;&lt;li&gt;â€¢ its active metabolites&lt;/li&gt;&lt;li&gt;â€¢ accumulate in patients with liver disease,&lt;/li&gt;&lt;li&gt;â€¢ prolonged sedation and increased toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Flunitrazepam: Flunitrazepam is also metabolized by the liver, and like diazepam, it can accumulate in patients with liver impairment, making it a less favorable option.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Flunitrazepam:&lt;/li&gt;&lt;li&gt;â€¢ metabolized by the liver,&lt;/li&gt;&lt;li&gt;â€¢ diazepam,&lt;/li&gt;&lt;li&gt;â€¢ accumulate in patients&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ impairment,&lt;/li&gt;&lt;li&gt;â€¢ less favorable option.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand that lorazepam is the preferred benzodiazepine for managing alcohol withdrawal symptoms in patients with liver disease due to its metabolism through glucuronidation, which is less affected by liver function compared to the oxidative metabolism of other benzodiazepines.&lt;/li&gt;&lt;li&gt;âž¤ lorazepam&lt;/li&gt;&lt;li&gt;âž¤ benzodiazepine&lt;/li&gt;&lt;li&gt;âž¤ alcohol withdrawal symptoms in patients with liver disease&lt;/li&gt;&lt;li&gt;âž¤ metabolism through glucuronidation,&lt;/li&gt;&lt;li&gt;âž¤ less&lt;/li&gt;&lt;li&gt;âž¤ liver function&lt;/li&gt;&lt;li&gt;âž¤ oxidative metabolism&lt;/li&gt;&lt;li&gt;âž¤ other benzodiazepines.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with bipolar disorder was treated with lithium. Hydrochlorothiazide was prescribed for his hypertension. He developed nausea, vomiting, coarse tremors and brisk reflexes 2 weeks after taking drugs. What is the likely reason for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Side effects of hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased metabolism of hydrochlorothiazide by lithium.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased renal tubular reabsorption of lithium.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiazide acts as an add on drug to lithium.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased renal tubular reabsorption of lithium.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased renal tubular reabsorption of lithium.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key learning point from this scenario is understanding the pharmacological interaction between lithium and thiazide diuretics , such as hydrochlorothiazide , and how this interaction can lead to increased serum lithium levels and subsequent lithium toxicity.&lt;/li&gt;&lt;li&gt;âž¤ pharmacological interaction&lt;/li&gt;&lt;li&gt;âž¤ between lithium and thiazide diuretics&lt;/li&gt;&lt;li&gt;âž¤ hydrochlorothiazide&lt;/li&gt;&lt;li&gt;âž¤ interaction&lt;/li&gt;&lt;li&gt;âž¤ increased serum lithium levels&lt;/li&gt;&lt;li&gt;âž¤ subsequent lithium toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Topiramate is used in the treatment of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lennox Gastaut syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Attention Deficit Hyperactivity Disorder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lennox Gastaut syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-182151.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lennox Gastaut syndrome.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true about Clozapine except&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;More potently blocks 5HT2 as compared to D2 receptors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood level below 350 ng/ml should be maintained to avoid agranulocytosis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Should not be used along with Carbamazepine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Should be discontinued if the WBC count is below 3,000/mm3 cells.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Blood level below 350 ng/ml should be maintained to avoid agranulocytosis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Blood level below 350 ng/ml should be maintained to avoid agranulocytosis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The false statement about clozapine is option B, which states that \&quot;Blood level below 350 ng/ml should be maintained to avoid agranulocytosis. \&quot; This statement is not true because there is no specific blood level of clozapine that is associated with the risk of agranulocytosis , which is dose-independent adverse effect of clozapine . High plasma concentration of Clozapine increases the risk of seizures (dose-dependent) . However, the usual plasma concentration required in many people is 300-600 ng/ml.&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ clozapine is option B,&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Blood level below 350&lt;/li&gt;&lt;li&gt;â€¢ ng/ml&lt;/li&gt;&lt;li&gt;â€¢ avoid agranulocytosis.&lt;/li&gt;&lt;li&gt;â€¢ not true&lt;/li&gt;&lt;li&gt;â€¢ no specific blood level of clozapine&lt;/li&gt;&lt;li&gt;â€¢ risk of agranulocytosis&lt;/li&gt;&lt;li&gt;â€¢ dose-independent adverse effect of clozapine&lt;/li&gt;&lt;li&gt;â€¢ High plasma&lt;/li&gt;&lt;li&gt;â€¢ concentration of Clozapine&lt;/li&gt;&lt;li&gt;â€¢ risk of seizures (dose-dependent)&lt;/li&gt;&lt;li&gt;â€¢ plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ 300-600 ng/ml.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine is an atypical antipsychotic drug that has high potency to block 5HT2 receptors as compared to D2 receptors. However, it also blocks D4 receptors, muscarinic receptors, alpha receptors and H1 receptors. It suppresses both positive as well as negative symptoms of schizophrenia . It is the first FDA approved drug for anti-suicide indication. It is used only as a reserve drug due to the risk of precipitation of seizures ( even in non-epileptics ) and agranulocytosis. Convulsions are dose-dependent adverse effects seen only at higher doses whereas agranulocytosis is independent of dose. Clozapine should be started at low doses (12.5 mg) and gradually dose should be increased. Baseline WBC counts should be measured, and then weekly counts should be done at least for the first 6 months . When WBC count becomes less than 3000/mm3 or absolute neutrophil count becomes less than 1500/mm3, Clozapine should be discontinued. After discontinuation, weekly WBC counts should be measured for an additional 4 weeks. It should not be used with Carbamazepine due to two reasons: Carbamazepine induces its metabolism and thus decreases plasma concentration. Carbamazepine has bone marrow suppressant action and can add to agranulocytosis caused by Clozapine .&lt;/li&gt;&lt;li&gt;â€¢ Clozapine is an atypical antipsychotic drug that has high potency to block 5HT2 receptors as compared to D2 receptors. However, it also blocks D4 receptors, muscarinic receptors, alpha receptors and H1 receptors.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine&lt;/li&gt;&lt;li&gt;â€¢ atypical antipsychotic&lt;/li&gt;&lt;li&gt;â€¢ high potency to block 5HT2&lt;/li&gt;&lt;li&gt;â€¢ receptors&lt;/li&gt;&lt;li&gt;â€¢ compared to D2 receptors.&lt;/li&gt;&lt;li&gt;â€¢ blocks D4 receptors,&lt;/li&gt;&lt;li&gt;â€¢ muscarinic receptors, alpha receptors&lt;/li&gt;&lt;li&gt;â€¢ H1 receptors.&lt;/li&gt;&lt;li&gt;â€¢ It suppresses both positive as well as negative symptoms of schizophrenia . It is the first FDA approved drug for anti-suicide indication.&lt;/li&gt;&lt;li&gt;â€¢ suppresses both positive&lt;/li&gt;&lt;li&gt;â€¢ negative symptoms of schizophrenia&lt;/li&gt;&lt;li&gt;â€¢ first FDA&lt;/li&gt;&lt;li&gt;â€¢ anti-suicide indication.&lt;/li&gt;&lt;li&gt;â€¢ It is used only as a reserve drug due to the risk of precipitation of seizures ( even in non-epileptics ) and agranulocytosis. Convulsions are dose-dependent adverse effects seen only at higher doses whereas agranulocytosis is independent of dose.&lt;/li&gt;&lt;li&gt;â€¢ reserve drug&lt;/li&gt;&lt;li&gt;â€¢ risk of precipitation of seizures&lt;/li&gt;&lt;li&gt;â€¢ even&lt;/li&gt;&lt;li&gt;â€¢ non-epileptics&lt;/li&gt;&lt;li&gt;â€¢ agranulocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Convulsions&lt;/li&gt;&lt;li&gt;â€¢ dose-dependent&lt;/li&gt;&lt;li&gt;â€¢ at higher doses&lt;/li&gt;&lt;li&gt;â€¢ agranulocytosis is independent&lt;/li&gt;&lt;li&gt;â€¢ dose.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine should be started at low doses (12.5 mg) and gradually dose should be increased. Baseline WBC counts should be measured, and then weekly counts should be done at least for the first 6 months . When WBC count becomes less than 3000/mm3 or absolute neutrophil count becomes less than 1500/mm3, Clozapine should be discontinued. After discontinuation, weekly WBC counts should be measured for an additional 4 weeks.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine&lt;/li&gt;&lt;li&gt;â€¢ started at low doses (12.5 mg)&lt;/li&gt;&lt;li&gt;â€¢ gradually dose&lt;/li&gt;&lt;li&gt;â€¢ increased.&lt;/li&gt;&lt;li&gt;â€¢ Baseline WBC counts&lt;/li&gt;&lt;li&gt;â€¢ measured,&lt;/li&gt;&lt;li&gt;â€¢ weekly counts&lt;/li&gt;&lt;li&gt;â€¢ at least for the first 6 months&lt;/li&gt;&lt;li&gt;â€¢ WBC count&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ than 3000/mm3&lt;/li&gt;&lt;li&gt;â€¢ absolute neutrophil&lt;/li&gt;&lt;li&gt;â€¢ less than 1500/mm3,&lt;/li&gt;&lt;li&gt;â€¢ Clozapine&lt;/li&gt;&lt;li&gt;â€¢ discontinued.&lt;/li&gt;&lt;li&gt;â€¢ After discontinuation,&lt;/li&gt;&lt;li&gt;â€¢ weekly WBC counts&lt;/li&gt;&lt;li&gt;â€¢ additional 4 weeks.&lt;/li&gt;&lt;li&gt;â€¢ It should not be used with Carbamazepine due to two reasons: Carbamazepine induces its metabolism and thus decreases plasma concentration. Carbamazepine has bone marrow suppressant action and can add to agranulocytosis caused by Clozapine .&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine induces its metabolism and thus decreases plasma concentration. Carbamazepine has bone marrow suppressant action and can add to agranulocytosis caused by Clozapine .&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine induces its metabolism and thus decreases plasma concentration.&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ induces its metabolism&lt;/li&gt;&lt;li&gt;â€¢ decreases plasma concentration.&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine has bone marrow suppressant action and can add to agranulocytosis caused by Clozapine .&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ bone marrow suppressant action&lt;/li&gt;&lt;li&gt;â€¢ agranulocytosis&lt;/li&gt;&lt;li&gt;â€¢ Clozapine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presents to the emergency department with altered mental status and hypotension. Her electrocardiogram (ECG) shows wide QRS complexes and right axis deviation. She has a history of depression and is taking an antidepressant medication. What is the next best step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer sodium bicarbonate .&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Consider hemodialysis .&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administer fomepizole .&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Administer flumazenil.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administer sodium bicarbonate .&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Consider hemodialysis: While useful in certain poisonings, it is not the first-line treatment for TCA overdose and is generally reserved for severe cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Consider hemodialysis:&lt;/li&gt;&lt;li&gt;â€¢ certain poisonings,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first-line treatment for TCA overdose&lt;/li&gt;&lt;li&gt;â€¢ reserved for severe cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administer fomepizole: This is used for methanol or ethylene glycol poisoning, not for TCA overdose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Administer fomepizole:&lt;/li&gt;&lt;li&gt;â€¢ methanol or ethylene glycol poisoning, not for TCA overdose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer flumazenil: This is an antidote for benzodiazepine overdose and is not useful in cases of TCA overdose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Administer flumazenil:&lt;/li&gt;&lt;li&gt;â€¢ antidote for benzodiazepine overdose&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ TCA overdose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sodium bicarbonate is crucial for managing TCA overdose due to its ability to quickly mitigate the cardiotoxic effects associated with this type of poisoning , emphasizing the importance of rapid and appropriate intervention in such emergencies.&lt;/li&gt;&lt;li&gt;âž¤ Sodium bicarbonate&lt;/li&gt;&lt;li&gt;âž¤ TCA overdose&lt;/li&gt;&lt;li&gt;âž¤ ability to quickly mitigate&lt;/li&gt;&lt;li&gt;âž¤ cardiotoxic effects&lt;/li&gt;&lt;li&gt;âž¤ type of poisoning&lt;/li&gt;&lt;li&gt;âž¤ importance of rapid and appropriate intervention&lt;/li&gt;&lt;li&gt;âž¤ emergencies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug is used in cigarette smoking cessation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Varenicline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bupropion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nicotine chewing gum.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-135415.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Varenicline: Correct in aiding smoking cessation but not the only option.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Varenicline:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ aiding smoking cessation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bupropion: Correct but is one among several options.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bupropion:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ one among&lt;/li&gt;&lt;li&gt;â€¢ options.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nicotine chewing gum: Also correct , functions as part of nicotine replacement therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nicotine chewing gum:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ part of nicotine replacement therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Several pharmacological options are available for smoking cessation , as discussed below&lt;/li&gt;&lt;li&gt;âž¤ Several pharmacological options&lt;/li&gt;&lt;li&gt;âž¤ smoking cessation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron dextran&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oprelvekin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Oprelvekin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Filgrastim: Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that is used to increase neutrophil counts in patients undergoing chemotherapy. It stimulates the production of white blood cells, not platelets, and is therefore used to treat or prevent neutropenia , not thrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Filgrastim:&lt;/li&gt;&lt;li&gt;â€¢ granulocyte colony-stimulating factor (G-CSF)&lt;/li&gt;&lt;li&gt;â€¢ increase neutrophil counts&lt;/li&gt;&lt;li&gt;â€¢ undergoing chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ stimulates&lt;/li&gt;&lt;li&gt;â€¢ white blood cells,&lt;/li&gt;&lt;li&gt;â€¢ used to treat&lt;/li&gt;&lt;li&gt;â€¢ prevent neutropenia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Erythropoietin: Erythropoietin is a glycoprotein hormone that stimulates erythropoiesis, or red blood cell production, in the bone marrow . It is used to treat anemia, particularly in chronic kidney disease and in patients undergoing chemotherapy. It does not directly increase platelet counts.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Erythropoietin:&lt;/li&gt;&lt;li&gt;â€¢ glycoprotein hormone&lt;/li&gt;&lt;li&gt;â€¢ stimulates erythropoiesis,&lt;/li&gt;&lt;li&gt;â€¢ red blood cell production,&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ used to&lt;/li&gt;&lt;li&gt;â€¢ anemia,&lt;/li&gt;&lt;li&gt;â€¢ chronic kidney disease&lt;/li&gt;&lt;li&gt;â€¢ undergoing chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ increase platelet counts.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron dextran: Iron dextran is an intravenous iron supplement used to treat iron deficiency anemia. It does not stimulate the production of platelets or megakaryocyte progenitors and is not used to treat thrombocytopenia secondary to anticancer therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iron dextran:&lt;/li&gt;&lt;li&gt;â€¢ intravenous iron supplement&lt;/li&gt;&lt;li&gt;â€¢ iron deficiency anemia.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ platelets or megakaryocyte progenitors&lt;/li&gt;&lt;li&gt;â€¢ not used&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia secondary to anticancer therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the hematopoietic growth factors and their role in treatment options for adverse effects of anticancer drugs .  and to recognize that oprelvekin is used for its ability to stimulate progenitor megakaryocytes , leading to an increase in platelet production.&lt;/li&gt;&lt;li&gt;âž¤ hematopoietic growth factors&lt;/li&gt;&lt;li&gt;âž¤ treatment&lt;/li&gt;&lt;li&gt;âž¤ adverse effects&lt;/li&gt;&lt;li&gt;âž¤ anticancer drugs&lt;/li&gt;&lt;li&gt;âž¤ oprelvekin&lt;/li&gt;&lt;li&gt;âž¤ used for its ability to stimulate progenitor megakaryocytes&lt;/li&gt;&lt;li&gt;âž¤ increase in platelet production.&lt;/li&gt;&lt;li&gt;âž¤ Hematopoietic Growth Factors:&lt;/li&gt;&lt;li&gt;âž¤ Hematopoietic Growth Factors:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anticoagulant therapy needs regular monitoring?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Argatroban&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fondaparinux&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Argatroban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Argatroban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enoxaparin: Enoxaparin is a low molecular weight heparin (LMWH) used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). While it has a mor e predictable dose-response relationship compared to unfractionated heparin , routine laboratory monitoring for anticoagulation effect is generally not required in most patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enoxaparin:&lt;/li&gt;&lt;li&gt;â€¢ low molecular weight heparin&lt;/li&gt;&lt;li&gt;â€¢ prevention and treatment of deep vein&lt;/li&gt;&lt;li&gt;â€¢ thrombosis (DVT) and pulmonary embolism (PE).&lt;/li&gt;&lt;li&gt;â€¢ mor&lt;/li&gt;&lt;li&gt;â€¢ dose-response&lt;/li&gt;&lt;li&gt;â€¢ unfractionated heparin&lt;/li&gt;&lt;li&gt;â€¢ laboratory monitoring&lt;/li&gt;&lt;li&gt;â€¢ not required in most patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabigatran: Dabigatran is a direct oral anticoagulant (DOAC) that inhibits thrombin. It is used for stroke prevention in non-valvular atrial fibrillation and treatment of DVT and PE, among other indications. Dabigatran offers the advantage of fixed dosing without the need for routine coagulation monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabigatran:&lt;/li&gt;&lt;li&gt;â€¢ direct oral anticoagulant (DOAC)&lt;/li&gt;&lt;li&gt;â€¢ inhibits thrombin.&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ stroke prevention&lt;/li&gt;&lt;li&gt;â€¢ non-valvular atrial fibrillation&lt;/li&gt;&lt;li&gt;â€¢ treatment of DVT&lt;/li&gt;&lt;li&gt;â€¢ PE,&lt;/li&gt;&lt;li&gt;â€¢ Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ fixed dosing without&lt;/li&gt;&lt;li&gt;â€¢ routine coagulation monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fondaparinux: Fondaparinux is a synthetic pentasaccharide that inhibits factor Xa indirectly by binding to antithrombin . It is used for DVT prevention and treatment and for preventing PE. Like LMWH, fondaparinux generally does not require routine monitoring due to its predictable pharmacokinetic profile.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fondaparinux:&lt;/li&gt;&lt;li&gt;â€¢ synthetic pentasaccharide&lt;/li&gt;&lt;li&gt;â€¢ inhibits factor Xa indirectly&lt;/li&gt;&lt;li&gt;â€¢ binding to antithrombin&lt;/li&gt;&lt;li&gt;â€¢ DVT prevention and treatment&lt;/li&gt;&lt;li&gt;â€¢ preventing PE. Like LMWH, fondaparinux&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ routine&lt;/li&gt;&lt;li&gt;â€¢ monitoring&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand which anticoagulant therapies require regular monitoring and which does not.&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ anticoagulant therapies&lt;/li&gt;&lt;li&gt;âž¤ regular monitoring&lt;/li&gt;&lt;li&gt;âž¤ does not.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is orally active direct Xa inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rivaroxaban&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Argatroban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bivalirudin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rivaroxaban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Rivaroxaban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Option B. Argatroban : Argatroban is a direct thrombin inhibitor, not a Factor Xa inhibitor. It is administered intravenously and is used primarily in patients with heparin-induced thrombocytopenia (HIT).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Argatroban&lt;/li&gt;&lt;li&gt;â€¢ direct thrombin inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ intravenously&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ heparin-induced thrombocytopenia (HIT).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabigatran: Dabigatran is also a direct thrombin inhibitor but differs from argatroban in that it is orally active . It is not a Factor Xa inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabigatran:&lt;/li&gt;&lt;li&gt;â€¢ Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ direct thrombin inhibitor&lt;/li&gt;&lt;li&gt;â€¢ differs from argatroban&lt;/li&gt;&lt;li&gt;â€¢ orally active&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Factor Xa inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bivalirudin: Bivalirudin is another direct thrombin inhibitor, used intravenously, particularly in patients undergoing percutaneous coronary intervention (PCI). It is not a Factor Xa inhibitor and not orally active.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bivalirudin:&lt;/li&gt;&lt;li&gt;â€¢ Bivalirudin&lt;/li&gt;&lt;li&gt;â€¢ another direct thrombin inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ intravenously,&lt;/li&gt;&lt;li&gt;â€¢ percutaneous coronary intervention (PCI).&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Factor Xa inhibitor&lt;/li&gt;&lt;li&gt;â€¢ not orally active.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize the classification of anticoagulant drugs , specifically identifying rivaroxaban as an orally active direct Factor Xa inhibitor.&lt;/li&gt;&lt;li&gt;âž¤ classification of anticoagulant drugs&lt;/li&gt;&lt;li&gt;âž¤ rivaroxaban&lt;/li&gt;&lt;li&gt;âž¤ orally active direct Factor Xa inhibitor.&lt;/li&gt;&lt;li&gt;âž¤ Classification of Anticoagulants&lt;/li&gt;&lt;li&gt;âž¤ Classification of Anticoagulants&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an antifibrinolytic agent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Protamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Epsilon aminocaproic acid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Epsilon aminocaproic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Epsilon aminocaproic acid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Dabigatran is a direct thrombin inhibitor that prevents the formation of blood clots by inhibiting the activity of thrombin, a key enzyme in the clotting process.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ direct thrombin inhibitor&lt;/li&gt;&lt;li&gt;â€¢ prevents&lt;/li&gt;&lt;li&gt;â€¢ blood clots&lt;/li&gt;&lt;li&gt;â€¢ inhibiting&lt;/li&gt;&lt;li&gt;â€¢ activity of thrombin,&lt;/li&gt;&lt;li&gt;â€¢ Option B: Protamine is a medication used to reverse the effects of heparin . Protamine works by binding to heparin , neutralizing its anticoagulant effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Protamine&lt;/li&gt;&lt;li&gt;â€¢ reverse the effects of heparin&lt;/li&gt;&lt;li&gt;â€¢ binding to heparin&lt;/li&gt;&lt;li&gt;â€¢ neutralizing its&lt;/li&gt;&lt;li&gt;â€¢ anticoagulant effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Alteplase is a thrombolytic agent that works by converting plasminogen to plasmin, which breaks down fibrin clots . It is used in cases of acute MI and stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Alteplase&lt;/li&gt;&lt;li&gt;â€¢ thrombolytic agent&lt;/li&gt;&lt;li&gt;â€¢ converting plasminogen to plasmin,&lt;/li&gt;&lt;li&gt;â€¢ breaks down fibrin clots&lt;/li&gt;&lt;li&gt;â€¢ cases of acute MI and stroke.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Epsilon aminocaproic acid and tranexamic acid are antifibrinolytic agents that inhibit the conversion of plasminogen to plasmin, preventing the breakdown of fibrin clots.&lt;/li&gt;&lt;li&gt;â€¢ Epsilon aminocaproic acid&lt;/li&gt;&lt;li&gt;â€¢ tranexamic acid&lt;/li&gt;&lt;li&gt;â€¢ antifibrinolytic agents&lt;/li&gt;&lt;li&gt;â€¢ inhibit the conversion of plasminogen to plasmin, preventing the breakdown of fibrin clots.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are ADP inhibitors except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ticlopidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tirofiban&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tirofiban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Tirofiban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ticlopidine: Ticlopidine is an ADP receptor inhibitor that inhibits platelet aggregation by blocking the P2Y12 ADP recepto r on the platelet surface, making it less responsive to stimuli that cause aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ticlopidine:&lt;/li&gt;&lt;li&gt;â€¢ ADP receptor inhibitor&lt;/li&gt;&lt;li&gt;â€¢ inhibits platelet aggregation&lt;/li&gt;&lt;li&gt;â€¢ blocking the P2Y12 ADP recepto&lt;/li&gt;&lt;li&gt;â€¢ platelet surface,&lt;/li&gt;&lt;li&gt;â€¢ less responsive to stimuli&lt;/li&gt;&lt;li&gt;â€¢ aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Clopidogrel: Clopidogrel is also an ADP receptor inhibitor , similar to ticlopidine, that works by irreversibly inhibiting the P2Y12 subtype of the ADP receptor on platelets, thus reducing platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Clopidogrel:&lt;/li&gt;&lt;li&gt;â€¢ Clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ ADP receptor inhibitor&lt;/li&gt;&lt;li&gt;â€¢ irreversibly inhibiting&lt;/li&gt;&lt;li&gt;â€¢ P2Y12 subtype of the ADP receptor&lt;/li&gt;&lt;li&gt;â€¢ reducing platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prasugrel: Prasugrel is a third example of an ADP receptor inhibitor. It is a prodrug that, once metabolized, inhibits the P2Y12 ADP receptor on platelets , leading to decreased platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prasugrel:&lt;/li&gt;&lt;li&gt;â€¢ ADP receptor inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ prodrug&lt;/li&gt;&lt;li&gt;â€¢ once metabolized,&lt;/li&gt;&lt;li&gt;â€¢ inhibits&lt;/li&gt;&lt;li&gt;â€¢ P2Y12 ADP receptor on platelets&lt;/li&gt;&lt;li&gt;â€¢ decreased platelet aggregation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to identify the classification of antiplatelet drugs, specifically distinguishing ADP receptor inhibitors (ticlopidine, clopidogrel, and prasugrel) from other classes such as glycoprotein IIb/IIIa inhibitors (tirofiban).&lt;/li&gt;&lt;li&gt;âž¤ identify the classification of antiplatelet drugs,&lt;/li&gt;&lt;li&gt;âž¤ ADP receptor inhibitors&lt;/li&gt;&lt;li&gt;âž¤ (ticlopidine, clopidogrel, and prasugrel)&lt;/li&gt;&lt;li&gt;âž¤ other classes&lt;/li&gt;&lt;li&gt;âž¤ glycoprotein IIb/IIIa inhibitors (tirofiban).&lt;/li&gt;&lt;li&gt;âž¤ Antiplatelet Drugs&lt;/li&gt;&lt;li&gt;âž¤ Antiplatelet Drugs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All adverse effects of theophylline are mediated by A1 receptor except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac arrhythmias&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Seizures&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GI discomfort&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. GI discomfort&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture2_UZNUPoT.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. GI discomfort&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac arrhythmias: These are associated with adenosine A1 receptor antagonism , which can increase the likelihood of arrhythmias due to increased cardiac excitability.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac arrhythmias:&lt;/li&gt;&lt;li&gt;â€¢ adenosine A1 receptor antagonism&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ increased cardiac excitability.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diuresis: Theophylline increases urine production partly through its antagonistic effects on adenosine A1 receptors, which normally promote sodium and water reabsorption.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diuresis:&lt;/li&gt;&lt;li&gt;â€¢ Theophylline increases urine production&lt;/li&gt;&lt;li&gt;â€¢ antagonistic effects on adenosine A1 receptors,&lt;/li&gt;&lt;li&gt;â€¢ normally promote sodium and water reabsorption.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Seizures: Also mediated by adenosine A1 receptor antagonism; adenosine typically has a neuroprotective role, and blocking its receptors increases seizure risk.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Seizures:&lt;/li&gt;&lt;li&gt;â€¢ adenosine A1 receptor antagonism;&lt;/li&gt;&lt;li&gt;â€¢ adenosine&lt;/li&gt;&lt;li&gt;â€¢ neuroprotective role,&lt;/li&gt;&lt;li&gt;â€¢ blocking its receptors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Side effects of theophylline and proposed mechanisms&lt;/li&gt;&lt;li&gt;âž¤ Side effects of theophylline and proposed mechanisms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not an adverse effect of salbutamol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tolerance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalaemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hypoglycaemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tachycardia: Salbutamol can cause tachycardia, particularly at high doses due to loss of selectivity for beta-2 receptors, impacting heart rate and potentially leading to palpitations or an uncomfortable awareness of the heartbeat.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tachycardia:&lt;/li&gt;&lt;li&gt;â€¢ Salbutamol&lt;/li&gt;&lt;li&gt;â€¢ tachycardia,&lt;/li&gt;&lt;li&gt;â€¢ high doses&lt;/li&gt;&lt;li&gt;â€¢ loss of selectivity for beta-2 receptors,&lt;/li&gt;&lt;li&gt;â€¢ heart rate&lt;/li&gt;&lt;li&gt;â€¢ leading to palpitations&lt;/li&gt;&lt;li&gt;â€¢ uncomfortable awareness of the heartbeat.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tolerance: With regular use of low doses of beta-2 agonists like salbutamol, there is evidence showing a reduction in the bronchodilator response, indicating tolerance. However, maximal bronchodilation is still achievable within the usual dosage range.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tolerance:&lt;/li&gt;&lt;li&gt;â€¢ low doses of beta-2 agonists&lt;/li&gt;&lt;li&gt;â€¢ salbutamol,&lt;/li&gt;&lt;li&gt;â€¢ reduction in the&lt;/li&gt;&lt;li&gt;â€¢ bronchodilator response,&lt;/li&gt;&lt;li&gt;â€¢ tolerance.&lt;/li&gt;&lt;li&gt;â€¢ maximal bronchodilation&lt;/li&gt;&lt;li&gt;â€¢ still&lt;/li&gt;&lt;li&gt;â€¢ usual dosage range.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypokalemia: Salbutamol may lead to hypokalemia due to an intracellular shift of potassium . This side effect is significant because it can result in changes to the ECG, indicating disturbances in heart rhythm that could be serious.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypokalemia:&lt;/li&gt;&lt;li&gt;â€¢ hypokalemia&lt;/li&gt;&lt;li&gt;â€¢ intracellular shift of potassium&lt;/li&gt;&lt;li&gt;â€¢ changes to the ECG,&lt;/li&gt;&lt;li&gt;â€¢ heart rhythm&lt;/li&gt;&lt;li&gt;â€¢ serious.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Adverse Effects of beta-2 agonists&lt;/li&gt;&lt;li&gt;âž¤ Adverse Effects of beta-2 agonists&lt;/li&gt;&lt;li&gt;âž¤ Tremors: Most common adverse effect of beta 2 agonists is tremors. It occurs due to stimulation of beta 2 receptors on skeletal muscle spindles. Tachycardia: At high dose , beta 2 agonists can result in tachycardia due to loss of selectivity. T-wave changes in ECG: Beta 2 agonists can result in hypokalaemia due to intracellular shift of potassium. This can lead to ECG changes. Tolerance : A reduction in the bronchodilator response to low-dose Î²-agonist treatment can be shown after several days of regular Î²-agonist use , but maximal bronchodilation is still achieved well within the range of doses usually given.&lt;/li&gt;&lt;li&gt;âž¤ Tremors: Most common adverse effect of beta 2 agonists is tremors. It occurs due to stimulation of beta 2 receptors on skeletal muscle spindles.&lt;/li&gt;&lt;li&gt;âž¤ Tremors:&lt;/li&gt;&lt;li&gt;âž¤ adverse effect of beta 2 agonists&lt;/li&gt;&lt;li&gt;âž¤ beta 2 receptors on&lt;/li&gt;&lt;li&gt;âž¤ skeletal muscle spindles.&lt;/li&gt;&lt;li&gt;âž¤ Tachycardia: At high dose , beta 2 agonists can result in tachycardia due to loss of selectivity.&lt;/li&gt;&lt;li&gt;âž¤ Tachycardia:&lt;/li&gt;&lt;li&gt;âž¤ high dose&lt;/li&gt;&lt;li&gt;âž¤ beta 2 agonists&lt;/li&gt;&lt;li&gt;âž¤ tachycardia due to loss of selectivity.&lt;/li&gt;&lt;li&gt;âž¤ T-wave changes in ECG: Beta 2 agonists can result in hypokalaemia due to intracellular shift of potassium. This can lead to ECG changes.&lt;/li&gt;&lt;li&gt;âž¤ T-wave&lt;/li&gt;&lt;li&gt;âž¤ Beta 2 agonists&lt;/li&gt;&lt;li&gt;âž¤ hypokalaemia&lt;/li&gt;&lt;li&gt;âž¤ intracellular shift of potassium.&lt;/li&gt;&lt;li&gt;âž¤ Tolerance : A reduction in the bronchodilator response to low-dose Î²-agonist treatment can be shown after several days of regular Î²-agonist use , but maximal bronchodilation is still achieved well within the range of doses usually given.&lt;/li&gt;&lt;li&gt;âž¤ Tolerance&lt;/li&gt;&lt;li&gt;âž¤ reduction in the bronchodilator response&lt;/li&gt;&lt;li&gt;âž¤ low-dose&lt;/li&gt;&lt;li&gt;âž¤ after several days&lt;/li&gt;&lt;li&gt;âž¤ regular Î²-agonist use&lt;/li&gt;&lt;li&gt;âž¤ maximal bronchodilation is still&lt;/li&gt;&lt;li&gt;âž¤ within&lt;/li&gt;&lt;li&gt;âž¤ range of doses usually given.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the drug of choice for treatment of chemotherapy-induced vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granisetron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dimenhydrinate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Granisetron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Granisetron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prazosin: Incorrect because Prazosin is an alpha-1 blocker used primarily for managing hypertension and benign prostatic hyperplasia, not for vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prazosin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Clonidine: Incorrect as Clonidine is an alpha-2 agonist, used mainly for hypertension, ADHD, and anxiety disorders, and does not have a primary role in controlling chemotherapy-induced vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Clonidine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dimenhydrinate: Incorrect because Dimenhydrinate, an antihistamine, is primarily used for motion sickness and vertigo. While it can treat nausea and vomiting, it is not the drug of choice for chemotherapy-induced vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dimenhydrinate:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Granisetron is the drug of choice for managing chemotherapy-induced vomiting due to its effective inhibition of 5-HT3 receptors, critical in blocking the emetic pathway triggered by chemotherapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the incorrect statement regarding proton pump inhibitors:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Available as enteric coated tablets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acts from the luminal side of gastric parietal cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactive at neutral pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Should be taken on empty stomach&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acts from the luminal side of gastric parietal cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acts from the luminal side of gastric parietal cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Available as enteric coated tablets: This statement is correct . All PPIs are administered orally in enteric coated form to protect them from molecular transformation in the acidic gastric juice.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Available as enteric coated tablets:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ PPIs&lt;/li&gt;&lt;li&gt;â€¢ orally&lt;/li&gt;&lt;li&gt;â€¢ enteric coated form&lt;/li&gt;&lt;li&gt;â€¢ protect&lt;/li&gt;&lt;li&gt;â€¢ from molecular transformation in the acidic gastric juice.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inactive at neutral pH: This statement is correct. Omeprazole is inactive at neutral pH , but at pH less than 5, it rearranges to two charged cationic forms (a sulphenic acid and a sulphenamide configurations ) that react covalently with SH groups of the H+K+ATPase enzyme and inactivate it irreversibly.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inactive at neutral pH:&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ inactive&lt;/li&gt;&lt;li&gt;â€¢ neutral pH&lt;/li&gt;&lt;li&gt;â€¢ pH less than 5,&lt;/li&gt;&lt;li&gt;â€¢ two charged cationic forms&lt;/li&gt;&lt;li&gt;â€¢ sulphenic acid&lt;/li&gt;&lt;li&gt;â€¢ sulphenamide configurations&lt;/li&gt;&lt;li&gt;â€¢ covalently with SH groups&lt;/li&gt;&lt;li&gt;â€¢ H+K+ATPase enzyme&lt;/li&gt;&lt;li&gt;â€¢ inactivate it irreversibly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Should be taken on an empty stomach: This statement is correct. Bioavailability of a ll PPIs is reduced by food; they should be taken on an empty stomach, followed 1 hour later by a meal to activate the H+K+ ATPase and make it more susceptible to the PPI.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Should be taken on an empty stomach:&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ Bioavailability&lt;/li&gt;&lt;li&gt;â€¢ ll PPIs is reduced&lt;/li&gt;&lt;li&gt;â€¢ food;&lt;/li&gt;&lt;li&gt;â€¢ empty stomach,&lt;/li&gt;&lt;li&gt;â€¢ 1 hour later&lt;/li&gt;&lt;li&gt;â€¢ activate the H+K+ ATPase&lt;/li&gt;&lt;li&gt;â€¢ more susceptible to&lt;/li&gt;&lt;li&gt;â€¢ the PPI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Proton pump inhibitors should be administered on an empty stomach to ensure maximum absorption and effectiveness . This should be followed by a meal an hour later to enhance the activation of gastric acid pumps, making them more susceptible to inhibition by the drug.&lt;/li&gt;&lt;li&gt;âž¤ Proton pump inhibitors&lt;/li&gt;&lt;li&gt;âž¤ administered on an empty stomach&lt;/li&gt;&lt;li&gt;âž¤ maximum absorption and effectiveness&lt;/li&gt;&lt;li&gt;âž¤ a meal an hour later to enhance the activation of gastric acid pumps,&lt;/li&gt;&lt;li&gt;âž¤ more susceptible&lt;/li&gt;&lt;li&gt;âž¤ inhibition by the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are effective against Pseudomonas aeruginosa EXCEPT.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Piperacillin-Tazobactam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Imipenem-cilstatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture22.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture23.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorrect because Piperacillin-Tazobactam is a penicillin antibiotic combined with a beta-lactamase inhibitor, effective against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Piperacillin-Tazobactam is a penicillin antibiotic&lt;/li&gt;&lt;li&gt;â€¢ beta-lactamase inhibitor, effective&lt;/li&gt;&lt;li&gt;â€¢ against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Incorrect because Cefoperazone is a third-generation cephalosporin with activity against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Cefoperazone is a third-generation cephalosporin&lt;/li&gt;&lt;li&gt;â€¢ activity against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorrect because Imipenem-cilastatin is a carbapenem antibiotic that is effective against a broad spectrum of bacteria , including Pseudomonas aeruginosa .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Imipenem-cilastatin&lt;/li&gt;&lt;li&gt;â€¢ carbapenem antibiotic&lt;/li&gt;&lt;li&gt;â€¢ effective against a broad spectrum of bacteria&lt;/li&gt;&lt;li&gt;â€¢ Pseudomonas aeruginosa&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Pseudomonal Drugs&lt;/li&gt;&lt;li&gt;âž¤ Anti-Pseudomonal Drugs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pre-XDR TB is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone and streptomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone, linezolide and bedaquiline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MDR plus resistance to amikacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. MDR plus resistance to fluoroquinolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture39.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. MDR plus resistance to fluoroquinolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: While resistance to streptomycin may occur, it does not define Pre-XDR TB; the critical factor is resistance to fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ resistance to streptomycin&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ Pre-XDR TB;&lt;/li&gt;&lt;li&gt;â€¢ critical factor&lt;/li&gt;&lt;li&gt;â€¢ resistance&lt;/li&gt;&lt;li&gt;â€¢ fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ Option C: The definition provided in this option refers to extensively drug-resistant TB (XDR-TB), not Pre-XDR TB.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ definition&lt;/li&gt;&lt;li&gt;â€¢ extensively drug-resistant TB (XDR-TB),&lt;/li&gt;&lt;li&gt;â€¢ Option D: Resistance to amikacin alone , in addition to MDR-TB , does not define Pre-XDR TB without concurrent resistance to fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Resistance to amikacin alone&lt;/li&gt;&lt;li&gt;â€¢ MDR-TB&lt;/li&gt;&lt;li&gt;â€¢ does not define Pre-XDR TB without concurrent resistance to fluoroquinolones.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents to the emergency department with a fever, headache, and muscle aches. He reports a recent camping trip in a rural area where he was exposed to ticks. On examination, there is a characteristic eschar at the site of a tick bite, as well as regional lymphadenopathy. Laboratory tests reveal thrombocytopenia and elevated liver enzymes. Based on the clinical presentation and laboratory findings, the healthcare provider suspects scrub typhus. What is the drug of choice for scrub typhus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sulfonamides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Doxycycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Doxycycline.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Erythromycin: While it can be used for some rickettsial diseases, it is not the first-line treatment for scrub typhus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Erythromycin:&lt;/li&gt;&lt;li&gt;â€¢ used for&lt;/li&gt;&lt;li&gt;â€¢ rickettsial diseases,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ first-line treatment for scrub typhus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metronidazole: This is primarily used for anaerobic bacterial infections and certain protozoal infections , not for scrub typhus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Metronidazole:&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ anaerobic bacterial infections&lt;/li&gt;&lt;li&gt;â€¢ protozoal infections&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sulfonamides: These are not effective against the organism that causes scrub typhus.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sulfonamides:&lt;/li&gt;&lt;li&gt;â€¢ not effective against&lt;/li&gt;&lt;li&gt;â€¢ causes scrub typhus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Doxycycline is the drug of choice for scrub typhus due to its effectiveness in treating infections caused by Orientia tsutsugamushi . Early treatment is crucial to prevent complications and improve outcomes in patients with this condition.&lt;/li&gt;&lt;li&gt;âž¤ Doxycycline&lt;/li&gt;&lt;li&gt;âž¤ drug of choice&lt;/li&gt;&lt;li&gt;âž¤ scrub typhus&lt;/li&gt;&lt;li&gt;âž¤ its effectiveness&lt;/li&gt;&lt;li&gt;âž¤ Orientia tsutsugamushi&lt;/li&gt;&lt;li&gt;âž¤ Early treatment&lt;/li&gt;&lt;li&gt;âž¤ prevent complications and improve outcomes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following anti-HIV drugs and their mechanism of action are correctly matched EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Raltegravir - Integrase inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indinavir - Protease inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nevirapine - Nonnucleoside reverse transcriptase inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Darunavir- Fusion inhibitor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Darunavir- Fusion inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture19.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture20.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Darunavir-Fusion inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Correct because Raltegravir is an Integrase Strand Transfer Inhibitor (INSTI), which inhibits the integrase enzyme responsible for the integration of viral DNA into the host cell genome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Raltegravir&lt;/li&gt;&lt;li&gt;â€¢ Integrase Strand Transfer Inhibitor (INSTI),&lt;/li&gt;&lt;li&gt;â€¢ inhibits&lt;/li&gt;&lt;li&gt;â€¢ integrase enzyme&lt;/li&gt;&lt;li&gt;â€¢ integration of viral DNA into the host cell genome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Correct becaus e Indinavir is a Protease Inhibitor (PI) , which inhibits the HIV protease enzyme necessary for the maturation of the viral particle.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ e Indinavir is a Protease Inhibitor (PI)&lt;/li&gt;&lt;li&gt;â€¢ inhibits the HIV protease enzyme&lt;/li&gt;&lt;li&gt;â€¢ maturation of the viral particle.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct because Nevirapine is a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) , which binds directly to the reverse transcriptase enzyme and inhibits its function.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Nevirapine is a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)&lt;/li&gt;&lt;li&gt;â€¢ binds&lt;/li&gt;&lt;li&gt;â€¢ reverse transcriptase enzyme&lt;/li&gt;&lt;li&gt;â€¢ inhibits its function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-retroviral Drug&lt;/li&gt;&lt;li&gt;âž¤ Anti-retroviral Drug&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are bacteriostatic except.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tetracycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Linezolid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clindamycin : This is a bacteriostatic antibiotic that works by inhibiting protein synthesis. It binds to the 50S subunit of the bacterial ribosome , preventing the elongation of the peptide chain during translation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Clindamycin&lt;/li&gt;&lt;li&gt;â€¢ bacteriostatic antibiotic&lt;/li&gt;&lt;li&gt;â€¢ inhibiting protein synthesis.&lt;/li&gt;&lt;li&gt;â€¢ 50S subunit of the&lt;/li&gt;&lt;li&gt;â€¢ bacterial ribosome&lt;/li&gt;&lt;li&gt;â€¢ elongation of the peptide chain&lt;/li&gt;&lt;li&gt;â€¢ translation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tetracycline : Also bacteriostatic, tetracycline inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome, blocking the attachment of tRNA to the ribosome and thus preventing the addition of amino acids to the growing peptide chain.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Tetracycline&lt;/li&gt;&lt;li&gt;â€¢ bacteriostatic,&lt;/li&gt;&lt;li&gt;â€¢ inhibits protein synthesis by binding to the 30S subunit of the bacterial&lt;/li&gt;&lt;li&gt;â€¢ ribosome,&lt;/li&gt;&lt;li&gt;â€¢ blocking&lt;/li&gt;&lt;li&gt;â€¢ tRNA to the ribosome&lt;/li&gt;&lt;li&gt;â€¢ preventing&lt;/li&gt;&lt;li&gt;â€¢ amino acids to the growing peptide chain.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Linezolid : Linezolid is bacteriostatic and inhibits protein synthesis by binding to the 50S subunit of the bacterial ribosome in a manner that prevents the formation of a functional 70S initiation complex, which is essential for the bacterial translation process.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Linezolid&lt;/li&gt;&lt;li&gt;â€¢ bacteriostatic&lt;/li&gt;&lt;li&gt;â€¢ inhibits protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ binding to the 50S subunit&lt;/li&gt;&lt;li&gt;â€¢ bacterial ribosome&lt;/li&gt;&lt;li&gt;â€¢ prevents the formation of a functional 70S initiation complex,&lt;/li&gt;&lt;li&gt;â€¢ bacterial translation&lt;/li&gt;&lt;li&gt;â€¢ process.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An important bactericidal drug is remembered as BEVAFA.&lt;/li&gt;&lt;li&gt;âž¤ An important bactericidal drug is remembered as BEVAFA.&lt;/li&gt;&lt;li&gt;âž¤ BE: BE ta lactams&lt;/li&gt;&lt;li&gt;âž¤ BE: BE&lt;/li&gt;&lt;li&gt;âž¤ VA: Va ncomycin&lt;/li&gt;&lt;li&gt;âž¤ VA: Va&lt;/li&gt;&lt;li&gt;âž¤ F: F luoroquinoles (floxacins)&lt;/li&gt;&lt;li&gt;âž¤ F: F&lt;/li&gt;&lt;li&gt;âž¤ A: A minoglycosides&lt;/li&gt;&lt;li&gt;âž¤ A: A&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antibiotic used for ESBL [Extended spectrum Î² lactamase] producing Klebsiella infection is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spectinomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbapenem&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aztreonam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Carbapenem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Carbapenem&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spectinomycin : This antibiotic, generally used for gonorrhea, is not effective against ESBL-producing Klebsiella due to its different target and mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Spectinomycin&lt;/li&gt;&lt;li&gt;â€¢ used for gonorrhea,&lt;/li&gt;&lt;li&gt;â€¢ not effective against ESBL-producing Klebsiella&lt;/li&gt;&lt;li&gt;â€¢ different target and mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aztreonam : Although a monobactam antibiotic , aztreonam is not effective against ESBL-producing Klebsiella because it is hydrolyzed by the ESBL enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Aztreonam&lt;/li&gt;&lt;li&gt;â€¢ monobactam antibiotic&lt;/li&gt;&lt;li&gt;â€¢ aztreonam is not effective against ESBL-producing Klebsiella&lt;/li&gt;&lt;li&gt;â€¢ hydrolyzed by the ESBL enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Streptomycin : This antibiotic, part of the aminoglycoside family, is primarily effective against Gram-positive and certain Gram-negative bacteria but does not cover ESBL-producing Klebsiella.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Streptomycin&lt;/li&gt;&lt;li&gt;â€¢ aminoglycoside family,&lt;/li&gt;&lt;li&gt;â€¢ effective against Gram-positive&lt;/li&gt;&lt;li&gt;â€¢ Gram-negative bacteria&lt;/li&gt;&lt;li&gt;â€¢ does not cover ESBL-producing Klebsiella.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For infections caused by ESBL-producing Klebsiella , carbapenems are the recommended antibiotics due to their ability to resist degradation by ESBL enzymes and their broad-spectrum efficacy. This is crucial for effectively managing and treating these resistant infections.&lt;/li&gt;&lt;li&gt;âž¤ ESBL-producing Klebsiella&lt;/li&gt;&lt;li&gt;âž¤ carbapenems&lt;/li&gt;&lt;li&gt;âž¤ antibiotics&lt;/li&gt;&lt;li&gt;âž¤ their ability to resist&lt;/li&gt;&lt;li&gt;âž¤ degradation by ESBL enzymes&lt;/li&gt;&lt;li&gt;âž¤ broad-spectrum efficacy.&lt;/li&gt;&lt;li&gt;âž¤ crucial&lt;/li&gt;&lt;li&gt;âž¤ effectively managing and treating these resistant infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antimalarial drug has gametocidal action against all species of Plasmodia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primaquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Artesunate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Primaquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Primaquine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Quinine : While quinine has some activity against the gametocytes of P. vivax , it does not have broad gametocidal activity against all Plasmodium species, especially not against P. falciparum gametocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Quinine&lt;/li&gt;&lt;li&gt;â€¢ quinine&lt;/li&gt;&lt;li&gt;â€¢ against&lt;/li&gt;&lt;li&gt;â€¢ gametocytes of P. vivax ,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ not against P. falciparum gametocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloroquine : Similar to quinine, chloroquine is effective against P. vivax gametocytes but lacks gametocidal activity against all species, particularly failing against P. falciparum .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Chloroquine&lt;/li&gt;&lt;li&gt;â€¢ Similar to quinine,&lt;/li&gt;&lt;li&gt;â€¢ against P. vivax gametocytes&lt;/li&gt;&lt;li&gt;â€¢ lacks gametocidal activity&lt;/li&gt;&lt;li&gt;â€¢ against P. falciparum .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Artesunate : Although artesunate is a very effective antimalarial, especially for the treatment of severe malaria, it does not have inherent gametocidal properties against Plasmodium species. However, it can enhance the gametocidal effects of other drugs when used in combination.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Artesunate&lt;/li&gt;&lt;li&gt;â€¢ artesunate is a very effective antimalarial,&lt;/li&gt;&lt;li&gt;â€¢ severe malaria,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ inherent gametocidal&lt;/li&gt;&lt;li&gt;â€¢ Plasmodium species.&lt;/li&gt;&lt;li&gt;â€¢ gametocidal effects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primaquine is the only antimalarial drug listed that has the capability to exert gametocidal action against all species of Plasmodium . This makes it a vital component of the malaria eradication strategy, particularly in efforts aimed at preventing the transmission of the disease.&lt;/li&gt;&lt;li&gt;âž¤ Primaquine&lt;/li&gt;&lt;li&gt;âž¤ antimalarial drug&lt;/li&gt;&lt;li&gt;âž¤ exert gametocidal action against all species of Plasmodium .&lt;/li&gt;&lt;li&gt;âž¤ malaria eradication strategy,&lt;/li&gt;&lt;li&gt;âž¤ preventing the&lt;/li&gt;&lt;li&gt;âž¤ transmission of the disease.&lt;/li&gt;&lt;li&gt;âž¤ When treating malaria, particularly P. vivax or P. ovale , primaquine is used to ensure the clearance of liver stages and to prevent relapse, highlighting its critical role in comprehensive malaria treatment protocols.&lt;/li&gt;&lt;li&gt;âž¤ treating malaria, particularly P. vivax or P. ovale , primaquine&lt;/li&gt;&lt;li&gt;âž¤ clearance of liver stages&lt;/li&gt;&lt;li&gt;âž¤ to prevent&lt;/li&gt;&lt;li&gt;âž¤ relapse,&lt;/li&gt;&lt;li&gt;âž¤ highlighting&lt;/li&gt;&lt;li&gt;âž¤ comprehensive malaria treatment protocols.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During the investigation for an outbreak of MRSA in the hospital, it was found that a nurse of NICU had MRSA colonization of anterior nares. What is the best treatment for her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Topical Mupirocin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhaled colistin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV cefazolin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Topical Mupirocin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Topical Mupirocin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral Vancomycin : Incorrect . Oral vancomycin is not absorbed from the gastrointestinal tract and thus is ineffective for treating MRSA colonization of the nares . It is used primarily to treat colitis caused by Clostridium difficile.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Oral Vancomycin&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ ineffective&lt;/li&gt;&lt;li&gt;â€¢ MRSA colonization of the nares&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ colitis&lt;/li&gt;&lt;li&gt;â€¢ Clostridium difficile.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhaled colistin : Incorrect. Colistin is used to treat infections caused by certain multi-resistant Gram-negative bacteria, typically in the lungs (e.g., for cystic fibrosis patients), and is not suitable for decolonization of MRSA in the nares.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Inhaled colistin&lt;/li&gt;&lt;li&gt;â€¢ Incorrect. Colistin&lt;/li&gt;&lt;li&gt;â€¢ certain multi-resistant Gram-negative bacteria,&lt;/li&gt;&lt;li&gt;â€¢ lungs (e.g., for cystic fibrosis patients),&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV cefazolin : Incorrect . Cefazolin is ineffective against MRSA due to the bacteriumâ€™s resistance mechanisms , and it is typically not used for nasal decolonization.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. IV cefazolin&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Cefazolin&lt;/li&gt;&lt;li&gt;â€¢ ineffective against MRSA&lt;/li&gt;&lt;li&gt;â€¢ bacteriumâ€™s resistance mechanisms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Topical Mupirocin is the first-line treatment for decolonization of MRSA in the anterior nares, especially in healthcare workers or patients where MRSA carriage poses a significant risk of infection transmission . This measure is part of infection control protocols to minimize the spread of MRSA in healthcare facilities.&lt;/li&gt;&lt;li&gt;âž¤ Topical Mupirocin&lt;/li&gt;&lt;li&gt;âž¤ first-line&lt;/li&gt;&lt;li&gt;âž¤ decolonization of MRSA&lt;/li&gt;&lt;li&gt;âž¤ anterior nares,&lt;/li&gt;&lt;li&gt;âž¤ healthcare workers or&lt;/li&gt;&lt;li&gt;âž¤ patients where MRSA carriage&lt;/li&gt;&lt;li&gt;âž¤ risk of infection transmission&lt;/li&gt;&lt;li&gt;âž¤ part of infection control protocols to minimize the spread of MRSA in healthcare facilities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antimicrobial resistance to which of the following drugs develop by synthesis of inactivating enzymes? Aminoglycosides Beta lactams Chloramphenicol Fluoroquinolones&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;I, II and III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;I and II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;II and IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;I, II, III and IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. I, II and III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture27.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. I, II and III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The following are mechanisms of drug resistance against antimicrobials:&lt;/li&gt;&lt;li&gt;âž¤ The following are mechanisms of drug resistance against antimicrobials:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Tafenoquine is a recently approved new drug. It is indicated for?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radical cure of P.vivax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prophylaxis of malaria in pregnancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Treatment of severe falciparum malaria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment in children &amp;lt; 2 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Radical cure of P.vivax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Radical cure of P. vivax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prophylaxis of malaria in pregnancy: This is not an indication for tafenoquine, as it can cause hemolysis in patients with G-6-PD deficiency, a condition that canno t be ruled out in the fetus, making it contraindicated during pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prophylaxis of malaria in pregnancy:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ indication for tafenoquine,&lt;/li&gt;&lt;li&gt;â€¢ hemolysis in patients&lt;/li&gt;&lt;li&gt;â€¢ G-6-PD deficiency,&lt;/li&gt;&lt;li&gt;â€¢ canno&lt;/li&gt;&lt;li&gt;â€¢ fetus,&lt;/li&gt;&lt;li&gt;â€¢ contraindicated during pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Treatment of severe falciparum malaria : Tafenoquine is not indicated for the treatment of severe falciparum malaria , where other medications such as intravenous artesunate are the treatments of choice.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Treatment of severe falciparum malaria&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ treatment of severe falciparum malaria&lt;/li&gt;&lt;li&gt;â€¢ intravenous artesunate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Treatment in children &amp;lt; 2 years: The drug is not approved for use in children under the age of 16 due to the lack of safety data and the risk of hemolysis , especially in those with G-6-PD deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Treatment in children &amp;lt; 2 years:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ children under the age of 16&lt;/li&gt;&lt;li&gt;â€¢ lack of safety&lt;/li&gt;&lt;li&gt;â€¢ data and the risk of hemolysis&lt;/li&gt;&lt;li&gt;â€¢ G-6-PD deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Tafenoquine is a valuable addition to the antimalarial arsenal, especially for the radical cure of P. vivax, which is notorious for causing relapses. However, it must be used cautiously considering its contraindications, including G-6-PD deficiency, pregnancy, and age restrictions.&lt;/li&gt;&lt;li&gt;â€¢ Tafenoquine&lt;/li&gt;&lt;li&gt;â€¢ antimalarial arsenal,&lt;/li&gt;&lt;li&gt;â€¢ radical cure of P. vivax,&lt;/li&gt;&lt;li&gt;â€¢ notorious&lt;/li&gt;&lt;li&gt;â€¢ causing relapses.&lt;/li&gt;&lt;li&gt;â€¢ cautiously&lt;/li&gt;&lt;li&gt;â€¢ contraindications,&lt;/li&gt;&lt;li&gt;â€¢ G-6-PD deficiency, pregnancy,&lt;/li&gt;&lt;li&gt;â€¢ age restrictions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common dose dependent adverse effect of Amphotericin B is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fever and chills&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephrotoxicity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Nephrotoxicity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Nephrotoxicity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fever and chills : These are indeed common side effects of Amphotericin B, typically manifesting as part of an infusion - related reaction; however, they are not dose-dependent and can often be managed with premedication.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Fever and chills&lt;/li&gt;&lt;li&gt;â€¢ common side effects of Amphotericin B,&lt;/li&gt;&lt;li&gt;â€¢ infusion&lt;/li&gt;&lt;li&gt;â€¢ related reaction;&lt;/li&gt;&lt;li&gt;â€¢ not dose-dependent&lt;/li&gt;&lt;li&gt;â€¢ managed with premedication.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperkalemia : This choice is incorrect ; Amphotericin B actually more commonly causes hypokalemia, not hyperkalemia, as part of its electrolyte imbalances.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Hyperkalemia&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ commonly causes hypokalemia,&lt;/li&gt;&lt;li&gt;â€¢ electrolyte imbalances.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anemia : While anemia can occur with Amphotericin B use , it is not the most common nor the most prominent dose-dependent adverse effect compared to nephrotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Anemia&lt;/li&gt;&lt;li&gt;â€¢ Amphotericin B use&lt;/li&gt;&lt;li&gt;â€¢ not the most common&lt;/li&gt;&lt;li&gt;â€¢ nor the most prominent dose-dependent&lt;/li&gt;&lt;li&gt;â€¢ nephrotoxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most significant dose-dependent adverse effect of Amphotericin B is nephrotoxicity . Recognizing and managing this risk is crucial, particularly in patients receiving prolonged treatment , and using liposomal formulations can help reduce this risk.&lt;/li&gt;&lt;li&gt;âž¤ dose-dependent adverse effect of Amphotericin B is nephrotoxicity&lt;/li&gt;&lt;li&gt;âž¤ Recognizing and managing&lt;/li&gt;&lt;li&gt;âž¤ crucial,&lt;/li&gt;&lt;li&gt;âž¤ prolonged treatment&lt;/li&gt;&lt;li&gt;âž¤ using liposomal formulations&lt;/li&gt;&lt;li&gt;âž¤ reduce this risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs acts by inhibiting bacterial RNA polymerase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aminoglycoside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Macrolide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cephalosporin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rifampicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Rifampicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aminoglycoside : Incorrect. Aminoglycosides interfere with bacterial protein synthesis by binding to the bacterial 30S ribosomal subunit, causing a misreading of mRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Aminoglycoside&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ bacterial protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ bacterial 30S&lt;/li&gt;&lt;li&gt;â€¢ ribosomal subunit,&lt;/li&gt;&lt;li&gt;â€¢ misreading of mRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Macrolide : Incorrect . Macrolides also target bacterial protein synthesis, but they do this by binding to the 50S subunit of the bacterial ribosome, preventing translocation during protein elongation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Macrolide&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ target bacterial protein synthesis,&lt;/li&gt;&lt;li&gt;â€¢ binding to the 50S subunit&lt;/li&gt;&lt;li&gt;â€¢ bacterial ribosome,&lt;/li&gt;&lt;li&gt;â€¢ preventing translocation&lt;/li&gt;&lt;li&gt;â€¢ protein elongation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cephalosporin : Incorrect. Cephalosporins belong to the beta-lactam class of antibiotics and disrupt bacterial cell wall synthesis , not RNA polymerase.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Cephalosporin&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ beta-lactam class of antibiotics&lt;/li&gt;&lt;li&gt;â€¢ disrupt bacterial cell wall&lt;/li&gt;&lt;li&gt;â€¢ synthesis&lt;/li&gt;&lt;li&gt;â€¢ not RNA polymerase.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rifampicin uniquely inhibits bacterial RNA polymerase, distinguishing it from other classes of antibiotics that either target bacterial protein synthesis (aminoglycosides, macrolides) or cell wall synthesis (cephalosporins) . This mechanism underlines the effectiveness of Rifampicin in treating infections like tuberculosis and leprosy.&lt;/li&gt;&lt;li&gt;âž¤ Rifampicin&lt;/li&gt;&lt;li&gt;âž¤ inhibits bacterial RNA polymerase,&lt;/li&gt;&lt;li&gt;âž¤ classes of antibiotics&lt;/li&gt;&lt;li&gt;âž¤ target bacterial&lt;/li&gt;&lt;li&gt;âž¤ protein synthesis (aminoglycosides, macrolides) or cell wall synthesis (cephalosporins)&lt;/li&gt;&lt;li&gt;âž¤ Rifampicin&lt;/li&gt;&lt;li&gt;âž¤ tuberculosis and leprosy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are penicillinase resistant penicillins EXCEPT.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dicloxacillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cloxacillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methicillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ampicillin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ampicillin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Correct because Dicloxacillin is a penicillinase-resistant penicillin.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Correct because Cloxacillin is a penicillinase-resistant penicillin.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Correct because Methicillin was the first penicillinase-resistant penicillin developed.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ ( Note - Historically important, but no longer in clinical use due to the high incidence of nephrotoxicity)&lt;/li&gt;&lt;li&gt;â€¢ Note&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Penicillinase resistant penicillinâ€™s are:&lt;/li&gt;&lt;li&gt;âž¤ Penicillinase resistant penicillinâ€™s are:&lt;/li&gt;&lt;li&gt;âž¤ C: C loxacillin&lt;/li&gt;&lt;li&gt;âž¤ C: C&lt;/li&gt;&lt;li&gt;âž¤ O: O xacillin&lt;/li&gt;&lt;li&gt;âž¤ O: O&lt;/li&gt;&lt;li&gt;âž¤ N: N afcillin&lt;/li&gt;&lt;li&gt;âž¤ N: N&lt;/li&gt;&lt;li&gt;âž¤ D: D icloxacillin&lt;/li&gt;&lt;li&gt;âž¤ D: D&lt;/li&gt;&lt;li&gt;âž¤ O:&lt;/li&gt;&lt;li&gt;âž¤ O:&lt;/li&gt;&lt;li&gt;âž¤ M: M ethicillin&lt;/li&gt;&lt;li&gt;âž¤ M: M&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child is started on chemotherapy. One of the medications used in the treatment is L-asparaginase. This drug works by depleting asparagine, an amino acid that is required for the growth and survival of leukemia cells. Which of the following cancers is L-asparaginase commonly used to treat?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia (ALL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Myeloblastic Leukemia (AML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic lymphocyctic leukemia (CLL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic Myelocytic Leukemia (CML)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute lymphoblastic leukemia (ALL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute lymphoblastic leukemia (ALL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute Myeloblastic Leukemia (AML): AML is another type of leukemia but primarily affects different lineages of cells within the bone marrow . L-asparaginase is not typically used in the treatment of AML.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute Myeloblastic Leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ type of leukemia&lt;/li&gt;&lt;li&gt;â€¢ different lineages of cells&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ L-asparaginase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ AML.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic lymphocytic leukemia (CLL): CLL progresses more slowly than ALL and generally affects older adults. It is not treated with L-asparaginase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic lymphocytic leukemia (CLL):&lt;/li&gt;&lt;li&gt;â€¢ progresses&lt;/li&gt;&lt;li&gt;â€¢ more slowly than ALL&lt;/li&gt;&lt;li&gt;â€¢ older adults.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ L-asparaginase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic Myelocytic Leukemia (CML): CML is a chronic form of leukemia affecting primarily adults . L-asparaginase is not effective against CML cells as they do not rely on external sources of asparagine like ALL cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic Myelocytic Leukemia (CML):&lt;/li&gt;&lt;li&gt;â€¢ chronic form of leukemia&lt;/li&gt;&lt;li&gt;â€¢ adults&lt;/li&gt;&lt;li&gt;â€¢ L-asparaginase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ against CML cells&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ external sources of asparagine&lt;/li&gt;&lt;li&gt;â€¢ ALL cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ L-asparaginase is particularly significant in the treatment of acute lymphoblastic leukemia (ALL) due to its unique mechanism of depleting asparagine , which is essential for the survival of ALL cells . This makes it a key component of chemotherapy regimens for ALL, especially in pediatric patients , where it can be combined with other drugs to enhance treatment efficacy and manage the disease effectively.&lt;/li&gt;&lt;li&gt;âž¤ L-asparaginase&lt;/li&gt;&lt;li&gt;âž¤ treatment of acute lymphoblastic leukemia (ALL)&lt;/li&gt;&lt;li&gt;âž¤ depleting asparagine&lt;/li&gt;&lt;li&gt;âž¤ essential for the survival of ALL cells&lt;/li&gt;&lt;li&gt;âž¤ key component&lt;/li&gt;&lt;li&gt;âž¤ chemotherapy regimens&lt;/li&gt;&lt;li&gt;âž¤ ALL,&lt;/li&gt;&lt;li&gt;âž¤ pediatric patients&lt;/li&gt;&lt;li&gt;âž¤ combined with other drugs&lt;/li&gt;&lt;li&gt;âž¤ treatment efficacy and&lt;/li&gt;&lt;li&gt;âž¤ disease effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements best describes the mechanism of action of basiliximab?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basiliximab directly inhibits the proliferation of T-cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Basiliximab promotes the activation of B-cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Basiliximab blocks the binding of interleukin-2 (IL-2) to its receptor on activated T-cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Basiliximab enhances the differentiation of dendritic cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Basiliximab blocks the binding of interleukin-2 (IL-2) to its receptor on activated T-cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Basiliximab blocks the binding of interleukin-2 (IL-2) to its receptor on activated T-cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Basiliximab directly inhibits the proliferation of T-cells: Incorrect. because basiliximab itself does not directly inhibit cell proliferation; instead, it prevents IL-2 from activating T-cells, which indirectly inhibits their proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Basiliximab directly inhibits the proliferation of T-cells:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ basiliximab&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ inhibit cell&lt;/li&gt;&lt;li&gt;â€¢ proliferation;&lt;/li&gt;&lt;li&gt;â€¢ prevents IL-2&lt;/li&gt;&lt;li&gt;â€¢ activating T-cells,&lt;/li&gt;&lt;li&gt;â€¢ indirectly inhibits their proliferation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Basiliximab promotes the activation of B-cells: Incorrect. Basiliximabâ€™s action is specific to T-cells and does not involve direct effects on B-cell activation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Basiliximab promotes the activation of B-cells:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect. Basiliximabâ€™s&lt;/li&gt;&lt;li&gt;â€¢ T-cells&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ direct effects on B-cell activation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Basiliximab enhances the differentiation of dendritic cells: Incorrect . Basiliximab&#x27;s mechanism of action is centered on T-cells and does not affect the differentiation of dendritic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Basiliximab enhances the differentiation of dendritic cells:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ centered on T-cells&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ differentiation of dendritic cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Basiliximab serves as an immunosuppressant by specifically blocking the IL-2 receptor on activated T-cells , thereby preventing their activation and proliferation. This selective inhibition is critical in preventing organ rejection following transplantation, making basiliximab a valuable therapeutic tool in transplant medicine.&lt;/li&gt;&lt;li&gt;âž¤ Basiliximab&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressant&lt;/li&gt;&lt;li&gt;âž¤ blocking the IL-2 receptor on activated T-cells&lt;/li&gt;&lt;li&gt;âž¤ preventing&lt;/li&gt;&lt;li&gt;âž¤ activation and proliferation.&lt;/li&gt;&lt;li&gt;âž¤ inhibition&lt;/li&gt;&lt;li&gt;âž¤ preventing organ rejection&lt;/li&gt;&lt;li&gt;âž¤ transplantation,&lt;/li&gt;&lt;li&gt;âž¤ basiliximab&lt;/li&gt;&lt;li&gt;âž¤ valuable therapeutic&lt;/li&gt;&lt;li&gt;âž¤ transplant medicine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are PD-L1 inhibitors except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avelumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Durvalumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cetuximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/402.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-131641.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cetuximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Avelumab: Avelumab is a PD-L1 inhibitor that blocks the interaction between PD-L1 on tumor cells and PD-1 on T cells. By doing so, it prevents the tumor from evading the immune response, enabling the immune system to attack the cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Avelumab:&lt;/li&gt;&lt;li&gt;â€¢ PD-L1 inhibitor&lt;/li&gt;&lt;li&gt;â€¢ blocks the interaction between PD-L1 on tumor cells&lt;/li&gt;&lt;li&gt;â€¢ PD-1 on T cells.&lt;/li&gt;&lt;li&gt;â€¢ prevents&lt;/li&gt;&lt;li&gt;â€¢ tumor&lt;/li&gt;&lt;li&gt;â€¢ immune response, enabling the immune system&lt;/li&gt;&lt;li&gt;â€¢ cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atezolizumab: Similar to Avelumab, Atezolizumab is a monoclonal antibody that binds to PD-L1, inhibiting its interaction with PD-1 . This blockade enhances the body&#x27;s immune response against tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Atezolizumab:&lt;/li&gt;&lt;li&gt;â€¢ Avelumab,&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ PD-L1,&lt;/li&gt;&lt;li&gt;â€¢ inhibiting&lt;/li&gt;&lt;li&gt;â€¢ interaction&lt;/li&gt;&lt;li&gt;â€¢ PD-1&lt;/li&gt;&lt;li&gt;â€¢ blockade&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s immune response against tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Durvalumab: Durvalumab also targets PD-L1 , preventing it from binding to PD-1. It is part of the group of immune checkpoint inhibitors that help to activate the immune system against cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Durvalumab:&lt;/li&gt;&lt;li&gt;â€¢ targets PD-L1&lt;/li&gt;&lt;li&gt;â€¢ preventing&lt;/li&gt;&lt;li&gt;â€¢ binding to PD-1.&lt;/li&gt;&lt;li&gt;â€¢ group of immune&lt;/li&gt;&lt;li&gt;â€¢ checkpoint inhibitors&lt;/li&gt;&lt;li&gt;â€¢ activate the immune system against cancer cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While Avelumab, Atezolizumab, and Durvalumab are all PD-L1 inhibitors enhancing the immune system&#x27;s ability to fight cancer, Cetuximab works through a different mechanism by targeting EGFR on cancer cells .&lt;/li&gt;&lt;li&gt;âž¤ Avelumab, Atezolizumab, and Durvalumab&lt;/li&gt;&lt;li&gt;âž¤ all PD-L1 inhibitors&lt;/li&gt;&lt;li&gt;âž¤ immune system&#x27;s ability to fight cancer,&lt;/li&gt;&lt;li&gt;âž¤ Cetuximab&lt;/li&gt;&lt;li&gt;âž¤ different mechanism&lt;/li&gt;&lt;li&gt;âž¤ targeting EGFR on cancer cells&lt;/li&gt;&lt;li&gt;âž¤ Immune Check Point inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Immune Check Point inhibitors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anticancer drugs act at the target shown in figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erlotinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ribociclib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dabrafenib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nilotinib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ribociclib&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/407.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ribociclib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Erlotinib : Erlotinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) pathway . It works by blocking the activity of the EGFR protein, which is often overexpressed in certain types of cancer cells and contributes to tumor growth and spread . Erlotinib is primarily used to treat non-small cell lung cancer and pancreatic cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Erlotinib&lt;/li&gt;&lt;li&gt;â€¢ Erlotinib&lt;/li&gt;&lt;li&gt;â€¢ tyrosine kinase inhibitor&lt;/li&gt;&lt;li&gt;â€¢ targets the epidermal growth factor receptor (EGFR) pathway&lt;/li&gt;&lt;li&gt;â€¢ blocking the activity of the EGFR protein,&lt;/li&gt;&lt;li&gt;â€¢ overexpressed&lt;/li&gt;&lt;li&gt;â€¢ cancer cells&lt;/li&gt;&lt;li&gt;â€¢ tumor growth and spread&lt;/li&gt;&lt;li&gt;â€¢ Erlotinib&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ non-small cell lung cancer and pancreatic cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabrafenib : Dabrafenib is a selective inhibitor of the BRAF protein , which is a key component of the MAP kinase signalling pathway . This pathway is frequently mutated in certain types of cancer , including melanoma, and drives tumor growth and survival . Dabrafenib is used to treat advanced melanoma with BRAF V600E or V600K mutations&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Dabrafenib&lt;/li&gt;&lt;li&gt;â€¢ Dabrafenib&lt;/li&gt;&lt;li&gt;â€¢ selective inhibitor of the BRAF protein&lt;/li&gt;&lt;li&gt;â€¢ MAP kinase signalling&lt;/li&gt;&lt;li&gt;â€¢ pathway&lt;/li&gt;&lt;li&gt;â€¢ frequently mutated in certain types of cancer&lt;/li&gt;&lt;li&gt;â€¢ melanoma, and drives tumor growth&lt;/li&gt;&lt;li&gt;â€¢ and survival&lt;/li&gt;&lt;li&gt;â€¢ used to treat advanced melanoma&lt;/li&gt;&lt;li&gt;â€¢ BRAF V600E or V600K mutations&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nilotinib : Nilotinib is a tyrosine kinase inhibitor that targets the BCR-ABL protein, which is a fusion protein that drives the growth of chronic myelogenous leukemia (CML) cells. It works by blocking the activity of the BCR-ABL protein , leading to inhibition of cell proliferation and induction of cell death . Nilotinib is taken orally and is primarily used to treat CML.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Nilotinib&lt;/li&gt;&lt;li&gt;â€¢ tyrosine kinase inhibitor&lt;/li&gt;&lt;li&gt;â€¢ BCR-ABL protein,&lt;/li&gt;&lt;li&gt;â€¢ fusion protein&lt;/li&gt;&lt;li&gt;â€¢ growth of chronic myelogenous leukemia (CML) cells.&lt;/li&gt;&lt;li&gt;â€¢ blocking the activity&lt;/li&gt;&lt;li&gt;â€¢ BCR-ABL protein&lt;/li&gt;&lt;li&gt;â€¢ inhibition&lt;/li&gt;&lt;li&gt;â€¢ cell proliferation and induction of cell death&lt;/li&gt;&lt;li&gt;â€¢ Nilotinib&lt;/li&gt;&lt;li&gt;â€¢ orally&lt;/li&gt;&lt;li&gt;â€¢ CML.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Ribociclib is a targeted anticancer therapy that inhibits CDK4/6 , key enzymes in cell cycle regulation . It is used to halt the progression of certain cancers by inducing cell cycle arrest at the G1 phase, thereby impeding the cancer cells from multiplying.&lt;/li&gt;&lt;li&gt;â€¢ Ribociclib&lt;/li&gt;&lt;li&gt;â€¢ targeted anticancer&lt;/li&gt;&lt;li&gt;â€¢ inhibits CDK4/6&lt;/li&gt;&lt;li&gt;â€¢ cell cycle regulation&lt;/li&gt;&lt;li&gt;â€¢ used to&lt;/li&gt;&lt;li&gt;â€¢ progression of certain cancers&lt;/li&gt;&lt;li&gt;â€¢ inducing cell cycle arrest at the G1 phase,&lt;/li&gt;&lt;li&gt;â€¢ impeding the cancer cells&lt;/li&gt;&lt;li&gt;â€¢ from multiplying.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pulmonary fibrosis is an adverse effect of which of the following anti-cancer drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitomycin C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydroxyurea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bleomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/05/whatsapp-image-2024-02-05-at-180437_nS2gu6G.jpeg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bleomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mitomycin C : This is an alkylating agent used in cancer chemotherapy. Its common side effects include bone marrow suppression, nausea, vomiting, and renal toxicity, but it is not primarily known for causing pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Mitomycin C&lt;/li&gt;&lt;li&gt;â€¢ alkylating agent&lt;/li&gt;&lt;li&gt;â€¢ cancer chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ side effects&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ suppression, nausea, vomiting, and renal toxicity,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ causing pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hydroxyurea : This medication is used for various myeloproliferative disorders and sickle cell disease. Its side effects often include bone marrow suppression and gastrointestinal symptoms, but it is not typically associated with pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Hydroxyurea&lt;/li&gt;&lt;li&gt;â€¢ used for&lt;/li&gt;&lt;li&gt;â€¢ myeloproliferative disorders&lt;/li&gt;&lt;li&gt;â€¢ sickle cell disease.&lt;/li&gt;&lt;li&gt;â€¢ side effects&lt;/li&gt;&lt;li&gt;â€¢ bone marrow suppression and gastrointestinal symptoms,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cisplatin : A platinum-containing chemotherapy drug used to treat various types of cancers. While nephrotoxicity (kidney damage) and ototoxicity (hearing damage) are common adverse effects, it is not typically associated with pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Cisplatin&lt;/li&gt;&lt;li&gt;â€¢ platinum-containing chemotherapy&lt;/li&gt;&lt;li&gt;â€¢ used to&lt;/li&gt;&lt;li&gt;â€¢ types of cancers.&lt;/li&gt;&lt;li&gt;â€¢ nephrotoxicity (kidney&lt;/li&gt;&lt;li&gt;â€¢ damage) and ototoxicity (hearing damage)&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bleomycin is known to cause pulmonary fibrosis , which is a condition characterized by the scarring and thickening of lung tissue.&lt;/li&gt;&lt;li&gt;âž¤ Bleomycin&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;âž¤ scarring and thickening of lung tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Epinephrine added to a solution of lignocaine for a peripheral nerve block will:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase risk of convulsions â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the duration of action of the local anesthetic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both a &amp;amp; b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increase the duration of action of the local anesthetic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Increase the duration of action of the local anesthetic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase risk of convulsions: Incorrect , as epinephrine does not typically increase the risk of convulsions related to local anesthetic use. Instead, by reducing systemic absorption , it might actually help prevent peak plasma levels that could lead to toxicity .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase risk of convulsions:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ increase the risk of convulsions&lt;/li&gt;&lt;li&gt;â€¢ reducing systemic absorption&lt;/li&gt;&lt;li&gt;â€¢ prevent peak plasma levels&lt;/li&gt;&lt;li&gt;â€¢ toxicity&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both A &amp;amp; B: Incorrect , since only B is true .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both A &amp;amp; B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ only B is true&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of these: Incorrect, as epinephrine does increase the duration of action .&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of these:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect,&lt;/li&gt;&lt;li&gt;â€¢ increase the duration of action&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Adding epinephrine to lignocaine not only enhances the duration of the anesthetic effect but also helps minimize bleeding, making it highly beneficial for longer procedures and areas of significant vascularization .&lt;/li&gt;&lt;li&gt;âž¤ Adding epinephrine&lt;/li&gt;&lt;li&gt;âž¤ lignocaine not only&lt;/li&gt;&lt;li&gt;âž¤ duration of the anesthetic effect&lt;/li&gt;&lt;li&gt;âž¤ minimize bleeding,&lt;/li&gt;&lt;li&gt;âž¤ highly beneficial&lt;/li&gt;&lt;li&gt;âž¤ procedures and areas of significant vascularization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A perioperative patient was given a skeletal muscle relaxant that acts by competitive inhibition of nicotinic ACh receptors. What agent can be used for the reversal of its effects? â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neostigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Succinylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbachol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neostigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Neostigmine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Physostigmine: Also a cholinesterase inhibitor but primarily crosses the blood-brain barrier and could cause CNS adverse effects ; not typically used for reversing NMBs.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Physostigmine:&lt;/li&gt;&lt;li&gt;â€¢ cholinesterase inhibitor&lt;/li&gt;&lt;li&gt;â€¢ blood-brain barrier&lt;/li&gt;&lt;li&gt;â€¢ CNS adverse effects&lt;/li&gt;&lt;li&gt;â€¢ Option C. Succinylcholine: A depolarizing NMB, which is inappropriate for reversal and instead causes muscle relaxation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Succinylcholine:&lt;/li&gt;&lt;li&gt;â€¢ depolarizing NMB,&lt;/li&gt;&lt;li&gt;â€¢ inappropriate&lt;/li&gt;&lt;li&gt;â€¢ muscle relaxation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carbachol: A cholinergic agonist used to treat glaucoma and urinary retention but not for reversing neuromuscular blockade .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Carbachol:&lt;/li&gt;&lt;li&gt;â€¢ cholinergic agonist&lt;/li&gt;&lt;li&gt;â€¢ glaucoma and urinary retention&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ neuromuscular blockade&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the use of neostigmine as a reversal agent for non-depolarizing neuromuscular blockers by its mechanism of increasing acetylcholine concentration , which competes with the blocker at the nicotinic receptors.&lt;/li&gt;&lt;li&gt;âž¤ neostigmine as a reversal agent for non-depolarizing neuromuscular blockers&lt;/li&gt;&lt;li&gt;âž¤ increasing acetylcholine concentration&lt;/li&gt;&lt;li&gt;âž¤ competes&lt;/li&gt;&lt;li&gt;âž¤ blocker at the nicotinic receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs undergoes Hoffmanâ€™s elimination?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atracurium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pancuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mivacurium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vecuronium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atracurium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Atracurium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pancuronium: Does not undergo Hoffman&#x27;s elimination ; it is metabolized by the liver and excreted by the kidneys .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pancuronium:&lt;/li&gt;&lt;li&gt;â€¢ Does not undergo Hoffman&#x27;s elimination&lt;/li&gt;&lt;li&gt;â€¢ metabolized by the liver&lt;/li&gt;&lt;li&gt;â€¢ excreted by the kidneys&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mivacurium: Is metabolized by plasma cholinesterases , not through Hoffmanâ€™s elimination.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mivacurium:&lt;/li&gt;&lt;li&gt;â€¢ metabolized by plasma cholinesterases&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vecuronium: Is primarily metabolized in the liver and excreted by the kidneys, not involving Hoffman&#x27;s elimination.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vecuronium:&lt;/li&gt;&lt;li&gt;â€¢ primarily metabolized&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ excreted by the kidneys,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Remember that Atracurium undergoes Hoffmanâ€™s elimination , a process allowing safe use in patients with liver and kidney dysfunction , distinguishing it from other neuromuscular blockers that require metabolic clearance by these organs .&lt;/li&gt;&lt;li&gt;âž¤ Atracurium undergoes Hoffmanâ€™s elimination&lt;/li&gt;&lt;li&gt;âž¤ safe use in patients with liver and kidney dysfunction&lt;/li&gt;&lt;li&gt;âž¤ distinguishing it&lt;/li&gt;&lt;li&gt;âž¤ neuromuscular blockers&lt;/li&gt;&lt;li&gt;âž¤ metabolic clearance by these organs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a ruptured spleen is taken for a laparotomy. His blood pressure is 80/50 and heart rate is 125/min. Induction agent of choice for this patient is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodium Thiopentone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fentanyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Halothane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ketamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ketamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sodium Thiopentone: This agent typically results in reduced blood pressure by depressing central sympathetic tone , which could be detrimental for a hypotensive patient, risking further cardiovascular compromise.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sodium Thiopentone:&lt;/li&gt;&lt;li&gt;â€¢ reduced blood pressure&lt;/li&gt;&lt;li&gt;â€¢ central sympathetic tone&lt;/li&gt;&lt;li&gt;â€¢ detrimental for a hypotensive patient,&lt;/li&gt;&lt;li&gt;â€¢ cardiovascular compromise.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fentanyl: A potent opioid that can lead to further depression of the central nervous system and potentially exacerbate hypotension and reduce heart rate , not ideal under the patient&#x27;s current circulatory stress.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fentanyl:&lt;/li&gt;&lt;li&gt;â€¢ potent opioid&lt;/li&gt;&lt;li&gt;â€¢ further depression of the central nervous system&lt;/li&gt;&lt;li&gt;â€¢ exacerbate hypotension&lt;/li&gt;&lt;li&gt;â€¢ reduce heart rate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Halothane: Known to decrease myocardial contractility and potentially worsen hypotension , Halothane would not be appropriate for someone whose blood pressure is already critically low .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Halothane:&lt;/li&gt;&lt;li&gt;â€¢ decrease myocardial contractility and&lt;/li&gt;&lt;li&gt;â€¢ hypotension&lt;/li&gt;&lt;li&gt;â€¢ would not&lt;/li&gt;&lt;li&gt;â€¢ blood pressure is already critically low&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ketamine uniquely preserves and can elevate blood pressure during induction of anesthesia, making it an optimal choice for patients presenting with hypotension.&lt;/li&gt;&lt;li&gt;âž¤ Ketamine&lt;/li&gt;&lt;li&gt;âž¤ elevate blood pressure&lt;/li&gt;&lt;li&gt;âž¤ induction of anesthesia,&lt;/li&gt;&lt;li&gt;âž¤ optimal choice for patients presenting with hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Postoperative vomiting is uncommon with this intravenous anaesthetic agent and patient are able to ambulate sooner than those who receive other anaesthetic agents:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enflurane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propofol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remifentanil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propofol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propofol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ketamine: Known for causing postoperative hallucinations and emergence reactions , which can delay recovery.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ketamine:&lt;/li&gt;&lt;li&gt;â€¢ postoperative hallucinations and emergence reactions&lt;/li&gt;&lt;li&gt;â€¢ delay recovery.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Enflurane: An older inhalation anesthetic associated with longer recovery times and higher incidences of PONV.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Enflurane:&lt;/li&gt;&lt;li&gt;â€¢ older inhalation&lt;/li&gt;&lt;li&gt;â€¢ longer recovery times and higher incidences of PONV.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Remifentanil: While effective for pain management , it is an opioid and does not inherently reduce PONV or quicken recovery times compared to Propofol.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Remifentanil:&lt;/li&gt;&lt;li&gt;â€¢ pain management&lt;/li&gt;&lt;li&gt;â€¢ opioid and does not&lt;/li&gt;&lt;li&gt;â€¢ reduce PONV&lt;/li&gt;&lt;li&gt;â€¢ quicken recovery times&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propofol is advantageous for its antiemetic properties and its ability to allow patients to ambulate sooner after surgery , which supports its preference in settings that require rapid recovery and minimal postoperative complications . This makes it the agent of choice for day surgeries and procedures requiring short recovery times .&lt;/li&gt;&lt;li&gt;âž¤ Propofol&lt;/li&gt;&lt;li&gt;âž¤ antiemetic properties&lt;/li&gt;&lt;li&gt;âž¤ ambulate sooner after surgery&lt;/li&gt;&lt;li&gt;âž¤ preference in settings&lt;/li&gt;&lt;li&gt;âž¤ rapid recovery and minimal postoperative complications&lt;/li&gt;&lt;li&gt;âž¤ agent of choice for day surgeries&lt;/li&gt;&lt;li&gt;âž¤ short recovery times&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test3" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D (Second Test)   23 05 2023   2023 05 23&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D (Second Test)   23 05 2023   2023 05 23&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Several monoclonal antibodies are now used as anticancer drugs. Which of the following monoclonal antibody is implicated in causing cardiomyopathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Trastuzumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Trastuzumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received procaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroprocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mepivacaine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mepivacaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Mepivacaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Epinephrine added to a solution of lignocaine for a peripheral nerve block will:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase risk of convulsions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the duration of action of the local anesthetic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both A &amp;amp; B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increase the duration of action of the local anesthetic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Increase the duration of action of the local anesthetic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug that binds to and inhibits Gp IIb /IIIa glycoprotein and is responsible for platelet antiaggregatory effects is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fondaparinux&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tirofiban&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tirofiban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tirofiban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Postoperative vomiting is uncommon with this intravenous anaesthetic agent and patient are able to ambulate sooner than those who receive other anaesthetic agents?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enflurane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propofol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remifentanil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propofol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Propofol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Long term use of pethidine is avoided because a metabolite of pethidine is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constipation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dependence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Seizures&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory depression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Seizures&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Seizures&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A psychiatric patient taking medication develops a tremor, thyroid enlargement and leucocytosis. Drug implicated is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clomipramine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lithium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Relative intensities of blocking effect (shown by symbol of +) of four drugs on different receptors is? Which drug is most likely to exacerbate the symptoms of Parkinsonism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Drug D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/23/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Drug D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;High cumulative doses of Bleomycin are associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardio toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemorrhagic cystitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peripheral neuropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pulmonary fibrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The drug reducing need of platelet transfusion in patients undergoing cancer chemotherapy is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sargramostim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Oprelvekin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Oprelvekin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-year-old girl is brought to the pediatrician for a severe sore throat. The pediatrician prescribes penicillin and sends the girl home. Later that day, she develops a diffuse maculopapular rash, shortness of breath, and wheezing. Her parents take her to the emergency department, where she is diagnosed with anaphylaxis and treated successfully with epinephrine. Three months later, the girl has dysuria and urinary frequency. Urine Gram&#x27;s stain reveals numerous gram-negative rods. Which of the following antibiotics could be safely given to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aztreonam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cephalexin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aztreonam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aztreonam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A worried mother complains to her pediatrician that both she and her 8-year-old son&#x27;s teacher have noticed that the child has become inattentive. She states that her son frequently stops what he is doing and \&quot;stares blankly into space\&quot; before resuming his activities. Electroencephalography reveals a 3/second spike and slow wave pattern of discharges. Which of the following agents would most effectively treat this child&#x27;s disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methylphenidate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Valproate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with severe bronchial asthma presents with white patches on the inside of the cheeks that can be easily wiped off, leaving a red, bleeding, sore surface. He is currently using beclomethasone and formoterol inhalers for his asthma and he is allergic to penicillin. Which of the following agents would be most appropriate for the treatment of this patient&#x27;s oral condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acyclovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefixime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nystatin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nystatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Nystatin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with well-controlled Parkinson&#x27;s disease and type 2 diabetes presents with akinesia, a festinating gait, rigidity, and loss of postural reflexes. The patient states that his symptoms began shortly after starting a new \&quot;stomach\&quot; medication. On the basis of this information, the patient is most likely receiving?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cisapride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nizatidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metoclopramide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Metoclopramide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While rescuing a child from a burning home, a firefighter was burned over 60% of his body. He is rushed to the emergency room and quickly taken into surgery. During the surgery, the anesthesiologist notices tall, peaked T waves and prolongation of the PR interval, accompanied by progressive widening of the QRS complex so that it appears to merge with the T waves. The patient goes into ventricular fibrillation, then asystole, and cannot be resuscitated. Which of the following agents is most likely responsible for this patient&#x27;s electrocardiographic changes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atracurium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Baclofen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Halothane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinylcholine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Succinylcholine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Succinylcholine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old female patient presents with complaints of a non-productive cough, low-grade fever, and a headache. The physician also notes a non-purulent otitis media. She is treated with an antibiotic that inhibits the translocation of the growing peptide chain along the mRNA. The antibiotic the patient was given was?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloramphenicol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Erythromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Erythromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metronidazole is least likely to be effective in treatment of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatic ameobiasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infection caused by bacteroides fragilis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudo membranous colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumocytosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pneumocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pneumocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True statement regarding vancomycin is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is bacteriostatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has the advantage of oral bioavailability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is not susceptible to penicillinases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Staphylococcal enterocolits occurs commonly with its use&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is not susceptible to penicillinases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is not susceptible to penicillinases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antibiotics is NOT effective against pseudomonas infections?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-549_DRuLjN2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents to the clinic with a palpable lump in her left breast that she noticed while showering. She reports no associated pain, discharge, or skin changes. Her past medical history is unremarkable and she has no known family history of breast or ovarian cancer. Her last mammogram was two years ago and showed no abnormalities. After appropriate investigations including mammogram, ultrasound, and biopsy, she is diagnosed with stage II breast cancer. The biopsy reveals that the cancer is HER2-positive, but estrogen receptor (ER) and progesterone receptor (PR) negative. Which of the following drugs, a tyrosine kinase inhibitor, would be suitable for treating this patient&#x27;s breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sorafenib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Imatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pazopanib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lapatinib&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lapatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lapatinib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding sedative hypnotic drugs is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzodiazepines exhibit a steeper dose response relationship as compared to barbiturates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Barbiturates may increase the half-lives of drugs metabolized by the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alkalization of the urine will accelerate the elimination of phenobarbitone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory depression caused by barbiturate overdosage can be reversed by flumazenil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alkalization of the urine will accelerate the elimination of phenobarbitone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alkalization of the urine will accelerate the elimination of phenobarbitone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Benzodiazepines actually have a safer (flat) dose-response curve compared to barbiturates. Barbiturates have a steep dose-response curve, meaning a small increase in dose can lead to a large increase in drug effect, potentially leading to fatal overdose. Barbiturates are known to induce liver enzymes, which can speed up the metabolism of other drugs. This effect can decrease the half-life of those drugs. Alkalization of the urine can accelerate the elimination of phenobarbital. This drug is weakly acidic and its elimination can be enhanced in an alkaline environment. Flumazenil is an antagonist of benzodiazepines, not barbiturates. It is used to reverse benzodiazepine overdoses and will not effectively reverse respiratory depression caused by barbiturate overdosage.&lt;/li&gt;&lt;li&gt;â€¢ Benzodiazepines actually have a safer (flat) dose-response curve compared to barbiturates. Barbiturates have a steep dose-response curve, meaning a small increase in dose can lead to a large increase in drug effect, potentially leading to fatal overdose. Barbiturates are known to induce liver enzymes, which can speed up the metabolism of other drugs. This effect can decrease the half-life of those drugs. Alkalization of the urine can accelerate the elimination of phenobarbital. This drug is weakly acidic and its elimination can be enhanced in an alkaline environment. Flumazenil is an antagonist of benzodiazepines, not barbiturates. It is used to reverse benzodiazepine overdoses and will not effectively reverse respiratory depression caused by barbiturate overdosage.&lt;/li&gt;&lt;li&gt;â€¢ Benzodiazepines actually have a safer (flat) dose-response curve compared to barbiturates. Barbiturates have a steep dose-response curve, meaning a small increase in dose can lead to a large increase in drug effect, potentially leading to fatal overdose. Barbiturates are known to induce liver enzymes, which can speed up the metabolism of other drugs. This effect can decrease the half-life of those drugs. Alkalization of the urine can accelerate the elimination of phenobarbital. This drug is weakly acidic and its elimination can be enhanced in an alkaline environment. Flumazenil is an antagonist of benzodiazepines, not barbiturates. It is used to reverse benzodiazepine overdoses and will not effectively reverse respiratory depression caused by barbiturate overdosage.&lt;/li&gt;&lt;li&gt;â€¢ Benzodiazepines actually have a safer (flat) dose-response curve compared to barbiturates. Barbiturates have a steep dose-response curve, meaning a small increase in dose can lead to a large increase in drug effect, potentially leading to fatal overdose.&lt;/li&gt;&lt;li&gt;â€¢ Barbiturates are known to induce liver enzymes, which can speed up the metabolism of other drugs. This effect can decrease the half-life of those drugs.&lt;/li&gt;&lt;li&gt;â€¢ Alkalization of the urine can accelerate the elimination of phenobarbital. This drug is weakly acidic and its elimination can be enhanced in an alkaline environment.&lt;/li&gt;&lt;li&gt;â€¢ Flumazenil is an antagonist of benzodiazepines, not barbiturates. It is used to reverse benzodiazepine overdoses and will not effectively reverse respiratory depression caused by barbiturate overdosage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of epilepsy has been taking phenytoin for seizure control. After starting another drug, plasma concentration of phenytoin was found to be 25 mcg/ml (therapeutic levels are 10-20 mcg/ml). This sudden rise in plasma drug concentration of phenytoin can cause which of the following adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hirsutism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gum hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ataxia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ataxia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Phenytoin is known to have several potential side effects that can become more apparent or severe as the level of the drug in the bloodstream increases beyond therapeutic levels. This phenomenon is often described as \&quot;dose-dependent toxicity.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ Ataxia, or a lack of muscle control during voluntary movements, can occur as a side effect of high levels of phenytoin. This could result in unsteady movements and difficulty with coordination. Arrhythmias are also noted with high plasma levels of phenytoin.&lt;/li&gt;&lt;li&gt;â€¢ Ataxia, or a lack of muscle control during voluntary movements, can occur as a side effect of high levels of phenytoin. This could result in unsteady movements and difficulty with coordination.&lt;/li&gt;&lt;li&gt;â€¢ Arrhythmias are also noted with high plasma levels of phenytoin.&lt;/li&gt;&lt;li&gt;â€¢ Other adverse effects of phenytoin like hirsutism and gum hyperplasia are seen on long term use (chronic) only.&lt;/li&gt;&lt;li&gt;â€¢ Adverse Effects of Phenytoin:&lt;/li&gt;&lt;li&gt;â€¢ Adverse Effects of Phenytoin:&lt;/li&gt;&lt;li&gt;â€¢ H:    H irsutism&lt;/li&gt;&lt;li&gt;â€¢ H:    H&lt;/li&gt;&lt;li&gt;â€¢ O:    O steomalacia&lt;/li&gt;&lt;li&gt;â€¢ O:    O&lt;/li&gt;&lt;li&gt;â€¢ T:    T eratogenicity (Fetal Hydantoin Syndrome)&lt;/li&gt;&lt;li&gt;â€¢ T:    T&lt;/li&gt;&lt;li&gt;â€¢ M:   M egaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ M:   M&lt;/li&gt;&lt;li&gt;â€¢ A:    A rrhythmia (Acute side effect seen at overdose only)&lt;/li&gt;&lt;li&gt;â€¢ A:    A&lt;/li&gt;&lt;li&gt;â€¢ L:     L ymphadenopathy&lt;/li&gt;&lt;li&gt;â€¢ L:     L&lt;/li&gt;&lt;li&gt;â€¢ I:     I ncrease in blood glucose (due to inhibition of insulin release)&lt;/li&gt;&lt;li&gt;â€¢ I:     I&lt;/li&gt;&lt;li&gt;â€¢ K: Vitamin K deficiency&lt;/li&gt;&lt;li&gt;â€¢ K:&lt;/li&gt;&lt;li&gt;â€¢ K&lt;/li&gt;&lt;li&gt;â€¢ A:    A taxia (Acute side effect seen at overdose only)&lt;/li&gt;&lt;li&gt;â€¢ A:    A&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs has a high affinity for 5-HT2 receptors in the brain, does not cause extrapyramidal dysfunction or agranulocytosis, and is reported to increase the risk of significant QT prolongation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorpromazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ziprasidone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ziprasidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Ziprasidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ziprasidone is an atypical antipsychotic that acts by blocking dopamine (D2) and serotonin (5-HT2) receptors in the brain. It is known to have less risk of causing extrapyramidal symptoms (EPS) or agranulocytosis compared to other antipsychotics. However, it has been associated with a risk of QT prolongation, a specific type of abnormal heart rhythm that can potentially lead to serious complications such as Torsades de pointes or sudden cardiac death. Chlorpromazine is a typical antipsychotic that can cause extrapyramidal symptoms. Clozapine, an atypical antipsychotic, has a risk of causing agranulocytosis (a severe and dangerous decrease in white blood cells), which necessitates routine blood monitoring. Olanzapine is an atypical antipsychotic and while it does have a high affinity for 5-HT2 receptors and does not typically cause agranulocytosis, it is not specifically associated with a high risk of QT prolongation.&lt;/li&gt;&lt;li&gt;â€¢ Ziprasidone is an atypical antipsychotic that acts by blocking dopamine (D2) and serotonin (5-HT2) receptors in the brain. It is known to have less risk of causing extrapyramidal symptoms (EPS) or agranulocytosis compared to other antipsychotics. However, it has been associated with a risk of QT prolongation, a specific type of abnormal heart rhythm that can potentially lead to serious complications such as Torsades de pointes or sudden cardiac death.&lt;/li&gt;&lt;li&gt;â€¢ Chlorpromazine is a typical antipsychotic that can cause extrapyramidal symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine, an atypical antipsychotic, has a risk of causing agranulocytosis (a severe and dangerous decrease in white blood cells), which necessitates routine blood monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Olanzapine is an atypical antipsychotic and while it does have a high affinity for 5-HT2 receptors and does not typically cause agranulocytosis, it is not specifically associated with a high risk of QT prolongation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following limitations of typical tricyclic antidepressants has been overcome by selective serotonin reuptake inhibitors except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Frequent anticholinergic, sedative and hypotensive side effects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High risk of cardiac arrhythmias and seizures in overdose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Delayed response&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Risk of metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Delayed response&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Delayed response&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Selective serotonin reuptake inhibitors (SSRIs) typically have fewer anticholinergic, sedative, and hypotensive side effects than tricyclic antidepressants (TCAs). SSRIs have a safer profile in terms of overdose than TCAs. Overdose with TCAs can lead to severe cardiac arrhythmias and seizures, while overdose with SSRIs is generally much less dangerous. Both SSRIs and TCAs typically take a few weeks to exert their full therapeutic effects. Thus, the delayed response is not a limitation that has been overcome by SSRIs. SSRIs generally have less of an impact on metabolic parameters, including acid-base balance, than TCAs, so they&#x27;re less likely to cause metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Selective serotonin reuptake inhibitors (SSRIs) typically have fewer anticholinergic, sedative, and hypotensive side effects than tricyclic antidepressants (TCAs).&lt;/li&gt;&lt;li&gt;â€¢ SSRIs have a safer profile in terms of overdose than TCAs. Overdose with TCAs can lead to severe cardiac arrhythmias and seizures, while overdose with SSRIs is generally much less dangerous.&lt;/li&gt;&lt;li&gt;â€¢ Both SSRIs and TCAs typically take a few weeks to exert their full therapeutic effects. Thus, the delayed response is not a limitation that has been overcome by SSRIs.&lt;/li&gt;&lt;li&gt;â€¢ SSRIs generally have less of an impact on metabolic parameters, including acid-base balance, than TCAs, so they&#x27;re less likely to cause metabolic acidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients should be cautioned not to consume alcohol when given a prescription for any of the following except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chlorpropamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Griseofulvin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ofloxacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ofloxacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man presents to his primary care physician complaining of a persistent, dull, gnawing pain in his upper abdomen. He mentions the discomfort has been on and off for several months now and seems to worsen on an empty stomach. He denies any changes in bowel habits or any symptoms of nausea, vomiting, or weight loss. His medical history is notable for osteoarthritis and he has been taking aspirin regularly for the past 5 years for pain relief. The physician suspects that chronic use of aspirin may have led to the development of a peptic ulcer. Which of the following drugs would be the best choice for treating this patient&#x27;s suspected peptic ulcer disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pirenzipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ranitidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Omeprazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Omeprazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole is a proton pump inhibitor (PPI) and is generally considered the first-line treatment for peptic ulcer disease, including ulcers that are suspected to have been caused by chronic NSAID (such as aspirin) use. Omeprazole and other PPIs work by irreversibly inhibiting the hydrogen/potassium ATPase pump in the stomach lining, which is responsible for the final step in the production of gastric acid. This reduces the amount of acid in the stomach, allowing ulcers to heal and reducing the likelihood of their formation. Misoprostol is a prostaglandin analog and is most specific drug for NSAID-induced ulcers. It acts by increasing bicarbonate and mucus production in the stomach, thereby protecting the stomach lining. However, it&#x27;s often not the first choice due to its side effects (such as diarrhea) and the need for frequent dosing (four times daily). Pirenzepine is a selective M1 muscarinic receptor antagonist that inhibits gastric acid secretion, but it is less effective and commonly used than PPIs or H2 blockers in peptic ulcer disease. Ranitidine is a H2-receptor antagonist and while it also decreases the production of stomach acid, it is not as potent as PPIs like omeprazole.&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole is a proton pump inhibitor (PPI) and is generally considered the first-line treatment for peptic ulcer disease, including ulcers that are suspected to have been caused by chronic NSAID (such as aspirin) use.&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole and other PPIs work by irreversibly inhibiting the hydrogen/potassium ATPase pump in the stomach lining, which is responsible for the final step in the production of gastric acid. This reduces the amount of acid in the stomach, allowing ulcers to heal and reducing the likelihood of their formation.&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol is a prostaglandin analog and is most specific drug for NSAID-induced ulcers. It acts by increasing bicarbonate and mucus production in the stomach, thereby protecting the stomach lining. However, it&#x27;s often not the first choice due to its side effects (such as diarrhea) and the need for frequent dosing (four times daily).&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol&lt;/li&gt;&lt;li&gt;â€¢ most specific drug&lt;/li&gt;&lt;li&gt;â€¢ Pirenzepine is a selective M1 muscarinic receptor antagonist that inhibits gastric acid secretion, but it is less effective and commonly used than PPIs or H2 blockers in peptic ulcer disease.&lt;/li&gt;&lt;li&gt;â€¢ Ranitidine is a H2-receptor antagonist and while it also decreases the production of stomach acid, it is not as potent as PPIs like omeprazole.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on cisplatin therapy develops intractable vomiting on the third day of treatment. Agent of choice for controlling this vomiting is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Netupitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prochlorperazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Netupitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Netupitant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cisplatin is a chemotherapeutic agent that is associated with a high risk of chemotherapy-induced nausea and vomiting (CINV). It can cause two types of vomiting. Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV. Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV. Netupitant is a NK1 receptor antagonist and is usually used in combination with a 5-HT3 receptor antagonist (like palonosetron) and dexamethasone. It is DOC for delayed CINV associated with highly emetogenic chemotherapy. Ondansetron is often the first choice for managing acute CINV due to its efficacy and tolerability. Metoclopramide, a dopamine receptor antagonist, may be used to manage CINV, but it&#x27;s generally not as effective as the 5-HT3 antagonists. Prochlorperazine is also used to manage CINV, but it&#x27;s not generally the first choice because of its potential to cause extrapyramidal symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Cisplatin is a chemotherapeutic agent that is associated with a high risk of chemotherapy-induced nausea and vomiting (CINV). It can cause two types of vomiting. Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV. Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV.&lt;/li&gt;&lt;li&gt;â€¢ Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV. Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV.&lt;/li&gt;&lt;li&gt;â€¢ Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV.&lt;/li&gt;&lt;li&gt;â€¢ Early vomiting:&lt;/li&gt;&lt;li&gt;â€¢ Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV.&lt;/li&gt;&lt;li&gt;â€¢ Delayed vomiting:&lt;/li&gt;&lt;li&gt;â€¢ Netupitant is a NK1 receptor antagonist and is usually used in combination with a 5-HT3 receptor antagonist (like palonosetron) and dexamethasone. It is DOC for delayed CINV associated with highly emetogenic chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ Ondansetron is often the first choice for managing acute CINV due to its efficacy and tolerability.&lt;/li&gt;&lt;li&gt;â€¢ Metoclopramide, a dopamine receptor antagonist, may be used to manage CINV, but it&#x27;s generally not as effective as the 5-HT3 antagonists.&lt;/li&gt;&lt;li&gt;â€¢ Prochlorperazine is also used to manage CINV, but it&#x27;s not generally the first choice because of its potential to cause extrapyramidal symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Choose the correct statement about the use of loperamide in the management of diarrhea:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is used to control diarrhea irrespective of its etiology&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is used as adjuvant to antimicrobial therapy of diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is the drug of choice in Travellerâ€™s diarrhea&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is an anti-diarrheal agent that works by slowing the movement of the intestines, which helps to reduce the frequency of bowel movements. It is not used to control diarrhea irrespective of its etiology. For instance, if diarrhea is caused by certain types of infections (such as those involving enteroinvasive organisms), loperamide can potentially worsen the situation by delaying the elimination of the pathogens from the gut. Loperamide is used as a short-term measure to manage symptoms of acute diarrhea. It is especially important to confirm that enteroinvasive organisms are not involved, as using loperamide in such cases could be harmful. Loperamide is not used as an adjuvant to antimicrobial therapy. It is primarily used for symptomatic relief. Loperamide is not the drug of choice for Traveller&#x27;s diarrhea, especially when the diarrhea is severe, bloody, or accompanied by fever. Antibiotics are often the preferred treatment in such cases.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is an anti-diarrheal agent that works by slowing the movement of the intestines, which helps to reduce the frequency of bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ It is not used to control diarrhea irrespective of its etiology. For instance, if diarrhea is caused by certain types of infections (such as those involving enteroinvasive organisms), loperamide can potentially worsen the situation by delaying the elimination of the pathogens from the gut.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is used as a short-term measure to manage symptoms of acute diarrhea. It is especially important to confirm that enteroinvasive organisms are not involved, as using loperamide in such cases could be harmful.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is not used as an adjuvant to antimicrobial therapy. It is primarily used for symptomatic relief.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is not the drug of choice for Traveller&#x27;s diarrhea, especially when the diarrhea is severe, bloody, or accompanied by fever. Antibiotics are often the preferred treatment in such cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-tubercular drugs is safe in hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethionamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Streptomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Streptomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man presents with a myocardial infarction. Angioplasty and stenting are not possible because the cardiac cath lab is busy with other high-priority patients, so administration of a thrombolytic drug is the only option. Which one of the following is the most important determinant, overall, of the success of thrombolytic therapy in terms of salvaging viable cardiac muscle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Choosing a â€œhumanâ€ t-PA like alteplase, rather than one that is bacterial-derived like streptokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infarct location (i.e., anterior wall of left ventricular vs. another site/wall)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of collateral blood vessels to the infarct-related coronary artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Time from onset of infarction to administration of the thrombolytic agent&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Time from onset of infarction to administration of the thrombolytic agent&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Time from onset of infarction to administration of the thrombolytic agent&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The benefit of thrombolytic therapy in myocardial infarction is highly dependent on the time from onset of symptoms to administration of the thrombolytic agent. The earlier the treatment is initiated, the more heart muscle can be saved, reducing the extent of damage and improving the prognosis. This principle is often referred to as \&quot;time is muscle\&quot; in cardiology. The choice between different types of thrombolytic agents (like alteplase, a recombinant tissue plasminogen activator, versus streptokinase, a bacterial-derived drug) can be important, but the most critical factor is generally the speed of administration. While the location of the infarct can affect the prognosis (anterior wall infarcts are typically more serious), it does not determine the success of thrombolytic therapy per se. The presence of collateral blood vessels may help preserve heart tissue during an infarct, but again, this does not determine the success of thrombolytic therapy itself. Overall, the most important determinant of the success of thrombolytic therapy in terms of salvaging viable cardiac muscle is the time from onset of infarction to administration of the thrombolytic agent.&lt;/li&gt;&lt;li&gt;â€¢ The benefit of thrombolytic therapy in myocardial infarction is highly dependent on the time from onset of symptoms to administration of the thrombolytic agent. The earlier the treatment is initiated, the more heart muscle can be saved, reducing the extent of damage and improving the prognosis. This principle is often referred to as \&quot;time is muscle\&quot; in cardiology.&lt;/li&gt;&lt;li&gt;â€¢ The choice between different types of thrombolytic agents (like alteplase, a recombinant tissue plasminogen activator, versus streptokinase, a bacterial-derived drug) can be important, but the most critical factor is generally the speed of administration.&lt;/li&gt;&lt;li&gt;â€¢ While the location of the infarct can affect the prognosis (anterior wall infarcts are typically more serious), it does not determine the success of thrombolytic therapy per se.&lt;/li&gt;&lt;li&gt;â€¢ The presence of collateral blood vessels may help preserve heart tissue during an infarct, but again, this does not determine the success of thrombolytic therapy itself.&lt;/li&gt;&lt;li&gt;â€¢ Overall, the most important determinant of the success of thrombolytic therapy in terms of salvaging viable cardiac muscle is the time from onset of infarction to administration of the thrombolytic agent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Biochemical mechanisms of drug resistance are shown in the given below figure. Most important mode of resistance in MRSA is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_STisk1C.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-550.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The combination of trimethoprim and sulfamethoxazole is effective against which of the following opportunistic infections in the AIDS patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disseminated Herpes simplex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cryptococcal meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumocystis jiroveci&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pneumocystis jiroveci&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pneumocystis jiroveci&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Trimethoprim-sulfamethoxazole (TMP-SMX), also known as co-trimoxazole, is a combination antibiotic that is effective against a wide range of bacteria. It is also the treatment and prophylaxis of choice for Pneumocystis jiroveci (formerly known as Pneumocystis carinii) pneumonia, an opportunistic infection that is common in individuals with AIDS. Disseminated Herpes simplex is generally treated with antiviral drugs, such as acyclovir. Cryptococcal meningitis is typically treated with a combination of antifungal medications, often including amphotericin B and flucytosine. Tuberculosis is typically treated with a combination of anti-tubercular drugs, such as isoniazid, rifampin, ethambutol, and pyrazinamide.&lt;/li&gt;&lt;li&gt;â€¢ Trimethoprim-sulfamethoxazole (TMP-SMX), also known as co-trimoxazole, is a combination antibiotic that is effective against a wide range of bacteria. It is also the treatment and prophylaxis of choice for Pneumocystis jiroveci (formerly known as Pneumocystis carinii) pneumonia, an opportunistic infection that is common in individuals with AIDS.&lt;/li&gt;&lt;li&gt;â€¢ Disseminated Herpes simplex is generally treated with antiviral drugs, such as acyclovir.&lt;/li&gt;&lt;li&gt;â€¢ Cryptococcal meningitis is typically treated with a combination of antifungal medications, often including amphotericin B and flucytosine.&lt;/li&gt;&lt;li&gt;â€¢ Tuberculosis is typically treated with a combination of anti-tubercular drugs, such as isoniazid, rifampin, ethambutol, and pyrazinamide.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is used for the radical cure of Plasmodium falciparum malaria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Artemisinin based combination therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primaquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Artemisinin based combination therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Artemisinin based combination therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following can be considered as a case of XDR tuberculosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Resistance to isoniazid and rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Resistance to isoniazid, rifampicin and levofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Resistance to isoniazid, rifampicin, levofloxacin and amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resistance to isoniazid, rifampicin, levofloxacin and linezolide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Resistance to isoniazid, rifampicin, levofloxacin and linezolide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-551.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Resistance to isoniazid, rifampicin, levofloxacin and linezolide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the fluoroquinolones is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonococcal resistance to fluoroquinolones may involve changes in DNA gyrase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Modification of ciprofloxacin dosage is required in patients if creatinine clearance is less than 50 mL/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Norfloxacin is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7 year-old girl&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fluoroquinolones inhibit relaxation of positively supercoiled DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Norfloxacin is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7 year-old girl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Norfloxacin is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7 year-old girl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A post operative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotics treatment, the review of the charts was done. It was found that that the resident doctor had started the combination of antibiotics which was mutually antagonistic in action. Which of the following is the most likely combination that was given?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vancomycin and Amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ampicillin and Chloramphenicol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cephalexin and Gentamicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin and Piperacillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ampicillin and Chloramphenicol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Ampicillin and Chloramphenicol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Regarding the antibacterial action of amikacin, which of the following statements is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibacterial activity is often reduced by the presence of an inhibitor of cell wall synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It continues to exert antibacterial effects even after plasma levels decrease below detectable range&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Efficacy is directly proportionate to the time that the plasma level of the drug is greater than the minimal inhibitory concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It has strong antibacterial activity against Salmonella&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It continues to exert antibacterial effects even after plasma levels decrease below detectable range&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It continues to exert antibacterial effects even after plasma levels decrease below detectable range&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following combination of drug and its indication is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pretomanid: MDR tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fostemsavir: Treatment of HIV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remdesivir: Moderate to severe COVID-19 pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Tafenoquine: Single dose treatment of P. falciparum malaria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is the oral drug for treatment of mucormycosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Voriconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Posaconazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Terbinafine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Posaconazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Posaconazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about warfarin group of oral anticoagulatns is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They interfere with an early step in the synthesis of clotting factors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Their dose is adjusted by repeated measurement of INR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is contraindicated during first trimester of pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They interfere with an early step in the synthesis of clotting factors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. They interfere with an early step in the synthesis of clotting factors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman has had a heart transplant. She receives cyclosporine as part of the immunosuppressant regimen. Which of the following is the main mechanism of cyclosporineâ€™s immunosuppressant effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blocks the CD3 site on T lymphocytes, blocks all T cell functions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Directly destroys proliferating lymphoid cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Directly inhibits B and T lymphocyte proliferation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibits calcineurin and resulting IL-2 synthesis that is necessary for B and T cell proliferation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inhibits calcineurin and resulting IL-2 synthesis that is necessary for B and T cell proliferation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Inhibits calcineurin and resulting IL-2 synthesis that is necessary for B and T cell proliferation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67 years old female was given rivaroxaban to prevent thromboembolism after total knee replacement surgery. She took overdose of the above drug. Which of the following drug can be used to reverse the effect of the anticoagulant taken by her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idarucizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Andexanet alpha&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin K&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Protamine sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Andexanet alpha&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Andexanet alpha&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about heparin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It act by inhibiting anti-thrombin III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin is preferred over warfarin for long-term treatment of DVT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Aducanumab is a recently approved new monoclonal antibody. It has been approved for treatment of ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-small cell lung carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COVID-19&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alzheimerâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Alzheimer&#x27;s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is not true of local anaesthetics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The local anaesthetic is required in the unionized form for penetrating the neuronal membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The local anaesthetic approaches its receptor from the intraneuronal face of the Na + channel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The local anaesthetic binds to its receptor mainly when the Na + channel is in the resting state&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The local anaesthetic combines with its receptor in the ionized cationic form&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The local anaesthetic binds to its receptor mainly when the Na + channel is in the resting state&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The local anaesthetic binds to its receptor mainly when the Na+channel is in the resting state&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of theophylline in bronchial asthma include all of the following except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phosphodiesterase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine receptor antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased histone deacetylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta -2 receptor stimulation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Beta -2 receptor stimulation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Beta -2 receptor stimulation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the mechanism of antifungal drug is wrongly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azoles- Inhibit ergosterol synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flucytosine- Inhibit microtubule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echinocandins- Inhibit glycan synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphotericin B- Create artificial pores in the membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flucytosine- Inhibit microtubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-552.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Flucytosine- Inhibit microtubule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male patient is currently receiving treatment in the oncology department for advanced non-small cell lung cancer (NSCLC). His oncologist has been discussing various therapeutic options with him, including a group of medications called immune checkpoint inhibitors. Immune checkpoints are regulators of the immune system that help to prevent the immune system from attacking cells indiscriminately. They do this by distinguishing between &#x27;self&#x27; and &#x27;non-self&#x27; cells. Some cancer cells can take advantage of these checkpoints to avoid being targeted by the immune system. Immune checkpoint inhibitors are a type of drug that blocks these immune checkpoints, allowing immune cells to better recognize and attack cancer cells. Given this information, which of the following drugs is not an immune check point inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avelumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Durvalumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cetuximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-553.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cetuximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following chelating agents can be used orally for the treatment of transfusion siderosis in thalassemia patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deferipirone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deferipirone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Deferipirone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following the treatment of an oral abscess with clindamycin, a patient develops a greenish, foul-smelling watery diarrhea with left lower quadrant pain. Other signs and symptoms include fever, leukocytosis, and lethargy. If the toxin produced by Clostridium difficile is detected in the stool, the patient would most appropriately be treated with?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fidaxomicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fidaxomicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Fidaxomicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test4" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D   Mission (2.0 Batch 3)   05 12 2024   2024 12 05&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D   Mission (2.0 Batch 3)   05 12 2024   2024 12 05&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 28-year-old pregnant woman in her first trimester visits her obstetrician for a routine check-up. She has a history of epilepsy and is currently taking antiepileptic medication. She expresses concern about the potential effects of the medication on her developing baby. The obstetrician discusses the risks of drug use during pregnancy, including the concepts of teratogenicity and placental transfer. Which of the following statements about drug use during pregnancy is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A drug is contraindicated in pregnancy if it crosses the placenta.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Maximum teratogenic effects are likely in the first trimester.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teratogenicity depends on the dose and duration of therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thalidomide teratogenicity occurs due to binding to cereblon.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A drug is contraindicated in pregnancy if it crosses the placenta.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A drug is contraindicated in pregnancy if it crosses the placenta.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that while the first trimester is the period of maximum vulnerability to teratogenic effects, not all drugs that cross the placenta are contraindicated during pregnancy. The decision to use a drug in pregnancy involves a careful evaluation of the risk-benefit ratio. Additionally, recognize that specific mechanisms, such as cereblon binding in the case of thalidomide, can be responsible for a drug&#x27;s teratogenicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented with left sided severe throbbing headache associated with nausea, vomiting, photophobia and phonophobia. Which of the following is a new drug that can provide immediate relief to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rimegepant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flunarizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fremanezumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Rimegepant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Rimegepant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For acute relief of migraine symptoms, Rimegepant , a CGRP receptor antagonist, is a newer option that provides rapid symptom relief without the cardiovascular risks associated with older treatments like triptans. Prophylactic treatments such as propranolol, flunarizine, and fremanezumab are used to prevent migraines but are not effective for immediate relief.&lt;/li&gt;&lt;li&gt;âž¤ Rimegepant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He was recently started on a new medication. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. Which of the following drugs is most likely responsible for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Quinidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Quinidine is the most likely cause of digoxin toxicity due to its effects on renal excretion and tissue displacement of digoxin. Other drugs like lisinopril, amlodipine, and metformin do not directly elevate digoxin levels, though they may contribute to related complications through other mechanisms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pure action potential prolonging drug without any other effect on action potential is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dofetilide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dofetilide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dofetilide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dofetilide is a pure action potential-prolonging drug that selectively blocks the IKr potassium current , thereby prolonging the action potential duration without affecting other phases of the action potential. Other drugs like procainamide, amiodarone, and phenytoin have additional mechanisms that disqualify them from being \&quot;pure\&quot; in their action.&lt;/li&gt;&lt;li&gt;âž¤ pure action potential-prolonging drug&lt;/li&gt;&lt;li&gt;âž¤ IKr potassium current&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following statement is NOT true about sotalol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a non-selective beta-blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It prolongs action potential duration of the heart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is primarily excreted through bile following hepatic metabolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can cause Torsadesâ€™de Pointes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is primarily excreted through bile following hepatic metabolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is primarily excreted through bile following hepatic metabolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a non-selective beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a non-selective beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ Sotalol is indeed a non-selective beta-blocker, meaning it blocks both beta-1 and beta-2 adrenergic receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option B: It prolongs action potential duration of the heart&lt;/li&gt;&lt;li&gt;â€¢ Option B: It prolongs action potential duration of the heart&lt;/li&gt;&lt;li&gt;â€¢ Sotalol has class III antiarrhythmic properties, which means it prolongs the action potential duration and refractory period of cardiac cells by blocking potassium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D: It can cause Torsades de Pointes&lt;/li&gt;&lt;li&gt;â€¢ Option D: It can cause Torsades de Pointes&lt;/li&gt;&lt;li&gt;â€¢ One of the known adverse effects of sotalol is Torsades de Pointes, a specific type of polymorphic ventricular tachycardia associated with prolongation of the QT interval on the ECG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sotalol is a non-selective beta-blocker with class III antiarrhythmic properties that prolong the action potential duration of the heart. It is primarily excreted unchanged by the kidneys and can cause Torsades de Pointes due to its effect on the QT interval.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The effect of different drugs was tested on heart rate. Curve A represents the effect of adrenaline (a pure beta 1 receptor agonist). Which of the curves most likely represents the effect of adrenaline after application of a irreversible competitive beta 1 receptor antagonist?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fyeGTTW.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Atropine is useful in organophosphate poisoning because it:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reactivates acetylcholine esterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Competes with acetylcholine release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Binds with both nicotinic and muscarinic acetylcholine receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is a competitive antagonist of acetylcholine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Is a competitive antagonist of acetylcholine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Is a competitive antagonist of acetylcholine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This drug is approved for the treatment of heart failure and angina pectoris. It is a dual-acting inhibitor of neprilysin and angiotensin-converting enzyme (ACE), resulting in vasodilation and reduced cardiac workload. Its adverse effects include hypotension and angioedema. Which drug is being discussed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Levosimendan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Omapatrilat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ARNI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Omapatrilat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Omapatrilat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Omapatrilat is a dual neprilysin and ACE inhibitor that reduces cardiac workload and improves symptoms of angina and heart failure by promoting vasodilation and reducing afterload. Its therapeutic use is limited due to its adverse effect profile, especially angioedema , which is linked to excessive bradykinin accumulation.&lt;/li&gt;&lt;li&gt;âž¤ dual neprilysin and ACE inhibitor&lt;/li&gt;&lt;li&gt;âž¤ angioedema&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following effects of adrenaline would be blocked by prazosin but NOT by propranolol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Release of renin from JG cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Relaxation of bronchial smooth muscle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tremors due to stimulation of muscle spindle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contraction of the vascular smooth muscle&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Contraction of the vascular smooth muscle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Contraction of the vascular smooth muscle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of atenolol in comparison to propranolol EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is ineffective in suppressing muscle tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is safer in asthmatics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is less likely to cause bradycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is less likely to worsen Raynaudâ€™s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is less likely to cause bradycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.C. It is less likely to cause bradycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which phase of clinical trials is conducted on volunteers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements best describes an â€˜orphan receptorâ€™?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a receptor for a drug required for the treatment or prevention of a rare disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a receptor which is not stimulated even when maximum amount of agonist is present.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a receptor for which no endogenous ligand is present.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is a receptor which has no therapeutic use.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is a receptor for which no endogenous ligand is present.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) It is a receptor for which no endogenous ligand is present.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An orphan receptor is defined as a receptor for which no known endogenous ligand has been identified. These receptors may still have biological or therapeutic significance, and their functions or ligands may be discovered in the future.&lt;/li&gt;&lt;li&gt;âž¤ orphan receptor&lt;/li&gt;&lt;li&gt;âž¤ endogenous ligand&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug can decrease bone resorption as well as increase bone formation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zolendronic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abaloparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Strontium ranelate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Strontium ranelate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Strontium ranelate is the only option that both decreases bone resorption and increases bone formation, making it uniquely suited for improving bone density and reducing fracture risk. Other agents like zoledronic acid and raloxifene are effective in reducing resorption but do not promote bone formation, while abaloparatide increases bone formation but does not significantly impact resorption. This dual mechanism makes strontium ranelate a valuable treatment option for osteoporosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young married couple has been trying to have a child for four years, but without success despite not using any contraceptives. The husband&#x27;s sperm count is within the normal range. The doctor advised the wife to undergo treatment to enhance fertility. Among the options below, which drug can either stimulate or inhibit ovulation, depending solely on how it&#x27;s scheduled to be taken?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Letrozole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clomiphene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leuprolide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Human chorionic gonadotropin (hCG)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Leuprolide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Leuprolide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old individual named Suresh, who has been diagnosed with insulin-dependent diabetes mellitus, has been prescribed insulin therapy. The discomfort from the injections has become unbearable for him, leading him to attempt consuming the insulin orally from the vial that was initially intended for subcutaneous injection. What is the most likely consequence of his action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrointestinal upset&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic high blood sugar levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kidney failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chronic high blood sugar levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Chronic high blood sugar levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents to his primary care physician with complaints of a persistent sore throat, fever, and swollen glands for the past week. On examination, the physician observes inflamed tonsils with a white exudate. The doctor is considering using a cephalosporin. She is debating which generation to use and recalls a drug she learned about during her medical training. Which of the following cephalosporins, that the doctor is considering, is a fifth-generation cephalosporin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefprozil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefadroxil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftizoxime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ceftobiprole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ceftobiprole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ceftobiprole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Among the options, Ceftobiprole is the fifth-generation cephalosporin. It is distinguished by its broad-spectrum coverage, particularly its activity against MRSA, which sets it apart from earlier generations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman with a history of Alzheimer&#x27;s disease presents to the clinic with complaints of frequent episodes of urgency, increased daytime urination, and occasional incontinence over the past three months. Her caregiver mentions that these symptoms have been disruptive, especially during outings. She is currently on donepezil for Alzheimer&#x27;s management. Physical examination is unremarkable, and urinalysis rules out infection. Which of the following is the most appropriate first-line pharmacological treatment for this patientâ€™s overactive bladder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxybutynin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trospium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tolterodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Solefenacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Trospium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Trospium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patient has overactive bladder and Alzheimer&#x27;s disease, making cognitive safety a priority. Trospium is the preferred agent due to its minimal CNS penetration, providing efficacy with reduced risk of exacerbating cognitive impairment.&lt;/li&gt;&lt;li&gt;âž¤ The patient has overactive bladder and Alzheimer&#x27;s disease, making cognitive safety a priority.&lt;/li&gt;&lt;li&gt;âž¤ Trospium is the preferred agent due to its minimal CNS penetration, providing efficacy with reduced risk of exacerbating cognitive impairment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Extensive drug resistant TB is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Resistance to isoniazid, rifampicin and levofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Resistance to isoniazid, rifampicin, moxifloxacin and streptomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Resistance to isoniazid, rifampicin, moxifloxacin and bedaquiline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resistance to rifampicin, pyrazinamide, ethambutol, levofloxacin, linezolide and bedaquiline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Resistance to isoniazid, rifampicin, moxifloxacin and bedaquiline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gt3pNuc.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Resistance to isoniazid, rifampicin, moxifloxacin and bedaquiline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In dog blood pressure experiment, adrenaline was given at the point shown by arrow and the effect noted is shown in the figure. Black represents the mean arterial pressure and red line indicates heart rate. What is this effect known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic response&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicotinic effects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Biphasic response&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation Of Options&lt;/li&gt;&lt;li&gt;â€¢ a. Vasomotor reversal of Dale : This phenomenon occurs when adrenaline is administered following the administration of alpha-blockers. In normal circumstances, adrenaline produces biphasic response; first increase in BP (due to stimulation of alpha-1 adrenergic receptors) and then decrease in BP (due to unopposed beta-2 stimulation). However, when alpha receptors are blocked, the administration of adrenaline leads to a predominant action on the beta receptors, causing vasodilation and an decrease in blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Vasomotor reversal of Dale&lt;/li&gt;&lt;li&gt;â€¢ c. Tachyphylaxis : Tachyphylaxis refers to a rapid decrease in the response to a drug after repeated doses over a short period of time. It is shown by drugs like tyramine and ephedrine etc. It does not describe the biphasic response seen with adrenaline in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Tachyphylaxis&lt;/li&gt;&lt;li&gt;â€¢ d. Nicotinic effects : Nicotinic effects pertain to the action on nicotinic acetylcholine receptors. In this there will be increase in BP and heart rate after giving high doses of acetylcholine. This is not relevant to the adrenaline-induced cardiovascular effects described in the question.&lt;/li&gt;&lt;li&gt;â€¢ Nicotinic effects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7 year old child opened his fatherâ€™s drawer and ingested multiple tablets of his cardiac medication, metoprolol. The child was brought to hospital with profound hypotension and bradycardia. Which of the following drug is least likely to be effective in improving the cardiac activity in this patient ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calcium gluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nor-adrenaline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nor-adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Nor-adrenaline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atropine , glucagon , and calcium gluconate act through mechanisms that are either independent of beta-adrenergic receptors or compensate for their blockade, making them effective in this situation. Nor-adrenaline , however, relies on beta-1 receptor stimulation for improving cardiac contractility, which is rendered ineffective in the presence of metoprolol-induced beta-blockade. This makes it the least effective option in improving cardiac activity in this patient.&lt;/li&gt;&lt;li&gt;âž¤ Atropine , glucagon , and calcium gluconate act through mechanisms that are either independent of beta-adrenergic receptors or compensate for their blockade, making them effective in this situation.&lt;/li&gt;&lt;li&gt;âž¤ Atropine&lt;/li&gt;&lt;li&gt;âž¤ glucagon&lt;/li&gt;&lt;li&gt;âž¤ calcium gluconate&lt;/li&gt;&lt;li&gt;âž¤ Nor-adrenaline , however, relies on beta-1 receptor stimulation for improving cardiac contractility, which is rendered ineffective in the presence of metoprolol-induced beta-blockade. This makes it the least effective option in improving cardiac activity in this patient.&lt;/li&gt;&lt;li&gt;âž¤ Nor-adrenaline&lt;/li&gt;&lt;li&gt;âž¤ beta-1 receptor stimulation&lt;/li&gt;&lt;li&gt;âž¤ least effective&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and efavirenz 600 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add efavirenz 600 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add dolutegravir 50 mg in the morning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. No dose adjustment is required&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. No dose adjustment is required&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine plus primaquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Artesunate plus sulfadoxine-pyrimethamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s consider each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Oral Labetalol: Labetalol is a beta-blocker with alpha-blocking activity. It is commonly used for hypertension in pregnancy. However, being a beta-blocker, it can potentially exacerbate bronchial asthma by causing bronchoconstriction.&lt;/li&gt;&lt;li&gt;â€¢ Oral Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ b. Intravenous Labetalol: This would be used for more immediate control of severely elevated blood pressure, like in a hypertensive crisis. The same concerns regarding bronchial asthma apply as with oral labetalol.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ c. Nifedipine: Nifedipine is a calcium channel blocker. It is effective in lowering blood pressure and is generally considered safe in pregnancy. It does not have the bronchoconstrictive effects associated with beta-blockers.&lt;/li&gt;&lt;li&gt;â€¢ Nifedipine:&lt;/li&gt;&lt;li&gt;â€¢ d. Propranolol: This is a non-selective beta-blocker and is generally contraindicated in asthma because it can cause bronchoconstriction. It is also not the first choice for managing hypertension in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Propranolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient presents with a history of chronic cough, weight loss, and night sweats. The patient has a history of HIV, was recently diagnosed with Plasmodium falciparum malaria, and was exposed to someone with COVID-19. The patient&#x27;s sputum test came back positive for Mycobacterium tuberculosis, resistant to rifampicin and isoniazid (indicating multi-drug resistant tuberculosis). Which of the following combination of drug and its indication is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pretomanid: MDR tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enfuvirtide: Treatment of HIV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remdesivir: Moderate to severe COVID-19 pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s evaluate each drug option:&lt;/li&gt;&lt;li&gt;â€¢ a. Pretomanid for MDR Tuberculosis : Pretomanid is used in the treatment of multi-drug resistant (MDR) tuberculosis, in combination with bedaquiline and linezolid. This combination is known as the BPaL regimen. So, this option is TRUE.&lt;/li&gt;&lt;li&gt;â€¢ Pretomanid for MDR Tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ b. Enfuvirtide for Treatment of HIV : Enfuvirtide is an antiretroviral drug used in the treatment of HIV/AIDS. It is a fusion inhibitor that prevents the virus from entering the host cell. This is a TRUE statement.&lt;/li&gt;&lt;li&gt;â€¢ Enfuvirtide for Treatment of HIV&lt;/li&gt;&lt;li&gt;â€¢ c. Tafenoquine for Single Dose Treatment of P. falciparum Malaria : Tafenoquine is used as a single-dose treatment for the radical cure of Plasmodium vivax malaria, not Plasmodium falciparum malaria. For P. falciparum, drugs like artemisinin-based combination therapies (ACTs) are typically used. Therefore, this statement is FALSE.&lt;/li&gt;&lt;li&gt;â€¢ Tafenoquine for Single Dose Treatment of P. falciparum Malaria&lt;/li&gt;&lt;li&gt;â€¢ d. Remdesivir for Moderate to Severe COVID-19 Pneumonia : Remdesivir is an antiviral drug that has been used for the treatment of COVID-19, particularly in hospitalized patients with severe disease. This statement is TRUE.&lt;/li&gt;&lt;li&gt;â€¢ Remdesivir for Moderate to Severe COVID-19 Pneumonia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old male diagnosed with HIV seeks guidance from his primary care doctor for appropriate treatment. Given the significant drop in his CD4 counts, initiation of HAART (Highly Active Antiretroviral Therapy) is being contemplated. Concerning the role of ritonavir for this patient, which statement holds true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;This agent is associated with resistance when used in combination with another protease inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is used primarily for its inhibitory effect on CYP3A4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;This is an excellent single agent for use in HAART therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is used primarily for its inhibitory effect on CYP3A4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ (A) This statement is not fully accurate. While ritonavir does inhibit the HIV protease enzyme, it&#x27;s not primarily used for that purpose in most modern HAART regimens. Instead, it&#x27;s given in low doses to boost the effect of other protease inhibitors by inhibiting CYP3A4. The dose of ritonavir used for boosting is lower than that required to inhibit the HIV protease.&lt;/li&gt;&lt;li&gt;â€¢ (B) This statement is incorrect. Ritonavir&#x27;s function as a booster in combination with another protease inhibitor is not typically associated with an increased resistance. On the contrary, its role is to enhance the effectiveness of the primary protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ (C) True. Ritonavir inhibits CYP3A4, an enzyme responsible for the metabolism of many drugs, including other protease inhibitors. By doing this, ritonavir can increase the plasma levels of these drugs, thus maximizing their effectiveness against the HIV virus.&lt;/li&gt;&lt;li&gt;â€¢ (D) This is not accurate. While ritonavir does have activity against HIV as a protease inhibitor, its primary use in current HAART regimens is as a booster to enhance the levels of other protease inhibitors. It&#x27;s not recommended as a standalone agent in therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old sexually active, HIV-negative male visits his healthcare provider with a painless sore on his inner lip and a non-itchy rash on the soles of his feet. He recalls having a non-tender ulcer on his scrotum about a month and a half ago, which resolved on its own. He receives an intramuscular injection of benzathine penicillin G and is discharged. How might the treatment approach for this patient have been modified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The choice of antibiotic was not appropriate, and another class should have been selected&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The correct treatment would involve a different form of penicillin G, rather than benzathine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;There is no need for changes; the treatment administered is correct&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;After the initial injection, a follow-up dose should be given after 7 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. There is no need for changes; the treatment administered is correct&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/screenshot-2024-02-01-153605.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s clinical presentation, including a painless sore followed by a rash on the soles of the feet, is consistent with secondary syphilis.&lt;/li&gt;&lt;li&gt;â€¢ The first-line treatment for syphilis at any stage is penicillin, specifically benzathine penicillin G, which is long-acting and given intramuscularly. Thus, another antibiotic class isn&#x27;t needed. Benzathine penicillin G is the appropriate form of penicillin for the treatment of syphilis. It is the recommended preparation due to its prolonged action which provides a sustained therapeutic level for an extended period. The single intramuscular injection of benzathine penicillin G is the appropriate treatment for early syphilis, which includes both primary and secondary stages. A single dose of benzathine penicillin G is sufficient for the treatment of primary or secondary syphilis in HIV-negative individuals. The follow-up dose after 7 days is recommended for the late latent stage or tertiary syphilis, but not for early syphilis.&lt;/li&gt;&lt;li&gt;â€¢ The first-line treatment for syphilis at any stage is penicillin, specifically benzathine penicillin G, which is long-acting and given intramuscularly. Thus, another antibiotic class isn&#x27;t needed.&lt;/li&gt;&lt;li&gt;â€¢ Benzathine penicillin G is the appropriate form of penicillin for the treatment of syphilis. It is the recommended preparation due to its prolonged action which provides a sustained therapeutic level for an extended period.&lt;/li&gt;&lt;li&gt;â€¢ The single intramuscular injection of benzathine penicillin G is the appropriate treatment for early syphilis, which includes both primary and secondary stages.&lt;/li&gt;&lt;li&gt;â€¢ A single dose of benzathine penicillin G is sufficient for the treatment of primary or secondary syphilis in HIV-negative individuals. The follow-up dose after 7 days is recommended for the late latent stage or tertiary syphilis, but not for early syphilis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman is taken to a neurologist by her family members. After thorough evaluation, the neurologist suggests the possibility of starting Lecanumab therapy, and the patient&#x27;s family starts researching the medication. Which of the following statements about Lecanumab is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lecanumab is a monoclonal antibody.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lecanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lecanumab has received FDA approval for the treatment of Alzheimer&#x27;s disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lecanumab targets amyloid-beta plaques in the brain.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lecanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lecanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thus, the statement that is FALSE about Lecanumab is that it works by inhibiting acetylcholinesterase to increase cholinergic transmission.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ubrogepant - CGRP receptor antagonist used for the treatment of acute migraine attacks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pembrolizumab â€“ Monoclonal antibody against her-2/neu for breast cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ertugliflozin â€“ SGLT2 inhibitor for treatment of CHF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omapatrilat â€“ Dual inhibitor of ACE and NEP for CHF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pembrolizumab â€“ Monoclonal antibody against her-2/neu for breast cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The incorrect match is B) because Pembrolizumab is a PD-1 inhibitor, not a HER-2/neu monoclonal antibody, and is not used for HER-2/neu-positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ B)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs should be given in sustained release oral dosage form?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;An anti-arrhythmic drug with a plasma half-life of 10 seconds used for acute treatment of PSVT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An anti-inflammatory drug with a plasma half-life of 24 hr&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A hypnotic drug with a plasma half-life of 2 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An antihypertensive with a plasma half-life of 3 hours&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. An antihypertensive with a plasma half-life of 3 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient comes 6 hours after consuming morphine and presents with pinpoint pupils and respiratory depression. The half-life of morphine is 3 hours and Volume of distribution (Vd) is 200 L. Plasma concentration of morphine at this time is 0.5 microgram/ml. Calculate the initial morphine dose consumed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;100 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;400 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;10 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;50 mg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 400 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diuretics does not require its presence in the tubular lumen for its pharmacological effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loop diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbonic anhydrase inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aldosterone antagonists&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aldosterone antagonists&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with schizophrenia was treated with haloperidol 5 mg once daily at bedtime, which was increased to 7.5 mg daily in the 2nd week and 10 mg daily in the 3rd week. His symptoms improved, but in the 5th week, his family reported that his restlessness had returned, and he kept pacing around in the room, though he was not aggressive. The patient also reported an uncontrollable urge to move around and difficulty in falling asleep. His past history reveals that he is prone to develop asthma attacks. Which of the following drugs would be the best choice for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Higher doses of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valbenazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benzhexol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Benzhexol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Benzhexol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male presents to the emergency department with fever, dyspnea, and a productive cough for the past three days. He has a history of diabetes and was recently hospitalized for a surgical procedure. Examination reveals a temperature of 101Â°F (38.3Â°C) and crackles in the right lower lung field. Sputum culture grows Pseudomonas aeruginosa. Which of the following drugs is NOT used in the treatment of Pseudomonas infections?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Piperacillin-tazobactam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tobramycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vancomycin is ineffective against Pseudomonas. Piperacillin-tazobactam and tobramycin are mainstays of Pseudomonas treatment. Rifampicin, while not routinely used, may have limited utility in specific resistant infections, but it is not a standard anti-pseudomonal agent.&lt;/li&gt;&lt;li&gt;âž¤ Vancomycin is ineffective against Pseudomonas.&lt;/li&gt;&lt;li&gt;âž¤ Piperacillin-tazobactam and tobramycin are mainstays of Pseudomonas treatment.&lt;/li&gt;&lt;li&gt;âž¤ Rifampicin, while not routinely used, may have limited utility in specific resistant infections, but it is not a standard anti-pseudomonal agent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an incorrect match regarding angiotensin receptor blocker (ARB) and its pharmacological property?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Telmisartan â€“ PPAR-Î³ agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Losartan â€“ TXA2 receptor antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valsartan â€“ Given with sacubitril as ARNI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candesartan â€“ Direct renin inhibitor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Candesartan â€“ Direct renin inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Candesartan â€“ Direct renin inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The incorrect match is D. Candesartan â€“ Direct renin inhibitor, as Candesartan works by blocking the AT1 receptor, not renin. The other options correctly describe the properties of their respective ARBs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a correct match regarding the drugs used in HIV&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Attachment inhibitor: Ibalizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Post-attachment inhibitor: Maraviroc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fusion inhibitor: Enfuvirtide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Co-receptor inhibitor: Fostemsavir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Fusion inhibitor: Enfuvirtide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pu1L6eG.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Fusion inhibitor: Enfuvirtide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Chlorthiazide and furosemide are members of different diuretic classes, in terms of mechanisms of action, but they share the ability to cause hypokalemia. Which of the following statements best describes the general mechanism by which these drugs cause their effects that lead to net renal loss of potassium?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibiting proximal tubular K+ reabsorption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibiting Na+-K+-2C1â€“ cotransport in the ascending limb of loop of Henle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potentiating the action of aldosterone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One of your clinic patients is being treated with spironolactone. Which of the following statements best describes the property of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits Na+ reabsorption in the proximal renal tubule of the nephron.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interferes with aldosterone synthesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Is a rational choice for a patient with an adrenal cortical tumor.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is more efficacious than hydrochlorothiazide in all patients who receive the drug.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Is a rational choice for a patient with an adrenal cortical tumor.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Is a rational choice for a patient with an adrenal cortical tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came to emergency with pus on the tip of the finger. You want to drain the pus and require a local anaesthetic. The history of the patient reveals that he is allergic to chlorprocaine. Which of the following local anaesthetics will be safe in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tetracaine with adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tetracaine without adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lignocaine with adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine without adrenaline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lignocaine without adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lignocaine without adrenaline.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old female discovered she was HIV-positive four weeks ago. Upon receiving her diagnosis, she initiated a HAART (Highly Active Antiretroviral Therapy) protocol. Currently, she&#x27;s experiencing symptoms of nausea, episodes of vomiting, and stomach pain. Lab tests indicate a heightened serum amylase level. If these symptoms are a result of her medication, which antiretroviral drug is most likely the culprit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Efavirenz&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Didanosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Raltegravir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nevirapine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Didanosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Didanosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Efavirenz&lt;/li&gt;&lt;li&gt;â€¢ A. Efavirenz&lt;/li&gt;&lt;li&gt;â€¢ Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is more commonly associated with central nervous system side effects such as dizziness, insomnia, and vivid dreams rather than gastrointestinal side effects and pancreatitis.&lt;/li&gt;&lt;li&gt;â€¢ C. Raltegravir&lt;/li&gt;&lt;li&gt;â€¢ C. Raltegravir&lt;/li&gt;&lt;li&gt;â€¢ Raltegravir is an integrase strand transfer inhibitor (INSTI) and is not typically associated with pancreatitis. Its common side effects include elevated creatine kinase, muscle pain, and insomnia.&lt;/li&gt;&lt;li&gt;â€¢ D. Nevirapine&lt;/li&gt;&lt;li&gt;â€¢ D. Nevirapine&lt;/li&gt;&lt;li&gt;â€¢ Nevirapine is another NNRTI that is primarily associated with hepatotoxicity and skin rash, including severe reactions like Stevens-Johnson syndrome, rather than pancreatitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Didanosine, an NRTI used in HAART regimens, is associated with gastrointestinal side effects, including pancreatitis. Elevated serum amylase levels, along with symptoms such as nausea, vomiting, and stomach pain, are indicative of pancreatitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the clinic with complaints of severe headaches, disturbances in sleep, and intermittent fever for the past few weeks. He recently returned from a trip to Central Africa. Lumbar puncture results reveal trypanosomes in the cerebrospinal fluid, suggesting a late-stage African trypanosomiasis with CNS involvement. Which drug would be most effective in treating both the blood and CNS stages of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Emetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Melarsoprol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nifurtimox&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suramin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Melarsoprol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Melarsoprol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is admitted with H. influenza meningitis. Cefotaxime is preferred over ampicillin in this patient because:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefotaxime is effective orally whereas ampicillin is not&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefotaxime is more effective against H. influenza having altered penicillin binding proteins.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefotaxime is cidal drug whereas ampicillin is static&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefotaxime is more active against beta lactamase producing strains of H. influenza.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cefotaxime is more active against beta lactamase producing strains of H. influenza.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Cefotaxime is more active against beta-lactamase producing strains of H. influenzae.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ One of the main reasons cefotaxime is preferred over ampicillin in the treatment of H. influenzae meningitis is due to its activity against beta-lactamase producing strains. Many strains of H. influenzae produce beta-lactamase, an enzyme that hydrolyzes the beta-lactam ring of ampicillin, rendering it ineffective. Cefotaxime, being a third-generation cephalosporin, is resistant to this enzyme and can effectively treat beta-lactamase producing strains of H. influenzae. Cefotaxime is primarily given intravenously or intramuscularly, not orally. Ampicillin can be given both orally and parenterally. Both cefotaxime and ampicillin target penicillin-binding proteins (PBPs). However, the resistance of H. influenzae to ampicillin is primarily due to the production of beta-lactamase, not the alteration of PBPs. Both cefotaxime and ampicillin are bactericidal agents. They kill bacteria by inhibiting the synthesis of the bacterial cell wall.&lt;/li&gt;&lt;li&gt;â€¢ One of the main reasons cefotaxime is preferred over ampicillin in the treatment of H. influenzae meningitis is due to its activity against beta-lactamase producing strains. Many strains of H. influenzae produce beta-lactamase, an enzyme that hydrolyzes the beta-lactam ring of ampicillin, rendering it ineffective. Cefotaxime, being a third-generation cephalosporin, is resistant to this enzyme and can effectively treat beta-lactamase producing strains of H. influenzae.&lt;/li&gt;&lt;li&gt;â€¢ Cefotaxime is primarily given intravenously or intramuscularly, not orally. Ampicillin can be given both orally and parenterally.&lt;/li&gt;&lt;li&gt;â€¢ Both cefotaxime and ampicillin target penicillin-binding proteins (PBPs). However, the resistance of H. influenzae to ampicillin is primarily due to the production of beta-lactamase, not the alteration of PBPs.&lt;/li&gt;&lt;li&gt;â€¢ Both cefotaxime and ampicillin are bactericidal agents. They kill bacteria by inhibiting the synthesis of the bacterial cell wall.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;TRUE statement regarding vancomycin is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is bacteriostatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has the advantage of high oral bioavailability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Staphylococcal enterocolits occurs commonly with its use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not susceptible to penicillinases&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is not susceptible to penicillinases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It is not susceptible to penicillinases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ It is bacteriostatic: Vancomycin is primarily bactericidal. This means it actively kills bacteria rather than merely inhibiting their growth. It has the advantage of high oral bioavailability: Vancomycin has poor oral bioavailability. When given orally, it doesn&#x27;t absorb well from the gastrointestinal tract, so its oral form is mainly used to treat C. difficile colitis. For systemic infections, it&#x27;s typically given intravenously. Staphylococcal enterocolitis occurs commonly with its use: Staphylococcal enterocolitis isn&#x27;t a common association with vancomycin use. However, antibiotics, including vancomycin, can be associated with antibiotic-induced diarrhea or colitis, most famously caused by Clostridium difficile. It is not susceptible to penicillinases: This is true. Vancomycin&#x27;s action is distinct from beta-lactams. It binds to the D-Ala-D-Ala terminus of the cell wall precursor units, preventing cell wall synthesis. As a result, penicillinases, which break down the beta-lactam ring in penicillins, don&#x27;t affect vancomycin.&lt;/li&gt;&lt;li&gt;â€¢ It is bacteriostatic: Vancomycin is primarily bactericidal. This means it actively kills bacteria rather than merely inhibiting their growth.&lt;/li&gt;&lt;li&gt;â€¢ It is bacteriostatic:&lt;/li&gt;&lt;li&gt;â€¢ It has the advantage of high oral bioavailability: Vancomycin has poor oral bioavailability. When given orally, it doesn&#x27;t absorb well from the gastrointestinal tract, so its oral form is mainly used to treat C. difficile colitis. For systemic infections, it&#x27;s typically given intravenously.&lt;/li&gt;&lt;li&gt;â€¢ It has the advantage of high oral bioavailability:&lt;/li&gt;&lt;li&gt;â€¢ Staphylococcal enterocolitis occurs commonly with its use: Staphylococcal enterocolitis isn&#x27;t a common association with vancomycin use. However, antibiotics, including vancomycin, can be associated with antibiotic-induced diarrhea or colitis, most famously caused by Clostridium difficile.&lt;/li&gt;&lt;li&gt;â€¢ Staphylococcal enterocolitis occurs commonly with its use:&lt;/li&gt;&lt;li&gt;â€¢ It is not susceptible to penicillinases: This is true. Vancomycin&#x27;s action is distinct from beta-lactams. It binds to the D-Ala-D-Ala terminus of the cell wall precursor units, preventing cell wall synthesis. As a result, penicillinases, which break down the beta-lactam ring in penicillins, don&#x27;t affect vancomycin.&lt;/li&gt;&lt;li&gt;â€¢ It is not susceptible to penicillinases:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with a recent surgical history presents with signs of abdominal sepsis. She is empirically started on intravenous ampicillin and gentamicin. Which of the following statements regarding her treatment is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A drug active against anaerobe should be included in the antibiotic regimen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Combination of ampicillin and gentamicin provides good coverage for all likely pathogens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;If the patient is severely allergic to ampicillin, then ceftriaxone should be used&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A drug active against anaerobe should be included in the antibiotic regimen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. A drug active against anaerobe should be included in the antibiotic regimen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin: While third-generation cephalosporins are often used for abdominal infections because of their broad-spectrum coverage, it&#x27;s not accurate to say they should \&quot;always\&quot; be included. A drug active against anaerobe should be included in the antibiotic regimen: This is accurate. Abdominal sepsis often involves a mixture of aerobic and anaerobic organisms, especially if the source is intra-abdominal. Thus, anaerobic coverage is important. Combination of ampicillin and gentamicin provides good coverage for all likely pathogens: This combination can be effective against many pathogens; however, it might lack sufficient anaerobic coverage for abdominal sepsis, which often involves anaerobic bacteria. If the patient is severely allergic to ampicillin, then ceftriaxone should be used: While ceftriaxone can be an alternative in many infections, if a patient is severely allergic to a penicillin like ampicillin, there&#x27;s a risk of cross-reactivity with cephalosporins like ceftriaxone. In such cases, it would be crucial to select an antibiotic considering the allergy history.&lt;/li&gt;&lt;li&gt;â€¢ Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin: While third-generation cephalosporins are often used for abdominal infections because of their broad-spectrum coverage, it&#x27;s not accurate to say they should \&quot;always\&quot; be included.&lt;/li&gt;&lt;li&gt;â€¢ Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin:&lt;/li&gt;&lt;li&gt;â€¢ A drug active against anaerobe should be included in the antibiotic regimen: This is accurate. Abdominal sepsis often involves a mixture of aerobic and anaerobic organisms, especially if the source is intra-abdominal. Thus, anaerobic coverage is important.&lt;/li&gt;&lt;li&gt;â€¢ A drug active against anaerobe should be included in the antibiotic regimen:&lt;/li&gt;&lt;li&gt;â€¢ Combination of ampicillin and gentamicin provides good coverage for all likely pathogens: This combination can be effective against many pathogens; however, it might lack sufficient anaerobic coverage for abdominal sepsis, which often involves anaerobic bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Combination of ampicillin and gentamicin provides good coverage for all likely pathogens:&lt;/li&gt;&lt;li&gt;â€¢ If the patient is severely allergic to ampicillin, then ceftriaxone should be used: While ceftriaxone can be an alternative in many infections, if a patient is severely allergic to a penicillin like ampicillin, there&#x27;s a risk of cross-reactivity with cephalosporins like ceftriaxone. In such cases, it would be crucial to select an antibiotic considering the allergy history.&lt;/li&gt;&lt;li&gt;â€¢ If the patient is severely allergic to ampicillin, then ceftriaxone should be used:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Biochemical mechanisms of drug resistance are shown in the given below figure. Most important mode of resistance in MRSA is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/untitled-13583.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/untitled-13584.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true about pseudomembranous colitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous vancomycin can be used as an alternative in patients not responding to fidaxomicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bezlotoxumab is a highly effective monoclonal antibody that can kill most of Clostridium difficile bacteria responsible for the infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clostridium difficile is the common organism implicated in the causation of Pseudomembranous colitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clostridium difficile is the common organism implicated in the causation of Pseudomembranous colitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Clostridium difficile is the common organism implicated in the causation of Pseudomembranous colitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Intravenous vancomycin is not typically used for pseudomembranous colitis. Instead, oral vancomycin is used because it achieves high concentrations in the colon, where the infection is located. Intravenous administration doesn&#x27;t reach effective concentrations in the colon. Now, the drug of choice for pseudomembranous colitis is fidaxomicin. Bezlotoxumab is a monoclonal antibody against toxin B of Clostridium difficile. While it can reduce the recurrence of Clostridium difficile infection (CDI) in patients who are at high risk for CDI recurrence, it does not \&quot;kill\&quot; the bacteria. Instead, it neutralizes one of the toxins produced by the bacteria. Clostridium difficile is indeed the common organism implicated in the causation of Pseudomembranous colitis. The disease arises from the toxin production of this bacterium, typically after antibiotic therapy has disrupted the normal gut flora.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous vancomycin is not typically used for pseudomembranous colitis. Instead, oral vancomycin is used because it achieves high concentrations in the colon, where the infection is located. Intravenous administration doesn&#x27;t reach effective concentrations in the colon. Now, the drug of choice for pseudomembranous colitis is fidaxomicin.&lt;/li&gt;&lt;li&gt;â€¢ Bezlotoxumab is a monoclonal antibody against toxin B of Clostridium difficile. While it can reduce the recurrence of Clostridium difficile infection (CDI) in patients who are at high risk for CDI recurrence, it does not \&quot;kill\&quot; the bacteria. Instead, it neutralizes one of the toxins produced by the bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Clostridium difficile is indeed the common organism implicated in the causation of Pseudomembranous colitis. The disease arises from the toxin production of this bacterium, typically after antibiotic therapy has disrupted the normal gut flora.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about warfarin group of oral anticoagulants is false ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They interfere with an early step in the synthesis of clotting factors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Their dose is adjusted by repeated measurement of INR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are contraindicated during first trimester of pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They interfere with an early step in the synthesis of clotting factors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. They interfere with an early step in the synthesis of clotting factors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin has a delayed onset of action because it does not affect clotting factors that have already been synthesized and are present in the bloodstream. It takes several days for these existing clotting factors to degrade and for the anticoagulant effect to become apparent.&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. The dose of warfarin is adjusted based on the International Normalized Ratio (INR) to ensure that the patient&#x27;s blood is maintained within the therapeutic range, which minimizes the risk of bleeding and thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin is contraindicated during pregnancy, especially in the first trimester, due to its teratogenic effects. It can cause fetal warfarin syndrome, characterized by nasal hypoplasia and stippled epiphyses, among other congenital abnormalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Warfarin is an oral anticoagulant that inhibits the enzyme vitamin K epoxide reductase, affecting the carboxylation and activation of certain clotting factors. It has a delayed onset of action, typically taking 4-5 days, and its dose is adjusted based on INR measurements. Warfarin is contraindicated during pregnancy due to its teratogenic potential, especially in the first trimester.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The plasma half-life of aspirin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Is independent of dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Is longer for anti-inflammatory doses compared to that for anti-platelet dose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Is shorter for anti-inflammatory doses compared to that for anti-platelet dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Can be increased by alkalinizing the urine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Is longer for anti-inflammatory doses compared to that for anti-platelet dose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.B. Is longer for anti-inflammatory doses compared to that for anti-platelet dose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ A. Is independent of dose&lt;/li&gt;&lt;li&gt;â€¢ A. Is independent of dose&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect because the half-life of aspirin is dose-dependent. At low doses, aspirin exhibits first-order kinetics, but at higher doses, it shifts to zero-order kinetics due to the saturation of metabolic pathways.&lt;/li&gt;&lt;li&gt;â€¢ C. Is shorter for anti-inflammatory doses compared to that for anti-platelet dose&lt;/li&gt;&lt;li&gt;â€¢ C. Is shorter for anti-inflammatory doses compared to that for anti-platelet dose&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. At higher doses used for anti-inflammatory purposes, the half-life of aspirin is longer due to the saturation of metabolic pathways, which causes a shift to zero-order kinetics.&lt;/li&gt;&lt;li&gt;â€¢ D. Can be increased by alkalinizing the urine&lt;/li&gt;&lt;li&gt;â€¢ D. Can be increased by alkalinizing the urine&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Alkalinizing the urine enhances the excretion of salicylate, decreasing its half-life. This approach is used to increase the elimination of salicylates in cases of overdose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The plasma half-life of aspirin is dose-dependent, demonstrating first-order kinetics at low, anti-platelet doses and zero-order kinetics at higher, anti-inflammatory doses. At low doses, aspirin is metabolized proportionally to its concentration, resulting in a shorter half-life. However, at higher doses, metabolic pathways become saturated, leading to a constant rate of metabolism and a longer half-life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman, Seema was a resident of Nubra Valley in Leh Ladakh. She underwent a kidney transplant at AIIMS, Delhi. After transplant she was started several immunosuppressant drugs, including daily prednisone. She had returned to her home at Nubra Valley and is taking prednisone for the past two months since her transplant. However, she is trapped in her house due to heavy snow and may soon run out of prednisone. What health risk is she most likely to face if she does not get her prednisone in time?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoporosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Higher susceptibility to infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiovascular collapse&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sleep disturbances or insomnia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiovascular collapse&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cardiovascular collapse&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old sexually active female approaches her family doctor seeking a contraceptive. She is a chronic smoker consuming around a pack of cigarettes daily. She also consumes few alcoholic drinks per week. She has no personal or family history of breast, ovarian, or endometrial cancer. What could be the reason for her physician to advise against using a contraceptive containing estrogen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased risk of disulfiram-like reactions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The potential for estrogen to disrupt the patient&#x27;s lipid profile like increasing LDL cholesterol, leading to an elevated risk of cardiovascular disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High risk of developing endometrial cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased risk of thromboembolism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased risk of thromboembolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Increased risk of thromboembolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metformin is least likely to reduce blood sugar in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obese diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-diabetics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2 diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetics not responding to sulfonylureas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-diabetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Non-diabetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Obese diabetics&lt;/li&gt;&lt;li&gt;â€¢ A. Obese diabetics&lt;/li&gt;&lt;li&gt;â€¢ Metformin is particularly effective in obese diabetics because it helps reduce insulin resistance and can aid in weight management, both of which are beneficial in managing type 2 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ C. Type 2 diabetics&lt;/li&gt;&lt;li&gt;â€¢ C. Type 2 diabetics&lt;/li&gt;&lt;li&gt;â€¢ Metformin is a first-line treatment for type 2 diabetes and is effective in reducing blood sugar levels in these patients by addressing the underlying pathophysiological mechanisms of the disease.&lt;/li&gt;&lt;li&gt;â€¢ D. Diabetics not responding to sulfonylureas&lt;/li&gt;&lt;li&gt;â€¢ D. Diabetics not responding to sulfonylureas&lt;/li&gt;&lt;li&gt;â€¢ Metformin can be effective in diabetics who do not respond to sulfonylureas. It works through different mechanisms, so it can be beneficial as monotherapy or in combination with other antidiabetic medications, including when sulfonylureas alone are insufficient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Metformin is a widely used antihyperglycemic agent for managing type 2 diabetes, particularly effective in patients with insulin resistance, such as obese diabetics. It works by decreasing hepatic glucose production and improving insulin sensitivity. However, in non-diabetic individuals, metformin is least likely to reduce blood sugar levels significantly, as their glucose metabolism is generally normal.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Relative intensities of blocking effect (represented by +) of four drugs on different receptors is Which drug is MOST LIKELY to exacerbate the symptoms of Parkinsonism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Drug D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture38.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Drug D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Drug A&lt;/li&gt;&lt;li&gt;â€¢ A. Drug A&lt;/li&gt;&lt;li&gt;â€¢ Drug A blocks Î²1 (++) and M1 (+++) receptors, as well as D2 receptors (+++). While it does block D2 receptors, which could exacerbate Parkinsonism, it also blocks M1 receptors. Blocking M1 receptors can help to mitigate some of the cholinergic overactivity, potentially balancing the dopaminergic-cholinergic activity. Thus, Drug A is less likely to exacerbate Parkinsonism compared to Drug D.&lt;/li&gt;&lt;li&gt;â€¢ B. Drug B&lt;/li&gt;&lt;li&gt;â€¢ B. Drug B&lt;/li&gt;&lt;li&gt;â€¢ Drug B primarily affects GABAA receptors (++++) and does not block D2 or M1 receptors. Since it does not interfere with dopaminergic or cholinergic pathways, it is unlikely to impact Parkinsonism symptoms.&lt;/li&gt;&lt;li&gt;â€¢ C. Drug C&lt;/li&gt;&lt;li&gt;â€¢ C. Drug C&lt;/li&gt;&lt;li&gt;â€¢ Drug C has a strong blocking effect on M1 receptors (++++), and a minimal effect on D2 receptors (+). The blockade of M1 receptors can help to reduce cholinergic activity, which is beneficial in managing Parkinsonism. The minimal D2 receptor blockade makes it less likely to exacerbate Parkinsonism compared to Drug D.&lt;/li&gt;&lt;li&gt;â€¢ D. Drug D&lt;/li&gt;&lt;li&gt;â€¢ D. Drug D&lt;/li&gt;&lt;li&gt;â€¢ Drug D primarily blocks D2 receptors with a high intensity (++++), which significantly exacerbates the dopamine deficiency in Parkinsonism, thereby worsening the symptoms. Its minor activities on Î²1 and GABAA receptors do not counteract the strong D2 blockade.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In Parkinsonism, there is a critical balance between dopaminergic and cholinergic activity. The disease is characterized by a deficiency in dopamine, leading to an imbalance favouring cholinergic activity. Drugs that block D2 receptors can exacerbate this dopamine deficiency, worsening parkinsonian symptoms. Conversely, blocking muscarinic (M1) receptors can help reduce cholinergic overactivity, potentially improving symptoms. Therefore, drugs that strongly block D2 receptors, such as Drug D, are more likely to worsen Parkinsonism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Therapeutic plasma concentration of phenytoin should be maintained between 10-20 mcg/dl. A patient on anti-epileptic drug therapy has plasma phenytoin level of 36 mcg/dl. Which of the following adverse effect is likely to be seen at this high plasma drug concentration of phenytoin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hirsutism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gum hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ataxia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ataxia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ B. Hirsutism&lt;/li&gt;&lt;li&gt;â€¢ B. Hirsutism&lt;/li&gt;&lt;li&gt;â€¢ Hirsutism is a potential side effect of phenytoin, but it typically develops with long-term use rather than from acute high plasma concentrations.&lt;/li&gt;&lt;li&gt;â€¢ C. Gum hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ C. Gum hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ Gum hyperplasia is another well-known side effect of long-term phenytoin therapy, but it is not specifically related to acute high plasma levels.&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect because, while hirsutism and gum hyperplasia can occur with phenytoin use, they are associated with chronic use and not specifically with acutely high plasma levels like ataxia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that acute high plasma concentrations of phenytoin can lead to cardiac side effects like arrhthmias and neurological side effects such as ataxia, while other adverse effects like hirsutism and gum hyperplasia are more commonly associated with long-term therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Poorly absorbed antibiotics are often used as adjunctive therapies in patients with hepatic encephalopathy. These may include:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tenofovir or Telbivudine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sofosbuvir or Velpatasvir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Levofloxacin or Clarithromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neomycin or Rifaximin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Neomycin or Rifaximin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Neomycin or Rifaximin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In conclusion, neomycin and rifaximin are the appropriate poorly absorbed antibiotics used for hepatic encephalopathy, making option (d) the correct answer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an inhibitor of the intestinal mucosal transporter NPC1L1, responsible for the absorption of dietary and biliary cholesterol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fenofibrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ezetimibe&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ezetimibe&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ezetimibe is the correct answer as it is the drug that inhibits the NPC1L1 transporter responsible for the absorption of dietary and biliary cholesterol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is incorrect regarding acetaminophen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It does not interfere with platelet function.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is toxic to the liver in high doses.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a non-narcotic analgesic.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It follows zero order kinetics&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It follows zero order kinetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It follows zero order kinetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old pregnant female with asthma presents with headache. On examination, Pulse: 84 beats/minute, BP: 160/100 mm Hg, Chest and CVS examination unremarkable. Which of the following antihypertensive should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methyl dopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Labetalol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â Labetalol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Labetalol should be avoided in this asthmatic pregnant patient due to the potential for bronchospasm.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following glucose lowering agent can be given as an injectable drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sitagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Semaglutide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Semaglutide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Semaglutide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following pharmacological agents can be used for the treatment of visceral Leishmaniasis EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pentavalent antimonials&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spiramycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paromomycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spiramycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Spiramycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In conclusion, the pharmacological agents that can be used for the treatment of visceral leishmaniasis are pentavalent antimonials, amphotericin B, and paromomycin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient developed difficulty in standing from a seated position, walking up steps, squatting, and lifting arms overhead. Chronic therapy with which of the following drugs is likely to result in such presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetaminophen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fexofenadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucocorticoids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucocorticoids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Glucocorticoids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Therefore, the most likely drug causing the presentation of muscle weakness described is glucocorticoids. Thus, the correct answer is (c) Glucocorticoids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hemorrhagic cystitis is a serious side effect of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mycophenolate mofetil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cyclophosphamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cyclophosphamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are used in the management of hyperkalemia EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10% calcium gluconate intravenously&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Regular insulin and intravenous glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nebulized ipratropium bromide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous sodium bicarbonate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nebulized ipratropium bromide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nebulized ipratropium bromide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In conclusion, the treatments used in the management of hyperkalemia are 10% calcium gluconate intravenously, regular insulin and intravenous glucose, and intravenous sodium bicarbonate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are indications to stop use of oral contraceptive pills EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cholestasis jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloasma and acne&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Venous thromboembolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Breast cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chloasma and acne&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chloasma and acne&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following drugs is most effective in the treatment of gestational trophoblastic neoplasia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gemcitabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Methotrexate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Methotrexate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a correct match of the adverse effect and mechanism of action of imipramine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sedation - H1 receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dry mouth â€“ M3 Muscarinic receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sexual dysfunctionâ€“ 5HT reuptake inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension â€“ D2 receptor blockade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypotension â€“ D2 receptor blockade&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160013.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypotension â€“ D2 receptor blockade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs binds to the site labelled as C in the given figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abciximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cangrelor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vorapaxar&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Abciximab&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-12-05%20115012.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Abciximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prasugrel is an irreversible P2Y12 receptor inhibitor used to reduce the risk of thrombotic events in patients with acute coronary syndrome. It permanently blocks ADP-mediated platelet activation. In contrast, other agents like Cangrelor provide reversible P2Y12 inhibition, and Abciximab inhibit Gp2b/3a.&lt;/li&gt;&lt;li&gt;âž¤ Prasugrel&lt;/li&gt;&lt;li&gt;âž¤ Cangrelor&lt;/li&gt;&lt;li&gt;âž¤ Abciximab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old obese female with schizophrenia is being considered for antipsychotic treatment. Which of the following antipsychotic drugs is associated with the least metabolic adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Risperidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ziprasidone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ziprasidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ziprasidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When treating patients with schizophrenia who are at risk of metabolic side effects, antipsychotics such as aripiprazole and ziprasidone should be considered due to their lower likelihood of causing weight gain and other metabolic disturbances compared to drugs like clozapine or risperidone.&lt;/li&gt;&lt;li&gt;âž¤ aripiprazole and ziprasidone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old pre-menopausal woman is diagnosed with estrogen receptor-positive (ER+) breast cancer. She has no significant history of other health conditions. Which of the following is the preferred drug for the treatment of breast cancer in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lapatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Letrozole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tamoxifen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tamoxifen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For pre-menopausal women with hormone receptor-positive breast cancer , tamoxifen (a SERM) is the preferred treatment. Aromatase inhibitors like letrozole are more commonly used in post-menopausal women, while HER2-targeted therapies like trastuzumab and lapatinib are reserved for HER2-positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ hormone receptor-positive breast cancer&lt;/li&gt;&lt;li&gt;âž¤ tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ HER2-targeted therapies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for treatment of chemotherapy induced diarrhea is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pantoprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Loperamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Loperamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron : Ondansetron is an antiemetic used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It works by blocking serotonin receptors in the brain and gut. While effective for nausea and vomiting, it is not used to treat diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pantoprazole : Pantoprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production and treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. It is not indicated for the treatment of diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pantoprazole&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dexamethasone : Dexamethasone is a corticosteroid with anti-inflammatory and immunosuppressant properties. It is used in various conditions, including to reduce inflammation and manage chemotherapy-induced nausea and vomiting, but it is not the primary treatment for diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dexamethasone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Loperamide is the preferred medication for managing chemotherapy-induced diarrhea due to its effectiveness in slowing intestinal motility and allowing for better fluid absorption. Understanding the appropriate use of medications for specific side effects of chemotherapy is crucial for optimizing patient care and improving quality of life during treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs act as HER-2 inhibitor&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necitumumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pertuzumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Panitumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pertuzumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pertuzumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ HER-2 (Human Epidermal Growth Factor Receptor 2) overactivation is involved in pathogenesis of breast cancer. Trastuzumab and pertuzumab are monoclonal antibodies against her-2/neu and are used in treatment of breast cancer. Oral her-2 inhibitor drug is lapatinib.&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s review each of the listed drugs:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s review each of the listed drugs:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cetuximab : Cetuximab is an EGFR (HER-1) inhibitor used primarily in the treatment of certain types of colorectal cancer and head and neck cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Cetuximab&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necitumumab : Necitumumab is also an EGFR (HER-1) inhibitor, used in the treatment of metastatic squamous non-small cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Necitumumab&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pertuzumab : Pertuzumab is a monoclonal antibody that targets HER-2 (Human Epidermal Growth Factor Receptor 2), not HER-1. It is used primarily in the treatment of HER-2 positive breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Pertuzumab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Panitumumab : Panitumumab is an EGFR (HER-1) inhibitor, used in the treatment of metastatic colorectal cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Panitumumab&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /930&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /930&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged male patient presents with chin protrusion, excessive sweating, impaired glucose tolerance, and hand and foot enlargement. What is a growth hormone receptor antagonist used to treat this condition? (NEET PG 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pegvisomant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cabergoline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Olcegepant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pegvisomant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pegvisomant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone at the receptor level, thereby reducing the symptoms associated with elevated growth hormone levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terlipressin is preferred over desmopressin for treatment of bleeding esophageal varices.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desmopressin is not useful for treatment of nephrogenic diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiloride is used for treatment of lithium induced diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Desmopressin can be used for treatment of both pituitary and renal diabetes insipidus&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Desmopressin can be used for treatment of both pituitary and renal diabetes insipidus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Desmopressin can be used for treatment of both pituitary and renal diabetes insipidus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Octreotide is used in all except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucagonoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carcinoid syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glioma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Glioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true regarding insulin &#x27;AFREZZA&#x27; except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is an inhalational insulin preparation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;By using afreeza, meal-time injectable bolus insulin requirement is not there.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is given in multiple doses.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is used in combination with short acting insulin.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is used in combination with short acting insulin.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It is used in combination with short acting insulin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is an inhalational insulin preparation: True. Afrezza is administered via inhalation, offering an alternative to injectable insulin forms for rapid-acting control of blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is an inhalational insulin preparation:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ alternative to injectable&lt;/li&gt;&lt;li&gt;â€¢ insulin&lt;/li&gt;&lt;li&gt;â€¢ rapid-acting control of blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. By using Afrezza, meal-time injectable bolus insulin requirement is not there: Generally true . Afrezza replaces the need for meal-time injectable insulin in many cases. However, some patients might still require an injectable form depending on their specific glucose control needs and diabetes management plan.&lt;/li&gt;&lt;li&gt;â€¢ Option B. By using Afrezza, meal-time injectable bolus insulin requirement is not there:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ replaces the need&lt;/li&gt;&lt;li&gt;â€¢ meal-time injectable insulin&lt;/li&gt;&lt;li&gt;â€¢ injectable form&lt;/li&gt;&lt;li&gt;â€¢ specific glucose control&lt;/li&gt;&lt;li&gt;â€¢ diabetes management plan.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is given in multiple doses: True. Afrezza is taken at the start of each meal , thus it is administered multiple times throughout the day depending on the number of meals consumed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is given in multiple doses:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ start of each meal&lt;/li&gt;&lt;li&gt;â€¢ multiple times&lt;/li&gt;&lt;li&gt;â€¢ throughout the day&lt;/li&gt;&lt;li&gt;â€¢ number of meals consumed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Afrezza is an innovative inhalational insulin that provides rapid-acting blood glucose control and can potentially reduce or eliminate the need for meal-time injectable insulin. It is not typically combined with other short-acting insulins , making option D the false statement in the context of this query.&lt;/li&gt;&lt;li&gt;âž¤ Afrezza&lt;/li&gt;&lt;li&gt;âž¤ innovative inhalational insulin&lt;/li&gt;&lt;li&gt;âž¤ rapid-acting blood glucose control&lt;/li&gt;&lt;li&gt;âž¤ reduce or eliminate&lt;/li&gt;&lt;li&gt;âž¤ meal-time injectable insulin.&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ combined with other short-acting insulins&lt;/li&gt;&lt;li&gt;âž¤ option D&lt;/li&gt;&lt;li&gt;âž¤ the false statement&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most important mechanism of methotrexate when used as a disease modifying anti-rheumatoid drug is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of dihydrofolate reductase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of AICAR transformylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of dihydroorotate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activaton of TNF-alpha&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of AICAR transformylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inhibition of AICAR transformylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This figure represents the mechanism of drugs used in the treatment of Parkinsonism. Which of the following options correctly represents the drugs shown in the figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture5_0nrzJgU.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-115403_fEfI5SB.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture6_ESUOBAX.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test5" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D   Mission 1.5   03 02 2024   2024 02 03&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D   Mission 1.5   03 02 2024   2024 02 03&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following factors can decrease iron absorption ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sprouts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s examine each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Vitamin C: Vitamin C, also known as ascorbic acid, actually enhances iron absorption, especially non-heme iron (the form of iron found in plant-based foods). It does this by converting iron into a form that is more easily absorbed by the body.&lt;/li&gt;&lt;li&gt;â€¢ Vitamin C:&lt;/li&gt;&lt;li&gt;â€¢ b. Tea: Tea, especially black tea, contains compounds called tannins. Tannins can bind to iron, making it harder for the body to absorb. Therefore, drinking tea, especially with meals, can decrease the absorption of iron.&lt;/li&gt;&lt;li&gt;â€¢ Tea:&lt;/li&gt;&lt;li&gt;â€¢ c. Sprouts: Sprouts, like other plant-based foods, contain phytates (phytic acid), which can bind to minerals like iron and inhibit their absorption. However, the process of sprouting reduces the phytate content, which may actually improve the availability of iron.&lt;/li&gt;&lt;li&gt;â€¢ Sprouts:&lt;/li&gt;&lt;li&gt;â€¢ d. Gastric Acid: Gastric acid is crucial for iron absorption as it helps convert iron into its ferrous (Fe2+) form, which is more easily absorbed. Reduced gastric acid can lead to decreased iron absorption, as seen in conditions like atrophic gastritis or with the use of certain medications (like proton pump inhibitors).&lt;/li&gt;&lt;li&gt;â€¢ Gastric Acid:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female had unprotected sexual intercourse and now more than 5 days have passed. She fears getting pregnant. What is the contraceptive of choice in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IUCD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;OCP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Levonorgestrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IUCD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s discuss each option:&lt;/li&gt;&lt;li&gt;â€¢ a. IUCD (Intrauterine Contraceptive Device): This is an effective form of emergency contraception. Certain types of IUCDs, particularly the copper IUCD, can be used as emergency contraception if inserted within five days (120 hours) after unprotected intercourse. They are one of the most effective forms of emergency contraception available.&lt;/li&gt;&lt;li&gt;â€¢ IUCD (Intrauterine Contraceptive Device):&lt;/li&gt;&lt;li&gt;â€¢ b. OCP (Oral Contraceptive Pills): These are typically used as a regular method of contraception and are not suitable for emergency contraception if more than 72 hours have passed since unprotected intercourse.&lt;/li&gt;&lt;li&gt;â€¢ OCP (Oral Contraceptive Pills):&lt;/li&gt;&lt;li&gt;â€¢ c. Levonorgestrel: This is a form of emergency contraceptive pill. It is most effective when taken within 72 hours (3 days) after unprotected sex and its effectiveness decreases significantly after this period.&lt;/li&gt;&lt;li&gt;â€¢ Levonorgestrel:&lt;/li&gt;&lt;li&gt;â€¢ d. None of the above: This option would be chosen if none of the other options were appropriate.&lt;/li&gt;&lt;li&gt;â€¢ None of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine plus primaquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Artemisinin based combination therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s analyze each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Chloroquine plus Primaquine: Chloroquine is considered safe and effective for the treatment of Plasmodium vivax malaria during pregnancy. However, primaquine is contraindicated in pregnancy due to the risk of hemolytic anemia in the fetus, especially if there is G6PD deficiency, which cannot be tested for in the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Chloroquine plus Primaquine:&lt;/li&gt;&lt;li&gt;â€¢ b. Quinine: Quinine is often used as a treatment for malaria during pregnancy, especially if other options are not available or suitable. However, it is usually more associated with the treatment of Plasmodium falciparum rather than Plasmodium vivax.&lt;/li&gt;&lt;li&gt;â€¢ Quinine:&lt;/li&gt;&lt;li&gt;â€¢ c. Artemisinin-Based Combination Therapy (ACT): While ACTs are very effective in treating Plasmodium falciparum malaria, their safety profile in the first trimester of pregnancy is not well-established. Generally, they are avoided in the first trimester unless no other options are available.&lt;/li&gt;&lt;li&gt;â€¢ Artemisinin-Based Combination Therapy (ACT):&lt;/li&gt;&lt;li&gt;â€¢ d. Doxycycline: Doxycycline is contraindicated in pregnancy due to the risk of interfering with bone and teeth development in the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Doxycycline:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following adverse effect is least likely to be associated with the use of amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gynaecomastia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gynaecomastia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Hypothyroidism: Amiodarone can cause both hypothyroidism and hyperthyroidism due to its high iodine content and its effect on thyroid hormone synthesis and metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Hypothyroidism:&lt;/li&gt;&lt;li&gt;â€¢ b. Hyperthyroidism: As mentioned above, hyperthyroidism is also a known side effect of amiodarone, along with hypothyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Hyperthyroidism:&lt;/li&gt;&lt;li&gt;â€¢ c. Gynaecomastia: Gynaecomastia is the enlargement of breast tissue in males and is typically associated with drugs that affect hormonal balance, such as some antiandrogens, spironolactone, and cimetidine. It is not commonly associated with amiodarone.&lt;/li&gt;&lt;li&gt;â€¢ Gynaecomastia:&lt;/li&gt;&lt;li&gt;â€¢ Drugs causing gynaecomastia include:&lt;/li&gt;&lt;li&gt;â€¢ Drugs causing gynaecomastia include:&lt;/li&gt;&lt;li&gt;â€¢ DI:        DI goxin&lt;/li&gt;&lt;li&gt;â€¢ DI:        DI&lt;/li&gt;&lt;li&gt;â€¢ S:         S pironolactone&lt;/li&gt;&lt;li&gt;â€¢ S:         S&lt;/li&gt;&lt;li&gt;â€¢ C:         C imetidine&lt;/li&gt;&lt;li&gt;â€¢ C:         C&lt;/li&gt;&lt;li&gt;â€¢ O:        O estrogens&lt;/li&gt;&lt;li&gt;â€¢ O:        O&lt;/li&gt;&lt;li&gt;â€¢ d. Pulmonary Fibrosis: Pulmonary fibrosis is a well-known and potentially serious side effect of amiodarone, likely due to its toxic effects on lung tissue and prolonged half-life.&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary Fibrosis:&lt;/li&gt;&lt;li&gt;â€¢ Adverse Effects of Amiodarone can be remembered as:&lt;/li&gt;&lt;li&gt;â€¢ Adverse Effects of Amiodarone can be remembered as:&lt;/li&gt;&lt;li&gt;â€¢ Th e: Th yroid problems (Hyper or hypothyroidism)&lt;/li&gt;&lt;li&gt;â€¢ Th&lt;/li&gt;&lt;li&gt;â€¢ Th&lt;/li&gt;&lt;li&gt;â€¢ Periphery of: Peripheral neuropathy&lt;/li&gt;&lt;li&gt;â€¢ Periphery&lt;/li&gt;&lt;li&gt;â€¢ Peripheral&lt;/li&gt;&lt;li&gt;â€¢ My:                              My ocardial depression&lt;/li&gt;&lt;li&gt;â€¢ My:                              My&lt;/li&gt;&lt;li&gt;â€¢ Lung:                           Lung fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Lung:                           Lung&lt;/li&gt;&lt;li&gt;â€¢ Liver and: Liver damage&lt;/li&gt;&lt;li&gt;â€¢ Liver&lt;/li&gt;&lt;li&gt;â€¢ Liver&lt;/li&gt;&lt;li&gt;â€¢ Cornea is: Corneal deposits&lt;/li&gt;&lt;li&gt;â€¢ Cornea&lt;/li&gt;&lt;li&gt;â€¢ Corneal&lt;/li&gt;&lt;li&gt;â€¢ Photosensitive:           Photosensitivity (Blue man syndrome)&lt;/li&gt;&lt;li&gt;â€¢ Photosensitive:           Photosensitivity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with ptosis which gets worsened by evening. He was diagnosed to be a case of myasthenia gravis. What is the preferred treatment of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plasma exchange&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyridostigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pyridostigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s discuss each treatment option:&lt;/li&gt;&lt;li&gt;â€¢ a. Plasma Exchange: This is used in myasthenia gravis, particularly in cases of myasthenic crisis or before surgery. It&#x27;s an acute treatment method rather than a long-term management strategy.&lt;/li&gt;&lt;li&gt;â€¢ Plasma Exchange:&lt;/li&gt;&lt;li&gt;â€¢ b. Cyclosporine: This is an immunosuppressant used in the treatment of myasthenia gravis, usually in cases where patients do not respond to first-line treatments or as an adjunct therapy.&lt;/li&gt;&lt;li&gt;â€¢ Cyclosporine:&lt;/li&gt;&lt;li&gt;â€¢ c. Pyridostigmine: This is a cholinesterase inhibitor and is the mainstay of treatment for myasthenia gravis. It helps increase the levels of acetylcholine at the neuromuscular junction, thereby improving muscle strength.&lt;/li&gt;&lt;li&gt;â€¢ Pyridostigmine:&lt;/li&gt;&lt;li&gt;â€¢ d. Physostigmine: Unlike pyridostigmine, physostigmine is not commonly used for myasthenia gravis because of its central adverse effects. It is a lipid soluble cholinesterase inhibitor and is mainly used in atropine poisoning.&lt;/li&gt;&lt;li&gt;â€¢ Physostigmine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s consider each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Oral Labetalol: Labetalol is a beta-blocker with alpha-blocking activity. It is commonly used for hypertension in pregnancy. However, being a beta-blocker, it can potentially exacerbate bronchial asthma by causing bronchoconstriction.&lt;/li&gt;&lt;li&gt;â€¢ Oral Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ b. Intravenous Labetalol: This would be used for more immediate control of severely elevated blood pressure, like in a hypertensive crisis. The same concerns regarding bronchial asthma apply as with oral labetalol.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ c. Nifedipine: Nifedipine is a calcium channel blocker. It is effective in lowering blood pressure and is generally considered safe in pregnancy. It does not have the bronchoconstrictive effects associated with beta-blockers.&lt;/li&gt;&lt;li&gt;â€¢ Nifedipine:&lt;/li&gt;&lt;li&gt;â€¢ d. Propranolol: This is a non-selective beta-blocker and is generally contraindicated in asthma because it can cause bronchoconstriction. It is also not the first choice for managing hypertension in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Propranolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the mechanism of action of thiazides in DCT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blockade of Na Cl symporter&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blockade of Na K 2Cl symporter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blockade of aldosterone receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blockade of epithelial sodium channels&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Blockade of Na Cl symporter&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s assess each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Blockade of Na-Cl Symporter: Thiazide diuretics primarily work by inhibiting the sodium-chloride symporter in the distal convoluted tubule of the kidney. This inhibition reduces sodium reabsorption, leading to increased excretion of sodium and water, thereby lowering blood pressure and reducing edema.&lt;/li&gt;&lt;li&gt;â€¢ Blockade of Na-Cl Symporter:&lt;/li&gt;&lt;li&gt;â€¢ b. Blockade of Na-K-2Cl Symporter: This is the mechanism of action of loop diuretics like furosemide, not thiazides. Loop diuretics inhibit the sodium-potassium-2 chloride symporter in the thick ascending limb of the loop of Henle.&lt;/li&gt;&lt;li&gt;â€¢ Blockade of Na-K-2Cl Symporter:&lt;/li&gt;&lt;li&gt;â€¢ c. Blockade of Aldosterone Receptors: This describes the mechanism of action of spironolactone and eplerenone, which are aldosterone antagonists. They work in the collecting ducts of the kidneys.&lt;/li&gt;&lt;li&gt;â€¢ Blockade of Aldosterone Receptors:&lt;/li&gt;&lt;li&gt;â€¢ d. Blockade of Epithelial Sodium Channels: This is the mechanism of action of potassium-sparing diuretics like amiloride and triamterene, which act on the collecting ducts of the kidneys.&lt;/li&gt;&lt;li&gt;â€¢ Blockade of Epithelial Sodium Channels:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was given 0.5% bupivacaine for brachial plexus block. After some time, the patient developed hypotension and cardiovascular collapse. What is the best treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amidoarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20% intralipid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 20% intralipid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ let&#x27;s evaluate each treatment option:&lt;/li&gt;&lt;li&gt;â€¢ a. Amiodarone: This is an antiarrhythmic medication used primarily for the treatment of certain types of serious arrhythmias. It&#x27;s not typically used for the acute management of bupivacaine-induced cardiovascular collapse.&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ b. Epinephrine: This is a critical care drug used in the management of various life-threatening conditions, including anaphylaxis and cardiac arrest. It could be used in this scenario for its vasoconstrictive and positive inotropic effects, but it might not be the first choice due to the risk of exacerbating cardiac arrhythmias, which can be a complication of bupivacaine toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Epinephrine:&lt;/li&gt;&lt;li&gt;â€¢ c. Dobutamine: This is a Î²1-selective vasoactive agent used primarily for the management of heart failure and cardiogenic shock. It increases cardiac output but would not be the first-line treatment for bupivacaine-induced cardiotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Dobutamine:&lt;/li&gt;&lt;li&gt;â€¢ d. 20% Intralipid: Intralipid therapy is the recommended treatment for severe local anesthetic systemic toxicity (LAST), which can occur with medications like bupivacaine. It acts by trapping lipophilic drugs like bupivacaine in an intravascular lipid emulsion, reducing their toxicity.&lt;/li&gt;&lt;li&gt;â€¢ 20% Intralipid:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic alcoholic patient with alcoholic liver disease was given some anti-ameobic drug. Later the patient presented with nausea, vomiting, flushing and hypotension. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Delirium tremens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psychosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Disulfiram like reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alcohol withdrawal&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Disulfiram like reaction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Delirium Tremens: This is a severe form of alcohol withdrawal characterized by confusion, tremors, hallucinations, and agitation. It typically occurs several days after the last drink, not usually in direct response to medication.&lt;/li&gt;&lt;li&gt;â€¢ Delirium Tremens:&lt;/li&gt;&lt;li&gt;â€¢ b. Psychosis: While chronic alcoholism can be associated with psychosis, the symptoms described (nausea, vomiting, flushing, hypotension) are not typical for a primary psychiatric condition.&lt;/li&gt;&lt;li&gt;â€¢ Psychosis:&lt;/li&gt;&lt;li&gt;â€¢ c. Disulfiram-Like Reaction: Certain drugs, including some anti-amoebic medications (like metronidazole), can inhibit the enzyme acetaldehyde dehydrogenase, leading to an accumulation of acetaldehyde when alcohol is consumed. This causes symptoms like nausea, vomiting, flushing, and hypotension, mimicking the effects of disulfiram, a drug used to support the treatment of chronic alcoholism.&lt;/li&gt;&lt;li&gt;â€¢ Disulfiram-Like Reaction:&lt;/li&gt;&lt;li&gt;â€¢ d. Alcohol Withdrawal: Symptoms of alcohol withdrawal typically include tremors, anxiety, nausea, vomiting, and seizures, but the specific combination of symptoms mentioned (particularly flushing and a direct connection to medication) is less typical for alcohol withdrawal.&lt;/li&gt;&lt;li&gt;â€¢ Alcohol Withdrawal:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old obese female presented with Schizophrenia. Which of the following antipsychotic drug causes least weight gain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorpromazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ziprasidone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ziprasidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s discuss each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Chlorpromazine: This is a typical antipsychotic. These drugs can cause weight gain, though chlorpromazine is not as strongly associated with weight gain as some atypical antipsychotics.&lt;/li&gt;&lt;li&gt;â€¢ Chlorpromazine:&lt;/li&gt;&lt;li&gt;â€¢ b. Clozapine: Clozapine is an atypical antipsychotic known for causing significant weight gain, along with other metabolic effects.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine:&lt;/li&gt;&lt;li&gt;â€¢ c. Olanzapine: Olanzapine is another atypical antipsychotic that is frequently associated with substantial weight gain and metabolic effects.&lt;/li&gt;&lt;li&gt;â€¢ Olanzapine:&lt;/li&gt;&lt;li&gt;â€¢ d. Ziprasidone: Among the options listed, ziprasidone is an atypical antipsychotic associated with a lower risk of weight gain. It is considered more weight-neutral compared to other atypical antipsychotics like clozapine and olanzapine.&lt;/li&gt;&lt;li&gt;â€¢ Ziprasidone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 53-year-old male presented with type 2 diabetes mellitus. Which of the following anti-diabetic drug acts by causing glucosuria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acarbose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glipizide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sitagliptin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Acarbose: This drug is an alpha-glucosidase inhibitor. It works by slowing down the digestion of carbohydrates in the intestine, thereby reducing the rise in blood glucose after meals. It does not cause glucosuria.&lt;/li&gt;&lt;li&gt;â€¢ Acarbose:&lt;/li&gt;&lt;li&gt;â€¢ b. Glipizide: Glipizide is a sulfonylurea. It works by stimulating insulin release from the pancreatic beta cells. It does not cause glucosuria.&lt;/li&gt;&lt;li&gt;â€¢ Glipizide:&lt;/li&gt;&lt;li&gt;â€¢ c. Empagliflozin: Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitor. It works by blocking glucose reabsorption in the kidney, leading to increased glucose excretion in the urine, i.e., glucosuria.&lt;/li&gt;&lt;li&gt;â€¢ Empagliflozin:&lt;/li&gt;&lt;li&gt;â€¢ d. Sitagliptin: Sitagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones, which increase insulin release and decrease glucagon release in a glucose-dependent manner. It does not cause glucosuria.&lt;/li&gt;&lt;li&gt;â€¢ Sitagliptin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old child with a previous history of GTCS presents with convulsions which are ongoing since 45 minutes. What should be the appropriate management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lorazepam followed by levetiracetam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate followed by gabapentin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethosuximide followed by gabapentin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamazepine followed by gabapentin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lorazepam followed by levetiracetam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Lorazepam followed by Levetiracetam: Lorazepam is a benzodiazepine and is one of the first-line treatments for the acute management of seizures, particularly in status epilepticus. Following the control of immediate seizures with lorazepam, levetiracetam can be used as maintenance antiepileptic therapy.&lt;/li&gt;&lt;li&gt;â€¢ Lorazepam followed by Levetiracetam:&lt;/li&gt;&lt;li&gt;â€¢ b. Valproate followed by Gabapentin: Valproate is an effective antiepileptic drug, but it&#x27;s not typically the first choice for acute seizure termination in the emergency setting of status epilepticus. Gabapentin is used as a maintenance therapy for seizures but not in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Valproate followed by Gabapentin:&lt;/li&gt;&lt;li&gt;â€¢ c. Ethosuximide followed by Gabapentin: Ethosuximide is used primarily for absence seizures and is not appropriate in the acute management of status epilepticus. Gabapentin, as mentioned, is for maintenance therapy.&lt;/li&gt;&lt;li&gt;â€¢ Ethosuximide followed by Gabapentin:&lt;/li&gt;&lt;li&gt;â€¢ d. Carbamazepine followed by Gabapentin: Carbamazepine is used for the treatment of epilepsy but is not the drug of choice in the acute management of status epilepticus. Gabapentin, again, is for longer-term control.&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine followed by Gabapentin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old hypertensive male patient was taking hydrochlorothiazide. He developed fatigue and hypokalemia. Which of the following drug can be added to prevent loss of potassium in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amiloride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Furosemide: Furosemide is a loop diuretic that actually increases the excretion of potassium, which would exacerbate hypokalemia rather than prevent it.&lt;/li&gt;&lt;li&gt;â€¢ Furosemide:&lt;/li&gt;&lt;li&gt;â€¢ b. Acetazolamide: Acetazolamide is a carbonic anhydrase inhibitor diuretic. It is not typically used for preventing potassium loss and can also lead to hypokalemia.&lt;/li&gt;&lt;li&gt;â€¢ Acetazolamide:&lt;/li&gt;&lt;li&gt;â€¢ c. Amiloride: Amiloride is a potassium-sparing diuretic. It works in the distal convoluted tubule and collecting duct of the nephron by inhibiting sodium channels. This action reduces potassium excretion, helping to prevent hypokalemia.&lt;/li&gt;&lt;li&gt;â€¢ Amiloride:&lt;/li&gt;&lt;li&gt;â€¢ d. Adenosine: Adenosine is primarily used as an antiarrhythmic agent for certain types of supraventricular tachycardias and is not used for managing electrolyte imbalances like hypokalemia.&lt;/li&gt;&lt;li&gt;â€¢ Adenosine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female in first trimester developed deep vein thrombosis. She requires anticoagulation. Which of the following will be the preferred drug in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Betrixaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Enoxaparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s review each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Clopidogrel: This is an antiplatelet drug, not typically used in the treatment of DVT, and its safety in pregnancy is not well-established.&lt;/li&gt;&lt;li&gt;â€¢ Clopidogrel:&lt;/li&gt;&lt;li&gt;â€¢ b. Warfarin: Warfarin is a vitamin K antagonist and is generally contraindicated in pregnancy, especially during the first trimester, due to the risk of teratogenic effects (warfarin embryopathy).&lt;/li&gt;&lt;li&gt;â€¢ Warfarin:&lt;/li&gt;&lt;li&gt;â€¢ c. Betrixaban: This is an oral Factor Xa inhibitor. The safety of betrixaban in pregnancy has not been established, and it is generally not recommended.&lt;/li&gt;&lt;li&gt;â€¢ Betrixaban:&lt;/li&gt;&lt;li&gt;â€¢ d. Enoxaparin: Enoxaparin is a low molecular weight heparin (LMWH). LMWHs are the preferred choice for anticoagulation in pregnancy because they do not cross the placenta and thus have a lower risk of fetal harm. Enoxaparin is effective in the treatment and prevention of DVT and is considered safe for use in pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Enoxaparin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of Schizophrenia was started on antipsychotic drug haloperidol. Few hours later, he presented with torticollis and muscular dystonia. What is the next best step for the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase dose of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Change haloperidol to clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give fluphenzine instead of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Give benztropine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Give benztropine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s assess each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Increase dose of haloperidol: Increasing the dose of haloperidol is not the appropriate response when a patient develops extrapyramidal symptoms (EPS) such as torticollis and muscular dystonia. It can exacerbate these side effects.&lt;/li&gt;&lt;li&gt;â€¢ Increase dose of haloperidol:&lt;/li&gt;&lt;li&gt;â€¢ b. Change haloperidol to clozapine: Clozapine is an atypical antipsychotic that is less likely to cause EPS compared to typical antipsychotics like haloperidol. Switching to clozapine can be a reasonable option to manage EPS.&lt;/li&gt;&lt;li&gt;â€¢ Change haloperidol to clozapine:&lt;/li&gt;&lt;li&gt;â€¢ c. Give fluphenzine instead of haloperidol: Fluphenazine is another typical antipsychotic and is not expected to be significantly different from haloperidol in terms of causing EPS. Switching to fluphenazine may not effectively address the EPS.&lt;/li&gt;&lt;li&gt;â€¢ Give fluphenzine instead of haloperidol:&lt;/li&gt;&lt;li&gt;â€¢ d. Give benztropine: Benztropine is an anticholinergic medication commonly used to manage extrapyramidal symptoms (EPS) caused by antipsychotic medications. It can be an appropriate choice to alleviate the torticollis and muscular dystonia.&lt;/li&gt;&lt;li&gt;â€¢ Give benztropine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does it mean when a drug has a bioavailability of 30 percent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;70 percent of the drug undergoes first pass metabolism in liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The drug is 30 percent pure in its chemical composition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The drug is 30 percent potent in producing therapeutic effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;30 percent of the drug reaches the systemic circulation in unchanged form&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 30 percent of the drug reaches the systemic circulation in unchanged form&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the preferred drug for treatment of post-menopausal breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anastrozole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anastrozole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Methotrexate: Methotrexate is a chemotherapy drug used in the treatment of various cancers, including some types of breast cancer. However, it is not typically the first-line choice for post-menopausal breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ b. Raloxifene: Raloxifene is a selective estrogen receptor modulator (SERM) primarily used for osteoporosis and the prevention of breast cancer, rather than its treatment.&lt;/li&gt;&lt;li&gt;â€¢ Raloxifene:&lt;/li&gt;&lt;li&gt;â€¢ c. Tamoxifen: Tamoxifen is a widely used medication for the treatment of hormone receptor-positive breast cancer in both pre-menopausal and post-menopausal women. It is often the preferred choice for breast cancer in pre-menopausal female.&lt;/li&gt;&lt;li&gt;â€¢ Tamoxifen:&lt;/li&gt;&lt;li&gt;â€¢ d. Anastrozole: Anastrozole is an aromatase inhibitor and is drug of choice for treatment of breast cancer (which is estrogen receptor positive) in post-menopausal females.&lt;/li&gt;&lt;li&gt;â€¢ Anastrozole:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-tubercular drugs cause visual problems as an adverse effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethambutol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyrazinamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ethambutol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s assess each option:&lt;/li&gt;&lt;li&gt;â€¢ a. Rifampicin: Rifampicin is not typically associated with visual problems as an adverse effect.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin:&lt;/li&gt;&lt;li&gt;â€¢ b. Isoniazid: Isoniazid is not known to cause visual problems. However, it is associated with hepatotoxicity and peripheral neuropathy as potential adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid:&lt;/li&gt;&lt;li&gt;â€¢ c. Ethambutol: Ethambutol is the anti-tubercular drug known for its association with visual problems. It can cause optic neuritis and changes in color vision, which may be reversible upon discontinuation of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Ethambutol:&lt;/li&gt;&lt;li&gt;â€¢ d. Pyrazinamide: Pyrazinamide is not commonly associated with visual problems as an adverse effect.&lt;/li&gt;&lt;li&gt;â€¢ Pyrazinamide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the likely ECG changes noted with the use of new anti-tubercular drug bedaquiline?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;QT prolongation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase in PR interval&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ST segment elevation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;QRS widening&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. QT prolongation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ a. QT prolongation: QT prolongation is a well-documented ECG change associated with the use of bedaquiline. It is one of the notable side effects of this drug.&lt;/li&gt;&lt;li&gt;â€¢ QT prolongation:&lt;/li&gt;&lt;li&gt;â€¢ b. Increase in PR interval: An increase in the PR interval is not a common ECG change associated with bedaquiline use.&lt;/li&gt;&lt;li&gt;â€¢ Increase in PR interval:&lt;/li&gt;&lt;li&gt;â€¢ c. ST segment elevation: ST segment elevation is not a typical ECG change associated with bedaquiline use.&lt;/li&gt;&lt;li&gt;â€¢ ST segment elevation:&lt;/li&gt;&lt;li&gt;â€¢ d. QRS widening: QRS widening is not a common ECG change associated with bedaquiline use.&lt;/li&gt;&lt;li&gt;â€¢ QRS widening:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and dolutegravir 50 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add lamivudine 300 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add dolutegravir 50 mg in the morning&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Add dolutegravir 50 mg in the morning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents to the clinic with a 3-month history of a persistent cough, unintentional weight loss, and night sweats. A chest X-ray reveals findings consistent with pulmonary tuberculosis. After confirming the diagnosis, the physician prescribes a multi-drug therapy (MDT) regimen. What is the most important reason for using MDT in her treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To enhance the speed of clinical recovery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To reduce the duration of treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To prevent the emergence of drug-resistant strains&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To reduce the adverse side effects of anti-tubercular drugs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. To prevent the emergence of drug-resistant strains&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ To enhance the speed of clinical recovery:&lt;/li&gt;&lt;li&gt;â€¢ To enhance the speed of clinical recovery:&lt;/li&gt;&lt;li&gt;â€¢ To enhance the speed of clinical recovery:&lt;/li&gt;&lt;li&gt;â€¢ Using multiple drugs might offer a more comprehensive approach to tackling the Mycobacterium tuberculosis bacteria and potentially speed up clinical recovery. However, this isn&#x27;t the primary reason for MDT. The main aim is to ensure thorough eradication of the bacteria, which prevents both relapse and resistance.&lt;/li&gt;&lt;li&gt;â€¢ To reduce the duration of treatment:&lt;/li&gt;&lt;li&gt;â€¢ To reduce the duration of treatment:&lt;/li&gt;&lt;li&gt;â€¢ To reduce the duration of treatment:&lt;/li&gt;&lt;li&gt;â€¢ The treatment for TB typically lasts for six months or more, especially in cases of drug-resistant TB. The duration is based on the nature of Mycobacterium tuberculosis, which has a slow replication cycle. Longer treatment ensures that all bacteria, including those in dormant phases, are eradicated. While MDT provides a thorough approach to treating TB, it doesn&#x27;t inherently shorten the treatment duration.&lt;/li&gt;&lt;li&gt;â€¢ To prevent the emergence of drug-resistant strains:&lt;/li&gt;&lt;li&gt;â€¢ To prevent the emergence of drug-resistant strains:&lt;/li&gt;&lt;li&gt;â€¢ To prevent the emergence of drug-resistant strains:&lt;/li&gt;&lt;li&gt;â€¢ When treating TB with a single drug, the bacteria might develop resistance to that drug. This happens when the bacteria mutate and evolve in a way that makes the drug ineffective. By using multiple drugs, it becomes highly improbable for the bacteria to mutate in a manner that overcomes the action of all the drugs simultaneously. Therefore, MDT is used primarily to prevent the emergence of these drug-resistant strains.&lt;/li&gt;&lt;li&gt;â€¢ To reduce the adverse side effects of anti-tubercular drugs:&lt;/li&gt;&lt;li&gt;â€¢ To reduce the adverse side effects of anti-tubercular drugs:&lt;/li&gt;&lt;li&gt;â€¢ To reduce the adverse side effects of anti-tubercular drugs:&lt;/li&gt;&lt;li&gt;â€¢ Each anti-tubercular drug can have side effects. By using multiple drugs, it&#x27;s possible to give each drug at a lower dose than if used alone, potentially reducing the severity of side effects. However, this is not the primary reason for using MDT. The main rationale behind MDT is the prevention of drug resistance, not the minimization of side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient presents with a history of chronic cough, weight loss, and night sweats. The patient has a history of HIV, was recently diagnosed with Plasmodium falciparum malaria, and was exposed to someone with COVID-19. The patient&#x27;s sputum test came back positive for Mycobacterium tuberculosis, resistant to rifampicin and isoniazid (indicating multi-drug resistant tuberculosis). Which of the following combination of drug and its indication is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pretomanid: MDR tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enfuvirtide: Treatment of HIV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remdesivir: Moderate to severe COVID-19 pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s evaluate each drug option:&lt;/li&gt;&lt;li&gt;â€¢ a. Pretomanid for MDR Tuberculosis : Pretomanid is used in the treatment of multi-drug resistant (MDR) tuberculosis, in combination with bedaquiline and linezolid. This combination is known as the BPaL regimen. So, this option is TRUE.&lt;/li&gt;&lt;li&gt;â€¢ Pretomanid for MDR Tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ b. Enfuvirtide for Treatment of HIV : Enfuvirtide is an antiretroviral drug used in the treatment of HIV/AIDS. It is a fusion inhibitor that prevents the virus from entering the host cell. This is a TRUE statement.&lt;/li&gt;&lt;li&gt;â€¢ Enfuvirtide for Treatment of HIV&lt;/li&gt;&lt;li&gt;â€¢ c. Tafenoquine for Single Dose Treatment of P. falciparum Malaria : Tafenoquine is used as a single-dose treatment for the radical cure of Plasmodium vivax malaria, not Plasmodium falciparum malaria. For P. falciparum, drugs like artemisinin-based combination therapies (ACTs) are typically used. Therefore, this statement is FALSE.&lt;/li&gt;&lt;li&gt;â€¢ Tafenoquine for Single Dose Treatment of P. falciparum Malaria&lt;/li&gt;&lt;li&gt;â€¢ d. Remdesivir for Moderate to Severe COVID-19 Pneumonia : Remdesivir is an antiviral drug that has been used for the treatment of COVID-19, particularly in hospitalized patients with severe disease. This statement is TRUE.&lt;/li&gt;&lt;li&gt;â€¢ Remdesivir for Moderate to Severe COVID-19 Pneumonia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old male diagnosed with HIV seeks guidance from his primary care doctor for appropriate treatment. Given the significant drop in his CD4 counts, initiation of HAART (Highly Active Antiretroviral Therapy) is being contemplated. Concerning the role of ritonavir for this patient, which statement holds true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;This agent is associated with resistance when used in combination with another protease inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is used primarily for its inhibitory effect on CYP3A4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;This is an excellent single agent for use in HAART therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is used primarily for its inhibitory effect on CYP3A4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ (A) This statement is not fully accurate. While ritonavir does inhibit the HIV protease enzyme, it&#x27;s not primarily used for that purpose in most modern HAART regimens. Instead, it&#x27;s given in low doses to boost the effect of other protease inhibitors by inhibiting CYP3A4. The dose of ritonavir used for boosting is lower than that required to inhibit the HIV protease.&lt;/li&gt;&lt;li&gt;â€¢ (B) This statement is incorrect. Ritonavir&#x27;s function as a booster in combination with another protease inhibitor is not typically associated with an increased resistance. On the contrary, its role is to enhance the effectiveness of the primary protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ (C) True. Ritonavir inhibits CYP3A4, an enzyme responsible for the metabolism of many drugs, including other protease inhibitors. By doing this, ritonavir can increase the plasma levels of these drugs, thus maximizing their effectiveness against the HIV virus.&lt;/li&gt;&lt;li&gt;â€¢ (D) This is not accurate. While ritonavir does have activity against HIV as a protease inhibitor, its primary use in current HAART regimens is as a booster to enhance the levels of other protease inhibitors. It&#x27;s not recommended as a standalone agent in therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old Indian man, pursuing his post-graduation, recently returned from Africa where he completed an academic research project. A few weeks after his return, he visits the hospital after testing positive for Plasmodium vivax malaria. The doctor recommends primaquine for the radical cure of his P. vivax infection. Shortly after beginning the regimen, the patient exhibits yellowing of the eyes. What could be the most probable reason for this symptom?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primaquine merely stains the tears yellow; this isn&#x27;t genuine yellowing of the eyes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interaction with another medication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deficiency of a specific enzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primaquine&#x27;s liver-damaging effects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deficiency of a specific enzyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The presented situation suggests a reaction attributable to G6PD (Glucose-6-phosphate dehydrogenase) deficiency. People from certain ethnic groups, including some Indians, are more likely to have this enzyme deficiency. When patients with G6PD deficiency are exposed to specific medications, such as primaquine, they can experience hemolysis (breakdown of red blood cells). This hemolysis can result in jaundice, leading to the yellowing of the eyes.&lt;/li&gt;&lt;li&gt;â€¢ While some medications can cause a discoloration of the tears, primaquine doesnâ€™t typically lead to yellow tears that would be mistaken for jaundice. Without additional details on other medications the patient might be taking, this is less probable than a G6PD deficiency. While primaquine can have side effects, the rapid onset of jaundice post-medication intake makes an enzyme deficiency a more likely reason.&lt;/li&gt;&lt;li&gt;â€¢ While some medications can cause a discoloration of the tears, primaquine doesnâ€™t typically lead to yellow tears that would be mistaken for jaundice.&lt;/li&gt;&lt;li&gt;â€¢ Without additional details on other medications the patient might be taking, this is less probable than a G6PD deficiency.&lt;/li&gt;&lt;li&gt;â€¢ While primaquine can have side effects, the rapid onset of jaundice post-medication intake makes an enzyme deficiency a more likely reason.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old sexually active, HIV-negative male visits his healthcare provider with a painless sore on his inner lip and a non-itchy rash on the soles of his feet. He recalls having a non-tender ulcer on his scrotum about a month and a half ago, which resolved on its own. He receives an intramuscular injection of benzathine penicillin G and is discharged. How might the treatment approach for this patient have been modified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The choice of antibiotic was not appropriate, and another class should have been selected&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The correct treatment would involve a different form of penicillin G, rather than benzathine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;There is no need for changes; the treatment administered is correct&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;After the initial injection, a follow-up dose should be given after 7 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. There is no need for changes; the treatment administered is correct&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/screenshot-2024-02-01-153605.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s clinical presentation, including a painless sore followed by a rash on the soles of the feet, is consistent with secondary syphilis.&lt;/li&gt;&lt;li&gt;â€¢ The first-line treatment for syphilis at any stage is penicillin, specifically benzathine penicillin G, which is long-acting and given intramuscularly. Thus, another antibiotic class isn&#x27;t needed. Benzathine penicillin G is the appropriate form of penicillin for the treatment of syphilis. It is the recommended preparation due to its prolonged action which provides a sustained therapeutic level for an extended period. The single intramuscular injection of benzathine penicillin G is the appropriate treatment for early syphilis, which includes both primary and secondary stages. A single dose of benzathine penicillin G is sufficient for the treatment of primary or secondary syphilis in HIV-negative individuals. The follow-up dose after 7 days is recommended for the late latent stage or tertiary syphilis, but not for early syphilis.&lt;/li&gt;&lt;li&gt;â€¢ The first-line treatment for syphilis at any stage is penicillin, specifically benzathine penicillin G, which is long-acting and given intramuscularly. Thus, another antibiotic class isn&#x27;t needed.&lt;/li&gt;&lt;li&gt;â€¢ Benzathine penicillin G is the appropriate form of penicillin for the treatment of syphilis. It is the recommended preparation due to its prolonged action which provides a sustained therapeutic level for an extended period.&lt;/li&gt;&lt;li&gt;â€¢ The single intramuscular injection of benzathine penicillin G is the appropriate treatment for early syphilis, which includes both primary and secondary stages.&lt;/li&gt;&lt;li&gt;â€¢ A single dose of benzathine penicillin G is sufficient for the treatment of primary or secondary syphilis in HIV-negative individuals. The follow-up dose after 7 days is recommended for the late latent stage or tertiary syphilis, but not for early syphilis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old girl comes to the medical office complaining of a severely pruritic skin condition that started 3 days ago. Three other children from her school have been diagnosed with similar skin complaints. On examination, the girl has itchy red bumps and clear linear tracks, particularly on her finger webs of hand and feet and on ankles. They somewhat resemble the marks left by tiny insects. What would be the best course of action for treating this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Topical agents like miconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral ivermectin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topical permethrin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skin creams containing steroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Topical permethrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation given â€” itchy red bumps and clear linear tracks, especially on the feet, ankles, and behind the knees â€” is indicative of scabies. Scabies is a skin infestation caused by the Sarcoptes scabiei mite.&lt;/li&gt;&lt;li&gt;â€¢ Topical agents like miconazole: Miconazole is an antifungal agent and is primarily used for fungal infections like athlete&#x27;s foot or ringworm. Scabies is caused by a mite, not a fungus, so miconazole would not be effective for this condition. Oral ivermectin: Ivermectin can be effective against scabies, especially in cases where the standard topical treatment fails or for severe forms such as crusted scabies. However, it is not typically the first-line treatment for common scabies. Topical permethrin: This is the correct choice. Permethrin cream is the first-line treatment for scabies. It is applied to the entire body from the neck down and left on for 8-14 hours, usually overnight. The treatment kills the mites and their eggs. It&#x27;s crucial that family members and other close contacts be treated simultaneously to prevent re-infestation, even if they are asymptomatic. Skin creams containing steroids: While steroid creams can reduce inflammation and itching, they do not address the underlying cause, which is the mite infestation. Using steroids alone would not eradicate the mites and could even make the condition worse.&lt;/li&gt;&lt;li&gt;â€¢ Topical agents like miconazole: Miconazole is an antifungal agent and is primarily used for fungal infections like athlete&#x27;s foot or ringworm. Scabies is caused by a mite, not a fungus, so miconazole would not be effective for this condition.&lt;/li&gt;&lt;li&gt;â€¢ Oral ivermectin: Ivermectin can be effective against scabies, especially in cases where the standard topical treatment fails or for severe forms such as crusted scabies. However, it is not typically the first-line treatment for common scabies.&lt;/li&gt;&lt;li&gt;â€¢ Topical permethrin: This is the correct choice. Permethrin cream is the first-line treatment for scabies. It is applied to the entire body from the neck down and left on for 8-14 hours, usually overnight. The treatment kills the mites and their eggs. It&#x27;s crucial that family members and other close contacts be treated simultaneously to prevent re-infestation, even if they are asymptomatic.&lt;/li&gt;&lt;li&gt;â€¢ Skin creams containing steroids: While steroid creams can reduce inflammation and itching, they do not address the underlying cause, which is the mite infestation. Using steroids alone would not eradicate the mites and could even make the condition worse.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old male patient with a history of type 2 diabetes and hypertension is admitted with a 7-day history of fever, cough, and increasing shortness of breath. A PCR test confirms a diagnosis of COVID-19. Chest X-ray demonstrates bilateral infiltrates indicative of pneumonia, and his oxygen saturation on room air registers at 88%. Considering the current understanding of COVID-19 treatments, which therapeutic approach is most suitable to enhance this patient&#x27;s clinical outcome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of remdesivir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Combination of high-flow oxygen and dexamethasone therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous administration of tocilizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment with monoclonal antibodies against SARS-CoV-2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Combination of high-flow oxygen and dexamethasone therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Administration of remdesivir:&lt;/li&gt;&lt;li&gt;â€¢ Administration of remdesivir:&lt;/li&gt;&lt;li&gt;â€¢ Administration of remdesivir:&lt;/li&gt;&lt;li&gt;â€¢ Remdesivir, an antiviral drug, has been shown to shorten the duration of symptoms in certain hospitalized COVID-19 patients, but its effect on mortality is less clear. It might be considered, especially in the earlier course of severe disease, but its benefit in terms of clinical outcomes isn&#x27;t as well-established as dexamethasone in hypoxic patients.&lt;/li&gt;&lt;li&gt;â€¢ High-flow oxygen and dexamethasone therapy:&lt;/li&gt;&lt;li&gt;â€¢ High-flow oxygen and dexamethasone therapy:&lt;/li&gt;&lt;li&gt;â€¢ High-flow oxygen and dexamethasone therapy:&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹ Hypoxemic patients with COVID-19 benefit from oxygen supplementation. Dexamethasone has shown mortality benefits in hypoxic COVID-19 patients, making it the recommended therapeutic approach for those with significant respiratory compromise, like in this presented case.&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹&lt;/li&gt;&lt;li&gt;â€¢ Intravenous administration of tocilizumab:&lt;/li&gt;&lt;li&gt;â€¢ Intravenous administration of tocilizumab:&lt;/li&gt;&lt;li&gt;â€¢ Intravenous administration of tocilizumab:&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹ Tocilizumab, an IL-6 receptor antagonist, is used to treat cytokine release syndrome, which can be a complication of severe COVID-19. While it can be beneficial for select hospitalized patients, its specific role in therapy isn&#x27;t as clearly defined as dexamethasone for those with significant hypoxemia.&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹&lt;/li&gt;&lt;li&gt;â€¢ Treatment with monoclonal antibodies against SARS-CoV-2:&lt;/li&gt;&lt;li&gt;â€¢ Treatment with monoclonal antibodies against SARS-CoV-2:&lt;/li&gt;&lt;li&gt;â€¢ Treatment with monoclonal antibodies against SARS-CoV-2:&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹ Monoclonal antibodies targeting SARS-CoV-2, such as bamlanivimab or casirivimab-imdevimab combo, have been authorized for use in certain non-hospitalized patients with mild to moderate symptoms and are at high risk for progressing to severe disease. They are less commonly used in severe hospitalized cases, like the patient described here.&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents to the clinic with recurrent vaginal itching and discharge. She reports that over-the-counter antifungal creams have provided only temporary relief. Given her history, the physician decides to initiate a prescription antifungal regimen. Based on the mechanisms of action of various antifungal medications, which of the following statements is incorrectly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azoles - Inhibit ergosterol synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flucytosine - Inhibit microtubule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echinocandins - Inhibit glycan synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphotericin B - Create artificial pores in the membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flucytosine - Inhibit microtubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Azoles - Inhibit ergosterol synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Azoles - Inhibit ergosterol synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Azoles - Inhibit ergosterol synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Azoles, including medications like fluconazole and itraconazole, inhibit the fungal cytochrome P450 enzyme that converts lanosterol to ergosterol, a key component of the fungal cell membrane. This leads to disrupted cell membrane function, making this a correct match.&lt;/li&gt;&lt;li&gt;â€¢ Flucytosine - Inhibit microtubule:&lt;/li&gt;&lt;li&gt;â€¢ Flucytosine - Inhibit microtubule:&lt;/li&gt;&lt;li&gt;â€¢ Flucytosine - Inhibit microtubule:&lt;/li&gt;&lt;li&gt;â€¢ This is incorrect. Flucytosine is a pyrimidine analog that is incorporated into fungal RNA, disrupting protein synthesis and DNA replication. It does not inhibit microtubules.&lt;/li&gt;&lt;li&gt;â€¢ Echinocandins - Inhibit glycan synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Echinocandins - Inhibit glycan synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Echinocandins - Inhibit glycan synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Echinocandins, such as caspofungin, inhibit the synthesis of beta-1,3-D-glucan, an essential component of the fungal cell wall. This is a correct match for the drug&#x27;s mechanism of action.&lt;/li&gt;&lt;li&gt;â€¢ â€‹â€‹â€‹â€‹â€‹â€‹â€‹&lt;/li&gt;&lt;li&gt;â€¢ Amphotericin B - Create artificial pores in the membrane:&lt;/li&gt;&lt;li&gt;â€¢ Amphotericin B - Create artificial pores in the membrane:&lt;/li&gt;&lt;li&gt;â€¢ Amphotericin B - Create artificial pores in the membrane:&lt;/li&gt;&lt;li&gt;â€¢ Amphotericin B binds to ergosterol in the fungal cell membrane and creates pores that allow leakage of intracellular components, leading to fungal cell death. This is also a correct match for its mechanism of action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-tubercular drugs is safe in hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethionamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Streptomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid:&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid:&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid:&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid is hepatotoxic and is one of the medications most commonly associated with drug-induced hepatitis. It is not considered safe in patients with preexisting liver disease such as hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin:&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin:&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin:&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin is another drug that has hepatotoxic potential. It can induce liver enzymes and, in some cases, can cause hepatocellular damage, especially when used in combination with other hepatotoxic drugs.&lt;/li&gt;&lt;li&gt;â€¢ Ethionamide:&lt;/li&gt;&lt;li&gt;â€¢ Ethionamide:&lt;/li&gt;&lt;li&gt;â€¢ Ethionamide:&lt;/li&gt;&lt;li&gt;â€¢ Ethionamide can also cause hepatic toxicity, including hepatitis. It is not recommended for use in patients with liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Streptomycin:&lt;/li&gt;&lt;li&gt;â€¢ Streptomycin:&lt;/li&gt;&lt;li&gt;â€¢ Streptomycin:&lt;/li&gt;&lt;li&gt;â€¢ Streptomycin is primarily nephrotoxic and ototoxic but is not associated with hepatotoxicity, making it a safer option in patients with liver disease like hepatitis. Therefore, it is considered safe in hepatitis compared to the other options listed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man is diagnosed with both HIV and chronic hepatitis B infection. His physician is considering a treatment regimen that can effectively address both conditions. Which of the following antiretroviral medications would also have activity against hepatitis B virus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indinavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Didanosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Efavirenz&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lamivudine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine:&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine:&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine:&lt;/li&gt;&lt;li&gt;â€¢ In the context of a patient with both HIV and HBV infections, Lamivudine stands out as a viable choice because it is a nucleoside reverse transcriptase inhibitor (NRTI) that has activity against both viruses. It inhibits the reverse transcriptase enzyme, thereby suppressing viral replication for both HIV and HBV.&lt;/li&gt;&lt;li&gt;â€¢ Indinavir:&lt;/li&gt;&lt;li&gt;â€¢ Indinavir:&lt;/li&gt;&lt;li&gt;â€¢ Indinavir:&lt;/li&gt;&lt;li&gt;â€¢ Indinavir is a protease inhibitor used primarily for the treatment of HIV infection. It does not have efficacy against HBV, making it unsuitable for treating both conditions in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Didanosine:&lt;/li&gt;&lt;li&gt;â€¢ Didanosine:&lt;/li&gt;&lt;li&gt;â€¢ Didanosine:&lt;/li&gt;&lt;li&gt;â€¢ Didanosine is another NRTI but is mainly used for treating HIV. It is not effective against HBV, so it would not meet the criteria for treating both conditions in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Efavirenz:&lt;/li&gt;&lt;li&gt;â€¢ Efavirenz:&lt;/li&gt;&lt;li&gt;â€¢ Efavirenz:&lt;/li&gt;&lt;li&gt;â€¢ Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for HIV treatment. It does not have activity against HBV, making it an inappropriate choice for treating both conditions simultaneously.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents to the emergency room with seizures. A CT scan of his head reveals a space-occupying lesion, suggesting a diagnosis of neurocysticercosis. Which of the following medications is NOT recommended for treating this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Di-Ethyl-Carbamezine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Albendazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Di-Ethyl-Carbamezine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Di-Ethyl-Carbamezine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine is an anticonvulsant medication commonly used to control seizures. Given that the patient presented with seizures, this drug would be an appropriate choice for symptom management.&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine:&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine:&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine:&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine is not typically used for treating neurocysticercosis or seizures associated with it. In fact, it is used for the treatment of filariasis and is not recommended for neurocysticercosis.&lt;/li&gt;&lt;li&gt;â€¢ Albendazole:&lt;/li&gt;&lt;li&gt;â€¢ Albendazole:&lt;/li&gt;&lt;li&gt;â€¢ Albendazole:&lt;/li&gt;&lt;li&gt;â€¢ Albendazole is an antiparasitic medication that is commonly used for treating neurocysticercosis. It kills the cysticercus, the larval form of the Taenia solium tapeworm that causes the condition.&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone is a corticosteroid that may be used to reduce inflammation and edema around the cysts in the brain, especially during the initial phase of anthelmintic therapy, to avoid inflammatory responses as the parasites die.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents to the clinic with symptoms of fever, weight loss, and splenomegaly. She has recently returned from a trip to a region known for endemic visceral leishmaniasis, also known as Kala-azar. Which of the following medications is suitable for single-dose treatment of Kala-azar?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pentamidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liposomal Amphotericin B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium stibogluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Miltefosine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liposomal Amphotericin B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pentamidine:&lt;/li&gt;&lt;li&gt;â€¢ Pentamidine:&lt;/li&gt;&lt;li&gt;â€¢ Pentamidine:&lt;/li&gt;&lt;li&gt;â€¢ Although Pentamidine can be used for the treatment of Kala-azar, it is not suitable for single-dose treatment and has significant side effects.&lt;/li&gt;&lt;li&gt;â€¢ Liposomal Amphotericin B:&lt;/li&gt;&lt;li&gt;â€¢ Liposomal Amphotericin B:&lt;/li&gt;&lt;li&gt;â€¢ Liposomal Amphotericin B:&lt;/li&gt;&lt;li&gt;â€¢ Liposomal Amphotericin B is the preferred drug for Kala-azar and has been successfully used in single-dose regimens. Its efficacy and safety profile make it suitable for single-dose treatment.&lt;/li&gt;&lt;li&gt;â€¢ Sodium stibogluconate:&lt;/li&gt;&lt;li&gt;â€¢ Sodium stibogluconate:&lt;/li&gt;&lt;li&gt;â€¢ Sodium stibogluconate:&lt;/li&gt;&lt;li&gt;â€¢ Sodium stibogluconate requires a more extended course of treatment and is not suitable for single-dose treatment.&lt;/li&gt;&lt;li&gt;â€¢ Miltefosine:&lt;/li&gt;&lt;li&gt;â€¢ Miltefosine:&lt;/li&gt;&lt;li&gt;â€¢ Miltefosine:&lt;/li&gt;&lt;li&gt;â€¢ Miltefosine is an oral medication and requires a more extended course of treatment, making it unsuitable for single-dose treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents to the clinic for a routine check-up. Blood tests reveal elevated liver enzymes, and subsequent tests confirm a diagnosis of chronic hepatitis C. She has no significant medical history and wishes to begin antiviral therapy to minimize the risk of progression to liver cirrhosis or hepatocellular carcinoma. Which of the following oral medications is recommended as a first-line treatment for hepatitis C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ribavirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tenofovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sofosbuvir&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sofosbuvir&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin:&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin:&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin:&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin is an older antiviral medication that was used in combination with interferon for treating hepatitis C. It is not commonly used as a monotherapy for hepatitis C and has largely been replaced by more effective and tolerable options.&lt;/li&gt;&lt;li&gt;â€¢ Tenofovir:&lt;/li&gt;&lt;li&gt;â€¢ Tenofovir:&lt;/li&gt;&lt;li&gt;â€¢ Tenofovir:&lt;/li&gt;&lt;li&gt;â€¢ Tenofovir is primarily used in the treatment of HIV and chronic hepatitis B, not hepatitis C.&lt;/li&gt;&lt;li&gt;â€¢ Sofosbuvir:&lt;/li&gt;&lt;li&gt;â€¢ Sofosbuvir:&lt;/li&gt;&lt;li&gt;â€¢ Sofosbuvir:&lt;/li&gt;&lt;li&gt;â€¢ Sofosbuvir is a first-line, direct-acting antiviral agent used for the treatment of chronic hepatitis C. It is often used in combination with other medications and has a high cure rate with a well-tolerated side effect profile.&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine:&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine:&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine:&lt;/li&gt;&lt;li&gt;â€¢ Lamivudine is used for the treatment of hepatitis B and HIV but is not effective for treating hepatitis C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents to her gynecologist with complaints of vaginal discharge and a fishy odor. After taking a history and performing a pelvic exam, a wet mount preparation shows a \&quot;clue cell\&quot; pattern. The pH of the vaginal fluid is found to be above 4.5. The diagnosis of bacterial vaginosis is made. Which of the following is the recommended first-line treatment for bacterial vaginosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metronidazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Fluconazole: Fluconazole is primarily used for treating fungal infections such as vaginal candidiasis, not bacterial vaginosis. Clindamycin: Clindamycin is an alternative treatment for bacterial vaginosis, but it is not the first-line choice. Metronidazole: Metronidazole is the recommended first-line treatment for bacterial vaginosis. It can be administered either orally or topically and has been proven effective for this condition. Ciprofloxacin: Ciprofloxacin is a broad-spectrum antibiotic mainly used for treating urinary tract infections and certain types of bacterial diarrhea but is not recommended for bacterial vaginosis.&lt;/li&gt;&lt;li&gt;â€¢ Fluconazole: Fluconazole is primarily used for treating fungal infections such as vaginal candidiasis, not bacterial vaginosis.&lt;/li&gt;&lt;li&gt;â€¢ Fluconazole:&lt;/li&gt;&lt;li&gt;â€¢ Clindamycin: Clindamycin is an alternative treatment for bacterial vaginosis, but it is not the first-line choice.&lt;/li&gt;&lt;li&gt;â€¢ Clindamycin:&lt;/li&gt;&lt;li&gt;â€¢ Metronidazole: Metronidazole is the recommended first-line treatment for bacterial vaginosis. It can be administered either orally or topically and has been proven effective for this condition.&lt;/li&gt;&lt;li&gt;â€¢ Metronidazole:&lt;/li&gt;&lt;li&gt;â€¢ Ciprofloxacin: Ciprofloxacin is a broad-spectrum antibiotic mainly used for treating urinary tract infections and certain types of bacterial diarrhea but is not recommended for bacterial vaginosis.&lt;/li&gt;&lt;li&gt;â€¢ Ciprofloxacin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman is taken to a neurologist by her family members. After thorough evaluation, the neurologist suggests the possibility of starting Aducanumab therapy, and the patient&#x27;s family starts researching the medication. Which of the following statements about Aducanumab is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aducanumab is a monoclonal antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aducanumab has received FDA approval for the treatment of Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aducanumab targets amyloid-beta plaques in the brain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Aducanumab is a monoclonal antibody: This statement is TRUE. Aducanumab is a monoclonal antibody designed to treat Alzheimer&#x27;s disease by targeting amyloid-beta plaques in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Aducanumab is a monoclonal antibody:&lt;/li&gt;&lt;li&gt;â€¢ B) Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission: This statement is FALSE. Aducanumab does not work by inhibiting acetylcholinesterase. Its primary mechanism is to target and remove amyloid-beta plaques.&lt;/li&gt;&lt;li&gt;â€¢ Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission:&lt;/li&gt;&lt;li&gt;â€¢ C) Aducanumab has received FDA approval for the treatment of Alzheimer&#x27;s disease: This statement is TRUE. Although its approval has been met with some controversy and debate, Aducanumab has been conditionally approved by the FDA for the treatment of Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Aducanumab has received FDA approval for the treatment of Alzheimer&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ D) Aducanumab targets amyloid-beta plaques in the brain: This statement is TRUE. The drug is designed to bind to amyloid-beta plaques, thereby aiding in their removal and potentially slowing the progression of Alzheimer&#x27;s disease, although definitive evidence for clinical benefit is still being evaluated.&lt;/li&gt;&lt;li&gt;â€¢ Aducanumab targets amyloid-beta plaques in the brain:&lt;/li&gt;&lt;li&gt;â€¢ Thus, the statement that is FALSE about Aducanumab is that it works by inhibiting acetylcholinesterase to increase cholinergic transmission.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pembrolizumab - Immune check point inhibitor used for endometrial carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ertugliflozin - SGLT2 inhibitor for treatment of diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine - Funny current blocker for treatment of decreased visual acuity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ivabradine - Funny current blocker for treatment of decreased visual acuity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks: This is a correct match. Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the treatment of acute migraine attacks. CGRP is a neuropeptide that plays a role in the pathophysiology of migraines, and antagonists like Zavegepant block its activity, thereby alleviating symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks:&lt;/li&gt;&lt;li&gt;â€¢ B) Pembrolizumab - Immune check point inhibitor used for endometrial carcinoma: This is also a correct match. Pembrolizumab is an immune checkpoint inhibitor that targets the PD-1 receptor. It is used for a variety of cancers, including endometrial carcinoma, especially in cases that are MSI-H or dMMR (microsatellite instability-high or mismatch repair deficient).&lt;/li&gt;&lt;li&gt;â€¢ Pembrolizumab - Immune check point inhibitor used for endometrial carcinoma:&lt;/li&gt;&lt;li&gt;â€¢ C) Ertugliflozin - SGLT2 inhibitor for treatment of diabetes mellitus: This is another correct match. Ertugliflozin is a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor, which is used to manage blood sugar levels in type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose in the kidneys, thereby leading to the excretion of glucose in the urine.&lt;/li&gt;&lt;li&gt;â€¢ Ertugliflozin - SGLT2 inhibitor for treatment of diabetes mellitus:&lt;/li&gt;&lt;li&gt;â€¢ D) Ivabradine - Funny current blocker for treatment of decreased visual acuity: This is the incorrect match. Ivabradine is indeed a \&quot;funny\&quot; current (If) blocker, but it is used for the treatment of certain types of chronic heart failure and angina pectoris (chest pain), not for treating decreased visual acuity.&lt;/li&gt;&lt;li&gt;â€¢ Ivabradine - Funny current blocker for treatment of decreased visual acuity:&lt;/li&gt;&lt;li&gt;â€¢ Therefore, option D is not a correct match concerning the mechanism of action and clinical use of the given drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with a history of hypertension is being considered for a new antihypertensive medication. His physician is weighing various options, taking into consideration their potential impact on plasma renin activity, which could have downstream effects on blood pressure control. All of the following drugs increase plasma renin activity except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clonidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Clonidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A) Amlodipine: This calcium channel blocker reduces arterial pressure and typically triggers a compensatory increase in renin release to restore blood pressure, thereby increasing plasma renin activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A)&lt;/li&gt;&lt;li&gt;â€¢ Amlodipine:&lt;/li&gt;&lt;li&gt;â€¢ Option C) Enalapril: This angiotensin-converting enzyme (ACE) inhibitor reduces levels of angiotensin II, a potent vasoconstrictor that also inhibits renin release. Lower angiotensin II levels result in increased renin activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C)&lt;/li&gt;&lt;li&gt;â€¢ Enalapril:&lt;/li&gt;&lt;li&gt;â€¢ Option D) Prazosin: This alpha-1 adrenergic antagonist reduces vascular tone, leading to a compensatory increase in renin release to restore blood pressure, thereby increasing plasma renin activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D) Prazosin:&lt;/li&gt;&lt;li&gt;â€¢ Therefore, among the options given, Methyl dopa is the drug that does not typically increase plasma renin activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs should be given in sustained release oral dosage form?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;An anti-arrhythmic drug with a plasma half-life of 10 seconds used for acute treatment of PSVT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An anti-inflammatory drug with a plasma half-life of 24 hr&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A hypnotic drug with a plasma half-life of 2 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An antihypertensive with a plasma half-life of 3 hours&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. An antihypertensive with a plasma half-life of 3 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new drug Z is being tested in animals for Anti-diabetic activity. When drug Z was given in a dose of 10 mg, 50 mice got the expected effect among the 100 who received the drug. However at 100 mg dose, half of the animals died. Which of the following statement about drug Z is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The final dose of drug Z in humans should be between 10 mg and 100 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ED50 of drug X is 10 mg.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LD50 of drug X is 100 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Therapeutic index of drug X is around 10&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The final dose of drug Z in humans should be between 10 mg and 100 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ a. The final dose of drug Z in humans cannot be determined solely based on the animal data provided. Animal studies are only the first step in the drug development process, and further studies are needed to determine the appropriate human dose. Other factors, such as pharmacokinetics, pharmacodynamics, and safety profile in humans, also need to be taken into consideration.&lt;/li&gt;&lt;li&gt;â€¢ b. ED50 is the dose at which 50% of the animals exhibit the desired effect. In this case, the ED50 of drug Z is 10 mg, which means that 50% of the mice experienced the expected effect at a dose of 10 mg.&lt;/li&gt;&lt;li&gt;â€¢ c. LD50 is the dose at which 50% of the animals die. In this case, the LD50 of drug Z 100 mg, as half of the animals died at this dose.&lt;/li&gt;&lt;li&gt;â€¢ d. Therapeutic index (TI) is the ratio of the LD50 to the ED50. It is a measure of the safety of the drug, with a higher TI indicating a safer drug. The TI of drug Z can be calculated as:&lt;/li&gt;&lt;li&gt;â€¢ TI = LD50/ED50&lt;/li&gt;&lt;li&gt;â€¢ TI = 100/10 = 10&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the therapeutic index of drug Z is around 10, which indicates that it is relatively safe.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements regarding steady state plasma concentration of a drug are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;At steady state, rate of administration of drug is equal to its rate of elimination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Steady state plasma concentration achieved depends upon half-life.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drugs with longer half-life can be given as loading dose to achieve steady state more quickly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Average steady state plasma concentration achieved is same irrespective of once daily or twice daily administration if total daily dose is same.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Steady state plasma concentration achieved depends upon half-life.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old patient with a history of atrial fibrillation is prescribed a new medication that requires an oral loading dose to quickly achieve therapeutic plasma concentrations. The physician is considering various factors to determine the appropriate loading dose for this patient. Oral loading dose of a drug depends on the following factors except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug concentration to be achieved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Volume of distribution&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bioavailability of drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clearance of the drug&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Clearance of the drug&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 51-year-old man with hypertension comes to the physician for a follow-up examination. At his last visit 3 months ago, his serum total cholesterol concentration was 320mg/dL. He then began a low-cholesterol diet. His blood pressure is 145/95 mm Hg. Physical examination shows no other abnormalities. Serum studies show a total cholesterol concentration of 310 mg/dL. Kidney and liver function test results are within normal limits. The most appropriate pharmacotherapy for this patient is a drug that has which of the following mechanisms of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Activates peroxisome proliferator-activated receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreases hepatic production of VLDL cholesterol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Forms insoluble complexes with bile acids in the gut&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibits 3-HMG-CoA reductase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inhibits 3-HMG-CoA reductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Inhibits 3-HMG-CoA reductase : Statins (e.g., atorvastatin, simvastatin) inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, which is a key enzyme in the cholesterol biosynthesis pathway in the liver. This leads to a significant reduction in LDL cholesterol and has been shown to decrease cardiovascular events and mortality in numerous studies. Given the patient&#x27;s high total cholesterol and the need for substantial reduction, statins are the most appropriate first-line pharmacotherapy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ (D)&lt;/li&gt;&lt;li&gt;â€¢ Inhibits 3-HMG-CoA reductase&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Activates peroxisome proliferator-activated receptors (PPARs) : Drugs that activate PPARs, such as fibrates (e.g., fenofibrate, gemfibrozil), primarily increase the oxidation of fatty acids and are most effective at lowering triglycerides and, to a lesser extent, increasing HDL cholesterol. They are not the first-line agents for reducing LDL cholesterol, which is the main target given this patient&#x27;s high total cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ (A)&lt;/li&gt;&lt;li&gt;â€¢ Activates peroxisome proliferator-activated receptors (PPARs)&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Decreases hepatic production of VLDL cholesterol : Drugs like niacin can decrease hepatic production of VLDL, which can lead to reduced LDL cholesterol. However, niacin also has other effects like increasing HDL cholesterol and can cause side effects such as flushing and hepatotoxicity. It is not typically the first choice for primary LDL reduction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ (B)&lt;/li&gt;&lt;li&gt;â€¢ Decreases hepatic production of VLDL cholesterol&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Forms insoluble complexes with bile acids in the gut : Bile acid sequestrants (e.g., cholestyramine, colestipol) bind bile acids in the intestine, preventing their reabsorption. This leads to increased conversion of cholesterol into bile acids in the liver, which can lower LDL cholesterol levels. However, these agents are not usually the first choice due to gastrointestinal side effects and less effectiveness compared to other options.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Forms insoluble complexes with bile acids in the gut&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most appropriate initial pharmacotherapy for a patient with significantly elevated LDL cholesterol, especially in the context of cardiovascular risk factors such as hypertension, is a statin. Statins work by inhibiting the HMG-CoA reductase enzyme, leading to decreased cholesterol synthesis in the liver and increased clearance of LDL cholesterol from the blood. This mechanism directly addresses the need to lower LDL cholesterol, making it the preferred option in such cases. Other therapies like fibrates, niacin, and bile acid sequestrants have roles in specific lipid abnormalities but are not the first choice for primary LDL reduction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 39-year-old woman with an 17-year history of type 1 diabetes mellitus and progressive renal failure is being considered for dialysis. Laboratory studies show normocytic, normochromic anemia. Which of the following medications is most appropriate to treat the anemia in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Folic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Folinic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B1 (thiamine)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Erythropoietin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Erythropoietin : Erythropoietin is a hormone produced by the kidneys that stimulates the bone marrow to produce red blood cells. In patients with CKD, the production of erythropoietin is reduced, leading to anemia. Administering synthetic erythropoietin (erythropoiesis-stimulating agents, ESAs) can effectively treat this type of anemia by compensating for the decreased endogenous production. This makes erythropoietin the most appropriate choice for treating anemia in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Erythropoietin&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Folic acid : Folic acid is necessary for the synthesis of DNA and, therefore, for the division and growth of cells, including red blood cells. While folic acid supplementation can be beneficial in cases of anemia due to folic acid deficiency, there is no indication in the scenario that this patient&#x27;s anemia is due to folic acid deficiency. Therefore, it&#x27;s not the most appropriate choice for this specific case.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Folic acid&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Folinic acid : Folinic acid (leucovorin) is a form of folate that can be used to manage certain drug toxicities (e.g., methotrexate toxicity) and in combination with other medications for treating specific types of cancer. Like folic acid, it could theoretically support red blood cell production but is not indicated for anemia due to CKD.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Folinic acid&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Vitamin B1 (thiamine) : Thiamine is essential for carbohydrate metabolism and neural function. Thiamine deficiency can lead to conditions such as beriberi or Wernicke encephalopathy but is not a cause of normocytic, normochromic anemia. Therefore, thiamine supplementation would not address the anemia in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Vitamin B1 (thiamine)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with chronic kidney disease, the most common cause of normocytic, normochromic anemia is a deficiency in erythropoietin production by the kidneys. The most appropriate treatment in such cases is the administration of synthetic erythropoietin (erythropoiesis-stimulating agents) to stimulate red blood cell production. Other supplements like folic acid, folinic acid, and vitamin B1 may be important in specific contexts but are not the primary treatment for anemia associated with CKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman is admitted to the hospital for treatment of pneumococcal pneumonia. Treatment with gentamicin and penicillin is initiated. Within 10 minutes of the administration of antimicrobial therapy, her respiratory rate increased to 30/min, and blood pressure decreased to 80/40 mm Hg. Epinephrine, antihistamine, and corticosteroid therapy is started. Her condition improves slowly during the next 2 hours. Her antimicrobial therapy is changed to gentamicin only, and her condition continues to improve. Administration of which of the following types of drugs is most likely to cause a similar adverse reaction in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cephalosporins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Macrolides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Quinolones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tetracyclines&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cephalosporins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Cephalosporins : Cephalosporins are Î²-lactam antibiotics, similar to penicillins, and share a Î²-lactam ring structure. There is a known cross-reactivity between penicillins and cephalosporins due to their structural similarities, though the risk is generally lower with later generations of cephalosporins. Patients with a history of anaphylaxis to penicillin may also react to cephalosporins, making this class the most likely to cause a similar adverse reaction in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Cephalosporins&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Macrolides : Macrolides (e.g., erythromycin, azithromycin) are a class of antibiotics that work by inhibiting bacterial protein synthesis. They are not structurally related to penicillins and generally do not carry a significant risk of cross-reactivity with penicillins. Allergic reactions are possible but less likely compared to cephalosporins in a patient with a history of penicillin allergy.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Macrolides&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Quinolones : Quinolones (e.g., ciprofloxacin, levofloxacin) are antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV. They are chemically and mechanistically distinct from penicillins, and the risk of cross-reactivity is minimal. While quinolones can cause adverse reactions, an anaphylactic reaction similar to that seen with penicillin is less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Quinolones&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Tetracyclines : Tetracyclines (e.g., doxycycline, minocycline) inhibit protein synthesis by binding to the bacterial ribosome. They are not related to penicillins in structure or mechanism and have a low risk of cross-reactivity with penicillins. Anaphylactic reactions are rare with tetracyclines.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Tetracyclines&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with a history of anaphylactic reactions to penicillin, cephalosporins are the class of antibiotics most likely to cause a similar adverse reaction due to structural similarities and potential cross-reactivity. It&#x27;s important to assess the risk of cross-reactivity when choosing antibiotics for patients with known severe allergies to specific drug classes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;17-year-old girl is brought to the physician by her parents 30 minutes after having a generalized tonic-clonic seizure while playing in a soccer game. She currently takes no medications. Physical examination shows no abnormalities. After further testing including 24-hour continuous EEG monitoring, carbamazepine is prescribed. This patientâ€™s use of additional medications should be monitored because of which of the following changes in drug disposition after starting pharmacotherapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased absorption in the intestine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased distribution to the brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased excretion by the kidneys&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased metabolism by the liver&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased metabolism by the liver&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Increased metabolism by the liver : This is the correct option. Carbamazepine induces hepatic cytochrome P450 enzymes, which can lead to increased metabolism of many drugs. This effect can decrease the plasma levels and effectiveness of co-administered medications that are substrates for these enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Increased metabolism by the liver&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Decreased absorption in the intestine : Carbamazepine does not significantly affect the absorption of drugs in the intestine. Its primary effects are on drug metabolism rather than on absorption, so this option is not directly relevant to the changes in drug disposition related to carbamazepine therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ (A)&lt;/li&gt;&lt;li&gt;â€¢ Decreased absorption in the intestine&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Decreased distribution to the brain : Carbamazepine does not primarily affect the distribution of drugs to the brain or other tissues in a way that would significantly alter their therapeutic effects. Its impact is more pronounced on the metabolism of drugs.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Decreased distribution to the brain&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Increased excretion by the kidneys : While carbamazepine can affect the excretion of some drugs indirectly by altering their metabolism and thus their pharmacokinetic profiles, its most notable effect is on hepatic enzyme induction rather than direct changes in renal excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Increased excretion by the kidneys&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key educational objective here is to understand the enzyme-inducing effects of carbamazepine on hepatic metabolism. Carbamazepine can increase the metabolism of various drugs by inducing cytochrome P450 enzymes in the liver. This effect necessitates close monitoring when carbamazepine is used in combination with other medications, as it may reduce their effectiveness by increasing their metabolic clearance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old man comes to the physician because of a 6-month history of occasional episodes of chest tightness, wheezing, and cough. The symptoms are often mild and resolve spontaneously. He has been otherwise healthy. His respiratory rate is 13/min. The lungs are clear to auscultation. Cardiac examination and chest x-ray show no abnormalities. Which of the following agents is most appropriate to treat acute episodes in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Formoterol plus budesonide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beclomethasone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cromolyn&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ipratropium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Formoterol plus budesonide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Formoterol : Formoterol is a fast-acting Î²2-adrenergic agonist that provides rapid relief from acute bronchoconstriction by causing bronchodilation. It along with inhalational corticosteroid like budesonide is the first-line treatment for acute asthma symptoms. Given the patient&#x27;s occasional acute episodes, formoterol plus budesonide is the most appropriate choice for on-demand relief of symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Formoterol&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Beclomethasone : Beclomethasone is an inhaled corticosteroid (ICS) used for long-term control of chronic asthma to reduce inflammation and hyperresponsiveness of the airways. While very effective for managing persistent asthma, it is not appropriate for immediate relief of acute symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Beclomethasone&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Cromolyn : Cromolyn sodium is a mast cell stabilizer used as a prophylactic treatment to prevent allergic reactions and asthma symptoms. It is not effective for the treatment of acute asthma symptoms and is less commonly used in current asthma management compared to other long-term control medications.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Cromolyn&lt;/li&gt;&lt;li&gt;â€¢ Option D) Ipratropium : Ipratropium is a short-acting anticholinergic agent that causes bronchodilation by blocking muscarinic receptors in the airways. While it can be used in the management of chronic obstructive pulmonary disease (COPD) and as an adjunct in asthma, it is generally not the first choice for acute asthma symptoms, especially in patients who are likely to respond well to Î²2-adrenergic agonists like albuterol.&lt;/li&gt;&lt;li&gt;â€¢ Option D)&lt;/li&gt;&lt;li&gt;â€¢ Ipratropium&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize that short-acting Î²2-adrenergic agonists (SABAs), such as albuterol, are the most appropriate choice for the immediate relief of acute asthma symptoms due to their rapid bronchodilatory effects. Inhaled corticosteroids and mast cell stabilizers are used for long-term control and prevention of chronic symptoms in asthma, and are not suitable for acute relief. Anticholinergics, while useful in COPD and as an adjunct in asthma, are not the first-line treatment for acute asthma exacerbations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with type 2 diabetes mellitus and a 30-pound weight loss over the past two months presents to the physician with a history of nausea and bloating. Symptoms are most prominent following a meal. An outpatient gastric emptying study shows esophageal dysmotility. The best treatment option for this patient is which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Esophageal resection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metoclopramide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Metoclopramide : Metoclopramide is a prokinetic agent that enhances gastric motility by increasing the amplitude of gastric contractions and accelerating gastric emptying. It also increases the tone of the lower esophageal sphincter and has antiemetic properties. Given its mechanism of action, metoclopramide is an appropriate treatment option for symptoms of gastroparesis in diabetic patients.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Metoclopramide&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Esophageal resection : This is a surgical intervention typically reserved for severe esophageal disease such as cancer or end-stage benign disease. It is not indicated for motility disorders like gastroparesis and carries significant risks.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Esophageal resection&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Omeprazole : Omeprazole is a proton pump inhibitor (PPI) used to reduce gastric acid production. It is used in the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and other conditions associated with excessive stomach acid. While it can relieve symptoms caused by acid, it does not address the underlying motility issue and is not the best option for this patient&#x27;s primary symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Ondansetron : Ondansetron is a serotonin 5-HT3 receptor antagonist used primarily as an antiemetic to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. While it can help manage nausea, it does not improve gastric emptying or motility and therefore would not be the most effective treatment for gastroparesis.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Ondansetron&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the management of gastroparesis, particularly in diabetic patients. Metoclopramide is a prokinetic agent that can improve gastric emptying and reduce symptoms of gastroparesis by enhancing gastrointestinal motility and providing antiemetic effects. It is important to choose treatment options that address the underlying pathophysiology of the condition, which in the case of gastroparesis, involves delayed gastric emptying and impaired motility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Class I antiarrhythmics are sodium channel blockers that slow or block cardiac conduction, especially in depolarized cells. Which of the following antiarrhythmics will increase both the action potential and the effective refractory period?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esmolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Procainamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Procainamide : Procainamide is a Class IA antiarrhythmic agent. It blocks sodium channels and also has potassium channel blocking effects, which leads to an increase in the action potential duration and the effective refractory period. Thus, procainamide fits the description of increasing both the APD and ERP.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Procainamide&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Encainide : Encainide is a Class IC antiarrhythmic drug. It markedly slows conduction through the heart but has minimal effect on the action potential duration or the effective refractory period. Therefore, it would not be expected to increase both the APD and ERP.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Encainide&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Phenytoin : Phenytoin is classified as a Class IB antiarrhythmic. It has a minimal effect on the action potential duration in normal tissues and may shorten it in depolarized or ischemic tissues. It is not known to significantly increase the ERP.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Phenytoin&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Esmolol : Esmolol is a beta blocker and belong to class II of anti-arrhythmics. It does not prolong APD or ERP. It acts by decreasing slope of phase 4 spontaneous diastolic depolarization in SA node.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Esmolol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the classification of Class I antiarrhythmic drugs and their effects on the action potential duration and effective refractory period. Class IA agents, like procainamide, not only block sodium channels but also have a moderate potassium channel blocking effect, leading to an increase in both the action potential duration and the effective refractory period. This is in contrast to Class IB and IC agents, which do not have this combined effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman presents to the emergency department following a motor vehicle collision. She did not sustain any serious physical injuries, but she appears drowsy and states that she is feeling very sleepy. Emergency medical staff collected several open medication bottles from the floor of her automobile. Although the contents of two of the bottles could not be determined, the patientâ€™s recently filled bottle of diazepam was almost empty. The patient quickly becomes unresponsive and stops breathing. Administration of which of the following agents will reverse these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midazolam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Naloxone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Flumazenil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Flumazenil : Flumazenil is a benzodiazepine antagonist used to reverse the effects of benzodiazepines. It competitively inhibits the action at the benzodiazepine binding site on the GABA-A receptor, thereby reversing the sedative, hypnotic, and respiratory depressant effects of benzodiazepines. It is the appropriate choice for reversing the symptoms caused by a benzodiazepine overdose such as that suggested by the nearly empty diazepam bottle.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Flumazenil&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Glucagon : Glucagon is primarily used to treat severe hypoglycemia in diabetes patients. It can also increase heart rate and force of contraction and is sometimes used in Î²-blocker overdose. However, it has no role in reversing benzodiazepine-induced sedation or respiratory depression.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Glucagon&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Midazolam : Midazolam is another benzodiazepine, used for sedation, anxiolysis, and anesthesia induction. Administering midazolam to a patient with a suspected benzodiazepine overdose would exacerbate the sedation and respiratory depression, not reverse it.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Midazolam&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Naloxone : Naloxone is an opioid antagonist used to reverse opioid overdose symptoms, including respiratory depression caused by opioids. While naloxone is effective in reversing opioid effects, it would not be effective in reversing the effects of a benzodiazepine overdose.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Naloxone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize flumazenil as the appropriate reversal agent for benzodiazepine overdose. Flumazenil works by competitively inhibiting benzodiazepines at their binding site on the GABA-A receptor, which can reverse the central nervous system depressant effects of benzodiazepines, including sedation and respiratory depression. It is crucial to choose the specific antidote based on the type of drug overdose to effectively reverse the symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients with hyperthyroidism have several options to treat their disease, including subtotal thyroidectomy and radioactive ablation. When a patient is unwilling or unable to undergo these procedures, pharmacological therapy is often pursued. One particular medication inhibits the conversion of iodide to iodine and inhibits the organification of iodine with tyrosine. Which of the following is an additional mechanism of action of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Permanently reducing thyroid activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Binding to and blocking the iodide transport mechanism of thyroid follicular cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Binding to intracellular nuclear receptors of peripheral tissue and activating genes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blocking the peripheral conversion of thyroxine to triiodothyronine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Blocking the peripheral conversion of thyroxine to triiodothyronine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Blocking the peripheral conversion of thyroxine to triiodothyronine : This is an additional mechanism of action for propylthiouracil (PTU), one of the thionamides. PTU, in addition to inhibiting thyroid hormone synthesis in the thyroid gland, also inhibits the peripheral conversion of thyroxine (T4) to the more active triiodothyronine (T3). Methimazole does not have this peripheral action.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Blocking the peripheral conversion of thyroxine to triiodothyronine&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Permanently reducing thyroid activity : Thionamides like PTU and methimazole do not permanently reduce thyroid activity. Their effects are reversible, and thyroid function often returns to its previous state upon discontinuation of the medication.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Permanently reducing thyroid activity&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Binding to and blocking the iodide transport mechanism of thyroid follicular cells : This mechanism is associated with perchlorate and pertechnetate, which inhibit the sodium-iodide symporter, not thionamides. Thionamides do not act by blocking iodide transport into thyroid cells.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Binding to and blocking the iodide transport mechanism of thyroid follicular cells&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Binding to intracellular nuclear receptors of peripheral tissue and activating genes : This mechanism describes the action of thyroid hormone itself, not the action of thionamides. Thyroid hormones bind to nuclear receptors and modulate gene expression, but this is not a mechanism of action for thionamide drugs.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Binding to intracellular nuclear receptors of peripheral tissue and activating genes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the mechanisms of action of thionamide medications, such as propylthiouracil (PTU) and methimazole, used in the treatment of hyperthyroidism. While both inhibit the synthesis of thyroid hormones by blocking the iodination of tyrosine residues in thyroglobulin and the coupling of iodotyrosines, PTU has the additional mechanism of blocking the peripheral conversion of T4 to T3. This understanding is crucial for selecting appropriate therapy in the management of hyperthyroidism, especially considering the specific clinical scenario and patient preferences.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with a history of stroke and hypertension comes to the emergency department because of a six-hour history of palpitations and light-headedness. He states that he has experienced shorter episodes of palpitations before, but nothing as severe as this. Physical examination reveals an irregular heart rhythm that eventually improves with various atrioventricular node blocking agents. The patient is prescribed a regimen of daily medications including a drug to prevent a potential complication of his condition. Which of the following drugs is most likely prescribed longterm to prevent such complications?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Protamine sulfate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unfractionated heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Warfarin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Warfarin : Warfarin is a vitamin K antagonist that inhibits the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X) in the liver, providing effective anticoagulation. Warfarin is commonly prescribed for long-term anticoagulation in patients with AFib to prevent stroke and other thromboembolic complications. Given its oral route of administration and efficacy, warfarin is a suitable choice for long-term prevention of thromboembolic events in AFib patients.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Warfarin&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Aspirin : Aspirin is an antiplatelet agent that inhibits cyclooxygenase, leading to decreased thromboxane A2 production and reduced platelet aggregation. While it does provide some antithrombotic effect, it is generally considered less effective than anticoagulants in preventing thromboembolic events in patients with AFib, especially those with additional risk factors for stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Protamine sulfate : Protamine sulfate is an antidote used to reverse the anticoagulant effects of heparin. It is not used for long-term prevention of thromboembolic complications in AFib.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Protamine sulfate&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Unfractionated heparin : Unfractionated heparin is an anticoagulant that works by binding to antithrombin III, thereby inactivating thrombin and factor Xa, leading to reduced clot formation. While it is effective as an anticoagulant, its short half-life and the need for intravenous administration or frequent subcutaneous injections make it impractical for long-term outpatient therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Unfractionated heparin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize that warfarin is often prescribed for long-term anticoagulation in patients with atrial fibrillation to prevent thromboembolic complications, including stroke. Warfarin&#x27;s mechanism of action as a vitamin K antagonist makes it effective in reducing the risk of clot formation in conditions where there is an increased risk of thrombosis, such as atrial fibrillation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old woman comes to a follow-up appointment complaining of weight gain three weeks after beginning a new medication for her refractory schizophrenia. Laboratory studies show a low WBC count and low absolute neutrophil count. Peripheral blood smear shows a total absence of neutrophils and bands. The rest of the laboratory results are within normal limits. Which of the following drug therapies did this patient most likely begin two weeks ago?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloramphenicol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polymyxin B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clozapine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Clozapine : Clozapine is an atypical antipsychotic used specifically for treatment-resistant schizophrenia. A well-known, serious side effect of clozapine is agranulocytosis, a condition characterized by a dramatic decrease in neutrophil count, which increases the risk of infection. The weight gain mentioned is also a common side effect of clozapine, making it the most likely medication started two weeks ago that led to the patient&#x27;s current condition.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Clozapine&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Chloramphenicol : This is an antibiotic that can cause bone marrow suppression, leading to aplastic anemia, thrombocytopenia, and granulocytopenia. While chloramphenicol can cause hematologic abnormalities, it is not typically used to treat schizophrenia, making it an unlikely choice in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Chloramphenicol&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Metronidazole : This is an antimicrobial agent used to treat various infections, including those caused by anaerobic bacteria and protozoa. While metronidazole can cause side effects such as gastrointestinal disturbances and neurotoxicity, it is not commonly associated with severe neutropenia or used in the treatment of schizophrenia.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Metronidazole&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Polymyxin B : This is an antibiotic that is mainly used to treat infections caused by gram-negative bacteria. Its side effects primarily include nephrotoxicity and neurotoxicity, but it does not commonly cause agranulocytosis and is not used for schizophrenia.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Polymyxin B&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to recognize that clozapine, an atypical antipsychotic used for refractory schizophrenia, can cause serious hematological side effects, including agranulocytosis (severe neutropenia), and is also associated with weight gain. This highlights the importance of monitoring blood counts in patients started on clozapine therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old medical student presents to a health clinic with fatigue, a sore throat, and chills. His temperature is 101.6Â°F. Findings on physical examination are significant for a red oropharynx with exudate and tender enlarged lymph nodes. A rapid strep test is positive for Streptococcus-induced pharyngitis. The physician plans to prescribe penicillin, but the patient reports that the last time he took penicillin, he experienced severe airway swelling and difficulty breathing that required hospitalization. Which of the following is the best choice for treating this patient, given his penicillin allergy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cephalexin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Meropenem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Azithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option (A) Amoxicillin : Amoxicillin is a penicillin antibiotic and shares a Î²-lactam ring similar to penicillin, making it likely to elicit an allergic reaction in patients with a history of penicillin allergy, especially those who have experienced severe reactions. Therefore, it is not a suitable option for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option (A)&lt;/li&gt;&lt;li&gt;â€¢ Amoxicillin&lt;/li&gt;&lt;li&gt;â€¢ Option (B) Azithromycin : Azithromycin is a macrolide antibiotic, which works by inhibiting bacterial protein synthesis. It is often used as an alternative in patients with penicillin allergies for treating infections like streptococcal pharyngitis. Its different mechanism of action and lack of a Î²-lactam ring make it a safe and effective alternative for patients with penicillin allergies.&lt;/li&gt;&lt;li&gt;â€¢ Option (B)&lt;/li&gt;&lt;li&gt;â€¢ Azithromycin&lt;/li&gt;&lt;li&gt;â€¢ Option (C) Cephalexin : Cephalexin is a cephalosporin, another class of Î²-lactam antibiotics. While the overall cross-reactivity rate between penicillins and first-generation cephalosporins like cephalexin is low, it&#x27;s generally advised to avoid cephalosporins in patients with a history of severe allergic reactions to penicillin, such as anaphylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option (C)&lt;/li&gt;&lt;li&gt;â€¢ Cephalexin&lt;/li&gt;&lt;li&gt;â€¢ Option (D) Doxycycline : Doxycycline is a tetracycline antibiotic that inhibits bacterial protein synthesis. It can be used in patients with penicillin allergy; however, it&#x27;s not typically the first choice for treating streptococcal pharyngitis due to concerns about resistance and its broader spectrum of activity, which might not be necessary for this specific infection.&lt;/li&gt;&lt;li&gt;â€¢ Option (D)&lt;/li&gt;&lt;li&gt;â€¢ Doxycycline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the importance of selecting an appropriate antibiotic in patients with a known severe allergy to penicillin. Azithromycin, a macrolide antibiotic, is a suitable choice for treating infections like streptococcal pharyngitis in patients with penicillin allergies, as it has a different mechanism of action and lacks the Î²-lactam structure responsible for allergic reactions in penicillin-sensitive individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man previously diagnosed with Hodgkin lymphoma complains of severe shortness of breath when he walks or climbs stairs. Examination reveals regular venous pressure of 18 cm H2O, bi-basilar rales, an S3 gallop, and 2+ lower-extremity edema. His physician suspects an adverse effect of treatment is causing this patientâ€™s symptoms. The pharmacologic agent most likely responsible for the symptoms in this patient has the same mechanism of action as which of the following cancer drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idarubicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Idarubicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ The clinical scenario describes a 67-year-old man with a history of Hodgkin lymphoma presenting with symptoms suggestive of heart failure (shortness of breath on exertion, elevated jugular venous pressure, bi-basilar rales, an S3 gallop, and lower-extremity edema). The question hints at a suspicion that these symptoms are an adverse effect of a treatment he received for his Hodgkin lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ The key to answering this question lies in recognizing the side effect profile of common chemotherapeutic agents used in the treatment of Hodgkin lymphoma and matching them with the mechanism of action of the drugs listed in the options.&lt;/li&gt;&lt;li&gt;â€¢ (A) Cisplatin : Cisplatin is a platinum-based chemotherapeutic agent. Its primary mechanism of action involves the formation of platinum-DNA adducts, leading to apoptosis. Its common side effects include nephrotoxicity and ototoxicity, but it is not typically associated with cardiac toxicity. (B) Cyclophosphamide : Cyclophosphamide is an alkylating agent. It cross-links DNA at guanine N-7 positions, leading to cell death. Cyclophosphamide can cause cardiac toxicity, particularly hemorrhagic cystitis and bladder cancer, but heart failure is not a prominent feature. (C) Idarubicin : Idarubicin is an anthracycline, similar to doxorubicin. Anthracyclines intercalate DNA and inhibit topoisomerase II, leading to DNA damage and apoptosis. A well-known side effect of anthracyclines is dose-dependent cardiotoxicity, which can lead to congestive heart failure. The description of the patient&#x27;s symptoms fits well with anthracycline-induced cardiomyopathy. (D) Methotrexate : Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, interfering with DNA synthesis and repair. Its common side effects include mucositis, hepatotoxicity, and myelosuppression, but it is not known for causing heart failure.&lt;/li&gt;&lt;li&gt;â€¢ (A) Cisplatin : Cisplatin is a platinum-based chemotherapeutic agent. Its primary mechanism of action involves the formation of platinum-DNA adducts, leading to apoptosis. Its common side effects include nephrotoxicity and ototoxicity, but it is not typically associated with cardiac toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Cisplatin&lt;/li&gt;&lt;li&gt;â€¢ (B) Cyclophosphamide : Cyclophosphamide is an alkylating agent. It cross-links DNA at guanine N-7 positions, leading to cell death. Cyclophosphamide can cause cardiac toxicity, particularly hemorrhagic cystitis and bladder cancer, but heart failure is not a prominent feature.&lt;/li&gt;&lt;li&gt;â€¢ Cyclophosphamide&lt;/li&gt;&lt;li&gt;â€¢ (C) Idarubicin : Idarubicin is an anthracycline, similar to doxorubicin. Anthracyclines intercalate DNA and inhibit topoisomerase II, leading to DNA damage and apoptosis. A well-known side effect of anthracyclines is dose-dependent cardiotoxicity, which can lead to congestive heart failure. The description of the patient&#x27;s symptoms fits well with anthracycline-induced cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ Idarubicin&lt;/li&gt;&lt;li&gt;â€¢ (D) Methotrexate : Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, interfering with DNA synthesis and repair. Its common side effects include mucositis, hepatotoxicity, and myelosuppression, but it is not known for causing heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old hypertensive patient with stage 5 chronic kidney disease was diagnosed recently with Type 2 diabetes mellitus. He does not want to take injectable drugs. Which of the following oral hypoglycemic agents will be preferred in this patient that does not require any dose modification in renal failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Linagliptin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vildagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exenatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Linagliptin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Linagliptin&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Linagliptin&lt;/li&gt;&lt;li&gt;â€¢ It is an incretin-mimetic drug that act by increasing the level of endogenous GLP-1. It inhibits the metabolism of GLP-1 by inhibiting DPP-4 enzyme. Gliptins are given orally. Linagliptin is predominantly excreted via enterohepatic system and is therefore safe in patients with renal failure (only gliptin). It is approved for use as monotherapy and in combination with metformin, glimepiride, and pioglitazone.&lt;/li&gt;&lt;li&gt;â€¢ It is an incretin-mimetic drug that act by increasing the level of endogenous GLP-1.&lt;/li&gt;&lt;li&gt;â€¢ It inhibits the metabolism of GLP-1 by inhibiting DPP-4 enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Gliptins are given orally.&lt;/li&gt;&lt;li&gt;â€¢ Linagliptin is predominantly excreted via enterohepatic system and is therefore safe in patients with renal failure (only gliptin).&lt;/li&gt;&lt;li&gt;â€¢ It is approved for use as monotherapy and in combination with metformin, glimepiride, and pioglitazone.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vildagliptin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vildagliptin&lt;/li&gt;&lt;li&gt;â€¢ It acts via a mechanism like linagliptin. It is also incretin-mimetic drug that act by increasing the level of endogenous GLP-1. It inhibits the metabolism of GLP-1 by inhibiting DPP-4 enzyme. Gliptins are given orally. It requires dose modification in renal like all the gliptins (except linagliptin).&lt;/li&gt;&lt;li&gt;â€¢ It acts via a mechanism like linagliptin.&lt;/li&gt;&lt;li&gt;â€¢ It is also incretin-mimetic drug that act by increasing the level of endogenous GLP-1.&lt;/li&gt;&lt;li&gt;â€¢ It inhibits the metabolism of GLP-1 by inhibiting DPP-4 enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Gliptins are given orally.&lt;/li&gt;&lt;li&gt;â€¢ It requires dose modification in renal like all the gliptins (except linagliptin).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exenatide&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exenatide&lt;/li&gt;&lt;li&gt;â€¢ It is a long-acting analogue of GLP-1. It needs to be given by injectable route because it not effective orally due to its peptide structure.&lt;/li&gt;&lt;li&gt;â€¢ It is a long-acting analogue of GLP-1.&lt;/li&gt;&lt;li&gt;â€¢ It needs to be given by injectable route because it not effective orally due to its peptide structure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metformin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metformin&lt;/li&gt;&lt;li&gt;â€¢ Normally, metformin is DOC for type 2 diabetes mellitus. However, it is contra-indicated in renal disease due to risk of development of lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Normally, metformin is DOC for type 2 diabetes mellitus.&lt;/li&gt;&lt;li&gt;â€¢ However, it is contra-indicated in renal disease due to risk of development of lactic acidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risk factors for metformin induced lactic acidosis :&lt;/li&gt;&lt;li&gt;âž¤ Hypotensive states Cardiovascular disease Respiratory disease Hepatic failure Renal failure Alcoholics&lt;/li&gt;&lt;li&gt;âž¤ Hypotensive states&lt;/li&gt;&lt;li&gt;âž¤ Cardiovascular disease&lt;/li&gt;&lt;li&gt;âž¤ Respiratory disease&lt;/li&gt;&lt;li&gt;âž¤ Hepatic failure&lt;/li&gt;&lt;li&gt;âž¤ Renal failure&lt;/li&gt;&lt;li&gt;âž¤ Alcoholics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient comes 6 hours after consuming morphine and presents with pinpoint pupils and respiratory depression. The half-life of morphine is 3 hours and Volume of distribution (Vd) is 200 L. Plasma concentration of morphine at this time is 0.5 microgram/ml. Calculate the initial morphine dose consumed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;100 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;400 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;10 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;50 mg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 400 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child opened his fatherâ€™s drawer and ingested multiple tablets of his cardiac medication, metoprolol. The child was brought to hospital with profound hypotension and bradycardia. What is the specific antidote used in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nor-adrenaline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glucagon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for each option:&lt;/li&gt;&lt;li&gt;â€¢ Option b. Glucagon :&lt;/li&gt;&lt;li&gt;â€¢ Option b.&lt;/li&gt;&lt;li&gt;â€¢ Glucagon&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Glucagon is a hormone that activates adenylate cyclase in cardiac cells, leading to increased levels of cyclic AMP (cAMP). This results in increased intracellular calcium and improved contractility and heart rate. Use in Toxicity: Glucagon is considered the specific antidote for beta-blocker toxicity. It works by bypassing the beta-adrenergic receptor blockade and stimulating cardiac function. It is particularly effective in cases of profound bradycardia and hypotension due to beta-blocker overdose.&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Glucagon is a hormone that activates adenylate cyclase in cardiac cells, leading to increased levels of cyclic AMP (cAMP). This results in increased intracellular calcium and improved contractility and heart rate.&lt;/li&gt;&lt;li&gt;â€¢ Use in Toxicity: Glucagon is considered the specific antidote for beta-blocker toxicity. It works by bypassing the beta-adrenergic receptor blockade and stimulating cardiac function. It is particularly effective in cases of profound bradycardia and hypotension due to beta-blocker overdose.&lt;/li&gt;&lt;li&gt;â€¢ Option a. Dobutamine :&lt;/li&gt;&lt;li&gt;â€¢ Option a.&lt;/li&gt;&lt;li&gt;â€¢ Dobutamine&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Dobutamine is a sympathomimetic drug that primarily stimulates beta-1 adrenergic receptors in the heart, leading to an increase in heart rate and contractility. Use in Toxicity: While dobutamine can increase heart rate and cardiac output, it may not be the first-line antidote for beta-blocker toxicity. Other agents with more specific mechanisms are preferred.&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Dobutamine is a sympathomimetic drug that primarily stimulates beta-1 adrenergic receptors in the heart, leading to an increase in heart rate and contractility.&lt;/li&gt;&lt;li&gt;â€¢ Use in Toxicity: While dobutamine can increase heart rate and cardiac output, it may not be the first-line antidote for beta-blocker toxicity. Other agents with more specific mechanisms are preferred.&lt;/li&gt;&lt;li&gt;â€¢ Option c. Adrenaline (Epinephrine) :&lt;/li&gt;&lt;li&gt;â€¢ Option c.&lt;/li&gt;&lt;li&gt;â€¢ Adrenaline (Epinephrine)&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Adrenaline is a sympathomimetic drug that acts on both alpha and beta adrenergic receptors. It increases heart rate, contractility, and systemic vascular resistance. Use in Toxicity: Adrenaline can be used to treat beta-blocker overdose; however, it may not be the specific antidote. It can be less effective in cases of severe beta-blocker toxicity, as it competes with the blocked beta receptors.&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Adrenaline is a sympathomimetic drug that acts on both alpha and beta adrenergic receptors. It increases heart rate, contractility, and systemic vascular resistance.&lt;/li&gt;&lt;li&gt;â€¢ Use in Toxicity: Adrenaline can be used to treat beta-blocker overdose; however, it may not be the specific antidote. It can be less effective in cases of severe beta-blocker toxicity, as it competes with the blocked beta receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option d. Noradrenaline (Norepinephrine) :&lt;/li&gt;&lt;li&gt;â€¢ Option d.&lt;/li&gt;&lt;li&gt;â€¢ Noradrenaline (Norepinephrine)&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Noradrenaline primarily stimulates alpha adrenergic receptors, leading to vasoconstriction and increased systemic vascular resistance. Use in Toxicity: Noradrenaline can be used to treat beta-blocker overdose by increasing blood pressure through vasoconstriction. However, it is not the specific antidote for beta-blocker toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Mechanism: Noradrenaline primarily stimulates alpha adrenergic receptors, leading to vasoconstriction and increased systemic vascular resistance.&lt;/li&gt;&lt;li&gt;â€¢ Use in Toxicity: Noradrenaline can be used to treat beta-blocker overdose by increasing blood pressure through vasoconstriction. However, it is not the specific antidote for beta-blocker toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the specific antidote for beta-blocker toxicity, which is glucagon . Glucagon can effectively counteract the profound hypotension and bradycardia caused by beta-blocker overdose by stimulating cardiac function through an alternative signaling pathway (Camp-mediated). It is important for healthcare providers to be aware of the appropriate antidotes and treatments for toxicities caused by various medications, especially in emergency situations involving children.&lt;/li&gt;&lt;li&gt;âž¤ glucagon&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For overdose of several drugs, we can change the pH of the urine. Urine can be made alkaline for increasing the excretion of all of the following drugs except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Morphine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given image shows the Log DRC of a drug alone (A) and in the presence of antagonists (B and C). Identify the type of antagonism shown in curve B and curve C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B is competitive and C is non-competitive antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B is non-competitive an C is competitive antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both are competitive antagonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both are non-competitive antagonists&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. B is competitive and C is non-competitive antagonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/picture2_kFjaZGu.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following gives the extent of drug absorption in plasma concentration vs time graph shown below in the figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Half life&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Area under the curve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cmax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Area under the curve&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/picture3_Qtz1BF4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents to you with hypothyroidism and you want to prescribe oral thyroxine at a dose of 100 microgram (0.1 milligram) daily for 30 days. As an Indian medical intern, which of the following is the correct format for prescription of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tablet Thyroxine 100 m g once a day orally for 30 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tablet Thyroxine 100 mcg OD orally for 30 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tablet Thyroxine .1 mg once a day orally for 30 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tablet Thyroxine 100 mcg once a day orally for 30 days&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tablet Thyroxine 100 mcg once a day orally for 30 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After eating a plant as shown in the figure below, A child presented to emergency in comatose state. The pupils were dilated and skin was dry. Body temperature is raised and heart rate is high. These signs and symptoms are similar to intake of which of the following substance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atropine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/picture4_ZzS0niK.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Repeated administration of a drug, produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nicotinic actions of acetylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Biphasic response of adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tachyphylaxis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/picture5_9X72Mdp.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient requires mild cholinomimetic stimulation following surgery. Physostigmine (an acetylcholinesterase inhibitor) and bethanechol (a direct acting muscarinic agonist) in small doses have significantly different effects on which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuromuscular junction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sweat glands&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ureteral tone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neuromuscular junction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tremors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchodilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male with insulin dependent diabetes having macular edema develops glaucoma. Which of the following anti-glaucoma drugs should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Netarsudil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brimonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Latanoprost&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/01/screenshot-2024-02-01-192723.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in mean arterial pressure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased renal perfusion and reduced urine output&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increase in mean arterial pressure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about Colchicine is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acts by inhibiting granulocyte migration in the joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It causes metaphase arrest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can result in myopathy as an adverse effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs block late inward sodium ion channels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fasudil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ranolazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the antiarrhythmic agent with the following mechanism of action:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flecainide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tocainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ibutilide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Flecainide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture1.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture2.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-094935.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Trimetazidine is a drug approved for treatment of angina pectoris. Its mechanism of action is assumed to be?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bradycardiac agent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rho kinase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;K channel opener&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibiting mitochondrial LC3- KAT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inhibiting mitochondrial LC3- KAT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diuretics does not require its presence in the tubular lumen for its pharmacological effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loop diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbonic anhydrase inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aldosterone antagonists&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aldosterone antagonists&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following statements about metformin is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Does not stimulate insulin release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreases hepatic glucose production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Can be safely used in patients with renal dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Can be combined with sulfonylureas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Can be safely used in patients with renal dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A lady who was treated for breast cancer is on long-term tamoxifen therapy as she is ER-positive. Drug tamoxifen can increase the risk for which of the following cancers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carcinoma of ovary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endometrial carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Breast carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic myeloid leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Endometrial carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the mechanism shown in figure. Drug X is likely to be:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exenatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pramlintide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vildagliptin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vildagliptin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What are the appropriate instructions to be given while prescribing bisphosphonates to a patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To be given empty stomach with a full glass of water&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Must be taken along with food&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Should be stopped if features of gastritis develop&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Should be stopped if bone pains occur&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. To be given empty stomach with a full glass of water&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Octreotide is used in all except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucagonoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carcinoid syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glioma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Glioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following drugs are used in treatment of osteoporosis except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Milnacipran&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Milnacipran&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-101852.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of bipolar disorder was treated with lithium. Hydrochlorothiazide was prescribed for his hypertension. He developed nausea, vomiting, coarse tremors and brisk reflexes 2 weeks after taking drugs. What is the likely reason for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Side effects of hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased metabolism of hydrochlorthiazide by lithium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased renal tubular reabsorption of lithium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiazide act as an add on drug to lithium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased renal tubular reabsorption of lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following agents is available as a patch for once-daily use and is likely to provide steady drug levels to treat Alzheimerâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rivastigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Donepezil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galantamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rivastigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with schizophrenia was treated with haloperidol 5 mg once daily at bedtime, which was increased to 7.5 mg daily in the 2nd week and 10 mg daily in the 3rd week. His symptoms improved, but in the 5th week, his family reported that his restlessness had returned, and he kept pacing around in the room, though he was not aggressive. The patient also reported an uncontrollable urge to move around and difficulty in falling asleep. Which of the following drugs would be the best choice for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Higher doses of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valbenazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dantrolene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s symptoms suggest that he may be experiencing akathisia, a side effect of antipsychotic medications like haloperidol. Akathisia is characterized by restlessness, an uncontrollable urge to move, and difficulty in sitting still.&lt;/li&gt;&lt;li&gt;â€¢ Propranolol, a beta-blocker, is often used to treat akathisia and could be an appropriate choice to address the patient&#x27;s symptoms. Higher doses of haloperidol may exacerbate the patient&#x27;s restlessness and are not recommended in this case. Valbenazine is used to treat tardive dyskinesia, a different movement disorder associated with long-term antipsychotic use. It is not indicated for treating akathisia. Dantrolene is a muscle relaxant used to treat muscle spasms and malignant hyperthermia. It is not used to treat akathisia.&lt;/li&gt;&lt;li&gt;â€¢ Propranolol, a beta-blocker, is often used to treat akathisia and could be an appropriate choice to address the patient&#x27;s symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Higher doses of haloperidol may exacerbate the patient&#x27;s restlessness and are not recommended in this case.&lt;/li&gt;&lt;li&gt;â€¢ Valbenazine is used to treat tardive dyskinesia, a different movement disorder associated with long-term antipsychotic use. It is not indicated for treating akathisia.&lt;/li&gt;&lt;li&gt;â€¢ Dantrolene is a muscle relaxant used to treat muscle spasms and malignant hyperthermia. It is not used to treat akathisia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is operated for bile duct stricture. Post operatively he is receiving 3 ml epidural morphine for pain relief. One day accidentally he received 12 ml of morphine. What will not occur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory depression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypotension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Miosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Tramadol acts on Âµ receptor as an agonist. Additionally, it also acts as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serotonin and nor-adrenaline reuptake inhibitor (SNRI)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nor-adrenaline and dopamine reuptake inhibitor (NDRI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antihistaminic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anticholinergic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Serotonin and nor-adrenaline reuptake inhibitor (SNRI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a antagonist of PAR-1 receptors of thrombin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ticlopidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tirofiban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vorapaxar&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vorapaxar&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron dextran&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oprelvekin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-104829.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man with a long history of asthma is referred to pulmonologist. The physician decides to prescribe zileuton. The mechanism of action of this drug is to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antagonize leukotriene D4 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits 5-lipoxygenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibit phosphodiesterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulate beta 2 receptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibits 5-lipoxygenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an antagonist of a peptide and is used to reduce chemotherapy induced nausea and vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial natriuretic peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aprepitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bradykinin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aprepitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are immune check point inhibitors except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avelumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Durvalumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cetuximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture4.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-110849.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Avelumab, atezolizumab, and durvalumab are all programmed death ligand-1 (PD-L1) inhibitors that work by blocking the interaction between PD-L1 and its receptor, PD-1, on T cells. This helps to activate the immune system and attack cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Cetuximab, on the other hand, is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on cancer cells. It does not inhibit PD-L1 and does not work through the same mechanism as PD-L1 inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Immune Check Point inhibitors&lt;/li&gt;&lt;li&gt;â€¢ Immune Check Point inhibitors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pre-XDR TB is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone and streptomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone, linezolide and bedaquiline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MDR plus resistance to amikacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. MDR plus resistance to fluoroquinolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-111414.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents to the emergency department with a fever, headache, and muscle aches. He reports a recent camping trip in a rural area where he was exposed to ticks. On examination, there is a characteristic eschar at the site of a tick bite, as well as regional lymphadenopathy. Laboratory tests reveal thrombocytopenia and elevated liver enzymes. Based on the clinical presentation and laboratory findings, the healthcare provider suspects scrub typhus. What is the drug of choice for scrub typhus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sulfonamides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Doxycycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Scrub typhus is an acute febrile illness caused by the bacteria Orientia tsutsugamushi, which is transmitted to humans by the bite of infected chiggers. The clinical presentation of scrub typhus is characterized by fever, headache, muscle aches, and the presence of an eschar at the site of the chigger bite. Laboratory findings may include thrombocytopenia, elevated liver enzymes, and leukocytosis. The drug of choice for the treatment of scrub typhus is doxycycline. Other antibiotics, such as azithromycin, chloramphenicol, and ciprofloxacin, may also be used to treat scrub typhus, but doxycycline is the preferred drug due to its effectiveness and low risk of adverse effects. Erythromycin, sulfonamides, and metronidazole are not recommended for the treatment of scrub typhus&lt;/li&gt;&lt;li&gt;â€¢ Scrub typhus is an acute febrile illness caused by the bacteria Orientia tsutsugamushi, which is transmitted to humans by the bite of infected chiggers. The clinical presentation of scrub typhus is characterized by fever, headache, muscle aches, and the presence of an eschar at the site of the chigger bite. Laboratory findings may include thrombocytopenia, elevated liver enzymes, and leukocytosis.&lt;/li&gt;&lt;li&gt;â€¢ The drug of choice for the treatment of scrub typhus is doxycycline. Other antibiotics, such as azithromycin, chloramphenicol, and ciprofloxacin, may also be used to treat scrub typhus, but doxycycline is the preferred drug due to its effectiveness and low risk of adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Erythromycin, sulfonamides, and metronidazole are not recommended for the treatment of scrub typhus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents to the emergency department with a fever, headache, and abdominal pain for the past five days. On examination, his temperature is 102Â°F (39Â°C), and he has tenderness in the right upper quadrant of his abdomen. Blood cultures are positive for Salmonella typhi. Which of the following drugs is NOT used in the treatment of enteric fever?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amikacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amikacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-112810.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Enteric fever is a bacterial infection caused by Salmonella typhi or Salmonella paratyphi. The mainstay of treatment for enteric fever is antibiotic therapy, which is typically initiated based on the results of a blood culture. Commonly used antibiotics for the treatment of enteric fever include ceftriaxone, ciprofloxacin, azithromycin, and other fluoroquinolones. Rifampicin is also effective in treating enteric fever and is often used in combination with other antibiotics. However, amikacin, which is an aminoglycoside antibiotic, is not typically used in the treatment of enteric fever.&lt;/li&gt;&lt;li&gt;â€¢ Enteric fever is a bacterial infection caused by Salmonella typhi or Salmonella paratyphi.&lt;/li&gt;&lt;li&gt;â€¢ The mainstay of treatment for enteric fever is antibiotic therapy, which is typically initiated based on the results of a blood culture.&lt;/li&gt;&lt;li&gt;â€¢ Commonly used antibiotics for the treatment of enteric fever include ceftriaxone, ciprofloxacin, azithromycin, and other fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin is also effective in treating enteric fever and is often used in combination with other antibiotics.&lt;/li&gt;&lt;li&gt;â€¢ However, amikacin, which is an aminoglycoside antibiotic, is not typically used in the treatment of enteric fever.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which antiepileptic drug can cause this adverse effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Phenytoin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-113623.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This figure represents the mechanism of drugs used in the treatment of Parkinsonism. Which of the following options correctly represents the drugs shown in the figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture5_0nrzJgU.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-115403_fEfI5SB.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture6_ESUOBAX.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients undergoing treatment for colorectal cancer have developed symptoms such as tingling, numbness, pain, and erythema on the palms and soles of their feet as shown in the figure below. Which of the following chemotherapy drugs could be the causative agent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cladribine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gemcitabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Capecitabine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Capecitabine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture7.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Capecitabine is a chemotherapy drug commonly used to treat colorectal cancer. It is a prodrug that is converted to 5-fluorouracil (5-FU) in the body. One of the known side effects of capecitabine is hand-foot syndrome, which can present as tingling, numbness, pain, and erythema on the palms and soles of the feet. This is thought to be due to the accumulation of the drug in the skin and the subsequent inflammation and damage to the small blood vessels in the affected areas.&lt;/li&gt;&lt;li&gt;â€¢ Capecitabine is a chemotherapy drug commonly used to treat colorectal cancer.&lt;/li&gt;&lt;li&gt;â€¢ It is a prodrug that is converted to 5-fluorouracil (5-FU) in the body.&lt;/li&gt;&lt;li&gt;â€¢ One of the known side effects of capecitabine is hand-foot syndrome, which can present as tingling, numbness, pain, and erythema on the palms and soles of the feet.&lt;/li&gt;&lt;li&gt;â€¢ This is thought to be due to the accumulation of the drug in the skin and the subsequent inflammation and damage to the small blood vessels in the affected areas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of two anticancer drugs X and Y is shown in the figure below. Which of following statements most correctly represent drug X and Y?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;X is 5-Fluorourcail and Y is Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;X is Methotrexate and Y is 5-Fluorouracil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;X is Vincristine and Y is Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both X and Y are methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. X is Methotrexate and Y is 5-Fluorouracil&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate inhibits dihydrofolate reductase (DHFRase), an enzyme that is involved in the synthesis of nucleotides. By inhibiting DHFRase, methotrexate prevents the formation of tetrahydrofolate, which is required for the synthesis of thymidylate, purines, and other nucleotides. 5-Fluorouracil (5-FU), on the other hand, inhibits thymidylate synthase, an enzyme that is required for the synthesis of thymidylate, which is essential for DNA replication. By inhibiting thymidylate synthase, 5-FU reduces the production of thymidylate and thereby inhibits DNA synthesis. Vincristine is a microtubule inhibitor that blocks cell division by inhibiting the formation of the mitotic spindle. It does not inhibit thymidylate synthase or DHFRase. Therefore, option C is incorrect. Option D is also incorrect because both X and Y cannot be methotrexate, as they have different targets of action.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate inhibits dihydrofolate reductase (DHFRase), an enzyme that is involved in the synthesis of nucleotides. By inhibiting DHFRase, methotrexate prevents the formation of tetrahydrofolate, which is required for the synthesis of thymidylate, purines, and other nucleotides.&lt;/li&gt;&lt;li&gt;â€¢ 5-Fluorouracil (5-FU), on the other hand, inhibits thymidylate synthase, an enzyme that is required for the synthesis of thymidylate, which is essential for DNA replication. By inhibiting thymidylate synthase, 5-FU reduces the production of thymidylate and thereby inhibits DNA synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Vincristine is a microtubule inhibitor that blocks cell division by inhibiting the formation of the mitotic spindle. It does not inhibit thymidylate synthase or DHFRase. Therefore, option C is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option D is also incorrect because both X and Y cannot be methotrexate, as they have different targets of action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After 15 days of chemotherapy, a patient develops rash and itching on the back as shown in the image. It can occur as a side effect of which of the following drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Actinomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doxorubicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitomycin C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bleomycin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In dog blood pressure experiment, adrenaline was given at the point shown by arrow and the effect noted is shown in the figure. Black represents the mean arterial pressure and red line indicates heart rate. What is this effect known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic response&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicotinic effects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Biphasic response&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation Of Options&lt;/li&gt;&lt;li&gt;â€¢ a. Vasomotor reversal of Dale : This phenomenon occurs when adrenaline is administered following the administration of alpha-blockers. In normal circumstances, adrenaline produces biphasic response; first increase in BP (due to stimulation of alpha-1 adrenergic receptors) and then decrease in BP (due to unopposed beta-2 stimulation). However, when alpha receptors are blocked, the administration of adrenaline leads to a predominant action on the beta receptors, causing vasodilation and an decrease in blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Vasomotor reversal of Dale&lt;/li&gt;&lt;li&gt;â€¢ c. Tachyphylaxis : Tachyphylaxis refers to a rapid decrease in the response to a drug after repeated doses over a short period of time. It is shown by drugs like tyramine and ephedrine etc. It does not describe the biphasic response seen with adrenaline in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Tachyphylaxis&lt;/li&gt;&lt;li&gt;â€¢ d. Nicotinic effects : Nicotinic effects pertain to the action on nicotinic acetylcholine receptors. In this there will be increase in BP and heart rate after giving high doses of acetylcholine. This is not relevant to the adrenaline-induced cardiovascular effects described in the question.&lt;/li&gt;&lt;li&gt;â€¢ Nicotinic effects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old patient is brought to psychiatry OPD. His wife states that he has been awake for last 3 days. He quit his job and plans to invest all his savings in a pig farm. He doesnâ€™t understand why his wife is upset. He has similar episodes last year too when he lost most of his money. Which drug is likely to be prescribed to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Modafinil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male patient with heart disease has been brought to the emergncy with breathlessness. He also has bipedal edema as shown in the image below. Which of the following is the best drug for the management of edema in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACE inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Na-K-2CI symporter inhibitor in loop of Henle&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Na-CI symporter inhibitor in DCT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aldosterone blocker in DCT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Na-K-2CI symporter inhibitor in loop of Henle&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of prinzmetalâ€™s angina is started on isosorbide mono nitrate. What is the mechanism of action of nitrates in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced cardiac contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased left ventricular end diastolic volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased diastolic perfusion pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endothelium independent coronary vasodilatation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Endothelium independent coronary vasodilatation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test6" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D   Mission 1.5, Lap 2   12 06 2024   2024 06 11&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D   Mission 1.5, Lap 2   12 06 2024   2024 06 11&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which among the following drugs doesnâ€™t require any renal dose modification in the patients with chronic kidney disease? (Fmge June 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Saxagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linagliptin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repaglinide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glyburide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Linagliptin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Linagliptin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients with chronic kidney disease, especially those at different stages of renal impairment, choosing antidiabetic medications that do not require renal adjustments can simplify management. Linagliptin stands out among the options given for its liver metabolism and minimal renal elimination, offering a safer profile for CKD patients without the need for dose modifications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient presented with greenish vaginal discharge and pruritus. Clue cells were present. What is the drug of choice for this condition? (FMGE DECEMBER 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fluconazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metronidazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Metronidazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metronidazole is the drug of choice for treating Bacterial Vaginosis due to its effectiveness against the anaerobic bacteria commonly associated with the condition. It can be administered either orally or as a topical gel or cream. In cases where metronidazole cannot be used, clindamycin is a suitable alternative. This knowledge is crucial for appropriate clinical management to relieve symptoms and prevent potential complications related to BV.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the shortest-acting cardioselective beta blocker? (Fmge June 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nadolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esmolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Esmolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Esmolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Esmolol is the shortest-acting cardioselective beta blocker due to its rapid metabolism by plasma cholinesterase. It is particularly useful for managing acute conditions such as intraoperative tachycardia, supraventricular tachycardia, and hypertensive emergencies where rapid onset and quick offset of action are desired.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition given in the graph? (Fmge Jan 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Non-competitive&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/2_h99LToF.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/3_UmZzKsx.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Non-competitive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The given graph illustrates non-competitive inhibition, where the inhibitor binds to an allosteric site, causing a decrease in Vmax while Km remains constant. This type of inhibition affects the enzyme&#x27;s activity without altering the substrate&#x27;s binding affinity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young male, diagnosed with thalassemia, is experiencing iron overload due to repeated blood transfusions over the years. Which of the following medications is the most appropriate for managing his chronic iron overload? (Fmge July 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;EDTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deferiprone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Penicillamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deferiprone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Deferiprone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Deferiprone is an effective oral iron chelator used to manage chronic iron overload in thalassemia patients, making it a convenient and appropriate choice for reducing excess iron levels resulting from repeated blood transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mechanism of action of bedaquiline, a new drug used in the treatment of multidrug-resistant tuberculosis (MDR-TB)? (FMGE July 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of ATP synthesis by mycobacteria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of mycolic acid synthesis in mycobacteria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of RNA polymerase in mycobacteria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of protein synthesis in mycobacteria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of ATP synthesis by mycobacteria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Inhibition of ATP synthesis by mycobacteria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bedaquiline treats multidrug-resistant tuberculosis by inhibiting ATP synthase in mycobacteria, thereby disrupting the production of ATP and hindering the bacteria&#x27;s growth and survival.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with a history of chronic stable angina is seen in the outpatient department. She is already taking aspirin and statins, but continues to experience occasional chest pain during exertion. Which of the following would be the most appropriate choice for prophylactic treatment of her angina? (Fmge July 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sublingual nitroglycerine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroglycerine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral nitroglycerine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intratracheal nitroglycerine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral nitroglycerine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oral nitroglycerine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oral nitroglycerine, a long-acting nitrate preparation, is the most appropriate choice for the prophylactic treatment of chronic stable angina to prevent angina episodes during exertion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine plus primaquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Artemisinin based combination therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Quinine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Quinine is often used as a treatment for malaria during pregnancy, especially if other options are not available or suitable. However, it is usually more associated with the treatment of Plasmodium falciparum rather than Plasmodium vivax.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was given digoxin. He started having side effects like nausea and vomiting. The serum concentration of digoxin was 4 mg/dL. The plasma therapeutic range is 1 mg/dL. If the half-life of digoxin is 40 hours, how long one should wait before resuming the treatment? (NEET PG 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;40 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;80 hours&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;120 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;140-180 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 80 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 80 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a patient experiencing side effects from digoxin with a serum concentration of 4 mg/dL, wait 80 hours (two half-lives) for the concentration to decrease to the therapeutic range before resuming treatment.&lt;/li&gt;&lt;li&gt;âž¤ 80 hours&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Theophylline was prescribed to a male patient with chronic obstructive pulmonary disease (COPD). The next day, he noticed that his urine output had increased. Which of the following receptors is responsible for the drug&#x27;s action? (NEET PG 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Interleukin-10&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Histone deacetylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine A1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta 2 adrenergic receptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adenosine A1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Adenosine A1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Theophylline increases urine output by antagonizing adenosine A1 receptors, leading to decreased water reabsorption in the renal tubules and resulting in diuresis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged male patient presents with chin protrusion, excessive sweating, impaired glucose tolerance, and hand and foot enlargement. What is a growth hormone receptor antagonist used to treat this condition? (NEET PG 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pegvisomant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cabergoline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Olcegepant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pegvisomant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pegvisomant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone at the receptor level, thereby reducing the symptoms associated with elevated growth hormone levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of depression was started on amitriptyline, a tricyclic antidepressant (TCA). The patient was later found unconscious at home and brought to the emergency department. On examination, the patient shows signs of arrhythmias, confusion, and pupillary dilation. Which of the following does NOT suggest TCA poisoning?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arrhythmias&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Confusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypothermia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pupillary dilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypothermia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypothermia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypothermia is not a typical feature of tricyclic antidepressant (TCA) poisoning, whereas arrhythmias, confusion, and pupillary dilation are common clinical manifestations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of diabetes mellitus presents with heart failure characterized by a reduced ejection fraction and low urine output. Which of the following anti-diabetic medications has been recently approved for the treatment of heart failure with reduced ejection fraction, and may also improve diuresis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rosiglitazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin degludec&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin, an SGLT2 inhibitor, is approved for the treatment of heart failure with reduced ejection fraction and provides cardiovascular benefits, including increased diuresis, which can help manage fluid overload in heart failure patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman with a history of chronic urticaria comes to the clinic for a consultation regarding her medication regimen. She reports no significant relief from her symptoms despite adherence to her prescribed medications. The physician suspects that genetic variations in drug metabolism may be influencing her response to treatment and decides to evaluate her medications based on their metabolic pathways, particularly acetylation, as individual variations in this process can alter drug effectiveness and toxicity. Which of the following drugs prescribed to this patient is not primarily metabolized by acetylation, potentially contributing to the ineffectiveness of her treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydrocortisone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dapsone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hydrocortisone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hydrocortisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dapsone : An antibacterial commonly used in the treatment of leprosy and dermatological conditions , dapsone is metabolized by acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dapsone&lt;/li&gt;&lt;li&gt;â€¢ antibacterial&lt;/li&gt;&lt;li&gt;â€¢ used in the treatment of leprosy&lt;/li&gt;&lt;li&gt;â€¢ dermatological conditions&lt;/li&gt;&lt;li&gt;â€¢ Option C. Procainamide : An antiarrhythmic agent that is metabolized through acetylation . Variations in acetylation rates can affect its efficacy and side effect profile.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Procainamide&lt;/li&gt;&lt;li&gt;â€¢ antiarrhythmic agent&lt;/li&gt;&lt;li&gt;â€¢ metabolized through acetylation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydralazine : Used primarily for hypertension , hydralazine is metabolized through acetylation . Slow acetylators may have a higher risk of drug-induced lupus erythematosus.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydralazine&lt;/li&gt;&lt;li&gt;â€¢ primarily for hypertension&lt;/li&gt;&lt;li&gt;â€¢ hydralazine is metabolized&lt;/li&gt;&lt;li&gt;â€¢ acetylation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Hydrocortisone is not metabolized by acetylation , unlike other drugs such as dapsone , procainamide , and hydralazine , which can influence individual responses to drug therapy due to variations in acetylation rates .&lt;/li&gt;&lt;li&gt;âž¤ Hydrocortisone&lt;/li&gt;&lt;li&gt;âž¤ not metabolized by acetylation&lt;/li&gt;&lt;li&gt;âž¤ drugs such as dapsone&lt;/li&gt;&lt;li&gt;âž¤ procainamide&lt;/li&gt;&lt;li&gt;âž¤ hydralazine&lt;/li&gt;&lt;li&gt;âž¤ influence individual responses&lt;/li&gt;&lt;li&gt;âž¤ drug therapy&lt;/li&gt;&lt;li&gt;âž¤ acetylation rates&lt;/li&gt;&lt;li&gt;âž¤ The drugs metabolized by acetylation include:&lt;/li&gt;&lt;li&gt;âž¤ S: S ulfonamides (including Dapsone)&lt;/li&gt;&lt;li&gt;âž¤ S: S&lt;/li&gt;&lt;li&gt;âž¤ H: H ydralazine&lt;/li&gt;&lt;li&gt;âž¤ H: H&lt;/li&gt;&lt;li&gt;âž¤ I: I soniazid&lt;/li&gt;&lt;li&gt;âž¤ I: I&lt;/li&gt;&lt;li&gt;âž¤ P: P rocainamide&lt;/li&gt;&lt;li&gt;âž¤ P: P&lt;/li&gt;&lt;li&gt;âž¤ All these drugs can cause SLE like syndrome.&lt;/li&gt;&lt;li&gt;âž¤ All these drugs can cause SLE like syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the provided drug response curve graph, what type of drug does the red-lined curve, represent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Partial agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Full agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inverse agonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inverse agonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/29/whatsapp-image-2023-09-29-at-120333.jpeg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-165152.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Inverse agonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Partial Agonist : This would produce a response , but its maximal effect is less than a full agonist , even when all receptors are occupied . The curve for a partial agonist would be above the baseline (indicating a positive response) but would not reach the same maximum as the full agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Partial Agonist&lt;/li&gt;&lt;li&gt;â€¢ produce a response&lt;/li&gt;&lt;li&gt;â€¢ maximal effect&lt;/li&gt;&lt;li&gt;â€¢ less than a full agonist&lt;/li&gt;&lt;li&gt;â€¢ receptors are occupied&lt;/li&gt;&lt;li&gt;â€¢ curve for a partial agonist&lt;/li&gt;&lt;li&gt;â€¢ above the baseline&lt;/li&gt;&lt;li&gt;â€¢ Option B: Full Agonist : This binds to the receptor and produces a maximum biological response. The curve would be expected to reach the highest point above the baseline in the graph, indicating the full efficacy of the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Full Agonist&lt;/li&gt;&lt;li&gt;â€¢ binds to the receptor&lt;/li&gt;&lt;li&gt;â€¢ produces a maximum biological response.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Antagonist : An antagonist would not produce any response itself ; it would only block the effect of an agonist . The curve for a pure antagonist would be flat, aligning with the baseline because it does not activate the receptor nor produce a response on its own.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Antagonist&lt;/li&gt;&lt;li&gt;â€¢ antagonist&lt;/li&gt;&lt;li&gt;â€¢ not produce any response itself&lt;/li&gt;&lt;li&gt;â€¢ block the effect of an agonist&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The red-lined curve that dips below the baseline represents an inverse agonist , which binds to a receptor and reduces its activity below the basal level .&lt;/li&gt;&lt;li&gt;âž¤ red-lined curve&lt;/li&gt;&lt;li&gt;âž¤ dips below the baseline&lt;/li&gt;&lt;li&gt;âž¤ inverse agonist&lt;/li&gt;&lt;li&gt;âž¤ receptor and reduces its activity below the basal level&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does IP in the figure shown stands for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug is an instant release preparation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Meant for intra pulmonary use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The standards according to Indian Pharmacopoeia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug tested preclinically via Intraperitoneal route&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The standards according to Indian Pharmacopoeia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/24/10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The standards according to Indian Pharmacopoeia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A : \&quot;Instant release preparation\&quot; refers to the formulation of the drug that affects how quickly it is released into the bloodstream; however, \&quot;IP\&quot; does not indicate this.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Instant release preparation\&quot;&lt;/li&gt;&lt;li&gt;â€¢ formulation of the drug&lt;/li&gt;&lt;li&gt;â€¢ how quickly it is released into the bloodstream;&lt;/li&gt;&lt;li&gt;â€¢ Option B : \&quot;Intra pulmonary use\&quot; suggests that the drug is to be used within the lungs , typically inhalation drugs fall under this category, but \&quot;IP\&quot; does not denote this.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Intra pulmonary use\&quot;&lt;/li&gt;&lt;li&gt;â€¢ drug is to be used within the lungs&lt;/li&gt;&lt;li&gt;â€¢ Option D : \&quot;Intraperitoneal route \&quot; is a method of drug administration used in research, but \&quot;IP\&quot; on a drug package does not relate to this.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ \&quot;Intraperitoneal route&lt;/li&gt;&lt;li&gt;â€¢ method of drug administration&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;IP\&quot; on a medication package indicates that the drug conforms to the standards set by the Indian Pharmacopoeia.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;IP\&quot; on a medication package&lt;/li&gt;&lt;li&gt;âž¤ drug conforms to the standards set by the Indian Pharmacopoeia.&lt;/li&gt;&lt;li&gt;âž¤ IP stands for Indian Pharmacopoeia BP: British Pharmacopoeia USP: United Nations Pharmacopoeia BNF: British National Formulary&lt;/li&gt;&lt;li&gt;âž¤ IP stands for Indian Pharmacopoeia&lt;/li&gt;&lt;li&gt;âž¤ BP: British Pharmacopoeia&lt;/li&gt;&lt;li&gt;âž¤ USP: United Nations Pharmacopoeia&lt;/li&gt;&lt;li&gt;âž¤ BNF: British National Formulary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is the new Î²3 agonist approved for overactive bladder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fesoterodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trospium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mirabegron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxybutynin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mirabegron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mirabegron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fesoterodine - Incorrect , it is an antimuscarinic agent used for overactive bladder but not a Î²3 agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fesoterodine&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic agent&lt;/li&gt;&lt;li&gt;â€¢ overactive bladder&lt;/li&gt;&lt;li&gt;â€¢ not a Î²3 agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trospium - Incorrect , also an antimuscarinic , not a Î²3 agonist .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Trospium&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic&lt;/li&gt;&lt;li&gt;â€¢ not a Î²3 agonist&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxybutynin - Incorrect, this is an older antimuscarinic drug used for overactive bladder .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxybutynin&lt;/li&gt;&lt;li&gt;â€¢ - Incorrect,&lt;/li&gt;&lt;li&gt;â€¢ older antimuscarinic drug&lt;/li&gt;&lt;li&gt;â€¢ overactive bladder&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Mirabegron is the first Î²3 agonist approved for the treatment of overactive bladder, offering a mechanism of action different from antimuscarinic agents, and can be an option for patients who cannot tolerate or do not respond to anticholinergic medications.&lt;/li&gt;&lt;li&gt;â€¢ Mirabegron&lt;/li&gt;&lt;li&gt;â€¢ first Î²3 agonist&lt;/li&gt;&lt;li&gt;â€¢ overactive bladder,&lt;/li&gt;&lt;li&gt;â€¢ mechanism of action different&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic agents,&lt;/li&gt;&lt;li&gt;â€¢ cannot tolerate&lt;/li&gt;&lt;li&gt;â€¢ do not respond to anticholinergic medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are contraindications to the use of atropine except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benign hyperplasia of prostate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Angle closure glaucoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AV block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paralytic ileus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. AV block&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/40.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) AV block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Benign hyperplasia of prostate: Atropine can cause urinary retention, which is why it is contraindicated in patients with benign prostatic hyperplasia (BPH). A tropine&#x27;s antimuscarinic effects reduce bladder muscle contraction, exacerbating t he difficulty in urination caused by prostate enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Benign hyperplasia of prostate: Atropine can cause urinary retention, which is why it is contraindicated in patients with benign prostatic hyperplasia (BPH). A tropine&#x27;s antimuscarinic effects reduce bladder muscle contraction, exacerbating t he difficulty in urination caused by prostate enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Benign hyperplasia of prostate:&lt;/li&gt;&lt;li&gt;â€¢ Atropine&lt;/li&gt;&lt;li&gt;â€¢ urinary retention,&lt;/li&gt;&lt;li&gt;â€¢ contraindicated in&lt;/li&gt;&lt;li&gt;â€¢ benign prostatic hyperplasia (BPH).&lt;/li&gt;&lt;li&gt;â€¢ tropine&#x27;s antimuscarinic effects reduce bladder muscle contraction,&lt;/li&gt;&lt;li&gt;â€¢ exacerbating t&lt;/li&gt;&lt;li&gt;â€¢ urination&lt;/li&gt;&lt;li&gt;â€¢ prostate enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Angle closure glaucoma: Atropine is contraindicated in patients with angle closure glaucoma because it can increase intraocular pressure . Its antimuscarinic action dilates the pupil (mydriasis), which can block the drainage of aqueous humor through the trabecular meshwork, worsening the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Angle closure glaucoma: Atropine is contraindicated in patients with angle closure glaucoma because it can increase intraocular pressure . Its antimuscarinic action dilates the pupil (mydriasis), which can block the drainage of aqueous humor through the trabecular meshwork, worsening the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Angle closure glaucoma:&lt;/li&gt;&lt;li&gt;â€¢ Atropine is contraindicated&lt;/li&gt;&lt;li&gt;â€¢ angle closure glaucoma&lt;/li&gt;&lt;li&gt;â€¢ increase intraocular pressure&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic action dilates the pupil (mydriasis),&lt;/li&gt;&lt;li&gt;â€¢ block the drainage of&lt;/li&gt;&lt;li&gt;â€¢ aqueous humor&lt;/li&gt;&lt;li&gt;â€¢ trabecular meshwork,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Paralytic ileus: Atropine is contraindicated in patients with paralytic ileus because its antimuscarinic effects can inhibit gastrointestinal motility, exacerbating the condition by further slowing or stopping the movement of the intestines.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Paralytic ileus: Atropine is contraindicated in patients with paralytic ileus because its antimuscarinic effects can inhibit gastrointestinal motility, exacerbating the condition by further slowing or stopping the movement of the intestines.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Paralytic ileus:&lt;/li&gt;&lt;li&gt;â€¢ Atropine is contraindicated&lt;/li&gt;&lt;li&gt;â€¢ paralytic ileus&lt;/li&gt;&lt;li&gt;â€¢ antimuscarinic effects&lt;/li&gt;&lt;li&gt;â€¢ inhibit gastrointestinal motility, exacerbating&lt;/li&gt;&lt;li&gt;â€¢ slowing or stopping the movement&lt;/li&gt;&lt;li&gt;â€¢ intestines.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to identify the contraindications of atropine use, focusing on its antimuscarinic effects on various organ systems. Here is a table listing the contraindications of atropine along with explanations for each:&lt;/li&gt;&lt;li&gt;âž¤ identify the contraindications of atropine&lt;/li&gt;&lt;li&gt;âž¤ antimuscarinic effects&lt;/li&gt;&lt;li&gt;âž¤ various organ systems.&lt;/li&gt;&lt;li&gt;âž¤ contraindications of atropine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug acts by stimulation of 5HT4 receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Buspirone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renzapride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Granisetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Renzapride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Renzapride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Buspirone - It is a 5-HT1A agonist and is primarily used for the treatment of anxiety .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Buspirone&lt;/li&gt;&lt;li&gt;â€¢ 5-HT1A agonist&lt;/li&gt;&lt;li&gt;â€¢ primarily used for the treatment of anxiety&lt;/li&gt;&lt;li&gt;â€¢ Option C. Granisetron - This is a 5-HT3 receptor antagonist , which is indicated for the prevention of chemotherapy-induced nausea and vomiting .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Granisetron -&lt;/li&gt;&lt;li&gt;â€¢ 5-HT3 receptor antagonist&lt;/li&gt;&lt;li&gt;â€¢ indicated for the prevention of chemotherapy-induced nausea&lt;/li&gt;&lt;li&gt;â€¢ vomiting&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoclopramide - It is an antagonist at D2 receptors and is used for its anti-emetic and prokinetic properties .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoclopramide&lt;/li&gt;&lt;li&gt;â€¢ antagonist at D2 receptors&lt;/li&gt;&lt;li&gt;â€¢ anti-emetic&lt;/li&gt;&lt;li&gt;â€¢ prokinetic properties&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Renzapride is a 5-HT4 receptor agonist used to increase peristalsis in the gastrointestinal tract . Many 5-HT4 agonists , useful for GERD , end in &#x27;pride&#x27; such as cisapride , mosapride , and prucalopride . It&#x27;s important to note that Tegaserod, another 5-HT4 agonist, was withdrawn due to increased risk of myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Renzapride is a 5-HT4 receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ increase peristalsis in the gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ 5-HT4 agonists&lt;/li&gt;&lt;li&gt;â€¢ GERD&lt;/li&gt;&lt;li&gt;â€¢ end in &#x27;pride&#x27; such as cisapride&lt;/li&gt;&lt;li&gt;â€¢ mosapride&lt;/li&gt;&lt;li&gt;â€¢ prucalopride&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are used for treatment of congestive heart failure except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Trimetazidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-094413.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Trimetazidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nesiritide: Nesiritide is a recombinant B-type natriuretic peptide that has vasodilatory effects and is used in the management of acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nesiritide:&lt;/li&gt;&lt;li&gt;â€¢ recombinant B-type natriuretic peptide&lt;/li&gt;&lt;li&gt;â€¢ vasodilatory effects&lt;/li&gt;&lt;li&gt;â€¢ acute decompensated heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sacubitril: When combined with valsartan (a neprilysin inhibitor and an angiotensin II receptor blocker, respectively), sacubitril is used to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sacubitril:&lt;/li&gt;&lt;li&gt;â€¢ combined with valsartan&lt;/li&gt;&lt;li&gt;â€¢ neprilysin inhibitor and an angiotensin II receptor blocker,&lt;/li&gt;&lt;li&gt;â€¢ reduce the risk of cardiovascular death&lt;/li&gt;&lt;li&gt;â€¢ hospitalization for heart failure in patients&lt;/li&gt;&lt;li&gt;â€¢ chronic heart&lt;/li&gt;&lt;li&gt;â€¢ failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol: Metoprolol is a beta-blocker that is used in the management of CHF. It reduces myocardial oxygen demand and can improve survival in patients with heart failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoprolol:&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ CHF.&lt;/li&gt;&lt;li&gt;â€¢ reduces myocardial oxygen demand&lt;/li&gt;&lt;li&gt;â€¢ improve survival in patients with heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most like:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Quinidine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/image-2-min.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lignocaine: Lignocaine (Lidocaine) is a Class IB antiarrhythmic drug that primarily works by shortening the action potential duration by blocking sodium channels , particularly in ischemic or depolarized cells . It does not prolong the action potential plateau.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ Class IB antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ shortening the action potential&lt;/li&gt;&lt;li&gt;â€¢ blocking sodium channels&lt;/li&gt;&lt;li&gt;â€¢ ischemic or depolarized cells&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action&lt;/li&gt;&lt;li&gt;â€¢ potential plateau.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Propranolol: Propranolol is a Class II antiarrhythmic , which is a beta-blocker that reduces sympathetic nervous system activity. It does not have a direct effect on the action potential duration or plateau phase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Propranolol:&lt;/li&gt;&lt;li&gt;â€¢ Class II antiarrhythmic&lt;/li&gt;&lt;li&gt;â€¢ beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ sympathetic nervous system&lt;/li&gt;&lt;li&gt;â€¢ activity.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action potential duration or plateau phase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Encainide: Encainide , which is no longer widely used, was a Class IC antiarrhythmic drug that significantly slows conduction by blocking sodium channels but does not typically prolong the action potential duration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Encainide:&lt;/li&gt;&lt;li&gt;â€¢ Encainide&lt;/li&gt;&lt;li&gt;â€¢ no longer widely used,&lt;/li&gt;&lt;li&gt;â€¢ Class IC antiarrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ blocking sodium channels&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ action potential duration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the electrophysiologic effects of antiarrhythmic drugs on the cardiac action potential. Understanding how these drugs affect the action potential can provide insights into their therapeutic uses and potential arrhythmogenic risks. Quinidine&#x27;s effect of prolonging the action potential duration is useful in the treatment of both atrial and ventricular arrhythmias, but it also carries the risk of proarrhythmia, underlining the need for careful patient selection and monitoring.&lt;/li&gt;&lt;li&gt;âž¤ electrophysiologic effects of antiarrhythmic drugs&lt;/li&gt;&lt;li&gt;âž¤ action potential&lt;/li&gt;&lt;li&gt;âž¤ therapeutic uses and potential&lt;/li&gt;&lt;li&gt;âž¤ arrhythmogenic risks. Quinidine&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ prolonging the action potential duration&lt;/li&gt;&lt;li&gt;âž¤ both atrial and&lt;/li&gt;&lt;li&gt;âž¤ ventricular arrhythmias,&lt;/li&gt;&lt;li&gt;âž¤ risk of proarrhythmia,&lt;/li&gt;&lt;li&gt;âž¤ careful patient selection&lt;/li&gt;&lt;li&gt;âž¤ monitoring.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was taking verapamil for PSVT prophylaxis. He was given propranolol for treatment of essential tremors. This combination can result in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia with AV block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Torsades de pointes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia with AV block&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bradycardia with AV block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation is not the most likely outcome of adding verapamil to propranolol therapy, although verapamil is sometimes used to control ventricular rate in patients with atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial fibrillation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ outcome&lt;/li&gt;&lt;li&gt;â€¢ verapamil to propranolol&lt;/li&gt;&lt;li&gt;â€¢ verapamil is&lt;/li&gt;&lt;li&gt;â€¢ to control ventricular rate&lt;/li&gt;&lt;li&gt;â€¢ atrial fibrillation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Torsadesâ€™ de pointes is a specific type of ventricular tachycardia often associated with a prolonged QT interval , which is not a typical side effect of either propranolol or verapamil.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Torsadesâ€™&lt;/li&gt;&lt;li&gt;â€¢ specific type of ventricular tachycardia&lt;/li&gt;&lt;li&gt;â€¢ prolonged QT interval&lt;/li&gt;&lt;li&gt;â€¢ not a typical side effect&lt;/li&gt;&lt;li&gt;â€¢ propranolol or verapamil.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachycardia , or increased heart rate , would be unlikely as both drug s work to slow the heart rate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachycardia&lt;/li&gt;&lt;li&gt;â€¢ increased heart rate&lt;/li&gt;&lt;li&gt;â€¢ unlikely as both drug&lt;/li&gt;&lt;li&gt;â€¢ slow the heart rate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Therefore, the most appropriate answer in the context of this clinical scenario is B. Bradycardia with AV block, considering the pharmacological actions of both propranolol and verapamil and the symptoms reported by the patient.&lt;/li&gt;&lt;li&gt;âž¤ B. Bradycardia&lt;/li&gt;&lt;li&gt;âž¤ AV block,&lt;/li&gt;&lt;li&gt;âž¤ pharmacological actions of both propranolol and verapamil&lt;/li&gt;&lt;li&gt;âž¤ symptoms&lt;/li&gt;&lt;li&gt;âž¤ Ref: KDT 8th/160&lt;/li&gt;&lt;li&gt;âž¤ Ref: KDT 8th/160&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following thiazide diuretic is active even if the GFR is 30-40 ml/min?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metolazone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chlorthalidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benz thiazide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Metolazone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Metolazone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chlorothiazide : Chlorothiazide is a thiazide diuretic that is generally less effective in patients with significantly reduced GFR, as its effectiveness is diminished when the GFR falls below approximately 30-40 ml/min.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chlorothiazide&lt;/li&gt;&lt;li&gt;â€¢ Chlorothiazide&lt;/li&gt;&lt;li&gt;â€¢ thiazide diuretic&lt;/li&gt;&lt;li&gt;â€¢ less effective&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ GFR,&lt;/li&gt;&lt;li&gt;â€¢ diminished&lt;/li&gt;&lt;li&gt;â€¢ GFR falls below approximately 30-40 ml/min.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chlorthalidone : Chlorthalidone is another thiazide-like diuretic that is more effective than traditional thiazides in patients with higher GFRs but may not be as effective as metolazone in patients with severely reduced renal function.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chlorthalidone&lt;/li&gt;&lt;li&gt;â€¢ Chlorthalidone&lt;/li&gt;&lt;li&gt;â€¢ thiazide-like diuretic&lt;/li&gt;&lt;li&gt;â€¢ more effective than traditional thiazides&lt;/li&gt;&lt;li&gt;â€¢ higher GFRs&lt;/li&gt;&lt;li&gt;â€¢ not be as effective as metolazone&lt;/li&gt;&lt;li&gt;â€¢ severely reduced renal function.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Benzthiazide : Similar to chlorothiazide and chlorthalidone, benzthiazide is a thiazide diuretic that typically requires a relatively normal renal function to be effective, and its efficacy may be reduced in patients with significant renal impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Benzthiazide&lt;/li&gt;&lt;li&gt;â€¢ chlorothiazide&lt;/li&gt;&lt;li&gt;â€¢ benzthiazide is a thiazide diuretic&lt;/li&gt;&lt;li&gt;â€¢ relatively normal renal function&lt;/li&gt;&lt;li&gt;â€¢ effective,&lt;/li&gt;&lt;li&gt;â€¢ its efficacy&lt;/li&gt;&lt;li&gt;â€¢ reduced in patients&lt;/li&gt;&lt;li&gt;â€¢ renal impairment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the importance of choosing the appropriate diuretic based on the patient&#x27;s renal function. Metolazone is effective even in patients with reduced GFR, such as 30-40 ml/min , making it a valuable option for managing fluid retention in patients with chronic kidney disease or heart failure where other thiazide diuretics might be less effective. This highlights the need for careful selection of diuretics to ensure efficacy and avoid adverse outcomes in patients with varying degrees of renal function.&lt;/li&gt;&lt;li&gt;âž¤ appropriate diuretic based on the patient&#x27;s renal function.&lt;/li&gt;&lt;li&gt;âž¤ Metolazone is effective&lt;/li&gt;&lt;li&gt;âž¤ reduced GFR, such as 30-40 ml/min&lt;/li&gt;&lt;li&gt;âž¤ fluid retention&lt;/li&gt;&lt;li&gt;âž¤ chronic kidney disease or heart failure&lt;/li&gt;&lt;li&gt;âž¤ other thiazide diuretics&lt;/li&gt;&lt;li&gt;âž¤ less&lt;/li&gt;&lt;li&gt;âž¤ effective.&lt;/li&gt;&lt;li&gt;âž¤ highlights&lt;/li&gt;&lt;li&gt;âž¤ careful selection of diuretics&lt;/li&gt;&lt;li&gt;âž¤ avoid adverse&lt;/li&gt;&lt;li&gt;âž¤ varying degrees of renal function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for central diabetes Insipidus is. â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desmopressin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leuprolide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Desmopressin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/01/picture1_dSWDtRK.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Desmopressin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Leuprolide : Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist used in the treatment of hormone-sensitive conditions like prostate cancer, endometriosis, and uterine fibroids. It is not used in the treatment of diabetes insipidus as it does not influence ADH secretion or action.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Leuprolide&lt;/li&gt;&lt;li&gt;â€¢ gonadotropin-releasing hormone (GnRH) agonist&lt;/li&gt;&lt;li&gt;â€¢ hormone-sensitive&lt;/li&gt;&lt;li&gt;â€¢ prostate cancer, endometriosis, and uterine fibroids.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ diabetes insipidus&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ADH secretion or action.&lt;/li&gt;&lt;li&gt;â€¢ Option C . Thiazide Diuretics : Thiazide diuretics are used in the treatment of both nephrogenic diabetes insipidus (a form of the condition caused by the kidneys&#x27; inability to respond to ADH) as well as central (neurogenic) diabetes insipidus. They are drug of choice for nephrogenic diabetes insipidus but not central diabetes insipidus. Thiazides reduce urine volume in diabetes insipidus by increasing water absorption in the distal tubules of the kidney, but they do not address the lack of ADH production in central diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Thiazide Diuretics&lt;/li&gt;&lt;li&gt;â€¢ both nephrogenic diabetes insipidus&lt;/li&gt;&lt;li&gt;â€¢ kidneys&#x27; inability to respond to ADH)&lt;/li&gt;&lt;li&gt;â€¢ central (neurogenic) diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ choice for nephrogenic diabetes insipidus&lt;/li&gt;&lt;li&gt;â€¢ not central diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ reduce urine volume&lt;/li&gt;&lt;li&gt;â€¢ increasing water absorption in the distal tubules&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ lack of ADH production in central&lt;/li&gt;&lt;li&gt;â€¢ diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ Option D . Insulin : Insulin is used in the treatment of diabetes mellitus, a completely different condition from diabetes insipidus. Diabetes mellitus involves problems with blood sugar control due to insufficient insulin production (Type 1 diabetes) or insulin resistance (Type 2 diabetes) . It does not directly affect the balance of water in the body, nor is it relevant to the treatment of diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Insulin&lt;/li&gt;&lt;li&gt;â€¢ treatment of diabetes mellitus,&lt;/li&gt;&lt;li&gt;â€¢ different&lt;/li&gt;&lt;li&gt;â€¢ from diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ Diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ blood sugar control&lt;/li&gt;&lt;li&gt;â€¢ insufficient insulin production (Type 1 diabetes)&lt;/li&gt;&lt;li&gt;â€¢ insulin&lt;/li&gt;&lt;li&gt;â€¢ resistance (Type 2 diabetes)&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ balance of water in the body, nor&lt;/li&gt;&lt;li&gt;â€¢ treatment&lt;/li&gt;&lt;li&gt;â€¢ diabetes insipidus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the mechanism shown in figure. Drug X is likely to be?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exenatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pramlintide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vildagliptin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vildagliptin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture18.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vildagliptin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Canagliflozin is incorrect because it is an SGLT-2 inhibitor, which promotes glucosuria by preventing glucose reabsorption in the renal tubules, which is unrelated to the DPP-4 inhibition pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Canagliflozin&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ SGLT-2 inhibitor,&lt;/li&gt;&lt;li&gt;â€¢ glucosuria&lt;/li&gt;&lt;li&gt;â€¢ preventing glucose reabsorption&lt;/li&gt;&lt;li&gt;â€¢ in the renal tubules,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exenatide is incorrect because it is a GLP-1 analogu e that mimics the action of GLP-1 to stimulate insulin release but does not inhibit DPP-4.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Exenatide&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ GLP-1 analogu&lt;/li&gt;&lt;li&gt;â€¢ action of GLP-1 to stimulate insulin release&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pramlintide is incorrect because it is an amylin analogue , which has a different mechanism of action involving the modulation of gastric emptying and promotion of satiety; it does not inhibit DPP-4.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Pramlintide&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ amylin analogue&lt;/li&gt;&lt;li&gt;â€¢ modulation of gastric emptying and promotion of satiety;&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vildagliptin is a DPP-4 inhibitor that enhances the action of incretins by preventing the breakdown of active GLP-1, leading to increased insulin release and decreased glucagon release , which helps to control blood glucose levels in diabetes mellitus.&lt;/li&gt;&lt;li&gt;âž¤ Vildagliptin&lt;/li&gt;&lt;li&gt;âž¤ DPP-4 inhibitor&lt;/li&gt;&lt;li&gt;âž¤ incretins by preventing the breakdown of active GLP-1,&lt;/li&gt;&lt;li&gt;âž¤ increased insulin release and decreased glucagon release&lt;/li&gt;&lt;li&gt;âž¤ control blood glucose levels&lt;/li&gt;&lt;li&gt;âž¤ diabetes mellitus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The oral contraceptives shown in the figure are.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monophasic combined OCPs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic combined OCPs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Triphasic combined OCPs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emergency pills&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Monophasic combined OCPs&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture19.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Monophasic combined OCPs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Biphasic pills will have three colors. The first 10 tablets with less content of E+P, the next 11 tablets of different color containing higher amounts of hormones and last 7 tablets of different color that contain only iron.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Biphasic pills will have three colors.&lt;/li&gt;&lt;li&gt;â€¢ first 10 tablets&lt;/li&gt;&lt;li&gt;â€¢ less content of E+P,&lt;/li&gt;&lt;li&gt;â€¢ 11 tablets of different color&lt;/li&gt;&lt;li&gt;â€¢ higher amounts of hormones&lt;/li&gt;&lt;li&gt;â€¢ 7 tablets of different color&lt;/li&gt;&lt;li&gt;â€¢ iron.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Triphasic pills will have four colors. First 6 tablets, 6-10 tablets, 11-21 tablets and last 7 tablets of different color.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Triphasic pills will have four colors.&lt;/li&gt;&lt;li&gt;â€¢ First 6 tablets, 6-10 tablets, 11-21 tablets and last 7 tablets&lt;/li&gt;&lt;li&gt;â€¢ different color.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Emergency pills are incorrect because emergency contraception is not presented in a 28-day format but rather as a one-time dose or a short series of pills intended for immediate use after unprotected sex.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;li&gt;â€¢ Emergency pills&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ emergency contraception&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ 28-day&lt;/li&gt;&lt;li&gt;â€¢ one-time dose&lt;/li&gt;&lt;li&gt;â€¢ short series of pills&lt;/li&gt;&lt;li&gt;â€¢ immediate use after unprotected sex.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Monophasic combined OCPs consist of 21 active pills with a consistent dose of estrogen and progesterone , followed by 7 non-hormonal (iron) pills, and are represented in a pack with two colorsâ€”21 of one color and 7 of another, not to be confused with biphasic or triphasic pills which have varying hormone dosages and more color variation.&lt;/li&gt;&lt;li&gt;âž¤ Monophasic combined OCPs&lt;/li&gt;&lt;li&gt;âž¤ 21 active pills&lt;/li&gt;&lt;li&gt;âž¤ estrogen and progesterone&lt;/li&gt;&lt;li&gt;âž¤ 7 non-hormonal (iron) pills,&lt;/li&gt;&lt;li&gt;âž¤ two colorsâ€”21 of one color&lt;/li&gt;&lt;li&gt;âž¤ 7 of another,&lt;/li&gt;&lt;li&gt;âž¤ biphasic or triphasic pills&lt;/li&gt;&lt;li&gt;âž¤ varying hormone dosages and more color variation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications is commonly used to promote abstinence in patients with alcohol use disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acamprosate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bupropion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methadone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Naloxone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acamprosate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acamprosate.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Parkinsonism developed this condition after treatment. Which of the following agents could be the causative agent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amantadine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trihexyphenidyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Selegiline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Amantadine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Amantadine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Levodopa : While levodopa is the most effective medication for the management of Parkinson&#x27;s disease symptoms, it is not commonly associated with skin changes like those depicted in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Levodopa&lt;/li&gt;&lt;li&gt;â€¢ most effective&lt;/li&gt;&lt;li&gt;â€¢ Parkinson&#x27;s disease symptoms,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ skin changes&lt;/li&gt;&lt;li&gt;â€¢ depicted in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Trihexyphenidyl : An anticholinergic drug used to treat Parkinsonism, but it is not typically linked with the skin condition shown.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Trihexyphenidyl&lt;/li&gt;&lt;li&gt;â€¢ anticholinergic drug&lt;/li&gt;&lt;li&gt;â€¢ treat Parkinsonism,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ linked with the skin condition&lt;/li&gt;&lt;li&gt;â€¢ shown.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Selegiline : An MAO-B inhibitor used to help control the symptoms of Parkinson&#x27;s disease . It also does not commonly cause the skin changes seen in the image .&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Selegiline&lt;/li&gt;&lt;li&gt;â€¢ MAO-B inhibitor&lt;/li&gt;&lt;li&gt;â€¢ symptoms of Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ skin changes seen in the image&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the side effects associated with medications used in the treatment of Parkinson&#x27;s disease . Amantadine can cause livedo reticularis , which is characterized by a purplish, mottled skin discoloration.&lt;/li&gt;&lt;li&gt;âž¤ side effects&lt;/li&gt;&lt;li&gt;âž¤ medications&lt;/li&gt;&lt;li&gt;âž¤ treatment of Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ Amantadine&lt;/li&gt;&lt;li&gt;âž¤ cause livedo reticularis&lt;/li&gt;&lt;li&gt;âž¤ purplish, mottled skin discoloration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which antiepileptic drug can cause this adverse effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Phenytoin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture7.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Phenytoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carbamazepine : While carbamazepine can have several side effects, it is not typically associated with gingival hyperplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phenobarbitone : Phenobarbitone (phenobarbital), another antiepileptic drug, also does not commonly cause gingival hyperplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ Option D. Valproate : Valproate does not typically cause gingival hyperplasia as a side effect.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Valproate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to recognize the side effects associated with antiepileptic drugs, particularly phenytoin, which is known to cause gingival hyperplasia. Healthcare providers should monitor patients on phenytoin for this condition and educate them about maintaining good oral hygiene to help prevent or minimize this adverse effect.&lt;/li&gt;&lt;li&gt;âž¤ Drugs causing gum hypertrophy are:&lt;/li&gt;&lt;li&gt;âž¤ Drugs causing gum hypertrophy are:&lt;/li&gt;&lt;li&gt;âž¤ Phenytoin Cyclosporine Calcium channel blockers like verapamil, diltiazem and nifedipine&lt;/li&gt;&lt;li&gt;âž¤ Phenytoin&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Calcium channel blockers like verapamil, diltiazem and nifedipine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received procaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroprocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mepivacaine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mepivacaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mepivacaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Benzocaine: Incorrect , as it is an ester local anesthetic like procaine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Benzocaine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloroprocaine: Incorrect, another ester local anesthetic.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloroprocaine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cocaine: Incorrect , also an ester local anesthetic and has additional significant side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cocaine:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients allergic to ester local anesthetics , amide local anesthetics lik e mepivacaine are preferred due to their different metabolic pathways , reducing the risk of allergic reactions.&lt;/li&gt;&lt;li&gt;âž¤ allergic to ester local anesthetics&lt;/li&gt;&lt;li&gt;âž¤ amide local anesthetics&lt;/li&gt;&lt;li&gt;âž¤ e mepivacaine&lt;/li&gt;&lt;li&gt;âž¤ metabolic pathways&lt;/li&gt;&lt;li&gt;âž¤ reducing&lt;/li&gt;&lt;li&gt;âž¤ allergic reactions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anticoagulant therapy needs regular monitoring?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Argatroban&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fondaparinux&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Argatroban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Argatroban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enoxaparin: Enoxaparin is a low molecular weight heparin (LMWH) used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). While it has a mor e predictable dose-response relationship compared to unfractionated heparin , routine laboratory monitoring for anticoagulation effect is generally not required in most patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enoxaparin:&lt;/li&gt;&lt;li&gt;â€¢ low molecular weight heparin&lt;/li&gt;&lt;li&gt;â€¢ prevention and treatment of deep vein&lt;/li&gt;&lt;li&gt;â€¢ thrombosis (DVT) and pulmonary embolism (PE).&lt;/li&gt;&lt;li&gt;â€¢ mor&lt;/li&gt;&lt;li&gt;â€¢ dose-response&lt;/li&gt;&lt;li&gt;â€¢ unfractionated heparin&lt;/li&gt;&lt;li&gt;â€¢ laboratory monitoring&lt;/li&gt;&lt;li&gt;â€¢ not required in most patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabigatran: Dabigatran is a direct oral anticoagulant (DOAC) that inhibits thrombin. It is used for stroke prevention in non-valvular atrial fibrillation and treatment of DVT and PE, among other indications. Dabigatran offers the advantage of fixed dosing without the need for routine coagulation monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dabigatran:&lt;/li&gt;&lt;li&gt;â€¢ direct oral anticoagulant (DOAC)&lt;/li&gt;&lt;li&gt;â€¢ inhibits thrombin.&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ stroke prevention&lt;/li&gt;&lt;li&gt;â€¢ non-valvular atrial fibrillation&lt;/li&gt;&lt;li&gt;â€¢ treatment of DVT&lt;/li&gt;&lt;li&gt;â€¢ PE,&lt;/li&gt;&lt;li&gt;â€¢ Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ fixed dosing without&lt;/li&gt;&lt;li&gt;â€¢ routine coagulation monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fondaparinux: Fondaparinux is a synthetic pentasaccharide that inhibits factor Xa indirectly by binding to antithrombin . It is used for DVT prevention and treatment and for preventing PE. Like LMWH, fondaparinux generally does not require routine monitoring due to its predictable pharmacokinetic profile.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fondaparinux:&lt;/li&gt;&lt;li&gt;â€¢ synthetic pentasaccharide&lt;/li&gt;&lt;li&gt;â€¢ inhibits factor Xa indirectly&lt;/li&gt;&lt;li&gt;â€¢ binding to antithrombin&lt;/li&gt;&lt;li&gt;â€¢ DVT prevention and treatment&lt;/li&gt;&lt;li&gt;â€¢ preventing PE. Like LMWH, fondaparinux&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ routine&lt;/li&gt;&lt;li&gt;â€¢ monitoring&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand which anticoagulant therapies require regular monitoring and which does not.&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ anticoagulant therapies&lt;/li&gt;&lt;li&gt;âž¤ regular monitoring&lt;/li&gt;&lt;li&gt;âž¤ does not.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man with a long history of asthma is referred to pulmonologist. The physician decides to prescribe zileuton. The mechanism of action of this drug is to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antagonize leukotriene D4 receptor.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits 5-lipoxygenase.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibit phosphodiesteraseâ€™s.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulate beta 2 receptors.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibits 5-lipoxygenase.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inhibits 5- lipoxygenase.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antagonize leukotriene D4 receptor: This is the mechanism of leukotriene receptor antagonists like montelukast and zafirlukast, not zileuton.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antagonize leukotriene D4 receptor:&lt;/li&gt;&lt;li&gt;â€¢ leukotriene receptor antagonists like montelukast and&lt;/li&gt;&lt;li&gt;â€¢ zafirlukast,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibit phosphodiesterase: This is the action of drugs like theophylline, which are used as bronchodilators and anti-inflammatory agents but are unrelated to the mechanism of zileuton.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibit phosphodiesterase:&lt;/li&gt;&lt;li&gt;â€¢ action of drugs&lt;/li&gt;&lt;li&gt;â€¢ theophylline,&lt;/li&gt;&lt;li&gt;â€¢ bronchodilators&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory agents&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stimulate beta 2 receptors: This describes the action of beta-2 agonists such as salbutamol and terbutaline, which are used as rescue inhalers for acute asthma exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stimulate beta 2 receptors:&lt;/li&gt;&lt;li&gt;â€¢ action of beta-2 agonists&lt;/li&gt;&lt;li&gt;â€¢ salbutamol and terbutaline,&lt;/li&gt;&lt;li&gt;â€¢ rescue inhalers for acute asthma exacerbations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zileuton&#x27;s ability to inhibit the 5-lipoxygenase enzyme and thus decrease leukotriene production is vital for its effectiveness in asthma management, targeting a specific part of the inflammatory pathway.&lt;/li&gt;&lt;li&gt;âž¤ Zileuton&#x27;s ability&lt;/li&gt;&lt;li&gt;âž¤ inhibit the 5-lipoxygenase enzyme&lt;/li&gt;&lt;li&gt;âž¤ decrease leukotriene production&lt;/li&gt;&lt;li&gt;âž¤ effectiveness in&lt;/li&gt;&lt;li&gt;âž¤ asthma management,&lt;/li&gt;&lt;li&gt;âž¤ targeting&lt;/li&gt;&lt;li&gt;âž¤ inflammatory pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The mechanism of action of vancomycin is.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of cell wall synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alteration of cell membrane integrity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of protein synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of transcription&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of cell wall synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alteration of cell membrane integrity : Incorrect. Vancomycin&#x27;s action is specific to cell wall synthesis and does not directly involve mechanisms that alter cell membrane integrity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Alteration of cell membrane integrity&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Vancomycin&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ cell wall synthesis&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ alter cell membrane integrity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of protein synthesis : Incorrect. Vancomycin does not interfere with protein synthesis; antibiotics such as tetracyclines and macrolides target this pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Inhibition of protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ protein synthesis;&lt;/li&gt;&lt;li&gt;â€¢ tetracyclines and macrolides&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of transcription : Incorrect. Vancomycin has no known effect on the transcription process within bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Inhibition of transcription&lt;/li&gt;&lt;li&gt;â€¢ : Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ no known effect&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drugs inhibiting cell wall synthesis are:&lt;/li&gt;&lt;li&gt;âž¤ Drugs inhibiting cell wall synthesis are:&lt;/li&gt;&lt;li&gt;âž¤ F irmly: F osfomycin&lt;/li&gt;&lt;li&gt;âž¤ F&lt;/li&gt;&lt;li&gt;âž¤ F&lt;/li&gt;&lt;li&gt;âž¤ B ind to: B eta lactams.&lt;/li&gt;&lt;li&gt;âž¤ B&lt;/li&gt;&lt;li&gt;âž¤ B&lt;/li&gt;&lt;li&gt;âž¤ Bac terial: Bac itracin&lt;/li&gt;&lt;li&gt;âž¤ Bac&lt;/li&gt;&lt;li&gt;âž¤ Bac&lt;/li&gt;&lt;li&gt;âž¤ C ell: C ycloserine&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ Va ll: Va ncomycin&lt;/li&gt;&lt;li&gt;âž¤ Va&lt;/li&gt;&lt;li&gt;âž¤ Va&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The process shown in figure is an important method of transfer of drug resistance in bacteria. This mechanism of horizontal transfer of drug resistance is known as? â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Conjugation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transduction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transformation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transposition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Conjugation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Conjugation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transduction: This is the transfer of genetic material between bacteria by a bacteriophage (a virus that infects bacteria ). If the genetic material contains a resistance gene , the bacterium can incorporate it into its genome and become resistant to the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transduction:&lt;/li&gt;&lt;li&gt;â€¢ genetic material between bacteria by a bacteriophage&lt;/li&gt;&lt;li&gt;â€¢ infects bacteria&lt;/li&gt;&lt;li&gt;â€¢ genetic material contains a resistance gene&lt;/li&gt;&lt;li&gt;â€¢ its genome&lt;/li&gt;&lt;li&gt;â€¢ resistant to the drug.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transformation : This is the uptake of free DNA from the environment by a bacterial cell . If the DNA contains a resistance gene, the bacterium can incorporate it into its genome and become resistant to the drug . It is least common method of horizontal transfer of resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Transformation&lt;/li&gt;&lt;li&gt;â€¢ uptake of free DNA&lt;/li&gt;&lt;li&gt;â€¢ bacterial cell&lt;/li&gt;&lt;li&gt;â€¢ DNA contains&lt;/li&gt;&lt;li&gt;â€¢ resistance&lt;/li&gt;&lt;li&gt;â€¢ gene, the bacterium&lt;/li&gt;&lt;li&gt;â€¢ its genome&lt;/li&gt;&lt;li&gt;â€¢ resistant to the drug&lt;/li&gt;&lt;li&gt;â€¢ least common&lt;/li&gt;&lt;li&gt;â€¢ horizontal&lt;/li&gt;&lt;li&gt;â€¢ transfer of resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transposition: This is the movement of a DNA sequence ( such as a resistance gene) from one location in the genome to another . Transposition occurs due to jumping genes called transposons.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transposition:&lt;/li&gt;&lt;li&gt;â€¢ movement of a DNA sequence (&lt;/li&gt;&lt;li&gt;â€¢ resistance gene)&lt;/li&gt;&lt;li&gt;â€¢ one location in the genome&lt;/li&gt;&lt;li&gt;â€¢ another&lt;/li&gt;&lt;li&gt;â€¢ jumping genes&lt;/li&gt;&lt;li&gt;â€¢ transposons.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Conjugation is a critical pathway for the horizontal transfer of genetic material, such as antibiotic resistance genes , between bacterial cells . This mode of genetic exchange plays a significant role in the spread of resistance in bacterial populations, highlighting the importance of understanding and monitoring antibiotic use to manage the risk of resistant infections.&lt;/li&gt;&lt;li&gt;âž¤ Conjugation&lt;/li&gt;&lt;li&gt;âž¤ horizontal transfer of genetic material,&lt;/li&gt;&lt;li&gt;âž¤ antibiotic resistance genes&lt;/li&gt;&lt;li&gt;âž¤ between&lt;/li&gt;&lt;li&gt;âž¤ bacterial cells&lt;/li&gt;&lt;li&gt;âž¤ mode of genetic exchange&lt;/li&gt;&lt;li&gt;âž¤ spread of resistance in bacterial populations,&lt;/li&gt;&lt;li&gt;âž¤ highlighting the importance of understanding&lt;/li&gt;&lt;li&gt;âž¤ monitoring antibiotic&lt;/li&gt;&lt;li&gt;âž¤ risk of resistant infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with a cough, shortness of breath, and chest pain. Imaging studies reveal a mass in the lung, and a biopsy confirms the diagnosis of carcinoma lung. The patient has a history of chronic obstructive pulmonary disease (COPD) and bronchiectasis. He is currently on bronchodilators, inhaled corticosteroids, and oxygen therapy. The oncologist recommends chemotherapy for the treatment of the cancer. Which of the following drugs should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vinblastine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mithramycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adriamycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bleomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bleomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vinblastine: While Vinblastine can have its own set of side effect s, including bone marrow suppression and neurotoxicity , it does not specifically exacerbate lung conditions like COPD or bronchiectasis, making it a safer option than Bleomycin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vinblastine:&lt;/li&gt;&lt;li&gt;â€¢ side effect&lt;/li&gt;&lt;li&gt;â€¢ bone marrow suppression&lt;/li&gt;&lt;li&gt;â€¢ neurotoxicity&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ exacerbate lung&lt;/li&gt;&lt;li&gt;â€¢ conditions&lt;/li&gt;&lt;li&gt;â€¢ COPD or bronchiectasis,&lt;/li&gt;&lt;li&gt;â€¢ safer&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mithramycin: This drug is used in the treatment of testicular cancer and certain types of hypercalcemia but is less commonly associated with pulmonary complications, making it a potentially safer option for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mithramycin:&lt;/li&gt;&lt;li&gt;â€¢ testicular cancer&lt;/li&gt;&lt;li&gt;â€¢ certain types&lt;/li&gt;&lt;li&gt;â€¢ hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ pulmonary complications,&lt;/li&gt;&lt;li&gt;â€¢ safer option&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adriamycin (Doxorubicin): Adriamycin is known for its cardiotoxicity rather than pulmonary toxicity, and therefore, it does not pose the same specific risk to patients with pre-existing lung diseases as Bleomycin .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adriamycin (Doxorubicin):&lt;/li&gt;&lt;li&gt;â€¢ cardiotoxicity rather than pulmonary toxicity,&lt;/li&gt;&lt;li&gt;â€¢ does not pose&lt;/li&gt;&lt;li&gt;â€¢ risk to patients with pre-existing lung diseases as Bleomycin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with pre-existing lung conditions such as COPD and bronchiectasis, Bleomycin should be avoided due to its potential to cause significant pulmonary toxicity.&lt;/li&gt;&lt;li&gt;âž¤ pre-existing lung&lt;/li&gt;&lt;li&gt;âž¤ COPD and bronchiectasis, Bleomycin&lt;/li&gt;&lt;li&gt;âž¤ avoided&lt;/li&gt;&lt;li&gt;âž¤ potential to&lt;/li&gt;&lt;li&gt;âž¤ pulmonary toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with head and neck cancer was given radiotherapy. After 6 months of radiotherapy, chemotherapy was started but patient presented with the clinical picture as shown after start of chemotherapy. What is the likely drug responsible for this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Doxorubicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carboplatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Doxorubicin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/405.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Doxorubicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carboplatin: While Carboplatin can have a variety of side effects, it is less commonly associated with radiation recall syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Carboplatin:&lt;/li&gt;&lt;li&gt;â€¢ Carboplatin&lt;/li&gt;&lt;li&gt;â€¢ variety of side effects,&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ radiation recall&lt;/li&gt;&lt;li&gt;â€¢ syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Methotrexate: Methotrexate can cause mucositis and skin reactions but is not typically associated with radiation recall.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ mucositis and skin reactions&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ radiation recall.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cetuximab: Cetuximab , a monoclonal antibody targeting EGFR, is associated with skin reactions; however, it is not typically cited as a cause of radiation recall syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cetuximab:&lt;/li&gt;&lt;li&gt;â€¢ Cetuximab&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody targeting EGFR,&lt;/li&gt;&lt;li&gt;â€¢ skin reactions;&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ typically&lt;/li&gt;&lt;li&gt;â€¢ cause of radiation recall syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common drugs associated with RRS are anthracyclines (such a s doxorubicin ), taxanes (such as paclitaxel ), and gemcitabine.&lt;/li&gt;&lt;li&gt;âž¤ The most common drugs associated with RRS are anthracyclines (such a s doxorubicin ), taxanes (such as paclitaxel ), and gemcitabine.&lt;/li&gt;&lt;li&gt;âž¤ most common drugs&lt;/li&gt;&lt;li&gt;âž¤ RRS are anthracyclines&lt;/li&gt;&lt;li&gt;âž¤ s doxorubicin&lt;/li&gt;&lt;li&gt;âž¤ taxanes&lt;/li&gt;&lt;li&gt;âž¤ paclitaxel&lt;/li&gt;&lt;li&gt;âž¤ gemcitabine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female has presented to the OPD with burning sensation during urination, increased frequency and urgency. Which of the following fluoroquinolones is unlikely to be effective in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pefloxacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levofloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pefloxacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pefloxacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male patient on anti-cancer therapy for prostate carcinoma presents with sore throat. The hemogram was ordered which shows the following values: Hb: 13 g/dL TLC: 2000/mm 3. RBC count: 5 million cells/microL Platelet count: 2,50,000 cells/microL If the condition is assumed to be due to anticancer drugs, which of the following drug is most likely to be effective in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Romiplostim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peg-filgrastim&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Darbopoietin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Peg-filgrastim&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Peg-filgrastim&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Propranolol should be avoided in all of the following conditions except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchial asthma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hyperthyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hyperthyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the listed medications are classified as a selective estrogen receptor modulators (SERM) except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clomiphene citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mifepristone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mifepristone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mifepristone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with a unilateral throbbing headache associated with nausea and vomiting. She reports that she had multiple episodes in the past and her headache lasts for 1-2 days. She also says that her headache is aggravated by bright light and is relieved when she sits in a dark room. Which of the following drugs can be used to prevent these episodes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5HT 1B/1D agonists like Sumatriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker like Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSAIDs like diclofenac&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SSRIs like Fluoxetine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Beta blocker like Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Beta blocker like Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer presents to the emergency department with pinpoint pupil, diarrhea, sweating, excessive lacrimation, salivation and muscle weakness. On examination there is bradycardia, BP is 80/60 mm Hg, pulse rate is 56/min and his plasma cholinesterase level was 52 U/mL. Which of the following drug can be effective for reversing the muscle weakness seen in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pralidoxime&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Edrophonium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pralidoxime&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pralidoxime&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A man had just returned from Assam when he developed fever, chills and rigors. The peripheral smear demonstrated the presence of Plasmodium falciparum. What is the treatment of choice for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral Chloroquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral artemether plus lumefantrine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous Artesunate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral artesunate with sulfadoxine-pyrimethamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oral artemether plus lumefantrine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oral artemether plus lumefantrine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements are true about the given dose-response curve EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B is the more efficacious than drug A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B is the most potent drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C is more potent than Drug D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug A is more potent than Drug C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Drug B is the more efficacious than drug A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-171157.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Drug B is the more efficacious than drug A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male went to Leh-Ladakh. He developed shortness of breath. Which of the following drug can be used to prevent mountain sickness at high altitude?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transdermal patch of scopolamine 12-24 hours before journey&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral scopolamine 30 minutes before journey&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral acetazolamide starting 2-3 days before reaching the hilly area&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous dexamethasone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral acetazolamide starting 2-3 days before reaching the hilly area&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oral acetazolamide starting 2-3 days before reaching the hilly area&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 9 young boy was brought to hospital with complaints of few episodes of fast blinking and staring at something for around 20 seconds. EEG shows spike and wave pattern. Which of the following drug should be used for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ethosuximide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ethosuximide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ethosuximide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old patient has developed tuberculosis. On laboratory investigations, the mycobacterium is found to be resistant to rifampicin, isoniazid and levofloxacin but sensitive to pyrazinamide, ethambutol, streptomycin, Bedaquiline and linezolide. This tuberculosis is referred to as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multi drug resistant TB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin resistant TB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pre- Extensive drug resistant TB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Extensive drug resistant TB&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pre- Extensive drug resistant TB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-171927.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pre-Extensive drug resistant TB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient who has just recovered from COVID-19 infection visits your OPD with black discoloration material in nose and posterior part of buccal cavity. He also gives history of using high dose steroid therapy during his treatment of COVID-19. Which of the following is most suitable oral drug for treatment of this organism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Itraconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Posaconazole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Posaconazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Posaconazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs does not reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Valsartan plus Sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Telmisartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Furosemide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Furosemide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male patient with the history of schizophrenia and on treatment for drug-induced Parkinsonism presents with complaints of constipation, blurred vision and dry mouth. Which of the following drugs may be responsible for the above symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pramipexole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Benzhexol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levo-dopa plus carbidopa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Benzhexol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Benzhexol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug acts at the site marked by arrow as shown in the diagram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Remikiren&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ramipril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repaglinide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rosiglitazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Remikiren&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-172655.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Remikiren&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is most appropriate regarding mechanism of action of enoxaparin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts as a calcium chelator and reduces the availability of calcium in coagulation pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It acts as a Vitamin K inhibitor that leads to inhibition of activation of clotting factors 2,7,9 and 10&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It inhibits tissue plasminogen activator resulting in stoppage of conversion of plasminogen to plasmin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Enoxaparin, a low molecular weight heparin, functions by binding to and activating antithrombin III. This accelerates the inactivation of thrombin and Factor Xa, thereby inhibiting the coagulation cascade and preventing clot formation. Understanding the specific mechanisms of action of different anticoagulants is crucial for their appropriate clinical use and for managing patients effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diuretic acts on the site Y shown in the figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spironolactone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-173120.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs undergoes Hoffmanâ€™s degradation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atracurium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mivacurium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vecuronium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atracurium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Atracurium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mivacurium: Mivacurium is metabolized by plasma cholinesterase, not through Hoffman&#x27;s degradation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Mivacurium:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancuronium: Pancuronium is primarily metabolized by the liver and excreted by the kidneys, not by Hoffman&#x27;s degradation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancuronium:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vecuronium: Vecuronium is also metabolized by the liver and excreted by the kidneys, and does not undergo Hoffmanâ€™s degradation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vecuronium:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following adverse effects is least likely to be seen after few years of using risperidone therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperprolactinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetes insipidus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tardive dyskinesia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diabetes insipidus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diabetes insipidus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obesity : Risperidone, like other atypical antipsychotics, is associated with weight gain, which can lead to obesity. This side effect is due to its impact on metabolism and appetite regulation, often seen with prolonged use.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obesity&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperprolactinemia : Risperidone is known to cause an increase in prolactin levels because it blocks dopamine D2 receptors in the tuberoinfundibular pathway. This can lead to hyperprolactinemia, resulting in symptoms such as galactorrhea, gynecomastia, and menstrual disturbances.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperprolactinemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tardive dyskinesia : Tardive dyskinesia is a serious and often irreversible side effect of long-term antipsychotic use, including risperidone. It involves involuntary, repetitive movements, especially of the face and tongue. While less common with atypical antipsychotics compared to typical ones, it is still a potential risk with prolonged therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tardive dyskinesia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risperidone, an atypical antipsychotic, has several long-term adverse effects, including obesity, hyperprolactinemia, and tardive dyskinesia. However, diabetes insipidus is not associated with risperidone use, making it the least likely adverse effect after years of therapy. Understanding the potential long-term side effects of antipsychotic medications is essential for monitoring and managing patients effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An HIV positive female is taking antiretroviral therapy and is well controlled. She has delivered a baby. What should be the initial treatment for the newborn to prevent vertical transmission?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nevirapine + Zidovudine for 6 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nevirapine for 6 weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nevirapine + Zidovudine for 6 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Zidovudine for 6 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Nevirapine for 6 weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-174039.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Nevirapine for 6 weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nevirapine + Zidovudine for 6 weeks : This regimen is typically recommended for infants whose mothers did not receive adequate ART during pregnancy or if the mother&#x27;s viral load was not well controlled near delivery. In such cases, combination therapy provides broader coverage to reduce the risk of transmission.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nevirapine + Zidovudine for 6 weeks&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nevirapine + Zidovudine for 6 months : Six months of combination therapy is excessive and not in line with standard guidelines. The recommended duration is typically 4 to 6 weeks for adequate prophylaxis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nevirapine + Zidovudine for 6 months&lt;/li&gt;&lt;li&gt;â€¢ Option D. Zidovudine for 6 months : zidovudine for 6 months is not the standard prophylaxis for newborns when the mother is well-controlled on ART.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Zidovudine for 6 months&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For newborns of HIV-positive mothers who are well-controlled on ART, the appropriate initial prophylaxis to prevent vertical transmission is Zidovudine for 6 weeks. This regimen is effective in reducing transmission risk when maternal viral load is suppressed. It&#x27;s important to follow guidelines that consider the maternal ART status to ensure optimal care for the newborn.&lt;/li&gt;&lt;li&gt;âž¤ Prevention of vertical transmission&lt;/li&gt;&lt;li&gt;âž¤ Prevention of vertical transmission&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female presented to your morning OPD on 11 th June 2024. She reported that she went to a club on 6 th June and after that she had unprotected sexual intercourse that night. She fears getting pregnant. What is the contraceptive of choice in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Combined oral contraceptives&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Levonorgestrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mifepristone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ulipristal&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ulipristal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ulipristal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Combined oral contraceptives : Combined oral contraceptives (COCs) can be used for emergency contraception but they need to be taken within 72 hours (3 days) of unprotected intercourse to be effective, which is beyond the time frame in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Combined oral contraceptives&lt;/li&gt;&lt;li&gt;â€¢ Option B. Levonorgestrel : Levonorgestrel is another commonly used emergency contraceptive. However, it is most effective when taken within 72 hours (3 days) after unprotected sex.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Levonorgestrel&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mifepristone : Mifepristone can be effective in higher doses for emergency contraception. Further it needs to be taken within 72 hours of unprotected intercourse.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mifepristone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ulipristal is the preferred emergency contraceptive for use up to 120 hours (5 days) after unprotected intercourse. In cases where unprotected intercourse occurred more than 72 hours but less than 120 hours prior, Ulipristal is more effective than Levonorgestrel and other methods. Understanding the time frames and efficacy of different emergency contraceptives is crucial for providing appropriate care and advice to patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an adverse effect that is associated with the use of amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Red man syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gynaecomastia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pulmonary fibrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Red man syndrome : Red man syndrome is associated with the rapid infusion of vancomycin, an antibiotic, and not with amiodarone. It is characterized by flushing, rash, and sometimes hypotension due to histamine release.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Red man syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tachycardia : Tachycardia is not a typical adverse effect of amiodarone. In fact, amiodarone is used to treat tachyarrhythmias. Some antiarrhythmics can cause arrhythmias as a side effect (proarrhythmia), but amiodarone is more commonly associated with bradycardia (slow heart rate) rather than tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tachycardia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gynaecomastia : Gynaecomastia, the development of breast tissue in men, is a side effect associated with certain medications, such as some anti-androgens and spironolactone. While amiodarone can cause a variety of endocrine disturbances, gynaecomastia is not a common adverse effect.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gynaecomastia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone is an effective antiarrhythmic drug but has a range of potential adverse effects, with pulmonary fibrosis being one of the most serious. It is essential for healthcare providers to monitor patients on amiodarone for signs of lung toxicity and other side effects, ensuring timely intervention to prevent severe complications.&lt;/li&gt;&lt;li&gt;âž¤ Adverse Effects of Amiodarone can be remembered as:&lt;/li&gt;&lt;li&gt;âž¤ Adverse Effects of Amiodarone can be remembered as:&lt;/li&gt;&lt;li&gt;âž¤ Th e: Th yroid problems (Hyper or hypothyroidism)&lt;/li&gt;&lt;li&gt;âž¤ Th&lt;/li&gt;&lt;li&gt;âž¤ Th&lt;/li&gt;&lt;li&gt;âž¤ Periphery of: Peripheral neuropathy&lt;/li&gt;&lt;li&gt;âž¤ Periphery&lt;/li&gt;&lt;li&gt;âž¤ Peripheral&lt;/li&gt;&lt;li&gt;âž¤ My:                              My ocardial depression&lt;/li&gt;&lt;li&gt;âž¤ My:                              My&lt;/li&gt;&lt;li&gt;âž¤ Lung:                           Lung fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Lung:                           Lung&lt;/li&gt;&lt;li&gt;âž¤ Liver and: Liver damage&lt;/li&gt;&lt;li&gt;âž¤ Liver&lt;/li&gt;&lt;li&gt;âž¤ Liver&lt;/li&gt;&lt;li&gt;âž¤ Cornea is: Corneal deposits&lt;/li&gt;&lt;li&gt;âž¤ Cornea&lt;/li&gt;&lt;li&gt;âž¤ Corneal&lt;/li&gt;&lt;li&gt;âž¤ Photosensitive:           Photosensitivity (Blue man syndrome)&lt;/li&gt;&lt;li&gt;âž¤ Photosensitive:           Photosensitivity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female (in first trimester) who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral methyl dopa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral Telmisartan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral methyl dopa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oral methyl dopa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s consider each option:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s consider each option:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral Labetalol: Labetalol is a beta-blocker with alpha-blocking activity. It is commonly used for hypertension in pregnancy. However, being a beta-blocker, it can potentially exacerbate bronchial asthma by causing bronchoconstriction.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Oral Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intravenous Labetalol: This would be used for more immediate control of severely elevated blood pressure, like in a hypertensive crisis. The same concerns regarding bronchial asthma apply as with oral labetalol.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous Labetalol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral Telmisartan : Telmisartan is an angiotensin II receptor blocker (ARB) and is contraindicated in pregnancy due to the risk of fetal toxicity, including renal dysfunction, oligohydramnios, and skeletal abnormalities. ARBs and ACE inhibitors should be avoided in pregnant women.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oral Telmisartan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When managing hypertension in pregnant women, especially in the first trimester, the safety of both the mother and the fetus is paramount. Methyldopa is the preferred antihypertensive due to its long-standing safety profile in pregnancy. Beta blockers like labetalol although safe in pregnancy but are contra-indicated in bronchial asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old obese female presented with Schizophrenia. Which of the following antipsychotic drug causes maximum weight gain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorpromazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aripiprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ziprasidone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clozapine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Clozapine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chlorpromazine : Chlorpromazine is a typical antipsychotic that can also cause weight gain, but it is generally considered less likely to cause as much weight gain as clozapine. Typical antipsychotics tend to have a different side effect profile compared to atypical antipsychotics.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chlorpromazine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aripiprazole : Aripiprazole is an atypical antipsychotic that is associated with a lower risk of weight gain compared to clozapine and some other atypical antipsychotics. It is often chosen for patients who are concerned about weight gain and metabolic side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aripiprazole&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ziprasidone : Ziprasidone is another atypical antipsychotic with a relatively low risk of weight gain. It is considered weight-neutral or associated with minimal weight gain, making it a suitable option for patients with concerns about obesity and metabolic issues.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ziprasidone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When selecting an antipsychotic medication for patients, especially those who are obese or have metabolic concerns, it is important to consider the potential for weight gain. Clozapine is associated with significant weight gain and may not be the best choice for patients who are already obese. Understanding the side effect profiles of antipsychotic medications helps in making informed decisions to optimize patient care and minimize adverse effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of Schizophrenia was started on antipsychotic drug haloperidol. Few hours later, he presented with torticollis and muscular dystonia. What is the next best step for the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase dose of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Change haloperidol to clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give fluphenzine instead of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Give promethazine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Give promethazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Give promethazine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s assess each option:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s assess each option:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase dose of haloperidol: Increasing the dose of haloperidol is not the appropriate response when a patient develops extrapyramidal symptoms (EPS) such as torticollis and muscular dystonia. It can exacerbate these side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Increase dose of haloperidol:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Change haloperidol to clozapine: Clozapine is an atypical antipsychotic that is less likely to cause EPS compared to typical antipsychotics like haloperidol. Switching to clozapine can be a reasonable option to manage EPS.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Change haloperidol to clozapine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Give fluphenzine instead of haloperidol: Fluphenazine is another typical antipsychotic and is not expected to be significantly different from haloperidol in terms of causing EPS. Switching to fluphenazine may not effectively address the EPS.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Give fluphenzine instead of haloperidol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the preferred drug for treatment of breast cancer in a 43-year-old pre-menopausal female?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anastrozole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tamoxifen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tamoxifen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate : Methotrexate is a chemotherapeutic agent that inhibits dihydrofolate reductase, interfering with DNA synthesis and cell replication. While it is used in some chemotherapy regimens for breast cancer, it is not the preferred first-line treatment for hormone receptor-positive breast cancer in pre-menopausal women.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ Option B. Raloxifene : Raloxifene is another SERM that is used primarily for the prevention and treatment of osteoporosis in post-menopausal women and for the reduction of breast cancer risk in certain high-risk post-menopausal women. It is not typically used for the treatment of breast cancer in pre-menopausal women.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Raloxifene&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anastrozole : Anastrozole is an aromatase inhibitor that reduces estrogen production by inhibiting the enzyme aromatase, which converts androgens to estrogen. Aromatase inhibitors are generally more effective in post-menopausal women because they target peripheral estrogen production. In pre-menopausal women, ovarian estrogen production remains active, making aromatase inhibitors less effective unless combined with ovarian suppression.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anastrozole&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For pre-menopausal women with hormone receptor-positive breast cancer, Tamoxifen is the preferred drug due to its effectiveness in blocking estrogen receptors and reducing the risk of cancer recurrence. Understanding the appropriate use of hormone therapies in breast cancer treatment is essential for optimizing patient outcomes and tailoring therapy to individual patient profiles.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and efavirenz 600 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add lamivudine 300 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add dolutegravir 50 mg in the morning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. No dose adjustment is required&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) No dose adjustment is required&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. What is the reason behind this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Postural hypotension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpha 2 receptor upregulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rebound hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha 2 Receptor hypersensitivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rebound hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rebound hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Postural hypotension : Postural hypotension, or orthostatic hypotension, is a condition where there is a significant drop in blood pressure upon standing up. This condition typically causes dizziness or light headedness rather than headaches and is not directly related to the abrupt cessation of clonidine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Postural hypotension&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alpha 2 receptor upregulation : Prolonged stimulation of Alpha-2 receptors can result in their downregulation (not upregulation). This leads to failure of brakes and excessive release of NA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alpha 2 receptor upregulation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alpha 2 Receptor hypersensitivity : Hypersensitivity of post synaptic alpha-1 and beta-1 receptors is responsible for excessive effect of NA when clonidine is stopped. It results in rebound hypertension. So hypersensitivity of alpha 2 receptor is wrong statement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alpha 2 Receptor hypersensitivity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clonidine is an antihypertensive medication that, when abruptly discontinued, can lead to rebound hypertension due to a sudden increase in sympathetic activity. This can cause symptoms such as headaches, which the patient is experiencing. It is important to taper off clonidine gradually to prevent such adverse effects. Understanding the potential withdrawal effects of medications used in addiction treatment is crucial for preventing complications and ensuring patient safety.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a PCSK9 inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alirocumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bempedoic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clofibrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alirocumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alirocumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ezetimibe : Ezetimibe works by inhibiting the absorption of cholesterol in the small intestine, which leads to a reduction in the total amount of cholesterol presented to the liver. It does not inhibit PCSK9.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bempedoic Acid : Bempedoic acid is a relatively new cholesterol-lowering medication. It inhibits ATP citrate lyase, an enzyme involved in cholesterol synthesis, but it is not a PCSK9 inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bempedoic Acid&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clofibrate : Clofibrate is a fibrate used to lower lipid levels, particularly triglycerides. It works by activating peroxisome proliferator-activated receptors (PPARs) and does not inhibit PCSK9.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clofibrate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old patient with a confirmed diagnosis of severe Alzheimer&#x27;s dementia has shown aversion and non-compliance to oral medications. The health care professional advised to go for a new treatment that is given intravenously once in a month only and can also target the underlying cause of Alzheimerâ€™s disease. Which of the following drug is being suggested by the healthcare provider?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aducanumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rivastigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galantamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aducanumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Aducanumab is a monoclonal antibody that targets amyloid-beta plaques in the brain, which are thought to be a contributing factor in Alzheimer&#x27;s disease. It is administered via intravenous (IV) infusion once a month. This aligns with the patient&#x27;s need for a non-oral medication that can be given less frequently and targets the underlying cause of Alzheimer&#x27;s disease, making it the drug being suggested by the healthcare provider.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Memantine : Memantine is an oral medication used to treat moderate to severe Alzheimer&#x27;s disease by modulating the activity of glutamate, a neurotransmitter involved in learning and memory. It does not target amyloid plaques and is not administered intravenously.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Memantine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rivastigmine : Rivastigmine is an acetylcholinesterase inhibitor used to treat mild to moderate Alzheimer&#x27;s disease. It can be administered orally or via a transdermal patch, but not intravenously. It also does not target amyloid plaques.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rivastigmine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Galantamine : Galantamine is another acetylcholinesterase inhibitor used for mild to moderate Alzheimer&#x27;s disease. It is available in oral formulations and does not target amyloid plaques. It is not administered intravenously.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Galantamine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aducanumab is the only treatment among the options provided that is given intravenously once a month and targets the underlying amyloid-beta plaques associated with Alzheimer&#x27;s disease. This makes it suitable for patients who have difficulty with oral medications and require a treatment that addresses the pathophysiology of the disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs used in treatment of leprosy can result in hyperpigmentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dapsone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clofazimine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Clofazimine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Clofazimine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dapsone:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dapsone:&lt;/li&gt;&lt;li&gt;â€¢ Dapsone is an antibiotic commonly used in the treatment of leprosy. While it has various side effects, hyperpigmentation is not typically associated with dapsone. Common side effects include hemolysis (especially in individuals with G6PD deficiency) and peripheral neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Dapsone is an antibiotic commonly used in the treatment of leprosy. While it has various side effects, hyperpigmentation is not typically associated with dapsone. Common side effects include hemolysis (especially in individuals with G6PD deficiency) and peripheral neuropathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ofloxacin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ofloxacin:&lt;/li&gt;&lt;li&gt;â€¢ Ofloxacin is a fluoroquinolone antibiotic that can be used as part of alternative regimens for leprosy. Hyperpigmentation is not a known side effect of ofloxacin. Its common side effects include gastrointestinal disturbances and tendinitis.&lt;/li&gt;&lt;li&gt;â€¢ Ofloxacin is a fluoroquinolone antibiotic that can be used as part of alternative regimens for leprosy. Hyperpigmentation is not a known side effect of ofloxacin. Its common side effects include gastrointestinal disturbances and tendinitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rifampicin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rifampicin:&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin is another cornerstone drug in the treatment of leprosy. It can cause orange-red discoloration of body fluids (such as urine, sweat, and tears), but it does not typically cause hyperpigmentation of the skin.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin is another cornerstone drug in the treatment of leprosy. It can cause orange-red discoloration of body fluids (such as urine, sweat, and tears), but it does not typically cause hyperpigmentation of the skin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clofazimine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Clofazimine:&lt;/li&gt;&lt;li&gt;â€¢ Clofazimine is known to cause hyperpigmentation of the skin. This drug is used in leprosy treatment for its anti-inflammatory properties and its ability to kill Mycobacterium leprae. Clofazimine can lead to a characteristic reddish-brown to black discoloration of the skin, which can be quite distressing to patients but is usually harmless.&lt;/li&gt;&lt;li&gt;â€¢ Clofazimine is known to cause hyperpigmentation of the skin. This drug is used in leprosy treatment for its anti-inflammatory properties and its ability to kill Mycobacterium leprae. Clofazimine can lead to a characteristic reddish-brown to black discoloration of the skin, which can be quite distressing to patients but is usually harmless.&lt;/li&gt;&lt;li&gt;â€¢ In this case, the patient&#x27;s hyperpigmentation is most likely due to clofazimine. This side effect is well-documented and is a result of the drug accumulating in the skin.&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /833&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /833&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an adverse effect with the long-term use of intermittent teriparatide for treatment of osteoporosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteonecrosis of jaw bone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Osteosarcoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subtrochantric fracture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Loss of bone mass&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Osteosarcoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Osteosarcoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In summary, the most significant potential adverse effect associated with the long-term use of teriparatide is the development of osteosarcoma, albeit this risk is based primarily on animal studies. Therefore, clinicians are advised to limit the duration of teriparatide therapy and monitor patients closely.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Goodman Gilman 13 th /899&lt;/li&gt;&lt;li&gt;âž¤ Ref: Goodman Gilman 13 th /899&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a known allergy to penicillin presents with a enterococcal endocarditis. The physician needs to prescribe an antibiotic but wants to ensure it is safe for a patient with a penicillin allergy. The patient has had previous allergic reactions to penicillin, including rash and swelling. Which of the following drugs can be used safely in a patient allergic to penicillin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aztreonam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Piperacillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs act as HER-2 inhibitor&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Necitumumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pertuzumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Panitumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pertuzumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pertuzumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ HER-2 (Human Epidermal Growth Factor Receptor 2) overactivation is involved in pathogenesis of breast cancer. Trastuzumab and pertuzumab are monoclonal antibodies against her-2/neu and are used in treatment of breast cancer. Oral her-2 inhibitor drug is lapatinib.&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s review each of the listed drugs:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s review each of the listed drugs:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cetuximab : Cetuximab is an EGFR (HER-1) inhibitor used primarily in the treatment of certain types of colorectal cancer and head and neck cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Cetuximab&lt;/li&gt;&lt;li&gt;â€¢ Option B. Necitumumab : Necitumumab is also an EGFR (HER-1) inhibitor, used in the treatment of metastatic squamous non-small cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Necitumumab&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pertuzumab : Pertuzumab is a monoclonal antibody that targets HER-2 (Human Epidermal Growth Factor Receptor 2), not HER-1. It is used primarily in the treatment of HER-2 positive breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Pertuzumab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Panitumumab : Panitumumab is an EGFR (HER-1) inhibitor, used in the treatment of metastatic colorectal cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Panitumumab&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /930&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /930&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male patient underwent surgery under general anaesthesia. Rocuronium was used as a muscle relaxant during the procedure. After the surgery, the patient has not regained muscle function, indicating prolonged muscle paralysis. The medical team needs to reverse the effects of rocuronium quickly to ensure patient safety and recovery. Which of the following can result in the fastest reversal?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sugammadex&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Edrophonium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sugammadex&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sugammadex&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sugammadex :&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Sugammadex&lt;/li&gt;&lt;li&gt;â€¢ Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neostigmine :&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Neostigmine&lt;/li&gt;&lt;li&gt;â€¢ Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.&lt;/li&gt;&lt;li&gt;â€¢ Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Edrophonium :&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Edrophonium&lt;/li&gt;&lt;li&gt;â€¢ Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.&lt;/li&gt;&lt;li&gt;â€¢ Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atropine :&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Atropine&lt;/li&gt;&lt;li&gt;â€¢ Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.&lt;/li&gt;&lt;li&gt;â€¢ Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.&lt;/li&gt;&lt;li&gt;â€¢ In summary, sugammadex is the most effective and fastest-acting agent for reversing the effects of rocuronium, making it the best choice in this clinical scenario.&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /381&lt;/li&gt;&lt;li&gt;â€¢ Ref: KDT 8 th /381&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old pregnant woman at 32 weeks of gestation presents to the obstetric clinic with signs of preterm labor. The medical team decides to administer corticosteroids to promote fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome. Choose the correct option that should be used for fetal lung maturation:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dexamethasone 12 mg 24 hourly 2 doses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dexamethasone 6 mg 12 hourly 4 doses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Betamethasone 12 mg 12 hourly 2 doses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Betamethasone 12 mg 24 hourly 4 doses&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dexamethasone 6 mg 12 hourly 4 doses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dexamethasone 6 mg 12 hourly 4 doses&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for treatment of chemotherapy induced diarrhea is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pantoprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Loperamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Loperamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron : Ondansetron is an antiemetic used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It works by blocking serotonin receptors in the brain and gut. While effective for nausea and vomiting, it is not used to treat diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pantoprazole : Pantoprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production and treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. It is not indicated for the treatment of diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pantoprazole&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dexamethasone : Dexamethasone is a corticosteroid with anti-inflammatory and immunosuppressant properties. It is used in various conditions, including to reduce inflammation and manage chemotherapy-induced nausea and vomiting, but it is not the primary treatment for diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dexamethasone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Loperamide is the preferred medication for managing chemotherapy-induced diarrhea due to its effectiveness in slowing intestinal motility and allowing for better fluid absorption. Understanding the appropriate use of medications for specific side effects of chemotherapy is crucial for optimizing patient care and improving quality of life during treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of antii-obesity drug, orlistat is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SGLT-2 inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lipase inhibition in GIT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GLP-1 receptor agonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5HT2c receptor agonism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lipase inhibition in GIT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lipase inhibition in GIT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. SGLT-2 inhibition: SGLT-2 inhibitors (Sodium-glucose co-transporter-2 inhibitors) work by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This mechanism is primarily used in the management of type 2 diabetes to lower blood sugar levels and has an indirect effect on weight loss due to the loss of calories through urine, but it is not the mechanism of action of orlistat.&lt;/li&gt;&lt;li&gt;â€¢ Option A. SGLT-2 inhibition:&lt;/li&gt;&lt;li&gt;â€¢ Option C. GLP-1 receptor agonism: GLP-1 (Glucagon-like peptide-1) receptor agonists mimic the action of the incretin hormone GLP-1, which increases insulin secretion, suppresses glucagon secretion, and slows gastric emptying. These effects help reduce blood sugar levels and also contribute to weight loss. Drugs like liraglutide and exenatide fall into this category, but this is not the mechanism by which orlistat works.&lt;/li&gt;&lt;li&gt;â€¢ Option C. GLP-1 receptor agonism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5HT2c receptor agonism: 5HT2c receptor agonists, such as lorcaserin, act on serotonin receptors in the brain, promoting a feeling of satiety and reducing appetite. By affecting the central nervous system, they help decrease food intake, leading to weight loss. However, orlistat does not work through this mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5HT2c receptor agonism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Orlistat is an anti-obesity drug that functions by inhibiting gastric and pancreatic lipases, enzymes necessary for the breakdown and absorption of dietary fats. This inhibition results in the excretion of unabsorbed fat, thus reducing caloric intake and promoting weight loss. Understanding the specific mechanisms of action for various weight loss medications is crucial for selecting the appropriate treatment based on individual patient needs and conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female presented to oncologist with breast lump. On examination and investigations, breast cancer was diagnosed. Echocardiography of the patient shows ejection fraction of 25%. Which of the following drug will you avoid in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daunorubicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irinotecan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Daunorubicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Daunorubicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test7" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D   Mission 2.0 (Batch 2)   27 09 2024   2024 09 27&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D   Mission 2.0 (Batch 2)   27 09 2024   2024 09 27&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 52-year-old female patient is undergoing chemotherapy for breast cancer. The oncology team is concerned about the risk of febrile neutropenia due to the chemotherapeutic regimen. They are contemplating the use of a granulocyte colony-stimulating factor (G-CSF) and discuss the option of using pegylated-filgrastim or filgrastim. Which of the following is true about pegylated-filgrastim as compared to filgrastim?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duration of action is longer than filgrastim&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Added advantage is that it can be taken orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pegylated filgrastim is GM-CSF whereas filgrastim is G-CSF.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not effective in the treatment of severe neutropenia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Duration of action is longer than filgrastim&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Duration of action is longer than filgrastim.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male patient is being treated for chronic neuropathic pain with an oral medication. The healthcare team monitors the drug&#x27;s plasma concentration over time. Which parameter on the plasma concentration vs. time graph helps to guide dose adjustments to maximize efficacy without causing toxicity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AUC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;T1/2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cmax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tmax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cmax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cmax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Important points about the PC-T graph:&lt;/li&gt;&lt;li&gt;âž¤ Cmax helps assess peak drug levels for efficacy and toxicity. Tmax indicates the rate of absorption. AUC tells about extent of drug absorption. T1/2 helps determine dosing intervals.&lt;/li&gt;&lt;li&gt;âž¤ Cmax helps assess peak drug levels for efficacy and toxicity.&lt;/li&gt;&lt;li&gt;âž¤ Cmax&lt;/li&gt;&lt;li&gt;âž¤ Tmax indicates the rate of absorption.&lt;/li&gt;&lt;li&gt;âž¤ Tmax&lt;/li&gt;&lt;li&gt;âž¤ AUC tells about extent of drug absorption.&lt;/li&gt;&lt;li&gt;âž¤ AUC&lt;/li&gt;&lt;li&gt;âž¤ T1/2 helps determine dosing intervals.&lt;/li&gt;&lt;li&gt;âž¤ T1/2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Acetylcholine acts through M3 receptor stimulation to cause increase in GI motility whereas adrenaline acts via beta 2 receptors to cause decrease in GI motility. Which type of antagonism it is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pharmacological antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chemical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physiological antagonism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Physiological antagonism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Physiological Antagonism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Physiological antagonism occurs when two drugs act on different receptors or pathways to produce opposite physiological effects, without interacting directly. This is in contrast to pharmacological antagonism , where two drugs compete for the same receptor, and chemical antagonism , where two substances chemically neutralize each other. Understanding the type of antagonism is critical in predicting and managing drug interactions in clinical practice.&lt;/li&gt;&lt;li&gt;âž¤ Physiological antagonism&lt;/li&gt;&lt;li&gt;âž¤ pharmacological antagonism&lt;/li&gt;&lt;li&gt;âž¤ chemical antagonism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition given in the graph?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mixed&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-155752.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-155830.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-155836.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mixed&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a correct match of the adverse effect and mechanism of action of imipramine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sedation - H1 receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dry mouth â€“ M3 Muscarinic receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sexual dysfunctionâ€“ 5HT reuptake inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension â€“ D2 receptor blockade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypotension â€“ D2 receptor blockade&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160013.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypotension â€“ D2 receptor blockade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic response of epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phentolamine epinephrine coupling&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vasomotor reversal of Dale&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vasomotor reversal of Dale&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man who received a kidney transplant three months ago is admitted to the hospital with high-grade fever, malaise, and abdominal discomfort. On examination, he exhibits right upper quadrant tenderness. Lab investigations reveal abnormal liver enzymes, and a blood culture returns positive for cytomegalovirus (CMV). His current immunosuppressive regimen includes tacrolimus. What is the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of calcineurin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blockade of IL-2 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IMP dehydrogenase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dihydro-orotate dehydrogenase inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of calcineurin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of calcineurin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Inhibition of calcineurin: Tacrolimus acts by inhibiting calcineurin, which plays a pivotal role in T-cell activation. This immunosuppressive action can make the patient susceptible to infections such as CMV.&lt;/li&gt;&lt;li&gt;â€¢ B) Blockade of IL-2 receptor: This is a mechanism of other immunosuppressive drugs like basiliximab but not tacrolimus. Therefore, it is not relevant to the patient&#x27;s current condition.&lt;/li&gt;&lt;li&gt;â€¢ C) IMP dehydrogenase inhibition: This is the mechanism of mycophenolate mofetil, another immunosuppressive drug. It is not applicable to tacrolimus.&lt;/li&gt;&lt;li&gt;â€¢ D) Dihydro-orotate dehydrogenase inhibition: This mechanism is associated with drugs like leflunomide but is not relevant to the action of tacrolimus.&lt;/li&gt;&lt;li&gt;â€¢ Thus, the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection is the inhibition of calcineurin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Appearance of eye is as shown in the figure. Which of the following anti-glaucoma drugs is likely to produce this adverse effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brimonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dorzolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Latanoprost&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160127.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Latanoprost.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He recently started on a new medication. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. On testing, plasma levels of digoxin were elevated. Which of the following drugs is most likely responsible for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Quinidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Quinidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drugs like quinidine that inhibit P-glycoprotein can significantly increase the plasma levels of digoxin , leading to toxicity. Classic symptoms of digoxin toxicity include nausea, vomiting, confusion, and visual disturbances (e.g., yellow or blurred vision). Clinicians must be aware of potential drug interactions, particularly with medications affecting renal or hepatic excretion pathways like P-glycoprotein inhibitors. Regular monitoring of digoxin levels is essential when such drugs are co-administered.&lt;/li&gt;&lt;li&gt;âž¤ quinidine&lt;/li&gt;&lt;li&gt;âž¤ P-glycoprotein&lt;/li&gt;&lt;li&gt;âž¤ digoxin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with symptoms of urinary urgency, frequency, and nocturia. He has been diagnosed with overactive bladder. On further questioning, the patients tells that he forgets the things easily and is on rivastigmine therapy for the same. Which of the following drugs is a beta-3 adrenergic receptor agonist that is effective in treating this patient&#x27;s symptoms without interfering with treatment of his dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tolterodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vibegron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levetiracetam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vibegron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients with overactive bladder who are also being treated for dementia , it is important to avoid antimuscarinic agents like tolterodine due to their cognitive side effects. Beta-3 adrenergic receptor agonists like vibegron are effective alternatives that increase bladder capacity without interfering with cholinergic medications like rivastigmine, thus preserving cognitive function.&lt;/li&gt;&lt;li&gt;âž¤ overactive bladder&lt;/li&gt;&lt;li&gt;âž¤ dementia&lt;/li&gt;&lt;li&gt;âž¤ tolterodine&lt;/li&gt;&lt;li&gt;âž¤ Beta-3 adrenergic receptor agonists&lt;/li&gt;&lt;li&gt;âž¤ vibegron&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following table gives the data of AUC of drug A alone and AUC of drug A when combined with drug B. p value is &amp;lt;0.01. Which of the following statement regarding these drugs is most correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B decreases the first pass metabolism of drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B decreases the systemic metabolism of drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug B decreases the intestinal absorption of drug A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug B decreases the renal clearance of drug A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug B decreases the intestinal absorption of drug A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160441_L3vs8N9.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Drug B decreases the intestinal absorption of drug A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The AUC represents the total drug exposure over time and is influenced by absorption, distribution, metabolism, and elimination. A significant reduction in AUC, as observed when drug A is combined with drug B, suggests that drug B is likely interfering with the absorption of drug A. When evaluating drug interactions, itâ€™s important to consider the mechanism of action (e.g., effects on absorption, metabolism, or excretion) to optimize therapeutic regimens and avoid suboptimal drug levels or adverse effects.&lt;/li&gt;&lt;li&gt;âž¤ AUC&lt;/li&gt;&lt;li&gt;âž¤ absorption&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old, insulin-dependent diabetic patient is diagnosed with migraine and begins therapy with a drug to prevent further attacks of migraine. Three days later, he measures his blood glucose at home and finds that it is 53 mg/dL. He recalibrates his glucose testing apparatus and repeats the test, only to find that the first reading was accurate. He is concerned that his hypoglycemia did not produce the normal premonitory signs and symptoms. Which of the following medications was most likely prescribed to him?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sumatriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lasmiditan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ubrogepant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propranolol , a non-selective beta-blocker, is often used for migraine prophylaxis but can mask the signs of hypoglycemia in diabetic patients by blunting the sympathetic nervous system&#x27;s response. This makes it challenging for patients to detect low blood sugar, as the typical warning signs are reduced. In managing diabetic patients who require beta-blocker therapy, close monitoring of blood glucose levels is essential to avoid hypoglycemia unawareness.&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Na channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac K channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-adrenoceptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-adrenoceptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-adrenoceptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Beta-adrenoceptors.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metformin is least likely to reduce blood sugar in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obese diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-diabetics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2 diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetics not respond to sulfonylureas.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-diabetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Non-diabetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old postmenopausal woman with a history of osteoporosis is being evaluated for potential pharmacological treatments to strengthen her bones. She has tried lifestyle modifications, including weight-bearing exercises and calcium supplements, with limited improvement. Her physician is considering various pharmacological agents to inhibit osteoclastic activity and thereby prevent further bone loss. Which of the following medications does NOT primarily act by inhibiting osteoclasts?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Teriparatide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Teriparatide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ a) Denosumab: This is a monoclonal antibody that inhibits the RANKL (Receptor Activator for Nuclear Factor Îº B Ligand), which is essential for the formation and function of osteoclasts. Thus, it inhibits osteoclast activity.&lt;/li&gt;&lt;li&gt;â€¢ b) Strontium ranelate: This drug is used in the treatment of osteoporosis and works by both promoting bone formation and inhibiting bone resorption. It is thought to inhibit osteoclasts, although the exact mechanism is not well understood.&lt;/li&gt;&lt;li&gt;â€¢ c) Teriparatide: This is the correct answer. Teriparatide is a recombinant form of parathyroid hormone. It is actually an anabolic (bone-building) agent that stimulates osteoblast activity, rather than inhibiting osteoclasts.&lt;/li&gt;&lt;li&gt;â€¢ d) Raloxifene: This is a selective estrogen receptor modulator (SERM) that inhibits bone resorption by osteoclasts, thus serving to preserve bone mass in conditions like osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Teriparatide does not inhibit osteoclasts but stimulates osteoblasts, making it the correct answer for the drug that does not act by inhibiting osteoclasts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received tetracaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorprocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prilocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benzocaine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prilocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Prilocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following the treatment of an oral abscess with clindamycin, a patient develops a greenish, foul-smelling watery diarrhea with left lower quadrant pain. Other signs and symptoms include fever, leukocytosis, and lethargy. If the toxin produced by Clostridium difficile is detected in the stool, the patient would most appropriately be treated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fidaxomicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fidaxomicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fidaxomicin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents to the clinic with a palpable lump in her left breast that she noticed while showering. She reports no associated pain, discharge, or skin changes. Her past medical history is unremarkable, and she has no known family history of breast or ovarian cancer. Her last mammogram was two years ago and showed no abnormalities. After appropriate investigations including mammogram, ultrasound, and biopsy, she is diagnosed with stage II breast cancer. The biopsy reveals that the cancer is HER2-positive, but estrogen receptor (ER) and progesterone receptor (PR) negative. Which of the following oral drugs is likely to be effective in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Letrozole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lapatinib&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lapatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lapatinib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In HER2-positive breast cancer, treatments that specifically target the HER2 receptor, such as lapatinib (an oral tyrosine kinase inhibitor), are effective. These cancers do not respond to hormonal therapies like tamoxifen or letrozole , which target estrogen receptor-positive breast cancers. Understanding the molecular profile of the cancer is essential in choosing the most effective treatment, as therapies are tailored to the specific receptors expressed by the tumor cells.&lt;/li&gt;&lt;li&gt;âž¤ lapatinib&lt;/li&gt;&lt;li&gt;âž¤ tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ letrozole&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents to the clinic with recurrent episodes of renal colic. Laboratory tests and imaging confirm the presence of high-calcium renal stones. He has no other significant past medical history. What is the most useful diuretic in the treatment of his recurrent calcium stones?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrochlorthiazide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hydrochlorthiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hydrochlorothiazide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man is scheduled for emergency surgery due to acute appendicitis. He has no significant past medical history, but his medical team is concerned about the use of succinylcholine as a neuromuscular blocking agent for intubation. Which of the following statements about succinylcholine is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It may induce life-threatening hyperkalemia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has a long duration of action.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is the drug of choice in non-traumatic rhabdomyolysis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is useful in patients with spinal cord injuries with paraplegia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It may induce life-threatening hyperkalemia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. It may induce life-threatening hyperkalemia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with acute liver and renal failure. Her lab reports show a serum bilirubin level of 8 mg/dl and a serum creatinine level of 4 mg/dl. She requires muscle relaxation for mechanical ventilation. What would be the muscle relaxant of choice in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pancuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mivacurium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atracurium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;d-Tubocurarine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atracurium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Atracurium.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following combination of drug and its indication is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pretomanid: MDR tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enfuvirtide: Treatment of HIV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remdesivir: Moderate to severe COVID-19 pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tafenoquine: Single dose treatment of P. falciparum malaria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tafenoquine is used for the radical cure of P. vivax malaria and is not indicated for single-dose treatment of P. falciparum malaria . First-line treatment for P. falciparum malaria typically involves artemisinin-based combination therapies (ACTs) . Pretomanid is crucial in the treatment of MDR tuberculosis, and Enfuvirtide is used in HIV management. Remdesivir is an antiviral used in moderate to severe cases of COVID-19 pneumonia.&lt;/li&gt;&lt;li&gt;âž¤ Tafenoquine is used for the radical cure of P. vivax malaria and is not indicated for single-dose treatment of P. falciparum malaria .&lt;/li&gt;&lt;li&gt;âž¤ Tafenoquine&lt;/li&gt;&lt;li&gt;âž¤ P. vivax malaria&lt;/li&gt;&lt;li&gt;âž¤ P. falciparum malaria&lt;/li&gt;&lt;li&gt;âž¤ First-line treatment for P. falciparum malaria typically involves artemisinin-based combination therapies (ACTs) .&lt;/li&gt;&lt;li&gt;âž¤ P. falciparum malaria&lt;/li&gt;&lt;li&gt;âž¤ artemisinin-based combination therapies (ACTs)&lt;/li&gt;&lt;li&gt;âž¤ Pretomanid is crucial in the treatment of MDR tuberculosis, and Enfuvirtide is used in HIV management.&lt;/li&gt;&lt;li&gt;âž¤ Pretomanid&lt;/li&gt;&lt;li&gt;âž¤ Enfuvirtide&lt;/li&gt;&lt;li&gt;âž¤ Remdesivir is an antiviral used in moderate to severe cases of COVID-19 pneumonia.&lt;/li&gt;&lt;li&gt;âž¤ Remdesivir&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old male diagnosed with HIV seeks guidance from his primary care doctor for appropriate treatment. Given the significant drop in his CD4 counts, initiation of HAART (Highly Active Antiretroviral Therapy) is being contemplated. Concerning the role of ritonavir for this patient, which statement holds true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;This agent is associated with resistance when used in combination with another protease inhibitor.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is used primarily for its inhibitory effect on CYP3A4.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;This is an excellent single agent for use in HAART therapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is used primarily for its inhibitory effect on CYP3A4.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is used primarily for its inhibitory effect on CYP3A4.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.&lt;/li&gt;&lt;li&gt;â€¢ A. Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.&lt;/li&gt;&lt;li&gt;â€¢ While ritonavir does have protease inhibitory activity, its primary role in HAART regimens is as a pharmacokinetic enhancer of other protease inhibitors rather than as the main protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ B. This agent is associated with resistance when used in combination with another protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ B. This agent is associated with resistance when used in combination with another protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Ritonavir, when used in low doses as a booster, does not contribute significantly to resistance. Its role is to increase the effectiveness of other protease inhibitors without leading to increased resistance.&lt;/li&gt;&lt;li&gt;â€¢ D. This is an excellent single agent for use in HAART therapy.&lt;/li&gt;&lt;li&gt;â€¢ D. This is an excellent single agent for use in HAART therapy.&lt;/li&gt;&lt;li&gt;â€¢ Ritonavir is not used as a single agent in HAART therapy due to its side effect profile and the development of resistance when used alone. It is always used in combination with other antiretroviral drugs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Ritonavir is primarily used in HAART regimens for its strong inhibitory effect on the cytochrome P450 enzyme CYP3A4. This inhibition enhances the pharmacokinetics of other protease inhibitors, increasing their plasma levels and efficacy, which allows for lower dosages and reduced side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old Indian man, pursuing his post-graduation, recently returned from Africa where he completed an academic research project. A few weeks after his return, he visits the hospital after testing positive for Plasmodium vivax malaria. The doctor recommends primaquine for the radical cure of his P. vivax infection. Shortly after beginning the regimen, the patient exhibits yellowing of the eyes. What could be the most probable reason for this symptom?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primaquine merely stains the tears yellow; this isn&#x27;t genuine yellowing of the eyes.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interaction with another medication.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deficiency of a specific enzyme.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primaquine&#x27;s liver-damaging effects.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deficiency of a specific enzyme.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Deficiency of a specific enzyme.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old sexually active, HIV-negative male visits his healthcare provider with a painless sore on his inner lip and a non-itchy rash on the soles of his feet. He recalls having a non-tender ulcer on his scrotum about a month and a half ago, which resolved on its own. He receives an intramuscular injection of benzathine penicillin G and is discharged. How might the treatment approach for this patient have been modified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The choice of antibiotic was not appropriate, and another class should have been selected.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The correct treatment would involve a different form of penicillin G, rather than benzathine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;There is no need for changes; the treatment administered is correct.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;After the initial injection, a follow-up dose should be given after 7 days.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. There is no need for changes; the treatment administered is correct.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/04/screenshot-2023-09-04-125631.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. There is no need for changes; the treatment administered is correct.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents to the clinic with symptoms of fever, weight loss, and splenomegaly. She has recently returned from a trip to a region known for endemic visceral leishmaniasis, also known as Kala-azar. Which of the following medications is suitable for single-dose treatment of Kala-azar?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pentamidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liposomal Amphotericin B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium stibogluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Miltefosine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liposomal Amphotericin B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Liposomal Amphotericin B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;35-year-old patient presents to the clinic with a swollen, painful abscess on the forehead that is discharging pus. The clinical findings strongly suggest a pus-forming gram-positive bacterial infection. Which of the following antibiotics is LEAST likely to be effective for treating this infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxycillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cloxacillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cotrimoxazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cephalexin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cotrimoxazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cotrimoxazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Amoxycillin: An aminopenicillin effective against many gram-positive bacteria, often utilized for skin infections. Cloxacillin: An isoxazolyl penicillin designed to counter gram-positive bacteria, especially strains of Staphylococcus aureus. Cotrimoxazole (Trimethoprim-sulfamethoxazole): Although it has broad-spectrum activity, Cotrimoxazole is not the preferred choice for purulent (pus-forming) gram-positive skin infections. Its efficacy can be reduced in the presence of pus, and it&#x27;s not the primary choice for such infections. Cephalexin: A first-generation cephalosporin that effectively targets gram-positive cocci and is often employed for skin and soft tissue infections.&lt;/li&gt;&lt;li&gt;â€¢ Amoxycillin: An aminopenicillin effective against many gram-positive bacteria, often utilized for skin infections.&lt;/li&gt;&lt;li&gt;â€¢ Cloxacillin: An isoxazolyl penicillin designed to counter gram-positive bacteria, especially strains of Staphylococcus aureus.&lt;/li&gt;&lt;li&gt;â€¢ Cotrimoxazole (Trimethoprim-sulfamethoxazole): Although it has broad-spectrum activity, Cotrimoxazole is not the preferred choice for purulent (pus-forming) gram-positive skin infections. Its efficacy can be reduced in the presence of pus, and it&#x27;s not the primary choice for such infections.&lt;/li&gt;&lt;li&gt;â€¢ Cephalexin: A first-generation cephalosporin that effectively targets gram-positive cocci and is often employed for skin and soft tissue infections.&lt;/li&gt;&lt;li&gt;â€¢ In the context of a purulent skin infection, Cotrimoxazole is less likely to be effective compared to the other options presented.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of diabetes presents to the hospital with a fever and worsening redness, swelling, and tenderness around his right leg. His blood cultures show methicillin-resistant Staphylococcus aureus (MRSA). The patient is started on intravenous vancomycin for suspected MRSA cellulitis. Which of the following is a true statement regarding vancomycin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is bacteriostatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has the advantage of high oral bioavailability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is highly effective against Pseudomonas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not susceptible to penicillinases&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is not susceptible to penicillinases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It is not susceptible to penicillinases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vancomycin is a bactericidal glycopeptide antibiotic that is primarily effective against Gram-positive organisms, including MRSA. It has poor oral bioavailability and is not effective against Gram-negative bacteria like Pseudomonas . Importantly, vancomycin is not susceptible to penicillinases because it does not work by targeting penicillin-binding proteins. This makes it effective against bacteria that produce Î²-lactamases, such as MRSA.&lt;/li&gt;&lt;li&gt;âž¤ bactericidal&lt;/li&gt;&lt;li&gt;âž¤ Gram-positive&lt;/li&gt;&lt;li&gt;âž¤ poor oral bioavailability&lt;/li&gt;&lt;li&gt;âž¤ not susceptible to penicillinases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Chemical structure of a drug is shown in the figure below. It is drug of choice for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enteric fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Q fever&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRSA penumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;P vivax malaria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Q fever&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-162205.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Q fever&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Doxycycline , a tetracycline antibiotic with a four-ring chemical structure, is the drug of choice for infections caused by intracellular organisms, such as Q fever (caused by Coxiella burnetii ). It is not the drug of choice for enteric fever, MRSA pneumonia, or P. vivax malaria.&lt;/li&gt;&lt;li&gt;âž¤ Doxycycline , a tetracycline antibiotic with a four-ring chemical structure, is the drug of choice for infections caused by intracellular organisms, such as Q fever (caused by Coxiella burnetii ). It is not the drug of choice for enteric fever, MRSA pneumonia, or P. vivax malaria.&lt;/li&gt;&lt;li&gt;âž¤ Doxycycline&lt;/li&gt;&lt;li&gt;âž¤ Q fever&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old male presents to the hospital with symptoms of fever, productive cough, and shortness of breath. His medical history includes recent surgery and prolonged hospitalization. A sputum culture reveals infection with Pseudomonas aeruginosa , and the infectious disease team decides to start treatment with a third-generation cephalosporin that has activity against Gram-negative bacteria, including Pseudomonas . Which of the following is a third-generation cephalosporin ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefoxitin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefadroxil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefpirome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ceftazidime&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ceftazidime&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Third-generation cephalosporins, like ceftazidime , are widely used for their broad spectrum of activity against Gram-negative organisms, including Pseudomonas aeruginosa . They are more resistant to Î²-lactamases than earlier generations, making them useful in treating hospital-acquired infections&lt;/li&gt;&lt;li&gt;âž¤ ceftazidime&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs binds irreversibly to the site labelled as B in the given figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abciximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cangrelor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vorapaxar&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prasugrel&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-162415.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Prasugrel&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prasugrel is an irreversible P2Y12 receptor inhibitor used to reduce the risk of thrombotic events in patients with acute coronary syndrome. It permanently blocks ADP-mediated platelet activation. In contrast, other agents like Cangrelor provide reversible P2Y12 inhibition, and Abciximab and Vorapaxar target different mechanisms of platelet inhibition.&lt;/li&gt;&lt;li&gt;âž¤ Prasugrel&lt;/li&gt;&lt;li&gt;âž¤ Cangrelor&lt;/li&gt;&lt;li&gt;âž¤ Abciximab&lt;/li&gt;&lt;li&gt;âž¤ Vorapaxar&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about warfarin group of oral anticoagulants is false ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They interfere with an early step in the synthesis of clotting factors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Their dose is adjusted by repeated measurement of INR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are contraindicated during first trimester of pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They interfere with an early step in the synthesis of clotting factors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. They interfere with an early step in the synthesis of clotting factors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin has a delayed onset of action because it does not affect clotting factors that have already been synthesized and are present in the bloodstream. It takes several days for these existing clotting factors to degrade and for the anticoagulant effect to become apparent.&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. The dose of warfarin is adjusted based on the International Normalized Ratio (INR) to ensure that the patient&#x27;s blood is maintained within the therapeutic range, which minimizes the risk of bleeding and thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin is contraindicated during pregnancy, especially in the first trimester, due to its teratogenic effects. It can cause fetal warfarin syndrome, characterized by nasal hypoplasia and stippled epiphyses, among other congenital abnormalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Warfarin is an oral anticoagulant that inhibits the enzyme vitamin K epoxide reductase, affecting the carboxylation and activation of certain clotting factors. It has a delayed onset of action, typically taking 4-5 days, and its dose is adjusted based on INR measurements. Warfarin is contraindicated during pregnancy due to its teratogenic potential, especially in the first trimester.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old female with atrial fibrillation is prescribed dabigatran, an oral direct thrombin inhibitor, for stroke prevention. A few months later, she is admitted to the emergency department with a gastrointestinal bleed. Which of the following drugs can be used to reverse the anticoagulant effect of dabigatran in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idarucizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Andexanet alpha&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin K&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Protamine sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Idarucizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-163033.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Idarucizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male undergoing chemotherapy for lung cancer is being treated with cisplatin , a platinum-based chemotherapeutic agent. On the third day of his treatment cycle, he develops severe, intractable vomiting. Which of the following is the agent of choice for controlling this vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fosaprepitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Granisetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Domperidone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fosaprepitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fosaprepitant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For chemotherapy-induced nausea and vomiting (CINV) , particularly with drugs like cisplatin that are highly emetogenic:&lt;/li&gt;&lt;li&gt;âž¤ chemotherapy-induced nausea and vomiting (CINV)&lt;/li&gt;&lt;li&gt;âž¤ cisplatin&lt;/li&gt;&lt;li&gt;âž¤ Fosaprepitant (an NK1 receptor antagonist) is most effective for preventing delayed-phase vomiting . Granisetron and other 5-HT3 antagonists are more effective for acute-phase vomiting . Metoclopramide and domperidone are generally used for motility-related nausea but are not the first choice for CINV.&lt;/li&gt;&lt;li&gt;âž¤ Fosaprepitant (an NK1 receptor antagonist) is most effective for preventing delayed-phase vomiting .&lt;/li&gt;&lt;li&gt;âž¤ Fosaprepitant&lt;/li&gt;&lt;li&gt;âž¤ delayed-phase vomiting&lt;/li&gt;&lt;li&gt;âž¤ Granisetron and other 5-HT3 antagonists are more effective for acute-phase vomiting .&lt;/li&gt;&lt;li&gt;âž¤ Granisetron&lt;/li&gt;&lt;li&gt;âž¤ 5-HT3 antagonists&lt;/li&gt;&lt;li&gt;âž¤ acute-phase vomiting&lt;/li&gt;&lt;li&gt;âž¤ Metoclopramide and domperidone are generally used for motility-related nausea but are not the first choice for CINV.&lt;/li&gt;&lt;li&gt;âž¤ Metoclopramide&lt;/li&gt;&lt;li&gt;âž¤ domperidone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine plus primaquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Artesunate plus sulfadoxine-pyrimethamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous Nicardipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral Amlodipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral Lisinopril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral Amlodipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oral Amlodipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For pregnant patients with both hypertension and asthma , calcium channel blockers like amlodipine are preferred because they are safe for both pregnancy and asthma management. Beta-blockers , like labetalol, can exacerbate bronchoconstriction and should be used cautiously in asthmatic patients.&lt;/li&gt;&lt;li&gt;âž¤ hypertension&lt;/li&gt;&lt;li&gt;âž¤ asthma&lt;/li&gt;&lt;li&gt;âž¤ amlodipine&lt;/li&gt;&lt;li&gt;âž¤ Beta-blockers&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male undergoing shoulder surgery receives a brachial plexus block with 0.5% lignocaine for anesthesia. Shortly after the procedure, the patient develops signs of severe hypotension and cardiovascular collapse. What is the most appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodium bicarbonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Norepinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20% lipid emulsion therapy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 20% lipid emulsion therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 20% lipid emulsion therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of local anesthetic systemic toxicity (LAST) , especially with agents like lignocaine and bupivacaine, 20% lipid emulsion therapy is the gold standard treatment to reverse the toxic effects on the cardiovascular and central nervous systems. Early recognition and prompt administration of lipid therapy can be life-saving in these scenarios.&lt;/li&gt;&lt;li&gt;âž¤ local anesthetic systemic toxicity (LAST)&lt;/li&gt;&lt;li&gt;âž¤ 20% lipid emulsion therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old obese female with schizophrenia is being considered for antipsychotic treatment. Which of the following antipsychotic drugs is associated with the least metabolic adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Risperidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aripiprazole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aripiprazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Aripiprazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When treating patients with schizophrenia who are at risk of metabolic side effects, antipsychotics such as aripiprazole should be considered due to their lower likelihood of causing weight gain and other metabolic disturbances compared to drugs like clozapine or risperidone.&lt;/li&gt;&lt;li&gt;âž¤ aripiprazole&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female with a previous history of GTCS presents with convulsions which are ongoing since 25 minutes. What should be the appropriate management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lorazepam followed by valproate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate followed by lamotrigine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethosuximide followed by gabapentin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamazepine followed by phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lorazepam followed by valproate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lorazepam followed by valproate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In status epilepticus , immediate control of seizures is critical. Lorazepam is the first-line agent for rapidly stopping seizures, and once the acute phase is managed, valproate can be used for long-term seizure prevention. Other agents like ethosuximide and carbamazepine are not suitable for this clinical scenario, as they either lack the rapid onset required or are not effective for generalized tonic-clonic seizures.&lt;/li&gt;&lt;li&gt;âž¤ status epilepticus&lt;/li&gt;&lt;li&gt;âž¤ Lorazepam&lt;/li&gt;&lt;li&gt;âž¤ valproate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with hypertension is on hydrochlorothiazide for blood pressure control. He presents with symptoms of fatigue, and lab results show hypokalemia. Which of the following drugs can be added to prevent the loss of potassium in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eplerenone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eplerenone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eplerenone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When patients on thiazide diuretics like hydrochlorothiazide develop hypokalemia , adding a potassium-sparing diuretic such as eplerenone can help prevent further potassium loss.&lt;/li&gt;&lt;li&gt;âž¤ thiazide diuretics&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;âž¤ eplerenone&lt;/li&gt;&lt;li&gt;âž¤ Furosemide and acetazolamide should be avoided, as they can exacerbate hypokalemia.&lt;/li&gt;&lt;li&gt;âž¤ Furosemide&lt;/li&gt;&lt;li&gt;âž¤ acetazolamide&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does it mean when a drug has an oral bioavailability of 20 percent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;80 percent of the drug undergoes first pass metabolism in liver.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20 percent of the drug is absorbed into portal circulation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The drug is 20 percent potent in producing therapeutic effect.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;20 percent of the drug reaches the systemic circulation in unchanged form&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 20 percent of the drug reaches the systemic circulation in unchanged form&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 30 percent of the drug reaches the systemic circulation in unchanged form&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oral bioavailability is the proportion of a drug that reaches the systemic circulation in an unchanged form after oral administration. A drug with 20 percent oral bioavailability means that only 20 percent of the administered dose enters the bloodstream and is available for therapeutic action.&lt;/li&gt;&lt;li&gt;âž¤ Oral bioavailability&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old post-menopausal woman is diagnosed with estrogen receptor-positive (ER+) breast cancer. She has no significant history of other health conditions. Which of the following is the preferred drug for the treatment of breast cancer in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lapatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Letrozole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Letrozole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Letrozole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For post-menopausal women with hormone receptor-positive breast cancer , letrozole (an aromatase inhibitor) is the preferred treatment. It reduces estrogen levels by inhibiting the aromatase enzyme, which is the primary source of estrogen in post-menopausal women. This helps to slow the growth of estrogen-dependent breast cancer. Tamoxifen is more commonly used in pre-menopausal women, while HER2-targeted therapies like trastuzumab and lapatinib are reserved for HER2-positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ hormone receptor-positive breast cancer&lt;/li&gt;&lt;li&gt;âž¤ letrozole&lt;/li&gt;&lt;li&gt;âž¤ Tamoxifen&lt;/li&gt;&lt;li&gt;âž¤ HER2-targeted therapies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and efavirenz 600 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add lamivudine 300 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add efavirenz 600 mg in the morning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. No dose adjustment is required&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) No dose adjustment is required&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When treating patients with HIV who develop tuberculosis and are placed on rifampicin-containing therapy , no dose adjustments are required for efavirenz , lamivudine , or tenofovir . Despite rifampicinâ€™s potential to induce drug metabolism, the standard dosing of these antiretroviral medications remains effective according to current guidelines.&lt;/li&gt;&lt;li&gt;âž¤ rifampicin-containing therapy&lt;/li&gt;&lt;li&gt;âž¤ efavirenz&lt;/li&gt;&lt;li&gt;âž¤ lamivudine&lt;/li&gt;&lt;li&gt;âž¤ tenofovir&lt;/li&gt;&lt;li&gt;âž¤ ADJUSTMENT OF ARV REGIMEN WITH CONCOMITANT ATT:&lt;/li&gt;&lt;li&gt;âž¤ ADJUSTMENT OF ARV REGIMEN WITH CONCOMITANT ATT:&lt;/li&gt;&lt;li&gt;âž¤ When a patient already on 2NRTIs + 1NNRTI (EFV)â€“based regimen has to be given 2HRZE + 4HREâ€“based ATT for the newly detected TB, same ART regimen can be continued without any modification. When a patient already on 2NRTIs + DTGâ€“based regimen has to be given Rifampicin-based ATT for the newly detected TB, same ART regimen can be continued. However, since co-administered rifampicin reduces bioavailability of DTG, which can be overcome by an additional tablet of DTG 50 mg (at an interval of 12 hours with the regular dose of DTG) till the completion of ATT. Once the ATT is completed, additional tablet of DTG 50 mg should be stopped 2 weeks after stoppage of Rifampicin-containing treatment regimen. When a patient already on 2NRTIs + PIâ€“based regimen develops TB, ART regimen has to be modified if 2HREZ + 4HREâ€“based ATT is co-administered. If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin&lt;/li&gt;&lt;li&gt;âž¤ When a patient already on 2NRTIs + 1NNRTI (EFV)â€“based regimen has to be given 2HRZE + 4HREâ€“based ATT for the newly detected TB, same ART regimen can be continued without any modification.&lt;/li&gt;&lt;li&gt;âž¤ When a patient already on 2NRTIs + DTGâ€“based regimen has to be given Rifampicin-based ATT for the newly detected TB, same ART regimen can be continued. However, since co-administered rifampicin reduces bioavailability of DTG, which can be overcome by an additional tablet of DTG 50 mg (at an interval of 12 hours with the regular dose of DTG) till the completion of ATT. Once the ATT is completed, additional tablet of DTG 50 mg should be stopped 2 weeks after stoppage of Rifampicin-containing treatment regimen.&lt;/li&gt;&lt;li&gt;âž¤ When a patient already on 2NRTIs + PIâ€“based regimen develops TB, ART regimen has to be modified if 2HREZ + 4HREâ€“based ATT is co-administered. If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin&lt;/li&gt;&lt;li&gt;âž¤ If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin&lt;/li&gt;&lt;li&gt;âž¤ If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section&lt;/li&gt;&lt;li&gt;âž¤ If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male is brought to the emergency department after ingesting an overdose of a medication. In order to enhance drug clearance, you consider the modification of urinary pH as a therapeutic measure. Knowing that manipulating the urinary pH can increase the excretion of certain drugs by altering their ionization state, which of the following drugs would not have its excretion increased by alkalinization of the urine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Morphine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Morphine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin : Aspirin (acetylsalicylic acid) is an acidic drug . Alkalinizing the urine with agents such as sodium bicarbonate can enhance its ionization and excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate : This is also an acidic drug , and alkalinization of the urine will increase its ionization , decreasing reabsorption and increasing elimination.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ alkalinization of the urine will increase its ionization&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenobarbitone : This is an acidic drug , and like aspirin and methotrexate , it is more ionized in alkaline urine, leading to increased excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ aspirin and methotrexate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of drug overdose , urinary alkalinization is utilized to increase the excretion of acidic drugs by enhancing their ionization , which does not apply to basic drugs like morphine that are better excreted in acidic conditions. Remember, the drugs ending with â€˜ineâ€™ are basic.&lt;/li&gt;&lt;li&gt;âž¤ drug overdose&lt;/li&gt;&lt;li&gt;âž¤ urinary alkalinization&lt;/li&gt;&lt;li&gt;âž¤ increase the excretion of acidic drugs&lt;/li&gt;&lt;li&gt;âž¤ enhancing their ionization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The volume of distribution of a drug is 100 L and the clearance is 50 L/hour and target plasma concentration of drug required is 0.5 mg/L. The drug needs to be given twice a day. What will be the maintenance dose of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;50 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;25 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;300 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;600 mg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 300 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) 300 mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs acts via the receptor show in figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aldosterone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sumatriptan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicotine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sumatriptan&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-165457.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Sumatriptan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sumatriptan acts via GPCRs , specifically the 5-HT1 receptor , which plays a key role in treating migraines. Other molecules like aldosterone, insulin, and nicotine act through different receptor pathways, such as nuclear receptors, tyrosine kinase receptors, or ion channels, respectively.&lt;/li&gt;&lt;li&gt;âž¤ Sumatriptan&lt;/li&gt;&lt;li&gt;âž¤ GPCRs&lt;/li&gt;&lt;li&gt;âž¤ 5-HT1 receptor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Log DRC of four drugs is shown in the given diagram. Which of the following statements is correct about these drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B is the most efficacious.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug D is more potent than drug C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug A and Drug C have same potency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug A is more efficacious than drug B&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Drug A is more efficacious than drug B&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-165724.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Drug A is more efficacious than drug B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In dose-response curves:&lt;/li&gt;&lt;li&gt;âž¤ Efficacy is determined by the height of the curve (how much response the drug can produce). Potency is determined by the position of the curve along the x-axis (lower doses indicate higher potency). In the diagram, Drug A is more efficacious than Drug B , and Drug C is more potent than Drug D .&lt;/li&gt;&lt;li&gt;âž¤ Efficacy is determined by the height of the curve (how much response the drug can produce).&lt;/li&gt;&lt;li&gt;âž¤ Efficacy&lt;/li&gt;&lt;li&gt;âž¤ height&lt;/li&gt;&lt;li&gt;âž¤ Potency is determined by the position of the curve along the x-axis (lower doses indicate higher potency). In the diagram, Drug A is more efficacious than Drug B , and Drug C is more potent than Drug D .&lt;/li&gt;&lt;li&gt;âž¤ Potency&lt;/li&gt;&lt;li&gt;âž¤ position&lt;/li&gt;&lt;li&gt;âž¤ Drug A&lt;/li&gt;&lt;li&gt;âž¤ Drug B&lt;/li&gt;&lt;li&gt;âž¤ Drug C&lt;/li&gt;&lt;li&gt;âž¤ Drug D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following acts on Î±1, Î±2 and Î²1 receptors but does not stimulate Î²2 receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Noradrenaline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isoprenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Noradrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115834.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Noradrenaline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Noradrenaline (norepinephrine) acts on Î±1, Î±2, and Î²1 adrenergic receptors. It is a naturally occurring catecholamine that functions as a neurotransmitter and hormone in the body . Noradrenaline&#x27;s action on Î±1 and Î±2 receptors is responsible for its vasoconstrictive effects , while its action on Î²1 receptors affects cardiac output by increasing the heart rate and myocardial contractility. It does not stimulate Î²2 receptors , which are primarily involved in bronchodilation and vasodilation .&lt;/li&gt;&lt;li&gt;â€¢ Noradrenaline (norepinephrine) acts on Î±1, Î±2, and Î²1 adrenergic receptors.&lt;/li&gt;&lt;li&gt;â€¢ catecholamine&lt;/li&gt;&lt;li&gt;â€¢ neurotransmitter and hormone in the body&lt;/li&gt;&lt;li&gt;â€¢ Î±1 and Î±2 receptors&lt;/li&gt;&lt;li&gt;â€¢ vasoconstrictive effects&lt;/li&gt;&lt;li&gt;â€¢ Î²1 receptors&lt;/li&gt;&lt;li&gt;â€¢ cardiac output by increasing the heart rate&lt;/li&gt;&lt;li&gt;â€¢ myocardial&lt;/li&gt;&lt;li&gt;â€¢ contractility.&lt;/li&gt;&lt;li&gt;â€¢ does not stimulate Î²2 receptors&lt;/li&gt;&lt;li&gt;â€¢ bronchodilation and vasodilation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tremors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypoglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Long-acting Î²2-agonists (LABAs) like formoterol can cause side effects such as tremors , hypokalemia , and hypotension due to their activation of Î²2-adrenergic receptors. However, they are not typically associated with hypoglycemia , as Î²2-agonists tend to increase blood glucose levels.&lt;/li&gt;&lt;li&gt;âž¤ formoterol&lt;/li&gt;&lt;li&gt;âž¤ tremors&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in mean arterial pressure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased renal perfusion and reduced urine output&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increase in mean arterial pressure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increase in mean arterial pressure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase in heart rate - Not the best indicator for the efficacy of nor-epinephrine in septic shock , as the drug may actually lead to a reflex bradycardia due to increased blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increase in heart rate&lt;/li&gt;&lt;li&gt;â€¢ Not the best indicator&lt;/li&gt;&lt;li&gt;â€¢ nor-epinephrine in septic shock&lt;/li&gt;&lt;li&gt;â€¢ reflex bradycardia due to increased blood pressure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decrease in heart rate - While nor-epinephrine can cause a reflex decrease in heart rate due to increased blood pressure, it&#x27;s not the primary indicator of therapeutic response in septic shock.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decrease in heart rate&lt;/li&gt;&lt;li&gt;â€¢ nor-epinephrine&lt;/li&gt;&lt;li&gt;â€¢ reflex decrease in heart rate&lt;/li&gt;&lt;li&gt;â€¢ increased blood pressure,&lt;/li&gt;&lt;li&gt;â€¢ not the primary indicator&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased renal perfusion and reduced urine output - These are potential adverse effects of nor-epinephrine due to its vasoconstrictive action , not indicators of a positive therapeutic response.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased renal perfusion and reduced urine output&lt;/li&gt;&lt;li&gt;â€¢ potential adverse effects of nor-epinephrine&lt;/li&gt;&lt;li&gt;â€¢ vasoconstrictive action&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ positive therapeutic response.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The effectiveness of nor-epinephrine in the management of septic shock is best monitored by an increase in mean arterial pressure , aiming to maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg to ensure adequate organ perfusion .&lt;/li&gt;&lt;li&gt;â€¢ nor-epinephrine&lt;/li&gt;&lt;li&gt;â€¢ septic shock&lt;/li&gt;&lt;li&gt;â€¢ monitored&lt;/li&gt;&lt;li&gt;â€¢ increase in mean arterial pressure&lt;/li&gt;&lt;li&gt;â€¢ maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg&lt;/li&gt;&lt;li&gt;â€¢ adequate organ perfusion&lt;/li&gt;&lt;li&gt;â€¢ Ref: Harrison 19 th /1761&lt;/li&gt;&lt;li&gt;â€¢ Ref:&lt;/li&gt;&lt;li&gt;â€¢ Harrison 19 th /1761&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patients would not benefit from the use of beta blockers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;64-year-old female with frequent attacks of migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;56-year-old male with erectile dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;74-year-old male with history of compensated heart failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 56-year-old male with erectile dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 56-year-old male with erectile dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 64-year-old female with frequent attacks of migraine:&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ prophylaxis of&lt;/li&gt;&lt;li&gt;â€¢ migraines&lt;/li&gt;&lt;li&gt;â€¢ reduce the frequency&lt;/li&gt;&lt;li&gt;â€¢ severity of migraine attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors:&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ useful&lt;/li&gt;&lt;li&gt;â€¢ hyperthyroidism&lt;/li&gt;&lt;li&gt;â€¢ tachycardia and tremors&lt;/li&gt;&lt;li&gt;â€¢ blocking the effects&lt;/li&gt;&lt;li&gt;â€¢ excess&lt;/li&gt;&lt;li&gt;â€¢ hyroid hormones on the heart and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 74-year-old male with history of compensated heart failure:&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers&lt;/li&gt;&lt;li&gt;â€¢ heart failure&lt;/li&gt;&lt;li&gt;â€¢ mprove survival and reduce&lt;/li&gt;&lt;li&gt;â€¢ hospitalization&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ failure,&lt;/li&gt;&lt;li&gt;â€¢ history of compensated heart failure,&lt;/li&gt;&lt;li&gt;â€¢ carefully selected and dosed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The objective is to understand the indications and contraindications for beta-blocker therapy . While beta-blockers are versatile medications with a broad range of clinical applications , their potential side effects, such as exacerbating erectile dysfunction , must be considered when prescribing these drugs to ensure they align with the patient&#x27;s overall health status and medical needs.&lt;/li&gt;&lt;li&gt;âž¤ indications and contraindications&lt;/li&gt;&lt;li&gt;âž¤ beta-blocker therapy&lt;/li&gt;&lt;li&gt;âž¤ beta-blockers are versatile&lt;/li&gt;&lt;li&gt;âž¤ medications&lt;/li&gt;&lt;li&gt;âž¤ broad range of clinical applications&lt;/li&gt;&lt;li&gt;âž¤ potential side effects,&lt;/li&gt;&lt;li&gt;âž¤ exacerbating erectile dysfunction&lt;/li&gt;&lt;li&gt;âž¤ prescribing these drugs to ensure they align&lt;/li&gt;&lt;li&gt;âž¤ health status and medical needs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are contraindications for the use of metformin except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypotensive state&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcoholics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypotensive state : While not a direct contraindication, caution is advised in conditions that may predispose patients to hypotension , as low perfusion may increase the risk of metformin induced lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypotensive state&lt;/li&gt;&lt;li&gt;â€¢ not a direct contraindication,&lt;/li&gt;&lt;li&gt;â€¢ predispose patients to hypotension&lt;/li&gt;&lt;li&gt;â€¢ low perfusion&lt;/li&gt;&lt;li&gt;â€¢ increase the risk of metformin&lt;/li&gt;&lt;li&gt;â€¢ lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholics : Chronic and excessive alcohol consumption is a contraindication for metformin use due to the increased risk of lactic acidosis , especially in cases of hepatic impairment and acute alcohol intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alcoholics&lt;/li&gt;&lt;li&gt;â€¢ Chronic and excessive alcohol&lt;/li&gt;&lt;li&gt;â€¢ contraindication for metformin&lt;/li&gt;&lt;li&gt;â€¢ increased risk of lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ hepatic impairment and acute alcohol intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal failure : Renal failure or significant renal impairment is a contraindication for the use of metformin due to the increased risk of accumulating metformin and subsequent lactic acidosis . Latest guidelines regarding use of metformin in renal dysfunction include:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal failure&lt;/li&gt;&lt;li&gt;â€¢ renal impairment is a contraindication&lt;/li&gt;&lt;li&gt;â€¢ metformin&lt;/li&gt;&lt;li&gt;â€¢ increased risk of accumulating metformin&lt;/li&gt;&lt;li&gt;â€¢ lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ metformin in renal dysfunction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risk factors for metformin induced lactic acidosis :&lt;/li&gt;&lt;li&gt;âž¤ Risk factors for metformin induced lactic acidosis&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Hepatic failure Renal failure Alcoholics Metabolic acidosis Elderly Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)&lt;/li&gt;&lt;li&gt;âž¤ Hepatic failure&lt;/li&gt;&lt;li&gt;âž¤ Renal failure&lt;/li&gt;&lt;li&gt;âž¤ Alcoholics&lt;/li&gt;&lt;li&gt;âž¤ Metabolic acidosis&lt;/li&gt;&lt;li&gt;âž¤ Elderly&lt;/li&gt;&lt;li&gt;âž¤ Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)&lt;/li&gt;&lt;li&gt;âž¤ Mnemonic:&lt;/li&gt;&lt;li&gt;âž¤ Mnemonic:&lt;/li&gt;&lt;li&gt;âž¤ MET: MET abolic acidosis&lt;/li&gt;&lt;li&gt;âž¤ MET: MET&lt;/li&gt;&lt;li&gt;âž¤ F: F ailure (Liver and Renal failure)&lt;/li&gt;&lt;li&gt;âž¤ F: F&lt;/li&gt;&lt;li&gt;âž¤ O R MIN: O xygen R eaching the tissues is MIN imum (means hypoxia causing conditions)&lt;/li&gt;&lt;li&gt;âž¤ O R MIN: O&lt;/li&gt;&lt;li&gt;âž¤ R&lt;/li&gt;&lt;li&gt;âž¤ MIN&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An obese diabetic patient was on metformin monotherapy, but his sugar levels were not well controlled. He does not comply with injectable drugs. He has a history of pancreatitis, and family history of bladder carcinoma. In view of the raised glucose levels, you wish to add another anti-diabetic drug. He does not comply with injectable drugs. Which one would you prefer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exenatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vildagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The given figure shows the mechanism of action of Drug Y in treatment of osteoporosis. Which of the following best represents drug Y?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bisphosphonates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Denosumab&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture16.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Denosumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Raloxifene: Incorrect for this mechanism. Raloxifene is a selective estrogen receptor modulator (SERM) that mimics estrogen&#x27;s bone-protective effect s by reducing osteoclast activity, but it does not work by targeting the RANKL-RANK interaction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Raloxifene:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Raloxifene is a selective estrogen receptor modulator (SERM)&lt;/li&gt;&lt;li&gt;â€¢ estrogen&#x27;s bone-protective effect&lt;/li&gt;&lt;li&gt;â€¢ reducing osteoclast activity,&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ RANKL-RANK interaction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bisphosphonates: Also incorrect. Bisphosphonates inhibit osteoclast-mediated bone resorption by inducing osteoclast apoptosis and interfering with the mevalonate pathway , not by RANKL inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bisphosphonates:&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ inhibit&lt;/li&gt;&lt;li&gt;â€¢ osteoclast-mediated bone resorption&lt;/li&gt;&lt;li&gt;â€¢ osteoclast&lt;/li&gt;&lt;li&gt;â€¢ apoptosis&lt;/li&gt;&lt;li&gt;â€¢ mevalonate pathway&lt;/li&gt;&lt;li&gt;â€¢ Option C. Teriparatide: Incorrect for this illustration. Teriparatide, a recombinant form of parathyroid hormone , primarily works by stimulating osteoblasts to promote bone formation rather than inhibiting osteoclasts.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Teriparatide:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Teriparatide,&lt;/li&gt;&lt;li&gt;â€¢ parathyroid hormone&lt;/li&gt;&lt;li&gt;â€¢ stimulating osteoblasts&lt;/li&gt;&lt;li&gt;â€¢ bone formation rather than inhibiting osteoclasts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Denosumab is used in the treatment of osteoporosis by targeting the RANKL-RANK interaction , effectively inhibiting osteoclast formation and activity, thus decreasing bone resorption.&lt;/li&gt;&lt;li&gt;âž¤ Denosumab&lt;/li&gt;&lt;li&gt;âž¤ osteoporosis by targeting the RANKL-RANK interaction&lt;/li&gt;&lt;li&gt;âž¤ inhibiting osteoclast&lt;/li&gt;&lt;li&gt;âž¤ decreasing bone resorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient presents to the clinic with a history of seizures. The patient is diagnosed with epilepsy and started on vigabatrin therapy. Which of the following statements is false about vigabatrin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vigabatrin can cause visual field defect.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vigabatrin can be used in the treatment of infantile spasms.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vigabatrin is a GABA transaminase inhibitor.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vigabatrin is a first-line drug for absence seizures.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vigabatrin is a first-line drug for absence seizures.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Â Vigabatrin is a first-line drug for absence seizures&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vigabatrin is not indicated for absence seizures and is primarily used for conditions such as infantile spasms and refractory epilepsy . It works by inhibiting GABA transaminase , increasing GABA levels in the brain, but carries a significant risk of visual field defects . The first-line drugs for absence seizures are typically ethosuximide or valproic acid .&lt;/li&gt;&lt;li&gt;âž¤ Vigabatrin&lt;/li&gt;&lt;li&gt;âž¤ absence seizures&lt;/li&gt;&lt;li&gt;âž¤ infantile spasms&lt;/li&gt;&lt;li&gt;âž¤ refractory epilepsy&lt;/li&gt;&lt;li&gt;âž¤ GABA transaminase&lt;/li&gt;&lt;li&gt;âž¤ visual field defects&lt;/li&gt;&lt;li&gt;âž¤ ethosuximide&lt;/li&gt;&lt;li&gt;âž¤ valproic acid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of schizophrenia was prescribed haloperidol. Next day, he presented to the hospital with the features shown in the figure. What should be the treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Give propranolol.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase dose of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reassurance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Give benzhexol.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Give benzhexol.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture6.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-164806.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Give benzhexol.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This figure shows torticollis . It is an acute muscular dystonia , an extrapyramidal side effect of typical antipsychotics. This can appear within a few hours after the administration of antipsychotic drugs . Extrapyramidal side effects are seen more commonly with the use of high potency drugs like haloperidol and fluphenazine. Benzhexol is the drug of choice for acute muscular dystonia.&lt;/li&gt;&lt;li&gt;â€¢ This figure shows torticollis . It is an acute muscular dystonia , an extrapyramidal side effect of typical antipsychotics.&lt;/li&gt;&lt;li&gt;â€¢ torticollis&lt;/li&gt;&lt;li&gt;â€¢ acute muscular dystonia&lt;/li&gt;&lt;li&gt;â€¢ extrapyramidal side effect of typical antipsychotics.&lt;/li&gt;&lt;li&gt;â€¢ This can appear within a few hours after the administration of antipsychotic drugs .&lt;/li&gt;&lt;li&gt;â€¢ can&lt;/li&gt;&lt;li&gt;â€¢ within a few hours&lt;/li&gt;&lt;li&gt;â€¢ administration of antipsychotic drugs&lt;/li&gt;&lt;li&gt;â€¢ Extrapyramidal side effects are seen more commonly with the use of high potency drugs like haloperidol and fluphenazine.&lt;/li&gt;&lt;li&gt;â€¢ Extrapyramidal side effects&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ use of high potency&lt;/li&gt;&lt;li&gt;â€¢ haloperidol and fluphenazine.&lt;/li&gt;&lt;li&gt;â€¢ Benzhexol is the drug of choice for acute muscular dystonia.&lt;/li&gt;&lt;li&gt;â€¢ Benzhexol&lt;/li&gt;&lt;li&gt;â€¢ drug of choice&lt;/li&gt;&lt;li&gt;â€¢ acute muscular dystonia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This figure represents the mechanism of drugs used in the treatment of Parkinsonism. Which of the following statement about these drugs is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A is the first line drug for treatment of Parkinsonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B can be entacapone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C can cause cheese reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug D decrease the peripheral adverse effects of levo-dopa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug C can cause cheese reaction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-170712.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-170753.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Drug C can cause a cheese reaction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female patient with a history of asthma presents to the clinic with worsening shortness of breath, cough, and wheezing. Her asthma is typically well-controlled with inhaled glucocorticoids and short-acting beta-2 agonists as needed, but she reports increased symptoms over the past several days. The patient is started on montelukast as an adjunct therapy. What is the mechanism of action of montelukast?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of leukotriene D4 receptor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of 5-lipoxygenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antagonism of muscarinic receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of phosphodiesterase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of leukotriene D4 receptor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of leukotriene D4 receptor.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inhibition of 5-lipoxygenase: This is the action of drugs like zileuton , not montelukast, and involves stopping leukotriene synthesis at an earlier stage in the pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inhibition of 5-lipoxygenase:&lt;/li&gt;&lt;li&gt;â€¢ action of drugs like zileuton&lt;/li&gt;&lt;li&gt;â€¢ stopping leukotriene&lt;/li&gt;&lt;li&gt;â€¢ synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Antagonism of muscarinic receptors: Typically associated with anticholinergic drugs like ipratropium , which are used to relax airway smooth muscles via a different mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Antagonism of muscarinic receptors:&lt;/li&gt;&lt;li&gt;â€¢ anticholinergic drugs like ipratropium&lt;/li&gt;&lt;li&gt;â€¢ relax airway smooth muscles&lt;/li&gt;&lt;li&gt;â€¢ different mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of phosphodiesterase: Associated with drugs like theophylline , which increase cAMP levels in smooth muscle cells, leading to bronchodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of phosphodiesterase:&lt;/li&gt;&lt;li&gt;â€¢ theophylline&lt;/li&gt;&lt;li&gt;â€¢ increase cAMP levels&lt;/li&gt;&lt;li&gt;â€¢ smooth muscle&lt;/li&gt;&lt;li&gt;â€¢ cells, leading to bronchodilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Montelukast blocks leukotriene D4 receptors, crucial for managing chronic asthma and preventing exercise-induced bronchospasm. This mechanism highlights its role beyond immediate symptom relief, focusing on long-term asthma control.&lt;/li&gt;&lt;li&gt;âž¤ Montelukast blocks leukotriene D4 receptors,&lt;/li&gt;&lt;li&gt;âž¤ chronic asthma and preventing exercise-induced bronchospasm.&lt;/li&gt;&lt;li&gt;âž¤ immediate symptom relief, focusing on long-term asthma control.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old individual with no significant past medical history presents to the emergency department with fever, malaise, and a new heart murmur. Blood cultures are drawn, and the results reveal Streptococcus viridans, indicating a diagnosis of streptococcal endocarditis. The patient is started on penicillin therapy but develops hives, pruritus, and respiratory distress within minutes of the first dose, suggesting an immediate hypersensitivity reaction to penicillin. Which of the following is an alternative drug that can be used to manage streptococcal endocarditis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meropenem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aztreonam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For the treatment of streptococcal endocarditis in patients with a history of severe penicillin allergy , such as anaphylaxis, vancomycin is the preferred alternative due to its efficacy against Gram-positive bacteria and lack of cross-reactivity with Î²-lactam antibiotics. Cephalosporins, carbapenems, and monobactams are not recommended due to the potential for allergic reactions and/or their ineffectiveness against Gram-positive organisms like Streptococcus viridans.&lt;/li&gt;&lt;li&gt;âž¤ streptococcal endocarditis&lt;/li&gt;&lt;li&gt;âž¤ penicillin allergy&lt;/li&gt;&lt;li&gt;âž¤ vancomycin&lt;/li&gt;&lt;li&gt;âž¤ Gram-positive bacteria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following drugs are effective against MRSA EXCEPT.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Linezolide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cefoperazone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cefoperazone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Most Î²-lactam antibiotics (except for a few, like ceftaroline ) are ineffective against MRSA . Vancomycin , rifampicin , and linezolid are effective treatments for MRSA, but cefoperazone , as a third-generation cephalosporin, does not cover MRSA due to the altered PBPs that confer resistance.&lt;/li&gt;&lt;li&gt;âž¤ Î²-lactam antibiotics&lt;/li&gt;&lt;li&gt;âž¤ ceftaroline&lt;/li&gt;&lt;li&gt;âž¤ ineffective&lt;/li&gt;&lt;li&gt;âž¤ MRSA&lt;/li&gt;&lt;li&gt;âž¤ Vancomycin&lt;/li&gt;&lt;li&gt;âž¤ rifampicin&lt;/li&gt;&lt;li&gt;âž¤ linezolid&lt;/li&gt;&lt;li&gt;âž¤ cefoperazone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with chronic cough since 3 months that is not responding to anitbiotics. The investigations confirms it to be a case of tuberculosis. Mycobacterium in this patient was found to be resistant to isoniazid, rifampicin, levofloxacin and linezolide. Which type of drug resistance it can be classified as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple Drug Resistance Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pre-Extensive Drug Resistance Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extremely Drug Resistance Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Extensive Drug Resistance Tuberculosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Extensive Drug Resistance Tuberculosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-173211.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Extensive Drug Resistance Tuberculosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child is started on chemotherapy. One of the medications used in the treatment is L-asparaginase. This drug works by depleting asparagine, an amino acid that is required for the growth and survival of leukemia cells. Which of the following cancers is L-asparaginase commonly used to treat?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute lymphoblastic leukemia (ALL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Myeloblastic Leukemia (AML)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic lymphocyctic leukemia (CLL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic Myelocytic Leukemia (CML)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute lymphoblastic leukemia (ALL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute lymphoblastic leukemia (ALL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute Myeloblastic Leukemia (AML): AML is another type of leukemia but primarily affects different lineages of cells within the bone marrow . L-asparaginase is not typically used in the treatment of AML.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute Myeloblastic Leukemia (AML):&lt;/li&gt;&lt;li&gt;â€¢ type of leukemia&lt;/li&gt;&lt;li&gt;â€¢ different lineages of cells&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ L-asparaginase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ AML.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic lymphocytic leukemia (CLL): CLL progresses more slowly than ALL and generally affects older adults. It is not treated with L-asparaginase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chronic lymphocytic leukemia (CLL):&lt;/li&gt;&lt;li&gt;â€¢ progresses&lt;/li&gt;&lt;li&gt;â€¢ more slowly than ALL&lt;/li&gt;&lt;li&gt;â€¢ older adults.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ L-asparaginase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic Myelocytic Leukemia (CML): CML is a chronic form of leukemia affecting primarily adults . L-asparaginase is not effective against CML cells as they do not rely on external sources of asparagine like ALL cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chronic Myelocytic Leukemia (CML):&lt;/li&gt;&lt;li&gt;â€¢ chronic form of leukemia&lt;/li&gt;&lt;li&gt;â€¢ adults&lt;/li&gt;&lt;li&gt;â€¢ L-asparaginase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ against CML cells&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ external sources of asparagine&lt;/li&gt;&lt;li&gt;â€¢ ALL cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ L-asparaginase is particularly significant in the treatment of acute lymphoblastic leukemia (ALL) due to its unique mechanism of depleting asparagine , which is essential for the survival of ALL cells . This makes it a key component of chemotherapy regimens for ALL, especially in pediatric patients , where it can be combined with other drugs to enhance treatment efficacy and manage the disease effectively.&lt;/li&gt;&lt;li&gt;âž¤ L-asparaginase&lt;/li&gt;&lt;li&gt;âž¤ treatment of acute lymphoblastic leukemia (ALL)&lt;/li&gt;&lt;li&gt;âž¤ depleting asparagine&lt;/li&gt;&lt;li&gt;âž¤ essential for the survival of ALL cells&lt;/li&gt;&lt;li&gt;âž¤ key component&lt;/li&gt;&lt;li&gt;âž¤ chemotherapy regimens&lt;/li&gt;&lt;li&gt;âž¤ ALL,&lt;/li&gt;&lt;li&gt;âž¤ pediatric patients&lt;/li&gt;&lt;li&gt;âž¤ combined with other drugs&lt;/li&gt;&lt;li&gt;âž¤ treatment efficacy and&lt;/li&gt;&lt;li&gt;âž¤ disease effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for treatment of hypothyroidism in first trimester of pregnancy is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbimazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;L-thyroxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radioactive iodine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. L-thyroxine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) L-thyroxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The drug of choice for treating hypothyroidism during pregnancy, including the first trimester, is L-thyroxine (levothyroxine) . It is essential for maintaining normal thyroid hormone levels to ensure proper fetal development. Other drugs like Propylthiouracil and Carbimazole are used to treat hyperthyroidism, not hypothyroidism, and radioactive iodine is contraindicated in pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ L-thyroxine (levothyroxine)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female with a history of epilepsy is being evaluated for her response to a new antiepileptic medication. The physician decides to review the dose-response characteristics of the drug to determine the optimal therapeutic dose. The drug&#x27;s efficacy and safety were assessed using a quantal dose-response curve (DRC) during clinical trials. Which of the following statements best describes the quantal dose-response curve (DRC)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A quantal DRC measures the intensity of a drug&#x27;s effect in a single patient at different doses.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A quantal DRC is used to determine the dose at which 50% of an individual patient&#x27;s maximum response is achieved.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A quantal DRC assesses the relationship between drug concentration and response in a continuous manner for each individual.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that a quantal dose-response curve (DRC) represents the cumulative percentage of a population exhibiting a specified all-or-none effect at varying doses. It is used to determine important pharmacological parameters like the median effective dose (ED50), which is the dose at which 50% of the population achieves the desired therapeutic effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old male with a history of chronic kidney disease (CKD) stage 4 presents with symptoms of fatigue, pallor, and shortness of breath. Laboratory investigations reveal hemoglobin levels of 8.5 g/dL (normal range: 13.8 to 17.2 g/dL in males), indicating anemia of CKD. Which of the following oral drugs can be used to treat anemia in this patient with CKD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daprodustat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Daprodustat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â A) Daprodustat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Daprodustat is a novel oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) used to treat anemia in CKD patients. It offers an alternative to injectable erythropoiesis-stimulating agents by promoting endogenous erythropoietin production through the HIF pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are HMG-CoA reductase inhibitors except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Simvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cilastatin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lovastatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cilastatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cilastatin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cilastatin is not a statin and has no role in cholesterol metabolism, while Simvastatin , Atorvastatin , and Lovastatin are HMG-CoA reductase inhibitors used in the treatment of hyperlipidemia.&lt;/li&gt;&lt;li&gt;âž¤ Cilastatin&lt;/li&gt;&lt;li&gt;âž¤ Simvastatin&lt;/li&gt;&lt;li&gt;âž¤ Atorvastatin&lt;/li&gt;&lt;li&gt;âž¤ Lovastatin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding Angiotensin II Receptor Blockers (ARBs) is not correctly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Losartan: Thromboxane A2 receptor antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Telmisartan: Can reverse insulin resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olmesartan: Causes hypokalaemia in patients with CKD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valsartan: Given in combination with sacubitril as ARNI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Olmesartan: Causes hypokalaemia in patients with CKD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Olmesartan: Causes hypokalaemia in patients with CKD.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that ARBs generally cause hyperkalemia in patients with chronic kidney disease due to aldosterone inhibition, and Olmesartan is no exception. This contrasts with the false statement regarding hypokalemia . Additionally, recognize the unique benefits of Telmisartan in insulin resistance and Valsartan in combination therapy with sacubitril.&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ Olmesartan&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ Telmisartan&lt;/li&gt;&lt;li&gt;âž¤ Valsartan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Some gram-negative bacteria produce an enzyme that blocks the action of beta lactam antibiotics in periplasmic space. Which arrow in the structural diagram of Penicillin G denotes the site of action of this enzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171731.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT an NMDA receptor antagonist?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amantadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Flumazenil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Flumazenil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that Ketamine , Memantine , and Amantadine are NMDA receptor antagonists . However, Flumazenil is a GABA-A receptor antagonist , and it does not interact with NMDA receptors.&lt;/li&gt;&lt;li&gt;âž¤ Ketamine&lt;/li&gt;&lt;li&gt;âž¤ Memantine&lt;/li&gt;&lt;li&gt;âž¤ Amantadine&lt;/li&gt;&lt;li&gt;âž¤ NMDA receptor antagonists&lt;/li&gt;&lt;li&gt;âž¤ Flumazenil&lt;/li&gt;&lt;li&gt;âž¤ GABA-A receptor antagonist&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All adverse effects of theophylline are mediated by adenosine A1 receptor antagonism except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac arrhythmias&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Seizures&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GI discomfort&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. GI discomfort&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) GI discomfort&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Most of the adverse effects of theophylline , including cardiac arrhythmias , diuresis , and seizures , are mediated by its antagonism of adenosine A1 receptors . However, GI discomfort is not related to adenosine receptor antagonism but is due to direct effects on gastric secretion and mucosal irritation.&lt;/li&gt;&lt;li&gt;âž¤ theophylline&lt;/li&gt;&lt;li&gt;âž¤ cardiac arrhythmias&lt;/li&gt;&lt;li&gt;âž¤ diuresis&lt;/li&gt;&lt;li&gt;âž¤ seizures&lt;/li&gt;&lt;li&gt;âž¤ adenosine A1 receptors&lt;/li&gt;&lt;li&gt;âž¤ GI discomfort&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presented to emergency with head trauma due to road traffic accident. In hospital, the patient developed seizures. Emergency CT scan revealed widespread cerebral edema. Which of the following is diuretic of choice for cerebral edema in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mannitol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female presented to oncologist with breast lump. On examination and investigations, breast cancer was diagnosed. Echocardiography of the patient shows ejection fraction of 25%. Which of the following drug will you avoid in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daunorubicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irinotecan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Daunorubicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Daunorubicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Adverse effect of orlistat is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Suicidal tendency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Steatorrhea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Weight gain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperglycemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Steatorrhea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Steatorrhea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Orlistat is a useful medication for those looking to lose weight, especially in cases where diet and exercise alone have not been sufficient. Patients prescribed Orlistat should be counseled about the possibility of experiencing gastrointestinal side effects such as steatorrhea and advised on dietary adjustments to manage or minimize such effects, emphasizing a reduced fat intake.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs does not reduce mortality in patients with chronic heart failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Valsartan plus Sacubitril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Telmisartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Furosemide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Furosemide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following adverse effects is least likely with the use of risperidone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperprolactinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tardive dyskinesia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vomiting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vomiting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risperidone , an atypical antipsychotic, is associated with side effects such as obesity , hyperprolactinemia , and, less frequently, tardive dyskinesia . However, due to its antiemetic properties , it is least likely to cause vomiting.&lt;/li&gt;&lt;li&gt;âž¤ Risperidone&lt;/li&gt;&lt;li&gt;âž¤ obesity&lt;/li&gt;&lt;li&gt;âž¤ hyperprolactinemia&lt;/li&gt;&lt;li&gt;âž¤ tardive dyskinesia&lt;/li&gt;&lt;li&gt;âž¤ antiemetic properties&lt;/li&gt;&lt;li&gt;âž¤ least likely&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test8" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D   Mission 2.0 (Inicet)   08 09 2024   2024 09 07&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D   Mission 2.0 (Inicet)   08 09 2024   2024 09 07&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 55-year-old woman is diagnosed with hormone receptor-positive, HER2-negative advanced breast cancer. Her oncologist discusses the treatment options, including targeted therapies. Which of the following drugs used in breast cancer treatment is a cyclin-dependent kinase (CDK) inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trastuzumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Olaparib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Palbociclib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lapatinib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Palbociclib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Palbociclib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Palbociclib is a CDK 4/6 inhibitor used in the treatment of hormone receptor-positive, HER2-negative advanced breast cancer. It works by inhibiting cell cycle progression and is often used in combination with hormonal therapies. Other drugs like Olaparib (a PARP inhibitor) and Lapatinib (a tyrosine kinase inhibitor) target different pathways and are not CDK inhibitors.&lt;/li&gt;&lt;li&gt;âž¤ Palbociclib&lt;/li&gt;&lt;li&gt;âž¤ Olaparib&lt;/li&gt;&lt;li&gt;âž¤ Lapatinib&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Thiazide diuretics can be used for the treatment of all of these conditions EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idiopathic hypercalciuria with nephrocalcinosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperlipidemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Congestive Heart Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hyperlipidemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hyperlipidemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that thiazide diuretics are useful in treating conditions such as hypertension, congestive heart failure, and hypercalciuria , but they are not indicated for the treatment of hyperlipidemia . Instead, they may slightly worsen lipid profiles.&lt;/li&gt;&lt;li&gt;âž¤ thiazide diuretics&lt;/li&gt;&lt;li&gt;âž¤ hypertension, congestive heart failure, and hypercalciuria&lt;/li&gt;&lt;li&gt;âž¤ not indicated&lt;/li&gt;&lt;li&gt;âž¤ hyperlipidemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a recent diagnosis of Graves&#x27; disease presents to the clinic with symptoms of tremors, weight loss, and palpitations. Her thyroid function tests show elevated free T4 and suppressed TSH. The physician discusses the treatment options with her and decides to start her on antithyroid medication. Which of the following statements about antithyroid drugs is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbimazole is the preferred drug for long-term management of Graves&#x27; disease due to its lower risk of liver toxicity compared to Propylthiouracil (PTU).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propylthiouracil (PTU) is the antithyroid drug of choice for treating thyroid storm due to its ability to inhibit both thyroid hormone synthesis and peripheral conversion of T4 to T3.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbimazole is associated with a higher risk of agranulocytosis compared to PTU, making regular monitoring of white blood cell counts essential.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propylthiouracil (PTU) should be avoided after the first trimester of pregnancy due to the higher risk of hepatotoxicity, with Carbimazole being the preferred option after this period.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Carbimazole is associated with a higher risk of agranulocytosis compared to PTU, making regular monitoring of white blood cell counts essential.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Carbimazole is associated with a higher risk of agranulocytosis compared to PTU, making regular monitoring of white blood cell counts essential.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carbimazole (or Methimazole) is preferred for long-term management due to lower liver toxicity, and PTU is preferred in the first trimester of pregnancy and for thyroid storm because it also inhibits the peripheral conversion of T4 to T3. Both drugs carry a risk of agranulocytosis, but this risk is not higher in Carbimazole compared to PTU, so careful monitoring is needed with either drug.&lt;/li&gt;&lt;li&gt;âž¤ Carbimazole (or Methimazole)&lt;/li&gt;&lt;li&gt;âž¤ PTU&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male patient with bronchial asthma is currently on inhaler therapy with budesonide and formoterol. Despite the medication, his symptoms are not improving due to his incoordination of hand and inhaler usage. What should be the next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Monitor plasma levels of formoterol and adjust dose accordingly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Monitor plasma levels of budesonide and adjust dose accordingly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Use nebulizer of formoterol and budesonide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Use budesonide along with formoterol and ipratropium inhaler&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Use nebulizer of formoterol and budesonide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In this case, the patient is experiencing difficulties with inhaler coordination, which is a common problem that can significantly impact asthma management. The main goal is to ensure effective delivery of the medication to the lungs to manage symptoms effectively. Monitoring plasma levels of inhaled medications like formoterol and budesonide is not practical or useful, as their therapeutic action is localized in the lungs. Introducing additional medications like ipratropium doesn&#x27;t solve the underlying issue of poor inhaler technique. The most appropriate solution is to switch to a nebulizer, which provides a more straightforward and effective method of delivering the medication, bypassing the need for hand-breath coordination and ensuring the patient receives the full benefit of the prescribed therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pharmaceutical company is developing a new medication for hypertension and is currently navigating through the various phases of clinical trials. The research team is focused on determining the Maximum Tolerated Dose (MTD) of the drug and conducting dose-ranging studies to identify the optimal dose for further testing. Which of the following statement about these parameters is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Both MTD determination and dose-ranging are conducted in Phase 1.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both MTD determination and dose-ranging are conducted in Phase 2.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MTD is determined in Phase 1, and dose-ranging studies are conducted in Phase 2.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MTD is determined in Phase 2, and dose-ranging studies are conducted in Phase 1.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MTD is determined in Phase 1, and dose-ranging studies are conducted in Phase 2.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) MTD is determined in Phase 1, and dose-ranging studies are conducted in Phase 2.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the Maximum Tolerated Dose (MTD) of a new drug is determined during Phase 1 clinical trials, where safety and tolerability are the primary focus. Dose-ranging studies, which identify the most effective dose with minimal side effects, are typically conducted during Phase 2 trials, where the drugâ€™s efficacy is further assessed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents to the emergency department after ingesting a large amount of an unknown substance in an apparent suicide attempt. The physician suspects drug poisoning and is considering alkalinization of the urine as a treatment strategy. The physician reviews the potential substances involved and their appropriate management. For which of the following drug poisonings is urine alkalinization NOT an appropriate treatment strategy? Select the correct combination. Morphine Amphetamine Phenobarbital Bupivacaine&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1, 2, 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1, 2, 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2, 3, 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1, 3, 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1, 2, 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1, 2, 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that urinary alkalinization is an effective treatment for poisoning involving weak acids like phenobarbital. It works by increasing the ionization of the drug in the renal tubules, preventing reabsorption and enhancing excretion. In contrast, this treatment is not appropriate for weak bases like morphine and amphetamines or drugs like bupivacaine that are primarily metabolized in the liver. Misapplication of this treatment to weak bases can exacerbate toxicity by increasing the reabsorption of the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old pregnant woman in her first trimester visits her obstetrician for a routine check-up. She has a history of epilepsy and is currently taking antiepileptic medication. She expresses concern about the potential effects of the medication on her developing baby. The obstetrician discusses the risks of drug use during pregnancy, including the concepts of teratogenicity and placental transfer. Which of the following statements about drug use during pregnancy is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A drug is contraindicated in pregnancy if it crosses the placenta.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Maximum teratogenic effects are likely in the first trimester.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teratogenicity depends on the dose and duration of therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thalidomide teratogenicity occurs due to binding to cereblon.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A drug is contraindicated in pregnancy if it crosses the placenta.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A drug is contraindicated in pregnancy if it crosses the placenta.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that while the first trimester is the period of maximum vulnerability to teratogenic effects, not all drugs that cross the placenta are contraindicated during pregnancy. The decision to use a drug in pregnancy involves a careful evaluation of the risk-benefit ratio. Additionally, recognize that specific mechanisms, such as cereblon binding in the case of thalidomide, can be responsible for a drug&#x27;s teratogenicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Propranolol, a non-selective beta-blocker, is commonly used for various conditions due to its effects on the cardiovascular system and outside. However, one of the following is not an approved indication for the use of propranolol. Which one is it?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Performance anxiety&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyrotoxicosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Open-angle glaucoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prophylaxis of migraine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Open-angle glaucoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Open-angle glaucoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that while propranolol has several therapeutic uses, including the treatment of performance anxiety, thyrotoxicosis, and migraine prophylaxis, it is not indicated for the treatment of open-angle glaucoma. Other beta-blockers, such as timolol, are specifically used in the management of glaucoma. Pindolol has intrinsic sympathomimetic activity and some membrane-stabilizing activity, but it is not cardioselective (it is non-selective for beta receptors). Propranolol has membrane-stabilizing activity and is non-selective, but it does not have intrinsic sympathomimetic activity. Identify acebutolol as a unique beta-blocker with cardioselectivity, intrinsic sympathomimetic activity (ISA), and membrane-stabilizing properties, distinguishing it from other beta-blockers like metoprolol, pindolol, and propranolol.&lt;/li&gt;&lt;li&gt;âž¤ Recognize that while propranolol has several therapeutic uses, including the treatment of performance anxiety, thyrotoxicosis, and migraine prophylaxis, it is not indicated for the treatment of open-angle glaucoma. Other beta-blockers, such as timolol, are specifically used in the management of glaucoma.&lt;/li&gt;&lt;li&gt;âž¤ Pindolol has intrinsic sympathomimetic activity and some membrane-stabilizing activity, but it is not cardioselective (it is non-selective for beta receptors).&lt;/li&gt;&lt;li&gt;âž¤ Pindolol&lt;/li&gt;&lt;li&gt;âž¤ Propranolol has membrane-stabilizing activity and is non-selective, but it does not have intrinsic sympathomimetic activity.&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ Identify acebutolol as a unique beta-blocker with cardioselectivity, intrinsic sympathomimetic activity (ISA), and membrane-stabilizing properties, distinguishing it from other beta-blockers like metoprolol, pindolol, and propranolol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with type 2 diabetes and chronic kidney disease (CKD) presents to the clinic for follow-up. His estimated glomerular filtration rate (eGFR) has been gradually declining, and recent lab results show worsening proteinuria. The physician decides to prescribe a drug to slow the progression of his renal disease. Which of the following mineralocorticoid receptor antagonists is specifically used to decrease the progression of renal disease in diabetic patients with chronic kidney disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eplerenone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Finerenone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Finerenone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Finerenone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist specifically designed for diabetic patients with CKD, helping to slow disease progression by reducing albuminuria and preserving renal function. It is distinct from older MRAs like spironolactone and eplerenone, which are not optimized for this indication. Lisinopril , while useful for CKD management, is an ACE inhibitor, not an MRA.&lt;/li&gt;&lt;li&gt;âž¤ Finerenone&lt;/li&gt;&lt;li&gt;âž¤ Lisinopril&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with acute asthma and the decision is made to initiate treatment with intravenous theophylline. The physician needs to calculate the appropriate loading dose to quickly achieve a therapeutic plasma concentration. The patient weighs 60 kg, the volume of distribution (Vd) for theophylline in this patient is 0.5 L/kg and renal clearance is 20 mL/min. The target plasma concentration required for theophylline is 10 mg/L. What is the appropriate loading dose of theophylline for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;200 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;300 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;600 mg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 300 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 300 mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Calculate the appropriate loading dose of a drug using the volume of distribution (Vd) and target plasma concentration, ensuring that the correct units and values are used for accurate dose determination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of open-angle glaucoma presents to the ophthalmology clinic for a routine follow-up. Despite being on multiple medications, his intraocular pressure (IOP) remains elevated. The ophthalmologist decides to adjust his treatment regimen by adding a medication that specifically increases trabecular outflow to help further reduce his IOP. Which of the following medications acts primarily by increasing trabecular outflow in the management of glaucoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Netarsudil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Netarsudil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Netarsudil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that Netarsudil is a unique medication in the treatment of glaucoma that specifically increases trabecular outflow. This differentiates it from other commonly used drugs like latanoprost (which increases uveoscleral outflow), acetazolamide (which reduces aqueous humor production), and timolol (which also reduces aqueous humor production).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents to the clinic with symptoms of overactive bladder, including frequent urination, urgency, and incontinence. His physician prescribes vibegron to help manage these symptoms. Which of the following best describes the type of receptor that vibegron primarily acts on?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ionotropic receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;G-protein-coupled receptor (GPCR)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enzymatic receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intracellular receptor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. G-protein-coupled receptor (GPCR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) G-protein-coupled receptor (GPCR)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that vibegron, a treatment for overactive bladder, targets the Î²3-adrenergic receptor, which is a type of G-protein-coupled receptor (GPCR). Understanding the type of receptor involved helps in comprehending the mechanism of action and therapeutic effects of the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Atorvastatin is a commonly prescribed drug for hyperlipidemia. What is the primary mechanism by which atorvastatin exerts its lipid-lowering effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stimulation of HMG-CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of HMG-CoA synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indirect increase in LDL receptor density&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Indirect increase in LDL receptor density&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Indirect increase in LDL receptor density&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atorvastatin primarily works by inhibiting HMG-CoA reductase, leading to a reduction in cholesterol synthesis and an indirect increase in LDL receptor density , which enhances LDL clearance from the blood.&lt;/li&gt;&lt;li&gt;âž¤ reduction in cholesterol synthesis&lt;/li&gt;&lt;li&gt;âž¤ indirect increase in LDL receptor density&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Therapeutic drug monitoring is required in all of the following except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metformin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Metformin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that therapeutic drug monitoring is essential for drugs with a narrow therapeutic index , such as Phenytoin , Tacrolimus , and Cyclosporine . In contrast, Metformin has a broad safety margin and does not require routine monitoring of serum drug levels.&lt;/li&gt;&lt;li&gt;âž¤ therapeutic drug monitoring&lt;/li&gt;&lt;li&gt;âž¤ narrow therapeutic index&lt;/li&gt;&lt;li&gt;âž¤ Phenytoin&lt;/li&gt;&lt;li&gt;âž¤ Tacrolimus&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Metformin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Some gram-negative bacteria produce an enzyme that blocks the action of beta lactam antibiotics in periplasmic space. Which arrow in the structural diagram of Penicillin G denotes the site of action of this enzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171731.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoing chemotherapy for pancreatic carcinoma develops fever, anemia, and neutropenia. Which of the following antimicrobial agents is not indicated for the treatment of this infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Linezolid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Imipenem-cilastatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Linezolid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Linezolid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the treatment of febrile neutropenia, it is essential to use bactericidal agents to rapidly kill bacteria, particularly because neutropenic patients have a weakened immune system. Linezolid , a bacteriostatic agent, is not appropriate for empirical therapy in febrile neutropenia, whereas vancomycin , cefoperazone , and imipenem-cilastatin are bactericidal and more suitable for this condition.&lt;/li&gt;&lt;li&gt;âž¤ bactericidal&lt;/li&gt;&lt;li&gt;âž¤ Linezolid&lt;/li&gt;&lt;li&gt;âž¤ vancomycin&lt;/li&gt;&lt;li&gt;âž¤ cefoperazone&lt;/li&gt;&lt;li&gt;âž¤ imipenem-cilastatin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Low molecular weight (LMW) heparin is preferred over unfractionated heparin because:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LMW heparin directly inhibits thrombin, whereas unfractionated heparin acts via activation of antithrombin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LMW heparins have a lesser risk of causing bleeding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LMW heparin can be given subcutaneously as well as orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;LMW heparin has consistent bioavailability&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. LMW heparin has consistent bioavailability&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) LMW heparin has consistent bioavailability&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that LMW heparins are preferred over unfractionated heparin primarily due to their consistent bioavailability and more predictable anticoagulant response, which allows for easier dosing and fewer complications. They are administered subcutaneously and do not require routine monitoring, making them more convenient in clinical practice.&lt;/li&gt;&lt;li&gt;âž¤ LMW heparins&lt;/li&gt;&lt;li&gt;âž¤ unfractionated heparin&lt;/li&gt;&lt;li&gt;âž¤ consistent bioavailability&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents to her physician for a check-up. She is recovering from a wrist fracture after a fall. Dual energy x-ray absorptiometry of the hip had shown her to have osteoporosis. She became menopausal at age 50 and did not begin hormone replacement therapy because of a strong family history of breast cancer. She now fears a future hip fracture and would like to begin a bone loss prevention regime. Which of the following pharmaceutical agents is most appropriate for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcitonin nasal spray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral conjugated estrogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Raloxifene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Raloxifene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Raloxifene is the most appropriate choice for preventing and treating osteoporosis in postmenopausal women with a family history of breast cancer, as it strengthens bone without increasing breast cancer risk. Estrogen therapy is generally avoided in women at high risk for breast cancer, and while Calcitonin and Tamoxifen have specific uses, they are less effective or less appropriate for osteoporosis management in this context.&lt;/li&gt;&lt;li&gt;âž¤ Raloxifene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Name a beta blocker which is cardioselective, possess intrinsic sympathomimetic activity and also has membrane stabilising activity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acebutolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pindolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acebutolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acebutolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Long term steroid therapy can lead to suppression of hypothalamic-pituitary-adrenal axis. It can be overcome by using alternate day therapy with corticosteroids. Which of the following steroids are unsuitable for alternate day therapy for such purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrocortisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dexamethasone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dexamethasone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dexamethasone is unsuitable for alternate-day corticosteroid therapy due to its long half-life and strong suppression of the hypothalamic-pituitary-adrenal (HPA) axis.&lt;/li&gt;&lt;li&gt;âž¤ Dexamethasone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old farmer presents to the clinic with progressive weakness in his legs, difficulty walking, and tingling in his hands and feet. He reports that about three weeks ago, he was exposed to an organophosphate pesticide while spraying his crops. Initially, he experienced some mild nausea and headaches, which resolved within a few days. However, the weakness and sensory symptoms began about a week after the exposure and have been worsening. Which of the following statements regarding the patientâ€™s condition are correct? It is OPIDN due to inhibition of neuropathy target esterase (NTE). It is acute OP poisoning due to inhibition of acetylcholinesterase (AChE). It is caused by a few organophosphates like tricresyl phosphate (TCP). Treatment is supportive, as there is no specific antidote for this condition. Treatment includes atropine and pralidoxime.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1, 3, 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2, 3, 5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1, 3, 5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1, 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1, 3, 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1, 3, 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that Organophosphate-Induced Delayed Neuropathy (OPIDN) is caused by the inhibition of neuropathy target esterase (NTE) and is associated with specific organophosphates like tricresyl phosphate (TCP). Unlike acute organophosphate poisoning, which is due to acetylcholinesterase (AChE) inhibition and treated with atropine and pralidoxime, OPIDN manifests weeks after exposure and is managed with supportive care, as no specific antidote exists.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male is brought to the emergency department by his friends after attending a party. He is agitated, confused, and reports seeing things that aren&#x27;t there. On examination, his pupils are dilated, his skin is flushed and dry, his heart rate is elevated, and he has slurred speech and an unsteady gait. The patient also complains of dry mouth and difficulty urinating. His friends mention that he might have ingested something at the party, but they are unsure what it was. Given the clinical presentation, which of the following substances is the most likely cause of this patientâ€™s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Datura&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alcohol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Datura&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Datura&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that the combination of agitation, confusion, hallucinations, mydriasis, dry skin, dry mouth, and tachycardia is characteristic of anticholinergic toxicity, which is most commonly associated with substances like Datura. Even with additional symptoms such as slurred speech and unsteady gait, Datura remains the most likely cause in this clinical scenario.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;If furosemide is administered to a person, the response seen within 24 hours on the excretion of different electrolytes is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodiumâ†‘ Potassiumâ†‘ Calciumâ†‘&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sodiumâ†“ Potassiumâ†“ Calciumâ†“&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodiumâ†‘ Potassiumâ†‘ Calciumâ†“&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodiumâ†“ Potassiumâ†“ Calciumâ†‘&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sodiumâ†‘ Potassiumâ†‘ Calciumâ†‘&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â A) Sodiumâ†‘ Potassiumâ†‘ Calciumâ†‘&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Furosemide is a potent loop diuretic that increases the excretion of sodium, potassium, and calcium in the urine within the first 24 hours. It achieves this by inhibiting the Naâº-Kâº-2Clâ» cotransporter in the thick ascending limb of the loop of Henle. Although these effects are prominent initially, compensatory mechanisms may later neutralize the changes in electrolyte balance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of epilepsy has been on phenytoin for seizure control. He was recently admitted to the hospital for dose adjustment due to subtherapeutic levels. After increasing the dose, his serum phenytoin levels rose sharply, leading to symptoms of toxicity, including nystagmus and ataxia. The physician is considering the pharmacokinetic properties of phenytoin in this patient. Which of the following best explains the sudden increase in serum phenytoin levels after the dose was adjusted?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenytoin exhibits first-order kinetics, where a constant proportion of the drug is eliminated per unit time, leading to a predictable increase in serum levels with dose adjustment.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenytoin exhibits zero-order kinetics at therapeutic doses, where a constant amount of the drug is eliminated per unit time, leading to a non-linear increase in serum levels with dose adjustment.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenytoin exhibits first-order kinetics at low doses but switches to zero-order kinetics at higher doses due to saturation of metabolizing enzymes, causing a disproportionate increase in serum levels.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin undergoes zero-order kinetics at all concentrations, where the rate of elimination is proportional to the plasma concentration, explaining the sharp rise in levels with dose adjustment.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phenytoin exhibits first-order kinetics at low doses but switches to zero-order kinetics at higher doses due to saturation of metabolizing enzymes, causing a disproportionate increase in serum levels.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Phenytoin exhibits first-order kinetics at low doses but switches to zero-order kinetics at higher doses due to saturation of metabolizing enzymes, causing a disproportionate increase in serum levels.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that phenytoin exhibits dose-dependent pharmacokinetics: it follows first-order kinetics at low or therapeutic doses, but can shift to zero-order kinetics at higher doses due to enzyme saturation, leading to a sharp and unpredictable rise in drug levels and an increased risk of toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents to the emergency department after accidental exposure to an organophosphate pesticide. He exhibits signs of cholinergic crisis, including excessive salivation, sweating, miosis, and bronchospasm. The patient is promptly treated with atropine. Which of the following is the most reliable sign of adequate atropinization in the management of organophosphate poisoning?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mydriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clear and dry lungs on auscultation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absent bowel sounds&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clear and dry lungs on auscultation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Clear and dry lungs on auscultation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that in the management of organophosphate poisoning, the most reliable sign of adequate atropinization is the resolution of bronchial secretions, as evidenced by clear and dry lungs on auscultation. This is the key indicator that atropine has effectively mitigated the dangerous respiratory effects of cholinergic excess, which is critical for patient survival and guides appropriate dosing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An overweight 48-year-old male presents with complaints of increased thirst and frequent urination. Laboratory examination reveals a blood glucose level of 180 mg/dL. The patient&#x27;s past medical history is unremarkable, except for an anaphylactic reaction that occurred one year ago when he was given trimethoprim-sulfamethoxazole for a sinus infection. Based on this information, which of the following agents should be prescribed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorpropamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glipizide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Desmopressin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Metformin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Metformin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In overweight patients with newly diagnosed type 2 diabetes, Metformin is the preferred first-line treatment. It improves insulin sensitivity without causing weight gain or significant hypoglycemia. Sulfonylureas like Chlorpropamide and Glipizide are generally avoided in patients with a history of sulfonamide allergy due to the risk of cross-reactivity, making Metformin the safest and most effective choice in this scenario.&lt;/li&gt;&lt;li&gt;âž¤ Metformin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Umesh, a 35-year-old male, presents to the outpatient department of Dr Mehtaâ€™s Hospitals, Chennai with intermittent fever, chills, and sweating for the past 10 days. He had recently returned from a 2-week trip to the Sundarbans, a forested region known for its endemicity with malaria. Laboratory investigations confirm the diagnosis of Plasmodium falciparum malaria, which is sensitive to chloroquine. Dr Dileep Kumar, the treating physician is planning to ensure a radical cure to prevent future relapses. Which of the following is the drug of choice for radical cure of malaria in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Artesunate + Sulfadoxine/Pyrimethamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Artemether + Lumefantrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primaquine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chloroquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A is 64-year-old male about to undergo therapy for Rhabdomyosarcoma. His chemotherapy include vincristine, dactinomycin, cyclophosphamide, doxorubicin and ifosfamide. Which of the following is most appropriate to include in chemotherapy orders for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV hydration, mesna, and frequent urinalyses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leucovorin and frequent LFT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amifostine and regular KFT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Regular dermatologist visit and prophylactic vitamin A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV hydration, mesna, and frequent urinalyses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV hydration, mesna, and frequent urinalyses.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ When using chemotherapy regimens that include ifosfamide and cyclophosphamide , it is crucial to address the risk of hemorrhagic cystitis . Mesna is specifically used to protect the bladder by neutralizing harmful metabolites, while IV hydration ensures that these metabolites are rapidly excreted. Frequent urinalyses help monitor for any signs of bladder irritation or bleeding. Other supportive treatments, like leucovorin or amifostine , are used in specific scenarios where drugs like methotrexate or cisplatin are involved, and skin protection measures are more relevant with certain dermatological treatments or radiation therapies.&lt;/li&gt;&lt;li&gt;âž¤ ifosfamide&lt;/li&gt;&lt;li&gt;âž¤ cyclophosphamide&lt;/li&gt;&lt;li&gt;âž¤ hemorrhagic cystitis&lt;/li&gt;&lt;li&gt;âž¤ Mesna&lt;/li&gt;&lt;li&gt;âž¤ IV hydration&lt;/li&gt;&lt;li&gt;âž¤ Frequent urinalyses&lt;/li&gt;&lt;li&gt;âž¤ leucovorin&lt;/li&gt;&lt;li&gt;âž¤ amifostine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is operated for bile duct stricture. Post operatively he is receiving 3 ml epidural morphine for pain relief. One day he accidentally received 12 ml of morphine. What will not occur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory depression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pin point pupil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tachycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In the context of a morphine overdose, especially when administered in significantly higher doses than intended, certain physiological effects are typically observed due to the drug&#x27;s action on the central nervous system and other systems in the body. These include respiratory depression , coma , and pinpoint pupils , all of which are characteristic of opioid intoxication. However, tachycardia is not typically associated with morphine, as opioids generally cause a decrease in heart rate (bradycardia).&lt;/li&gt;&lt;li&gt;âž¤ respiratory depression&lt;/li&gt;&lt;li&gt;âž¤ coma&lt;/li&gt;&lt;li&gt;âž¤ pinpoint pupils&lt;/li&gt;&lt;li&gt;âž¤ tachycardia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with a history of hypertension is being considered for a new antihypertensive medication. His physician is weighing various options, taking into consideration their potential impact on plasma renin activity, which could have downstream effects on blood pressure control. All of the following drugs increase plasma renin activity except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clonidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Clonidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation for Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A) Amlodipine: This calcium channel blocker reduces arterial pressure and typically triggers a compensatory increase in renin release to restore blood pressure, thereby increasing plasma renin activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A)&lt;/li&gt;&lt;li&gt;â€¢ Amlodipine:&lt;/li&gt;&lt;li&gt;â€¢ Option C) Enalapril: This angiotensin-converting enzyme (ACE) inhibitor reduces levels of angiotensin II, a potent vasoconstrictor that also inhibits renin release. Lower angiotensin II levels result in increased renin activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C)&lt;/li&gt;&lt;li&gt;â€¢ Enalapril:&lt;/li&gt;&lt;li&gt;â€¢ Option D) Prazosin: This alpha-1 adrenergic antagonist reduces vascular tone, leading to a compensatory increase in renin release to restore blood pressure, thereby increasing plasma renin activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D) Prazosin:&lt;/li&gt;&lt;li&gt;â€¢ Therefore, among the options given, Methyl dopa is the drug that does not typically increase plasma renin activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with a history of poorly controlled diabetes presents to the emergency department with a painful, swollen mass in the left thigh. The area is warm, tender, and fluctuant, suggesting the presence of an abscess. He also complains of fever and chills. Cultures from the abscess reveal the presence of anaerobic bacteria. Which of the following drugs is NOT effective for treating his anaerobic infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amikacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefoxitin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amikacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Amikacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that aminoglycosides like Amikacin are ineffective in anaerobic infections due to their oxygen-dependent mechanism of action. In contrast, drugs like Metronidazole , Clindamycin , and Cefoxitin (a second-generation cephalosporin) are effective choices for treating anaerobic bacterial infections.&lt;/li&gt;&lt;li&gt;âž¤ aminoglycosides&lt;/li&gt;&lt;li&gt;âž¤ Amikacin&lt;/li&gt;&lt;li&gt;âž¤ Metronidazole&lt;/li&gt;&lt;li&gt;âž¤ Clindamycin&lt;/li&gt;&lt;li&gt;âž¤ Cefoxitin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of type 2 diabetes mellitus and hypertension presents to the clinic for a routine follow-up. Despite being on metformin and an ACE inhibitor, his blood sugar levels remain poorly controlled, with an HbA1c of 8.5%. His blood pressure is well-controlled, but recent laboratory results indicate elevated triglycerides and low HDL cholesterol. The physician is considering adding a medication that has beneficial effects on both glucose metabolism and lipid profile through PPAR-gamma activation. Which of the following medications act as PPAR-gamma agonists and may be beneficial in managing this patientâ€™s metabolic syndrome? Telmisartan Pioglitazone Saraglitazar Metformin&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;only 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1 and 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1, 2 and 3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1, 2, 3 and 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1, 2 and 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 1, 2, and 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key takeaway is that Telmisartan, Pioglitazone, and Saraglitazar are all medications that exert PPAR-gamma agonist effects, contributing to improved insulin sensitivity and potentially beneficial effects on lipid metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Telmisartan, Pioglitazone, and Saraglitazar&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old pregnant woman, in her second trimester, presents to the clinic with a painless ulcer on her genital area. She mentions having unprotected intercourse a few months ago. Serologic tests for syphilis come back positive, confirming the diagnosis of primary syphilis. What is the drug of choice for treating syphilis in this pregnant patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Penicillin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tetracycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Penicillin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Penicillin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that penicillin is the gold standard for treating syphilis in pregnant women to prevent both maternal disease progression and congenital syphilis. Alternative antibiotics such as azithromycin , tetracycline , and ceftriaxone are not first-line treatments in this context due to concerns about efficacy, safety, or resistance.&lt;/li&gt;&lt;li&gt;âž¤ penicillin&lt;/li&gt;&lt;li&gt;âž¤ syphilis&lt;/li&gt;&lt;li&gt;âž¤ azithromycin&lt;/li&gt;&lt;li&gt;âž¤ tetracycline&lt;/li&gt;&lt;li&gt;âž¤ ceftriaxone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old female with a 10-year history of episodic migraines presents to the clinic for a follow-up. She reports an increase in frequency, experiencing migraines 12-15 days per month. Over the years, she has tried several medications for both acute treatment and prevention, including triptans and older prophylactic agents like beta-blockers and anticonvulsants, with minimal relief. The physician is considering prescribing a newer class of drugs targeting specific migraine-related pathways. Which of the following newer drugs is specifically designed for migraine prophylaxis and works by targeting the calcitonin gene-related peptide (CGRP) receptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eptinezumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ubrogepant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lasmiditan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Eptinezumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Eptinezumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Monoclonal antibodies like eptinezumab represent a new class of migraine-specific prophylactic drugs that target the CGRP pathway. These therapies are particularly beneficial for patients who do not respond to traditional migraine prevention treatments. Understanding the distinction between acute treatment and prophylaxis is critical for optimizing migraine management.&lt;/li&gt;&lt;li&gt;âž¤ eptinezumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female patient with a history of depression and anxiety is currently being treated with multiple medications. During a routine ECG, she is found to have a prolonged QT interval. The treating physician reviews her medication list to identify any drugs that could contribute to this finding. Which of the following drugs is LEAST likely to cause QT prolongation in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methadone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lignocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-152359.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lignocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the potential risks associated with drugs that can cause QT interval prolongation, including the risk of life-threatening arrhythmias such as Torsades de Pointes. The important drugs causing QT prolongation are:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During your rural posting after the internship, you encounter a patient of acute cardiac failure. Your preferred drug for this condition is dobutamine. However, it is not available there. Which of the following other drugs, or combination of drugs, would be a suitable alternative, giving the pharmacologic equivalent of what you want the dobutamine to do?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Norepinephrine plus phentolamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dopamine (at a very high dose)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ephedrine plus propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenylephrine plus atropine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Norepinephrine plus phentolamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs can result in cyanide poisoning?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodium Nitroprusside&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amyl nitrite&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydroxycobalamin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodium thiosulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sodium Nitroprusside&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sodium Nitroprusside&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that Sodium Nitroprusside can lead to cyanide poisoning due to its metabolism, especially with prolonged use or high doses. Amyl nitrite, Hydroxycobalamin, and Sodium thiosulphate are involved in the treatment of cyanide poisoning, not its causation.&lt;/li&gt;&lt;li&gt;âž¤ Sodium Nitroprusside&lt;/li&gt;&lt;li&gt;âž¤ cyanide poisoning&lt;/li&gt;&lt;li&gt;âž¤ Amyl nitrite, Hydroxycobalamin, and Sodium thiosulphate&lt;/li&gt;&lt;li&gt;âž¤ treatment&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug has activity against both gonococcal as well as non-gonococcal urethritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone 250 mg IM single dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefixime 400 mg oral single dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciprofloxacin 500 mg oral single dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azithromycin 2 g oral single dose&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Azithromycin 2 g oral single dose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Azithromycin 2 g oral single dose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For the treatment of both gonococcal and non-gonococcal urethritis with a single drug , Azithromycin 2 g oral single dose is effective. It treats Neisseria gonorrhoeae (GU) and Chlamydia trachomatis or Ureaplasma (NGU), eliminating the need for multiple medications.&lt;/li&gt;&lt;li&gt;âž¤ gonococcal&lt;/li&gt;&lt;li&gt;âž¤ non-gonococcal urethritis&lt;/li&gt;&lt;li&gt;âž¤ single drug&lt;/li&gt;&lt;li&gt;âž¤ Azithromycin 2 g oral single dose&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of atrial fibrillation presents to the emergency department with palpitations and dizziness. His ECG shows atrial fibrillation with a rapid ventricular response. The physician decides to administer an antiarrhythmic drug to convert him back to normal sinus rhythm. The physician is considering using a drug that works by prolonging the action potential duration (APD). Which of the following antiarrhythmic drugs act as a pure action potential duration (APD) prolonging agent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ibutilide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ibutilide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ibutilide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ibutilide is a pure action potential duration (APD) prolonging agent that primarily prolongs the repolarization phase (Phase 3) by inhibiting potassium channels without affecting other parts of the action potential. Amiodarone affects multiple phases of the action potential, including sodium and calcium channels, and has beta-blocker-like effects. Quinidine affects both sodium and potassium channels, altering depolarization and repolarization, while Lidocaine shortens the APD by blocking sodium channels, making it unsuitable for APD prolongation.&lt;/li&gt;&lt;li&gt;âž¤ Ibutilide&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone&lt;/li&gt;&lt;li&gt;âž¤ Quinidine&lt;/li&gt;&lt;li&gt;âž¤ Lidocaine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most important mechanism of methotrexate when used as a disease modifying anti-rheumatoid drug is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of dihydrofolate reductase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of AICAR transformylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of dihydroorotate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activaton of TNF-alpha&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of AICAR transformylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inhibition of AICAR transformylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with schizophrenia was treated with haloperidol 5 mg once daily at bedtime, which was increased to 7.5 mg daily in the 2nd week and 10 mg daily in the 3rd week. His symptoms improved, but in the 5th week, his family reported that his restlessness had returned, and he kept pacing around in the room, though he was not aggressive. The patient also reported an uncontrollable urge to move around and difficulty in falling asleep. Which of the following drugs would be the best choice for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Higher doses of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valbenazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dantrolene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following drugs with their respective mechanisms of action as represented in the diagram below 1. Isoniazid 2. Rifampicin 3. Bedaquiline 4. Kanamycin A. Drug A B. Drug D C. Drug E D. Drug F&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-A, 2-C, 3-B, 4-D&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-A, 2-D, 3-C, 4-B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-B, 2-A, 3-D, 4-C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-C, 2-B, 3-A, 4-D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-A, 2-C, 3-B, 4-D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-165917.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1-A, 2-C, 3-B, 4-D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of the drugs and their mechanisms from the diagram:&lt;/li&gt;&lt;li&gt;â€¢ Drug A (Isoniazid) : Isoniazid, represented by Drug A, is activated by KatG enzyme and inhibits the synthesis of mycolic acids , which are essential components of the mycobacterial cell wall. This leads to the disruption of the bacterial cell wall. Drug B (Ethambutol) : This drug interferes with the synthesis of arabinogalactan , another key component of the mycobacterial cell wall. Drug C (Pyrazinamide) : Pyrazinamide works at the cell membrane level, affecting the cytoplasmic membrane of Mycobacterium tuberculosis , potentially by inhibiting membrane transport functions and disrupting the energy metabolism of the bacteria. Drug D (Bedaquiline) : Bedaquiline inhibits ATP synthase , specifically in the mycobacteria, leading to a failure in ATP generation, which is crucial for bacterial survival. Drug E (Rifampicin) : Rifampicin inhibits RNA polymerase , which blocks transcription and thereby halts protein synthesis in the bacteria. Drug F (Kanamycin) : Kanamycin is an aminoglycoside that inhibits protein synthesis by binding to the bacterial ribosome , disrupting mRNA translation and leading to faulty proteins.&lt;/li&gt;&lt;li&gt;â€¢ Drug A (Isoniazid) : Isoniazid, represented by Drug A, is activated by KatG enzyme and inhibits the synthesis of mycolic acids , which are essential components of the mycobacterial cell wall. This leads to the disruption of the bacterial cell wall.&lt;/li&gt;&lt;li&gt;â€¢ Drug A (Isoniazid)&lt;/li&gt;&lt;li&gt;â€¢ KatG&lt;/li&gt;&lt;li&gt;â€¢ mycolic acids&lt;/li&gt;&lt;li&gt;â€¢ Drug B (Ethambutol) : This drug interferes with the synthesis of arabinogalactan , another key component of the mycobacterial cell wall.&lt;/li&gt;&lt;li&gt;â€¢ Drug B (Ethambutol)&lt;/li&gt;&lt;li&gt;â€¢ arabinogalactan&lt;/li&gt;&lt;li&gt;â€¢ Drug C (Pyrazinamide) : Pyrazinamide works at the cell membrane level, affecting the cytoplasmic membrane of Mycobacterium tuberculosis , potentially by inhibiting membrane transport functions and disrupting the energy metabolism of the bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Drug C (Pyrazinamide)&lt;/li&gt;&lt;li&gt;â€¢ cytoplasmic membrane&lt;/li&gt;&lt;li&gt;â€¢ Drug D (Bedaquiline) : Bedaquiline inhibits ATP synthase , specifically in the mycobacteria, leading to a failure in ATP generation, which is crucial for bacterial survival.&lt;/li&gt;&lt;li&gt;â€¢ Drug D (Bedaquiline)&lt;/li&gt;&lt;li&gt;â€¢ ATP synthase&lt;/li&gt;&lt;li&gt;â€¢ Drug E (Rifampicin) : Rifampicin inhibits RNA polymerase , which blocks transcription and thereby halts protein synthesis in the bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Drug E (Rifampicin)&lt;/li&gt;&lt;li&gt;â€¢ RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ Drug F (Kanamycin) : Kanamycin is an aminoglycoside that inhibits protein synthesis by binding to the bacterial ribosome , disrupting mRNA translation and leading to faulty proteins.&lt;/li&gt;&lt;li&gt;â€¢ Drug F (Kanamycin)&lt;/li&gt;&lt;li&gt;â€¢ ribosome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the mechanism of action of first-line and second-line anti-tuberculosis drugs, particularly in how they disrupt mycobacterial processes like cell wall synthesis, protein synthesis, energy generation, and RNA transcription.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of asthma is prescribed salbutamol for acute bronchospasm. During a follow-up visit, he complains of feeling jittery and experiencing occasional palpitations. He is concerned about other potential side effects of the medication. Which of the following is NOT an adverse effect of salbutamol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tremors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypoglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that salbutamol , a beta-2 agonist, can cause side effects like tremors, tachycardia , and hypokalemia . However, it does not cause hypoglycemia ; instead, it may lead to hyperglycemia due to its effect on glucose metabolism.&lt;/li&gt;&lt;li&gt;âž¤ salbutamol&lt;/li&gt;&lt;li&gt;âž¤ tremors, tachycardia&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ not cause hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ hyperglycemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old postmenopausal woman presents to the outpatient clinic with a history of recurrent fractures over the past two years. She has been diagnosed with osteoporosis and has a T-score of -3.2. Despite being on oral bisphosphonates for the last year, she continues to experience fractures and reports gastrointestinal discomfort. The physician decides to switch her to a medication that is used subcutaneously every six months and act by inhibiting osteoclasts. Which of the following drug is being talked about?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Zoledronic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcitonin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Denosumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Denosumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The take-home message from this question is understanding the role of Denosumab as a long-acting, subcutaneously administered medication for osteoporosis that works by inhibiting osteoclasts. It is particularly useful for patients who do not tolerate or respond to oral bisphosphonates.&lt;/li&gt;&lt;li&gt;âž¤ Denosumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The mechanism of action of cyclosporine is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits IL-2 receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits TNF-alpha&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decrease in transcription of IL-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Targets inactivated T cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decrease in transcription of IL-2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Decrease in transcription of IL-2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine suppresses the immune system by inhibiting calcineurin , which reduces the transcription of IL-2 , a critical cytokine for T-cell activation. It is widely used in preventing organ transplant rejection and treating autoimmune diseases.&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ calcineurin&lt;/li&gt;&lt;li&gt;âž¤ IL-2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female with a history of epilepsy is being evaluated for her response to a new antiepileptic medication. The physician decides to review the dose-response characteristics of the drug to determine the optimal therapeutic dose. The drug&#x27;s efficacy and safety were assessed using a quantal dose-response curve (DRC) during clinical trials. Which of the following statements best describes the quantal dose-response curve (DRC)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A quantal DRC measures the intensity of a drug&#x27;s effect in a single patient at different doses.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A quantal DRC is used to determine the dose at which 50% of an individual patient&#x27;s maximum response is achieved.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A quantal DRC assesses the relationship between drug concentration and response in a continuous manner for each individual.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A quantal DRC plots the cumulative percentage of a population that exhibits a specified all-or-none effect (e.g., seizure prevention) at different doses.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that a quantal dose-response curve (DRC) represents the cumulative percentage of a population exhibiting a specified all-or-none effect at varying doses. It is used to determine important pharmacological parameters like the median effective dose (ED50), which is the dose at which 50% of the population achieves the desired therapeutic effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are HMG-CoA reductase inhibitors except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Simvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cilastatin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lovastatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cilastatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cilastatin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cilastatin is not a statin and has no role in cholesterol metabolism, while Simvastatin , Atorvastatin , and Lovastatin are HMG-CoA reductase inhibitors used in the treatment of hyperlipidemia.&lt;/li&gt;&lt;li&gt;âž¤ Cilastatin&lt;/li&gt;&lt;li&gt;âž¤ Simvastatin&lt;/li&gt;&lt;li&gt;âž¤ Atorvastatin&lt;/li&gt;&lt;li&gt;âž¤ Lovastatin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pilocarpine is an:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Active Miosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Passive miotic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Active mydriatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Passive mydriatic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Active Miosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)ActiveMiosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that pilocarpine is an active miotic agent, meaning it directly stimulates muscarinic receptors on the iris sphincter muscle to cause pupil constriction . It is used clinically in conditions such as glaucoma . Active and passive mydriasis and miosis involve either direct receptor stimulation or inhibition of opposing pathways (adrenergic or cholinergic), with drugs like atropine or phenylephrine causing mydriasis and agents like pilocarpine inducing miosis.&lt;/li&gt;&lt;li&gt;âž¤ pilocarpine&lt;/li&gt;&lt;li&gt;âž¤ active miotic&lt;/li&gt;&lt;li&gt;âž¤ muscarinic receptors&lt;/li&gt;&lt;li&gt;âž¤ pupil constriction&lt;/li&gt;&lt;li&gt;âž¤ glaucoma&lt;/li&gt;&lt;li&gt;âž¤ mydriasis&lt;/li&gt;&lt;li&gt;âž¤ miosis&lt;/li&gt;&lt;li&gt;âž¤ atropine&lt;/li&gt;&lt;li&gt;âž¤ phenylephrine&lt;/li&gt;&lt;li&gt;âž¤ pilocarpine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT an NMDA receptor antagonist?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amantadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Flumazenil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Flumazenil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that Ketamine , Memantine , and Amantadine are NMDA receptor antagonists . However, Flumazenil is a GABA-A receptor antagonist , and it does not interact with NMDA receptors.&lt;/li&gt;&lt;li&gt;âž¤ Ketamine&lt;/li&gt;&lt;li&gt;âž¤ Memantine&lt;/li&gt;&lt;li&gt;âž¤ Amantadine&lt;/li&gt;&lt;li&gt;âž¤ NMDA receptor antagonists&lt;/li&gt;&lt;li&gt;âž¤ Flumazenil&lt;/li&gt;&lt;li&gt;âž¤ GABA-A receptor antagonist&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male patient presents with symptoms of enzyme deficiency, leading to an altered metabolic pathway. You decide to study the enzyme kinetics to determine the type of inhibition affecting the enzyme&#x27;s function. After isolating the enzyme, you perform a series of experiments to measure its activity in the presence and absence of a specific inhibitor. You then construct a Lineweaver-Burk plot using the obtained data as shown in the figure below. Based on the Lineweaver-Burk plot provided, what type of inhibition is depicted?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive Inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-Competitive Inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uncompetitive Inhibition&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed Inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Uncompetitive Inhibition&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-151825.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Uncompetitive Inhibition&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Remember the effect of different enzyme inhibitors on lineweaver burke plot&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pembrolizumab â€“ Immune check point inhibitor used for endometrial carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ertugliflozin â€“ SGLT2 inhibitor for treatment of diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â  D) Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a 10-year history of type 2 diabetes mellitus presents to the clinic for a routine follow-up. His current medications include metformin and glimepiride. Despite this regimen, his HbA1c remains elevated at 8.3%. He also has a history of chronic kidney disease (CKD) stage 2 and hypertension, which is well-controlled with an ACE inhibitor. The physician decides to add a medication that not only helps with glycemic control but also provides cardiovascular and renal protection. Which of the following medications is the most appropriate addition to this patientâ€™s regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Linagliptin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glibenclamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The take-home message from this question is that Empagliflozin , an SGLT-2 inhibitor, is an excellent choice for patients with type 2 diabetes, particularly those with chronic kidney disease and cardiovascular risk, due to its glycemic, cardiovascular, and renal benefits.&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of atrial fibrillation is on warfarin therapy for stroke prevention. He presents to the clinic for routine follow-up, and his INR is noted to be elevated. He reports taking several medications for various conditions. Which of the following drugs does not increase the risk of bleeding when taken with warfarin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cimetidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Carbamazepine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Carbamazepine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that drugs inhibiting the cytochrome P450 system , such as isoniazid, ciprofloxacin, and cimetidine , increase the risk of bleeding in patients on warfarin by elevating warfarin levels. In contrast, carbamazepine , a CYP450 inducer , increases warfarin metabolism, potentially lowering its anticoagulant effect, which decreases the risk of bleeding.&lt;/li&gt;&lt;li&gt;âž¤ cytochrome P450 system&lt;/li&gt;&lt;li&gt;âž¤ isoniazid, ciprofloxacin, and cimetidine&lt;/li&gt;&lt;li&gt;âž¤ warfarin&lt;/li&gt;&lt;li&gt;âž¤ carbamazepine&lt;/li&gt;&lt;li&gt;âž¤ CYP450 inducer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of coronary artery disease and a prior stent placement is currently on dual antiplatelet therapy. His cardiologist decides to switch him to a P2Y12 inhibitor that has a reversible mechanism of action and does not require hepatic activation. Which of the following drugs is the most appropriate choice for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ticagrelor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vorapaxar&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ticagrelor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ticagrelor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the distinction between reversible and irreversible P2Y12 inhibitors. Ticagrelor is the only reversible inhibitor of the P2Y12 receptor in the list, while Clopidogrel and Prasugrel are irreversible inhibitors. Vorapaxar acts on a different receptor, PAR-1 , and is not involved in the P2Y12 pathway.&lt;/li&gt;&lt;li&gt;âž¤ reversible&lt;/li&gt;&lt;li&gt;âž¤ irreversible&lt;/li&gt;&lt;li&gt;âž¤ Ticagrelor&lt;/li&gt;&lt;li&gt;âž¤ Clopidogrel&lt;/li&gt;&lt;li&gt;âž¤ Prasugrel&lt;/li&gt;&lt;li&gt;âž¤ Vorapaxar&lt;/li&gt;&lt;li&gt;âž¤ PAR-1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for treatment of hypothyroidism in first trimester of pregnancy is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbimazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;L-thyroxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radioactive iodine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. L-thyroxine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) L-thyroxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The drug of choice for treating hypothyroidism during pregnancy, including the first trimester, is L-thyroxine (levothyroxine) . It is essential for maintaining normal thyroid hormone levels to ensure proper fetal development. Other drugs like Propylthiouracil and Carbimazole are used to treat hyperthyroidism, not hypothyroidism, and radioactive iodine is contraindicated in pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ L-thyroxine (levothyroxine)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male with a history of atrial fibrillation has been on long-term warfarin therapy for stroke prevention. He presents to the emergency department with significant epistaxis that has persisted for over an hour despite attempts to control the bleeding. He reports feeling lightheaded and weak. On examination, his blood pressure is 90/60 mmHg, and heart rate is 110 beats per minute. Laboratory tests show an INR of 8.0. Apart from stopping warfarin, what is the most appropriate next step in managing this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Measure serum warfarin levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Give vitamin K&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give protamine sulfate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Give prothrombin factor complex&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Give prothrombin factor complex&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Give prothrombin factor complex&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with warfarin-induced coagulopathy and significant or life-threatening bleeding, the most appropriate step is to administer prothrombin factor complex for rapid reversal of the anticoagulation. While vitamin K is also necessary, it has a delayed onset, and prothrombin complex concentrate provides immediate correction. Protamine sulfate is not effective in this setting as it is used to reverse heparin.&lt;/li&gt;&lt;li&gt;âž¤ prothrombin factor complex&lt;/li&gt;&lt;li&gt;âž¤ vitamin K&lt;/li&gt;&lt;li&gt;âž¤ prothrombin complex concentrate&lt;/li&gt;&lt;li&gt;âž¤ Protamine sulfate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old pregnant woman at 32 weeks of gestation presents to the obstetric clinic with signs of preterm labor. The medical team decides to administer corticosteroids to promote fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome. Choose the correct option that should be used for fetal lung maturation: ( INICET May 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dexamethasone 12 mg 24 hourly 2 doses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dexamethasone 6 mg 12 hourly 4 doses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Betamethasone 12 mg 12 hourly 2 doses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Betamethasone 12 mg 24 hourly 4 doses&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dexamethasone 6 mg 12 hourly 4 doses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding Angiotensin II Receptor Blockers (ARBs) is not correctly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Losartan: Thromboxane A2 receptor antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Telmisartan: Can reverse insulin resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olmesartan: Causes hypokalaemia in patients with CKD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valsartan: Given in combination with sacubitril as ARNI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Olmesartan: Causes hypokalaemia in patients with CKD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Olmesartan: Causes hypokalaemia in patients with CKD.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that ARBs generally cause hyperkalemia in patients with chronic kidney disease due to aldosterone inhibition, and Olmesartan is no exception. This contrasts with the false statement regarding hypokalemia . Additionally, recognize the unique benefits of Telmisartan in insulin resistance and Valsartan in combination therapy with sacubitril.&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ Olmesartan&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ Telmisartan&lt;/li&gt;&lt;li&gt;âž¤ Valsartan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with a history of epilepsy and type 2 diabetes mellitus presents to the clinic for a follow-up visit. She is currently on carbamazepine for seizure control and metformin for diabetes management. The physician considers starting her on warfarin for a newly diagnosed deep vein thrombosis (DVT). The physician is concerned about potential drug interactions involving cytochrome P450 (CYP) isoforms. Which of the following CYP isoforms is primarily responsible for the metabolism of warfarin, and which substrate is most likely to have a clinically significant interaction with warfarin in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CYP3A4; Simvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CYP2E1; Acetaminophen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CYP2C9; Carbamazepine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CYP2D6; Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CYP2C9; Carbamazepine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CYP2C9; Carbamazepine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that warfarin is primarily metabolized by the CYP2C9 enzyme and that carbamazepine, a known inducer of CYP2C9, can increase the metabolism of warfarin, potentially reducing its anticoagulant effect and necessitating dose adjustments.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What type of antagonism is demonstrated when ipratropium causes bronchodilation via blockade of M3 muscarinic receptors while leukotrienes cause bronchoconstriction through Cys-LT receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Physiological antagonism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chemical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pharmacological antagonism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Physiological antagonism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Physiological antagonism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that physiological antagonism occurs when two drugs produce opposite effects by acting on different receptors or pathways, as seen with ipratropium (acting on M3 receptors) and leukotrienes (acting on Cys-LT receptors) in the context of bronchoconstriction and bronchodilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which group of anticancer drugs does Temozolomide belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral alkylating agent&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antitumor antibiotic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antimetabolite&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitotic spindle inhibitor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oral alkylating agent&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oral alkylating agent&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that Temozolomide is an oral alkylating agent used in the treatment of certain cancers, particularly brain tumors like glioblastoma . It works by inducing DNA damage through alkylation, leading to cell death&lt;/li&gt;&lt;li&gt;âž¤ Temozolomide&lt;/li&gt;&lt;li&gt;âž¤ oral alkylating agent&lt;/li&gt;&lt;li&gt;âž¤ glioblastoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following scales or nomograms is used to assess the risk of acetaminophen (paracetamol) toxicity and guide treatment with N-acetylcysteine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rumack-Matthew Nomogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Naranjo Algorithm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hartford Nomogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Matzke Scale&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rumack-Matthew Nomogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rumack-Matthew Nomogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Rumack-Matthew Nomogram is the standard tool for assessing the risk of acetaminophen toxicity and guiding the initiation of N-acetylcysteine (NAC) treatment, while other tools like the Naranjo Algorithm , Hartford Nomogram , and Matzke Scale serve different purposes in drug monitoring and toxicity management.&lt;/li&gt;&lt;li&gt;âž¤ Rumack-Matthew Nomogram&lt;/li&gt;&lt;li&gt;âž¤ Naranjo Algorithm&lt;/li&gt;&lt;li&gt;âž¤ Hartford Nomogram&lt;/li&gt;&lt;li&gt;âž¤ Matzke Scale&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following agents used for the treatment of Alzheimerâ€™s disease is not available by oral route?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Donepezil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rivastigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lecanumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lecanumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lecanumab is the only agent among the listed options that is not available by the oral route. The others (Donepezil, Rivastigmine, and Memantine) are available in oral forms.&lt;/li&gt;&lt;li&gt;âž¤ Lecanumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person has been consuming large quantities of alcohol daily for 20 years and is physically dependent on alcohol. Which of the following drugs should not be given to this person?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disulfiram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acamprosate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Naltrexone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lorazepam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Disulfiram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Disulfiram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Disulfiram should not be used in individuals who are still actively drinking alcohol due to the risk of severe reactions. Acamprosate , Naltrexone , and Lorazepam are safer options for managing alcohol dependence and withdrawal symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Disulfiram&lt;/li&gt;&lt;li&gt;âž¤ Acamprosate&lt;/li&gt;&lt;li&gt;âž¤ Naltrexone&lt;/li&gt;&lt;li&gt;âž¤ Lorazepam&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Important difference between goserelin and cetrorelix is that the latter&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Can be given orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immediately reduces gonadotropin secretion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Must be given in a pulsatile fashion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initially stimulates release of LH and FSH&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immediately reduces gonadotropin secretion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Immediately reduces gonadotropin secretion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cetrorelix, a GnRH antagonist, immediately suppresses gonadotropin secretion without the initial surge seen with GnRH agonists like Goserelin, making it useful in clinical settings where rapid suppression of gonadotropins is required.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old male with a history of chronic kidney disease (CKD) stage 4 presents with symptoms of fatigue, pallor, and shortness of breath. Laboratory investigations reveal hemoglobin levels of 8.5 g/dL (normal range: 13.8 to 17.2 g/dL in males), indicating anemia of CKD. Which of the following oral drugs can be used to treat anemia in this patient with CKD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daprodustat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Daprodustat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â A) Daprodustat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Daprodustat is a novel oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) used to treat anemia in CKD patients. It offers an alternative to injectable erythropoiesis-stimulating agents by promoting endogenous erythropoietin production through the HIF pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The analgesic effect of paracetamol is mediated by which receptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NK 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;BK 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Px23&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TRPV 1&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TRPV 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) TRPV 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The analgesic effect of paracetamol is thought to be mediated indirectly through the TRPV1 receptor, modulating pain perception, rather than through neurokinin or bradykinin receptors.&lt;/li&gt;&lt;li&gt;âž¤ analgesic effect of paracetamol&lt;/li&gt;&lt;li&gt;âž¤ TRPV1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are true about clozapine except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It can cause hypersalivation as an adverse effect despite its anticholinergic properties&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood level below 350 ng/mL should be maintained to avoid agranulocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is associated with high risk of weight gain and metabolic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Overdose can result in convulsions&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Blood level below 350 ng/mL should be maintained to avoid agranulocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â B) Blood level below 350 ng/mL should be maintained to avoid agranulocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clozapineâ€™s risk of agranulocytosis is not linked to plasma drug levels but is instead an idiosyncratic reaction. Regular hematological monitoring is required for early detection. Clozapine is associated with hypersalivation, significant weight gain, metabolic syndrome, and an increased risk of seizures, especially at higher doses.&lt;/li&gt;&lt;li&gt;âž¤ agranulocytosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All adverse effects of theophylline are mediated by adenosine A1 receptor antagonism except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac arrhythmias&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Seizures&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GI discomfort&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. GI discomfort&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) GI discomfort&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Most of the adverse effects of theophylline , including cardiac arrhythmias , diuresis , and seizures , are mediated by its antagonism of adenosine A1 receptors . However, GI discomfort is not related to adenosine receptor antagonism but is due to direct effects on gastric secretion and mucosal irritation.&lt;/li&gt;&lt;li&gt;âž¤ theophylline&lt;/li&gt;&lt;li&gt;âž¤ cardiac arrhythmias&lt;/li&gt;&lt;li&gt;âž¤ diuresis&lt;/li&gt;&lt;li&gt;âž¤ seizures&lt;/li&gt;&lt;li&gt;âž¤ adenosine A1 receptors&lt;/li&gt;&lt;li&gt;âž¤ GI discomfort&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following actions of drugs on the serotoninergic system is not correctly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Buspirone: Agonist at 5-HT1D receptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Olanzapine: Blocks 5-HT2A receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ondansetron: 5-HT3 antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prucalopride: 5-HT4 receptor agonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Buspirone: Agonist at 5-HT1D receptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Buspirone: Agonist at 5-HT1D receptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dr. Apurv Mehra is managing a 45-year-old patient named Rakesh, who presents with recurring episodes of joint pain and inflammation. After a thorough assessment, Dr. Mehra diagnoses him with hyperuricemia predisposing to gout. To better understand the patient&#x27;s uric acid metabolism, the doctor decides to measure the total amount of uric acid. After receiving the baseline measurements, Rakesh is prescribed an \&quot;antigout\&quot; medication. Several weeks into the therapy, Dr. Mehra repeats the 24-hour urine uric acid measurement to evaluate the drug&#x27;s effectiveness. He observes a significant reduction in the urate content in the post-treatment sample. Throughout the treatment period, Rakesh confirms no new health concerns, and he assures Dr. Mehra that his daily proteins and purine intake remains unchanged. Given these observations, which of the following drugs was most likely prescribed to Rakesh?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Probenecid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Allopurinol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Allopurinol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antimicrobials shows time-dependent killing?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Penicillin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Penicillin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Penicillin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Time-dependent killing is characteristic of drugs like penicillin , which require sustained levels above the MIC for optimal bactericidal effect. In contrast, aminoglycosides and fluoroquinolones exhibit concentration-dependent killing , where the peak concentration is more critical for efficacy.&lt;/li&gt;&lt;li&gt;âž¤ Time-dependent killing&lt;/li&gt;&lt;li&gt;âž¤ penicillin&lt;/li&gt;&lt;li&gt;âž¤ aminoglycosides and fluoroquinolones&lt;/li&gt;&lt;li&gt;âž¤ concentration-dependent killing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following drugs require dose reduction in renal failure except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gentamicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Doxycycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-172651.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Doxycycline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following binds to viral envelope glycoprotein preventing the conformational changes required for the fusion of viral and cellular membranes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abacavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indinavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enfuvirtide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oseltamivir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enfuvirtide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Enfuvirtide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient with a history of chronic kidney disease (CKD) presents to the clinic for routine follow-up. He has been prescribed warfarin for atrial fibrillation. During the visit, the patient complains of increased bruising and episodes of nosebleeds. On examination, the INR is found to be elevated at 3.5 (target range 2.0â€“3.0). The physician suspects an interaction with another drug the patient is taking for his kidney condition. Which of the following scenarios best explains the elevated INR in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The patient started taking aspirin, which competes with warfarin for binding to albumin, leading to an increased free fraction of warfarin and increased anticoagulant effect.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The patient has started taking phenytoin, which induces cytochrome P450 enzymes, increasing the metabolism of warfarin and leading to a decreased anticoagulant effect.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The patientâ€™s CKD has progressed, leading to decreased renal excretion of warfarin and increased plasma concentration, causing an elevated INR.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The patient started taking rifampicin, which displaces warfarin from plasma protein binding sites, leading to an increased free fraction of warfarin and increased anticoagulant effect.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The patient started taking aspirin, which competes with warfarin for binding to albumin, leading to an increased free fraction of warfarin and increased anticoagulant effect.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) The patient started taking aspirin, which competes with warfarin for binding to albumin, leading to an increased free fraction of warfarin and increased anticoagulant effect.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize that warfarin is highly protein-bound and that drugs like aspirin can displace it from albumin binding sites. Understand that displacement increases the free fraction of warfarin, leading to an enhanced anticoagulant effect and elevated INR, which can manifest as increased bleeding risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test9" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D   Mission 2.0, Lap 2   13 03 2025   2025 03 13&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D   Mission 2.0, Lap 2   13 03 2025   2025 03 13&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                60 Questions | 240 Total Marks | 70 min Duration | ~70.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 58-year-old male with a history of chronic heart failure (EF = 35%) and hypertension presents to the emergency department with complaints of worsening shortness of breath and dizziness. He was recently started on a new medication for heart failure. On examination, his heart rate is 48 bpm, and his blood pressure is 95/60 mmHg. ECG shows sinus bradycardia without AV block. Which of the following medications is most likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bisoprolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bisoprolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bisoprolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with non-small cell lung cancer is receiving highly emetogenic chemotherapy. His oncologist prescribes a combination of ondansetron, dexamethasone, and aprepitant for nausea and vomiting prevention. A few days later, the patient, who is also on warfarin for a history of deep vein thrombosis (DVT), undergoes routine INR monitoring, which reveals a significant drop in INR levels. Which of the following best explains the interaction between aprepitant and warfarin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aprepitant induces CYP2C9, increasing warfarin metabolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aprepitant inhibits CYP2C9, decreasing warfarin metabolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aprepitant induces CYP3A4, increasing warfarin metabolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aprepitant inhibits CYP3A4, decreasing warfarin metabolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aprepitant induces CYP2C9, increasing warfarin metabolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Aprepitant induces CYP2C9, increasing warfarin metabolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old hiker is brought to the emergency department by his friends after eating wild berries during a trek. He is agitated, confused, and hallucinating, attempting to grab imaginary objects in the air. His skin is dry and flushed, pupils are bilaterally dilated, and he has urinary retention. His heart rate is 120 bpm, and his temperature is 39.5Â°C (103Â°F). Which of the following drugs is the best treatment for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Naloxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Physostigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Physostigmine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman at 8 weeks of gestation is diagnosed with hypothyroidism. Which of the following is the most appropriate treatment option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methimazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;L-thyroxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Radioactive iodine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. L-thyroxine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) L-thyroxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman at 35 weeks of gestation is receiving LMWH for a history of deep vein thrombosis (DVT) earlier in pregnancy. She presents to the hospital in early labor. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue LMWH until delivery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Switch to intravenous unfractionated heparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop LMWH and induce labor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch to warfarin immediately&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Switch to intravenous unfractionated heparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Switch to intravenous unfractionated heparin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man undergoes prostate surgery (TURP). During the procedure, he develops persistent bleeding due to excessive fibrinolysis. The surgeon decides to administer a medication to inhibit fibrinolysis and control bleeding. Which of the following is the most appropriate drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tranexamic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tranexamic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tranexamic acid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with hypertension and chronic kidney disease (CKD) stage 3 presents with recurrent hyperkalemia on routine blood tests. He is currently on an ACE inhibitor for hypertension. Which of the following diuretics would be the most appropriate choice for managing his hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Furosemide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Furosemide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old male with a history of Alzheimerâ€™s disease presents with urinary urgency, frequency, and nocturia. He has had multiple episodes of urinary incontinence over the past few months. Digital rectal examination reveals a normal-sized prostate with no nodularity. Post-void residual urine is 20 mL (within normal range). Which of the following is the most appropriate treatment for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxybutynin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mirabegron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamsulosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mirabegron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mirabegron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child is brought to the emergency department with complaints of irritability, poor appetite, and abdominal pain. On examination, the child has pallor, cognitive delay, and a bluish line on the gums (Burtonâ€™s line). Blood investigations reveal a microcytic hypochromic anemia with a blood lead level of 75 Âµg/dL. Which of the following is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium disodium EDTA (CaNaâ‚‚EDTA) alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dimercaprol (BAL) + Calcium disodium EDTA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Penicillamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deferoxamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dimercaprol (BAL) + Calcium disodium EDTA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ez18Apk.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dimercaprol (BAL) + Calcium disodium EDTA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of ischemic heart disease and a recent myocardial infarction develops ventricular tachycardia. He is given an intravenous loading dose of lignocaine followed by a maintenance infusion. Which of the following factors primarily determines the loading dose of lignocaine in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clearance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Volume of distribution&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Half-life&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bioavailability&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Volume of distribution&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AURUiAi.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Volume of Distribution&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old hypertensive male has been on an antihypertensive drug for several months. He reports persistent drowsiness, dry mouth, and lethargy but continued the medication. However, after forgetting to take it for 3 days, he presents to the ER with severe hypertension, tachycardia, diaphoresis, and anxiety. Which of the following best explains the mechanism of his rebound hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Upregulation of Î±2-receptors in the CNS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased norepinephrine release due to loss of presynaptic inhibition&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reflex activation of the renin-angiotensin-aldosterone system (RAAS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased sensitivity of vascular smooth muscle to circulating catecholamines&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased norepinephrine release due to loss of presynaptic inhibition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Increased norepinephrine release due to loss of presynaptic inhibition&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with dyslipidemia was started on a lipid-lowering drug. He later developed muscle pain, weakness, and dark-colored urine. His creatine kinase (CK) levels are markedly elevated, and his renal function is worsening. On history, he reports that he was recently prescribed erythromycin for a respiratory infection. Which of the following lipid-lowering drugs is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colesevelam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alirocumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atorvastatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Atorvastatin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Statins + CYP3A4 inhibitors (e.g., erythromycin, clarithromycin, azoles, cyclosporine, amiodarone, grapefruit juice) = Increased risk of rhabdomyolysis. Monitor CK levels in patients taking statins with CYP3A4 inhibitors. Switch to statins less dependent on CYP3A4 (e.g., Rosuvastatin, Pravastatin) in high-risk patients.&lt;/li&gt;&lt;li&gt;âž¤ Statins + CYP3A4 inhibitors (e.g., erythromycin, clarithromycin, azoles, cyclosporine, amiodarone, grapefruit juice) = Increased risk of rhabdomyolysis.&lt;/li&gt;&lt;li&gt;âž¤ Monitor CK levels in patients taking statins with CYP3A4 inhibitors.&lt;/li&gt;&lt;li&gt;âž¤ Switch to statins less dependent on CYP3A4 (e.g., Rosuvastatin, Pravastatin) in high-risk patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs, when given with ketoconazole, can cause QT prolongation and Torsadesâ€™ de pointes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cisapride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cetirizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loratadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Promethazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cisapride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cisapride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female with mild persistent asthma is prescribed an inhaled corticosteroid. She is concerned about potential side effects. Which of the following measures can help minimize the risk of local side effects from inhaled corticosteroids?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Using a high-dose inhaled corticosteroid from the start&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rinsing the mouth with water after inhalation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Using a systemic corticosteroid instead of an inhaled one&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Taking the inhaled corticosteroid on an empty stomach&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Rinsing the mouth with water after inhalation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Rinsing the mouth with water after inhalation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rinsing the mouth after ICS use prevents oropharyngeal candidiasis. Use the lowest effective dose to minimize side effects. A spacer device can also help reduce local side effects.&lt;/li&gt;&lt;li&gt;âž¤ Rinsing the mouth after ICS use prevents oropharyngeal candidiasis.&lt;/li&gt;&lt;li&gt;âž¤ Use the lowest effective dose to minimize side effects.&lt;/li&gt;&lt;li&gt;âž¤ A spacer device can also help reduce local side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition from the given graph:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed Inhibition&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mixed Inhibition&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_oq1Tr8V.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mixed Inhibition&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which phase of clinical trials is the maximum tolerated dose (MTD) of a drug determined?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phase 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Phase 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Phase 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with a history of coronary artery disease and chronic stable angina is brought to the emergency department after collapsing at home. His wife reports that he took a medication for erectile dysfunction earlier that evening. His blood pressure is 70/40 mmHg, and he appears confused. Which of the following medications is most likely to have interacted with his erectile dysfunction drug, causing this severe hypotension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isosorbide dinitrate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Isosorbide dinitrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Isosorbide dinitrate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sildenafil is absolutely contraindicated in patients on nitrates due to the risk of life-threatening hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male with bacterial meningitis is admitted to the hospital. The physician decides to start empirical therapy with a bactericidal antibiotic to ensure rapid bacterial eradication. Which of the following drugs is the most appropriate choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linezolid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ceftriaxone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ceftriaxone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bactericidal drugs like Î²-lactams (e.g., ceftriaxone) are preferred for serious infections like meningitis to rapidly clear the infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old HIV-positive male with a CD4 count of 180 cells/mmÂ³ is started on antiretroviral therapy (ART). Two weeks later, he presents with complaints of vivid dreams, nightmares, dizziness, and difficulty concentrating, especially at night. Which of the following drugs is most likely responsible for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abacavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Efavirenz&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Emtricitabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ritonavir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Efavirenz&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Efavirenz&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Efavirenz is known for its CNS side effects, which typically improve over time and are more pronounced when taken close to bedtime.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old farmer presents with high-grade fever, headache, and myalgia for the past 7 days. On examination, he has generalized lymphadenopathy, a maculopapular rash on the trunk, and an eschar with surrounding erythema on his right thigh. His travel history reveals recent work in a forest area. Laboratory tests show thrombocytopenia and elevated liver enzymes. Which of the following is the drug of choice for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Doxycycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Doxycycline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Doxycycline is the first-line treatment for scrub typhus and most rickettsial infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of chronic heart failure with reduced ejection fraction (HFrEF) presents to the clinic for routine follow-up. He is currently on carvedilol, furosemide, and enalapril but continues to have dyspnea on exertion and fatigue. His physician decides to replace his ACE inhibitor with a newer drug that enhances natriuretic peptide activity and improves vasodilation and natriuresis. Which of the following drugs works through this mechanism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ramipril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aliskiren&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sacubitril&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sacubitril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Sacubitril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sacubitril (part of ARNI therapy) improves outcomes in HFrEF by inhibiting neprilysin, increasing natriuretic peptide levels, and reducing cardiac remodeling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of deep vein thrombosis (DVT) is started on an anticoagulant for long-term thromboprophylaxis. His physician prefers a drug that does not require routine coagulation monitoring for dose adjustments. Which of the following anticoagulants meets this criterion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dalteparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unfractionated heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Argatroban&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dalteparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dalteparin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LMWHs like dalteparin and enoxaparin do not require routine monitoring, making them preferable for outpatient anticoagulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old pregnant woman at 26 weeks of gestation presents with chronic hypertension and requires antihypertensive therapy. She has a history of bronchial asthma and was recently diagnosed with autoimmune hemolytic anemia. Which of the following is the most appropriate choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Nifedipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors like Enalapril are strictly contraindicated in pregnancy. Methyldopa should be avoided in hemolytic anemia, and Labetalol should be avoided in asthma. Nifedipine is the preferred choice when these contraindications exist.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man with treatment-resistant schizophrenia has been on multiple antipsychotic medications without significant improvement. His psychiatrist decides to start him on a drug that is known to be effective for treatment-resistant schizophrenia. Three weeks after starting the medication, he develops fever, sore throat, and malaise. Laboratory investigations reveal a WBC count of 2,000/mmÂ³ with an absolute neutrophil count (ANC) of 800/mmÂ³. Which of the following medications is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Risperidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Quetiapine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clozapine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Clozapine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clozapine is highly effective in treatment-resistant schizophrenia but requires frequent blood monitoring due to the risk of agranulocytosis. Regular ANC checks are mandatory to detect neutropenia early and prevent life-threatening infections.&lt;/li&gt;&lt;li&gt;âž¤ Clozapine is highly effective in treatment-resistant schizophrenia but requires frequent blood monitoring due to the risk of agranulocytosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old pregnant woman at 30 weeks of gestation is admitted with preterm labor. To enhance fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome (RDS), the obstetrician decides to administer a corticosteroid. Which of the following regimens is the most appropriate choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydrocortisone 100 mg IV every 8 hours for 48 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methylprednisolone 16 mg IM once daily for 2 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Betamethasone 12 mg IM every 24 hours for 2 doses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dexamethasone 12 mg IM every 24 hours for 2 doses&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Betamethasone 12 mg IM every 24 hours for 2 doses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Betamethasone 12 mg IM every 24 hours for 2 doses&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For fetal lung maturation in preterm labor , the preferred corticosteroids are:&lt;/li&gt;&lt;li&gt;âž¤ fetal lung maturation in preterm labor&lt;/li&gt;&lt;li&gt;âž¤ Betamethasone 12 mg IM every 24 hours (2 doses) Dexamethasone 6 mg IM every 12 hours (4 doses)&lt;/li&gt;&lt;li&gt;âž¤ Betamethasone 12 mg IM every 24 hours (2 doses)&lt;/li&gt;&lt;li&gt;âž¤ Dexamethasone 6 mg IM every 12 hours (4 doses)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old immunocompromised male with febrile neutropenia is diagnosed with disseminated mucormycosis. He is started on an antifungal agent that is drug of choice for this condition. What is the primary site of action of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nucleic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ribosome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cell membrane&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cytoplasm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cell membrane&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cell membrane&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amphotericin B acts on the fungal cell membrane by binding to ergosterol and forming pores, leading to fungal cell death. It is the drug of choice for life-threatening systemic fungal infections like mucormycosis and cryptococcal meningitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old postmenopausal woman with osteoporosis and a history of multiple fractures is prescribed a medication that acts without inhibiting osteoclast function. Which of the following drugs fits this mechanism of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ibandronate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Teriparatide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Teriparatide (PTH analog) is the only option that acts without directly inhibiting osteoclasts, making it suitable for osteoporosis treatment when bone formation needs to be enhanced.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of chronic gout presents to the emergency department with sudden onset severe pain, redness, and swelling in his first metatarsophalangeal joint. On examination, the joint is tender, swollen, and warm, and the patient rates his pain as 9/10. You decide to start acute gout treatment. Which of the following is UNLIKELY to be the mechanism of action of the drug used in this setting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits synthesis of uric acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits cyclooxygenase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibits phospholipase A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Binds to tubulin and inhibits granulocyte migration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibits synthesis of uric acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute gout is treated with NSAIDs, colchicine, or corticosteroids. Drugs that lower uric acid (allopurinol, febuxostat) are NOT used during an acute attack.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old male with a history of hypertension, type 2 diabetes, and recent myocardial infarction (MI) undergoes percutaneous coronary intervention (PCI) with stent placement. He is prescribed dual antiplatelet therapy (DAPT)consisting of aspirin and ticagrelor to prevent stent thrombosis. Which of the following statements is true about ticagrelor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is an irreversible P2Y12 receptor inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a pro-drug requiring hepatic activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It has a faster onset of action than clopidogrel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is affected by CYP2C19 inhibitors like omeprazole, reducing its efficacy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It has a faster onset of action than clopidogrel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ticagrelor is a reversible, direct-acting P2Y12 inhibitor with a faster onset and more consistent action than clopidogrel, making it a preferred choice in ACS patients undergoing PCI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is administered Drug A, and its dose-response curve is plotted. Later, the patient receives Drug B or Drug C before administering Drug A again. The changes in the dose response curve are shown in the diagram below. Which of the following best describes the type of inhibition caused by Drug B and Drug C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B is a reversible competitive inhibitor, and Drug C is a non-competitive inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B is an irreversible competitive inhibitor, and Drug C is a reversible competitive inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug B is a reversible competitive inhibitor, and Drug C is an irreversible competitive inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug B is a non-competitive inhibitor, and Drug C is an irreversible competitive inhibitor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Drug B is a reversible competitive inhibitor, and Drug C is a non-competitive inhibitor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DqAjA1s.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Drug B is a reversible competitive inhibitor, and Drug C is a non-competitive inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatric patient is brought to the emergency department with signs of ocular hypotension and apnea. The parents are concerned about the child&#x27;s condition and have provided a history of recent medication use. It is crucial to determine which drug may have caused these symptoms in the infant. Drug capable of causing ocular hypotension with apnea in infants is: (NEET PG 2019)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brimonidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dorzolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Brimonidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Brimonidine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of atrial fibrillation and hypertension is started on an anticoagulant to reduce his risk of stroke. He is prescribed an oral direct thrombin inhibitor that does not require routine INR monitoring. Unlike warfarin, this drug directly inhibits thrombin (factor IIa) and has a specific reversal agent available. Which of the following drugs was most likely prescribed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bivalirudin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dabigatran&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rivaroxaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dabigatran&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dabigatran&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old child is found to be an asymptomatic carrier of Corynebacterium diphtheriae during a school health screening. He has no signs of pharyngitis or systemic illness. To prevent transmission to others, he is started on an antibiotic to eradicate the bacteria from his nasopharynx. What is the drug of choice for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tetracycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Erythromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Erythromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with a history of stable angina presents with complaints of exertional chest pain that is relieved by rest. His ECG and cardiac enzymes are normal. He is started on a drug that acts via a dual mechanismâ€”by releasing nitric oxide (NO) and activating potassium (Kâº) channels, leading to coronary vasodilation and cardioprotective effects. Which of the following drugs has this dual mechanism of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nicorandil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glyceryl trinitrate (GTN)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Nicorandil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Nicorandil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male undergoing chemotherapy for lung cancer develops severe vomiting on the third day after chemotherapy. He had mild nausea on the first day, which was controlled with medications. Now, despite taking oral antiemetics, he continues to have episodes of vomiting. Which of the following is the most effective drug for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granisetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aprepitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Domperidone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aprepitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aprepitant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While 5-HT3 receptor antagonists (Granisetron, Ondansetron) are commonly used for chemotherapy-induced nausea and vomiting, delayed vomiting (after 24 hours) is best managed with NK1 receptor antagonists like Aprepitant.&lt;/li&gt;&lt;li&gt;âž¤ delayed vomiting (after 24 hours)&lt;/li&gt;&lt;li&gt;âž¤ NK1 receptor antagonists like Aprepitant.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with hospital-acquired pneumonia is started on a broad-spectrum antibiotic. However, this antibiotic is rapidly metabolized by renal dehydropeptidase-I, leading to its inactivation. To prevent this metabolism and prolong the drugâ€™s action, Cilastatin is co-administered. Which of the following antibiotics requires Cilastatin for its efficacy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Meropenem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Imipenem&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefazolin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Piperacillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Imipenem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Imipenem&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cilastatin is always combined with Imipenem to prevent renal metabolism and improve its efficacy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female with breast cancer is undergoing chemotherapy and develops severe neutropenia. To stimulate neutrophil production, her oncologist prescribes pegylated-filgrastim instead of filgrastim. Which of the following is true about pegylated-filgrastim?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duration of action is longer than filgrastim&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a GM-CSF analog&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It increases the risk of febrile neutropenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these are correct&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Duration of action is longer than filgrastim&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Duration of action is longer than filgrastim&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pegylated-filgrastim has a longer duration of action than filgrastim, reducing the frequency of administration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Osmotic diuretics, such as mannitol, work by increasing the osmolarity of plasma and renal tubular fluid, drawing water out of cells and into the intravascular space. This leads to increased urine output (diuresis). In which of the following conditions should intravenous mannitol be avoided?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebral edema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute angle-closure glaucoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Raised intracranial pressure (ICP) due to trauma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary edema&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary edema&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pulmonary edema&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mannitol is contraindicated in pulmonary edema and anuric renal failure due to the risk of fluid overload . However, it remains useful in neurological conditions like cerebral edema, raised ICP, and glaucoma .&lt;/li&gt;&lt;li&gt;âž¤ contraindicated in pulmonary edema and anuric renal failure&lt;/li&gt;&lt;li&gt;âž¤ fluid overload&lt;/li&gt;&lt;li&gt;âž¤ useful in neurological conditions&lt;/li&gt;&lt;li&gt;âž¤ cerebral edema, raised ICP, and glaucoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a long-standing history of bipolar disorder has been stable on lithium therapy. Recently, he was diagnosed with hypertension and started on thiazide diuretics. After a few days, he presented with coarse tremors and other symptoms suggestive of lithium toxicity. What is the likely mechanism of this interaction between lithium and thiazides? (NEET PG 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiazide inhibits the metabolism of lithium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thiazides act as an add-on drug to lithium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiazides increase the tubular resorption of lithium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiazides cause water loss thereby increasing lithium levels&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thiazides increase the tubular resorption of lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Thiazides increase the tubular resorption of lithium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thiazide diuretics increase the tubular reabsorption of lithium, leading to elevated blood levels and potential toxicity. This interaction is crucial to consider when prescribing thiazides to patients on lithium therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female with rheumatoid arthritis presents with complaints of fatigue, oral ulcers, and occasional nausea over the past few months. She has been on long-term treatment for her condition. Laboratory tests reveal macrocytic anemia. Liver function tests show mildly elevated transaminases. Which of the following drugs she might be taking is most likely responsible for this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sulfasalazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Methotrexate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Methotrexate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Methotrexate toxicity is characterized by oral ulcers, nausea, macrocytic anemia, and hepatotoxicity. Folic acid supplementation is essential to prevent these side effects.&lt;/li&gt;&lt;li&gt;âž¤ Methotrexate toxicity is characterized by oral ulcers, nausea, macrocytic anemia, and hepatotoxicity.&lt;/li&gt;&lt;li&gt;âž¤ Folic acid supplementation is essential to prevent these side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male with a history of bronchial asthma was recently started on an antipsychotic for schizophrenia. After a few days, he complains of severe restlessness, inability to sit still, and a strong urge to move his legs constantly, making it difficult for him to focus on daily activities. Which of the following is the most appropriate management for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reassure the patient that it will settle in a few days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the dose of antipsychotic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Benzhexol (Trihexyphenidyl)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Benzhexol (Trihexyphenidyl)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Benzhexol (Trihexyphenidyl)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propranolol is the first-line treatment for akathisia, but in asthma patients, benzhexol (Trihexyphenidyl) is preferred.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of atrial fibrillation, hypertension, and coronary artery disease has been on multiple medications, including metoprolol, atorvastatin, warfarin, amiodarone, and aspirin. He now presents with bluish-gray skin discoloration on sun-exposed areas. Which of the following drugs is the most likely cause of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Amiodarone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Amiodarone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient on multiple drugs, amiodarone should be suspected if they develop blue-gray skin discoloration, especially on sun-exposed areas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male is planning a trip to the mountainous region of Shimla. He has a history of motion sickness and is concerned about developing symptoms such as nausea, dizziness, and vomiting during the winding road journey. He visits his physician for advice on prophylactic medication. Which of the following drugs would be most appropriate for the prevention of motion sickness?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetazolamide oral tablet 250 mg twice daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Scopolamine transdermal patch (apply 30 minutes before travel)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Promethazine oral tablet (take 30 minutes before travel)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ondansetron oral tablet (take 30 minutes before travel)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Promethazine oral tablet (take 30 minutes before travel)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Promethazine oral tablet (take 30 minutes before travel)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Many students may wrongly choose option B (Scopolamine patch 30 min before), but the correct answer is C (Promethazine 30 min before travel)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of chronic heart failure (CHF) with reduced ejection fraction (HFrEF) and hypertension was started on a new antihypertensive medication. A few days later, he developed a persistent dry coughwithout fever or dyspnea. His current medications include furosemide, carvedilol, spironolactone, and a recently introduced drug for heart failure. Which of the following drugs is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omapatrilat&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Omapatrilat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Omapatrilat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on low dose aspirin therapy presented with occult blood in the stool. Which of the following best describes the mechanism of this adverse effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of cyclooxygenase by aspirin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of thromboxane A2 synthase by aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastric bleeding caused by aspirin to peptic ulcer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these. give answer and explanation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of cyclooxygenase by aspirin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Inhibition of Cyclooxygenase by Aspirin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Low-dose aspirin does not cause peptic ulcers but increases the risk of GI bleeding. Aspirin inhibits COX, not thromboxane Aâ‚‚ synthase. COX-1 inhibition leads to decreased gastric protection and increased risk of occult bleeding. Aspirin-induced GI bleeding can be reduced with PPIs (e.g., omeprazole) or enteric-coated formulations.&lt;/li&gt;&lt;li&gt;âž¤ Low-dose aspirin does not cause peptic ulcers but increases the risk of GI bleeding.&lt;/li&gt;&lt;li&gt;âž¤ Aspirin inhibits COX, not thromboxane Aâ‚‚ synthase.&lt;/li&gt;&lt;li&gt;âž¤ COX-1 inhibition leads to decreased gastric protection and increased risk of occult bleeding.&lt;/li&gt;&lt;li&gt;âž¤ Aspirin-induced GI bleeding can be reduced with PPIs (e.g., omeprazole) or enteric-coated formulations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old postmenopausal woman presents with lower back pain and a history of height loss over the past few years. She has a history of a Colles&#x27; fracture from a minor fall a year ago. A DEXA scan reveals a T-score of -3.0, confirming severe osteoporosis. Which of the following is the most appropriate initial pharmacological treatment for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alendronate (Bisphosphonate)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcitonin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alendronate (Bisphosphonate)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alendronate (Bisphosphonate)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bisphosphonates (e.g., alendronate, risedronate) are first-line therapy for osteoporosis. Denosumab is an alternative for patients intolerant to bisphosphonates or with renal issues. Raloxifene is mainly used for vertebral fractures, not hip fractures. Calcium (1200 mg/day) and Vitamin D (800â€“1000 IU/day) supplementation is essential.&lt;/li&gt;&lt;li&gt;âž¤ Bisphosphonates (e.g., alendronate, risedronate) are first-line therapy for osteoporosis.&lt;/li&gt;&lt;li&gt;âž¤ Denosumab is an alternative for patients intolerant to bisphosphonates or with renal issues.&lt;/li&gt;&lt;li&gt;âž¤ Raloxifene is mainly used for vertebral fractures, not hip fractures.&lt;/li&gt;&lt;li&gt;âž¤ Calcium (1200 mg/day) and Vitamin D (800â€“1000 IU/day) supplementation is essential.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male patient was diagnosed with atrial fibrillation with a controlled ventricular rate. The medication charts reveal that he was taking digoxin, potassium chloride, clarithromycin, atenolol, and triamterene. Suspecting the symptoms to be due to digoxin overdose, plasma levels of digoxin were ordered. It was found that his blood levels of digoxin have increased significantly. Which of his medications is most likely responsible for this increase in digoxin levels? (NEET PG 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Potassium chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triamterene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Clarithromycin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clarithromycin can significantly increase plasma levels of digoxin by inhibiting its metabolism through the cytochrome P450 system and by inhibiting P-glycoprotein, leading to an increased risk of digoxin toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with chronic kidney disease (CKD) stage 4 presents with chronic lower back pain and asks for pain relief. Which of the following analgesics is the safest choice for long-term use in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tramadol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diclofenac&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetaminophen (Paracetamol)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acetaminophen (Paracetamol)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Acetaminophen (Paracetamol)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acetaminophen is the safest choice for mild-to-moderate pain in CKD. Tramadol can be used cautiously with dose adjustments. NSAIDs (Indomethacin, Diclofenac) should be avoided in CKD. If stronger pain relief is needed, opioids like tramadol (adjusted dose) or buprenorphine are preferred over NSAIDs.&lt;/li&gt;&lt;li&gt;âž¤ Acetaminophen is the safest choice for mild-to-moderate pain in CKD.&lt;/li&gt;&lt;li&gt;âž¤ Tramadol can be used cautiously with dose adjustments.&lt;/li&gt;&lt;li&gt;âž¤ NSAIDs (Indomethacin, Diclofenac) should be avoided in CKD.&lt;/li&gt;&lt;li&gt;âž¤ If stronger pain relief is needed, opioids like tramadol (adjusted dose) or buprenorphine are preferred over NSAIDs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female with rheumatoid arthritis has persistent joint pain and swelling despite being on methotrexate. Her rheumatologist is considering adding anakinra to her treatment regimen. What is the mechanism of action of anakinra?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of TNF-alpha&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IL-1 receptor antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monoclonal antibody against IL-6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Extracellular increase in adenosine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IL-1 receptor antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IL-1 receptor antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anakinra is an IL-1 receptor antagonist, blocking IL-1 effects in inflammatory diseases. Used in RA, Stillâ€™s disease, and auto-inflammatory syndromes. Does not inhibit TNF-alpha, IL-6, or increase extracellular adenosine. Less commonly used than TNF inhibitors but helpful in certain cases.&lt;/li&gt;&lt;li&gt;âž¤ Anakinra is an IL-1 receptor antagonist, blocking IL-1 effects in inflammatory diseases.&lt;/li&gt;&lt;li&gt;âž¤ Used in RA, Stillâ€™s disease, and auto-inflammatory syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Does not inhibit TNF-alpha, IL-6, or increase extracellular adenosine.&lt;/li&gt;&lt;li&gt;âž¤ Less commonly used than TNF inhibitors but helpful in certain cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with obesity (BMI 34 kg/mÂ²) and dyslipidemia visits the clinic for weight management. He is prescribed a drug that reduces dietary fat absorption in the intestine. Which of the following drugs is being referred to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ezetimibe, which inhibits NPC1L1 protein in the intestine to reduce cholesterol absorption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Orlistat, which inhibits pancreatic lipase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liraglutide, which stimulates GLP-1 receptors to induce satiety&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tirzepatide which is dual agonist of GLP-1 and GIP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Orlistat, which inhibits pancreatic lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Orlistat, which inhibits pancreatic lipase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Orlistat inhibits pancreatic lipase â†’ reduces fat absorption â†’ aids in weight loss. Ezetimibe inhibits cholesterol absorption but does NOT affect dietary fat. Liraglutide &amp;amp; Tirzepatide help in weight loss via appetite suppression, not fat absorption inhibition. Students may confuse Ezetimibe with Orlistatâ€”both affect absorption, but one targets cholesterol, the other targets fat&lt;/li&gt;&lt;li&gt;âž¤ Orlistat inhibits pancreatic lipase â†’ reduces fat absorption â†’ aids in weight loss.&lt;/li&gt;&lt;li&gt;âž¤ Ezetimibe inhibits cholesterol absorption but does NOT affect dietary fat.&lt;/li&gt;&lt;li&gt;âž¤ Liraglutide &amp;amp; Tirzepatide help in weight loss via appetite suppression, not fat absorption inhibition.&lt;/li&gt;&lt;li&gt;âž¤ Students may confuse Ezetimibe with Orlistatâ€”both affect absorption, but one targets cholesterol, the other targets fat&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with enlarged hands and feet, coarse facial features, excessive sweating, and glucose intolerance. MRI reveals a pituitary adenoma. The patient prefers an oral medication for treatment. Which of the following drugs is an oral agent used to treat acromegaly?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Octreotide, a somatostatin analog that inhibits GH secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pegvisomant, a GH receptor antagonist that blocks GH action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cabergoline, a dopamine agonist that suppresses GH secretion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lanreotide, a long-acting somatostatin analog&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cabergoline, a dopamine agonist that suppresses GH secretion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cabergoline, a dopamine agonist that suppresses GH secretion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A diabetic patient presented with rhinitis and swelling of the face. Intranasal biopsy revealed the presence of broad-based aseptate hyphae with right-angle branching. There was evidence of vascular invasion. What will be the preferred oral treatment for this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Caspofungin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Posaconazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Terbinafine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Posaconazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Posaconazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IV Amphotericin B = First-line for mucormycosis Posaconazole or Isavuconazole = Oral step-down therapy Echinocandins (Caspofungin) &amp;amp; Terbinafine are ineffective Surgical debridement is essential&lt;/li&gt;&lt;li&gt;âž¤ IV Amphotericin B = First-line for mucormycosis&lt;/li&gt;&lt;li&gt;âž¤ Posaconazole or Isavuconazole = Oral step-down therapy&lt;/li&gt;&lt;li&gt;âž¤ Echinocandins (Caspofungin) &amp;amp; Terbinafine are ineffective&lt;/li&gt;&lt;li&gt;âž¤ Surgical debridement is essential&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloroquine plus primaquine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Artemisinin based combination therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Quinine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Quinine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Quinine is often used as a treatment for malaria during pregnancy, especially if other options are not available or suitable. However, it is usually more associated with the treatment of Plasmodium falciparum rather than Plasmodium vivax.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the mechanism of action of amloride?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blockade of Na-Cl symporter in DCT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blockade of Na K 2Cl symporter in Loop of Henle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blockade of aldosterone receptors in collecting duct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blockade of epithelial sodium channels in collecting duct&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Blockade of epithelial sodium channels in collecting duct&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Blockade of epithelial sodium channels in the collecting duct&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiloride blocks ENaC in the collecting duct â†’ potassium-sparing diuretic Used to counteract hypokalemia from thiazide or loop diuretics Thiazides block Na-Cl symporter in DCT, loop diuretics block Na-K-2Cl symporter in Henle Aldosterone antagonists block aldosterone receptors, not ENaC directly&lt;/li&gt;&lt;li&gt;âž¤ Amiloride blocks ENaC in the collecting duct â†’ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;âž¤ Used to counteract hypokalemia from thiazide or loop diuretics&lt;/li&gt;&lt;li&gt;âž¤ Thiazides block Na-Cl symporter in DCT, loop diuretics block Na-K-2Cl symporter in Henle&lt;/li&gt;&lt;li&gt;âž¤ Aldosterone antagonists block aldosterone receptors, not ENaC directly&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 53-year-old male presented with type 2 diabetes mellitus. Which of the following anti-diabetic drug acts by causing glucosuria? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acarbose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glipizide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sitagliptin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitor, works by blocking glucose reabsorption in the kidney, leading to increased glucose excretion in the urine, i.e., glucosuria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old child with a previous history of GTCS presents with convulsions which are ongoing since 25 minutes. What should be the appropriate immediate management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lorazepam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethosuximide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lorazepam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lorazepam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the preferred drug for treatment of post-menopausal breast cancer? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anastrozole&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anastrozole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Anastrozole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anastrozole is an aromatase inhibitor and is drug of choice for treatment of breast cancer (which is estrogen receptor positive) in post-menopausal females.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and dolutegravir 50 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add lamivudine 300 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add dolutegravir 50 mg in the morning&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Add dolutegravir 50 mg in the morning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Add dolutegravir 50 mg in the morning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients on a dolutegravir-based regimen who start rifampicin-based anti-tubercular therapy, an additional dose of dolutegravir 50 mg should be taken in the morning (12 hours apart from the regular dose) to maintain effective drug levels and manage HIV effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male is brought to the emergency department after ingesting an overdose of a medication. In order to enhance drug clearance, you consider the modification of urinary pH as a therapeutic measure. Knowing that manipulating the urinary pH can increase the excretion of certain drugs by altering their ionization state, which of the following drugs would not have its excretion increased by alkalinization of the urine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Morphine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Morphine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspirin : Aspirin (acetylsalicylic acid) is an acidic drug . Alkalinizing the urine with agents such as sodium bicarbonate can enhance its ionization and excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ Aspirin&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate : This is also an acidic drug , and alkalinization of the urine will increase its ionization , decreasing reabsorption and increasing elimination.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ alkalinization of the urine will increase its ionization&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenobarbitone : This is an acidic drug , and like aspirin and methotrexate , it is more ionized in alkaline urine, leading to increased excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ acidic drug&lt;/li&gt;&lt;li&gt;â€¢ aspirin and methotrexate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of drug overdose , urinary alkalinization is utilized to increase the excretion of acidic drugs by enhancing their ionization , which does not apply to basic drugs like morphine that are better excreted in acidic conditions. Remember, the drugs ending with â€˜ineâ€™ are basic.&lt;/li&gt;&lt;li&gt;âž¤ drug overdose&lt;/li&gt;&lt;li&gt;âž¤ urinary alkalinization&lt;/li&gt;&lt;li&gt;âž¤ increase the excretion of acidic drugs&lt;/li&gt;&lt;li&gt;âž¤ enhancing their ionization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of Prinzmetalâ€™s angina is started on isosorbide mono nitrate. What is the mechanism of action of nitrates in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reduced cardiac contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased left ventricular end diastolic volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased diastolic perfusion pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endothelium independent coronary vasodilatation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Endothelium independent coronary vasodilatation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Endothelium independent coronary vasodilatation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced cardiac contractility: Incorrect as nitrates do not primarily act by reducing the contractility of the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reduced cardiac contractility:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not&lt;/li&gt;&lt;li&gt;â€¢ reducing the contractility of the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased left ventricular end diastolic volume: Incorrect because nitrates do not typically increase left ventricular end-diastolic volume; they reduce preload and afterload through vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased left ventricular end diastolic volume:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not&lt;/li&gt;&lt;li&gt;â€¢ increase left ventricular end-diastolic volume;&lt;/li&gt;&lt;li&gt;â€¢ reduce preload and afterload&lt;/li&gt;&lt;li&gt;â€¢ vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased diastolic perfusion pressure: Incorrect as nitrates do not reduce diastolic perfusion pressure; their action is aimed at reducing vasospasm and increasing perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased diastolic perfusion pressure:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ nitrates do not reduce diastolic perfusion pressure;&lt;/li&gt;&lt;li&gt;â€¢ reducing vasospasm and increasing perfusion.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ In Prinzmetalâ€™s angina, nitrates like isosorbide mononitrate work by causing endothelium independent coronary vasodilation, acting directly on the vascular smooth muscle through NO donation, which leads to pain relief by reversing the coronary vasospasm.&lt;/li&gt;&lt;li&gt;â€¢ Prinzmetalâ€™s angina,&lt;/li&gt;&lt;li&gt;â€¢ isosorbide mononitrate&lt;/li&gt;&lt;li&gt;â€¢ causing endothelium independent coronary vasodilation,&lt;/li&gt;&lt;li&gt;â€¢ vascular smooth muscle through NO donation,&lt;/li&gt;&lt;li&gt;â€¢ leads to pain relief&lt;/li&gt;&lt;li&gt;â€¢ reversing the coronary vasospasm.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 70 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test10" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D 1 (Mission Neet Pg 1.0)   27 09 2023   2023 09 27&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D 1 (Mission Neet Pg 1.0)   27 09 2023   2023 09 27&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 67-year-old man with a history of chronic obstructive pulmonary disease (COPD) is admitted to the intensive care unit for acute exacerbation of his respiratory symptoms. Cultures are taken, and Pseudomonas aeruginosa is isolated from his sputum sample. The healthcare team is considering various antibiotic options to target this specific bacterial strain. Which of the following antibiotics is not effective against infections caused by Pseudomonas aeruginosa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Adrenaline acting via beta 2 receptors causes bronchodilation whereas histamine acting through H1 receptors cause bronchoconstriction. Which type of antagonism it is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pharmacological antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chemical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physiological antagonism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Physiological antagonism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Physiological Antagonism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ A) Pharmacological Antagonism: This term generally refers to one drug reducing the effectiveness of another drug, typically through receptor competition or a similar mechanism at the molecular level. Since adrenaline and histamine act on different receptors to produce opposite physiological effects, this option is not correct.&lt;/li&gt;&lt;li&gt;â€¢ B) Chemical Antagonism: This occurs when one drug directly reacts with another to neutralize its effects e.g. antacids neutralize gastric acid and protamine neutralize heparin. There is no direct chemical reaction between adrenaline and histamine, making this option incorrect.&lt;/li&gt;&lt;li&gt;â€¢ C) Physical Antagonism: This would imply that the drugs physically interfere with each other e.g. charcoal adbsorbs many drugs and is used in drug poisoning.&lt;/li&gt;&lt;li&gt;â€¢ D) Physiological Antagonism: This is the correct answer. Physiological antagonism occurs when two drugs produce opposite effects in the same physiological system. Adrenaline causes bronchodilation via beta-2 receptors, while histamine causes bronchoconstriction via H1 receptors. These drugs act on different receptor types but have opposite effects on the same physiological system, namely the bronchial smooth muscle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer presents to the emergency department with pinpoint pupil, diarrhea, sweating, excessive lacrimation, salivation and garlic dour. on examination there is bradycardia and BP is 80/60 mm Hg pulse rate is 56/min and his plasma cholinesterase level was 52 U/mL. Which of the following is antidote for treatment of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pralidoxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;N-acetylcysteine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Atropine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Atropine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ A) Pralidoxine: This drug is typically used alongside atropine for treating organophosphate poisoning to reactivate acetylcholinesterase, but it does not counteract the cholinergic symptoms the patient is experiencing.&lt;/li&gt;&lt;li&gt;â€¢ B) Atropine: This is the correct answer. The farmer&#x27;s symptoms such as pinpoint pupils, excessive salivation, and bradycardia suggest cholinergic toxicity, likely from organophosphate exposure. Atropine acts as an antagonist at muscarinic cholinergic receptors and would counteract many of the symptoms observed.&lt;/li&gt;&lt;li&gt;â€¢ C) Physostigmine: This drug is a cholinesterase inhibitor and would worsen the symptoms of cholinergic toxicity, making it an inappropriate treatment in this case.&lt;/li&gt;&lt;li&gt;â€¢ D) N-acetylcysteine: This is commonly used for acetaminophen overdose and would not be effective for treating symptoms of cholinergic toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of benign prostatic hyperplasia (BPH) is scheduled to receive a new medication. The physician explains the mechanism of action and potential side effects of finasteride to the patient and his family. Which of the following is true about finasteride?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It increases the production of testosterone.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It act as an antagonist of androgen receptors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can cause sexual side effects such as decreased libido and erectile dysfunction.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is only effective in reducing symptoms of BPH in the short-term.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It can cause sexual side effects such as decreased libido and erectile dysfunction.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It can cause sexual side effects such as decreased libido and erectile dysfunction.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Finasteride like drugs are a class of medications used to treat BPH by reducing the size of the prostate gland. They work by inhibiting the enzyme 5 alpha reductase, which converts testosterone to dihydrotestosterone (DHT). By reducing the levels of DHT, 5 alpha reductase inhibitors can shrink the prostate gland and improve urinary symptoms associated with BPH. A potential side effect of these medications is sexual dysfunction, including decreased libido and erectile dysfunction. These medications can take several months to achieve their maximum effect and can provide long-term relief of BPH symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Finasteride like drugs are a class of medications used to treat BPH by reducing the size of the prostate gland.&lt;/li&gt;&lt;li&gt;â€¢ They work by inhibiting the enzyme 5 alpha reductase, which converts testosterone to dihydrotestosterone (DHT).&lt;/li&gt;&lt;li&gt;â€¢ By reducing the levels of DHT, 5 alpha reductase inhibitors can shrink the prostate gland and improve urinary symptoms associated with BPH.&lt;/li&gt;&lt;li&gt;â€¢ A potential side effect of these medications is sexual dysfunction, including decreased libido and erectile dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ These medications can take several months to achieve their maximum effect and can provide long-term relief of BPH symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match of symptoms and action of antidepressants and the receptors involved?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sedation and weight gain - H1 receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dry mouth and constipation - Muscarinic receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sexual dysfunction and anorgasmia â€“ 5HT reuptake inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension - Alpha-1 receptor blockade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypertension - Alpha-1 receptor blockade&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/5_hniNzH3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hypertension - Alpha-1 receptor blockade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic response of epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phentolamine epinephrine coupling&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vasomotor reversal of Dale&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vasomotor reversal of Dale&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old male with a history of tuberculosis presents to the clinic with complaints of cough, fever, and night sweats. The patient reports completing a course of anti-tuberculosis medications but reports recurrent symptoms. Sputum culture reveals that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin and sensitive to other first line drugs and linezolide as well as bedaquiline. Which type of tuberculosis it can be referred to as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDR Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pre-XDR Tuberculosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;XDR Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin resistant Tuberculosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pre-XDR Tuberculosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Pre-XDR Tuberculosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s history and sputum culture indicate that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin, but is sensitive to other first-line drugs and linezolide, as well as bedaquiline. Based on this information, the patient&#x27;s condition can be referred to as Pre-XDR Tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s history and sputum culture indicate that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin, but is sensitive to other first-line drugs and linezolide, as well as bedaquiline. Based on this information, the patient&#x27;s condition can be referred to as Pre-XDR Tuberculosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old researcher is studying a novel antiviral drug that has shown promise in in-vitro studies. The researcher is in the process of planning the clinical development of the drug. She explains to her team that the next step involves a phase zero clinical trial, which will be crucial in determining whether to move on to phase I trials. The team is confused, as they are not familiar with phase zero clinical trials. Which of the following statements is true regarding phase zero clinical trials, that would help the team understand its significance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement and metabolism of the drug in the human body.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug: This statement is incorrect. Phase zero clinical trials are human trials that precede phase I trials. They are not animal studies.&lt;/li&gt;&lt;li&gt;â€¢ B) Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug: This is incorrect. Phase zero trials are not designed to provide comprehensive data on safety and efficacy but are focused on pharmacokinetics and perhaps some initial pharmacodynamic data.&lt;/li&gt;&lt;li&gt;â€¢ C) Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body: This is correct. The main aim of phase zero trials is to gather preliminary data on pharmacokinetics and assess whether the drug behaves in humans as it does in preclinical models.&lt;/li&gt;&lt;li&gt;â€¢ D) Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question: This is incorrect. Phase zero trials are exploratory trials that precede phase I trials; they are not focused on therapeutic outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the statement that would best help the team understand the significance of phase zero trials is that they primarily focus on pharmacokinetics and provide initial human data on the movement and metabolism of the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of chronic kidney disease presents to the emergency department with complaints of muscle weakness, nausea, and abdominal cramping. Laboratory testing shows that the patient has hyperkalemia, with a serum potassium level of 6.5 mEq/L. The patient&#x27;s medications are reviewed, and it is discovered that he has been taking several drugs for his cardiac conditions and hypertension. Upon further evaluation, it is determined that one of these drugs may be contributing to the patient&#x27;s hyperkalemia. Which of the following drugs should be stopped in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Enalapril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Enalapril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of gastroesophageal reflux disease (GERD) consults his physician for treatment options. The physician recommends the use of rabeprazole, a proton pump inhibitor. Which of the following statements about proton pump inhibitors is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proton pump inhibitors are available as enteric-coated tablets.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proton pump inhibitors act from the luminal side of gastric parietal cells.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proton pump inhibitors are inactive at neutral pH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proton pump inhibitors should be taken half an hour before food&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Proton pump inhibitors act from the luminal side of gastric parietal cells.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Proton pump inhibitors act from the luminal side of gastric parietal cells.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A) Proton pump inhibitors are available as enteric-coated tablets: This statement is TRUE. The enteric coating allows the medication to pass through the stomach without being destroyed by the stomach acid, eventually dissolving in the intestine for absorption.&lt;/li&gt;&lt;li&gt;â€¢ B) Proton pump inhibitors act from the luminal side of gastric parietal cells: This statement is FALSE. Proton pump inhibitors, including rabeprazole, act from the acidic canaliculus inside the gastric parietal cell, not from the luminal side.&lt;/li&gt;&lt;li&gt;â€¢ C) Proton pump inhibitors are inactive at neutral pH: This statement is TRUE. Proton pump inhibitors are prodrugs that are activated in an acidic environment, which allows them to act specifically on the stomach&#x27;s acid-secreting cells.&lt;/li&gt;&lt;li&gt;â€¢ D) Proton pump inhibitors should be taken half an hour before food: This statement is TRUE. Taking proton pump inhibitors around 30 minutes before eating ensures better activation of the drug, as the stomach starts producing acid in response to eating, thereby optimizing the drug&#x27;s efficacy.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the statement that is INCORRECT regarding proton pump inhibitors is that they act from the luminal side of gastric parietal cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with symptoms of urinary urgency, frequency, and nocturia. He has been diagnosed with overactive bladder and his previous medication (oxybutynin) was not effective in managing his symptoms. Which of the following drugs is a beta-3 adrenergic receptor agonist that may be effective in treating this patient&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tolterodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vibegron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levetiracetam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vibegron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Vibegron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Tolterodine: This drug is an antimuscarinic agent, not a beta-3 adrenergic receptor agonist. It is commonly used in the treatment of overactive bladder but works through a different mechanism of action than beta-3 adrenergic receptor agonists.&lt;/li&gt;&lt;li&gt;â€¢ B) Memantine: Memantine is an NMDA receptor antagonist used primarily in the treatment of moderate-to-severe Alzheimer&#x27;s disease. It has no role in the treatment of overactive bladder.&lt;/li&gt;&lt;li&gt;â€¢ C) Vibegron: This is a beta-3 adrenergic receptor agonist (similar to mirabegron) that is used in the treatment of overactive bladder. By stimulating beta-3 adrenergic receptors in the detrusor muscle of the bladder, it relaxes the muscle and improves symptoms like urinary urgency and frequency.&lt;/li&gt;&lt;li&gt;â€¢ D) Levetiracetam: Levetiracetam is an antiepileptic drug that is used to treat various types of seizures. It has no role in the treatment of overactive bladder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is admitted to the emergency department for treatment of a drug overdose. The identity of the drug is unknown, but it is observed that when the urine pH is acidic, the renal clearance of the drug is less than GFR and that when the urine pH is alkaline, the clearance is greater than GFR. The drug probably is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Strong acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Weak acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Weak base&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Strong base&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Weak acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Weak acid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ When the urine pH is acidic, the renal clearance of a weak acid drug is less than the glomerular filtration rate (GFR). This is because in acidic urine, weak acid drugs remain predominantly in their non-ionized form, which hinders their excretion into the urine. As a result, their renal clearance is limited.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, when the urine pH is alkaline, the renal clearance of a weak acid drug is greater than the GFR. In alkaline urine, weak acid drugs become ionized, which promotes their excretion into the urine. This leads to a higher renal clearance compared to the GFR.&lt;/li&gt;&lt;li&gt;â€¢ Strong acids (Choice A) and strong bases (Choice D) are usually fully ionized and do not undergo significant changes in their excretion based on urine pH.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, based on the observed changes in renal clearance in response to urine pH, the drug in question is most likely a weak acid (Choice B).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old, insulin-dependent diabetic patient is diagnosed with hypertension and begins therapy with an antihypertensive agent. Three days later, he measures his blood glucose at home and finds that it is 53 mg/dL. He recalibrates his glucose testing apparatus and repeats the test, only to find that the first reading was accurate. He is concerned that his hypoglycemia did not produce the normal premonitory signs and symptoms. Which of the following medications was most likely prescribed to treat his hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is WRONG about amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is the longest acting anti arrhythmic drug.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has positive ionotropic action.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It contains iodine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It causes pulmonary fibrosis.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It has positive ionotropic action.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metformin is least likely to reduce blood sugar in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obese diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-diabetics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2 diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetics not respond to sulfonylureas.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-diabetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Non-diabetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received chlorprocaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Procaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lignocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lignocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following the treatment of an oral abscess with clindamycin, a patient develops a greenish, foul-smelling watery diarrhea with left lower quadrant pain. Other signs and symptoms include fever, leukocytosis, and lethargy. If the toxin produced by Clostridium difficile is detected in the stool, the patient would most appropriately be treated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fidaxomicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fidaxomicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fidaxomicin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents to the clinic with a palpable lump in her left breast that she noticed while showering. She reports no associated pain, discharge, or skin changes. Her past medical history is unremarkable, and she has no known family history of breast or ovarian cancer. Her last mammogram was two years ago and showed no abnormalities. After appropriate investigations including mammogram, ultrasound, and biopsy, she is diagnosed with stage II breast cancer. The biopsy reveals that the cancer is HER2-positive, but estrogen receptor (ER) and progesterone receptor (PR) negative. Which of the following drugs, a tyrosine kinase inhibitor, would be suitable for treating this patient&#x27;s breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sorafenib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Imatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pazopanib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lapatinib&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lapatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lapatinib.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old female patient is undergoing chemotherapy for breast cancer. The oncology team is concerned about the risk of febrile neutropenia due to the chemotherapeutic regimen. They are contemplating the use of a granulocyte colony-stimulating factor (G-CSF) and discuss the option of using pegylated-filgrastim. Which of the following is true about pegylated-filgrastim?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duration of action is longer than filgrastim&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Added advantage is that it can be taken orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It requires renal dose adjustment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not effective in the treatment of severe neutropenia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Duration of action is longer than filgrastim&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Duration of action is longer than filgrastim.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man is experiencing recurrent urinary tract infections. His healthcare team is considering various antibiotics, including fluoroquinolones, for his treatment. Which of the following fluoroquinolones is not typically effective for treating urinary tract infections?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Levofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Moxifloxacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lomefloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Moxifloxacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Moxifloxacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Ofloxacin: This fluoroquinolone is commonly used for treating urinary tract infections and is generally effective against a wide range of bacteria that can cause UTIs.&lt;/li&gt;&lt;li&gt;â€¢ B) Levofloxacin: This is another fluoroquinolone antibiotic frequently used in the treatment of UTIs and is generally effective for this purpose.&lt;/li&gt;&lt;li&gt;â€¢ C) Moxifloxacin: This is the correct answer. Moxifloxacin is generally not recommended for treating UTIs. It has reduced effectiveness against the typical bacteria that cause UTIs as compared to other fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ D) Lomefloxacin: Like ofloxacin and levofloxacin, lomefloxacin is generally effective for treating UTIs.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, among the given options, Moxifloxacin is typically not effective for treating urinary tract infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs act through intracellular receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parathyroid hormone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroxine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Thyroxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male patient with a history of chronic pain is being managed on an oral pain medication. The healthcare team is monitoring the patient&#x27;s response to medication and decides to take periodic plasma concentration samples. The team wants to evaluate the rate at which the drug is absorbed into the patient&#x27;s system. Which of the following parameters on a plasma concentration vs. time graph would be most indicative of the rate of drug absorption for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AUC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Half-life (T1/2)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tmax&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tmax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tmax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ A) Area under the Curve (AUC): This parameter reflects the total drug exposure over time but does not give insights into the rate of drug absorption.&lt;/li&gt;&lt;li&gt;â€¢ B) Half-life (T1/2): This measures how long it takes for the drug concentration to decrease to half its initial value, more related to the elimination phase rather than the absorption rate.&lt;/li&gt;&lt;li&gt;â€¢ C) Maximum concentration (Cmax): This indicates the peak concentration of the drug in the bloodstream but doesn&#x27;t specify how quickly this level is reached.&lt;/li&gt;&lt;li&gt;â€¢ D) Time to reach maximum concentration (Tmax): This is the time it takes for the drug to reach its peak concentration in the plasma. It gives an indication of how quickly the drug is absorbed into the system.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the time to reach maximum concentration (Tmax) is the best parameter to evaluate the rate of drug absorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition given in the graph&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-competitive.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Non-competitive.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/3.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/4.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Non-competitive.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient with chronic gout is under consideration for a change in treatment plan due to poor response to conventional therapies like allopurinol and colchicine. The healthcare team is discussing the potential use of rasburicase. What is the mechanism of action of rasburicase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of xanthine oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conversion of uric acid to allantoin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase excretion of uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of granulocyte migration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Conversion of uric acid to allantoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Conversion of uric acid to allantoin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old woman has been diagnosed with stage IV melanoma and is scheduled to receive immune checkpoint inhibitor therapy. The physician explains the mechanism of action and potential side effects of immune checkpoint inhibitors to the patient and her family. Which of the following is true about immune checkpoint inhibitors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nivolumab works by blocking the PD-1 receptor and is used to treat various types of cancer.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bevacizumab works by inhibiting angiogenesis and is used to treat solid tumors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rituximab works by depleting B cells and is used to treat lymphoma and autoimmune disorders.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trastuzumab works by targeting the HER2 receptor and is used to treat breast cancer.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nivolumab works by blocking the PD-1 receptor and is used to treat various types of cancer.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Nivolumab works by blocking the PD-1 receptor and is used to treat various types of cancer.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Among the given options, only nivolumab is an immune check point inhibitor whereas other drugs mentioned in the options act by other mechanisms.&lt;/li&gt;&lt;li&gt;â€¢ Immune checkpoint inhibitors are a type of immunotherapy that work by releasing the brakes on the immune system, allowing it to attack cancer cells more effectively. Nivolumab is a monoclonal antibody that blocks the PD-1 receptor on T cells, which prevents the inhibition of T cell activation and enhances the immune system&#x27;s ability to attack cancer cells. Nivolumab has been approved for the treatment of various types of cancer, including Hodgkinâ€™s lymphoma,  melanoma, non-small cell lung cancer, and kidney cancer. Bevacizumab is a monoclonal antibody against VEGF that inhibits angiogenesis, the formation of new blood vessels, and is used to treat solid tumors. Rituximab is a monoclonal antibody against CD20 that depletes B cells and is used to treat lymphoma and autoimmune disorders. Trastuzumab is a monoclonal antibody that targets the HER2 receptor and is used to treat breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Immune checkpoint inhibitors are a type of immunotherapy that work by releasing the brakes on the immune system, allowing it to attack cancer cells more effectively. Nivolumab is a monoclonal antibody that blocks the PD-1 receptor on T cells, which prevents the inhibition of T cell activation and enhances the immune system&#x27;s ability to attack cancer cells. Nivolumab has been approved for the treatment of various types of cancer, including Hodgkinâ€™s lymphoma,  melanoma, non-small cell lung cancer, and kidney cancer.&lt;/li&gt;&lt;li&gt;â€¢ Bevacizumab is a monoclonal antibody against VEGF that inhibits angiogenesis, the formation of new blood vessels, and is used to treat solid tumors.&lt;/li&gt;&lt;li&gt;â€¢ Rituximab is a monoclonal antibody against CD20 that depletes B cells and is used to treat lymphoma and autoimmune disorders.&lt;/li&gt;&lt;li&gt;â€¢ Trastuzumab is a monoclonal antibody that targets the HER2 receptor and is used to treat breast cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pembrolizumab â€“ Immune check point inhibitor used for endometrial carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ertugliflozin â€“ SGLT2 inhibitor for treatment of diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks: This is a correct match. Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the treatment of acute migraine attacks. CGRP is a neuropeptide that plays a role in the pathophysiology of migraines, and antagonists like Zavegepant block its activity, thereby alleviating symptoms.&lt;/li&gt;&lt;li&gt;â€¢ B) Pembrolizumab â€“ Immune check point inhibitor used for endometrial carcinoma: This is also a correct match. Pembrolizumab is an immune checkpoint inhibitor that targets the PD-1 receptor. It is used for a variety of cancers, including endometrial carcinoma, especially in cases that are MSI-H or dMMR (microsatellite instability-high or mismatch repair deficient).&lt;/li&gt;&lt;li&gt;â€¢ C) Ertugliflozin â€“ SGLT2 inhibitor for treatment of diabetes mellitus: This is another correct match. Ertugliflozin is a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor, which is used to manage blood sugar levels in type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose in the kidneys, thereby leading to the excretion of glucose in the urine.&lt;/li&gt;&lt;li&gt;â€¢ D) Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity: This is the incorrect match. Ivabradine is indeed a \&quot;funny\&quot; current (If) blocker, but it is used for the treatment of certain types of chronic heart failure and angina pectoris (chest pain), not for treating decreased visual acuity.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, option D is not a correct match concerning the mechanism of action and clinical use of the given drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents to the emergency department with chest pain and shortness of breath. The patient has a past medical history of hypertension and hyperlipidemia. An electrocardiogram (ECG) reveals ST-segment elevation. The patient is diagnosed with acute myocardial infarction (AMI) and undergoes percutaneous coronary intervention (PCI). The cardiologist orders the patient to take an antiplatelet drug after the procedure to prevent further clot formation. Which of the following best describes the mechanism of action of clopidogrel, a commonly used antiplatelet drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits cyclooxygenase-1 (COX-1) and decreases production of thromboxane A2, thereby reducing platelet activation and aggregation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibits the formation of fibrin by blocking the conversion of fibrinogen to fibrin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Binds to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B describes the mechanism of action of P2Y12 receptor inhibitors, such as clopidogrel, prasugrel, and ticagrelor. These drugs inhibit the activation and aggregation of platelets by blocking the P2Y12 receptor on the platelet surface. Option A: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), which is responsible for the production of thromboxane A2, a potent platelet activator and aggregator. By decreasing the production of thromboxane A2, aspirin reduces the activation and aggregation of platelets, thereby preventing further clot formation. Aspirin is commonly used as an antiplatelet drug for the prevention of cardiovascular events, such as myocardial infarction and stroke. Option C describes the mechanism of action of anticoagulants, such as heparin and warfarin. These drugs inhibit the formation of fibrin by blocking the coagulation cascade and the conversion of fibrinogen to fibrin. Option D describes the mechanism of action of glycoprotein IIb/IIIa receptor inhibitors, such as abciximab, eptifibatide, and tirofiban. These drugs bind to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.&lt;/li&gt;&lt;li&gt;â€¢ Option B describes the mechanism of action of P2Y12 receptor inhibitors, such as clopidogrel, prasugrel, and ticagrelor. These drugs inhibit the activation and aggregation of platelets by blocking the P2Y12 receptor on the platelet surface.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), which is responsible for the production of thromboxane A2, a potent platelet activator and aggregator. By decreasing the production of thromboxane A2, aspirin reduces the activation and aggregation of platelets, thereby preventing further clot formation. Aspirin is commonly used as an antiplatelet drug for the prevention of cardiovascular events, such as myocardial infarction and stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option C describes the mechanism of action of anticoagulants, such as heparin and warfarin. These drugs inhibit the formation of fibrin by blocking the coagulation cascade and the conversion of fibrinogen to fibrin.&lt;/li&gt;&lt;li&gt;â€¢ Option D describes the mechanism of action of glycoprotein IIb/IIIa receptor inhibitors, such as abciximab, eptifibatide, and tirofiban. These drugs bind to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old female with a history of breast cancer presents to the clinic for a routine follow-up. She has recently completed a course of chemotherapy that included doxorubicin, cyclophosphamide, and paclitaxel. Shortly after her chemotherapy, she developed febrile neutropenia and was treated with filgrastim and cefepime. She also has a history of hypertension controlled with amlodipine. She now reports experiencing symptoms of shortness of breath, fatigue, and palpitations. An echocardiogram reveals her ejection fraction has decreased to 40%. What is the most likely drug-related cause of her reduced ejection fraction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doxorubicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefepime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Doxorubicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Doxorubicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Filgrastim: This drug is used to stimulate the production of neutrophils and is commonly used to treat febrile neutropenia. It is not generally associated with cardiomyopathy or a reduced ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ B) Doxorubicin: Doxorubicin is a chemotherapy agent known for its cardiotoxic effects, which can result in reduced ejection fraction and symptoms like shortness of breath, fatigue, and palpitations. Given the patient&#x27;s recent chemotherapy regimen that included doxorubicin, this is the most likely cause of her decreased ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ C) Cefepime: This antibiotic is commonly used to treat bacterial infections, including those that may occur with febrile neutropenia. It is not typically associated with reduced ejection fraction or cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ D) Amlodipine: This drug is a calcium channel blocker used to treat hypertension. While it has cardiovascular effects, it is not generally associated with a reduced ejection fraction or cardiomyopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding varenicline is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Varenicline is a long-acting beta2-agonist that is used to treat asthma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a medication that is used to aid smoking cessation. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and decreases nicotine cravings.&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a medication that is used to aid smoking cessation. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and decreases nicotine cravings.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch: this is incorrect because varenicline is not a nicotine replacement therapy that delivers nicotine through a transdermal patch. Nicotine replacement therapies include nicotine gum, lozenges, patches, and inhalers.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression: this is incorrect because varenicline is not a selective serotonin reuptake inhibitor (SSRI). SSRIs are a class of medications that are primarily used to treat depression and anxiety disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Varenicline is a long-acting beta2-agonist that is used to treat asthma: this is incorrect because varenicline is not a long-acting beta2-agonist (LABA). LABAs are a class of medications that are used to treat asthma and chronic obstructive pulmonary disease (COPD).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Varenicline is a long-acting beta2-agonist that is used to treat asthma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man who received a kidney transplant three months ago is admitted to the hospital with high-grade fever, malaise, and abdominal discomfort. On examination, he exhibits right upper quadrant tenderness. Lab investigations reveal abnormal liver enzymes, and a blood culture returns positive for cytomegalovirus (CMV). His current immunosuppressive regimen includes tacrolimus. What is the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of calcineurin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blockade of IL-2 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IMP dehydrogenase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dihydro-orotate dehydrogenase inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of calcineurin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of calcineurin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Inhibition of calcineurin: Tacrolimus acts by inhibiting calcineurin, which plays a pivotal role in T-cell activation. This immunosuppressive action can make the patient susceptible to infections such as CMV.&lt;/li&gt;&lt;li&gt;â€¢ B) Blockade of IL-2 receptor: This is a mechanism of other immunosuppressive drugs like basiliximab but not tacrolimus. Therefore, it is not relevant to the patient&#x27;s current condition.&lt;/li&gt;&lt;li&gt;â€¢ C) IMP dehydrogenase inhibition: This is the mechanism of mycophenolate mofetil, another immunosuppressive drug. It is not applicable to tacrolimus.&lt;/li&gt;&lt;li&gt;â€¢ D) Dihydro-orotate dehydrogenase inhibition: This mechanism is associated with drugs like leflunomide but is not relevant to the action of tacrolimus.&lt;/li&gt;&lt;li&gt;â€¢ Thus, the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection is the inhibition of calcineurin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Upon further evaluation, it is discovered that the patient has experienced darkening of the iris and eyelid skin as well as increased length, thickness, and pigmentation of the eyelashes. Which of the following anti-glaucoma drugs is likely to produce these adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brimonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dorzolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Latanoprost&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Latanoprost.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman is taken to a neurologist by her family members. After thorough evaluation, the neurologist suggests the possibility of starting Aducanumab therapy, and the patient&#x27;s family starts researching the medication. Which of the following statements about Aducanumab is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aducanumab is a monoclonal antibody.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aducanumab has received FDA approval for the treatment of Alzheimer&#x27;s disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aducanumab targets amyloid-beta plaques in the brain.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Aducanumab is a monoclonal antibody: This statement is TRUE. Aducanumab is a monoclonal antibody designed to treat Alzheimer&#x27;s disease by targeting amyloid-beta plaques in the brain.&lt;/li&gt;&lt;li&gt;â€¢ B) Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission: This statement is FALSE. Aducanumab does not work by inhibiting acetylcholinesterase. Its primary mechanism is to target and remove amyloid-beta plaques.&lt;/li&gt;&lt;li&gt;â€¢ C) Aducanumab has received FDA approval for the treatment of Alzheimer&#x27;s disease: This statement is TRUE. Although its approval has been met with some controversy and debate, Aducanumab has been conditionally approved by the FDA for the treatment of Alzheimer&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ D) Aducanumab targets amyloid-beta plaques in the brain: This statement is TRUE. The drug is designed to bind to amyloid-beta plaques, thereby aiding in their removal and potentially slowing the progression of Alzheimer&#x27;s disease, although definitive evidence for clinical benefit is still being evaluated.&lt;/li&gt;&lt;li&gt;â€¢ Thus, the statement that is FALSE about Aducanumab is that it works by inhibiting acetylcholinesterase to increase cholinergic transmission.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male patient with a history of chronic obstructive pulmonary disease (COPD) is on theophylline therapy. He presents to the emergency department with symptoms of nausea, vomiting, and tremors. On examination, he has a heart rate of 110 beats per minute and a serum theophylline level of 30 mg/L (normal range 5-15 mg/L). Which of the following drugs is most likely responsible for the patient&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Montelukast&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Clarithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Clarithromycin can interact with theophylline by inhibiting its metabolism, leading to an increase in serum concentration and an increased risk of toxicity. Symptoms of theophylline toxicity include nausea, vomiting, tremors, seizures, and tachycardia. In severe cases, theophylline toxicity can lead to cardiac arrhythmias and seizures. Other drugs that can interact with theophylline include ciprofloxacin, erythromycin, and fluvoxamine.&lt;/li&gt;&lt;li&gt;â€¢ Clarithromycin can interact with theophylline by inhibiting its metabolism, leading to an increase in serum concentration and an increased risk of toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Symptoms of theophylline toxicity include nausea, vomiting, tremors, seizures, and tachycardia. In severe cases, theophylline toxicity can lead to cardiac arrhythmias and seizures.&lt;/li&gt;&lt;li&gt;â€¢ Other drugs that can interact with theophylline include ciprofloxacin, erythromycin, and fluvoxamine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old patient with no significant medical history presents to the emergency department with a fever of 102Â°F and altered sensorium. Upon examination, you notice a petechial rash on the patient&#x27;s arms and legs. You suspect meningococcal septicemia. Which of the following antibiotics is recommended as the first-line empiric therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Penicillin G&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Piperacillin-Tazobactam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cotrimoxazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ceftriaxone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ceftriaxone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Meningococcal septicemia is a medical emergency that requires prompt antibiotic therapy. Empiric therapy with intravenous ceftriaxone is recommended as the first-line treatment for suspected meningococcal septicemia. Penicillin G is an alternative option but is less commonly used due to increasing resistance. Piperacillin-tazobactam and cotrimoxazole are not recommended as first-line treatments for meningococcal septicemia. Definitive therapy should be based on culture and susceptibility results.&lt;/li&gt;&lt;li&gt;â€¢ Meningococcal septicemia is a medical emergency that requires prompt antibiotic therapy.&lt;/li&gt;&lt;li&gt;â€¢ Empiric therapy with intravenous ceftriaxone is recommended as the first-line treatment for suspected meningococcal septicemia.&lt;/li&gt;&lt;li&gt;â€¢ Penicillin G is an alternative option but is less commonly used due to increasing resistance.&lt;/li&gt;&lt;li&gt;â€¢ Piperacillin-tazobactam and cotrimoxazole are not recommended as first-line treatments for meningococcal septicemia.&lt;/li&gt;&lt;li&gt;â€¢ Definitive therapy should be based on culture and susceptibility results.&lt;/li&gt;&lt;li&gt;â€¢ DOC for empirical therapy of meningitis&lt;/li&gt;&lt;li&gt;â€¢ DOC for empirical therapy of meningitis&lt;/li&gt;&lt;li&gt;â€¢ Note:&lt;/li&gt;&lt;li&gt;â€¢ Note:&lt;/li&gt;&lt;li&gt;â€¢ Vancomycin is given to cover gram positive bacteria like Streptococcus pneumoniae and Staphylococcus (including MRSA) Ampicillin is given to cover Listeria Meropenem is given to cover gram negative bacteria Cefotaxime can be used in place of ceftriaxone Cefepime can be used in place of meropenem&lt;/li&gt;&lt;li&gt;â€¢ Vancomycin is given to cover gram positive bacteria like Streptococcus pneumoniae and Staphylococcus (including MRSA)&lt;/li&gt;&lt;li&gt;â€¢ Ampicillin is given to cover Listeria&lt;/li&gt;&lt;li&gt;â€¢ Meropenem is given to cover gram negative bacteria&lt;/li&gt;&lt;li&gt;â€¢ Cefotaxime can be used in place of ceftriaxone&lt;/li&gt;&lt;li&gt;â€¢ Cefepime can be used in place of meropenem&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does IP in the figure shown stands for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug is an instant release preparation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Meant for intra pulmonary use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The standards according to Indian Pharmacopoeia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug tested preclinically via Intraperitoneal route&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The standards according to Indian Pharmacopoeia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/mcq-no-32-min.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The standards according to Indian Pharmacopoeia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ a. Drug is an instant release preparation: The term \&quot;IP\&quot; on a drug strip doesn&#x27;t typically signify that the drug is an instant release preparation. This would usually be denoted by terms like \&quot;IR\&quot; rather than \&quot;IP.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ b. Meant for intra pulmonary use: The abbreviation \&quot;IP\&quot; is not commonly used to denote that a drug is meant for intrapulmonary use. Instead, you would likely see terms such as \&quot;inhaler\&quot; or \&quot;nebulizer\&quot; or specific abbreviations for pulmonary administration.&lt;/li&gt;&lt;li&gt;â€¢ c. The standards according to Indian Pharmacopoeia: This is the correct answer. The term \&quot;IP\&quot; is often used on pharmaceutical packaging in India to denote that the drug meets the standards laid out in the Indian Pharmacopoeia.&lt;/li&gt;&lt;li&gt;â€¢ d. Drug tested preclinically via IntraPeritoneal route: \&quot;IP\&quot; is commonly used as an abbreviation for intraperitoneal in scientific research, but it is unlikely to be used in this context on a drug strip meant for patient use.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the correct interpretation of \&quot;IP\&quot; on the drug strip of asthalin is that the drug complies with the standards of the Indian Pharmacopoeia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most similar to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Procainamide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Procainamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following table gives the data of AUC of drug A alone and AUC of drug A when combined with drug B. p value is &amp;lt;0.01. Which of the following statement regarding these drugs is most correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B decreases the first pass metabolism of drug A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B increases the systemic metabolism of drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug B decreases the intestinal absorption of drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug B increases the renal clearance of drug A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Drug B decreases the first pass metabolism of drug A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/12.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Drug B decreases the first pass metabolism of drug A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anticholinergic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholinomimetic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Opioid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Salicylate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anticholinergic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Na channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac K channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-adrenoceptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-adrenoceptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-adrenoceptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Beta-adrenoceptors.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of statins is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of HMG - CoA synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stimulation of HMG-CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indirect increase of LDL receptors synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of intestinal cholesterol absorption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Indirect increase of LDL receptors synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Indirect increase of LDL receptor synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One of the health benefits of the use of combined oral contraceptives in pre-menopausal women is that these contraceptives reduce the risk of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deep vein thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ovarian cancer&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ovarian cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Ovarian cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old postmenopausal woman with a history of osteoporosis is being evaluated for potential pharmacological treatments to strengthen her bones. She has tried lifestyle modifications, including weight-bearing exercises and calcium supplements, with limited improvement. Her physician is considering various pharmacological agents to inhibit osteoclastic activity and thereby prevent further bone loss. Which of the following medications does NOT primarily act by inhibiting osteoclasts?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Teriparatide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Teriparatide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ a) Denosumab: This is a monoclonal antibody that inhibits the RANKL (Receptor Activator for Nuclear Factor Îº B Ligand), which is essential for the formation and function of osteoclasts. Thus, it inhibits osteoclast activity.&lt;/li&gt;&lt;li&gt;â€¢ b) Strontium ranelate: This drug is used in the treatment of osteoporosis and works by both promoting bone formation and inhibiting bone resorption. It is thought to inhibit osteoclasts, although the exact mechanism is not well understood.&lt;/li&gt;&lt;li&gt;â€¢ c) Teriparatide: This is the correct answer. Teriparatide is a recombinant form of parathyroid hormone. It is actually an anabolic (bone-building) agent that stimulates osteoblast activity, rather than inhibiting osteoclasts.&lt;/li&gt;&lt;li&gt;â€¢ d) Raloxifene: This is a selective estrogen receptor modulator (SERM) that inhibits bone resorption by osteoclasts, thus serving to preserve bone mass in conditions like osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Teriparatide does not inhibit osteoclasts but stimulates osteoblasts, making it the correct answer for the drug that does not act by inhibiting osteoclasts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of bipolar disorder presents to the clinic with complaints of confusion, agitation, diarrhea, hand tremors, and excessive thirst. The patient reports taking lithium for the past year as part of his treatment plan. Recently, he also started taking hydrochlorothiazide for hypertension. On examination, the patient has a fine tremor in both hands and is noted to have a serum lithium level of 2.8 mEq/L. Which of the following is the most likely cause of the patient&#x27;s elevated serum lithium level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Additive diuretic effect of hydrochlorothiazide and lithium.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased renal reabsorption of lithium due to hydrochlorothiazide.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased gastrointestinal absorption of lithium due to hydrochlorothiazide.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide-induced enhancement of lithium metabolism.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased renal reabsorption of lithium due to hydrochlorothiazide.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Increased renal reabsorption of lithium due to hydrochlorothiazide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Additive diuretic effect of hydrochlorothiazide and lithium: While both hydrochlorothiazide and lithium can have diuretic effects, this option doesn&#x27;t directly explain the elevated serum lithium level. The primary concern here is the elevated lithium level, not an additive diuretic effect.&lt;/li&gt;&lt;li&gt;â€¢ B) Increased renal reabsorption of lithium due to hydrochlorothiazide: Hydrochlorothiazide can increase the renal reabsorption of lithium, leading to elevated serum lithium levels and symptoms of toxicity. This is the most likely explanation for the patient&#x27;s elevated lithium level.&lt;/li&gt;&lt;li&gt;â€¢ C) Decreased gastrointestinal absorption of lithium due to hydrochlorothiazide: This option is misleading because decreased gastrointestinal absorption of lithium would lead to lower serum lithium levels, not higher.&lt;/li&gt;&lt;li&gt;â€¢ D) Hydrochlorothiazide-induced enhancement of lithium metabolism: This is also a distractor. Enhancement of lithium metabolism would typically result in reduced serum lithium levels, not elevated levels.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the most likely cause for the elevated serum lithium level and symptoms in this patient is the increased renal reabsorption of lithium due to hydrochlorothiazide.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of epilepsy presents to the dentist with complaints of difficulty in eating and cleaning the teeth. On Examination, the findings were shown as seen in the diagram below. The patient reports that he has been taking an anti-epileptic drug for the past six months, and his symptoms began to appear gradually over the past few weeks. Which of the following anti-epileptic drugs is likely to produce these adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gabapentin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Levetiracetam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenytoin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Phenytoin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He recently started on a new medication for hypertension. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. Which of the following drugs is most likely responsible for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hydrochlorothiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hydrochlorothiazide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Symptoms of digoxin toxicity include nausea, vomiting, loss of appetite, and visual disturbances. Other symptoms can include dizziness, confusion, and changes in heart rate or rhythm. Hydrochlorothiazide can cause electrolyte abnormalities such as hypokalemia, which can increase the risk of digoxin toxicity. Metformin is an oral antidiabetic medication that does not interact with digoxin. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor and amlodipine is a calcium channel blocker, both of which do not interact with digoxin.&lt;/li&gt;&lt;li&gt;â€¢ Symptoms of digoxin toxicity include nausea, vomiting, loss of appetite, and visual disturbances. Other symptoms can include dizziness, confusion, and changes in heart rate or rhythm. Hydrochlorothiazide can cause electrolyte abnormalities such as hypokalemia, which can increase the risk of digoxin toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Metformin is an oral antidiabetic medication that does not interact with digoxin.&lt;/li&gt;&lt;li&gt;â€¢ Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor and amlodipine is a calcium channel blocker, both of which do not interact with digoxin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given image shows the Log DRC of a drug alone (A) and in the presence of antagonists (B and C). Identify the type of antagonism shown in curve B and curve C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B is competitive and C is non-competitive antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B is non-competitive an C is competitive antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both are competitive antagonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both are non-competitive antagonists&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. B is competitive and C is non-competitive antagonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. B is competitive and C is non-competitive antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. B is competitive and C is non-competitive antagonist: This is the correct answer. B shows a parallel shift to the right, which is characteristic of competitive antagonism. Increasing the concentration of the agonist can overcome the antagonist. C shows a reduction in the maximal response that the agonist can produce, characteristic of a non-competitive antagonist.&lt;/li&gt;&lt;li&gt;â€¢ B. B is non-competitive and C is competitive antagonist: This is incorrect. B shows a parallel shift to the right, which is indicative of competitive antagonism. C shows a reduction in the maximal response, which is indicative of non-competitive antagonism.&lt;/li&gt;&lt;li&gt;â€¢ C. Both are competitive antagonists: This is incorrect. Curve B shows characteristics of competitive antagonism, but curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.&lt;/li&gt;&lt;li&gt;â€¢ D. Both are non-competitive antagonists: This is incorrect. Curve B shows characteristics of competitive antagonism as it shifts parallel to the right, while curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented with left sided severe throbbing headache associated with nausea, vomiting, photophobia and phonophobia. Which of the following is a new drug that can provide immediate relief to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lasmiditan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Erenumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lasmiditan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Lasmiditan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Relative intensities of blocking effect (shown by symbol of +) of four drugs on different receptors is: Which drug is most likely to exacerbate the symptoms of Parkinsonism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Drug D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/13.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Drug D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following chelating agents can be used orally for the treatment of transfusion siderosis in thalassemia patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deferipirone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deferipirone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Deferipirone.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the mechanism of antifungal drug is wrongly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azoles- Inhibit ergosterol synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flucytosine- Inhibit microtubule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echinocandins- Inhibit glycan synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphotericin B- Create artificial pores in the membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flucytosine- Inhibit microtubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Flucytosine: Inhibit microtubule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test11" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D Part 1, Mission 3.0 (Early Intern Batch)   12 05 2025   2025 05 12&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D Part 1, Mission 3.0 (Early Intern Batch)   12 05 2025   2025 05 12&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following drugs act through intracellular receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroxine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parathyroid hormone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroxine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Thyroxine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male patient with a history of chronic pain is being managed on an oral pain medication. The healthcare team is monitoring the patient&#x27;s response to medication and decides to take periodic plasma concentration samples. The team wants to evaluate the rate at which the drug is absorbed into the patient&#x27;s system. Which of the following parameters on a plasma concentration vs. time graph would be most indicative of the rate of drug absorption for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AUC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Half-life (T1/2)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tmax&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tmax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tmax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ A) Area under the Curve (AUC): This parameter reflects the total drug exposure over time but does not give insights into the rate of drug absorption.&lt;/li&gt;&lt;li&gt;â€¢ B) Half-life (T1/2): This measures how long it takes for the drug concentration to decrease to half its initial value, more related to the elimination phase rather than the absorption rate.&lt;/li&gt;&lt;li&gt;â€¢ C) Maximum concentration (Cmax): This indicates the peak concentration of the drug in the bloodstream but doesn&#x27;t specify how quickly this level is reached.&lt;/li&gt;&lt;li&gt;â€¢ D) Time to reach maximum concentration (Tmax): This is the time it takes for the drug to reach its peak concentration in the plasma. It gives an indication of how quickly the drug is absorbed into the system.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the time to reach maximum concentration (Tmax) is the best parameter to evaluate the rate of drug absorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Adrenaline acting via beta 2 receptors causes bronchodilation whereas histamine acting through H1 receptors cause bronchoconstriction. Which type of antagonism it is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pharmacological antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chemical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physical antagonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physiological antagonism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Physiological antagonism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Physiological Antagonism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ A) Pharmacological Antagonism: This term generally refers to one drug reducing the effectiveness of another drug, typically through receptor competition or a similar mechanism at the molecular level. Since adrenaline and histamine act on different receptors to produce opposite physiological effects, this option is not correct.&lt;/li&gt;&lt;li&gt;â€¢ B) Chemical Antagonism: This occurs when one drug directly reacts with another to neutralize its effects e.g. antacids neutralize gastric acid and protamine neutralize heparin. There is no direct chemical reaction between adrenaline and histamine, making this option incorrect.&lt;/li&gt;&lt;li&gt;â€¢ C) Physical Antagonism: This would imply that the drugs physically interfere with each other e.g. charcoal adbsorbs many drugs and is used in drug poisoning.&lt;/li&gt;&lt;li&gt;â€¢ D) Physiological Antagonism: This is the correct answer. Physiological antagonism occurs when two drugs produce opposite effects in the same physiological system. Adrenaline causes bronchodilation via beta-2 receptors, while histamine causes bronchoconstriction via H1 receptors. These drugs act on different receptor types but have opposite effects on the same physiological system, namely the bronchial smooth muscle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition given in the graph?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Non-competitive&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/untitled-13660.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/untitled-13661.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Non-competitive.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer presents to the emergency department with pinpoint pupil, diarrhea, sweating, excessive lacrimation, salivation and muscle weakness. On examination there is bradycardia and BP is 80/60 mm Hg pulse rate is 56/min and his plasma cholinesterase level was 52 U/mL. Which of the following drugs can be used for treatment of muscle weakness in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pralidoxime&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;N-acetylcysteine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pralidoxime&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pralidoxime&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ A) Pralidoxine: This drug is typically used alongside atropine for treating organophosphate poisoning to reactivate acetylcholinesterase. It can reverse muscle weakness.&lt;/li&gt;&lt;li&gt;â€¢ B) Atropine: Atropine acts as an antagonist at muscarinic cholinergic receptors and would counteract many of the symptoms observed like pinpoint pupils, excessive salivation, and bradycardia. However it cannot reverse muscle weakness.&lt;/li&gt;&lt;li&gt;â€¢ C) Physostigmine: This drug is a cholinesterase inhibitor and would worsen the symptoms of cholinergic toxicity, making it an inappropriate treatment in this case.&lt;/li&gt;&lt;li&gt;â€¢ D) N-acetylcysteine: This is commonly used for acetaminophen overdose and would not be effective for treating symptoms of cholinergic toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient with chronic gout is under consideration for a change in treatment plan due to poor response to conventional therapies like allopurinol and colchicine. The healthcare team is discussing the potential use of rasburicase. What is the mechanism of action of rasburicase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of xanthine oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conversion of uric acid to allantoin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase excretion of uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of granulocyte migration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Conversion of uric acid to allantoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Conversion of uric acid to allantoin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of benign prostatic hyperplasia (BPH) is scheduled to receive a new medication. The physician explains the mechanism of action and potential side effects of dutasteride to the patient and his family. Which of the following is true about finasteride?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It increases the production of testosterone.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It act as an antagonist of androgen receptors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can cause sexual side effects such as decreased libido and erectile dysfunction.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is only effective in reducing symptoms of BPH in the short-term.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It can cause sexual side effects such as decreased libido and erectile dysfunction.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It can cause sexual side effects such as decreased libido and erectile dysfunction.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Finasteride and dutasteride like drugs are a class of medications used to treat BPH by reducing the size of the prostate gland. They work by inhibiting the enzyme 5 alpha reductase, which converts testosterone to dihydrotestosterone (DHT). By reducing the levels of DHT, 5 alpha reductase inhibitors can shrink the prostate gland and improve urinary symptoms associated with BPH. A potential side effect of these medications is sexual dysfunction, including decreased libido and erectile dysfunction. These medications can take several months to achieve their maximum effect and can provide long-term relief of BPH symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Finasteride and dutasteride like drugs are a class of medications used to treat BPH by reducing the size of the prostate gland.&lt;/li&gt;&lt;li&gt;â€¢ They work by inhibiting the enzyme 5 alpha reductase, which converts testosterone to dihydrotestosterone (DHT).&lt;/li&gt;&lt;li&gt;â€¢ By reducing the levels of DHT, 5 alpha reductase inhibitors can shrink the prostate gland and improve urinary symptoms associated with BPH.&lt;/li&gt;&lt;li&gt;â€¢ A potential side effect of these medications is sexual dysfunction, including decreased libido and erectile dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ These medications can take several months to achieve their maximum effect and can provide long-term relief of BPH symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pembrolizumab â€“ Immune check point inhibitor used for endometrial carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ertugliflozin â€“ SGLT2 inhibitor for treatment of diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks: This is a correct match. Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the treatment of acute migraine attacks. CGRP is a neuropeptide that plays a role in the pathophysiology of migraines, and antagonists like Zavegepant block its activity, thereby alleviating symptoms.&lt;/li&gt;&lt;li&gt;â€¢ B) Pembrolizumab â€“ Immune check point inhibitor used for endometrial carcinoma: This is also a correct match. Pembrolizumab is an immune checkpoint inhibitor that targets the PD-1 receptor. It is used for a variety of cancers, including endometrial carcinoma, especially in cases that are MSI-H or dMMR (microsatellite instability-high or mismatch repair deficient).&lt;/li&gt;&lt;li&gt;â€¢ C) Ertugliflozin â€“ SGLT2 inhibitor for treatment of diabetes mellitus: This is another correct match. Ertugliflozin is a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor, which is used to manage blood sugar levels in type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose in the kidneys, thereby leading to the excretion of glucose in the urine.&lt;/li&gt;&lt;li&gt;â€¢ D) Ivabradine â€“ Funny current blocker for treatment of decreased visual acuity: This is the incorrect match. Ivabradine is indeed a \&quot;funny\&quot; current (If) blocker, but it is used for the treatment of certain types of chronic heart failure and angina pectoris (chest pain), not for treating decreased visual acuity.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, option D is not a correct match concerning the mechanism of action and clinical use of the given drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a correct match of symptoms and action of antidepressants and the receptors involved?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sedation and weight gain - H1 receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dry mouth and constipation - Muscarinic receptor blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sexual dysfunction and anorgasmia â€“ 5HT reuptake inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension - Alpha-1 receptor blockade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypertension - Alpha-1 receptor blockade&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/5_hniNzH3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hypertension - Alpha-1 receptor blockade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biphasic response of epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phentolamine epinephrine coupling&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vasomotor reversal of Dale&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vasomotor reversal of Dale&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old researcher is studying a novel antiviral drug that has shown promise in in-vitro studies. The researcher is in the process of planning the clinical development of the drug. She explains to her team that the next step involves a phase zero clinical trial, which will be crucial in determining whether to move on to phase I trials. The team is confused, as they are not familiar with phase zero clinical trials. Which of the following statements is true regarding phase zero clinical trials, that would help the team understand its significance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement and metabolism of the drug in the human body.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug: This statement is incorrect. Phase zero clinical trials are human trials that precede phase I trials. They are not animal studies.&lt;/li&gt;&lt;li&gt;â€¢ B) Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug: This is incorrect. Phase zero trials are not designed to provide comprehensive data on safety and efficacy but are focused on pharmacokinetics and perhaps some initial pharmacodynamic data.&lt;/li&gt;&lt;li&gt;â€¢ C) Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body: This is correct. The main aim of phase zero trials is to gather preliminary data on pharmacokinetics and assess whether the drug behaves in humans as it does in preclinical models.&lt;/li&gt;&lt;li&gt;â€¢ D) Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question: This is incorrect. Phase zero trials are exploratory trials that precede phase I trials; they are not focused on therapeutic outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the statement that would best help the team understand the significance of phase zero trials is that they primarily focus on pharmacokinetics and provide initial human data on the movement and metabolism of the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Upon further evaluation, it is discovered that the patient has experienced darkening of the iris and eyelid skin as well as increased length, thickness, and pigmentation of the eyelashes. Which of the following anti-glaucoma drugs is likely to produce these adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brimonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dorzolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Latanoprost&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Latanoprost.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of chronic kidney disease presents to the emergency department with complaints of muscle weakness, nausea, and abdominal cramping. Laboratory testing shows that the patient has hyperkalemia, with a serum potassium level of 6.5 mEq/L. The patient&#x27;s medications are reviewed, and it is discovered that he has been taking several drugs for his cardiac conditions and hypertension. Upon further evaluation, it is determined that one of these drugs may be contributing to the patient&#x27;s hyperkalemia. Which of the following drugs should be stopped in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Enalapril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Enalapril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He was recently started on a new medication for hypertension. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. Which of the following drugs is most likely responsible for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hydrochlorothiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hydrochlorothiazide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with symptoms of urinary urgency, frequency, and nocturia. He has been diagnosed with overactive bladder and his previous medication (oxybutynin) was not effective in managing his symptoms. Which of the following drugs is a beta-3 adrenergic receptor agonist that may be effective in treating this patient&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tolterodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vibegron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levetiracetam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vibegron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Vibegron&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Tolterodine: This drug is an antimuscarinic agent, not a beta-3 adrenergic receptor agonist. It is commonly used in the treatment of overactive bladder but works through a different mechanism of action than beta-3 adrenergic receptor agonists.&lt;/li&gt;&lt;li&gt;â€¢ B) Memantine: Memantine is an NMDA receptor antagonist used primarily in the treatment of moderate-to-severe Alzheimer&#x27;s disease. It has no role in the treatment of overactive bladder.&lt;/li&gt;&lt;li&gt;â€¢ C) Vibegron: This is a beta-3 adrenergic receptor agonist (similar to mirabegron) that is used in the treatment of overactive bladder. By stimulating beta-3 adrenergic receptors in the detrusor muscle of the bladder, it relaxes the muscle and improves symptoms like urinary urgency and frequency.&lt;/li&gt;&lt;li&gt;â€¢ D) Levetiracetam: Levetiracetam is an antiepileptic drug that is used to treat various types of seizures. It has no role in the treatment of overactive bladder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given image shows the Log DRC of a drug alone (A) and in the presence of antagonists (B and C). Identify the type of antagonism shown in curve B and curve C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B is competitive and C is non-competitive antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B is non-competitive an C is competitive antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both are competitive antagonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both are non-competitive antagonists&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. B is competitive and C is non-competitive antagonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. B is competitive and C is non-competitive antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. B is competitive and C is non-competitive antagonist: This is the correct answer. B shows a parallel shift to the right, which is characteristic of competitive antagonism. Increasing the concentration of the agonist can overcome the antagonist. C shows a reduction in the maximal response that the agonist can produce, characteristic of a non-competitive antagonist.&lt;/li&gt;&lt;li&gt;â€¢ B. B is non-competitive and C is competitive antagonist: This is incorrect. B shows a parallel shift to the right, which is indicative of competitive antagonism. C shows a reduction in the maximal response, which is indicative of non-competitive antagonism.&lt;/li&gt;&lt;li&gt;â€¢ C. Both are competitive antagonists: This is incorrect. Curve B shows characteristics of competitive antagonism, but curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.&lt;/li&gt;&lt;li&gt;â€¢ D. Both are non-competitive antagonists: This is incorrect. Curve B shows characteristics of competitive antagonism as it shifts parallel to the right, while curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does IP in the figure shown stands for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug is an instant release preparation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Meant for intra pulmonary use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The standards according to Indian Pharmacopoeia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug tested preclinically via Intraperitoneal route&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The standards according to Indian Pharmacopoeia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/mcq-no-32-min.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The standards according to Indian Pharmacopoeia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ a. Drug is an instant release preparation: The term \&quot;IP\&quot; on a drug strip doesn&#x27;t typically signify that the drug is an instant release preparation. This would usually be denoted by terms like \&quot;IR\&quot; rather than \&quot;IP.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ b. Meant for intra pulmonary use: The abbreviation \&quot;IP\&quot; is not commonly used to denote that a drug is meant for intrapulmonary use. Instead, you would likely see terms such as \&quot;inhaler\&quot; or \&quot;nebulizer\&quot; or specific abbreviations for pulmonary administration.&lt;/li&gt;&lt;li&gt;â€¢ c. The standards according to Indian Pharmacopoeia: This is the correct answer. The term \&quot;IP\&quot; is often used on pharmaceutical packaging in India to denote that the drug meets the standards laid out in the Indian Pharmacopoeia.&lt;/li&gt;&lt;li&gt;â€¢ d. Drug tested preclinically via IntraPeritoneal route: \&quot;IP\&quot; is commonly used as an abbreviation for intraperitoneal in scientific research, but it is unlikely to be used in this context on a drug strip meant for patient use.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the correct interpretation of \&quot;IP\&quot; on the drug strip of asthalin is that the drug complies with the standards of the Indian Pharmacopoeia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most similar to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Procainamide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Procainamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is admitted to the emergency department for treatment of a drug overdose. The identity of the drug is unknown, but it is observed that when the urine pH is acidic, the renal clearance of the drug is less than GFR and that when the urine pH is alkaline, the clearance is greater than GFR. The drug probably is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Strong acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Weak acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Weak base&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Strong base&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Weak acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Weak acid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ When the urine pH is acidic, the renal clearance of a weak acid drug is less than the glomerular filtration rate (GFR). This is because in acidic urine, weak acid drugs remain predominantly in their non-ionized form, which hinders their excretion into the urine. As a result, their renal clearance is limited.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, when the urine pH is alkaline, the renal clearance of a weak acid drug is greater than the GFR. In alkaline urine, weak acid drugs become ionized, which promotes their excretion into the urine. This leads to a higher renal clearance compared to the GFR.&lt;/li&gt;&lt;li&gt;â€¢ Strong acids (Choice A) and strong bases (Choice D) are usually fully ionized and do not undergo significant changes in their excretion based on urine pH.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, based on the observed changes in renal clearance in response to urine pH, the drug in question is most likely a weak acid (Choice B).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old, insulin-dependent diabetic patient is diagnosed with hypertension and begins therapy with an antihypertensive agent. Three days later, he measures his blood glucose at home and finds that it is 53 mg/dL. He recalibrates his glucose testing apparatus and repeats the test, only to find that the first reading was accurate. He is concerned that his hypoglycemia did not produce the normal premonitory signs and symptoms. Which of the following medications was most likely prescribed to treat his hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anticholinergic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholinomimetic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Opioid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Salicylate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anticholinergic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented with left sided severe throbbing headache associated with nausea, vomiting, photophobia and phonophobia. Which of the following is a new drug that can provide immediate relief to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lasmiditan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Erenumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lasmiditan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Lasmiditan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Na channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac K channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-adrenoceptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-adrenoceptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-adrenoceptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Beta-adrenoceptors.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is wrong about amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is longest acting anti-arrhythmic drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has positive ionotropic action&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It contains iodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It causes pulmonary fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It has positive ionotropic action&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It has positive ionotropic action&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of statins is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of HMG - CoA synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stimulation of HMG-CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indirect increase of LDL receptors synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of intestinal cholesterol absorption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Indirect increase of LDL receptors synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Indirect increase of LDL receptor synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metformin is least likely to reduce blood sugar in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obese diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-diabetics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2 diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetics not respond to sulfonylureas.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-diabetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Non-diabetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One of the health benefits of the use of combined oral contraceptives in pre-menopausal women is that these contraceptives reduce the risk of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deep vein thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ovarian cancer&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ovarian cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ovarian cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old postmenopausal woman with a history of osteoporosis is being evaluated for potential pharmacological treatments to strengthen her bones. She has tried lifestyle modifications, including weight-bearing exercises and calcium supplements, with limited improvement. Her physician is considering various pharmacological agents to inhibit osteoclastic activity and thereby prevent further bone loss. Which of the following medications does NOT primarily act by inhibiting osteoclasts?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Teriparatide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Teriparatide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Options:&lt;/li&gt;&lt;li&gt;â€¢ a) Denosumab: This is a monoclonal antibody that inhibits the RANKL (Receptor Activator for Nuclear Factor Îº B Ligand), which is essential for the formation and function of osteoclasts. Thus, it inhibits osteoclast activity.&lt;/li&gt;&lt;li&gt;â€¢ b) Strontium ranelate: This drug is used in the treatment of osteoporosis and works by both promoting bone formation and inhibiting bone resorption. It is thought to inhibit osteoclasts, although the exact mechanism is not well understood.&lt;/li&gt;&lt;li&gt;â€¢ c) Teriparatide: This is the correct answer. Teriparatide is a recombinant form of parathyroid hormone. It is actually an anabolic (bone-building) agent that stimulates osteoblast activity, rather than inhibiting osteoclasts.&lt;/li&gt;&lt;li&gt;â€¢ d) Raloxifene: This is a selective estrogen receptor modulator (SERM) that inhibits bone resorption by osteoclasts, thus serving to preserve bone mass in conditions like osteoporosis.&lt;/li&gt;&lt;li&gt;â€¢ Teriparatide does not inhibit osteoclasts but stimulates osteoblasts, making it the correct answer for the drug that does not act by inhibiting osteoclasts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of epilepsy presents to the clinic for medication review. The patient is currently taking multiple medications, including isoniazid, hydralazine, procainamide, and phenytoin, for their various medical conditions. During the discussion, the patient asks about the differences in the metabolism of these drugs. The healthcare provider explains that all the drugs mentioned are metabolized by different pathways except for one. Which of the following drugs is NOT metabolized by acetylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenytoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Phenytoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation. On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects.&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body.&lt;/li&gt;&lt;li&gt;â€¢ Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statement is correct regarding the given graph?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A represents agonist and Drug B represents inverse agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug C represents agonist and Drug D is inverse agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug A is agonist and Drug D is inverse agonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug B is partial agonist and Drug C is inverse agonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug A is agonist and Drug D is inverse agonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/17/farma-1.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/farma-13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Drug A is agonist and Drug D is inverse agonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A continuous intravenous infusion of a drug was started at a rate of 3 mg/min. The drug has a half-life of 3 hours, a volume of distribution of 120 L, and a clearance of 0.6 L/min. If the rate of infusion remains constant, what will be the plasma concentration at steady-state?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.005 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.4 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2.0 mg/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5.0 mg/L&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 5.0 mg/L&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male patient presents to the clinic with sudden onset of weakness and numbness on the right side of his body, difficulty speaking, and a sudden severe headache. He denies any recent trauma or significant changes in his lifestyle. On physical examination, there is evidence of right-sided hemiparesis and decreased sensation. The patient&#x27;s speech is slurred, and he exhibits mild confusion. His blood pressure is within normal limits, and the rest of the physical examination is unremarkable. He has a past medical history significant for a stroke that occurred 6 months ago. At that time, he was initiated on clopidogrel for secondary prevention. The patient has been compliant with his medications, including clopidogrel, since his initial stroke. Given this clinical scenario, the most probable cause for the patient&#x27;s recurrent stroke despite being on clopidogrel is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rapid metabolism by CYP 1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poor metabolism by CYP 2C19&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Poor metabolism by CYP 2D6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Poor metabolism by CYP 2E1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Poor metabolism by CYP 2C19&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Given this clinical scenario, the most probable cause for the patient&#x27;s recurrent stroke despite being on clopidogrel is poor metabolism by CYP 2C19. Clopidogrel is a prodrug that requires hepatic activation by cytochrome P450 enzymes, primarily CYP 2C19, to form its active metabolite. This active metabolite inhibits platelet aggregation and helps prevent further clot formation in patients at risk for stroke. However, some individuals have genetic variations that result in poor metabolism of clopidogrel by CYP 2C19, leading to reduced effectiveness of the drug. This phenomenon is known as clopidogrel resistance. Patients who are poor metabolizers of clopidogrel may have a higher risk of recurrent stroke despite taking the medication as prescribed&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young boy presents to the emergency department with constant crying due to pain after a history of bite from an insect. The patient complains of severe pain at the sting site, restlessness, sweating, and increased heart rate. On examination, the patient has local erythema and swelling at the site. The patient&#x27;s blood pressure is elevated. What is the most appropriate treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of prazosin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of antihistamines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administration of corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Application of ice packs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administration of prazosin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â A. Administration of prazosin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The symptoms described by the patient, including severe pain, restlessness, sweating, and increased heart rate, are consistent with scorpion envenomation. Scorpion venom can cause an excessive release of catecholamines, leading to sympathetic overactivity. Prazosin acts by blocking alpha-1 adrenergic receptors, counteracting the effects of the released catecholamines. Options B and C, administration of antihistamines and corticosteroids, respectively, are not the mainstays of treatment for scorpion stings. Antihistamines are primarily used for the management of allergic reactions, which are not the primary mechanism of scorpion envenomation. Corticosteroids may have a limited role in certain cases, but they are not the initial treatment of choice. Option D, application of ice packs, may help provide local pain relief, but it does not address the systemic symptoms associated with scorpion envenomation.Top of Form&lt;/li&gt;&lt;li&gt;â€¢ The symptoms described by the patient, including severe pain, restlessness, sweating, and increased heart rate, are consistent with scorpion envenomation. Scorpion venom can cause an excessive release of catecholamines, leading to sympathetic overactivity.&lt;/li&gt;&lt;li&gt;â€¢ Prazosin acts by blocking alpha-1 adrenergic receptors, counteracting the effects of the released catecholamines.&lt;/li&gt;&lt;li&gt;â€¢ Options B and C, administration of antihistamines and corticosteroids, respectively, are not the mainstays of treatment for scorpion stings. Antihistamines are primarily used for the management of allergic reactions, which are not the primary mechanism of scorpion envenomation. Corticosteroids may have a limited role in certain cases, but they are not the initial treatment of choice.&lt;/li&gt;&lt;li&gt;â€¢ Option D, application of ice packs, may help provide local pain relief, but it does not address the systemic symptoms associated with scorpion envenomation.Top of Form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug addict patient presented with agitation and ulceration on skin. The patient had severe itching and scratch marks on the body. On examination there is presence of tachycardia, mydriasis and hypertension. Likely substance responsible for these symptoms is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannabis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LSD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heroin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Cocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A college student is brought to emergency after taking an overdose of a non-prescription drug. The patient is confused and lethargic. He has been hyperventilating and dehydrated. Arterial blood gas analysis demonstrates metabolic acidosis. In the management of this patient, which is NOT likely to be of any therapeutic value?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkalinization of urine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Correction of metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastric lavage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment with acetyl cysteine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Treatment with acetyl cysteine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Treatment with acetyl cysteine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Individuals with alcoholic cirrhosis of liver may develop severe hepatotoxicity after doses of acetaminophen that are not toxic to individuals with normal liver function. This increase sensitivity to acetaminophenâ€™s toxicity is due to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decrease availability of acetaldehyde dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased hepatocellular stores of glutathione&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased activity of Cytochrome P450 enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased liver blood flow&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased hepatocellular stores of glutathione&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Decreased hepatocellular stores of glutathione&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen is primarily metabolized in the liver through a process that involves the formation of a toxic metabolite called N-acetyl-p-benzoquinone imine (NAPQI). Under normal circumstances, NAPQI is rapidly detoxified by glutathione, preventing liver damage. However, individuals with alcoholic cirrhosis often have reduced levels of glutathione in their hepatocytes (liver cells). This decreased glutathione availability impairs the detoxification of NAPQI, leading to an accumulation of the toxic metabolite in the liver. Consequently, the hepatocytes are more susceptible to damage and toxicity, even with lower doses of acetaminophen that would be well-tolerated by individuals with normal liver function. Factors such as decreased availability of acetaldehyde dehydrogenase (choice A), decreased activity of Cytochrome P450 enzymes (choice C), or increased liver blood flow (choice D) may contribute to liver damage in other contexts or with different substances, but they are not the primary reasons for the increased sensitivity to acetaminophen&#x27;s toxicity in individuals with alcoholic cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen is primarily metabolized in the liver through a process that involves the formation of a toxic metabolite called N-acetyl-p-benzoquinone imine (NAPQI). Under normal circumstances, NAPQI is rapidly detoxified by glutathione, preventing liver damage.&lt;/li&gt;&lt;li&gt;â€¢ However, individuals with alcoholic cirrhosis often have reduced levels of glutathione in their hepatocytes (liver cells). This decreased glutathione availability impairs the detoxification of NAPQI, leading to an accumulation of the toxic metabolite in the liver. Consequently, the hepatocytes are more susceptible to damage and toxicity, even with lower doses of acetaminophen that would be well-tolerated by individuals with normal liver function.&lt;/li&gt;&lt;li&gt;â€¢ Factors such as decreased availability of acetaldehyde dehydrogenase (choice A), decreased activity of Cytochrome P450 enzymes (choice C), or increased liver blood flow (choice D) may contribute to liver damage in other contexts or with different substances, but they are not the primary reasons for the increased sensitivity to acetaminophen&#x27;s toxicity in individuals with alcoholic cirrhosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new born was diagnosed as having a congenital abnormality that resulted in transposition of great vessels. While preparing the infant for surgery, the medical team needed to keep the ducts arteriosus open. They did this by infusing?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alprostadil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alprostadil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alprostadil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the fastest urate lowering therapy in tumor lysis syndrome to prevent renal damage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Febuxostat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rasburicase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rasburicase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Rasburicase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not true about use of Î² blockers in CHF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;These should be started at very low dose and slowly titrated upwards&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol is most widely used Î² blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;These are drug of choice in acute decompensated heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;These can reduce mortality in CHF patient&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. These are drug of choice in acute decompensated heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. These are drug of choice in acute decompensated heart failure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following patients would enalapril be the best first line agent for high blood pressure control?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A 62 year old man with bilateral renal artery stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A 32 year old pregnant female&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A 41 year old woman with hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A 56 year old diabetic woman&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A 56 year old diabetic woman&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. A 56 year old diabetic woman&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these drugs DO NOT decrease angiotensin II activity:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valsartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omapatrilat&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nesiritide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Nesiritide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following hyperpolarizes AV nodal tissue, used in PSVT and has short lasting adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adenosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Adenosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug can decrease bone resorption as well as increase bone formation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Romosozumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cinacalcet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Romosozumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Romosozumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A professor in medical college is teaching students about the adverse effects of a drug. Which of the following drug can cause gynaecomastia in men and menstrual irregularities in women?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxytocin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;At a high altitude of 3000m, a person complains of breathlessness. All of the following can be used for management of this person except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous digoxin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen supplementation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Intravenous digoxin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Intravenous digoxin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mannitol is used in the management of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congestive Cardiac Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Congestive Glaucoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute Renal Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary edema&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute Congestive Glaucoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/17/untitled-385.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Acute Congestive Glaucoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patients is most likely to be treated with intravenous glucagon?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A young man who took cocaine and has a blood pressure of 190/110 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A middle aged man with type II diabetes who has not taken his regular dose of glipizide for last 4 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An old woman with lactic acidosis as a complication of severe infection and shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An old man with severe bradycardia and hypotension resulting from ingestion of overdose of atenolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. An old man with severe bradycardia and hypotension resulting from ingestion of overdose of atenolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. An old man with severe bradycardia and hypotension resulting from ingestion of overdose of atenolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year old obese patient with type 2 diabetes mellitus and a history of alcoholism probably should not receive metformin because it can increase the risk of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disulfiram like reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe hepatic toxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lactic acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lactic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the statements about liraglutide are FALSE except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by releasing insulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is an amylin analog useful in diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is effective orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can be used for treatment of type 1 as well as type 2 diabetes mellitus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It acts by releasing insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. It acts by releasing insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about dapagliflozin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Its major mode of action in diabetes mellitus is to cause glucosuria when serum glucose is above 180 mg/dL.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It acts by inhibiting SGLT2 present in collecting tubules of the nephron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urinary tract infections are common with its use&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Urinary tract infections are common with its use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Urinary tract infections are common with its use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test12" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology E&amp;amp;D Part 2, Mission 3.0 (Early Intern Batch)   17 05 2025   2025 05 17&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology E&amp;amp;D Part 2, Mission 3.0 (Early Intern Batch)   17 05 2025   2025 05 17&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 52-year-old female patient is undergoing chemotherapy for breast cancer. The oncology team is concerned about the risk of febrile neutropenia due to the chemotherapeutic regimen. They are contemplating the use of a granulocyte colony-stimulating factor (G-CSF) and discuss the option of using pegylated-filgrastim. Which of the following is true about pegylated-filgrastim?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Duration of action is longer than filgrastim&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Added advantage is that it can be taken orally&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It requires renal dose adjustment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not effective in the treatment of severe neutropenia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Duration of action is longer than filgrastim&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Duration of action is longer than filgrastim.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man is experiencing recurrent urinary tract infections. His healthcare team is considering various antibiotics, including fluoroquinolones, for his treatment. Which of the following fluoroquinolones is not typically effective for treating urinary tract infections?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Levofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Moxifloxacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lomefloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Moxifloxacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Moxifloxacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Ofloxacin: This fluoroquinolone is commonly used for treating urinary tract infections and is generally effective against a wide range of bacteria that can cause UTIs.&lt;/li&gt;&lt;li&gt;â€¢ B) Levofloxacin: This is another fluoroquinolone antibiotic frequently used in the treatment of UTIs and is generally effective for this purpose.&lt;/li&gt;&lt;li&gt;â€¢ C) Moxifloxacin: This is the correct answer. Moxifloxacin is generally not recommended for treating UTIs. It has reduced effectiveness against the typical bacteria that cause UTIs as compared to other fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ D) Lomefloxacin: Like ofloxacin and levofloxacin, lomefloxacin is generally effective for treating UTIs.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, among the given options, Moxifloxacin is typically not effective for treating urinary tract infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with a history of chronic obstructive pulmonary disease (COPD) is admitted to the intensive care unit for acute exacerbation of his respiratory symptoms. Cultures are taken, and Pseudomonas aeruginosa is isolated from his sputum sample. The healthcare team is considering various antibiotic options to target this specific bacterial strain. Which of the following antibiotics is not effective against infections caused by Pseudomonas aeruginosa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents to the emergency department with chest pain and shortness of breath. The patient has a past medical history of hypertension and hyperlipidemia. An electrocardiogram (ECG) reveals ST-segment elevation. The patient is diagnosed with acute myocardial infarction (AMI) and undergoes percutaneous coronary intervention (PCI). The cardiologist orders the patient to take an antiplatelet drug after the procedure to prevent further clot formation. Which of the following best describes the mechanism of action of clopidogrel, a commonly used antiplatelet drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits cyclooxygenase-1 (COX-1) and decreases production of thromboxane A2, thereby reducing platelet activation and aggregation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibits the formation of fibrin by blocking the conversion of fibrinogen to fibrin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Binds to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B describes the mechanism of action of P2Y12 receptor inhibitors, such as clopidogrel, prasugrel, and ticagrelor. These drugs inhibit the activation and aggregation of platelets by blocking the P2Y12 receptor on the platelet surface. Option A: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), which is responsible for the production of thromboxane A2, a potent platelet activator and aggregator. By decreasing the production of thromboxane A2, aspirin reduces the activation and aggregation of platelets, thereby preventing further clot formation. Aspirin is commonly used as an antiplatelet drug for the prevention of cardiovascular events, such as myocardial infarction and stroke. Option C describes the mechanism of action of anticoagulants, such as heparin and warfarin. These drugs inhibit the formation of fibrin by blocking the coagulation cascade and the conversion of fibrinogen to fibrin. Option D describes the mechanism of action of glycoprotein IIb/IIIa receptor inhibitors, such as abciximab, eptifibatide, and tirofiban. These drugs bind to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.&lt;/li&gt;&lt;li&gt;â€¢ Option B describes the mechanism of action of P2Y12 receptor inhibitors, such as clopidogrel, prasugrel, and ticagrelor. These drugs inhibit the activation and aggregation of platelets by blocking the P2Y12 receptor on the platelet surface.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), which is responsible for the production of thromboxane A2, a potent platelet activator and aggregator. By decreasing the production of thromboxane A2, aspirin reduces the activation and aggregation of platelets, thereby preventing further clot formation. Aspirin is commonly used as an antiplatelet drug for the prevention of cardiovascular events, such as myocardial infarction and stroke.&lt;/li&gt;&lt;li&gt;â€¢ Option C describes the mechanism of action of anticoagulants, such as heparin and warfarin. These drugs inhibit the formation of fibrin by blocking the coagulation cascade and the conversion of fibrinogen to fibrin.&lt;/li&gt;&lt;li&gt;â€¢ Option D describes the mechanism of action of glycoprotein IIb/IIIa receptor inhibitors, such as abciximab, eptifibatide, and tirofiban. These drugs bind to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old female with a history of breast cancer presents to the clinic for a routine follow-up. She has recently completed a course of chemotherapy that included doxorubicin, cyclophosphamide, and paclitaxel. Shortly after her chemotherapy, she developed febrile neutropenia and was treated with filgrastim and cefepime. She also has a history of hypertension controlled with amlodipine. She now reports experiencing symptoms of shortness of breath, fatigue, and palpitations. An echocardiogram reveals her ejection fraction has decreased to 40%. What is the most likely drug-related cause of her reduced ejection fraction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doxorubicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefepime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Doxorubicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Doxorubicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Filgrastim: This drug is used to stimulate the production of neutrophils and is commonly used to treat febrile neutropenia. It is not generally associated with cardiomyopathy or a reduced ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ B) Doxorubicin: Doxorubicin is a chemotherapy agent known for its cardiotoxic effects, which can result in reduced ejection fraction and symptoms like shortness of breath, fatigue, and palpitations. Given the patient&#x27;s recent chemotherapy regimen that included doxorubicin, this is the most likely cause of her decreased ejection fraction.&lt;/li&gt;&lt;li&gt;â€¢ C) Cefepime: This antibiotic is commonly used to treat bacterial infections, including those that may occur with febrile neutropenia. It is not typically associated with reduced ejection fraction or cardiomyopathy.&lt;/li&gt;&lt;li&gt;â€¢ D) Amlodipine: This drug is a calcium channel blocker used to treat hypertension. While it has cardiovascular effects, it is not generally associated with a reduced ejection fraction or cardiomyopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of bipolar disorder presents to the clinic with complaints of confusion, agitation, diarrhea, hand tremors, and excessive thirst. The patient reports taking lithium for the past year as part of his treatment plan. Recently, he also started taking hydrochlorothiazide for hypertension. On examination, the patient has a fine tremor in both hands and is noted to have a serum lithium level of 2.8 mEq/L. Which of the following is the most likely cause of the patient&#x27;s elevated serum lithium level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Additive diuretic effect of hydrochlorothiazide and lithium.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased renal reabsorption of lithium due to hydrochlorothiazide.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased gastrointestinal absorption of lithium due to hydrochlorothiazide.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide-induced enhancement of lithium metabolism.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased renal reabsorption of lithium due to hydrochlorothiazide.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Increased renal reabsorption of lithium due to hydrochlorothiazide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Additive diuretic effect of hydrochlorothiazide and lithium: While both hydrochlorothiazide and lithium can have diuretic effects, this option doesn&#x27;t directly explain the elevated serum lithium level. The primary concern here is the elevated lithium level, not an additive diuretic effect.&lt;/li&gt;&lt;li&gt;â€¢ B) Increased renal reabsorption of lithium due to hydrochlorothiazide: Hydrochlorothiazide can increase the renal reabsorption of lithium, leading to elevated serum lithium levels and symptoms of toxicity. This is the most likely explanation for the patient&#x27;s elevated lithium level.&lt;/li&gt;&lt;li&gt;â€¢ C) Decreased gastrointestinal absorption of lithium due to hydrochlorothiazide: This option is misleading because decreased gastrointestinal absorption of lithium would lead to lower serum lithium levels, not higher.&lt;/li&gt;&lt;li&gt;â€¢ D) Hydrochlorothiazide-induced enhancement of lithium metabolism: This is also a distractor. Enhancement of lithium metabolism would typically result in reduced serum lithium levels, not elevated levels.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the most likely cause for the elevated serum lithium level and symptoms in this patient is the increased renal reabsorption of lithium due to hydrochlorothiazide.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old male with a history of tuberculosis presents to the clinic with complaints of cough, fever, and night sweats. The patient reports completing a course of anti-tuberculosis medications but reports recurrent symptoms. Sputum culture reveals that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin and sensitive to other first line drugs and linezolide as well as bedaquiline. Which type of tuberculosis it can be referred to as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDR Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pre-XDR Tuberculosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;XDR Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin resistant Tuberculosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pre-XDR Tuberculosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Pre-XDR Tuberculosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s history and sputum culture indicate that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin, but is sensitive to other first-line drugs and linezolide, as well as bedaquiline. Based on this information, the patient&#x27;s condition can be referred to as Pre-XDR Tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s history and sputum culture indicate that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin, but is sensitive to other first-line drugs and linezolide, as well as bedaquiline. Based on this information, the patient&#x27;s condition can be referred to as Pre-XDR Tuberculosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding varenicline is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Varenicline is a long-acting beta2-agonist that is used to treat asthma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a medication that is used to aid smoking cessation. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and decreases nicotine cravings.&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a medication that is used to aid smoking cessation. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and decreases nicotine cravings.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch: this is incorrect because varenicline is not a nicotine replacement therapy that delivers nicotine through a transdermal patch. Nicotine replacement therapies include nicotine gum, lozenges, patches, and inhalers.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression: this is incorrect because varenicline is not a selective serotonin reuptake inhibitor (SSRI). SSRIs are a class of medications that are primarily used to treat depression and anxiety disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Varenicline is a long-acting beta2-agonist that is used to treat asthma: this is incorrect because varenicline is not a long-acting beta2-agonist (LABA). LABAs are a class of medications that are used to treat asthma and chronic obstructive pulmonary disease (COPD).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Varenicline is a long-acting beta2-agonist that is used to treat asthma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man who received a kidney transplant three months ago is admitted to the hospital with high-grade fever, malaise, and abdominal discomfort. On examination, he exhibits right upper quadrant tenderness. Lab investigations reveal abnormal liver enzymes, and a blood culture returns positive for cytomegalovirus (CMV). His current immunosuppressive regimen includes tacrolimus. What is the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of calcineurin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blockade of IL-2 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IMP dehydrogenase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dihydro-orotate dehydrogenase inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of calcineurin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of calcineurin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of all the options:&lt;/li&gt;&lt;li&gt;â€¢ A) Inhibition of calcineurin: Tacrolimus acts by inhibiting calcineurin, which plays a pivotal role in T-cell activation. This immunosuppressive action can make the patient susceptible to infections such as CMV.&lt;/li&gt;&lt;li&gt;â€¢ B) Blockade of IL-2 receptor: This is a mechanism of other immunosuppressive drugs like basiliximab but not tacrolimus. Therefore, it is not relevant to the patient&#x27;s current condition.&lt;/li&gt;&lt;li&gt;â€¢ C) IMP dehydrogenase inhibition: This is the mechanism of mycophenolate mofetil, another immunosuppressive drug. It is not applicable to tacrolimus.&lt;/li&gt;&lt;li&gt;â€¢ D) Dihydro-orotate dehydrogenase inhibition: This mechanism is associated with drugs like leflunomide but is not relevant to the action of tacrolimus.&lt;/li&gt;&lt;li&gt;â€¢ Thus, the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection is the inhibition of calcineurin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of epilepsy presents to the dentist with complaints of difficulty in eating and cleaning the teeth. On Examination, the findings were shown as seen in the diagram below. The patient reports that he has been taking an anti-epileptic drug for the past six months, and his symptoms began to appear gradually over the past few weeks. Which of the following anti-epileptic drugs is likely to produce these adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gabapentin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Levetiracetam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenytoin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Phenytoin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male patient with a history of chronic obstructive pulmonary disease (COPD) is on theophylline therapy. He presents to the emergency department with symptoms of nausea, vomiting, and tremors. On examination, he has a heart rate of 110 beats per minute and a serum theophylline level of 30 mg/L (normal range 5-15 mg/L). Which of the following drugs is most likely responsible for the patient&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Montelukast&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Clarithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Clarithromycin can interact with theophylline by inhibiting its metabolism, leading to an increase in serum concentration and an increased risk of toxicity. Symptoms of theophylline toxicity include nausea, vomiting, tremors, seizures, and tachycardia. In severe cases, theophylline toxicity can lead to cardiac arrhythmias and seizures. Other drugs that can interact with theophylline include ciprofloxacin, erythromycin, and fluvoxamine.&lt;/li&gt;&lt;li&gt;â€¢ Clarithromycin can interact with theophylline by inhibiting its metabolism, leading to an increase in serum concentration and an increased risk of toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Symptoms of theophylline toxicity include nausea, vomiting, tremors, seizures, and tachycardia. In severe cases, theophylline toxicity can lead to cardiac arrhythmias and seizures.&lt;/li&gt;&lt;li&gt;â€¢ Other drugs that can interact with theophylline include ciprofloxacin, erythromycin, and fluvoxamine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of gastroesophageal reflux disease (GERD) consults his physician for treatment options. The physician recommends the use of rabeprazole, a proton pump inhibitor. Which of the following statements about proton pump inhibitors is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proton pump inhibitors are available as enteric-coated tablets.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proton pump inhibitors act from the luminal side of gastric parietal cells.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proton pump inhibitors are inactive at neutral pH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proton pump inhibitors should be taken half an hour before food&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Proton pump inhibitors act from the luminal side of gastric parietal cells.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Proton pump inhibitors act from the luminal side of gastric parietal cells.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A) Proton pump inhibitors are available as enteric-coated tablets: This statement is TRUE. The enteric coating allows the medication to pass through the stomach without being destroyed by the stomach acid, eventually dissolving in the intestine for absorption.&lt;/li&gt;&lt;li&gt;â€¢ B) Proton pump inhibitors act from the luminal side of gastric parietal cells: This statement is FALSE. Proton pump inhibitors, including rabeprazole, act from the acidic canaliculus inside the gastric parietal cell, not from the luminal side.&lt;/li&gt;&lt;li&gt;â€¢ C) Proton pump inhibitors are inactive at neutral pH: This statement is TRUE. Proton pump inhibitors are prodrugs that are activated in an acidic environment, which allows them to act specifically on the stomach&#x27;s acid-secreting cells.&lt;/li&gt;&lt;li&gt;â€¢ D) Proton pump inhibitors should be taken half an hour before food: This statement is TRUE. Taking proton pump inhibitors around 30 minutes before eating ensures better activation of the drug, as the stomach starts producing acid in response to eating, thereby optimizing the drug&#x27;s efficacy.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the statement that is INCORRECT regarding proton pump inhibitors is that they act from the luminal side of gastric parietal cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received chlorprocaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Procaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lignocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lignocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Relative intensities of blocking effect (shown by symbol of +) of four drugs on different receptors is: Which drug is most likely to exacerbate the symptoms of Parkinsonism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Drug D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/13.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Drug D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following the treatment of an oral abscess with clindamycin, a patient develops a greenish, foul-smelling watery diarrhea with left lower quadrant pain. Other signs and symptoms include fever, leukocytosis, and lethargy. If the toxin produced by Clostridium difficile is detected in the stool, the patient would most appropriately be treated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fidaxomicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fidaxomicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fidaxomicin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following chelating agents can be used orally for the treatment of transfusion siderosis in thalassemia patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ferrioxamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deferipirone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deferipirone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Deferipirone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the mechanism of antifungal drug is wrongly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azoles- Inhibit ergosterol synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flucytosine- Inhibit microtubule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echinocandins- Inhibit glycan synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphotericin B- Create artificial pores in the membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flucytosine- Inhibit microtubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Flucytosine: Inhibit microtubule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Epinephrine added to a solution of lignocaine for a peripheral nerve block will:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase risk of convulsions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the duration of action of the local anesthetic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both A &amp;amp; B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increase the duration of action of the local anesthetic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Increase the duration of action of the local anesthetic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Long term use of pethidine is avoided because a metabolite of pethidine is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constipation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dependence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Seizures&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory depression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Seizures&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Seizures&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Postoperative vomiting is uncommon with this intravenous anaesthetic agent and patient are able to ambulate sooner than those who receive other anaesthetic agents:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enflurane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propofol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remifentanil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propofol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propofol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A psychiatric patient taking medication develops a tremor, thyroid enlargement and leucocytosis. Drug implicated is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clomipramine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lithium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The drug reducing need of platelet transfusion in patients undergoing cancer chemotherapy is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sargramostim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Oprelvekin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Oprelvekin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-year-old girl is brought to the pediatrician for a severe sore throat. The pediatrician prescribes penicillin and sends the girl home. Later that day, she develops a diffuse maculopapular rash, shortness of breath, and wheezing. Her parents take her to the emergency department, where she is diagnosed with anaphylaxis and treated successfully with epinephrine. Three months later, the girl has dysuria and urinary frequency. Urine Gram&#x27;s stain reveals numerous gram-negative rods. Which of the following antibiotics could be safely given to this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aztreonam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cephalexin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aztreonam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aztreonam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A worried mother complains to her pediatrician that both she and her 8-year-old son&#x27;s teacher have noticed that the child has become inattentive. She states that her son frequently stops what he is doing and \&quot;stares blankly into space\&quot; before resuming his activities. Electroencephalography reveals a 3/second spike and slow wave pattern of discharges. Which of the following agents would most effectively treat this child&#x27;s disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methylphenidate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Valproate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with severe bronchial asthma presents with white patches on the inside of the cheeks that can be easily wiped off, leaving a red, bleeding, sore surface. He is currently using beclomethasone and formoterol inhalers for his asthma and he is allergic to penicillin. Which of the following agents would be most appropriate for the treatment of this patient&#x27;s oral condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acyclovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefixime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nystatin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nystatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Nystatin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with well-controlled Parkinson&#x27;s disease and type 2 diabetes presents with akinesia, a festinating gait, rigidity, and loss of postural reflexes. The patient states that his symptoms began shortly after starting a new \&quot;stomach\&quot; medication. On the basis of this information, the patient is most likely receiving?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cisapride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nizatidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metoclopramide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Metoclopramide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While rescuing a child from a burning home, a firefighter was burned over 60% of his body. He is rushed to the emergency room and quickly taken into surgery. During the surgery, the anesthesiologist notices tall, peaked T waves and prolongation of the PR interval, accompanied by progressive widening of the QRS complex so that it appears to merge with the T waves. The patient goes into ventricular fibrillation, then asystole, and cannot be resuscitated. Which of the following agents is most likely responsible for this patient&#x27;s electrocardiographic changes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atracurium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Baclofen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Halothane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinylcholine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Succinylcholine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Succinylcholine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True statement regarding vancomycin is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is bacteriostatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has the advantage of oral bioavailability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is not susceptible to penicillinases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Staphylococcal enterocolits occurs commonly with its use&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is not susceptible to penicillinases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is not susceptible to penicillinases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metronidazole is least likely to be effective in treatment of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatic ameobiasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infection caused by bacteroides fragilis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudo membranous colitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumocytosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pneumocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pneumocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;High cumulative doses of Bleomycin are associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardio toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemorrhagic cystitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peripheral neuropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pulmonary fibrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of epilepsy has been taking phenytoin for seizure control. After starting another drug, plasma concentration of phenytoin was found to be 25 mcg/ml (therapeutic levels are 10-20 mcg/ml). This sudden rise in plasma drug concentration of phenytoin can cause which of the following adverse effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hirsutism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gum hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ataxia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ataxia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Phenytoin is known to have several potential side effects that can become more apparent or severe as the level of the drug in the bloodstream increases beyond therapeutic levels. This phenomenon is often described as \&quot;dose-dependent toxicity.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ Ataxia, or a lack of muscle control during voluntary movements, can occur as a side effect of high levels of phenytoin. This could result in unsteady movements and difficulty with coordination. Arrhythmias are also noted with high plasma levels of phenytoin.&lt;/li&gt;&lt;li&gt;â€¢ Ataxia, or a lack of muscle control during voluntary movements, can occur as a side effect of high levels of phenytoin. This could result in unsteady movements and difficulty with coordination.&lt;/li&gt;&lt;li&gt;â€¢ Arrhythmias are also noted with high plasma levels of phenytoin.&lt;/li&gt;&lt;li&gt;â€¢ Other adverse effects of phenytoin like hirsutism and gum hyperplasia are seen on long term use (chronic) only.&lt;/li&gt;&lt;li&gt;â€¢ Adverse Effects of Phenytoin:&lt;/li&gt;&lt;li&gt;â€¢ Adverse Effects of Phenytoin:&lt;/li&gt;&lt;li&gt;â€¢ H:    H irsutism&lt;/li&gt;&lt;li&gt;â€¢ H:    H&lt;/li&gt;&lt;li&gt;â€¢ O:    O steomalacia&lt;/li&gt;&lt;li&gt;â€¢ O:    O&lt;/li&gt;&lt;li&gt;â€¢ T:    T eratogenicity (Fetal Hydantoin Syndrome)&lt;/li&gt;&lt;li&gt;â€¢ T:    T&lt;/li&gt;&lt;li&gt;â€¢ M:   M egaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ M:   M&lt;/li&gt;&lt;li&gt;â€¢ A:    A rrhythmia (Acute side effect seen at overdose only)&lt;/li&gt;&lt;li&gt;â€¢ A:    A&lt;/li&gt;&lt;li&gt;â€¢ L:     L ymphadenopathy&lt;/li&gt;&lt;li&gt;â€¢ L:     L&lt;/li&gt;&lt;li&gt;â€¢ I:     I ncrease in blood glucose (due to inhibition of insulin release)&lt;/li&gt;&lt;li&gt;â€¢ I:     I&lt;/li&gt;&lt;li&gt;â€¢ K: Vitamin K deficiency&lt;/li&gt;&lt;li&gt;â€¢ K:&lt;/li&gt;&lt;li&gt;â€¢ K&lt;/li&gt;&lt;li&gt;â€¢ A:    A taxia (Acute side effect seen at overdose only)&lt;/li&gt;&lt;li&gt;â€¢ A:    A&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs has a high affinity for 5-HT2 receptors in the brain, does not cause extrapyramidal dysfunction or agranulocytosis, and is reported to increase the risk of significant QT prolongation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chlorpromazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ziprasidone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ziprasidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Ziprasidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ziprasidone is an atypical antipsychotic that acts by blocking dopamine (D2) and serotonin (5-HT2) receptors in the brain. It is known to have less risk of causing extrapyramidal symptoms (EPS) or agranulocytosis compared to other antipsychotics. However, it has been associated with a risk of QT prolongation, a specific type of abnormal heart rhythm that can potentially lead to serious complications such as Torsades de pointes or sudden cardiac death. Chlorpromazine is a typical antipsychotic that can cause extrapyramidal symptoms. Clozapine, an atypical antipsychotic, has a risk of causing agranulocytosis (a severe and dangerous decrease in white blood cells), which necessitates routine blood monitoring. Olanzapine is an atypical antipsychotic and while it does have a high affinity for 5-HT2 receptors and does not typically cause agranulocytosis, it is not specifically associated with a high risk of QT prolongation.&lt;/li&gt;&lt;li&gt;â€¢ Ziprasidone is an atypical antipsychotic that acts by blocking dopamine (D2) and serotonin (5-HT2) receptors in the brain. It is known to have less risk of causing extrapyramidal symptoms (EPS) or agranulocytosis compared to other antipsychotics. However, it has been associated with a risk of QT prolongation, a specific type of abnormal heart rhythm that can potentially lead to serious complications such as Torsades de pointes or sudden cardiac death.&lt;/li&gt;&lt;li&gt;â€¢ Chlorpromazine is a typical antipsychotic that can cause extrapyramidal symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Clozapine, an atypical antipsychotic, has a risk of causing agranulocytosis (a severe and dangerous decrease in white blood cells), which necessitates routine blood monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Olanzapine is an atypical antipsychotic and while it does have a high affinity for 5-HT2 receptors and does not typically cause agranulocytosis, it is not specifically associated with a high risk of QT prolongation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following limitations of typical tricyclic antidepressants has been overcome by selective serotonin reuptake inhibitors except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Frequent anticholinergic, sedative and hypotensive side effects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High risk of cardiac arrhythmias and seizures in overdose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Delayed response&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Risk of metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Delayed response&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Delayed response&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Selective serotonin reuptake inhibitors (SSRIs) typically have fewer anticholinergic, sedative, and hypotensive side effects than tricyclic antidepressants (TCAs). SSRIs have a safer profile in terms of overdose than TCAs. Overdose with TCAs can lead to severe cardiac arrhythmias and seizures, while overdose with SSRIs is generally much less dangerous. Both SSRIs and TCAs typically take a few weeks to exert their full therapeutic effects. Thus, the delayed response is not a limitation that has been overcome by SSRIs. SSRIs generally have less of an impact on metabolic parameters, including acid-base balance, than TCAs, so they&#x27;re less likely to cause metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Selective serotonin reuptake inhibitors (SSRIs) typically have fewer anticholinergic, sedative, and hypotensive side effects than tricyclic antidepressants (TCAs).&lt;/li&gt;&lt;li&gt;â€¢ SSRIs have a safer profile in terms of overdose than TCAs. Overdose with TCAs can lead to severe cardiac arrhythmias and seizures, while overdose with SSRIs is generally much less dangerous.&lt;/li&gt;&lt;li&gt;â€¢ Both SSRIs and TCAs typically take a few weeks to exert their full therapeutic effects. Thus, the delayed response is not a limitation that has been overcome by SSRIs.&lt;/li&gt;&lt;li&gt;â€¢ SSRIs generally have less of an impact on metabolic parameters, including acid-base balance, than TCAs, so they&#x27;re less likely to cause metabolic acidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients should be cautioned not to consume alcohol when given a prescription for any of the following except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ofloxacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chlorpropamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Griseofulvin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ofloxacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ofloxacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man presents to his primary care physician complaining of a persistent, dull, gnawing pain in his upper abdomen. He mentions the discomfort has been on and off for several months now and seems to worsen on an empty stomach. He denies any changes in bowel habits or any symptoms of nausea, vomiting, or weight loss. His medical history is notable for osteoarthritis and he has been taking aspirin regularly for the past 5 years for pain relief. The physician suspects that chronic use of aspirin may have led to the development of a peptic ulcer. Which of the following drugs would be the best choice for treating this patient&#x27;s suspected peptic ulcer disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Omeprazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pirenzipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ranitidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Omeprazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Omeprazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole is a proton pump inhibitor (PPI) and is generally considered the first-line treatment for peptic ulcer disease, including ulcers that are suspected to have been caused by chronic NSAID (such as aspirin) use. Omeprazole and other PPIs work by irreversibly inhibiting the hydrogen/potassium ATPase pump in the stomach lining, which is responsible for the final step in the production of gastric acid. This reduces the amount of acid in the stomach, allowing ulcers to heal and reducing the likelihood of their formation. Misoprostol is a prostaglandin analog and is most specific drug for NSAID-induced ulcers. It acts by increasing bicarbonate and mucus production in the stomach, thereby protecting the stomach lining. However, it&#x27;s often not the first choice due to its side effects (such as diarrhea) and the need for frequent dosing (four times daily). Pirenzepine is a selective M1 muscarinic receptor antagonist that inhibits gastric acid secretion, but it is less effective and commonly used than PPIs or H2 blockers in peptic ulcer disease. Ranitidine is a H2-receptor antagonist and while it also decreases the production of stomach acid, it is not as potent as PPIs like omeprazole.&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole is a proton pump inhibitor (PPI) and is generally considered the first-line treatment for peptic ulcer disease, including ulcers that are suspected to have been caused by chronic NSAID (such as aspirin) use.&lt;/li&gt;&lt;li&gt;â€¢ Omeprazole and other PPIs work by irreversibly inhibiting the hydrogen/potassium ATPase pump in the stomach lining, which is responsible for the final step in the production of gastric acid. This reduces the amount of acid in the stomach, allowing ulcers to heal and reducing the likelihood of their formation.&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol is a prostaglandin analog and is most specific drug for NSAID-induced ulcers. It acts by increasing bicarbonate and mucus production in the stomach, thereby protecting the stomach lining. However, it&#x27;s often not the first choice due to its side effects (such as diarrhea) and the need for frequent dosing (four times daily).&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol&lt;/li&gt;&lt;li&gt;â€¢ most specific drug&lt;/li&gt;&lt;li&gt;â€¢ Pirenzepine is a selective M1 muscarinic receptor antagonist that inhibits gastric acid secretion, but it is less effective and commonly used than PPIs or H2 blockers in peptic ulcer disease.&lt;/li&gt;&lt;li&gt;â€¢ Ranitidine is a H2-receptor antagonist and while it also decreases the production of stomach acid, it is not as potent as PPIs like omeprazole.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on cisplatin therapy develops intractable vomiting on the third day of treatment. Agent of choice for controlling this vomiting is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Netupitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prochlorperazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Netupitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Netupitant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cisplatin is a chemotherapeutic agent that is associated with a high risk of chemotherapy-induced nausea and vomiting (CINV). It can cause two types of vomiting. Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV. Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV. Netupitant is a NK1 receptor antagonist and is usually used in combination with a 5-HT3 receptor antagonist (like palonosetron) and dexamethasone. It is DOC for delayed CINV associated with highly emetogenic chemotherapy. Ondansetron is often the first choice for managing acute CINV due to its efficacy and tolerability. Metoclopramide, a dopamine receptor antagonist, may be used to manage CINV, but it&#x27;s generally not as effective as the 5-HT3 antagonists. Prochlorperazine is also used to manage CINV, but it&#x27;s not generally the first choice because of its potential to cause extrapyramidal symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Cisplatin is a chemotherapeutic agent that is associated with a high risk of chemotherapy-induced nausea and vomiting (CINV). It can cause two types of vomiting. Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV. Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV.&lt;/li&gt;&lt;li&gt;â€¢ Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV. Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV.&lt;/li&gt;&lt;li&gt;â€¢ Early vomiting: It occurs within first 24 hours of administration of cisplatin. 5-HT3 receptor antagonists like ondansetron are drug of choice for managing early CINV.&lt;/li&gt;&lt;li&gt;â€¢ Early vomiting:&lt;/li&gt;&lt;li&gt;â€¢ Delayed vomiting: It occurs after first day of administration of cisplatin. NK1 receptor anatagonists like aprepitant, netupitant etc are DOC for delayed CINV.&lt;/li&gt;&lt;li&gt;â€¢ Delayed vomiting:&lt;/li&gt;&lt;li&gt;â€¢ Netupitant is a NK1 receptor antagonist and is usually used in combination with a 5-HT3 receptor antagonist (like palonosetron) and dexamethasone. It is DOC for delayed CINV associated with highly emetogenic chemotherapy.&lt;/li&gt;&lt;li&gt;â€¢ Ondansetron is often the first choice for managing acute CINV due to its efficacy and tolerability.&lt;/li&gt;&lt;li&gt;â€¢ Metoclopramide, a dopamine receptor antagonist, may be used to manage CINV, but it&#x27;s generally not as effective as the 5-HT3 antagonists.&lt;/li&gt;&lt;li&gt;â€¢ Prochlorperazine is also used to manage CINV, but it&#x27;s not generally the first choice because of its potential to cause extrapyramidal symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Choose the correct statement about the use of loperamide in the management of diarrhea:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is used to control diarrhea irrespective of its etiology&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is used as adjuvant to antimicrobial therapy of diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is the drug of choice in Travellerâ€™s diarrhea&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is an anti-diarrheal agent that works by slowing the movement of the intestines, which helps to reduce the frequency of bowel movements. It is not used to control diarrhea irrespective of its etiology. For instance, if diarrhea is caused by certain types of infections (such as those involving enteroinvasive organisms), loperamide can potentially worsen the situation by delaying the elimination of the pathogens from the gut. Loperamide is used as a short-term measure to manage symptoms of acute diarrhea. It is especially important to confirm that enteroinvasive organisms are not involved, as using loperamide in such cases could be harmful. Loperamide is not used as an adjuvant to antimicrobial therapy. It is primarily used for symptomatic relief. Loperamide is not the drug of choice for Traveller&#x27;s diarrhea, especially when the diarrhea is severe, bloody, or accompanied by fever. Antibiotics are often the preferred treatment in such cases.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is an anti-diarrheal agent that works by slowing the movement of the intestines, which helps to reduce the frequency of bowel movements.&lt;/li&gt;&lt;li&gt;â€¢ It is not used to control diarrhea irrespective of its etiology. For instance, if diarrhea is caused by certain types of infections (such as those involving enteroinvasive organisms), loperamide can potentially worsen the situation by delaying the elimination of the pathogens from the gut.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is used as a short-term measure to manage symptoms of acute diarrhea. It is especially important to confirm that enteroinvasive organisms are not involved, as using loperamide in such cases could be harmful.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is not used as an adjuvant to antimicrobial therapy. It is primarily used for symptomatic relief.&lt;/li&gt;&lt;li&gt;â€¢ Loperamide is not the drug of choice for Traveller&#x27;s diarrhea, especially when the diarrhea is severe, bloody, or accompanied by fever. Antibiotics are often the preferred treatment in such cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-tubercular drugs is safe in hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethionamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Streptomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Streptomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The combination of trimethoprim and sulfamethoxazole is effective against which of the following opportunistic infections in the AIDS patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disseminated Herpes simplex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cryptococcal meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumocystis jiroveci&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pneumocystis jiroveci&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pneumocystis jiroveci&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Trimethoprim-sulfamethoxazole (TMP-SMX), also known as co-trimoxazole, is a combination antibiotic that is effective against a wide range of bacteria. It is also the treatment and prophylaxis of choice for Pneumocystis jiroveci (formerly known as Pneumocystis carinii) pneumonia, an opportunistic infection that is common in individuals with AIDS. Disseminated Herpes simplex is generally treated with antiviral drugs, such as acyclovir. Cryptococcal meningitis is typically treated with a combination of antifungal medications, often including amphotericin B and flucytosine. Tuberculosis is typically treated with a combination of anti-tubercular drugs, such as isoniazid, rifampin, ethambutol, and pyrazinamide.&lt;/li&gt;&lt;li&gt;â€¢ Trimethoprim-sulfamethoxazole (TMP-SMX), also known as co-trimoxazole, is a combination antibiotic that is effective against a wide range of bacteria. It is also the treatment and prophylaxis of choice for Pneumocystis jiroveci (formerly known as Pneumocystis carinii) pneumonia, an opportunistic infection that is common in individuals with AIDS.&lt;/li&gt;&lt;li&gt;â€¢ Disseminated Herpes simplex is generally treated with antiviral drugs, such as acyclovir.&lt;/li&gt;&lt;li&gt;â€¢ Cryptococcal meningitis is typically treated with a combination of antifungal medications, often including amphotericin B and flucytosine.&lt;/li&gt;&lt;li&gt;â€¢ Tuberculosis is typically treated with a combination of anti-tubercular drugs, such as isoniazid, rifampin, ethambutol, and pyrazinamide.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Biochemical mechanisms of drug resistance are shown in the given below figure. Most important mode of resistance in MRSA is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_STisk1C.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-550.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A post operative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotics treatment, the review of the charts was done. It was found that that the resident doctor had started the combination of antibiotics which was mutually antagonistic in action. Which of the following is the most likely combination that was given?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vancomycin and Amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ampicillin and Chloramphenicol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cephalexin and Gentamicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin and Piperacillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ampicillin and Chloramphenicol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Ampicillin and Chloramphenicol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is the oral drug for treatment of mucormycosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Voriconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Posaconazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Terbinafine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Posaconazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Posaconazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about warfarin group of oral anticoagulants is false ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They interfere with an early step in the synthesis of clotting factors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Their dose is adjusted by repeated measurement of INR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are contraindicated during first trimester of pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They interfere with an early step in the synthesis of clotting factors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. They interfere with an early step in the synthesis of clotting factors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin has a delayed onset of action because it does not affect clotting factors that have already been synthesized and are present in the bloodstream. It takes several days for these existing clotting factors to degrade and for the anticoagulant effect to become apparent.&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. The dose of warfarin is adjusted based on the International Normalized Ratio (INR) to ensure that the patient&#x27;s blood is maintained within the therapeutic range, which minimizes the risk of bleeding and thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin is contraindicated during pregnancy, especially in the first trimester, due to its teratogenic effects. It can cause fetal warfarin syndrome, characterized by nasal hypoplasia and stippled epiphyses, among other congenital abnormalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Warfarin is an oral anticoagulant that inhibits the enzyme vitamin K epoxide reductase, affecting the carboxylation and activation of certain clotting factors. It has a delayed onset of action, typically taking 4-5 days, and its dose is adjusted based on INR measurements. Warfarin is contraindicated during pregnancy due to its teratogenic potential, especially in the first trimester.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67 years old female was given rivaroxaban to prevent thromboembolism after total knee replacement surgery. She took overdose of the above drug. Which of the following drug can be used to reverse the effect of the anticoagulant taken by her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idarucizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Andexanet alpha&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin K&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Protamine sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Andexanet alpha&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Andexanet alpha&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about heparin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It act by inhibiting anti-thrombin III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin is preferred over warfarin for long-term treatment of DVT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male patient is currently receiving treatment in the oncology department for advanced non-small cell lung cancer (NSCLC). His oncologist has been discussing various therapeutic options with him, including a group of medications called immune checkpoint inhibitors. Immune checkpoints are regulators of the immune system that help to prevent the immune system from attacking cells indiscriminately. They do this by distinguishing between &#x27;self&#x27; and &#x27;non-self&#x27; cells. Some cancer cells can take advantage of these checkpoints to avoid being targeted by the immune system. Immune checkpoint inhibitors are a type of drug that blocks these immune checkpoints, allowing immune cells to better recognize and attack cancer cells. Given this information, which of the following drugs is not an immune check point inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avelumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Durvalumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cetuximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-553.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cetuximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the preferred drug for treatment of pre-menopausal breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tamoxifen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anastrozole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tamoxifen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Tamoxifen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ Now, let&#x27;s evaluate each option:&lt;/li&gt;&lt;li&gt;â€¢ A. Methotrexate: Methotrexate is a chemotherapy drug used in the treatment of various cancers, including some types of breast cancer. However, it is not typically the first-line choice for post-menopausal breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ B. Raloxifene: Raloxifene is a selective estrogen receptor modulator (SERM) primarily used for osteoporosis and the prevention of breast cancer, rather than its treatment.&lt;/li&gt;&lt;li&gt;â€¢ Raloxifene:&lt;/li&gt;&lt;li&gt;â€¢ C. Tamoxifen: Tamoxifen is a widely used medication for the treatment of hormone receptor-positive breast cancer in both pre-menopausal and post-menopausal women. It is often the preferred choice for breast cancer in pre-menopausal female.&lt;/li&gt;&lt;li&gt;â€¢ Tamoxifen:&lt;/li&gt;&lt;li&gt;â€¢ D. Anastrozole: Anastrozole is an aromatase inhibitor and is drug of choice for treatment of breast cancer (which is estrogen receptor positive) in post-menopausal females.&lt;/li&gt;&lt;li&gt;â€¢ Anastrozole:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and efavirenz 600 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add lamivudine 300 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add dolutegravir 50 mg in the morning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. No dose adjustment is required&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) No dose adjustment is required&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents to the emergency room with seizures. A CT scan of his head reveals a space-occupying lesion, suggesting a diagnosis of neurocysticercosis. Which of the following medications is NOT recommended for treating this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Di-Ethyl-Carbamezine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Albendazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Di-Ethyl-Carbamezine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Di-Ethyl-Carbamezine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine:&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine is an anticonvulsant medication commonly used to control seizures. Given that the patient presented with seizures, this drug would be an appropriate choice for symptom management.&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine:&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine:&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine:&lt;/li&gt;&lt;li&gt;â€¢ Di-Ethyl-Carbamezine is not typically used for treating neurocysticercosis or seizures associated with it. In fact, it is used for the treatment of filariasis and is not recommended for neurocysticercosis.&lt;/li&gt;&lt;li&gt;â€¢ Albendazole:&lt;/li&gt;&lt;li&gt;â€¢ Albendazole:&lt;/li&gt;&lt;li&gt;â€¢ Albendazole:&lt;/li&gt;&lt;li&gt;â€¢ Albendazole is an antiparasitic medication that is commonly used for treating neurocysticercosis. It kills the cysticercus, the larval form of the Taenia solium tapeworm that causes the condition.&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Prednisolone is a corticosteroid that may be used to reduce inflammation and edema around the cysts in the brain, especially during the initial phase of anthelmintic therapy, to avoid inflammatory responses as the parasites die.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents to the clinic for a routine check-up. Blood tests reveal elevated liver enzymes, and subsequent tests confirm a diagnosis of chronic hepatitis C. She has no significant medical history and wishes to begin antiviral therapy to minimize the risk of progression to liver cirrhosis or hepatocellular carcinoma. Which of the following oral medications is recommended as a first-line treatment for hepatitis C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ribavirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tenofovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paritaprevir&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interferons&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paritaprevir&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin: Ribavirin is an older antiviral medication that was used in combination with interferon for treating hepatitis C. It is not commonly used as a monotherapy for hepatitis C and has largely been replaced by more effective and tolerable options. Tenofovir: Tenofovir is primarily used in the treatment of HIV and chronic hepatitis B, not hepatitis C. Paritaprevir: Paritaprevir is a first-line, direct-acting antiviral agent used for the treatment of chronic hepatitis C. It is often used in combination with other medications and has a high cure rate with a well-tolerated side effect profile. Interferons: These are injectable drugs used in treatment of hepatitis C. These are not effective orally.&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin: Ribavirin is an older antiviral medication that was used in combination with interferon for treating hepatitis C. It is not commonly used as a monotherapy for hepatitis C and has largely been replaced by more effective and tolerable options.&lt;/li&gt;&lt;li&gt;â€¢ Ribavirin:&lt;/li&gt;&lt;li&gt;â€¢ Tenofovir: Tenofovir is primarily used in the treatment of HIV and chronic hepatitis B, not hepatitis C.&lt;/li&gt;&lt;li&gt;â€¢ Tenofovir:&lt;/li&gt;&lt;li&gt;â€¢ Paritaprevir: Paritaprevir is a first-line, direct-acting antiviral agent used for the treatment of chronic hepatitis C. It is often used in combination with other medications and has a high cure rate with a well-tolerated side effect profile.&lt;/li&gt;&lt;li&gt;â€¢ Paritaprevir:&lt;/li&gt;&lt;li&gt;â€¢ Interferons: These are injectable drugs used in treatment of hepatitis C. These are not effective orally.&lt;/li&gt;&lt;li&gt;â€¢ Interferons:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test13" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology Revision E&amp;amp;D 2 (Mission Neet Pg 1.0)   17 11 2023   2023 11 17&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology Revision E&amp;amp;D 2 (Mission Neet Pg 1.0)   17 11 2023   2023 11 17&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                50 Questions | 200 Total Marks | 60 min Duration | ~72.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Most important mechanism of methotrexate when used as a disease modifying anti-rheumatoid drug is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of dihydrofolate reductase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of AICAR transformylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of dihydroorotate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activaton of TNF-alpha&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of AICAR transformylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inhibition of AICAR transformylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following binds to viral envelope glycoprotein preventing the conformational changes required for the fusion of viral and cellular membranes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abacavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indinavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enfuvirtide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oseltamivir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enfuvirtide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Enfuvirtide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify Drug X and Drug Y according to the mechanism of action shown in the figure below:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;X is ceftriaxone and Y is Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;X is vancomycin and Y is imipenem&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;X is meropenem and Y is Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;X is ceftriaxone and Y is amoxicillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. X is vancomycin and Y is imipenem&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture1_yCaIwl2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. X is vancomycin and Y is imipenem.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ubrogepant is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CGRP receptor antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serotonin 1F agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bradykinin receptor agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kallikrein antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CGRP receptor antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture2_pvObEZC.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. CGRP receptor antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For overdose of several drugs, we can change the pH of the urine. Urine can be made alkaline for increasing the excretion of all of the following drugs except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Morphine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Morphine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Volume of distribution of a drug is 50 L and target plasma concentration of drug required is 5 mg/L. If 20% of orally administered drug reaches the systemic circulation, what will be the oral loading dose of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;250 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;125 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1.25 g&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2.5 g&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1.25 g&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â  C. 1.25 g&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given image shows the Log DRC of a drug alone (A) and in the presence of antagonists (B and C). Identify the type of antagonism shown in curve B and curve C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Both are competitive antagonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both are non-competitive antagonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;B is competitive and C is non-competitive antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B is non-competitive an C is competitive antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. B is competitive and C is non-competitive antagonist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture3_7XaaxAu.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. B is competitive and C is non competitive antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following gives the extent of drug absorption in plasma concentration vs time graph shown below in the figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Half life&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Area under the curve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cmax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Area under the curve&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C. Area under the curve&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents to you with hypothyroidism and you want to prescribe oral thyroxine at a dose of 100 microgram (0.1 milligram) daily for 30 days. As an Indian medical intern, which of the following is the correct format for prescription of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tablet Thyroxine 100 Âµg once a day orally for 30 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tablet Thyroxine 100 mcg OD orally for 30 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tablet Thyroxine .1 mg once a day orally for 30 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tablet Thyroxine 100 mcg once a day orally for 30 days&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tablet Thyroxine 100 mcg once a day orally for 30 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tablet Thyroxine 100 mcg once a day orally for 30 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After eating a plant as shown in the figure below, A child presented to emergency in comatose state. The pupils were dilated and skin was dry. Body temperature is raised and heart rate is high. These signs and symptoms are similar to intake of which of the following substance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atropine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Atropine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Repeated administration of a drug, produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachyphylaxis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nicotinic actions of acetylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Biphasic response of adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vasomotor reversal of Dale&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tachyphylaxis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Tachyphylaxis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A hypertensive patient was on metoprolol treatment. Verapamil was added to the therapy of this patient. This can result in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia with AV block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Torsades de pointes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia with AV block&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Bradycardia with AV block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient requires mild cholinomimetic stimulation following surgery. Physostigmine and bethanechol in small doses have significantly different effects on which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuromuscular junction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sweat glands&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ureteral tone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neuromuscular junction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Neuromuscular junction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tremors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchodilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Hypoglycemia (Ref: KDT 6/e p124)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male with insulin dependent diabetes having macular edema develops glaucoma. Which of the following anti-glaucoma drugs should be avoided in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Latanoprost&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Netarsudil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brimonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Timolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Latanoprost&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-130106.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Latanoprost&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease in heart rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in mean arterial pressure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased renal perfusion and reduced urine output&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increase in mean arterial pressure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Increase in mean arterial pressure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diuretics does not require its presence in the tubular lumen for its pharmacological effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loop diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbonic anhydrase inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aldosterone antagonists&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aldosterone antagonists&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Aldosterone antagonists&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34- year old man with a long history of asthma is referred to pulmonologist. The physician decides to prescribe zileuton. The mechanism of action of this drug is to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antagonize leukotriene D4 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits 5-lipoxygenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibit phosphodiesterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulate beta 2 receptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibits 5-lipoxygenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inhibits 5- lipoxygenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following statements about metformin is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Does not stimulate insulin release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreases hepatic glucose production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Can be safely used in patients with renal dysfunction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Can be combined with sulfonylureas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Can be safely used in patients with renal dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Can be safely used in patients with renal dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is an antagonist of a peptide and is used to reduce chemotherapy induced nausea and vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial natriuretic peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aprepitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bradykinin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aprepitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Aprepitant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about Colchicine is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acts by inhibiting granulocyte migration in the joint.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It causes metaphase arrest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can result in myopathy as an adverse effect.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A lady who was treated for breast cancer is on long-term tamoxifen therapy as she is ER-positive. Drug tamoxifen can increase the risk for which of the following cancers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carcinoma of ovary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endometrial carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Breast carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic myeloid leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Endometrial carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Endometrial carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person is planning a road trip from Chandigarh to Manali. He developed severe vomiting during his last trip to Manali. Which of the following drug should be taken by the person to avoid the motion sickness?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fexofenadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cetirizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loratadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Promethazine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Promethazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-190636.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Promethazine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female with renal disease was admitted for pyelolithotomy. Postoperative analgesic of choice in this patient is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diclofenac&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Naproxen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetaminophen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acetaminophen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Acetaminophen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the mechanism shown in figure. Drug X is likely to be:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exenatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pramlintide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vildagliptin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vildagliptin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture3_2OD4jpH.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vildagliptin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are immune check point inhibitors except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avelumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Durvalumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cetuximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture4_3R8idux.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-134550.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cetuximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Avelumab, atezolizumab, and durvalumab are all programmed death ligand-1 (PD-L1) inhibitors that work by blocking the interaction between PD-L1 and its receptor, PD-1, on T cells. This helps to activate the immune system and attack cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Cetuximab, on the other hand, is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on cancer cells. It does not inhibit PD-L1 and does not work through the same mechanism as PD-L1 inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Immune Check Point inhibitors&lt;/li&gt;&lt;li&gt;â€¢ Immune Check Point inhibitors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What are the appropriate instructions to be given while prescribing bisphosphonates to a patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To be given empty stomach with a full glass of water&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Must be taken along with food&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Should be stopped if features of gastritis develop&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Should be stopped if bone pains occur&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. To be given empty stomach with a full glass of water&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. To be given empty stomach with a glass of water&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on digoxin therapy had a level of 1 ng/ml. He was receiving several other drugs and presented 2 months later with flattening of T waves in ECG. Now the plasma level of digoxin is 3.8 ng/ml. Which of the following drug is likely to be responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Triamterene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;KCI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Clarithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Octreotide is used in all except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucagonoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carcinoid syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glioma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Glioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs block late inward sodium ion channels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ranolazine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trimetazidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fasudil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ranolazine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ranolazine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the antiarrhythmic agent with the following mechanism of action:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flecainide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tocainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ibutilide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Flecainide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture8.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture9.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-130443.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Flecainide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pre-XDR TB is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone and streptomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MDR plus resistance to fluoroquinolone, linezolide and bedaquiline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MDR plus resistance to amikacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. MDR plus resistance to fluoroquinolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-135104.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. MDR plus resistance to fluoroquinolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements about nesiritide are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a BNP analogue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It can be used in decompensated CHF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can be administered orally&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It causes loss of Na + in the urine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It can be administered orally&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It can be administered orally&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following drugs are used in treatment of osteoporosis except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Milnacipran&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Strontium ranelate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Milnacipran&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-135153.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Milnacipran&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with breast carcinoma is receiving treatment with paclitaxel. During a routine follow-up visit, the patient reports feeling unwell and develops a fever. A complete blood count shows that the patient has a total leukocyte count of 2400/mm 3 . The healthcare provider suspects that the patient has developed neutropenia, a common side effect of chemotherapy that increases the risk of infections. Which of the following antimicrobial is not suitable for treatment of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Meropenem&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Linezolid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefepime&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Linezolid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Linezolid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient of bipolar disorder was treated with lithium. Hydrochlorothiazide was prescribed for his hypertension. He developed nausea, vomiting, coarse tremors and brisk reflexes 2 weeks after taking drugs. What is the likely reason for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Side effects of hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased metabolism of hydrochlorthiazide by lithium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased renal tubular reabsorption of lithium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiazide act as an add on drug to lithium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased renal tubular reabsorption of lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Increased renal tubular reabsorption of lithium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are adverse effects of amiodarone except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corneal microdeposits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Photosensitivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tachycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Trimetazidine is a drug approved for treatment of angina pectoris. Its mechanism of action is assumed to be?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bradycardiac agent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rho kinase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;K channel opener&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibiting mitochondrial LC3- KAT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Inhibiting mitochondrial LC3- KAT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Inhibiting mitochondrial LC3-KAT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents to the emergency department with a fever, headache, and muscle aches. He reports a recent camping trip in a rural area where he was exposed to ticks. On examination, there is a characteristic eschar at the site of a tick bite, as well as regional lymphadenopathy. Laboratory tests reveal thrombocytopenia and elevated liver enzymes. Based on the clinical presentation and laboratory findings, the healthcare provider suspects scrub typhus. What is the drug of choice for scrub typhus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sulfonamides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Doxycycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Scrub typhus is an acute febrile illness caused by the bacteria Orientia tsutsugamushi, which is transmitted to humans by the bite of infected chiggers. The clinical presentation of scrub typhus is characterized by fever, headache, muscle aches, and the presence of an eschar at the site of the chigger bite. Laboratory findings may include thrombocytopenia, elevated liver enzymes, and leukocytosis. The drug of choice for the treatment of scrub typhus is doxycycline. Other antibiotics, such as azithromycin, chloramphenicol, and ciprofloxacin, may also be used to treat scrub typhus, but doxycycline is the preferred drug due to its effectiveness and low risk of adverse effects. Erythromycin, sulfonamides, and metronidazole are not recommended for the treatment of scrub typhus&lt;/li&gt;&lt;li&gt;â€¢ Scrub typhus is an acute febrile illness caused by the bacteria Orientia tsutsugamushi, which is transmitted to humans by the bite of infected chiggers. The clinical presentation of scrub typhus is characterized by fever, headache, muscle aches, and the presence of an eschar at the site of the chigger bite. Laboratory findings may include thrombocytopenia, elevated liver enzymes, and leukocytosis.&lt;/li&gt;&lt;li&gt;â€¢ The drug of choice for the treatment of scrub typhus is doxycycline. Other antibiotics, such as azithromycin, chloramphenicol, and ciprofloxacin, may also be used to treat scrub typhus, but doxycycline is the preferred drug due to its effectiveness and low risk of adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ Erythromycin, sulfonamides, and metronidazole are not recommended for the treatment of scrub typhus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following agents is available as a patch for once-daily use and is likely to provide steady drug levels to treat Alzheimerâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rivastigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Donepezil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Memantine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galantamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rivastigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Rivastigmine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Angiotensin receptor blocker which blocks thromboxane A2 receptor is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Losartan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Telmisartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Candesartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Olmesartan&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Losartan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Losartan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with schizophrenia was treated with haloperidol 5 mg once daily at bedtime, which was increased to 7.5 mg daily in the 2nd week and 10 mg daily in the 3rd week. His symptoms improved, but in the 5th week, his family reported that his restlessness had returned, and he kept pacing around in the room, though he was not aggressive. The patient also reported an uncontrollable urge to move around and difficulty in falling asleep. Which of the following drugs would be the best choice for this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Higher doses of haloperidol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valbenazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dantrolene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s symptoms suggest that he may be experiencing akathisia, a side effect of antipsychotic medications like haloperidol. Akathisia is characterized by restlessness, an uncontrollable urge to move, and difficulty in sitting still.&lt;/li&gt;&lt;li&gt;â€¢ Propranolol, a beta-blocker, is often used to treat akathisia and could be an appropriate choice to address the patient&#x27;s symptoms. Higher doses of haloperidol may exacerbate the patient&#x27;s restlessness and are not recommended in this case. Valbenazine is used to treat tardive dyskinesia, a different movement disorder associated with long-term antipsychotic use. It is not indicated for treating akathisia. Dantrolene is a muscle relaxant used to treat muscle spasms and malignant hyperthermia. It is not used to treat akathisia.&lt;/li&gt;&lt;li&gt;â€¢ Propranolol, a beta-blocker, is often used to treat akathisia and could be an appropriate choice to address the patient&#x27;s symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Higher doses of haloperidol may exacerbate the patient&#x27;s restlessness and are not recommended in this case.&lt;/li&gt;&lt;li&gt;â€¢ Valbenazine is used to treat tardive dyskinesia, a different movement disorder associated with long-term antipsychotic use. It is not indicated for treating akathisia.&lt;/li&gt;&lt;li&gt;â€¢ Dantrolene is a muscle relaxant used to treat muscle spasms and malignant hyperthermia. It is not used to treat akathisia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presents to the emergency department with a fever, headache, and abdominal pain for the past five days. On examination, his temperature is 102Â°F (39Â°C), and he has tenderness in the right upper quadrant of his abdomen. Blood cultures are positive for Salmonella typhi. Which of the following drugs is NOT used in the treatment of enteric fever?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amikacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amikacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-135731_ZCAHXPE.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Amikacin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Enteric fever is a bacterial infection caused by Salmonella typhi or Salmonella paratyphi. The mainstay of treatment for enteric fever is antibiotic therapy, which is typically initiated based on the results of a blood culture. Commonly used antibiotics for the treatment of enteric fever include ceftriaxone, ciprofloxacin, azithromycin, and other fluoroquinolones. Rifampicin is also effective in treating enteric fever and is often used in combination with other antibiotics. However, amikacin, which is an aminoglycoside antibiotic, is not typically used in the treatment of enteric fever.&lt;/li&gt;&lt;li&gt;â€¢ Enteric fever is a bacterial infection caused by Salmonella typhi or Salmonella paratyphi.&lt;/li&gt;&lt;li&gt;â€¢ The mainstay of treatment for enteric fever is antibiotic therapy, which is typically initiated based on the results of a blood culture.&lt;/li&gt;&lt;li&gt;â€¢ Commonly used antibiotics for the treatment of enteric fever include ceftriaxone, ciprofloxacin, azithromycin, and other fluoroquinolones.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin is also effective in treating enteric fever and is often used in combination with other antibiotics.&lt;/li&gt;&lt;li&gt;â€¢ However, amikacin, which is an aminoglycoside antibiotic, is not typically used in the treatment of enteric fever.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is operated for bile duct stricture. Post operatively he is receiving 3 ml epidural morphine for pain relief. One day accidentally he received 12 ml of morphine. What will not occur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory depression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypotension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Miosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Tachycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are penicillinase resistant penicillins EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dicloxacillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cloxacillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methicillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ampicillin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ampicillin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Tramadol acts on Âµ receptor as an agonist. Additionally, it also acts as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SNRI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NDRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antihistaminic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anticholinergic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SNRI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. SNRI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Imipenem, an antibiotic with a broad antibacterial spectrum, is co-administered with cilastatin. What is the reason for the same?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Combination is synergistic against Pseudomonas species&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cilastatin aids gastrointestinal absorption of active moiety&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cilastatin inhibits beta-lactamase enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cilastatin inhibits an enzyme in kidney that destroys imipenem&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cilastatin inhibits an enzyme in kidney that destroys imipenem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Cilastatin inhibits an enzyme in kidney that destroys imipenem&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a antagonist of PAR-1 receptors of thrombin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ticlopidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tirofiban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vorapaxar&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vorapaxar&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vorapaxar&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male had fever for the past 1 week with abdominal distention and loss of appetite. It is not responding to antibiotics and antimalarials. Widal test is negative but RK39 dipstick test is positive. Which of the following drugs can be used in the above patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bedaquiline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linezolid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fluconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liposomal amphotericin B&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Liposomal amphotericin B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Liposomal amphotericin B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron dextran&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oprelvekin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-140329.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Oprelvekin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 60 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test14" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Pharmacology Test (The Champion Batch Hyderabad)   26 09 2024   2024 09 26&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Pharmacology Test (The Champion Batch Hyderabad)   26 09 2024   2024 09 26&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following suggests storage of drugs in tissue ( AIIMS Nov 2017)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Excretion in saliva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Excretion in urine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Large volume of distribution&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Small volume of distribution&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Large volume of distribution&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Large volume of distribution&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A large volume of distribution (Vd) suggests that a drug is extensively distributed and stored in the body&#x27;s tissues, which can result in a prolonged half-life and slower elimination from the body.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 39-year-old man presents to the clinic for management of chronic pain. He has a history of non-adherence to oral medications and is seeking alternative routes of administration. He inquires about the use of transdermal therapeutic systems for his condition. When considering the rate of systemic absorption of drugs administered through the skin, which of the following correctly orders anatomical sites from the fastest to the slowest absorption rate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plantar surface&amp;gt; scalp&amp;gt; forearm&amp;gt;postauricular skin &amp;gt; scrotum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Postauricular skin &amp;gt; forearm &amp;gt; scrotum &amp;gt; scalp &amp;gt; plantar surface&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Scrotum &amp;gt; postauricular skin &amp;gt; forearm &amp;gt; scalp &amp;gt; plantar surface&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scrotum &amp;gt; forearm &amp;gt; scalp &amp;gt;postauricular skin &amp;gt; plantar surface&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Scrotum &gt; postauricular skin &gt; forearm &gt; scalp &gt; plantar surface&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Scrotum &amp;gt; postauricular skin &amp;gt; forearm &amp;gt; scalp &amp;gt; plantar surface&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The absorption rate through the skin is influenced by the anatomical site&#x27;s skin thickness, hair follicle density , capillary density, lipid content, and degree of hydration . The correct sequence from fastest to slowest is:&lt;/li&gt;&lt;li&gt;â€¢ absorption rate through the skin&lt;/li&gt;&lt;li&gt;â€¢ influenced by the anatomical site&#x27;s skin thickness,&lt;/li&gt;&lt;li&gt;â€¢ hair follicle density&lt;/li&gt;&lt;li&gt;â€¢ capillary density,&lt;/li&gt;&lt;li&gt;â€¢ lipid content,&lt;/li&gt;&lt;li&gt;â€¢ degree of hydration&lt;/li&gt;&lt;li&gt;â€¢ Scrotum : Has thin skin with high permeability. Postauricular skin (behind the ear) : Relatively thin and well-perfused, allowing for good absorption. Forearm : More commonly used for drug absorption testing, has moderate absorption rates. Scalp : While well-vascularized, the presence of hair and thicker skin can decrease the rate of absorption compared to other areas. Plantar surface : The skin of the palms and soles is the thickest, making absorption slower.&lt;/li&gt;&lt;li&gt;â€¢ Scrotum : Has thin skin with high permeability.&lt;/li&gt;&lt;li&gt;â€¢ Scrotum&lt;/li&gt;&lt;li&gt;â€¢ Postauricular skin (behind the ear) : Relatively thin and well-perfused, allowing for good absorption.&lt;/li&gt;&lt;li&gt;â€¢ Postauricular skin (behind the ear)&lt;/li&gt;&lt;li&gt;â€¢ Forearm : More commonly used for drug absorption testing, has moderate absorption rates.&lt;/li&gt;&lt;li&gt;â€¢ Forearm&lt;/li&gt;&lt;li&gt;â€¢ Scalp : While well-vascularized, the presence of hair and thicker skin can decrease the rate of absorption compared to other areas.&lt;/li&gt;&lt;li&gt;â€¢ Scalp&lt;/li&gt;&lt;li&gt;â€¢ Plantar surface : The skin of the palms and soles is the thickest, making absorption slower.&lt;/li&gt;&lt;li&gt;â€¢ Plantar surface&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The rate of systemic absorption of a drug through the skin is fastest in areas with thinner skin and rich blood supply, such as the scrotum and postauricular area, and slowest through thick skin like that of the plantar surface.&lt;/li&gt;&lt;li&gt;âž¤ rate of systemic absorption&lt;/li&gt;&lt;li&gt;âž¤ drug through the skin is fastest in areas&lt;/li&gt;&lt;li&gt;âž¤ thinner skin&lt;/li&gt;&lt;li&gt;âž¤ rich blood supply,&lt;/li&gt;&lt;li&gt;âž¤ scrotum and postauricular area,&lt;/li&gt;&lt;li&gt;âž¤ slowest through thick skin&lt;/li&gt;&lt;li&gt;âž¤ plantar surface.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of epilepsy presents to the clinic for medication review. The patient is currently taking multiple medications, including isoniazid, hydralazine, procainamide, and phenytoin, for their various medical conditions. During the discussion, the patient asks about the differences in the metabolism of these drugs. The healthcare provider explains that all the drugs mentioned are metabolized by different pathways except for one. Which of the following drugs is NOT metabolized by acetylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenytoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Phenytoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation. On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects.&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body.&lt;/li&gt;&lt;li&gt;â€¢ Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is presents with pain along the course of trigeminal nerve while speaking and chewing. Which of the following drug should be given for the management? (FMGE AUGUST 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lamotrigine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Haloperidol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Carbamazepine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Carbamazepine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carbamazepine is the preferred initial treatment for trigeminal neuralgia due to its effectiveness in reducing the hyperactivity of sodium channels that contributes to the neuropathic pain characteristic of this condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient being treated for hypertriglyceridemia developed flushing, gout, hyperglycemia, and raised liver enzymes. Which drug is the most likely cause? (NEET PG 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fenofibrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nicotinamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nicotinamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nicotinamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nicotinamide (niacin) is associated with flushing, gout, hyperglycemia, and raised liver enzymes, making it the likely cause of these symptoms in a patient being treated for hypertriglyceridemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a PCSK-9 inhibtior? ( INICET May 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Evolocumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Evinacumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Everolimus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Evolocumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Evolocumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In summary, evolocumab is the correct answer as it is a PCSK-9 inhibitor used to lower LDL cholesterol levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old female presents with breast carcinoma, and she was prescribed Herceptin (trastuzumab). Which of the following statements regarding this drug is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is an antibody produced entirely from mice containing no human component&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a monoclonal antibody produced by injecting the HER2 antigen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a polyclonal antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is a monoclonal antibody containing only human components&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is a monoclonal antibody produced by injecting the HER2 antigen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is a monoclonal antibody produced by injecting the HER2 antigen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is an antibody produced entirely from mice containing no human component: This statement is incorrect. Trastuzumab is not a fully murine ( mouse-derived ) antibody. It is, in fact, a humanized monoclonal antibody, which means it is predominantly of human origin , but with mouse-derived antigen-binding regions.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ It is an antibody produced entirely from mice containing no human component:&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Trastuzumab&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ fully murine&lt;/li&gt;&lt;li&gt;â€¢ mouse-derived&lt;/li&gt;&lt;li&gt;â€¢ antibody.&lt;/li&gt;&lt;li&gt;â€¢ humanized monoclonal antibody,&lt;/li&gt;&lt;li&gt;â€¢ predominantly of&lt;/li&gt;&lt;li&gt;â€¢ human origin&lt;/li&gt;&lt;li&gt;â€¢ mouse-derived antigen-binding regions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is a polyclonal antibody: This statement is incorrect. Trastuzumab is a monoclonal antibody, meaning it is made by identical immune cells that are all clones of a unique parent cell , and it targets a specific epitope on the HER2 receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is a polyclonal antibody:&lt;/li&gt;&lt;li&gt;â€¢ incorrect. Trastuzumab&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody,&lt;/li&gt;&lt;li&gt;â€¢ identical immune cells&lt;/li&gt;&lt;li&gt;â€¢ clones&lt;/li&gt;&lt;li&gt;â€¢ unique parent cell&lt;/li&gt;&lt;li&gt;â€¢ targets a specific epitope&lt;/li&gt;&lt;li&gt;â€¢ HER2 receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is a monoclonal antibody containing only human components: This is not accurate . Trastuzumab is humanized, meaning it combines both human and mouse antibody components. The majority of the antibody is human, with mouse components in the antigen-binding region.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ It is a monoclonal antibody containing only human components:&lt;/li&gt;&lt;li&gt;â€¢ not accurate&lt;/li&gt;&lt;li&gt;â€¢ Trastuzumab&lt;/li&gt;&lt;li&gt;â€¢ humanized,&lt;/li&gt;&lt;li&gt;â€¢ combines both human and mouse antibody components.&lt;/li&gt;&lt;li&gt;â€¢ majority&lt;/li&gt;&lt;li&gt;â€¢ antibody is human,&lt;/li&gt;&lt;li&gt;â€¢ mouse&lt;/li&gt;&lt;li&gt;â€¢ components&lt;/li&gt;&lt;li&gt;â€¢ antigen-binding region.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Trastuzumab (Herceptin) is a humanized monoclonal antibody used in the treatment of HER2-positive breast cancer. It is crucial to understand that it targets the HER2 receptor, which is overexpressed in certain aggressive forms of breast cancer , helping to inhibit the growth and spread of cancer cells.&lt;/li&gt;&lt;li&gt;âž¤ Trastuzumab (Herceptin)&lt;/li&gt;&lt;li&gt;âž¤ humanized monoclonal antibody&lt;/li&gt;&lt;li&gt;âž¤ HER2-positive breast cancer.&lt;/li&gt;&lt;li&gt;âž¤ targets the HER2 receptor,&lt;/li&gt;&lt;li&gt;âž¤ overexpressed&lt;/li&gt;&lt;li&gt;âž¤ aggressive forms of breast cancer&lt;/li&gt;&lt;li&gt;âž¤ inhibit&lt;/li&gt;&lt;li&gt;âž¤ growth and&lt;/li&gt;&lt;li&gt;âž¤ spread of cancer cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Time for peak plasma concentration (Tmax) indicates?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The rate of elimination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The rate of absorption&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The duration of effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The extent of absorption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The rate of absorption&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) The rate of absorption&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The rate of elimination: Incorrect. The rate of elimination is more closely related to the drug&#x27;s half-life (t1/2), which is the time required for the plasma concentration of the drug to reduce to half its initial value . Tmax does not provide direct information about the rate at which the drug is eliminated from the body.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The rate of elimination:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ rate of elimination&lt;/li&gt;&lt;li&gt;â€¢ closely related to the drug&#x27;s half-life (t1/2),&lt;/li&gt;&lt;li&gt;â€¢ time required for the plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ reduce to half its initial value&lt;/li&gt;&lt;li&gt;â€¢ Tmax does not&lt;/li&gt;&lt;li&gt;â€¢ information&lt;/li&gt;&lt;li&gt;â€¢ rate at&lt;/li&gt;&lt;li&gt;â€¢ drug is eliminated&lt;/li&gt;&lt;li&gt;â€¢ Option C. The duration of effect: Incorrect . The duration of effect of a drug is influenced by its half-life and the duration of interaction with its target receptors , not just the time to reach peak concentration. Tmax alone does not provide complete information about how long a drug&#x27;s effects will last.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The duration of effect:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ duration of effect of a drug&lt;/li&gt;&lt;li&gt;â€¢ its half-life and the duration of&lt;/li&gt;&lt;li&gt;â€¢ interaction&lt;/li&gt;&lt;li&gt;â€¢ target receptors&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ time to reach peak concentration.&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ complete&lt;/li&gt;&lt;li&gt;â€¢ information&lt;/li&gt;&lt;li&gt;â€¢ long a drug&#x27;s effects&lt;/li&gt;&lt;li&gt;â€¢ last.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The extent of absorption: Incorrect. The extent of absorption is more accurately indicated by the area under the curve (AUC) or the total plasma concentration of the drug over time . Tmax tells us when the peak concentration occurs but does not indicate the total amount of drug absorbed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The extent of absorption:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ extent of absorption&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ indicated&lt;/li&gt;&lt;li&gt;â€¢ area under the curve&lt;/li&gt;&lt;li&gt;â€¢ total plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ drug over time&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ peak concentration&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ indicate&lt;/li&gt;&lt;li&gt;â€¢ total amount of drug absorbed.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Tmax is a pharmacokinetic parameter that indicates the time at which a drug reaches its maximum concentration in plasma , reflecting the rate of absorption from the site of administration into the systemic circulation.&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ pharmacokinetic&lt;/li&gt;&lt;li&gt;â€¢ indicates the time&lt;/li&gt;&lt;li&gt;â€¢ drug&lt;/li&gt;&lt;li&gt;â€¢ its maximum concentration in plasma&lt;/li&gt;&lt;li&gt;â€¢ reflecting the rate of absorption&lt;/li&gt;&lt;li&gt;â€¢ site of administration&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is undergoing treatment for cancer with methotrexate. What is the mechanism of action? (FMGE JULY 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits DNA gyrase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits topoisomerase II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibits dihydrofolic acid reductase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alkylates DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inhibits dihydrofolic acid reductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Inhibits dihydrofolic acid reductase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Methotrexate is an antimetabolite drug that inhibits dihydrofolic acid reductase, an enzyme crucial for DNA synthesis. This mechanism disrupts cell division, making it effective in treating cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with recurrent attacks of gout was started on a therapy that inhibits the synthesis of uric acid. His symptoms were relieved after therapy. Identify the drug he was prescribed? (NEET PG 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Probenecid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colchicine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diclofenac&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Allopurinol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-171027.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Allopurinol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol is the drug of choice for reducing uric acid synthesis in patients with chronic gout by inhibiting the xanthine oxidase enzyme. It effectively lowers serum and urinary uric acid levels, thereby preventing gout attacks.&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The manufacturer of a drug company labels a drug as having 500 mg paracetamol. On quantitative analysis of the drug, it actually contained only 200 mg of paracetamol. What is this type of drug called? ( AIIMS May 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spurious drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adulterated drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unethical drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Misbranded drug&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Misbranded drug&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Misbranded drug&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A drug that is labeled as containing a certain amount of an active ingredient but actually contains a different amount is considered misbranded. Misbranded drugs can lead to ineffective treatment and potential harm due to incorrect dosing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is not true about clonidine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a selective alpha 2 receptor agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It decreases central sympathetic outflow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It increases the release of renin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can be used for treatment of hypertension.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It increases the release of renin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It increases the release of renin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acts as a selective Î±2 receptor agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ selective Î±2 receptor agonist.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stimulation of alpha 2A receptors in brainstem result in decrease sympathetic outflow â€”, fall in BP and bradycardia (also due to enhanced vagal tone).&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Stimulation of alpha 2A receptors&lt;/li&gt;&lt;li&gt;â€¢ brainstem&lt;/li&gt;&lt;li&gt;â€¢ decrease sympathetic outflow&lt;/li&gt;&lt;li&gt;â€¢ fall in BP and bradycardia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Used to treat various conditions including hypertension, menopausal syndrome, and withdrawal syndromes .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ hypertension, menopausal syndrome, and withdrawal syndromes&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Noradrenaline is specific to Î±1, Î±2, and Î²1 receptors and does not activate Î²2 receptors . Clonidine, an Î±2 receptor agonist , decreases sympathetic outflow and renin release , contrary to increasing it, which is an important consideration in its pharmacological profile and clinical use.&lt;/li&gt;&lt;li&gt;â€¢ Noradrenaline is specific to Î±1, Î±2, and Î²1 receptors and does not activate Î²2 receptors .&lt;/li&gt;&lt;li&gt;â€¢ Noradrenaline&lt;/li&gt;&lt;li&gt;â€¢ Î±1, Î±2, and Î²1 receptors&lt;/li&gt;&lt;li&gt;â€¢ does not activate Î²2 receptors&lt;/li&gt;&lt;li&gt;â€¢ Clonidine, an Î±2 receptor agonist , decreases sympathetic outflow and renin release , contrary to increasing it, which is an important consideration in its pharmacological profile and clinical use.&lt;/li&gt;&lt;li&gt;â€¢ Clonidine, an Î±2 receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ decreases sympathetic outflow&lt;/li&gt;&lt;li&gt;â€¢ renin release&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In general, structures that are affected by sympathetic activation respond to both sympathetic neural activation and to the hormonal component, adrenaline released from the adrenal medulla. Which of the following structures is unique in that it responds to adrenaline, but not nor-adrenaline?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrioventricular node&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iris of the eye&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bronchus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal juxtaglomerular apparatus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bronchus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Bronchus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with a unilateral throbbing headache associated with nausea and vomiting. She reports that she had multiple episodes in the past and her headache lasts for 1-2 days. She also says that her headache is aggravated by bright light and is relieved when she sits in a dark room. Which of the following drugs can be used to prevent these episodes? (FMGE DECEMBER 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alprazolam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drugs used in prophylaxis of Migraine:&lt;/li&gt;&lt;li&gt;âž¤ Propranolol Amitriptyline Methysergide Valproate, Topiramate Flunarizine&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ Amitriptyline&lt;/li&gt;&lt;li&gt;âž¤ Amitriptyline&lt;/li&gt;&lt;li&gt;âž¤ Methysergide&lt;/li&gt;&lt;li&gt;âž¤ Methysergide&lt;/li&gt;&lt;li&gt;âž¤ Valproate, Topiramate&lt;/li&gt;&lt;li&gt;âž¤ Valproate, Topiramate&lt;/li&gt;&lt;li&gt;âž¤ Flunarizine&lt;/li&gt;&lt;li&gt;âž¤ Flunarizine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;When the pH = pKa of a drug, which of the following statements is true? (NEET PG 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Concentration of the drug is 50% ionized and 50 % non-ionized&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Concentration of the drug is 90% ionized and 10% non-ionized&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Concentration of the drug is 75% ionized and 25 % non-ionized&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Concentration of the drug is 25% ionized and 75 % non-ionized&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Concentration of the drug is 50% ionized and 50 % non-ionized&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Concentration of the drug is 50% ionized and 50 % non-ionized&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When the pH of the environment is equal to the pKa of the drug, the drug exists in a state where 50% is ionized and 50% is non-ionized. This is a critical concept in understanding drug solubility and absorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young patient undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) presents with symptoms of weight gain, cold intolerance, and lethargy. Laboratory investigations reveal high levels of thyroid-stimulating hormone (TSH) and low levels of T3 (triiodothyronine) and T4 (thyroxine). Which of the following drugs is likely responsible for these symptoms? (INICET NOV 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cycloserine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ethionamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyrazinamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ethionamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ethionamide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ethionamide, a second-line drug used in the treatment of multidrug-resistant tuberculosis (MDR-TB), can cause hypothyroidism, characterized by symptoms such as weight gain, cold intolerance, lethargy, elevated TSH, and low T3 and T4 levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is incorrect about rifabutin as compared to rifampicin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rifabutin has stronger activity against all mycobacterium species than rifampicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifabutin has a longer half-life than rifampicin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifabutin has lesser potential of drug interactions as compared to rifampicin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifabutin is preferred over rifampicin in patients with MAC infections&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rifabutin has stronger activity against all mycobacterium species than rifampicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/04/picture4_aMd0pKr.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Rifabutin has stronger activity against all mycobacterium species than rifampicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rifabutin has a longer half-life than rifampicin : This statement is correct. Rifabutin has a significantly longer half-life (45 hours) compared to Rifampicin (3-5 hours) , allowing for less frequent dosing.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Rifabutin has a longer half-life than rifampicin&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ longer half-life (45&lt;/li&gt;&lt;li&gt;â€¢ hours)&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin (3-5 hours)&lt;/li&gt;&lt;li&gt;â€¢ less frequent dosing.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rifabutin has lesser potential of drug interactions as compared to rifampicin : This is also correct . Rifabutin is a less potent inducer of cytochrome P450 enzymes compared to Rifampicin , leading to fewer drug interactions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Rifabutin has lesser potential of drug interactions as compared to rifampicin&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ less potent&lt;/li&gt;&lt;li&gt;â€¢ inducer of cytochrome P450 enzymes&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin&lt;/li&gt;&lt;li&gt;â€¢ fewer drug interactions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rifabutin is preferred over rifampicin in patients with MAC infections : True, due to its higher activity against MAC, Rifabutin is often preferred over Rifampicin for treating MAC infections , particularly in HIV-infected patients.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Rifabutin is preferred over rifampicin in patients with MAC infections&lt;/li&gt;&lt;li&gt;â€¢ True,&lt;/li&gt;&lt;li&gt;â€¢ higher activity against MAC,&lt;/li&gt;&lt;li&gt;â€¢ Rifabutin&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin for treating MAC infections&lt;/li&gt;&lt;li&gt;â€¢ HIV-infected patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man with a history of chronic obstructive pulmonary disease (COPD) and hypertension is being managed in an outpatient clinic. He has been prescribed a nonselective beta-blocker to manage his hypertension. Based on the receptor shown in the figure, which of the following drugs prescribed to the patient acts through this type of receptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucocorticoids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Estrogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicotine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/24/7_ybtpG0K.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glucocorticoids: Act through cytoplasmic receptors that, upon activation , translocate to the nucleus to affect gene transcription .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Glucocorticoids:&lt;/li&gt;&lt;li&gt;â€¢ cytoplasmic receptors&lt;/li&gt;&lt;li&gt;â€¢ upon activation&lt;/li&gt;&lt;li&gt;â€¢ translocate to the nucleus&lt;/li&gt;&lt;li&gt;â€¢ affect gene transcription&lt;/li&gt;&lt;li&gt;â€¢ Option B. Estrogen: Binds to nuclear receptors which directly interact with DNA to regulate gene expression .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Estrogen: Binds to nuclear receptors&lt;/li&gt;&lt;li&gt;â€¢ directly interact with DNA to regulate gene expression&lt;/li&gt;&lt;li&gt;â€¢ Option D . Nicotine: Primarily acts through nicotinic acetylcholine receptors , which are ionotropic receptors, not GPCRs.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Nicotine:&lt;/li&gt;&lt;li&gt;â€¢ nicotinic acetylcholine receptors&lt;/li&gt;&lt;li&gt;â€¢ ionotropic receptors,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Propranolol acts via G-protein coupled receptors , which are characterized by their seven-transmembrane domain structure .&lt;/li&gt;&lt;li&gt;âž¤ Propranolol acts via G-protein coupled receptors&lt;/li&gt;&lt;li&gt;âž¤ seven-transmembrane domain structure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old child with a previous history of GTCS presents with convulsions which are ongoing since 45 minutes. What should be the appropriate management of this patient? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lorazepam followed by levetiracetam.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate followed by gabapentin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethosuximide followed by gabapentin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamazepine followed by gabapentin.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lorazepam followed by levetiracetam.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lorazepam followed by levetiracetam.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lorazepam is a benzodiazepine and is one of the first-line treatments for the acute management of seizures, particularly in status epilepticus. Following the control of immediate seizures with lorazepam, levetiracetam can be used as maintenance antiepileptic therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly man with diabetic nephropathy presented to the emergency department with palpitations and chest discomfort. The ECG revealed large T-waves. Laboratory tests revealed elevated potassium levels. Which of the following drugs can cause intracellular movement of potassium? (NEET PG 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Epinephrine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Epinephrine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Epinephrine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Beta-2 agonists, such as Epinephrine, are effective in promoting the intracellular movement of potassium, thereby reducing serum potassium levels in cases of hyperkalemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mechanism by which acetylcholine causes a decrease in the heart rate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Delayed diastolic depolarization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase in plateau&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decrease in preload&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase in afterload&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Delayed diastolic depolarization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Delayed diastolic depolarization&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The acetylcholine acts on the M2 receptor present on the SA node. This opens a special set of potassium channels causing an efflux of potassium (kAch) which hyperpolarizes the SA node. This leads to delayed depolarization of the SA node during ventricular diastole, thus leading to a slow heart rate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antihistamines has minimal or no CNS depressant activity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Promethazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Meclizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cinnarizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fexofenadine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Fexofenadine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-110939.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Fexofenadine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Promethazine: A first-generation antihistamine with sedative properties .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Promethazine:&lt;/li&gt;&lt;li&gt;â€¢ first-generation antihistamine&lt;/li&gt;&lt;li&gt;â€¢ sedative properties&lt;/li&gt;&lt;li&gt;â€¢ Option B. Meclizine :  Another first-generation antihistamine that can cause sedation .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Meclizine&lt;/li&gt;&lt;li&gt;â€¢ first-generation antihistamine&lt;/li&gt;&lt;li&gt;â€¢ cause sedation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cinnarizine :  Also a first-generation antihistamine with CNS depressant effects .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cinnarizine&lt;/li&gt;&lt;li&gt;â€¢ first-generation antihistamine&lt;/li&gt;&lt;li&gt;â€¢ CNS depressant effects&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Fexofenadine is a second-generation antihistamine with minimal to no CNS depressant activity . It is selective for the H1 receptor and does not have significant anticholinergic activity or additional anti-allergic mechanisms beyond histamine blockade , unlike first-generation antihistamines which can cause sedation as they cross the blood-brain barrier.&lt;/li&gt;&lt;li&gt;â€¢ Fexofenadine&lt;/li&gt;&lt;li&gt;â€¢ second-generation antihistamine&lt;/li&gt;&lt;li&gt;â€¢ minimal to no CNS depressant activity&lt;/li&gt;&lt;li&gt;â€¢ selective for the H1 receptor&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ anticholinergic activity&lt;/li&gt;&lt;li&gt;â€¢ anti-allergic mechanisms&lt;/li&gt;&lt;li&gt;â€¢ histamine blockade&lt;/li&gt;&lt;li&gt;â€¢ first-generation antihistamines&lt;/li&gt;&lt;li&gt;â€¢ cause sedation&lt;/li&gt;&lt;li&gt;â€¢ H 1 ANTIHISTAMINES&lt;/li&gt;&lt;li&gt;â€¢ H 1 ANTIHISTAMINES&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Raj Kumar, a 50-year-old patient with schizophrenia, has been stable on clozapine therapy for the last 3 years. His regular blood tests have been satisfactory and his plasma clozapine level remains within the therapeutic range. He has no other major health issues. Which of the following statements about clozapine is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clozapine is considered a last resort antipsychotic due to its risk of severe side effects.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Regular monitoring of total leucocyte count is recommended while patient is on clozapine therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The risk of agranulocytosis with clozapine is significantly high if plasma concentration exceeds 600 ng/mL.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clozapine is associated with an increased risk of cardiovascular disease.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The risk of agranulocytosis with clozapine is significantly high if plasma concentration exceeds 600 ng/mL.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The risk of agranulocytosis with clozapine is significantly high if plasma concentration exceeds 600 ng/mL.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Clozapine is an atypical antipsychotic reserved for treatment-resistant schizophrenia due to its risk of severe side effects, including agranulocytosis. Regular monitoring of total leukocyte count is essential to detect potential agranulocytosis early. However, the risk of agranulocytosis is dose independent. Clozapine is also associated with an increased risk of cardiovascular disease, requiring careful monitoring of patients for cardiovascular health.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dopamine at low doses? (Fmge June 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increases cardiac contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Causes vasoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increases blood pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increases renal blood flow&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increases renal blood flow&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-140428.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Increases renal blood flow&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Effects of Dopamine at different doses:&lt;/li&gt;&lt;li&gt;âž¤ Effects of Dopamine at different doses:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mechanism of triazoles? (NEET PG 2019)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Interferes with DNA and RNA synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of ergosterol synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Forms pores in fungal membranes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibits epoxidation of squalene in fungi&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of ergosterol synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/16/screenshot-2024-07-16-182250.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inhibition of ergosterol synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is diagnosed with non-small cell lung carcinoma (NSCLC). Molecular testing reveals a specific mutation in the EGFR gene. The oncologist is considering using targeted therapy. For which of the following EGFR mutations is Osimertinib most appropriately used to treat non-small cell lung carcinoma? (INICET MAY 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;T790M mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;L858R mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T890M mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M790T mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. T790M mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-110037.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. T790M mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Lubiprostone is a?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chloride channel activator&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloride channel inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium channel activator&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodium channel inhibitor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chloride channel activator&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-110054.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chloride channel activator&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloride channel inhibitor: Incorrect as Lubiprostone does the opposite by activating, not inhibiting, chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chloride channel inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ opposite by activating,&lt;/li&gt;&lt;li&gt;â€¢ not inhibiting,&lt;/li&gt;&lt;li&gt;â€¢ chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium channel activator: Incorrect because Lubiprostone does not affect sodium channels ; its action is specific to chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sodium channel activator:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone does not&lt;/li&gt;&lt;li&gt;â€¢ sodium channels&lt;/li&gt;&lt;li&gt;â€¢ specific to&lt;/li&gt;&lt;li&gt;â€¢ chloride channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodium channel inhibitor: Incorrect as Lubiprostone has no activity on sodium channels , either as an activator or inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodium channel inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ Lubiprostone&lt;/li&gt;&lt;li&gt;â€¢ no activity&lt;/li&gt;&lt;li&gt;â€¢ sodium channels&lt;/li&gt;&lt;li&gt;â€¢ either as an activator or&lt;/li&gt;&lt;li&gt;â€¢ inhibitor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child opened his fatherâ€™s drawer and ingested multiple tablets of his cardiac medication, metoprolol. The child was brought to hospital with profound hypotension and bradycardia. What is the specific antidote used in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nor-adrenaline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glucagon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glucagon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old HIV-positive male arrives at the hospital complaining of blurred vision and floaters in his left eye. Fundus examination reveals a pizza pie appearance and cotton wool spots, leading to a diagnosis of cytomegalovirus (CMV) retinitis. What is the most appropriate treatment for this patient&#x27;s condition? (Fmge July 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cotrimoxazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ganciclovir&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tenofovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acyclovir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ganciclovir&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ganciclovir is the most appropriate treatment for cytomegalovirus retinitis in HIV-positive patients, as it effectively inhibits CMV replication and helps preserve vision.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old postmenopausal female patient with a history of Colle&#x27;s fracture comes to the outpatient department complaining of lower back pain. After undergoing a bone density test, her T score is found to be -2.5. Which of the following statements about the management of her condition is incorrect? (NEET PG 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Teriparatide should be started before supplementing with bisphosphonates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bisphosphonates are not given for more than a year&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calcium requirement is 1200 mg per day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral vitamin D3 is given along with oral calcium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bisphosphonates are not given for more than a year&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bisphosphonates are not given for more than a year&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bisphosphonates are recommended for up to 5 years, not just one year, in the treatment of osteoporosis in postmenopausal women.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following drugs poisoning with the antidotes:(AIIMS MAY 2019)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-A, 2-E, 3-B, 4-C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-F, 2- E, 3-D, 4- B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-F, 2-E, 3-B, 4-A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-B, 2-C, 3-D, 4-E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1-F, 2-E, 3-B, 4-A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-163314.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HCN poisoning: DOC is Hydroxocobalamin. Amyl Nitrite(inhalational) with sodium thiosulphate (iv) can also be used. Paracetamol poisoning (causes hepatoxicity): N-acetylcysteine is used. Morphine poisoning: DOC is Naloxone. Nalorphine can also be used. Nicotine poisoning: Trimethaphan and Hexamethonium â€“ Nn receptor blockers&lt;/li&gt;&lt;li&gt;âž¤ HCN poisoning: DOC is Hydroxocobalamin. Amyl Nitrite(inhalational) with sodium thiosulphate (iv) can also be used.&lt;/li&gt;&lt;li&gt;âž¤ HCN poisoning:&lt;/li&gt;&lt;li&gt;âž¤ Paracetamol poisoning (causes hepatoxicity): N-acetylcysteine is used.&lt;/li&gt;&lt;li&gt;âž¤ Paracetamol poisoning (causes hepatoxicity):&lt;/li&gt;&lt;li&gt;âž¤ Morphine poisoning: DOC is Naloxone. Nalorphine can also be used.&lt;/li&gt;&lt;li&gt;âž¤ Morphine poisoning:&lt;/li&gt;&lt;li&gt;âž¤ Nicotine poisoning: Trimethaphan and Hexamethonium â€“ Nn receptor blockers&lt;/li&gt;&lt;li&gt;âž¤ Nicotine poisoning:&lt;/li&gt;&lt;li&gt;âž¤ (ganglionic blockers) are used.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference: - KDT 8 TH /590, 223, 509, 134&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Fenoldopam is used in the management of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertensive emergencies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congestive heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Migraine prophylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachyarrhythmias&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypertensive emergencies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypertensive emergencies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure: Fenoldopam is not typically used in the management of congestive heart failure (CHF). Drugs commonly used in CHF include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists , which work by different mechanisms to reduce the workload on the heart and improve cardiac output .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Congestive heart failure:&lt;/li&gt;&lt;li&gt;â€¢ Fenoldopam&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ congestive heart failure (CHF).&lt;/li&gt;&lt;li&gt;â€¢ CHF include ACE inhibitors, beta-blockers, diuretics, and aldosterone antagonists&lt;/li&gt;&lt;li&gt;â€¢ reduce the workload on the heart&lt;/li&gt;&lt;li&gt;â€¢ improve cardiac output&lt;/li&gt;&lt;li&gt;â€¢ Option C. Migraine prophylaxis: Fenoldopam is not used for migraine prophylaxis . Medications for migraine prevention include beta-blockers (such as propranolol), calcium channel blockers, antidepressants, and antiepileptic drugs , which have different mechanisms of action aimed at reducing the frequency and severity of migraine attacks .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Migraine prophylaxis:&lt;/li&gt;&lt;li&gt;â€¢ Fenoldopam&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ migraine prophylaxis&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers (such as propranolol), calcium channel blockers, antidepressants, and antiepileptic drugs&lt;/li&gt;&lt;li&gt;â€¢ reducing the frequency and severity of migraine attacks&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachyarrhythmias: Fenoldopam is not indicated for the treatment of tachyarrhythmias. Drugs used to manage tachyarrhythmias include beta-blockers, calcium channel blockers, antiarrhythmic agents, and sometimes digoxin , depending on the type and cause of the arrhythmia. These medications work by modulating cardiac electrical activity to normalize heart rhythm .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tachyarrhythmias:&lt;/li&gt;&lt;li&gt;â€¢ Fenoldopam&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ tachyarrhythmias. Drugs used&lt;/li&gt;&lt;li&gt;â€¢ beta-blockers, calcium channel blockers, antiarrhythmic agents, and sometimes digoxin&lt;/li&gt;&lt;li&gt;â€¢ type and cause of the arrhythmia.&lt;/li&gt;&lt;li&gt;â€¢ modulating cardiac electrical activity&lt;/li&gt;&lt;li&gt;â€¢ normalize heart rhythm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational goal is to understand the specific indications for fenoldopam, particularly its role in managing hypertensive emergencies due to its vasodilatory effects and positive impact on renal perfusion . Additionally, recognizing that fenoldopam is not indicated for congestive heart failure, migraine prophylaxis, or tachyarrhythmias underscores the importance of selecting appropriate medications based on the clinical condition being treated.&lt;/li&gt;&lt;li&gt;âž¤ specific indications for fenoldopam,&lt;/li&gt;&lt;li&gt;âž¤ managing hypertensive emergencies&lt;/li&gt;&lt;li&gt;âž¤ its vasodilatory effects&lt;/li&gt;&lt;li&gt;âž¤ renal perfusion&lt;/li&gt;&lt;li&gt;âž¤ fenoldopam is not&lt;/li&gt;&lt;li&gt;âž¤ congestive heart failure, migraine prophylaxis, or tachyarrhythmias&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man has insulin-dependent diabetes. He desires to take insulin glargine because of its efficacy and ease of dosing. This would be represented as which of the following labels on the above diagram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/whatsapp-image-2023-07-22-at-51728-pm.jpeg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/untitled-1152.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old patient has developed tuberculosis in which mycobacterium is resistant to rifampicin, isoniazid, bedaquiline, and levofloxacin. This tuberculosis is referred to as? (FMGE DECEMBER 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MDR TB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin resistant TB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extensively drug resistant TB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Extremely drug resistant TB&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Extensively drug resistant TB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-112751.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Extensively drug resistant TB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Terminologies used for tuberculosis are as follows:&lt;/li&gt;&lt;li&gt;âž¤ Terminologies used for tuberculosis are as follows:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient has been receiving first-line pharmacological treatment for bipolar disorder for 6 months. She is fasting for religious reasons and is experiencing seizures, coarse tremors, confusion, and limb weakness. Which of the following tests should be performed to help diagnose her condition? (NEET PG 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum potassium level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum lithium level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum sodium level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum lithium level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum lithium level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum lithium level should be checked in a patient receiving lithium therapy for bipolar disorder who presents with symptoms such as seizures, coarse tremors, confusion, and limb weakness, especially in the context of fasting or dehydration. This is crucial to diagnosing and managing lithium toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young man sustained a scorpion sting 2 hours ago. On examination, his blood pressure is 104/ 55 mm Hg; Heart Rate 72 beats/minute, and respiratory rate 32 breaths/ minute. He also complains of breathlessness. Which of the following is the preferred drug for management of this patient? ( INICET Nov 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frusemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prazosin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Prazosin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prazosin is the preferred drug for managing the symptoms of a scorpion sting, as it counteracts the effects of catecholamines released due to the venom, providing relief from hypertension and pulmonary edema. Other drugs listed do not directly address the primary pathophysiological effects of a scorpion sting.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Select the correct statement regarding use of inhaled glucocorticoids in bronchial asthma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are used alone for the treatment of acute attacks of asthma.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They have high systemic activity.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are superior to Î²2 agonists in symptom control.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral candidiasis can occur as a side effect.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Oral candidiasis can occur as a side effect.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Oral candidiasis can occur as a side effect.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are used alone for the treatment of acute attacks of asthma: This is incorrect as i nhaled glucocorticoids do not provide the immediate symptom relief required during an acute asthma attack.&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are used alone for the treatment of acute attacks of asthma:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ nhaled glucocorticoids&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ immediate symptom relief&lt;/li&gt;&lt;li&gt;â€¢ acute asthma attack.&lt;/li&gt;&lt;li&gt;â€¢ Option B. They have high systemic activity: Inhaled glucocorticoids are designed to minimize systemic absorption , thus reducing s ystemic side effects compared to oral glucocorticoids.&lt;/li&gt;&lt;li&gt;â€¢ Option B. They have high systemic activity:&lt;/li&gt;&lt;li&gt;â€¢ Inhaled glucocorticoids&lt;/li&gt;&lt;li&gt;â€¢ minimize systemic absorption&lt;/li&gt;&lt;li&gt;â€¢ ystemic side effects&lt;/li&gt;&lt;li&gt;â€¢ oral glucocorticoids.&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are superior to Î²2 agonists in symptom control: This is incorrect as Î²2 agonists are the drugs of choice for immediate relief of symptoms due to their rapid bronchodilatory effects , whereas inhaled glucocorticoids are used for long-term control and prevention of symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are superior to Î²2 agonists in symptom control:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ Î²2 agonists&lt;/li&gt;&lt;li&gt;â€¢ immediate relief of symptoms&lt;/li&gt;&lt;li&gt;â€¢ rapid bronchodilatory effects&lt;/li&gt;&lt;li&gt;â€¢ inhaled glucocorticoids&lt;/li&gt;&lt;li&gt;â€¢ long-term&lt;/li&gt;&lt;li&gt;â€¢ control and prevention of symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The potential for developing oral candidiasis is a significant consideration when using inhaled glucocorticoids for asthma management, emphasizing the importance of proper inhaler use and oral hygiene practices&lt;/li&gt;&lt;li&gt;âž¤ developing oral candidiasis&lt;/li&gt;&lt;li&gt;âž¤ inhaled glucocorticoids for asthma&lt;/li&gt;&lt;li&gt;âž¤ importance of proper inhaler use and oral hygiene practices&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antibiotics is NOT effective against pseudomonas infections?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-549_DRuLjN2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-dyslipidemic drug work by stimulating Peroxisome proliferator activated receptor (PPAR) alpha? (Fmge Jan 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gemfibrozil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Niacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gemfibrozil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Gemfibrozil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fibrates, including gemfibrozil, work by stimulating PPAR-Î±, which enhances the activity of lipoprotein lipase, leading to increased clearance of VLDL and triglycerides. This mechanism makes fibrates particularly effective in treating hypertriglyceridemia and related disorders. Other hypolipidemic drugs like atorvastatin, ezetimibe, and niacin have different mechanisms of action targeting other aspects of lipid metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;W hich of the following is clinical use of tafenoquine? ( AIIMS Nov 2019&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radical cure of Plasmodium vivax&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prophylaxis of malaria in pregnancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Treatment of severe falciparum malaria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment of endemic malaria in children &amp;lt; 2 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Radical cure of Plasmodium vivax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Radical cure of Plasmodium vivax&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference: KDT 8th/. 878&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for central diabetes Insipidus is&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desmopressin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leuprolide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Desmopressin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/07/screenshot-2024-05-07-120405.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Desmopressin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leuprolide: Leuprolide is a gonadotropin-releasing hormone (GnRH) analogue used primarily in the treatment of hormone-responsive cancers such as prostate cancer and conditions like endometriosis and uterine fibroids . It is not used in the treatment of diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leuprolide:&lt;/li&gt;&lt;li&gt;â€¢ gonadotropin-releasing hormone&lt;/li&gt;&lt;li&gt;â€¢ treatment of&lt;/li&gt;&lt;li&gt;â€¢ hormone-responsive cancers&lt;/li&gt;&lt;li&gt;â€¢ prostate cancer&lt;/li&gt;&lt;li&gt;â€¢ endometriosis and uterine fibroids&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thiazide diuretics: While thiazide diuretics are used in the management of nephrogenic diabetes insipidus (a form of the disease caused by the kidney&#x27;s insensitivity to ADH), they are not the drug of choice for central diabetes insipidus . Thiazides reduce urine volume in nephrogenic diabetes insipidus by inducing a mild volume depletion and increasing the absorption of sodium and water in proximal nephron segments.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thiazide diuretics:&lt;/li&gt;&lt;li&gt;â€¢ management of nephrogenic diabetes insipidus&lt;/li&gt;&lt;li&gt;â€¢ not the drug of choice for central diabetes insipidus&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulin: Insulin is used in the treatment of diabetes mellitus , a condition characterized by high blood sugar levels due to insulin deficiency or resistance. It is not used in the treatment of diabetes insipidus, which is a completely different condition related to ADH deficiency affecting water balance and urine production.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulin:&lt;/li&gt;&lt;li&gt;â€¢ treatment of diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ high blood sugar levels&lt;/li&gt;&lt;li&gt;â€¢ insulin deficiency or resistance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Desmopressin is used as the drug of choice for central diabetes insipidus due to its ability to mimic the action of natural antidiuretic hormone (ADH) and effectively manage symptoms of the disease.&lt;/li&gt;&lt;li&gt;âž¤ Desmopressin&lt;/li&gt;&lt;li&gt;âž¤ drug of choice for central diabetes insipidus&lt;/li&gt;&lt;li&gt;âž¤ ability to mimic the action of natural antidiuretic&lt;/li&gt;&lt;li&gt;âž¤ hormone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about heparin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by inhibiting anti-thrombin III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin is preferred over warfarin for long-term treatment of DVT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient aged 55 years with hyperglycemia and positive ketone bodies in urine comes to you in hospital with altered sensorium. Which of the following drug therapy is most suitable to start? (Fmge June 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Potassium chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insulin and IV fluid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ringer lactate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Insulin and IV fluid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Insulin and IV fluid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Management of DKA&lt;/li&gt;&lt;li&gt;âž¤ Management of DKA&lt;/li&gt;&lt;li&gt;âž¤ The mainstay of therapy in DKA is correction of dehydration by giving IV fluids and correction of hyperglycemia and acidosis by giving IV Regular Insulin. If there is development of hypokalemia during infusion of insulin , then Inj. Potassium Chloride can be given. Sometimes, Sodium Bicarbonate can be used to correct the acidosis (if pH &amp;lt;7.1). It is also important to look for the underlying precipitating factor like infections, myocardial infarction etc.&lt;/li&gt;&lt;li&gt;âž¤ The mainstay of therapy in DKA is correction of dehydration by giving IV fluids and correction of hyperglycemia and acidosis by giving IV Regular Insulin.&lt;/li&gt;&lt;li&gt;âž¤ The mainstay of therapy in DKA is correction of dehydration by giving IV fluids and correction of hyperglycemia and acidosis by giving IV Regular Insulin.&lt;/li&gt;&lt;li&gt;âž¤ If there is development of hypokalemia during infusion of insulin , then Inj. Potassium Chloride can be given.&lt;/li&gt;&lt;li&gt;âž¤ If there is development of hypokalemia during infusion of insulin , then Inj. Potassium Chloride can be given.&lt;/li&gt;&lt;li&gt;âž¤ Sometimes, Sodium Bicarbonate can be used to correct the acidosis (if pH &amp;lt;7.1).&lt;/li&gt;&lt;li&gt;âž¤ Sometimes, Sodium Bicarbonate can be used to correct the acidosis (if pH &amp;lt;7.1).&lt;/li&gt;&lt;li&gt;âž¤ It is also important to look for the underlying precipitating factor like infections, myocardial infarction etc.&lt;/li&gt;&lt;li&gt;âž¤ It is also important to look for the underlying precipitating factor like infections, myocardial infarction etc.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the mechanism of action of cyclosporine? ( INICET Nov 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of calcineurin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AMP kinase stimulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IMP dehydrogenase inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dihydro-orotate dehydrogenase inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of calcineurin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibition of calcineurin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine exerts its immunosuppressive effects by inhibiting calcineurin, thereby preventing the activation of T cells and reducing the production of cytokines such as IL-2. This mechanism is crucial for its role in preventing graft rejection and managing autoimmune diseases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Regarding Xenon anesthesia all are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Slow induction and recovery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-explosive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Minimal cardiovascular side-effects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Low blood solubility&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Slow induction and recovery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Slow induction and recovery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-explosive: Correct, Xenon is non-explosive, which contributes to its safety profile in anesthetic applications.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-explosive:&lt;/li&gt;&lt;li&gt;â€¢ Correct, Xenon is non-explosive,&lt;/li&gt;&lt;li&gt;â€¢ safety profile in anesthetic applications.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Minimal cardiovascular side-effects: Correct, it has minimal effects on the cardiovascular system, making it suitable for patients with cardiovascular instability.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Minimal cardiovascular side-effects:&lt;/li&gt;&lt;li&gt;â€¢ Correct,&lt;/li&gt;&lt;li&gt;â€¢ minimal effects on the cardiovascular system,&lt;/li&gt;&lt;li&gt;â€¢ patients with cardiovascular instability.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Low blood solubility: Correct, the low solubility facilitates quick onset and offset of its anesthetic effects , leading to rapid recovery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Low blood solubility:&lt;/li&gt;&lt;li&gt;â€¢ Correct, the low solubility facilitates&lt;/li&gt;&lt;li&gt;â€¢ , leading to rapid recovery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Xenon is Greek for stranger. It is the only noble gas to be anaesthetic under normobaric conditions . Xenon is extremely rare with an average room containing only 4 ml . It is very close to the â€˜ ideal agentâ€™.&lt;/li&gt;&lt;li&gt;âž¤ Xenon&lt;/li&gt;&lt;li&gt;âž¤ stranger.&lt;/li&gt;&lt;li&gt;âž¤ anaesthetic under normobaric conditions&lt;/li&gt;&lt;li&gt;âž¤ extremely rare&lt;/li&gt;&lt;li&gt;âž¤ average room&lt;/li&gt;&lt;li&gt;âž¤ 4 ml&lt;/li&gt;&lt;li&gt;âž¤ ideal agentâ€™.&lt;/li&gt;&lt;li&gt;âž¤ Advantages of Xenon Anesthesia&lt;/li&gt;&lt;li&gt;âž¤ Advantages of Xenon Anesthesia&lt;/li&gt;&lt;li&gt;âž¤ Inert (probably non-toxic to liver and kidney with no metabolism) Minimal effect on CVS function Lowest blood solubility (Lowest blood gas partition coefficient) therefore rapid induction and recovery. Does not trigger malignant hyperthermia Environment friendly Non-explosive&lt;/li&gt;&lt;li&gt;âž¤ Inert (probably non-toxic to liver and kidney with no metabolism)&lt;/li&gt;&lt;li&gt;âž¤ Minimal effect on CVS function&lt;/li&gt;&lt;li&gt;âž¤ Lowest blood solubility (Lowest blood gas partition coefficient) therefore rapid induction and recovery.&lt;/li&gt;&lt;li&gt;âž¤ Does not trigger malignant hyperthermia&lt;/li&gt;&lt;li&gt;âž¤ Environment friendly&lt;/li&gt;&lt;li&gt;âž¤ Non-explosive&lt;/li&gt;&lt;li&gt;âž¤ Disadvantages of Xenon Anesthesia&lt;/li&gt;&lt;li&gt;âž¤ Disadvantages of Xenon Anesthesia&lt;/li&gt;&lt;li&gt;âž¤ High cost Low potency (MAC = 70%) No commercially available anaesthesia equipment.&lt;/li&gt;&lt;li&gt;âž¤ High cost&lt;/li&gt;&lt;li&gt;âž¤ Low potency (MAC = 70%)&lt;/li&gt;&lt;li&gt;âž¤ No commercially available anaesthesia equipment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anticholinergic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholinomimetic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Opioid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Salicylate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anticholinergic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Anticholinergic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following dilution of adrenaline and its use? ( INICET Nov 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-1 B-2 C-3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-2 B-1 C-3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-3 B-2 C-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-1 B-3 C-2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A-2 B-1 C-3&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154726.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154955.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. A-2 B-1 C-3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following pairs of drugs and its indications is matched incorrectly?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bromocriptine- Treatment of precocious puberty&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide- treatment of diarrhea associated with vasoactive intestinal peptide tumors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Desmopressin- treatment of diabetes insipidus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Leuprolide- treatment of infertility&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bromocriptine- Treatment of precocious puberty&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Bromocriptine- Treatment of precocious puberty&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide: Correctly matched. Octreotide, an octapeptide analog of somatostatin, is effective in reducing the severe secretory diarrhea associated with conditions like carcinoid syndrome and vasoactive intestinal peptide tumors (VIPomas).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Octreotide:&lt;/li&gt;&lt;li&gt;â€¢ Correctly&lt;/li&gt;&lt;li&gt;â€¢ octapeptide analog of somatostatin,&lt;/li&gt;&lt;li&gt;â€¢ severe&lt;/li&gt;&lt;li&gt;â€¢ secretory diarrhea&lt;/li&gt;&lt;li&gt;â€¢ carcinoid syndrome and vasoactive intestinal peptide tumors (VIPomas).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Desmopressin: Correctly matched. Desmopressin is used in the management of central diabetes insipidus, nocturnal enuresis, and von Willebrandâ€™s disease. It acts by mimicking vasopressin , thus helping control urine production and improving blood clotting factors.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Desmopressin:&lt;/li&gt;&lt;li&gt;â€¢ Correctly&lt;/li&gt;&lt;li&gt;â€¢ central diabetes insipidus, nocturnal&lt;/li&gt;&lt;li&gt;â€¢ enuresis, and von Willebrandâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ mimicking vasopressin&lt;/li&gt;&lt;li&gt;â€¢ urine production&lt;/li&gt;&lt;li&gt;â€¢ improving&lt;/li&gt;&lt;li&gt;â€¢ blood clotting factors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leuprolide: Correctly matched when considering its use in reproductive health. Leuprolide, a GnRH analog , can be administered in a pulsatile fashion to treat conditions like anovulatory infertility , which relies on stimulating follicular development and ovulation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leuprolide:&lt;/li&gt;&lt;li&gt;â€¢ Correctly matched&lt;/li&gt;&lt;li&gt;â€¢ reproductive health.&lt;/li&gt;&lt;li&gt;â€¢ GnRH analog&lt;/li&gt;&lt;li&gt;â€¢ pulsatile&lt;/li&gt;&lt;li&gt;â€¢ anovulatory infertility&lt;/li&gt;&lt;li&gt;â€¢ stimulating follicular development and ovulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bromocriptine: Used for treatment of hyperprolactinemia, acromegaly, and type 2 diabetes mellitus.&lt;/li&gt;&lt;li&gt;âž¤ Bromocriptine:&lt;/li&gt;&lt;li&gt;âž¤ hyperprolactinemia, acromegaly, and type 2 diabetes mellitus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following antihypertensive are not used in pregnancy? (NEET PG 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antihypertensive to be avoided in pregnancy:&lt;/li&gt;&lt;li&gt;âž¤ Antihypertensive to be avoided in pregnancy:&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors, ARBS Diuretics Nonselective beta-blockers Nitroprusside&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors, ARBS&lt;/li&gt;&lt;li&gt;âž¤ Diuretics&lt;/li&gt;&lt;li&gt;âž¤ Nonselective beta-blockers&lt;/li&gt;&lt;li&gt;âž¤ Nitroprusside&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs does not reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF)? (Fmge June 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydralazine + isosorbide dinitrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ACE inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Digoxin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Digoxin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The drugs which reduce mortality in patients with HFrEF are :&lt;/li&gt;&lt;li&gt;âž¤ The drugs which reduce mortality in patients with HFrEF are :&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers ACE inhibitors Angiotensin receptor blockers (ARBs) Mineralocorticoid receptor antagonists Angiotensin receptor-neprilysin inhibitor (ARNI) Hydralazine + isosorbide dinitrate&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Angiotensin receptor blockers (ARBs)&lt;/li&gt;&lt;li&gt;âž¤ Angiotensin receptor blockers (ARBs)&lt;/li&gt;&lt;li&gt;âž¤ Mineralocorticoid receptor antagonists&lt;/li&gt;&lt;li&gt;âž¤ Mineralocorticoid receptor antagonists&lt;/li&gt;&lt;li&gt;âž¤ Angiotensin receptor-neprilysin inhibitor (ARNI)&lt;/li&gt;&lt;li&gt;âž¤ Angiotensin receptor-neprilysin inhibitor (ARNI)&lt;/li&gt;&lt;li&gt;âž¤ Hydralazine + isosorbide dinitrate&lt;/li&gt;&lt;li&gt;âž¤ Hydralazine + isosorbide dinitrate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old patient has developed tuberculosis. On laboratory investigations, the mycobacterium is found to be resistant to rifampicin, isoniazid and levofloxacin but sensitive to pyrazinamide, ethambutol, streptomycin, Bedaquiline and linezolide. This tuberculosis is referred to as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multi drug resistant TB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin resistant TB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pre- Extensive drug resistant TB&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Extensive drug resistant TB&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pre- Extensive drug resistant TB&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-171927.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pre-Extensive drug resistant TB&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is NOT a characteristic feature of treatment of iron deficiency anaemia with oral iron supplements?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;If 200-300 mg elemental iron is consumed, about 50 mg is absorbed.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The proportion of iron absorbed reduces as haemoglobin improves.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The reticulocyte count should begin to increase in two weeks and peak in four weeks - this suggests a good response to treatment.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The treatment should be discontinued immediately once haemoglobin normalizes to prevent side effects of iron.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The treatment should be discontinued immediately once haemoglobin normalizes to prevent side effects of iron.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. The treatment should not be discontinued immediately once haemoglobin normalizes to prevent recurrence of iron deficiency anaemia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ When treating iron deficiency anemia with oral iron supplements , it is essential to understand that the body absorbs about 10-20% of the elemental iron from these supplements , meaning that from a dose of 200-300 mg, around 20-60 mg is absorbed . As hemoglobin levels improve, the efficiency of iron absorption decreases due to the body&#x27;s natural regulatory mechanisms to prevent iron overload. An effective response to treatment is indicated by an increase in reticulocyte count , typically observed within 2 weeks and peaking at 4 weeks. Importantly, iron supplementation should continue for 3-6 months after hemoglobin normalization to ensure complete replenishment of iron stores and prevent the recurrence of anemia, highlighting that stopping treatment immediately after normalization is incorrect. Understanding these principles helps in the effective management of iron deficiency anemia and in preventing its recurrence.&lt;/li&gt;&lt;li&gt;âž¤ iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ oral iron supplements&lt;/li&gt;&lt;li&gt;âž¤ body absorbs&lt;/li&gt;&lt;li&gt;âž¤ 10-20%&lt;/li&gt;&lt;li&gt;âž¤ elemental iron&lt;/li&gt;&lt;li&gt;âž¤ supplements&lt;/li&gt;&lt;li&gt;âž¤ dose of 200-300 mg,&lt;/li&gt;&lt;li&gt;âž¤ 20-60&lt;/li&gt;&lt;li&gt;âž¤ mg&lt;/li&gt;&lt;li&gt;âž¤ absorbed&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin levels improve,&lt;/li&gt;&lt;li&gt;âž¤ efficiency of iron absorption decreases&lt;/li&gt;&lt;li&gt;âž¤ natural regulatory mechanisms&lt;/li&gt;&lt;li&gt;âž¤ prevent iron overload.&lt;/li&gt;&lt;li&gt;âž¤ increase in reticulocyte count&lt;/li&gt;&lt;li&gt;âž¤ within 2 weeks&lt;/li&gt;&lt;li&gt;âž¤ peaking at 4 weeks.&lt;/li&gt;&lt;li&gt;âž¤ iron&lt;/li&gt;&lt;li&gt;âž¤ supplementation&lt;/li&gt;&lt;li&gt;âž¤ continue for 3-6 months&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin normalization&lt;/li&gt;&lt;li&gt;âž¤ complete replenishment&lt;/li&gt;&lt;li&gt;âž¤ iron stores&lt;/li&gt;&lt;li&gt;âž¤ prevent&lt;/li&gt;&lt;li&gt;âž¤ recurrence of anemia,&lt;/li&gt;&lt;li&gt;âž¤ stopping&lt;/li&gt;&lt;li&gt;âž¤ immediately&lt;/li&gt;&lt;li&gt;âž¤ after normalization&lt;/li&gt;&lt;li&gt;âž¤ incorrect.&lt;/li&gt;&lt;li&gt;âž¤ helps&lt;/li&gt;&lt;li&gt;âž¤ effective management of iron deficiency&lt;/li&gt;&lt;li&gt;âž¤ anemia&lt;/li&gt;&lt;li&gt;âž¤ preventing its recurrence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common drawback of the given device? (INICET NOV 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bacterial contamination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ï»¿ï»¿ï»¿Does not provide multiple doses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ï»¿ï»¿ï»¿Drug deposition in the oropharynx&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not portable&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ï»¿ï»¿ï»¿Drug deposition in the oropharynx&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/picture3_4FJIap8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common drawback of metered-dose inhalers (MDIs) is drug deposition in the oropharynx, which reduces the efficiency of drug delivery to the lungs and can increase the risk of local side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with deep vein thrombosis was started on a new drug. After 2 days, he presented with the given finding. Which of the following drugs is implicated in causing the below condition? (NEET PG 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ï»¿ï»¿ï»¿Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ï»¿ï»¿ï»¿Dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ï»¿ï»¿ï»¿Rivaroxaban&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Warfarin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/04/2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Warfarin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Warfarin can cause dermal vascular necrosis, particularly in patients with protein C deficiency, presenting as painful, necrotic skin lesions shortly after initiation of therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and dolutegravir 50 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient? (Fmge Jan 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No dose adjustment is required&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add tenofovir 150 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Add lamivudine 300 mg in the morning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Add dolutegravir 50 mg in the morning&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Add dolutegravir 50 mg in the morning&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Add dolutegravir 50 mg in the morning&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients on a dolutegravir-based regimen who start rifampicin-based anti-tubercular therapy, an additional dose of dolutegravir 50 mg should be taken in the morning (12 hours apart from the regular dose) to maintain effective drug levels and manage HIV effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young man having pheochromocytoma has BP of 188/92 mm Hg and a hematocrit of around 50%. Pulmonary function tests and renal functions are normal. His catecholamines are elevated. Which of the following drugs should not be included in the anesthesia protocol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desflurane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fentanyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Halothane&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Midazolam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Halothane&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Halothane.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patients should be treated with either an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A 24-year-old woman with type 1 diabetes with two positive spot microalbuminuria tests 1 week apart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A 32-year-old woman with type 1 diabetes with a blood glucose of 328 mg/dL and a positive spot microalbuminuria test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A 48-year-old man with type 2 diabetes with a positive spot microalbuminuria test 1 week after starting a new exercise program&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The testing interval of 1 week is too soon for confirmation of persistent microalbuminuria.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ interval of 1 week&lt;/li&gt;&lt;li&gt;â€¢ persistent microalbuminuria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The presence of severe hyperglycemia can transiently increase albumin excretion , potentially confounding the test result.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ severe hyperglycemia&lt;/li&gt;&lt;li&gt;â€¢ transiently increase albumin excretion&lt;/li&gt;&lt;li&gt;â€¢ test result.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Vigorous exercise can also transiently increase albumin excretion, making the test result unreliable.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Vigorous exercise&lt;/li&gt;&lt;li&gt;â€¢ increase albumin excretion,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the management of diabetic nephropathy, ACE inhibitors or ARBs should be initiated in patients with type 2 diabetes who have confirmed persistent microalbuminuria, indicated by at least two positive microalbuminuria tests spaced 3 to 6 months apart, without the influence of confounding factors.&lt;/li&gt;&lt;li&gt;âž¤ diabetic nephropathy, ACE inhibitors or ARBs&lt;/li&gt;&lt;li&gt;âž¤ type 2 diabetes&lt;/li&gt;&lt;li&gt;âž¤ confirmed persistent microalbuminuria,&lt;/li&gt;&lt;li&gt;âž¤ at least two positive microalbuminuria tests&lt;/li&gt;&lt;li&gt;âž¤ 3 to 6 months&lt;/li&gt;&lt;li&gt;âž¤ without&lt;/li&gt;&lt;li&gt;âž¤ confounding factors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs exacerbates myasthenia and is usually avoided in a patient with myasthenia gravis? ( INICET Nov 2020) 1. Lidocaine 2. Aspirin 3. Meropenem 4. Phenytoin&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 and 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1 and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1 only&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1 and 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-161810.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. 1 and 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DRUGS THAT SHOULD BE AVOIDED IN MYSTHENIA GRAVIS&lt;/li&gt;&lt;li&gt;âž¤ DRUGS THAT SHOULD BE AVOIDED IN MYSTHENIA GRAVIS&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presented to the emergency department with head trauma due to a road traffic accident. In the hospital, the patient developed seizures. An emergency CT scan revealed widespread cerebral edema. Which of the following is the diuretic of choice for cerebral edema in this patient? (NEET PG 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mannitol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mannitol is the diuretic of choice for treating cerebral edema, particularly in emergency settings following traumatic brain injury, due to its ability to reduce intracranial pressure by drawing fluid out of the brain tissue.&lt;/li&gt;&lt;li&gt;âž¤ Mannitol is the diuretic of choice for treating cerebral edema,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male patient with the history of schizophrenia and on treatment for drug-induced Parkinsonism presents with complaints of constipation, blurred vision and dry mouth. Which of the following drugs may be responsible for the above symptoms? (Fmge June 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pramipexole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Benzhexol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Selegiline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Benzhexol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Benzhexol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Benzhexol, used to treat drug-induced Parkinsonism, can cause significant anticholinergic side effects such as constipation, blurred vision, and dry mouth. These symptoms are a direct result of its anticholinergic action, which reduces parasympathetic activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents to the pediatric clinic with a 2-week history of an evolving cough. The mother reports that the child initially had a mild cough with cold-like symptoms that has progressed to episodes of severe coughing followed by a high-pitched \&quot;whoop\&quot; sound during inhalation. The episodes are often followed by vomiting. The child is afebrile and has not received all of his scheduled immunizations. Based on the clinical presentation, which is the preferred antibiotic for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Azithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Azithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of pertussis, commonly known as whooping cough. Pertussis is a highly contagious bacterial disease caused by Bordetella pertussis. The preferred treatment for children and adults with pertussis is azithromycin. Azithromycin is often preferred because of its shorter treatment course and better side-effect profile.&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of pertussis, commonly known as whooping cough.&lt;/li&gt;&lt;li&gt;â€¢ Pertussis is a highly contagious bacterial disease caused by Bordetella pertussis.&lt;/li&gt;&lt;li&gt;â€¢ The preferred treatment for children and adults with pertussis is azithromycin.&lt;/li&gt;&lt;li&gt;â€¢ Azithromycin is often preferred because of its shorter treatment course and better side-effect profile.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old boy presented with slow growing mass on the medial side of thigh. Investigations revealed it to be osteosarcoma and patient was started on methotrexate. Mechanism of action of methotrexate as an anticancer drug is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of Dihydrofolate reductase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of N5 tetrahydro folate reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of tyrosine kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of purine metabolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibition of Dihydrofolate reductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Inhibition of Dihydrofolate reductase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inhibition of N5 tetrahydro folate reductase: This option is incorrect because there is no enzyme named N5 tetrahydro folate reductase that methotrexate is known to inhibit.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inhibition of N5 tetrahydro folate reductase:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ no enzyme&lt;/li&gt;&lt;li&gt;â€¢ N5 tetrahydro&lt;/li&gt;&lt;li&gt;â€¢ folate reductase&lt;/li&gt;&lt;li&gt;â€¢ methotrexate&lt;/li&gt;&lt;li&gt;â€¢ inhibit.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of tyrosine kinase: This is the action of drugs like imatinib, not methotrexate. Tyrosine kinase inhibitors are used in the treatment of certain types of leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of tyrosine kinase:&lt;/li&gt;&lt;li&gt;â€¢ action of&lt;/li&gt;&lt;li&gt;â€¢ imatinib,&lt;/li&gt;&lt;li&gt;â€¢ not methotrexate. Tyrosine kinase inhibitors&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ types of leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of purine metabolism: While methotrexate can impact purine metabolism indirectly by its action on DHFR , the direct inhibition of purine metabolism is characteristic of drugs like 6-mercaptopurine, not methotrexate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of purine metabolism:&lt;/li&gt;&lt;li&gt;â€¢ methotrexate&lt;/li&gt;&lt;li&gt;â€¢ impact purine metabolism indirectly&lt;/li&gt;&lt;li&gt;â€¢ its action&lt;/li&gt;&lt;li&gt;â€¢ DHFR&lt;/li&gt;&lt;li&gt;â€¢ direct inhibition of purine metabolism&lt;/li&gt;&lt;li&gt;â€¢ 6-mercaptopurine, not methotrexate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key mechanism of action of methotrexate in the treatment of cancer , including osteosarcoma, is the inhibition of dihydrofolate reductase. This action results in decreased nucleotide biosynthesis , which is vital for DNA replication and cell division in rapidly dividing cancer cells.&lt;/li&gt;&lt;li&gt;âž¤ mechanism of action&lt;/li&gt;&lt;li&gt;âž¤ methotrexate&lt;/li&gt;&lt;li&gt;âž¤ cancer&lt;/li&gt;&lt;li&gt;âž¤ osteosarcoma,&lt;/li&gt;&lt;li&gt;âž¤ inhibition of dihydrofolate&lt;/li&gt;&lt;li&gt;âž¤ reductase.&lt;/li&gt;&lt;li&gt;âž¤ decreased nucleotide biosynthesis&lt;/li&gt;&lt;li&gt;âž¤ vital for DNA replication&lt;/li&gt;&lt;li&gt;âž¤ cell division in rapidly&lt;/li&gt;&lt;li&gt;âž¤ dividing cancer cells.&lt;/li&gt;&lt;li&gt;âž¤ Understanding this mechanism is critical when using methotrexate as an anticancer agent , as it informs both its therapeutic effects and its toxicity profile.&lt;/li&gt;&lt;li&gt;âž¤ mechanism&lt;/li&gt;&lt;li&gt;âž¤ using methotrexate&lt;/li&gt;&lt;li&gt;âž¤ anticancer agent&lt;/li&gt;&lt;li&gt;âž¤ both its therapeutic effects&lt;/li&gt;&lt;li&gt;âž¤ and its toxicity profile.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Many GPCR receptors act via increase in cAMP. There are several steps involved in this mechanism as given below. Which of the following is correct sequence of events in cAMP signal transduction pathway? ( INICET May 2024) Steps involved 1. Activation of adenylate cyclase 2. Activation of PKA 3. Conversion of ATP to cAMP 4. Phosphorylation of target proteins&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1, 2, 3 and 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1, 3, 2 and 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1, 3, 4 and 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4, 2, 1 and 3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1, 3, 2 and 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 1, 3, 2 and 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The mechanism of action of tissue plasminogen activator is: (NEET PG 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibit extrinsic pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibits platelet aggregation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enhance fibrin degradation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibit clot formation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enhance fibrin degradation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Enhance fibrin degradation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tissue plasminogen activator (tPA) enhances fibrin degradation by converting plasminogen to plasmin, leading to the dissolution of blood clots.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with symptoms of psychosis is prescribed aripiprazole. Which of the following best describes this drug, when compared to other antipsychotic drugs? (FMGE DECEMBER 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No intrinsic activity, high affinity for D2 receptors, less extra-pyramidal symptoms and more weight gain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High intrinsic activity, no affinity for D2 receptor, more extra-pyramidal symptoms and less weight gain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High intrinsic activity, low affinity for D2 receptor, less extrapyramidal symptoms and less weight gain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Low intrinsic activity, high affinity for D2 receptor, less extra-pyramidal symptoms and less weight gain&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Low intrinsic activity, high affinity for D2 receptor, less extra-pyramidal symptoms and less weight gain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-115700.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Low intrinsic activity, high affinity for D2 receptor, less extra-pyramidal symptoms and less weight gain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aripiprazole is characterized by low intrinsic activity and high affinity for D2 receptors, leading to fewer extra-pyramidal symptoms and less weight gain compared to other antipsychotic drugs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male patient is currently receiving treatment in the oncology department for advanced non-small cell lung cancer (NSCLC). His oncologist has been discussing various therapeutic options with him, including a group of medications called immune checkpoint inhibitors. Immune checkpoints are regulators of the immune system that help to prevent the immune system from attacking cells indiscriminately. They do this by distinguishing between &#x27;self&#x27; and &#x27;non-self&#x27; cells. Some cancer cells can take advantage of these checkpoints to avoid being targeted by the immune system. Immune checkpoint inhibitors are a type of drug that blocks these immune checkpoints, allowing immune cells to better recognize and attack cancer cells. Given this information, which of the following drugs is not an immune check point inhibitor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avelumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atezolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cetuximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Durvalumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cetuximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/30/untitled-553.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cetuximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a prokinetic drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5HT4-agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D2 blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macrolides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diphenoxymethane&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diphenoxymethane&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/screenshot-2024-05-03-121706.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diphenoxymethane&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5HT4-agonist: Incorrect as 5HT4-agonists , such as mosapride, tegaserod, and prucalopride, are indeed prokinetic drugs. They stimulate peristalsis and increase gastric emptying by acting on the 5HT4 receptors in the gastrointestinal tract.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5HT4-agonist:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ 5HT4-agonists&lt;/li&gt;&lt;li&gt;â€¢ mosapride, tegaserod, and prucalopride,&lt;/li&gt;&lt;li&gt;â€¢ prokinetic drugs.&lt;/li&gt;&lt;li&gt;â€¢ stimulate peristalsis&lt;/li&gt;&lt;li&gt;â€¢ increase gastric emptying&lt;/li&gt;&lt;li&gt;â€¢ 5HT4 receptors in the gastrointestinal tract.&lt;/li&gt;&lt;li&gt;â€¢ Option B. D2 blocker: Incorrect because D2 blockers like metoclopramide and domperidone are used as prokinetic drugs due to their ability to enhance gastrointestinal motility by blocking dopamine receptors, which promotes gastric emptying and decreases nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. D2 blocker:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ D2 blockers&lt;/li&gt;&lt;li&gt;â€¢ metoclopramide and domperidone&lt;/li&gt;&lt;li&gt;â€¢ prokinetic drugs&lt;/li&gt;&lt;li&gt;â€¢ ability to enhance gastrointestinal motility&lt;/li&gt;&lt;li&gt;â€¢ blocking dopamine receptors,&lt;/li&gt;&lt;li&gt;â€¢ gastric emptying&lt;/li&gt;&lt;li&gt;â€¢ decreases&lt;/li&gt;&lt;li&gt;â€¢ nausea and vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macrolides: Incorrect as certain macrolides, such as erythromycin , act as motilin receptor agonists in the gut and are used for their prokinetic effects to stimulate gastric motility.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Macrolides:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ erythromycin&lt;/li&gt;&lt;li&gt;â€¢ motilin receptor agonists&lt;/li&gt;&lt;li&gt;â€¢ prokinetic effects to stimulate gastric motility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug solution containing 500 mg/5 ml of the drug is given to you. You are provided with a 2 ml syringe (having 10 divisions for each mI). How many divisions of the 2 m syringe need to be administered to deliver 180 mg of the drug to a patient? ( AIIMS May 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1.8&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;14&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;18&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 18&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. 18&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To deliver 180 mg of the drug using the provided 2 ml syringe with 10 divisions per ml, you need to fill the syringe to 18 divisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with a history of rheumatoid arthritis is not responding well to conventional treatment. Her rheumatologist is considering adding tocilizumab to her treatment regimen. Which of the following interleukins (IL) is primarily targeted by tocilizumab? (NEET PG 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IL-6&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IL-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IL-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IL-5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IL-6&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IL-6&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tocilizumab targets the IL-6 receptor, making it effective for managing rheumatoid arthritis and certain other inflammatory conditions by inhibiting the IL-6 signaling pathway.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with a history of chronic stable angina is seen in the outpatient department. She is already taking aspirin and statins, but continues to experience occasional chest pain during exertion. Which of the following would be the most appropriate choice for prophylactic treatment of her angina? (Fmge July 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sublingual nitroglycerine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroglycerine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral nitroglycerine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intratracheal nitroglycerine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral nitroglycerine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oral nitroglycerine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oral nitroglycerine, a long-acting nitrate preparation, is the most appropriate choice for the prophylactic treatment of chronic stable angina to prevent angina episodes during exertion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the mechanism of antifungal drug is wrongly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azoles- Inhibit ergosterol synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flucytosine- Inhibit microtubule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echinocandins- Inhibit glycan synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphotericin B- Create artificial pores in the membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flucytosine- Inhibit microtubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Flucytosine: Inhibit microtubule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which mechanism of action of theophylline is responsible for diuresis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PDE-3 inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PDE-4 inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine A1 receptor antagonism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta-2 agonism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adenosine A1 receptor antagonism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/09/picture9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Adenosine A1 receptor antagonism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. PDE-3 inhibition: Phosphodiesterase-3 (PDE-3) inhibitors increase cAMP levels , leading to cardiac and vascular effects, but they are not the primary mechanism for theophylline&#x27;s diuretic effect. PDE-3 inhibition is more related to inotropic and chronotropic effects on the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ PDE-3 inhibition:&lt;/li&gt;&lt;li&gt;â€¢ Phosphodiesterase-3 (PDE-3) inhibitors&lt;/li&gt;&lt;li&gt;â€¢ increase cAMP levels&lt;/li&gt;&lt;li&gt;â€¢ cardiac and vascular effects,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ theophylline&#x27;s diuretic effect.&lt;/li&gt;&lt;li&gt;â€¢ inotropic and&lt;/li&gt;&lt;li&gt;â€¢ chronotropic effects on the heart.&lt;/li&gt;&lt;li&gt;â€¢ Option B. PDE-4 inhibition: Phosphodiesterase-4 (PDE-4) inhibition by theophylline plays a role in anti-inflammatory effects and bronchodilation but is not directly responsible for its diuretic effect . PDE-4 is more associated with the modulation of inflammatory cells in the airways.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ PDE-4 inhibition: Phosphodiesterase-4 (PDE-4) inhibition&lt;/li&gt;&lt;li&gt;â€¢ theophylline&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory effects and&lt;/li&gt;&lt;li&gt;â€¢ bronchodilation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ its diuretic effect&lt;/li&gt;&lt;li&gt;â€¢ PDE-4&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ modulation of inflammatory&lt;/li&gt;&lt;li&gt;â€¢ cells&lt;/li&gt;&lt;li&gt;â€¢ Option D. Beta-2 agonism: While beta-2 agonists can lead to smooth muscle relaxation and bronchodilation, theophylline&#x27;s diuretic effect is not primarily mediated through beta-2 agonism. Beta-2 agonists are not known for producing significant diuretic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Beta-2 agonism:&lt;/li&gt;&lt;li&gt;â€¢ smooth muscle relaxation and bronchodilation,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ beta-2 agonism.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ producing&lt;/li&gt;&lt;li&gt;â€¢ diuretic effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The educational objective is to understand the multifaceted mechanisms of action of theophylline , a medication used primarily for respiratory diseases like asthma and COPD. Specifically, its ability to antagonize adenosine A1 receptors contributes to its diuretic effect, an important consideration in managing patients with concurrent respiratory and fluid balance issues. This highlights the need for a comprehensive understanding of drug actions , particularly for medications with multiple physiological effects.&lt;/li&gt;&lt;li&gt;âž¤ multifaceted mechanisms of action of theophylline&lt;/li&gt;&lt;li&gt;âž¤ primarily&lt;/li&gt;&lt;li&gt;âž¤ respiratory diseases&lt;/li&gt;&lt;li&gt;âž¤ antagonize adenosine A1 receptors&lt;/li&gt;&lt;li&gt;âž¤ its diuretic&lt;/li&gt;&lt;li&gt;âž¤ effect,&lt;/li&gt;&lt;li&gt;âž¤ concurrent respiratory and fluid balance issues.&lt;/li&gt;&lt;li&gt;âž¤ comprehensive&lt;/li&gt;&lt;li&gt;âž¤ drug actions&lt;/li&gt;&lt;li&gt;âž¤ medications&lt;/li&gt;&lt;li&gt;âž¤ multiple physiological effects.&lt;/li&gt;&lt;li&gt;âž¤ Side effects of theophylline and proposed mechanisms&lt;/li&gt;&lt;li&gt;âž¤ Side effects of theophylline and proposed mechanisms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following a hysterectomy, the patient received morphine for pain management both during the post-operative period and while in the ward. The current symptoms include respiratory depression and constricted (pinpoint) pupils. What would be the recommended medication for this patient? ( INICET MAY 2023)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pethidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Naloxone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Buprenorphine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Naloxone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Naloxone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Naloxone is the drug of choice for treating acute opioid overdose, characterized by symptoms such as respiratory depression, pinpoint pupils, and coma. It acts rapidly to reverse the effects of opioids by competitively inhibiting their action at opioid receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug of choice for treatment of chemotherapy induced diarrhea is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pantoprazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Loperamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Loperamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron : Ondansetron is an antiemetic used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It works by blocking serotonin receptors in the brain and gut. While effective for nausea and vomiting, it is not used to treat diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ondansetron&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pantoprazole : Pantoprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production and treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. It is not indicated for the treatment of diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pantoprazole&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dexamethasone : Dexamethasone is a corticosteroid with anti-inflammatory and immunosuppressant properties. It is used in various conditions, including to reduce inflammation and manage chemotherapy-induced nausea and vomiting, but it is not the primary treatment for diarrhea.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dexamethasone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Loperamide is the preferred medication for managing chemotherapy-induced diarrhea due to its effectiveness in slowing intestinal motility and allowing for better fluid absorption. Understanding the appropriate use of medications for specific side effects of chemotherapy is crucial for optimizing patient care and improving quality of life during treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male patient was diagnosed with atrial fibrillation with a controlled ventricular rate. The medication charts reveal that he was taking digoxin, potassium chloride, clarithromycin, atenolol, and triamterene. Suspecting the symptoms to be due to digoxin overdose, plasma levels of digoxin were ordered. It was found that his blood levels of digoxin have increased significantly. Which of his medications is most likely responsible for this increase in digoxin levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Potassium chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clarithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triamterene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clarithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Clarithromycin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test15" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 1 (Pharmacokinetics)   03 05 2023   2023 05 03&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 1 (Pharmacokinetics)   03 05 2023   2023 05 03&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following is not an example of the clinical importance of enzyme induction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenobarbitone is used in the treatment of neonatal jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenytoin is contraindicated in acute intermittent porphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tolerance occurs to anticonvulsant action of carbamazepine in few doses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Omeprazole increases metabolism and thus inhibits the action of clopidogrel&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Omeprazole increases metabolism and thus inhibits the action of clopidogrel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Omeprazole increases the metabolism and thus inhibits the action of clopidogrel.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The concept of enzyme induction is clinically important, as it can inform treatment decisions, such as using phenobarbitone for neonatal jaundice due to its inducing effects, avoiding phenytoin in porphyria, and being aware of potential tolerance to drugs like carbamazepine . Conversely, enzyme inhibition , such as the interaction between omeprazole and clopidogrel, can significantly impact drug efficacy.&lt;/li&gt;&lt;li&gt;âž¤ enzyme induction&lt;/li&gt;&lt;li&gt;âž¤ inform treatment&lt;/li&gt;&lt;li&gt;âž¤ using phenobarbitone&lt;/li&gt;&lt;li&gt;âž¤ neonatal jaundice&lt;/li&gt;&lt;li&gt;âž¤ its inducing effects, avoiding phenytoin&lt;/li&gt;&lt;li&gt;âž¤ porphyria,&lt;/li&gt;&lt;li&gt;âž¤ aware of potential tolerance&lt;/li&gt;&lt;li&gt;âž¤ carbamazepine&lt;/li&gt;&lt;li&gt;âž¤ enzyme inhibition&lt;/li&gt;&lt;li&gt;âž¤ interaction between omeprazole and clopidogrel,&lt;/li&gt;&lt;li&gt;âž¤ impact drug efficacy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The extent to which ionization of a drug takes place is dependent upon pKa of the drug and the pH of the solution in which the drug is dissolved. Which of the following statements is NOT correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;pKa of a drug is the pH at which the drug is 50% ionized&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Small changes of pH near the pKa of a weak acidic drug will not affect its degree of ionization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Knowledge of pKa of a drug is useful in predicting its behavior in various body fluids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone with a pKa of 7.2 is largely unionized at acid pH and will be about 40% non-ionized in plasma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Small changes of pH near the pKa of a weak acidic drug will not affect its degree of ionization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Small changes of pH near the pKa of a weak acidic drug will not affect its degree of ionization&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The ionization of a drug in the body is critical to its pharmacokinetics and can be predicted by knowing the pKa of the drug and the pH of the environment; however, small changes in pH near the pKa can significantly affect the drug&#x27;s ionization state.&lt;/li&gt;&lt;li&gt;âž¤ The ionization of a drug in the body is critical to its pharmacokinetics and can be predicted by knowing the pKa of the drug and the pH of the environment; however, small changes in pH near the pKa can significantly affect the drug&#x27;s ionization state.&lt;/li&gt;&lt;li&gt;âž¤ ionization of a drug&lt;/li&gt;&lt;li&gt;âž¤ its pharmacokinetics&lt;/li&gt;&lt;li&gt;âž¤ predicted by knowing the pKa&lt;/li&gt;&lt;li&gt;âž¤ drug&lt;/li&gt;&lt;li&gt;âž¤ pH of the environment;&lt;/li&gt;&lt;li&gt;âž¤ small changes in pH near the pKa&lt;/li&gt;&lt;li&gt;âž¤ affect the drug&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ ionization state.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70 Kg person was started on a drug with Vd =10 L and exhibits first-order elimination kinetics. The rate of drug clearance is calculated to be 6.93 L/hr. It is determined that repeating the second dose when 75% of the drug is eliminated will minimize toxicity while maintaining trough levels above the minimum inhibitory concentration. Based on these research findings, which of the following is the most appropriate dosing interval for this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 hour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 hours&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1 day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;12 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 2 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 2 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ To determine the dosing interval for this drug , we need to first calculate the half-life (t1/2) of the drug. We can use the formula:&lt;/li&gt;&lt;li&gt;â€¢ dosing interval for this drug&lt;/li&gt;&lt;li&gt;â€¢ first calculate the half-life (t1/2)&lt;/li&gt;&lt;li&gt;â€¢ t1/2 = 0.693 x Vd / clearance&lt;/li&gt;&lt;li&gt;â€¢ t1/2 = 0.693 x Vd / clearance&lt;/li&gt;&lt;li&gt;â€¢ where Vd is the volume of distribution and clearance is the rate of drug clearance.&lt;/li&gt;&lt;li&gt;â€¢ Vd&lt;/li&gt;&lt;li&gt;â€¢ volume of distribution&lt;/li&gt;&lt;li&gt;â€¢ clearance&lt;/li&gt;&lt;li&gt;â€¢ rate of drug clearance.&lt;/li&gt;&lt;li&gt;â€¢ Substituting the given values, we get:&lt;/li&gt;&lt;li&gt;â€¢ Substituting&lt;/li&gt;&lt;li&gt;â€¢ values,&lt;/li&gt;&lt;li&gt;â€¢ t1/2 = 0.693 x 10 / 6.93 t1/2 = 1 hour&lt;/li&gt;&lt;li&gt;â€¢ t1/2&lt;/li&gt;&lt;li&gt;â€¢ 1 hour&lt;/li&gt;&lt;li&gt;â€¢ The time to eliminate 75% of the drug would be 2 half-lives (in 1 half-life 50 percent is eliminated and in 2 half-lives 75 percent will be eliminated ) . Therefore, the time to eliminate 75% of the drug would be:&lt;/li&gt;&lt;li&gt;â€¢ time to eliminate 75% of the drug&lt;/li&gt;&lt;li&gt;â€¢ 2 half-lives&lt;/li&gt;&lt;li&gt;â€¢ 1 half-life 50 percent&lt;/li&gt;&lt;li&gt;â€¢ eliminated&lt;/li&gt;&lt;li&gt;â€¢ 2 half-lives 75 percent&lt;/li&gt;&lt;li&gt;â€¢ eliminated&lt;/li&gt;&lt;li&gt;â€¢ time to eliminate 75% of the drug&lt;/li&gt;&lt;li&gt;â€¢ t = 2 x t1/2 = 2 x 1 = 2 hours&lt;/li&gt;&lt;li&gt;â€¢ t = 2 x t1/2&lt;/li&gt;&lt;li&gt;â€¢ 2 hours&lt;/li&gt;&lt;li&gt;â€¢ So, the appropriate dosing interval would be around 2 hours to ensure that 75% of the previous dose is eliminated before the next dose is given.&lt;/li&gt;&lt;li&gt;â€¢ dosing interval&lt;/li&gt;&lt;li&gt;â€¢ around 2 hours&lt;/li&gt;&lt;li&gt;â€¢ 75% of the previous dose&lt;/li&gt;&lt;li&gt;â€¢ eliminated before&lt;/li&gt;&lt;li&gt;â€¢ next&lt;/li&gt;&lt;li&gt;â€¢ dose is given.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For a drug with first-order elimination kinetics , a dosing interval should be set based on its half-life to minimize toxicity and maintain effective drug concentrations.&lt;/li&gt;&lt;li&gt;âž¤ first-order elimination kinetics&lt;/li&gt;&lt;li&gt;âž¤ dosing interval&lt;/li&gt;&lt;li&gt;âž¤ its half-life&lt;/li&gt;&lt;li&gt;âž¤ minimize toxicity&lt;/li&gt;&lt;li&gt;âž¤ maintain effective drug concentrations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs should be given in sustained release oral dosage form?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;An anti-arrhythmic drug with a plasma half-life of 10 seconds used for acute treatment of PSVT.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An anti-inflammatory drug with a plasma half-life of 24 hr&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A hypnotic drug with a plasma half-life of 2 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An antihypertensive with a plasma half-life of 3 hours&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. An antihypertensive with a plasma half-life of 3 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) An antihypertensive with a plasma half-life of 3 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Sustained release oral dosage forms are most appropriate for drugs that have a short plasma half-life and are used for chronic conditions, such as an antihypertensive with a 3-hour half-life, to maintain consistent therapeutic levels and improve patient compliance with less frequent dosing.&lt;/li&gt;&lt;li&gt;âž¤ Sustained release&lt;/li&gt;&lt;li&gt;âž¤ forms&lt;/li&gt;&lt;li&gt;âž¤ short plasma half-life&lt;/li&gt;&lt;li&gt;âž¤ used for chronic&lt;/li&gt;&lt;li&gt;âž¤ antihypertensive with a 3-hour half-life,&lt;/li&gt;&lt;li&gt;âž¤ consistent therapeutic levels&lt;/li&gt;&lt;li&gt;âž¤ improve patient compliance with less frequent dosing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new drug Z is being tested in animals for Anti-diabetic activity. When drug Z was given in a dose of 10 mg, 50 mice got the expected effect among the 100 who received the drug. However, at 100 mg dose, half of the animals died. Which of the following statements about drug Z is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The final dose of drug Z in humans should be between 10 mg and 100 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ED50 of drug Z is 10 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LD50 of drug Z is 100 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Therapeutic index of drug Z is around 10&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The final dose of drug Z in humans should be between 10 mg and 100 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) The final dose of drug Z in humans should be between 10 mg and 100 mg.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The therapeutic index (TI) of drug Z is 10 , determined by the ratio of the LD50 (dose lethal to 50% of subjects) to the ED50 (dose effective in 50% of subjects) , but the appropriate dose for humans cannot be extrapolated directly from animal data without further clinical investigation.&lt;/li&gt;&lt;li&gt;âž¤ therapeutic index (TI)&lt;/li&gt;&lt;li&gt;âž¤ drug Z&lt;/li&gt;&lt;li&gt;âž¤ 10&lt;/li&gt;&lt;li&gt;âž¤ ratio of the LD50 (dose lethal to 50% of subjects) to the ED50&lt;/li&gt;&lt;li&gt;âž¤ effective in 50% of subjects)&lt;/li&gt;&lt;li&gt;âž¤ dose for humans&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ extrapolated&lt;/li&gt;&lt;li&gt;âž¤ from animal data without&lt;/li&gt;&lt;li&gt;âž¤ clinical investigation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Experiments show that 50% of an oral 100-mg dose of Drug A is absorbed in a 60-kg test subject. However, the fractional bioavailability was only 0.2. Assuming a liver blood flow of 1500 mL/min, which of the following is the hepatic clearance of Drug A in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;300 mL/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;450 mL/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;600 mL/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;900 mL/min&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 900 mL/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 900 mL/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Absorption and Bioavailability : 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver. The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg . Amount Extracted by the Liver : 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation. Therefore, the amount extracted by the liver is: 50â€‰mg âˆ’ 20 â€‰mg = 30â€‰mg Hepatic Extraction Ratio (ER) : The hepatic extraction ratio is the fraction of the drug extracted by the liver : ER = Amount extracted by the liver/Amount reaching the liver = 30â€‰mg / 50â€‰mg = 0.6 Hepatic Clearance (Clâ‚•) : Hepatic clearance is given by the formula: CL = Liver Blood Flow (Q) Ã— Extraction Ratio Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 : CL = 1500â€‰mL/min Ã— 0.6 = 900â€‰mL/min&lt;/li&gt;&lt;li&gt;â€¢ Absorption and Bioavailability : 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver. The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg .&lt;/li&gt;&lt;li&gt;â€¢ Absorption and Bioavailability :&lt;/li&gt;&lt;li&gt;â€¢ Absorption and Bioavailability&lt;/li&gt;&lt;li&gt;â€¢ 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver. The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg .&lt;/li&gt;&lt;li&gt;â€¢ 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver.&lt;/li&gt;&lt;li&gt;â€¢ 50% of the 100 mg dose&lt;/li&gt;&lt;li&gt;â€¢ 50 mg&lt;/li&gt;&lt;li&gt;â€¢ The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg .&lt;/li&gt;&lt;li&gt;â€¢ fractional bioavailability (F)&lt;/li&gt;&lt;li&gt;â€¢ 0.2&lt;/li&gt;&lt;li&gt;â€¢ 20%&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation&lt;/li&gt;&lt;li&gt;â€¢ 20 mg&lt;/li&gt;&lt;li&gt;â€¢ Amount Extracted by the Liver : 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation. Therefore, the amount extracted by the liver is: 50â€‰mg âˆ’ 20 â€‰mg = 30â€‰mg&lt;/li&gt;&lt;li&gt;â€¢ Amount Extracted by the Liver :&lt;/li&gt;&lt;li&gt;â€¢ Amount Extracted by the Liver&lt;/li&gt;&lt;li&gt;â€¢ 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation. Therefore, the amount extracted by the liver is: 50â€‰mg âˆ’ 20 â€‰mg = 30â€‰mg&lt;/li&gt;&lt;li&gt;â€¢ 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation.&lt;/li&gt;&lt;li&gt;â€¢ 50 mg&lt;/li&gt;&lt;li&gt;â€¢ 20 mg&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the amount extracted by the liver is: 50â€‰mg âˆ’ 20 â€‰mg = 30â€‰mg&lt;/li&gt;&lt;li&gt;â€¢ amount extracted by the liver&lt;/li&gt;&lt;li&gt;â€¢ Hepatic Extraction Ratio (ER) : The hepatic extraction ratio is the fraction of the drug extracted by the liver : ER = Amount extracted by the liver/Amount reaching the liver = 30â€‰mg / 50â€‰mg = 0.6&lt;/li&gt;&lt;li&gt;â€¢ Hepatic Extraction Ratio (ER) :&lt;/li&gt;&lt;li&gt;â€¢ Hepatic Extraction Ratio (ER)&lt;/li&gt;&lt;li&gt;â€¢ The hepatic extraction ratio is the fraction of the drug extracted by the liver : ER = Amount extracted by the liver/Amount reaching the liver = 30â€‰mg / 50â€‰mg = 0.6&lt;/li&gt;&lt;li&gt;â€¢ The hepatic extraction ratio is the fraction of the drug extracted by the liver :&lt;/li&gt;&lt;li&gt;â€¢ hepatic extraction ratio&lt;/li&gt;&lt;li&gt;â€¢ fraction of the drug extracted by the liver&lt;/li&gt;&lt;li&gt;â€¢ ER = Amount extracted by the liver/Amount reaching the liver = 30â€‰mg / 50â€‰mg = 0.6&lt;/li&gt;&lt;li&gt;â€¢ Hepatic Clearance (Clâ‚•) : Hepatic clearance is given by the formula: CL = Liver Blood Flow (Q) Ã— Extraction Ratio Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 : CL = 1500â€‰mL/min Ã— 0.6 = 900â€‰mL/min&lt;/li&gt;&lt;li&gt;â€¢ Hepatic Clearance (Clâ‚•) :&lt;/li&gt;&lt;li&gt;â€¢ Hepatic Clearance (Clâ‚•)&lt;/li&gt;&lt;li&gt;â€¢ Hepatic clearance is given by the formula: CL = Liver Blood Flow (Q) Ã— Extraction Ratio Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 : CL = 1500â€‰mL/min Ã— 0.6 = 900â€‰mL/min&lt;/li&gt;&lt;li&gt;â€¢ Hepatic clearance is given by the formula:&lt;/li&gt;&lt;li&gt;â€¢ CL = Liver Blood Flow (Q) Ã— Extraction Ratio&lt;/li&gt;&lt;li&gt;â€¢ Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 :&lt;/li&gt;&lt;li&gt;â€¢ liver blood flow (Q)&lt;/li&gt;&lt;li&gt;â€¢ 1500 mL/min&lt;/li&gt;&lt;li&gt;â€¢ extraction ratio (ER)&lt;/li&gt;&lt;li&gt;â€¢ 0.6&lt;/li&gt;&lt;li&gt;â€¢ CL = 1500â€‰mL/min Ã— 0.6 = 900â€‰mL/min&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ To calculate the hepatic clearance of a drug , apply the formula hepatic clearance = hepatic extraction ratio Ã— hepatic blood flow, using the fraction of the drug dose absorbed and the fractional bioavailability to determine the extraction ratio .&lt;/li&gt;&lt;li&gt;âž¤ hepatic clearance of a drug&lt;/li&gt;&lt;li&gt;âž¤ hepatic clearance = hepatic extraction ratio Ã— hepatic blood flow,&lt;/li&gt;&lt;li&gt;âž¤ fraction of the drug&lt;/li&gt;&lt;li&gt;âž¤ absorbed and the fractional bioavailability&lt;/li&gt;&lt;li&gt;âž¤ extraction ratio&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following figures correctly represent the relationship between clearance and plasma concentration for a drug following first order kinetics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/screenshot-2023-05-03-111308.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Figure a represents a scenario where clearance is independent of plasma concentration . This is consistent with first-order kinetics, where a constant fraction of the drug is eliminated per unit time. Figure b suggests that clearance increases linearly with increasing plasma concentration, which would imply dose-dependent kinetics , not first-order kinetics. Figure c and d both show clearance changing with plasma concentration , which suggests non-linear kinetics.&lt;/li&gt;&lt;li&gt;â€¢ Figure a represents a scenario where clearance is independent of plasma concentration . This is consistent with first-order kinetics, where a constant fraction of the drug is eliminated per unit time.&lt;/li&gt;&lt;li&gt;â€¢ Figure a&lt;/li&gt;&lt;li&gt;â€¢ clearance is independent of plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ first-order kinetics,&lt;/li&gt;&lt;li&gt;â€¢ constant fraction of the drug&lt;/li&gt;&lt;li&gt;â€¢ eliminated&lt;/li&gt;&lt;li&gt;â€¢ unit time.&lt;/li&gt;&lt;li&gt;â€¢ Figure b suggests that clearance increases linearly with increasing plasma concentration, which would imply dose-dependent kinetics , not first-order kinetics.&lt;/li&gt;&lt;li&gt;â€¢ Figure b&lt;/li&gt;&lt;li&gt;â€¢ clearance increases linearly&lt;/li&gt;&lt;li&gt;â€¢ increasing plasma concentration,&lt;/li&gt;&lt;li&gt;â€¢ dose-dependent kinetics&lt;/li&gt;&lt;li&gt;â€¢ Figure c and d both show clearance changing with plasma concentration , which suggests non-linear kinetics.&lt;/li&gt;&lt;li&gt;â€¢ Figure c and d&lt;/li&gt;&lt;li&gt;â€¢ show clearance&lt;/li&gt;&lt;li&gt;â€¢ with plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ non-linear kinetics.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the figure that correctly represents the relationship between clearance and plasma concentration for a drug following first-order kinetics is: Figure a .&lt;/li&gt;&lt;li&gt;â€¢ the figure&lt;/li&gt;&lt;li&gt;â€¢ correctly represents&lt;/li&gt;&lt;li&gt;â€¢ relationship between clearance and plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ first-order kinetics&lt;/li&gt;&lt;li&gt;â€¢ Figure a&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In first-order kinetics, the clearance of a drug remains constant regardless of plasma concentration , which is depicted as a horizontal line parallel to the plasma concentration axis in a graph of clearance versus plasma concentration.&lt;/li&gt;&lt;li&gt;âž¤ first-order kinetics,&lt;/li&gt;&lt;li&gt;âž¤ clearance of a drug&lt;/li&gt;&lt;li&gt;âž¤ constant&lt;/li&gt;&lt;li&gt;âž¤ plasma concentration&lt;/li&gt;&lt;li&gt;âž¤ horizontal&lt;/li&gt;&lt;li&gt;âž¤ line parallel to the plasma concentration&lt;/li&gt;&lt;li&gt;âž¤ axis&lt;/li&gt;&lt;li&gt;âž¤ clearance versus plasma concentration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Phenytoin is a drug that follows zero order kinetics at high doses and first order kinetics at low doses. Suppose 400 mg phenytoin is present in the body and its rate of elimination at this dose is 200 mg/hr., how much will remain in plasma after 2 hours?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;100 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;50 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Zero&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cannot be predicted from this information&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cannot be predicted from this information&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cannot be predicted from this information.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ For drugs like phenytoin , which exhibit zero-order kinetics at higher doses and first-order kinetics at lower doses , the specific plasma concentration at which this shift occurs must be known to accurately predict plasma levels after a given period.&lt;/li&gt;&lt;li&gt;âž¤ phenytoin&lt;/li&gt;&lt;li&gt;âž¤ exhibit zero-order kinetics at higher doses&lt;/li&gt;&lt;li&gt;âž¤ first-order kinetics at lower doses&lt;/li&gt;&lt;li&gt;âž¤ plasma concentration&lt;/li&gt;&lt;li&gt;âž¤ shift&lt;/li&gt;&lt;li&gt;âž¤ accurately predict plasma levels&lt;/li&gt;&lt;li&gt;âž¤ given period.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs would most likely need a loading dose to help reach therapeutic levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetaminophen, t (1/2) = 2 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspirin, t (1/2) = 15 min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Digitoxin, t (1/2) = 161 h&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenosine, t (1/2) = 10 s&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Digitoxin, t (1/2) = 161 h&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Digitoxin, t1/2= 161 hrs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Aspirin (tÂ½ = 15 minutes) : Aspirin has a very short half-life, meaning it rapidly reaches steady-state levels with regular dosing. A loading dose is typically unnecessary because the drug accumulates quickly.&lt;/li&gt;&lt;li&gt;â€¢ Aspirin (tÂ½ = 15 minutes)&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen (tÂ½ = 2 hours) : While acetaminophen has a longer half-life compared to aspirin, it still reaches therapeutic levels relatively quickly with regular dosing, making a loading dose unnecessary.&lt;/li&gt;&lt;li&gt;â€¢ Acetaminophen (tÂ½ = 2 hours)&lt;/li&gt;&lt;li&gt;â€¢ Adenosine (tÂ½ = 10 seconds) : Adenosine has an extremely short half-life and is used for acute, rapid-onset effects, such as in the treatment of supraventricular tachycardia. Because of its immediate action and short duration, no loading dose is needed.&lt;/li&gt;&lt;li&gt;â€¢ Adenosine (tÂ½ = 10 seconds)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Drugs with a long half-life (such as digitoxin) require a loading dose to achieve therapeutic concentrations quickly. This is particularly important in clinical scenarios where immediate drug effects are needed. For drugs with short half-lives, a loading dose is typically unnecessary because steady-state levels are rapidly reached with regular dosing.&lt;/li&gt;&lt;li&gt;âž¤ long half-life&lt;/li&gt;&lt;li&gt;âž¤ loading dose&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Constant intravenous infusion (at a rate of 200 mg/hour) of a drug with half-life of 1 hour is started and plasma concentration is measured at different intervals. If steady state plasma concentration is 400 Âµg/dl, what was the likely plasma concentration at 2 hoursâ€™ time after starting the infusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;100 Âµg/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;150 Âµg/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;200 Âµg/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;300 Âµg/dl&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 300 Âµg/dl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 300 Âµg/dl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ During constant intravenous infusion , plasma concentration of a drug with a half-life of 1 hour at 2 hours is likely to be 75% of the steady-state concentration due to exponential accumulation.&lt;/li&gt;&lt;li&gt;âž¤ constant intravenous infusion&lt;/li&gt;&lt;li&gt;âž¤ plasma concentration&lt;/li&gt;&lt;li&gt;âž¤ half-life of 1 hour at 2 hours&lt;/li&gt;&lt;li&gt;âž¤ 75%&lt;/li&gt;&lt;li&gt;âž¤ steady-state concentration&lt;/li&gt;&lt;li&gt;âž¤ exponential accumulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Time for peak plasma concentration (Tmax) indicates?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The rate of elimination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The rate of absorption&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The duration of effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The extent of absorption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The rate of absorption&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) The rate of absorption&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The rate of elimination: Incorrect. The rate of elimination is more closely related to the drug&#x27;s half-life (t1/2), which is the time required for the plasma concentration of the drug to reduce to half its initial value . Tmax does not provide direct information about the rate at which the drug is eliminated from the body.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The rate of elimination:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ rate of elimination&lt;/li&gt;&lt;li&gt;â€¢ closely related to the drug&#x27;s half-life (t1/2),&lt;/li&gt;&lt;li&gt;â€¢ time required for the plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ reduce to half its initial value&lt;/li&gt;&lt;li&gt;â€¢ Tmax does not&lt;/li&gt;&lt;li&gt;â€¢ information&lt;/li&gt;&lt;li&gt;â€¢ rate at&lt;/li&gt;&lt;li&gt;â€¢ drug is eliminated&lt;/li&gt;&lt;li&gt;â€¢ Option C. The duration of effect: Incorrect . The duration of effect of a drug is influenced by its half-life and the duration of interaction with its target receptors , not just the time to reach peak concentration. Tmax alone does not provide complete information about how long a drug&#x27;s effects will last.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The duration of effect:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ duration of effect of a drug&lt;/li&gt;&lt;li&gt;â€¢ its half-life and the duration of&lt;/li&gt;&lt;li&gt;â€¢ interaction&lt;/li&gt;&lt;li&gt;â€¢ target receptors&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ time to reach peak concentration.&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ complete&lt;/li&gt;&lt;li&gt;â€¢ information&lt;/li&gt;&lt;li&gt;â€¢ long a drug&#x27;s effects&lt;/li&gt;&lt;li&gt;â€¢ last.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The extent of absorption: Incorrect. The extent of absorption is more accurately indicated by the area under the curve (AUC) or the total plasma concentration of the drug over time . Tmax tells us when the peak concentration occurs but does not indicate the total amount of drug absorbed.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The extent of absorption:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect.&lt;/li&gt;&lt;li&gt;â€¢ extent of absorption&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ indicated&lt;/li&gt;&lt;li&gt;â€¢ area under the curve&lt;/li&gt;&lt;li&gt;â€¢ total plasma concentration&lt;/li&gt;&lt;li&gt;â€¢ drug over time&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ peak concentration&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ indicate&lt;/li&gt;&lt;li&gt;â€¢ total amount of drug absorbed.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Tmax is a pharmacokinetic parameter that indicates the time at which a drug reaches its maximum concentration in plasma , reflecting the rate of absorption from the site of administration into the systemic circulation.&lt;/li&gt;&lt;li&gt;â€¢ Tmax&lt;/li&gt;&lt;li&gt;â€¢ pharmacokinetic&lt;/li&gt;&lt;li&gt;â€¢ indicates the time&lt;/li&gt;&lt;li&gt;â€¢ drug&lt;/li&gt;&lt;li&gt;â€¢ its maximum concentration in plasma&lt;/li&gt;&lt;li&gt;â€¢ reflecting the rate of absorption&lt;/li&gt;&lt;li&gt;â€¢ site of administration&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following factors tend to increase the volume of distribution of a drug EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High plasma protein binding&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low ionization at physiological pH values&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High lipid solubility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High tissue binding&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. High plasma protein binding&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) High plasma protein binding.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ While high lipid solubility, low ionization , and high tissue binding increase a drug&#x27;s volume of distribution , high plasma protein binding generally decreases it.&lt;/li&gt;&lt;li&gt;âž¤ high lipid solubility,&lt;/li&gt;&lt;li&gt;âž¤ low ionization&lt;/li&gt;&lt;li&gt;âž¤ high tissue binding increase&lt;/li&gt;&lt;li&gt;âž¤ drug&#x27;s volume of distribution&lt;/li&gt;&lt;li&gt;âž¤ high plasma protein&lt;/li&gt;&lt;li&gt;âž¤ binding&lt;/li&gt;&lt;li&gt;âž¤ decreases it.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements regarding steady state plasma concentration of a drug are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;At steady state, rate of administration of drug is equal to its rate of elimination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Steady state plasma concentration achieved depends upon half-life&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drugs with longer half-life can be given as loading dose to achieve steady state more quickly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Average steady state plasma concentration achieved is same irrespective of once daily or twice daily administration if total daily dose is same&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Steady state plasma concentration achieved depends upon half-life&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Steady state plasma concentration achieved depends upon half-life.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug x is secreted through renal tubules, tubular secretion of this drug can be confirmed if renal clearance of drug x is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Equal to the GFR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;More than the GFR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Less than the GFR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;More than volume of distribution&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. More than the GFR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. More than the GFR&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new drug is found to be highly lipid soluble. It is metabolized at a slower rate of 10% per hour. On intravenous injection it produces general anaesthesia that lasts only for 15 min. This short duration of anaesthesia is due to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolism of the drug in liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High plasma protein binding of the drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Excretion of drug by kidney&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Redistribution&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Redistribution&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Redistribution&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Oral loading dose of a drug depends on the following factors except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug concentration to be achieved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Volume of distribution&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bioavailability of drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clearance of the drug&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Clearance of the drug&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Clearance of the drug&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A three-year-old child is brought to the emergency department having just ingested a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues including the brain. On physical examination the heart rate is 100/minute, blood pressure is 110/60 mm Hg and the respiratory rate is 20/ minute. In this case of poisoning?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urinary excretion would be accelerated by administration of NaHCO3, an alkalinizing agent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;More of the drug would be ionized at blood pH than at stomach pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absorption of the drug would be faster from the stomach than from the small intestine.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Â Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;About first order kinetics true statement is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clearance remains constant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fixed amount of the drug is eliminated per unit time&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Half-life increases with dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rate of elimination is constant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Clearance remains constant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug X is normally administered to patients at a rate of 50 mg/hour. Elimination of the drug X from body takes place as: - Hepatic Metabolism 10% - Biliary Secretion 10% - Renal Excretion 80% This drug has to be administered to a 65 years old patient Uttam Singh, with a GFR of 60 ml/min. (assuming normal GFR is 120 ml/min). Liver and biliary functions are normal in this patient. What should be the dose rate of drug X in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;50 mg/hour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;25 mg/hour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;30 mg/hour&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;100 mg/hour&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 30 mg/hour&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. 30 mg/hour&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient, Rajesh with a history of wheezing, coughing and shortness of breath is being evaluated in the asthma clinic. Several drug treatments with different routes are under consideration. Which of the following statements about routes of administration is most correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of a bronchodilator drug by inhaled aerosol is usually associated with more adverse effects than administration of this drug by mouth&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bioavailability of most drugs is greater with rectal administration than with sublingual administration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Administration of a drug by transdermal patch is often faster but is associated with more first pass metabolism than oral administration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. is incorrect because inhaled aerosol administration of bronchodilator drugs is associated with fewer adverse effects than oral administration , as it allows for targeted delivery of the drug to the site of action in the lungs, with minimal systemic absorption.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ inhaled aerosol administration&lt;/li&gt;&lt;li&gt;â€¢ fewer adverse effects&lt;/li&gt;&lt;li&gt;â€¢ oral administration&lt;/li&gt;&lt;li&gt;â€¢ allows for targeted delivery of the drug&lt;/li&gt;&lt;li&gt;â€¢ site of action in the lungs,&lt;/li&gt;&lt;li&gt;â€¢ minimal systemic&lt;/li&gt;&lt;li&gt;â€¢ absorption.&lt;/li&gt;&lt;li&gt;â€¢ Option B. is incorrect because sublingual administration generally results in greater bioavailability than rectal administration, as the sublingual route allows for rapid absorption of the drug into the bloodstream through the rich network of blood vessels under the tongue , bypassing the first-pass metabolism in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ sublingual administration&lt;/li&gt;&lt;li&gt;â€¢ greater bioavailability&lt;/li&gt;&lt;li&gt;â€¢ rectal administration,&lt;/li&gt;&lt;li&gt;â€¢ sublingual route&lt;/li&gt;&lt;li&gt;â€¢ rapid absorption of the drug&lt;/li&gt;&lt;li&gt;â€¢ bloodstream&lt;/li&gt;&lt;li&gt;â€¢ rich network of blood vessels&lt;/li&gt;&lt;li&gt;â€¢ tongue&lt;/li&gt;&lt;li&gt;â€¢ bypassing&lt;/li&gt;&lt;li&gt;â€¢ first-pass metabolism in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option C. is incorrect because transdermal administration of a drug is associated with slower onset of action than oral administration, as the drug must penetrate the skin barrier to enter systemic circulation.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ transdermal administration&lt;/li&gt;&lt;li&gt;â€¢ slower onset of action&lt;/li&gt;&lt;li&gt;â€¢ oral&lt;/li&gt;&lt;li&gt;â€¢ administration,&lt;/li&gt;&lt;li&gt;â€¢ drug&lt;/li&gt;&lt;li&gt;â€¢ penetrate the skin&lt;/li&gt;&lt;li&gt;â€¢ enter systemic circulation.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ First pass effect refers to the metabolism of a drug within the liver that significantly reduces the bioavailability of the drug before it reaches systemic circulation , as opposed to comparing routes of administration and their impact on drug delivery and metabolism.&lt;/li&gt;&lt;li&gt;â€¢ First pass effect&lt;/li&gt;&lt;li&gt;â€¢ metabolism of a drug&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ reduces&lt;/li&gt;&lt;li&gt;â€¢ bioavailability of the drug before&lt;/li&gt;&lt;li&gt;â€¢ systemic circulation&lt;/li&gt;&lt;li&gt;â€¢ comparing routes of administration&lt;/li&gt;&lt;li&gt;â€¢ their impact&lt;/li&gt;&lt;li&gt;â€¢ drug delivery&lt;/li&gt;&lt;li&gt;â€¢ metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test16" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 10 (Kidney, Respiratory System &amp;amp; Anaesthesia)   18 09 2023   2023 09 18&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 10 (Kidney, Respiratory System &amp;amp; Anaesthesia)   18 09 2023   2023 09 18&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Amiloride differs from spironolactone in that:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It has greater natriuretic action.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Its diuretic action is more in the presence of conditions with elevated aldosterone levels.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It acts from the luminal membrane side of the distal tubular cells.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can cause hypokalemia in long term use.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It acts from the luminal membrane side of the distal tubular cells.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It acts from the luminal membrane side of the distal tubular cells.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents to the clinic with recurrent episodes of renal colic. Laboratory tests and imaging confirm the presence of high-calcium renal stones. He has no other significant past medical history. What is the most useful diuretic in the treatment of his recurrent calcium stones?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrochlorthiazide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hydrochlorthiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hydrochlorothiazide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Chlorthiazide and furosemide are members of different diuretic classes, in terms of mechanisms of action, but they share the ability to cause hypokalemia. Which of the following statements best describes the general mechanism by which these drugs cause their effects that lead to net renal loss of potassium?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibiting proximal tubular K+ reabsorption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibiting Na+-K+-2C1â€“ cotransport in the ascending limb of loop of Henle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potentiating the action of aldosterone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Postoperative vomiting is uncommon with this intravenous anaesthetic agent and patients can ambulate sooner than those who receive other anaesthetic agents:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enflurane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propofol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remifentanil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propofol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Propofol.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man is scheduled for emergency surgery due to acute appendicitis. He has no significant past medical history, but his medical team is concerned about the use of succinylcholine as a neuromuscular blocking agent for intubation. Which of the following statements about succinylcholine is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It may induce life-threatening hyperkalemia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has a long duration of action.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is the drug of choice in non-traumatic rhabdomyolysis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is useful in patients with spinal cord injuries with paraplegia.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It may induce life-threatening hyperkalemia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. It may induce life-threatening hyperkalemia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman is scheduled for a minor surgical procedure. She has a history of chronic pain and is looking for an anaesthetic that provides both analgesia and amnesia but allows her to maintain some level of consciousness. Which anaesthetic is known for producing â€œdissociative anaesthesiaâ€?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fentanyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propofol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ketamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sevoflurane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ketamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Ketamine.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following beta 2 agonists is given by inhalation, and is suitable for both terminating acute asthma attacks as well as for prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terbutaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Formoterol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Salmeterol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Formoterol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Formoterol.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of carpel tunnel syndrome is scheduled for a peripheral nerve block procedure. The anaesthesiologist is considering adding epinephrine to the lignocaine solution for the nerve block. What will be the effect of adding epinephrine to lignocaine in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase risk of convulsions.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase the duration of action of the local anaesthetic.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Accelerate the onset of local anaesthesia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both (a) and (b).&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increase the duration of action of the local anaesthetic.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Increase the duration of action of the local anaesthetic.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with acute liver and renal failure. Her lab reports show a serum bilirubin level of 8 mg/dl and a serum creatinine level of 4 mg/dl. She requires muscle relaxation for mechanical ventilation. What would be the muscle relaxant of choice in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pancuronium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mivacurium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atracurium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;d-Tubocurarine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atracurium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Atracurium.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;We have a patient with heart failure, unacceptably low cardiac output, and intense reflex-mediated sympathetic activation of the peripheral vasculature that is attempting to keep vital organ perfusion pressure sufficiently high. The patient is edematous, and has ascites, because of the poor cardiac function and renal compensations for it. Which one of the following drugs should be avoided in this patient because it is most likely to compromise function of the already failing heart by increasing intravascular volume?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Mannitol.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One of your clinic patients is being treated with spironolactone. Which of the following statements best describes the property of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibits Na+ reabsorption in the proximal renal tubule of the nephron.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interferes with aldosterone synthesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Is a rational choice for a patient with an adrenal cortical tumor.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is more efficacious than hydrochlorothiazide in all patients who receive the drug.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Is a rational choice for a patient with an adrenal cortical tumor.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Is a rational choice for a patient with an adrenal cortical tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with a history of hypertension has been on long-term therapy with lisinopril. Despite medication, his blood pressure remains poorly controlled. His physician decides to add triamterene to his medication regimen. What is the most likely outcome of combining these two drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Better BP control, but with a risk of hyperkalemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac depression, because both drugs directly depress the heart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cough that may be severe, even though there was no cough with lisinopril alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypernatremia, because ACE inhibitors counteract triamtereneâ€™s natriuretic effect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Better BP control, but with a risk of hyperkalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Better BP control, but with a risk of hyperkalemia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Your patient, who lives in Delhi, is planning a vacation that includes a short hike to the top of Mount Everest (altitude approx. 29,000 feet above sea level). Youâ€™re concerned about â€œaltitude sickness.â€ He has no other significant medical conditions and takes no other drugs that would interact with the drug you will prescribe for his trip. Which of the following drugs would you recommend that this adventurer start taking before his trek, and continue until he returns to an altitude much closer to sea level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triamterene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acetazolamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Acetazolamide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young man having pheochromocytoma has BP of 188/92 mm Hg and a hematocrit of around 50%. Pulmonary function tests and renal functions are normal. His catecholamines are elevated. Which of the following drugs should not be included in the anesthesia protocol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desflurane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fentanyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Halothane&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Midazolam&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Halothane&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Halothane.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is not true of local anaesthetics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The local anaesthetic is required in the unionized form for penetrating the neuronal membrane.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The local anaesthetic approaches its receptor only from the intraneuronal face of the Na+ channel.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The local anaesthetic binds to its receptor mainly when the Na+ channel is in the resting state.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The local anaesthetic combines with its receptor in the ionized cationic form.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The local anaesthetic binds to its receptor mainly when the Na+ channel is in the resting state.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The local anaesthetic binds to its receptor mainly when the Na+ channel is in the resting state.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came to emergency with pus on the tip of the finger. You want to drain the pus and require a local anaesthetic. The history of the patient reveals that he is allergic to chlorprocaine. Which of the following local anaesthetics will be safe in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tetracaine with adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tetracaine without adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lignocaine with adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine without adrenaline&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lignocaine without adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lignocaine without adrenaline.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has very high serum uric acid levels, has had two acute gout attacks, and is at imminent risk of developing acute uric acid nephropathy. We will treat the patient with proper anti-inflammatory drugs and other agents but feel that reducing solubility of uric acid in the urine, by raising urine pH, might help stave-off the development of renal problems. Which of the following drugs produce this desired renal effect without appreciably increasing systemic risks of the hyperuricemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vasopressin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acetazolamide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Acetazolamide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with bronchial asthma has been on theophylline therapy. After the addition of a new medication to his regimen, he starts exhibiting symptoms of theophylline toxicity. Which of the following drugs was most likely added to his regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Griseofulvin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Erythromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Erythromycin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with COPD was given intravenous aminophylline therapy following which the patient developed diuresis. This is due to action on which effector?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenosine receptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta 2 adrenergic receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IL-10&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histone deacetylase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Adenosine receptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Adenosine receptors.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented to hospital for treatment of gout. She did not talk about pre-existing history of asthma. The intern gave aspirin after which acute attack of asthma was precipitated. Which of the following is the likely cause of the bronchoconstriction in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blockade of COX pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PG mediated bronchoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Augmentation of LOX pathway&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Release of histamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Augmentation of LOX pathway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Augmentation of LOX pathway.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test17" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 2 (Pharmacodynamics)   18 05 2023   2023 05 18&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 2 (Pharmacodynamics)   18 05 2023   2023 05 18&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Therapeutic Drug Monitoring (TDM) involves measurement of plasma concentrations of drugs to find whether the drug levels are within the therapeutic range or not. For TDM to be clinically useful the following criteria should be fulfilled?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The clinical response cannot be easily monitored&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;There should be good relationship between plasma concentration and drug dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The relationship between plasma drug concentration and therapeutic response and/or toxicity should be poor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The clinical response cannot be easily monitored&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. The clinical response cannot be easily monitored&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Therapeutic Drug Monitoring (TDM) is beneficial when the clinical response to a drug cannot be easily monitored, drug has narrow therapeutic index and it shows significant interindividual pharmacokinetic variations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The effect of different drugs was tested on heart rate. Curve A represents the effect of adrenaline (a pure beta 1 re ceptor agonist). Which of the curves most likely represents the effect of adrenaline after application of a reversible competitive beta 1 receptor antagonist?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;E&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. E&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/phar-test1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â  D. E&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the signaling process involved in the action of growth hormone releasing hormone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Action on a tyrosine kinase receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Action on a G protein that activates adenylyl cyclase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffusion across the membrane and binding to an intracellular receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Opening of trans-membrane ion channels&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Action on a G protein that activates adenylyl cyclase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Action on a G protein that activates adenylyl cyclase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Do not get confused between GH and GHRH. These are two different substances. GH acts on enzymatic receptors whereas GHRH acts on GPCR.&lt;/li&gt;&lt;li&gt;â€¢ Growth hormone-releasing hormone (GHRH) acts by binding to its specific G protein-coupled receptor (GHRH receptor) on the surface of pituitary cells. This binding activates a G protein, which in turn activates adenylyl cyclase. The activation of adenylyl cyclase increases the levels of cyclic AMP (cAMP) within the cell, leading to the activation of protein kinase A (PKA). This cascade ultimately results in the release of growth hormone (GH) from the anterior pituitary gland.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other :&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Options A. Action on a tyrosine kinase receptor&lt;/li&gt;&lt;li&gt;â€¢ Options A. Action on a tyrosine kinase receptor&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Tyrosine kinase receptors are typically involved in the action of growth factors such as insulin and epidermal growth factor (EGF). These receptors have intrinsic enzymatic activity that phosphorylates tyrosine residues on target proteins, initiating downstream signaling pathways. GHRH does not act through tyrosine kinase receptors.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Diffusion across the membrane and binding to an intracellular receptor&lt;/li&gt;&lt;li&gt;â€¢ Options C. Diffusion across the membrane and binding to an intracellular receptor&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Steroid hormones and thyroid hormones typically diffuse across the cell membrane and bind to intracellular receptors, which then act as transcription factors to regulate gene expression. GHRH, being a peptide hormone, does not diffuse across the membrane and does not bind to intracellular receptors.&lt;/li&gt;&lt;li&gt;â€¢ Options D. Opening of trans-membrane ion channels&lt;/li&gt;&lt;li&gt;â€¢ Options D. Opening of trans-membrane ion channels&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Neurotransmitters such as acetylcholine and GABA often work by binding to receptors that are part of ion channels, causing them to open and allow ions to flow across the membrane, leading to changes in cell membrane potential. GHRH does not act by opening ion channels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that growth hormone-releasing hormone (GHRH) signals through a G protein-coupled receptor whereas growth hormone (GH) acts via enzymatic receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Three alpha-agonist drugs are tested as potential vasoconstrictors. The following curves are obtained. Which of the following is the best statement concerning the effects of these drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug 1 has lower potency than Drug 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug 2 has higher affinity for alpha-receptors than Drug 3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug 2 and 3 are equally effective&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug 1 is more efficacious than drug 2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Drug 2 has higher affinity for alpha-receptors than Drug 3&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/phar-test2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Drug 2 has higher affinity for alpha-receptors than Drug 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following condition is most likely to be a pharmacogenetic condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypotension caused by Nitroprusside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic anemia caused due to primaquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diarrhea caused by physostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hemolytic anemia caused due to primaquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Hemolytic anemia caused due to primaquine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Hypotension caused by Nitroprusside&lt;/li&gt;&lt;li&gt;â€¢ Options A. Hypotension caused by Nitroprusside&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect as hypotension caused by nitroprusside is not typically related to pharmacogenetics. Nitroprusside induces hypotension by releasing nitric oxide, which dilates blood vessels. This effect is predictable and dose-dependent rather than influenced by genetic variability.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Diarrhea caused by physostigmine&lt;/li&gt;&lt;li&gt;â€¢ Options C. Diarrhea caused by physostigmine&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Diarrhea caused by physostigmine is due to its mechanism of action as a cholinesterase inhibitor, increasing acetylcholine levels and stimulating the gastrointestinal tract. This side effect is pharmacodynamic rather than pharmacogenetic.&lt;/li&gt;&lt;li&gt;â€¢ Options D. All of these&lt;/li&gt;&lt;li&gt;â€¢ Options D. All of these&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect because not all the listed conditions are pharmacogenetic. Among the options provided, only hemolytic anemia caused by primaquine is a classic example of a pharmacogenetic condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that pharmacogenetic conditions are adverse drug reactions influenced by genetic variations in individuals. Hemolytic anemia due to primaquine in G6PD-deficient individuals is a classic example of a pharmacogenetic condition, unlike hypotension from nitroprusside or diarrhea from physostigmine, which are pharmacodynamic effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statement is TRUE about the drug label shown below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Red line indicates that the drug should not be given without the prescription of a registered medical practitioner&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IP means that this brand CLOBA 5 is Intellectual Property right of the company INTAS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The dose of this drug is 5 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Red line indicates that the drug should not be given without the prescription of a registered medical practitioner&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/phar-test3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Red line indicates that the drug should not be given without the prescription of a registered medical practitioner&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;As an Indian medical intern, which of the following is the correct format for prescription of L-thyroxine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tablet L-thyroxine 25 m g once a day orally at night for 15 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tablet L-thyroxine 25 mcg once a day orally at night for 15 days&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tablet L-thyroxine .025 mg OD orally at night for 15 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tablet L-thyroxine 25 microgram HS orally for 15 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tablet L-thyroxine 25 mcg once a day orally at night for 15 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Tablet L-thyroxine 25 mcg once a day orally at night for 15 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;With respect to clinical trials of new drugs, which of the following is most CORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase I involves the study of a small number of normal volunteers by highly trained clinical pharmacologists&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase II involves the use of the new drug in a large number of patients (1000-5000) who have the disease to be treated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase III involves the determination of the drugâ€™s therapeutic index by the cautious induction of toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phase IV involves the detailed study of toxic effects that have been discovered in phase III.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Phase I involves the study of a small number of normal volunteers by highly trained clinical pharmacologists&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Phase I involves the study of a small number of normal volunteers by highly trained clinical pharmacologists&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Phase I clinical trials are the first stage of testing in human subjects. These trials are typically conducted on a small number of healthy volunteers to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug. The primary focus is to determine the drug&#x27;s safety profile and the appropriate dosage range. These studies are usually conducted by highly trained clinical pharmacologists.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options B. Phase II involves the use of the new drug in a large number of patients (1000-5000) who have the disease to be treated&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ B. Phase II involves the use of the new drug in a large number of patients (1000-5000) who have the disease to be treated&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Phase II clinical trials are conducted on a relatively small group of patients (usually a few hundred) who have the disease or condition the drug is intended to treat. The purpose is to evaluate the drug&#x27;s efficacy and to further assess its safety.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Phase III involves the determination of the drugâ€™s therapeutic index by the cautious induction of toxicity&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. Phase III involves the determination of the drugâ€™s therapeutic index by the cautious induction of toxicity&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Phase III clinical trials involve a larger number of patients (typically several hundred to several thousand) and aim to confirm the drug&#x27;s effectiveness, monitor side effects, and compare it to commonly used treatments. The therapeutic index is not determined by inducing toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Options D. Phase IV involves the detailed study of toxic effects that have been discovered in phase III&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ D. Phase IV involves the detailed study of toxic effects that have been discovered in phase III&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Phase IV clinical trials, also known as post-marketing surveillance, occur after a drug has been approved for use by regulatory authorities. These trials continue to monitor the drug&#x27;s safety and effectiveness in the general population, but they are not specifically focused on studying toxic effects discovered in Phase III. Instead, they monitor for any long-term or rare side effects that may not have been apparent in earlier phases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the phases of clinical trials: Phase I focuses on safety in a small group of healthy volunteers, Phase II evaluates efficacy and safety in patients with the disease, Phase III involves large-scale testing for effectiveness and safety comparison with standard treatments, and Phase IV monitors long-term effects post-marketing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which phase of clinical trials is conducted on volunteers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following terms best describes the antagonism of leukotrienesâ€™ bronchoconstrictor effect (mediated at the leukotriene receptors) by terbutaline (acting at the adrenoceptors) in a patient with asthma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pharmacologic antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Partial agonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Physiologic antagonist&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chemical antagonist&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Physiologic antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Pharmacologic antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A physiologic antagonist refers to a situation where two drugs produce opposite effects on the same physiological function by acting on different receptors or mechanisms. In this case, leukotrienes cause bronchoconstriction by acting on leukotriene receptors, while terbutaline causes bronchodilation by acting on adrenoceptors. Terbutaline does not directly block leukotriene receptors but rather counteracts the bronchoconstriction through a different pathway, which is characteristic of physiologic antagonism.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Pharmacologic antagonist&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A. Pharmacologic antagonist&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. A pharmacologic antagonist directly competes with or blocks the action of an agonist at the same receptor. Terbutaline does not block leukotriene receptors; instead, it acts on adrenoceptors to produce an opposite effect.&lt;/li&gt;&lt;li&gt;â€¢ Options B. Partial agonist&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ B. Partial agonist&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. A partial agonist is a drug that binds to and activates a receptor but produces a lower response than a full agonist. Terbutaline is a full agonist at adrenoceptors and does not fit the definition of a partial agonist in this context.&lt;/li&gt;&lt;li&gt;â€¢ Options D. Chemical antagonist&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ D. Chemical antagonist&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. A chemical antagonist directly interacts with the agonist itself to neutralize or remove it, rather than interacting with a receptor. Terbutaline does not chemically interact with leukotrienes; it produces its effects through receptor-mediated mechanisms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that physiologic antagonism occurs when two drugs produce opposing effects on the same physiological function through different mechanisms or receptors. In asthma treatment, terbutaline (acting on adrenoceptors) counteracts the bronchoconstriction caused by leukotrienes (acting on leukotriene receptors) through physiologic antagonism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True about G protein coupled receptors is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug binds to G proteins on the cell membrane.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;G proteins act as inhibitory and excitatory because of difference in alpha subunit&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G protein in bound to GTP in resting phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these are correct&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. G proteins act as inhibitory and excitatory because of difference in alpha subunit&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. G proteins act as inhibitory and excitatory because of difference in alpha subunit&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ G protein-coupled receptors (GPCRs) are a large family of cell surface receptors that transmit signals inside the cell through the activation of G proteins. Here are the clarifications for each option:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Drug binds to G proteins on the cell membrane.&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A. Drug binds to G proteins on the cell membrane.&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Drugs and ligands bind to the GPCRs themselves, not directly to the G proteins. The GPCRs are located on the cell membrane, and upon binding of a ligand, they undergo a conformational change that activates the associated G proteins.&lt;/li&gt;&lt;li&gt;â€¢ Options B. G proteins act as inhibitory and excitatory because of difference in alpha subunit&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ B. G proteins act as inhibitory and excitatory because of difference in alpha subunit&lt;/li&gt;&lt;li&gt;â€¢ This option is correct. G proteins can be classified as stimulatory (Gs) or inhibitory (Gi), and this distinction is largely due to differences in their alpha subunits. The alpha subunit determines the specific downstream effects, whether it promotes or inhibits the production of second messengers like cAMP.&lt;/li&gt;&lt;li&gt;â€¢ Options C. G protein in bound to GTP in resting phase&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. G protein in bound to GTP in resting phase&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. In the resting phase, the G protein is bound to GDP, not GTP. When the receptor is activated by a ligand, the GDP is exchanged for GTP, leading to the activation of the G protein and subsequent signaling.&lt;/li&gt;&lt;li&gt;â€¢ Options D. All of these are correct&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ D. All of these are correct&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect because options A and C are not accurate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that G protein-coupled receptors (GPCRs) function by binding ligands, which leads to activation of G proteins. The G proteins have different types of alpha subunits that can either stimulate or inhibit intracellular signaling pathways. In the resting state, G proteins are bound to GDP, and upon activation, they exchange GDP for GTP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old patient with a history of epilepsy presents to the clinic for medication review. The patient is currently taking multiple medications, including isoniazid, hydralazine, procainamide, and phenytoin, for their various medical conditions. During the discussion, the patient asks about the differences in the metabolism of these drugs. The healthcare provider explains that all the drugs mentioned are metabolized by different pathways except for one. Which of the following drugs is NOT metabolized by acetylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydralazine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenytoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Phenytoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation. On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Among the drugs mentioned, phenytoin is not metabolized by acetylation. Phenytoin is primarily metabolized through hepatic oxidation, mediated by cytochrome P450 enzymes, specifically CYP2C9. It undergoes extensive hepatic metabolism rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, the other drugs mentioned are metabolized by acetylation: Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects. Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body. Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity. Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;li&gt;â€¢ Isoniazid (Choice A) is an antituberculosis medication that undergoes rapid acetylation in the liver. Acetylation plays a significant role in the metabolism of isoniazid, and variations in acetylation rates can impact its therapeutic efficacy and side effects.&lt;/li&gt;&lt;li&gt;â€¢ Hydralazine (Choice B), an antihypertensive drug, is also metabolized by acetylation. Acetylation is a major pathway involved in the elimination of hydralazine from the body.&lt;/li&gt;&lt;li&gt;â€¢ Procainamide (Choice C), an antiarrhythmic medication, undergoes extensive acetylation for its metabolism. Acetylation is a major metabolic pathway for procainamide, and acetylator phenotype variations can affect the drug&#x27;s efficacy and potential toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the drug that is NOT metabolized by acetylation among the options provided is phenytoin (Choice D). It is primarily metabolized through hepatic oxidation rather than acetylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the type of inhibition from the given graph:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Un-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Competitive&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Competitive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ The figure shown in the question is Lineweaver-Burk plot, also known as the double reciprocal plot. It is constructed by taking the reciprocal of both the reaction velocity (1/V) and the substrate concentration (1/[S]) and plotting them against each other. In this plot, the x-axis represents 1/[S] (the reciprocal of the substrate concentration), and the y-axis represents 1/V (the reciprocal of the reaction velocity). The slope of the Lineweaver-Burk plot is equal to Km/Vmax, and the intercept on the y-axis is equal to 1/Vmax.&lt;/li&gt;&lt;li&gt;â€¢ The figure shown in the question is Lineweaver-Burk plot, also known as the double reciprocal plot. It is constructed by taking the reciprocal of both the reaction velocity (1/V) and the substrate concentration (1/[S]) and plotting them against each other.&lt;/li&gt;&lt;li&gt;â€¢ In this plot, the x-axis represents 1/[S] (the reciprocal of the substrate concentration), and the y-axis represents 1/V (the reciprocal of the reaction velocity).&lt;/li&gt;&lt;li&gt;â€¢ The slope of the Lineweaver-Burk plot is equal to Km/Vmax, and the intercept on the y-axis is equal to 1/Vmax.&lt;/li&gt;&lt;li&gt;â€¢ How to interpret this graph?&lt;/li&gt;&lt;li&gt;â€¢ How to interpret this graph?&lt;/li&gt;&lt;li&gt;â€¢ X-axis represents Km and Y-axis represents Vmax. If the lines of two graphs (with inhibitor and without inhibitor) intersect at Y-axis, it means Vmax is same and Km is different. This is a case of competitive inhibition. If the lines of two graphs (with inhibitor and without inhibitor) intersect at X-axis, it means Km is same and Vmax is different. This is a case of non-competitive inhibition.&lt;/li&gt;&lt;li&gt;â€¢ X-axis represents Km and Y-axis represents Vmax.&lt;/li&gt;&lt;li&gt;â€¢ If the lines of two graphs (with inhibitor and without inhibitor) intersect at Y-axis, it means Vmax is same and Km is different. This is a case of competitive inhibition.&lt;/li&gt;&lt;li&gt;â€¢ If the lines of two graphs (with inhibitor and without inhibitor) intersect at X-axis, it means Km is same and Vmax is different. This is a case of non-competitive inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are advantages of enteric coated tablets except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To prolong half-life of drug&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To protect the acid labile drugs from acid secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To protect stomach from irritant effects of drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To increase the absorption of drugs preferentially absorbed distal to stomach&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. To prolong half-life of drug&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. â€˜Aâ€™ To prolong half-life of drug&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following cannot be considered as the side effect of a drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dry mouth caused by atropine when used for producing mydriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia caused by propanolol when used for treatment of tachycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscular dystonia caused by metoclopramide when used for treatment of vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Asthma precipitated by bethanechol when used for treatment of atonic bladder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia caused by propanolol when used for treatment of tachycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Bradycardia caused by propranolol when used for treatment of tachycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Dry mouth caused by atropine when used for producing mydriasis&lt;/li&gt;&lt;li&gt;â€¢ Options A. Dry mouth caused by atropine when used for producing mydriasis&lt;/li&gt;&lt;li&gt;â€¢ Dry mouth is an adverse effect of atropine when used for producing mydriasis. Atropine&#x27;s anticholinergic action causes inhibition of salivary gland secretion, leading to dry mouth. This effect is pharmacological but not related to the intended use (mydriasis), making it a side effect.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Muscular dystonia caused by metoclopramide when used for treatment of vomiting&lt;/li&gt;&lt;li&gt;â€¢ Options C. Muscular dystonia caused by metoclopramide when used for treatment of vomiting&lt;/li&gt;&lt;li&gt;â€¢ Muscular dystonia is a side effect of metoclopramide. This drug&#x27;s dopamine antagonist action can cause extrapyramidal symptoms, including dystonia, which are adverse effects unrelated to its use in treating vomiting.&lt;/li&gt;&lt;li&gt;â€¢ Options D. Asthma precipitated by bethanechol when used for treatment of atonic bladder&lt;/li&gt;&lt;li&gt;â€¢ Options D. Asthma precipitated by bethanechol when used for treatment of atonic bladder&lt;/li&gt;&lt;li&gt;â€¢ Asthma is a side effect of bethanechol when used for treating atonic bladder. Bethanechol, a cholinergic agonist, can cause bronchoconstriction and increase bronchial secretions, leading to asthma. This adverse effect is unrelated to its intended action on the bladder.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that side effects are adverse pharmacological actions unrelated to the intended therapeutic use of the drug. Therapeutic actions at higher doses, resulting in adverse effects, are termed toxic effects. Recognize that bradycardia from propranolol in treating tachycardia is a therapeutic effect, not a side effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Efficacy of a drug refers to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Effectiveness of drug in life threatening conditions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The maximal intensity of response that can be produced by the drug&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The dose of the drug needed to produce half-maximal effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The minimum dose of the drug needed to produce toxic effect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The maximal intensity of response that can be produced by the drug&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. The maximal intensity of response that can be produced by the drug&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Efficacy refers to the maximum effect that a drug can produce, regardless of dose. It is a measure of the drug&#x27;s ability to achieve its intended effect at its highest possible intensity. This concept is essential for understanding the potential therapeutic benefits of a drug.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Effectiveness of drug in life-threatening conditions&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A. Effectiveness of drug in life-threatening conditions&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. This describes the clinical effectiveness of a drug in specific scenarios, such as emergencies, but does not define the drug&#x27;s maximal response capability.&lt;/li&gt;&lt;li&gt;â€¢ Options C. The dose of the drug needed to produce half-maximal effect&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. The dose of the drug needed to produce half-maximal effect&lt;/li&gt;&lt;li&gt;â€¢ This option describes the potency of a drug, typically indicated by the EC50 (the concentration required to produce 50% of the drug&#x27;s maximal effect). Potency is about the amount of drug needed to achieve a certain effect, not the maximal effect itself.&lt;/li&gt;&lt;li&gt;â€¢ potency&lt;/li&gt;&lt;li&gt;â€¢ Options D. The minimum dose of the drug needed to produce a toxic effect&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ D. The minimum dose of the drug needed to produce a toxic effect&lt;/li&gt;&lt;li&gt;â€¢ This option refers to the drug&#x27;s toxic dose or its safety profile. It indicates the lowest dose at which the drug causes toxicity, important for determining the therapeutic window and overdose potential.&lt;/li&gt;&lt;li&gt;â€¢ toxic dose&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the efficacy of a drug is defined by its ability to produce the maximal response, highlighting its therapeutic potential at its highest effect. This differs from potency (the dose required for half-maximal effect) and the minimum toxic dose (the lowest dose causing toxicity).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Therapeutic index is an assessment of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Potency of a drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Onset of action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Duration of action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Margin of safety&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Margin of safety&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Margin of safety&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The therapeutic index (TI) is a measure of a drug&#x27;s margin of safety. It is calculated as the ratio of the median lethal dose (TD50) to the median effective dose (ED50) of a drug. A higher therapeutic index indicates a greater margin of safety, meaning there is a larger window between the effective dose and the toxic dose, making the drug safer for clinical use.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Potency of a drug&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A. Potency of a drug&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Potency refers to the amount of drug needed to produce a certain effect, often indicated by the EC50 (the concentration required to achieve 50% of the drug&#x27;s maximal effect). It does not assess safety.&lt;/li&gt;&lt;li&gt;â€¢ Options B. Onset of action&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ B. Onset of action&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Onset of action refers to the time it takes for a drug to produce its therapeutic effect after administration. It is not related to the therapeutic index.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Duration of action&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. Duration of action&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Duration of action refers to the length of time that a drug exerts its therapeutic effect. It does not relate to the safety margin of the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that the therapeutic index is a measure of a drug&#x27;s margin of safety, calculated by the ratio of the median lethal dose to the median effective dose. A higher therapeutic index indicates a wider safety margin, making the drug safer for use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36 yr old man, Rajat with hypertension is to be treated with an antihypertensive drug. Drugs A and B have same mechanism of action. Drug A in a dose of 10 mg produces the same magnitude of antihypertensive effect as 100 mg of drug B. This suggests that:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug B is less efficacious than drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug A is more potent than drug B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug A is a safer drug than drug B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug A is shorter acting than Drug B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Drug A is more potent than drug B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Drug A is more potent than drug B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Drug potency refers to the amount of drug needed to produce a given effect. In this scenario, Drug A requires only 10 mg to achieve the same antihypertensive effect that 100 mg of Drug B produces. This indicates that Drug A is more potent than Drug B, as a smaller dose of Drug A is needed to produce the same effect.&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Drug B is less efficacious than drug A&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A. Drug B is less efficacious than drug A&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Efficacy refers to the maximal effect a drug can produce, regardless of dose. Since both drugs produce the same magnitude of effect, they have the same efficacy. The difference lies in the amount of drug needed to achieve that effect, not in the maximal effect itself.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Drug A is a safer drug than drug B&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. Drug A is a safer drug than drug B&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Safety of a drug is assessed by its therapeutic index and its adverse effect profile, not by the dose required to achieve a therapeutic effect. Potency does not directly relate to the safety of a drug.&lt;/li&gt;&lt;li&gt;â€¢ Options D. Drug A is shorter acting than Drug B&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ D. Drug A is shorter acting than Drug B&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. The duration of action refers to how long a drug&#x27;s effects last, which is not indicated by the dose required to achieve the effect. The information given does not provide any insight into the duration of action of either drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that drug potency refers to the amount of drug needed to produce a specific effect, with a more potent drug requiring a lower dose to achieve the same effect. This differs from efficacy, which is the maximal effect a drug can achieve, and from safety and duration of action, which are assessed by other criteria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements best describes an â€˜orphan drugâ€™?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a drug which acts on orphanin receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a very cheap drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a drug which has no therapeutic use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is a drug required for treatment or prevention of a rare disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is a drug required for treatment or prevention of a rare disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It is a drug required for treatment or prevention of a rare disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. It is a drug which acts on orphanin receptors&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ A. It is a drug which acts on orphanin receptors&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Orphanin receptors are specific receptors in the body, but the term \&quot;orphan drug\&quot; does not refer to drugs acting on these receptors. The term is instead related to the rarity of the diseases the drugs treat.&lt;/li&gt;&lt;li&gt;â€¢ Options B. It is a very cheap drug&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ B. It is a very cheap drug&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. The cost of a drug does not determine whether it is considered an orphan drug. In fact, orphan drugs can be very expensive due to the limited market and the cost of development.&lt;/li&gt;&lt;li&gt;â€¢ Options C. It is a drug which has no therapeutic use&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. It is a drug which has no therapeutic use&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Orphan drugs are specifically developed for therapeutic use in rare diseases. They are not without therapeutic use; rather, they are crucial for the treatment or prevention of conditions that affect a small number of people.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that orphan drugs are developed for the treatment or prevention of rare diseases, often supported by government incentives due to the limited market for such drugs. This is distinct from the drug&#x27;s cost, receptor activity, or therapeutic utility in general.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dose response curves of salbutamol for tachycardia and bronchodilation are widely separated on the dose axis. This information suggests that salbutamol is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Highly potent bronchodilator&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Highly efficacious drug for bradycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Highly toxic drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Highly selective drug&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Highly selective drug&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-095826.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Highly selective drug&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The fact that dose response curves of salbutamol for tachycardia and bronchodilation are widely separated on the dose axis suggests that salbutamol has a high degree of selectivity. This means that salbutamol can achieve its desired therapeutic effect (bronchodilation) at a dose that is significantly lower than the dose required to produce an adverse effect (tachycardia). Selectivity is a desirable property in drugs as it allows for effective treatment with minimal side effects.&lt;/li&gt;&lt;li&gt;â€¢ The graph above illustrates the dose-response curves of salbutamol for bronchodilation and tachycardia. The blue curve represents the bronchodilation response, while the red curve represents the tachycardia response.&lt;/li&gt;&lt;li&gt;â€¢ Bronchodilation Response : The curve shows that a lower dose of salbutamol (around 2 mg) is sufficient to achieve a significant bronchodilation effect. Tachycardia Response : The curve shows that a higher dose of salbutamol (around 7 mg) is needed to produce tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Bronchodilation Response : The curve shows that a lower dose of salbutamol (around 2 mg) is sufficient to achieve a significant bronchodilation effect.&lt;/li&gt;&lt;li&gt;â€¢ Bronchodilation Response&lt;/li&gt;&lt;li&gt;â€¢ Tachycardia Response : The curve shows that a higher dose of salbutamol (around 7 mg) is needed to produce tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Tachycardia Response&lt;/li&gt;&lt;li&gt;â€¢ The wide separation between the effective dose for bronchodilation and the dose causing tachycardia demonstrates the selectivity of salbutamol. This selectivity allows salbutamol to provide the desired therapeutic effect (bronchodilation) at a dose much lower than that required to produce the side effect (tachycardia).&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Highly potent bronchodilator&lt;/li&gt;&lt;li&gt;â€¢ Options A. Highly potent bronchodilator&lt;/li&gt;&lt;li&gt;â€¢ While salbutamol may be a potent bronchodilator, the separation of the dose response curves specifically indicates selectivity rather than just potency. Potency refers to the amount of drug needed to produce a given effect, but the question focuses on the differential doses required for different effects, indicating selectivity.&lt;/li&gt;&lt;li&gt;â€¢ Options B. Highly efficacious drug for bradycardia&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ B. Highly efficacious drug for bradycardia&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. Salbutamol is not used for treating bradycardia. It is a bronchodilator used primarily in the treatment of asthma and other conditions involving bronchospasm. The question does not provide information about the efficacy of salbutamol for bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Highly toxic drug&lt;/li&gt;&lt;li&gt;â€¢ Options&lt;/li&gt;&lt;li&gt;â€¢ C. Highly toxic drug&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect. While any drug can be toxic at high doses, the separation of the dose response curves indicates that salbutamol can produce its therapeutic effect at a dose much lower than the dose causing tachycardia, suggesting selectivity rather than inherent toxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that a wide separation in the dose response curves of a drug for its therapeutic effect and an adverse effect indicates high selectivity. This allows the drug to achieve its intended therapeutic outcome with minimal side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test18" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 3 (Ans)   08 06 2023   2023 06 08&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 3 (Ans)   08 06 2023   2023 06 08&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following effects of adrenaline would be blocked by phentolamine (alpha receptor blocker) but NOT by propranolol (beta receptor antagonist)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Release of renin from JG cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Relaxation of bronchial smooth muscle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tremors due to stimulation of muscle spindle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contraction of the vascular smooth muscle&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Contraction of the vascular smooth muscle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Atropine is useful in organophosphate poisoning because it:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reactivates acetylcholine esterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Competes with acetylcholine release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Binds with both nicotinic and muscarinic acetylcholine receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is a competitive antagonist of acetylcholine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Is a competitive antagonist of acetylcholine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Is a competitive antagonist of acetylcholine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During your rural posting after the internship, you encounter a patient of acute cardiac failure. Your preferred drug for this condition is dobutamine. However, it is not available there. Which of the following other drugs, or combination of drugs, would be a suitable alternative, giving the pharmacologic equivalent of what you want the dobutamine to do?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Norepinephrine plus phentolamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dopamine (at a very high dose)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ephedrine plus propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenylephrine plus atropine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Norepinephrine plus phentolamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Norepinephrine plus phentolamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An old patient Ravi, having asthma and glaucoma is to receive a Î² blocker. Regarding Î² blocking drugs:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol blocks Î² 2 receptors selectively&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esmololâ€™s pharmacokinetics are compatible with chronic topical use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nadolol lacks Î² 2 blocking action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Timolol lacks the local anaesthetic effects of propranolol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Timolol lacks the local anaesthetic effects of propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Timolol lacks the local anesthetic effects of propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Jugal, a patient suffering from hypertension, was administered propranolol. While it successfully managed the hypertension, it unfortunately dropped his resting heart rate to 50 beats per minute. Which of the following Î² blockers can be used as a suitable replacement for propranolol in Jugal&#x27;s case that wouldn&#x27;t result in severe bradycardia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pindolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bisoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pindolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Pindolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient receives bethanechol after abdominal surgery. Her heart rate falls slightly and she experiences some wheezing. Which of the following best explains these cardiac and pulmonary responses?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Expected side effects of bethanechol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patient has undiagnosed AV block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patient has undiagnosed interstitial lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both B and C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Expected side effects of bethanechol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Expected side effects of bethanechol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;After undergoing a comprehensive eye exam, a patient exits the ophthalmologist&#x27;s office and steps into bright sunlight. The topical drug administered during the exam not only dilated the patient&#x27;s pupils but also affected their ability to focus on nearby objects. Which of the following drugs is most similar in its effects to the one given to the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Physostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Homatropine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pilocarpine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Donepezil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Homatropine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Homatropine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old woman with diagnosed myasthenia gravis presents with profound skeletal muscle weakness. We are unsure whether she is experiencing a cholinergic crisis or a myasthenic crisis, so we administer a usually appropriate dose of parenteral edrophonium. Assume the patient was actually experiencing a cholinergic crisis. Which of the following is the most likely response to the drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertensive crisis from peripheral vascular constriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myocardial ischemia, and angina, from drug-induced tachycardia and coronary vasoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prompt improvement of skeletal muscle tone and function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventilatory distress or failure due to paralysis of respiratory muscles&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ventilatory distress or failure due to paralysis of respiratory muscles&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Neeraj, a farmer comes to you in the emergency in comatose state. Patient had profuse sweating and lacrimation. Diarrhea and urination were apparent. On examination pupil was constricted and BP of the farmer was 80/60 mm Hg. You make a diagnosis of anticholinesterase poisoning. You decide to administer him atropine. All of the following actions will be reversed by atropine EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscle paralysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchoconstriction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Muscle paralysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Muscle paralysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has supraventricular tachycardia. We inject a drug and heart rate falls to a normal or at least more acceptable level. Although this drug caused the desired response, it did so without any direct effect on the heart. Which of the following drugs was most likely used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenylephrine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Phenylephrine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Phenylephrine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A substance abuser self-administers cocaine and experiences a variety of significant changes in cardiovascular function, in addition to the CNS-stimulating effects for which the drug is used. Which of the following is the most likely mechanism by which the cocaine causes its main peripheral effects?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Activation of Î±-2-adrenergic receptors leading to increased NA release&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blockage of NA reuptake via the amine pump&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Direct activation of postsynaptic Î±-and â€“Î² adrenergic receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prevention of NA exocytosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Blockage of NA reuptake via the amine pump&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Blockage of NA reuptake via the amine pump&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;We administer an â€œeffectiveâ€ dose of a drug Y and observe the following responses: Stimulates the heart Dilates some blood vessels but constricts none Dilates the bronchi Raises blood glucose levels in presence of hypoglycemia No effect on the size of the pupil Drug Y acts on which of the following receptors?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antagonist of muscarinic receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Agonist of all Î± and Î²-adrenergic receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Agonist of Î±1 and Î±2 receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Agonist of Î²1 and Î²2 receptors&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Agonist of Î²1 and Î²2 receptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Agonist of Î²1 and Î²2 receptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following can be blocked by atropine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bradycardia caused by infusion of acetylcholine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased blood pressure caused by nicotine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased skeletal muscle strength caused by neostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bradycardia caused by infusion of acetylcholine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Bradycardia caused by infusion of acetylcholine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new drug has been found to act by inhibiting VMAT-2. Which of the following statement regarding this drug is likely to be TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blocks both Î± and Î² receptor mediated effects of injected adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Does not block any effect of injected nor-adrenaline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Does not block the effects of sympathetic nerve Stimulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Does not block any effect of injected nor-adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Does not block any effect of injected nor-adrenaline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A healthy adult subject is given an intravenous injection of a test drug. Both blood pressure and total peripheral resistance rise promptly. This is associated with a reduction of heart rate. In repeated experiments we find that the vasopressor response is not affected by pretreatment with prazosin (alpha blocker). However, pretreatment with atropine prevents the bardycardia. The test drug was most likely which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoprenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Angiotensin II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Noradrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Angiotensin II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cholinomimetic drugs can be used for the treatment of all the following conditions except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Closed angle glaucoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cobra bite&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myasthenia gravis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Bradycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents in the emergency department in great distress and with the following signs and symptoms: Mental confusion Clear lungs, no wheezing or crepitations High heart rate Absence of bowel sounds Distended abdomen Full bladder Hot, dry skin Absence of lacrimal, salivary secretions Very high fever Dilated pupils that do not respond to light Which of the following drug overdose is most likely to be responsible for these signs and symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Organophosphates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atropine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atropine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Atropine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of atenolol in comparison to propranolol EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is ineffective in suppressing muscle tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is safer in asthmatics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is less likely to cause bradycardia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is less likely to worsen Raynaudâ€™s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is less likely to cause bradycardia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.C. It is less likely to cause bradycardia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In general, structures that are affected by sympathetic activation respond to both sympathetic neural activation and to the hormonal component, adrenaline released from the adrenal medulla. Which of the following structures is unique in that it responds to adrenaline, but not nor-adrenaline?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrioventricular node&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iris of the eye&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bronchus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal juxtaglomerular apparatus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bronchus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Bronchus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28 yr old woman has been treated with several autonomic drugs for about a month. Which of the following signs would distinguish between an overdose of a muscarinic blocker and a ganglionic blocker?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blurred vision&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Postural hypotension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dry mouth, constipation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mydriasis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Postural hypotension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Postural hypotension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test19" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 4 (Cvs)   29 06 2023   2023 06 29&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 4 (Cvs)   29 06 2023   2023 06 29&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following drugs acts as an antagonist of nicotinic receptors and is useful as an antidote for nicotine poisoning?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trimethoprim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Triazolam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trimethaphan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triclabendazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Trimethaphan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Trimethaphan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Trimethoprim&lt;/li&gt;&lt;li&gt;â€¢ Option A: Trimethoprim&lt;/li&gt;&lt;li&gt;â€¢ Trimethoprim is an antibiotic that inhibits bacterial dihydrofolate reductase. It has no action on nicotinic receptors and is not used as an antidote for nicotine poisoning.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Triazolam&lt;/li&gt;&lt;li&gt;â€¢ Option B: Triazolam&lt;/li&gt;&lt;li&gt;â€¢ Triazolam is a short-acting benzodiazepine used for the treatment of insomnia. It does not act on nicotinic receptors and is not relevant for treating nicotine poisoning.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Triclabendazole&lt;/li&gt;&lt;li&gt;â€¢ Option D: Triclabendazole&lt;/li&gt;&lt;li&gt;â€¢ Triclabendazole is an antiparasitic drug used to treat infections caused by liver flukes. It does not affect nicotinic receptors and is not used as an antidote for nicotine poisoning.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Trimethaphan is a nicotinic receptor antagonist that can be used as an antidote for nicotine poisoning by blocking the effects of nicotine at autonomic ganglia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT true about the use of beta blockers in CHF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;These should be started at very low dose and slowly titrated upwards&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol is most widely used beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;These are drug of choice in acute decompensated heart failure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;These can reduce mortality in CHF patients&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. These are drug of choice in acute decompensated heart failure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. These are drug of choice in acute decompensated heart failure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: These should be started at very low dose and slowly titrated upwards&lt;/li&gt;&lt;li&gt;â€¢ Option A: These should be started at very low dose and slowly titrated upwards&lt;/li&gt;&lt;li&gt;â€¢ Beta blockers should indeed be started at very low doses and slowly titrated upwards. This cautious approach is necessary to avoid acute decompensation and to allow the patientâ€™s body to adjust to the medication gradually.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carvedilol is most widely used beta blocker&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carvedilol is most widely used beta blocker&lt;/li&gt;&lt;li&gt;â€¢ Carvedilol is one of the most widely used beta blockers in the management of chronic heart failure due to its non-selective beta-blocking properties and additional alpha-blocking effects, which can provide beneficial vasodilation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: These can reduce mortality in CHF patients&lt;/li&gt;&lt;li&gt;â€¢ Option D: These can reduce mortality in CHF patients&lt;/li&gt;&lt;li&gt;â€¢ Beta blockers have been shown to reduce mortality in patients with chronic heart failure. They help by reducing the heart rate, decreasing myocardial oxygen demand, and preventing the detrimental effects of chronic sympathetic nervous system activation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Beta blockers are crucial in managing chronic heart failure, started at low doses and titrated slowly to avoid acute decompensation. They are not used in acute decompensated heart failure but can reduce mortality in chronic heart failure patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pure action potential prolonging drug without any other effect on action potential is :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ibutilide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ibutilide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Ibutilide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Quinidine&lt;/li&gt;&lt;li&gt;â€¢ Option A: Quinidine&lt;/li&gt;&lt;li&gt;â€¢ Quinidine is a class IA antiarrhythmic drug that not only prolongs the action potential but also has effects on sodium channels, leading to a decrease in the slope of phase 0 (depolarization) of the action potential.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Option B: Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone is a class III antiarrhythmic drug that prolongs the action potential duration but also has multiple effects on sodium, potassium, and calcium channels, as well as adrenergic receptors, making its action more complex and not purely limited to action potential prolongation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lignocaine&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lignocaine&lt;/li&gt;&lt;li&gt;â€¢ Lignocaine (also known as Lidocaine) is a class IB antiarrhythmic drug that primarily shortens the action potential duration and has effects on sodium channels, leading to a decrease in the slope of phase 0 (depolarization) of the action potential.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ibutilide is a pure action potential prolonging drug, primarily affecting potassium channels without other significant effects on the action potential, unlike other antiarrhythmics like amiodarone, lignocaine and quinidine, which have multiple channel effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a first line anti-hypertensive drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Telmisartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metoprolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Metoprolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Enalapril&lt;/li&gt;&lt;li&gt;â€¢ Option A: Enalapril&lt;/li&gt;&lt;li&gt;â€¢ Enalapril is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors are commonly used as first-line agents in the management of hypertension due to their efficacy and benefits in reducing cardiovascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Telmisartan&lt;/li&gt;&lt;li&gt;â€¢ Option B: Telmisartan&lt;/li&gt;&lt;li&gt;â€¢ Telmisartan is an angiotensin II receptor blocker (ARB). ARBs are also considered first-line antihypertensive agents, particularly useful in patients who cannot tolerate ACE inhibitors.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Amlodipine&lt;/li&gt;&lt;li&gt;â€¢ Option D: Amlodipine&lt;/li&gt;&lt;li&gt;â€¢ Amlodipine is a calcium channel blocker (CCB). Calcium channel blockers are first-line antihypertensive agents due to their effectiveness in lowering blood pressure and their favourable safety profile.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Beta-blockers like metoprolol are not considered first-line therapy for hypertension unless there are specific indications such as heart failure or post-myocardial infarction. Diuretics, ACE inhibitors, ARBs, and calcium channel blockers are preferred first-line antihypertensive drugs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old obese man has extremely high plasma triglyceride levels, but cholesterol levels are within normal limits. Following treatment with a drug specifically indicated for hypertriglyceridemia, triglyceride levels decrease to almost normal. Which of the following agents is most likely to have caused this desired change?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholestyramine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ezitemibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fenofibrate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Fenofibrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Fenofibrate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Atorvastatin&lt;/li&gt;&lt;li&gt;â€¢ Option A: Atorvastatin&lt;/li&gt;&lt;li&gt;â€¢ Atorvastatin is an HMG-CoA reductase inhibitor (statin) primarily used to lower LDL cholesterol. While statins can modestly lower triglyceride levels, they are not the first choice for patients with isolated hypertriglyceridemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cholestyramine&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cholestyramine&lt;/li&gt;&lt;li&gt;â€¢ Cholestyramine is a bile acid sequestrant that primarily lowers LDL cholesterol. It is not effective for significantly lowering triglyceride levels and is not indicated for isolated hypertriglyceridemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Option C: Ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Ezetimibe is a cholesterol absorption inhibitor that primarily lowers LDL cholesterol by inhibiting the absorption of cholesterol in the small intestine. It does not have a significant effect on triglyceride levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fenofibrate is the drug of choice for the treatment of hypertriglyceridemia, effectively reducing plasma triglyceride levels by activating PPAR-Î± and increasing fatty acid oxidation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with angina is started on a nitroglycerin transdermal delivery system (â€œskin patchâ€) for prophylaxis of his angina. He wears the patch 24 h a day, 7 days a week, except for the few minutes when he showers each day. Which of the following is the main concern with â€œaround-the-clockâ€ administration of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyanide poisoning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Development of tolerance to their vasodilator actions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Onset of delayed, characteristic adverse responses including thrombosis and thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paradoxical vasoconstriction leading to hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Development of tolerance to their vasodilator actions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Development of tolerance to their vasodilator actions&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cyanide poisoning&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cyanide poisoning&lt;/li&gt;&lt;li&gt;â€¢ Cyanide poisoning is associated with the use of sodium nitroprusside, not nitroglycerine. Nitroglycerine does not release cyanide as a byproduct.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Onset of delayed, characteristic adverse responses including thrombosis and thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option C: Onset of delayed, characteristic adverse responses including thrombosis and thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ There is no significant association between nitroglycerine use and delayed adverse responses such as thrombosis or thrombocytopenia. These effects are not typical of nitroglycerine therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Paradoxical vasoconstriction leading to hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option D: Paradoxical vasoconstriction leading to hypertension&lt;/li&gt;&lt;li&gt;â€¢ Nitroglycerine does not cause paradoxical vasoconstriction or hypertension. Its primary action is vasodilation, and tolerance development does not lead to paradoxical vasoconstriction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Continuous, around-the-clock administration of nitroglycerine can lead to the development of tolerance, reducing the drug&#x27;s effectiveness in preventing angina attacks. It is important to have a nitrate-free interval to prevent tolerance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is WRONG about amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is longest acting anti-arrhythmic drug&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has positive inotropic action&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It contains iodine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It causes pulmonary fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It has positive inotropic action&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It has positive inotropic action&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is the longest acting anti-arrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is the longest acting anti-arrhythmic drug&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone has a very long half-life, often measured in weeks to months, making it one of the longest-acting antiarrhythmic drugs.&lt;/li&gt;&lt;li&gt;â€¢ Option C: It contains iodine&lt;/li&gt;&lt;li&gt;â€¢ Option C: It contains iodine&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone contains iodine in its molecular structure, which is partly responsible for its effects on thyroid function, potentially leading to either hypothyroidism or hyperthyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option D: It causes pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: It causes pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ One of the serious adverse effects of long-term amiodarone therapy is pulmonary fibrosis. This potentially life-threatening condition requires regular monitoring of pulmonary function in patients taking the drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone is a long-acting antiarrhythmic drug that contains iodine and can cause serious side effects like pulmonary fibrosis. It does not have a positive inotropic effect on the heart.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This drug is approved for treatment of angina pectoris as well as for CHF. Its primary action is to decrease heart rate without affecting the AV nodal conduction or ventricular contractility. It may produce adverse effects on the vision. Which drug is being discussed about?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Levosimendan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Omapatrilat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ARNI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ivabradine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ivabradine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Levosimendan&lt;/li&gt;&lt;li&gt;â€¢ Option B: Levosimendan&lt;/li&gt;&lt;li&gt;â€¢ Levosimendan enhances cardiac contractility by sensitizing troponin C to calcium and opening ATP-sensitive potassium channels. It is primarily used for acute decompensated heart failure. Although it can cause hypotension and arrhythmias, it does not lead to significant visual disturbances, distinguishing it from ivabradine.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Omapatrilat&lt;/li&gt;&lt;li&gt;â€¢ Option C: Omapatrilat&lt;/li&gt;&lt;li&gt;â€¢ Omapatrilat inhibits both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). It was investigated for heart failure and hypertension but is not widely approved due to safety concerns, particularly the risk of angioedema. Unlike ivabradine, omapatrilat does not cause visual disturbances.&lt;/li&gt;&lt;li&gt;â€¢ Option D: ARNI (Angiotensin Receptor-Neprilysin Inhibitor)&lt;/li&gt;&lt;li&gt;â€¢ Option D: ARNI (Angiotensin Receptor-Neprilysin Inhibitor)&lt;/li&gt;&lt;li&gt;â€¢ ARNI, such as sacubitril/valsartan, combines neprilysin inhibition with angiotensin II receptor blockade, promoting vasodilation, natriuresis, and inhibition of the renin-angiotensin-aldosterone system. It is approved for heart failure with reduced ejection fraction (HFrEF). Common adverse effects of ARNI include hypotension, hyperkalemia, and renal impairment, but visual disturbances are not a typical side effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ivabradine is used to treat angina and heart failure by decreasing heart rate through selective inhibition of the If current in the sinoatrial node, without affecting AV nodal conduction or ventricular contractility. It can cause visual disturbances as a notable side effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old patient with Parkinsonism, hypertension and past history of MI is taking several drugs including low dose aspirin, ramipril, nitroglycerine, atorvastatin and pramipexole, He complains of muscle aches, pain, and tenderness. These affect the legs and trunk. There is no fever, bruising, or any recent history of muscle trauma. There is myoglobinuria, a clinically significant fall of creatinine clearance, and a rise of serum creatine kinase (CK) to levels nearly 10 times the upper limit of normal. Which of the following drugs is the most likely cause of these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pramipexole to control his symptoms of Parkinsonism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ramipril for hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nitroglycerin, sublingual, for effort-induced angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atorvastatin to control his hypercholesterolemia and the associated risks&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Atorvastatin to control his hypercholesterolemia and the associated risks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Atorvastatin to control his hypercholesterolemia and the associated risks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pramipexole to control his symptoms of Parkinsonism&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pramipexole to control his symptoms of Parkinsonism&lt;/li&gt;&lt;li&gt;â€¢ Pramipexole, a dopamine agonist used to treat Parkinson&#x27;s disease, is not commonly associated with severe muscle-related side effects or rhabdomyolysis. Its side effects are more commonly related to the central nervous system, such as hallucinations and sleep disturbances.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ramipril for hypertension&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ramipril for hypertension&lt;/li&gt;&lt;li&gt;â€¢ Ramipril, an ACE inhibitor used to treat hypertension, does not typically cause muscle aches, myopathy, or rhabdomyolysis. Its common side effects include cough, hyperkalemia, and renal impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Nitroglycerine, sublingual, for effort-induced angina&lt;/li&gt;&lt;li&gt;â€¢ Option C: Nitroglycerine, sublingual, for effort-induced angina&lt;/li&gt;&lt;li&gt;â€¢ Nitroglycerine, a nitrate used for angina, is not associated with muscle-related side effects. It primarily causes vasodilation, which can lead to side effects like headaches, dizziness, and hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Statins, such as atorvastatin, are known to cause muscle-related side effects, including myopathy and rhabdomyolysis. Patients on statin therapy presenting with muscle pain, elevated CK levels, and myoglobinuria should be evaluated for statin-induced rhabdomyolysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are indications of nitrates except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse esophageal spasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute attack of angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supraventricular arrhythmia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biliary colic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Supraventricular arrhythmia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Supraventicular arrhythmia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diffuse esophageal spasm Nitrates are indicated for diffuse esophageal spasm because they help relax smooth muscle, alleviating the spasm and associated chest pain.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Diffuse esophageal spasm&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acute attack of angina&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acute attack of angina&lt;/li&gt;&lt;li&gt;â€¢ Nitrates are commonly used for the acute relief of angina pectoris. They act by dilating coronary arteries and reducing myocardial oxygen demand, providing rapid symptom relief.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Biliary colic&lt;/li&gt;&lt;li&gt;â€¢ Option D: Biliary colic&lt;/li&gt;&lt;li&gt;â€¢ Nitrates can be used for biliary colic as they relax the smooth muscle in the biliary tract, helping to alleviate the pain caused by biliary spasm.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nitrates are indicated for conditions involving smooth muscle spasm and angina due to their vasodilatory properties. They are not used to treat supraventricular arrhythmias, as their effects do not influence the electrical activity of the heart in a way that would manage these types of arrhythmias.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown as below. The effect of this new drug is most similar to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propanolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Encainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Procainamide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Procainamide&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Procainamide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Lignocaine&lt;/li&gt;&lt;li&gt;â€¢ Option A: Lignocaine&lt;/li&gt;&lt;li&gt;â€¢ Lignocaine is a class IB antiarrhythmic drug that primarily shortens the action potential duration and acts on ischemic or depolarized tissues. It does not prolong the action potential as depicted in the graph.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Propranolol&lt;/li&gt;&lt;li&gt;â€¢ Option B: Propranolol&lt;/li&gt;&lt;li&gt;â€¢ Propranolol is a class II antiarrhythmic (beta-blocker) that works by reducing sympathetic nervous system effects on the heart, decreasing heart rate and contractility. It does not have a significant effect on the action potential duration itself.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Encainide&lt;/li&gt;&lt;li&gt;â€¢ Option C: Encainide&lt;/li&gt;&lt;li&gt;â€¢ Encainide is a class IC antiarrhythmic that works by significantly slowing conduction through the heart without a significant effect on the action potential duration. It does not exhibit the action potential prolonging effects seen in the graph.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Class IA antiarrhythmic drugs like procainamide and quinidine, decrease the slope of phase 0 and prolong the action potential duration by blocking sodium and potassium channels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The following statement is NOT true about sotalol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a non-selective beta-blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It prolongs action potential duration of the heart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is primarily excreted through bile following hepatic metabolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can cause Torsadesâ€™de Pointes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is primarily excreted through bile following hepatic metabolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is primarily excreted through bile following hepatic metabolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a non-selective beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a non-selective beta-blocker&lt;/li&gt;&lt;li&gt;â€¢ Sotalol is indeed a non-selective beta-blocker, meaning it blocks both beta-1 and beta-2 adrenergic receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option B: It prolongs action potential duration of the heart&lt;/li&gt;&lt;li&gt;â€¢ Option B: It prolongs action potential duration of the heart&lt;/li&gt;&lt;li&gt;â€¢ Sotalol has class III antiarrhythmic properties, which means it prolongs the action potential duration and refractory period of cardiac cells by blocking potassium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D: It can cause Torsades de Pointes&lt;/li&gt;&lt;li&gt;â€¢ Option D: It can cause Torsades de Pointes&lt;/li&gt;&lt;li&gt;â€¢ One of the known adverse effects of sotalol is Torsades de Pointes, a specific type of polymorphic ventricular tachycardia associated with prolongation of the QT interval on the ECG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sotalol is a non-selective beta-blocker with class III antiarrhythmic properties that prolong the action potential duration of the heart. It is primarily excreted unchanged by the kidneys and can cause Torsades de Pointes due to its effect on the QT interval.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Na + channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac K + channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-1 adrenoceptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-adrenoceptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-1 adrenoceptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Beta-1 adrenoceptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cardiac Na+ channels&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cardiac Na+ channels&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone has some sodium channel blocking properties (class I antiarrhythmic effect), but timolol does not block cardiac sodium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cardiac K+ channels&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cardiac K+ channels&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone blocks cardiac potassium channels, leading to prolonged action potentials (class III antiarrhythmic effect), but timolol does not block potassium channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Alpha-adrenoceptors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Alpha-adrenoceptors&lt;/li&gt;&lt;li&gt;â€¢ Neither timolol nor amiodarone is known for blocking alpha-adrenoceptors as a primary therapeutic effect. Amiodarone has some weak alpha-blocking properties, but this is not a significant part of its clinical use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Both timolol, a non-selective beta-blocker, and amiodarone, a multi-class antiarrhythmic agent with beta-blocking properties, can block beta-1 adrenoceptors as part of their therapeutic actions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements about sampatrilat are true except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It inhibits both ACE as well as neprilysin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It can cause angioedema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can cause hypokalemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is used for treatment of CHF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It can cause hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It can cause hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It inhibits both ACE as well as neprilysin&lt;/li&gt;&lt;li&gt;â€¢ Option A: It inhibits both ACE as well as neprilysin&lt;/li&gt;&lt;li&gt;â€¢ Sampatrilat is known to inhibit both ACE and neprilysin, which helps in managing heart failure by reducing the breakdown of natriuretic peptides and angiotensin II.&lt;/li&gt;&lt;li&gt;â€¢ Option B: It can cause angioedema&lt;/li&gt;&lt;li&gt;â€¢ Option B: It can cause angioedema&lt;/li&gt;&lt;li&gt;â€¢ Similar to other ACE inhibitors, sampatrilat can cause angioedema, a potentially serious side effect related to increased bradykinin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D: It is used for treatment of CHF&lt;/li&gt;&lt;li&gt;â€¢ Option D: It is used for treatment of CHF&lt;/li&gt;&lt;li&gt;â€¢ Sampatrilat is used in the treatment of chronic heart failure (CHF) due to its dual inhibitory action on ACE and neprilysin, which helps to improve cardiac function and reduce symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sampatrilat is a dual inhibitor of ACE and neprilysin, used for the treatment of CHF. It can cause angioedema and hyperkalemia similar to other ACE inhibitors, but it does not cause hypokalemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You decide not to prescribe sildenafil in a patient because the patient told you that he is taking an antianginal drug. Which of the following can it be?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium channel blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta adrenergic blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Organic nitrates&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Angiotensin converting enzyme inhibitors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Organic nitrates&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Organic nitrates&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Calcium channel blockers&lt;/li&gt;&lt;li&gt;â€¢ Option A: Calcium channel blockers&lt;/li&gt;&lt;li&gt;â€¢ Calcium channel blockers are used as antianginal drugs, but they do not interact with sildenafil in a way that causes severe hypotension. Therefore, the use of calcium channel blockers does not contraindicate the prescription of sildenafil.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Beta adrenergic blockers&lt;/li&gt;&lt;li&gt;â€¢ Option B: Beta adrenergic blockers&lt;/li&gt;&lt;li&gt;â€¢ Beta adrenergic blockers are also used in the treatment of angina. They primarily work by reducing heart rate and myocardial oxygen demand. They do not have the same severe interaction with sildenafil as organic nitrates do.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Angiotensin converting enzyme inhibitors&lt;/li&gt;&lt;li&gt;â€¢ Option D: Angiotensin converting enzyme inhibitors&lt;/li&gt;&lt;li&gt;â€¢ ACE inhibitors are commonly used in treating hypertension and heart failure. They do not pose a significant risk of severe hypotension when used with sildenafil, unlike organic nitrates.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sildenafil should not be prescribed with organic nitrates due to the risk of severe hypotension. The combination of these drugs can cause a significant and potentially dangerous drop in blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Surinder singh developed acute CHF and was put on digitalis therapy. ECG of this patient revealed the presence of ventricular extrasystoles. Which of the following drugs can be administered safely to this patient in order to counteract this arrhythmia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lignocaine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Lignocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Quinidine&lt;/li&gt;&lt;li&gt;â€¢ Option B: Quinidine&lt;/li&gt;&lt;li&gt;â€¢ Quinidine is a class 1A antiarrhythmic drug. It is not preferred in digitalis-induced arrhythmias because it can enhance the effects of digitalis and potentially worsen the arrhythmia.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Option C: Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone is a class III antiarrhythmic drug that can be used in various types of arrhythmias, including ventricular arrhythmias. However, in the context of acute digitalis toxicity, lignocaine is typically preferred due to its specific safety profile and effectiveness.&lt;/li&gt;&lt;li&gt;â€¢ Option D: All of the above&lt;/li&gt;&lt;li&gt;â€¢ Option D: All of the above&lt;/li&gt;&lt;li&gt;â€¢ This is incorrect because not all the listed drugs are safe or appropriate for managing digitalis-induced ventricular arrhythmias. Lignocaine is the preferred choice due to its safety and efficacy in this specific scenario.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lignocaine is the preferred treatment for digitalis-induced ventricular arrhythmias due to its rapid action and effectiveness, without exacerbating heart failure. Other antiarrhythmic drugs like quinidine and amiodarone are not as safe in this context.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT an adverse effect of chronic amiodarone therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary Fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Systemic lupus erythematosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Systemic lupus erythematosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pulmonary Fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pulmonary Fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary fibrosis is a serious and well-documented adverse effect of chronic amiodarone therapy. It can be life-threatening and requires regular monitoring of lung function during treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hypothyroidism&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hypothyroidism&lt;/li&gt;&lt;li&gt;â€¢ Hypothyroidism is a common adverse effect of amiodarone because the drug contains iodine and can affect thyroid function. Regular thyroid function tests are recommended for patients on long-term amiodarone therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hyperthyroidism&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hyperthyroidism&lt;/li&gt;&lt;li&gt;â€¢ Hyperthyroidism can also occur as an adverse effect of amiodarone due to its high iodine content and its effects on thyroid hormone metabolism. This condition requires careful monitoring and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic amiodarone therapy is associated with adverse effects such as pulmonary fibrosis, hypothyroidism, and hyperthyroidism, but not typically with SLE. Regular monitoring of lung and thyroid function is crucial in patients receiving long-term amiodarone.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true about laropiprant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A bile acid sequestrant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A cholesterol absorption inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Has no hypolipidemic action, but combined with niacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MTP inhibitor used to decrease VLDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Has no hypolipidemic action, but combined with niacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Has no hypolipidemic action, but combined with niacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: A bile acid sequestrant&lt;/li&gt;&lt;li&gt;â€¢ Option A: A bile acid sequestrant&lt;/li&gt;&lt;li&gt;â€¢ Bile acid sequestrants are a class of drugs that bind bile acids in the intestine, preventing their reabsorption and thereby lowering cholesterol levels. Examples include cholestyramine, colestipol, and colesevelam. Laropiprant is not a bile acid sequestrant.&lt;/li&gt;&lt;li&gt;â€¢ Option B: A cholesterol absorption inhibitor&lt;/li&gt;&lt;li&gt;â€¢ Option B: A cholesterol absorption inhibitor&lt;/li&gt;&lt;li&gt;â€¢ Cholesterol absorption inhibitors, such as ezetimibe, work by preventing the absorption of cholesterol from the intestine, leading to lower blood cholesterol levels. Laropiprant is not a cholesterol absorption inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D: MTP inhibitor used to decrease VLDL&lt;/li&gt;&lt;li&gt;â€¢ Option D: MTP inhibitor used to decrease VLDL&lt;/li&gt;&lt;li&gt;â€¢ MTP (microsomal triglyceride transfer protein) inhibitors, like lomitapide, are used to decrease very-low-density lipoprotein (VLDL) and LDL cholesterol levels by inhibiting the assembly and secretion of lipoproteins. Laropiprant is not an MTP inhibitor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Laropiprant is used in combination with niacin to reduce niacin-induced flushing, improving the tolerability of niacin therapy, which is effective in managing dyslipidemia. It does not have hypolipidemic action on its own.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug can reduce LDL cholesterol independent of its effect on LDL receptor density?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atorvastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Evolocumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Evinacumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cholestyramine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Evinacumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Evinacumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Atorvastatin&lt;/li&gt;&lt;li&gt;â€¢ Option A: Atorvastatin&lt;/li&gt;&lt;li&gt;â€¢ Atorvastatin is a statin that reduces LDL cholesterol levels primarily by inhibiting HMG-CoA reductase, which leads to an upregulation of LDL receptors on hepatocytes, increasing the clearance of LDL from the bloodstream. Its effect is dependent on LDL receptor density.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Evolocumab&lt;/li&gt;&lt;li&gt;â€¢ Option B: Evolocumab&lt;/li&gt;&lt;li&gt;â€¢ Evolocumab is a PCSK9 inhibitor that lowers LDL cholesterol levels by increasing the number of LDL receptors available to clear LDL from the blood. It directly influences LDL receptor density.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cholestyramine&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cholestyramine&lt;/li&gt;&lt;li&gt;â€¢ Cholestyramine is a bile acid sequestrant that lowers LDL cholesterol by binding bile acids in the intestine, preventing their reabsorption. This leads to an increased conversion of cholesterol to bile acids in the liver, which indirectly increases LDL receptor expression to clear more LDL from the blood.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Evinacumab reduces LDL cholesterol levels independent of LDL receptor density by inhibiting ANGPTL3, making it effective in conditions where traditional LDL receptor-dependent therapies are less effective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An experimental drug is found to preferentially dilate small autoregulatory coronary arterioles without affecting large conducting vessels. It is likely to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Evoke coronary steal phenomenon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitigate classical angina but not variant angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Produce tachycardia as an adverse effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Useful in CHF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Evoke coronary steal phenomenon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Evoke coronary steal phenomenon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Mitigate classical angina but not variant angina&lt;/li&gt;&lt;li&gt;â€¢ Option B: Mitigate classical angina but not variant angina&lt;/li&gt;&lt;li&gt;â€¢ While preferential dilation of small coronary arterioles can theoretically improve blood flow to areas of the heart with atherosclerotic narrowing, it may not be as effective in mitigating classical angina as it does not address the underlying problem of fixed coronary obstruction effectively. Rather it may increase the frequency of anginal attacks due to coronary steal phenomenon. Variant (Prinzmetal&#x27;s) angina is caused by vasospasm of the coronary arteries, which involves both large and small vessels. Since the drug does not affect large conducting vessels, it would not be effective in relieving the vasospasm characteristic of variant angina.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Produce tachycardia as an adverse effect&lt;/li&gt;&lt;li&gt;â€¢ Option C: Produce tachycardia as an adverse effect&lt;/li&gt;&lt;li&gt;â€¢ Drugs that cause significant vasodilation can lead to reflex tachycardia as the body attempts to maintain blood pressure. However, this specific drug targets only the small coronary arterioles, and without systemic vasodilation, it is less likely to produce reflex tachycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Useful in CHF&lt;/li&gt;&lt;li&gt;â€¢ Option D: Useful in CHF&lt;/li&gt;&lt;li&gt;â€¢ In chronic heart failure (CHF), improving myocardial perfusion can be beneficial. However, for a drug to be useful in CHF, it generally needs to have systemic effects that reduce cardiac workload and improve overall hemodynamics. Preferential dilation of small coronary arterioles may improve local myocardial blood flow but is unlikely to provide significant benefit in the management of CHF, where broader systemic effects are often required.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drugs that preferentially dilate small autoregulatory coronary arterioles without affecting large conducting vessels can evoke the coronary steal phenomenon, where blood flow is diverted from ischemic to non-ischemic myocardial regions, potentially worsening ischemia. This selective action does not adequately address the mechanisms of classical or variant angina, nor does it provide comprehensive benefits for chronic heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test20" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 5 (Cns)   10 07 2023   2023 07 10&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 5 (Cns)   10 07 2023   2023 07 10&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Sonam, a 28-year-old woman with a known history of bipolar disorder, comes to her psychiatrist&#x27;s office for a regular check-up. She reveals that she and her partner are planning to start a family soon and are concerned about the potential effects of her current medication regimen on a developing fetus. The psychiatrist starts considering which medication could be safest for her during pregnancy. Which of the following drugs would be effective for bipolar disorder and could be considered relatively safe to continue during pregnancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Olanzapine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Olanzapine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Olanzapine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When considering the treatment of bipolar disorder during pregnancy, the safety profile of medications must be carefully evaluated. Olanzapine, an atypical antipsychotic, is considered relatively safer compared to lithium and valproate, which have higher teratogenic risks. Fluoxetine, while safer for treating depression during pregnancy, is not the first choice for bipolar disorder management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Raj Kumar, a 50-year-old patient with schizophrenia, has been stable on clozapine therapy for the last 3 years. His regular blood tests have been satisfactory and his plasma clozapine level remains within the therapeutic range. He has no other major health issues. Which of the following statements about clozapine is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clozapine is considered a last resort antipsychotic due to its risk of severe side effects.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Regular monitoring of total leucocyte count is recommended while patient is on clozapine therapy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The risk of agranulocytosis with clozapine is significantly high if plasma concentration exceeds 600 ng/mL.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clozapine is associated with an increased risk of cardiovascular disease.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The risk of agranulocytosis with clozapine is significantly high if plasma concentration exceeds 600 ng/mL.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The risk of agranulocytosis with clozapine is significantly high if plasma concentration exceeds 600 ng/mL.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Clozapine is an atypical antipsychotic reserved for treatment-resistant schizophrenia due to its risk of severe side effects, including agranulocytosis. Regular monitoring of total leukocyte count is essential to detect potential agranulocytosis early. However, the risk of agranulocytosis is dose independent. Clozapine is also associated with an increased risk of cardiovascular disease, requiring careful monitoring of patients for cardiovascular health.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are adverse effects associated with haloperidol except :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Akathisia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperprolactinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vomiting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Vomiting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Akathisia&lt;/li&gt;&lt;li&gt;â€¢ A. Akathisia&lt;/li&gt;&lt;li&gt;â€¢ Akathisia is a common adverse effect of haloperidol. It is characterized by a feeling of inner restlessness and an inability to stay still, often due to the drug&#x27;s D2 receptor blockade in the basal ganglia.&lt;/li&gt;&lt;li&gt;â€¢ B. Hyperprolactinemia&lt;/li&gt;&lt;li&gt;â€¢ B. Hyperprolactinemia&lt;/li&gt;&lt;li&gt;â€¢ Hyperprolactinemia is another adverse effect of haloperidol. This occurs because haloperidol blocks D2 receptors in the pituitary gland, leading to increased secretion of prolactin.&lt;/li&gt;&lt;li&gt;â€¢ D. Hypotension&lt;/li&gt;&lt;li&gt;â€¢ D. Hypotension&lt;/li&gt;&lt;li&gt;â€¢ Hypotension, particularly orthostatic hypotension, can occur with haloperidol use. This is due to its alpha-adrenergic blocking properties, which cause vasodilation and a subsequent drop in blood pressure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Haloperidol, a typical antipsychotic, can cause various adverse effects such as akathisia, hyperprolactinemia, and hypotension due to its pharmacological actions, including D2 receptor blockade. However, its D2 blocking action in the chemoreceptor trigger zone (CTZ) also provides antiemetic properties, making vomiting an unlikely adverse effect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following adverse effects of levodopa is not decreased by the addition of carbidopa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nausea and vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Orthostatic hypotension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiac arrhythmias&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hallucinations&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hallucinations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hallucinations&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Nausea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ A. Nausea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ Carbidopa helps reduce nausea and vomiting by preventing the peripheral conversion of levodopa to dopamine, which can stimulate the chemoreceptor trigger zone and induce these symptoms.&lt;/li&gt;&lt;li&gt;â€¢ B. Orthostatic hypotension&lt;/li&gt;&lt;li&gt;â€¢ B. Orthostatic hypotension&lt;/li&gt;&lt;li&gt;â€¢ Carbidopa can reduce orthostatic hypotension by minimizing the peripheral conversion of levodopa to dopamine, which can lead to vasodilation and blood pressure changes.&lt;/li&gt;&lt;li&gt;â€¢ C. Cardiac arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ C. Cardiac arrhythmias&lt;/li&gt;&lt;li&gt;â€¢ Carbidopa reduces the risk of cardiac arrhythmias by decreasing the peripheral formation of dopamine, which can affect cardiac conduction.&lt;/li&gt;&lt;li&gt;â€¢ D. Hallucinations&lt;/li&gt;&lt;li&gt;â€¢ D. Hallucinations&lt;/li&gt;&lt;li&gt;â€¢ Hallucinations are due to increased dopamine levels in the central nervous system. Since carbidopa does not cross the blood-brain barrier, it cannot mitigate this central side effect of levodopa.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ The addition of carbidopa to levodopa therapy helps reduce peripheral side effects such as nausea, vomiting, orthostatic hypotension, and cardiac arrhythmias by inhibiting the peripheral conversion of levodopa to dopamine. However, carbidopa does not cross the blood-brain barrier and therefore does not reduce central nervous system side effects like hallucinations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Entacapone may be useful in patients being treated with levodopa-carbidopa combination because it:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Activates COMT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreases the formation of 3-O-Methyl Dopa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibits monoamine oxidase type B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibits dopamine uptake&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreases the formation of 3-O-Methyl Dopa&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Decreases the formation of 3-O-Methyl Dopa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Activates COMT&lt;/li&gt;&lt;li&gt;â€¢ A. Activates COMT&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Entacapone does not activate COMT; instead, it inhibits the COMT enzyme, reducing the metabolism of levodopa.&lt;/li&gt;&lt;li&gt;â€¢ C. Inhibits monoamine oxidase type B&lt;/li&gt;&lt;li&gt;â€¢ C. Inhibits monoamine oxidase type B&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Entacapone does not inhibit monoamine oxidase type B (MAO-B). MAO-B inhibitors, such as selegiline and rasagiline, are different classes of drugs used in Parkinson&#x27;s disease management.&lt;/li&gt;&lt;li&gt;â€¢ D. Inhibits dopamine uptake&lt;/li&gt;&lt;li&gt;â€¢ D. Inhibits dopamine uptake&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Entacapone does not inhibit dopamine uptake. Its primary action is the inhibition of the COMT enzyme to prolong the effect of levodopa.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Entacapone is beneficial for patients being treated with a levodopa-carbidopa combination because it inhibits the enzyme catechol-O-methyltransferase (COMT). This inhibition reduces the peripheral conversion of levodopa to 3-O-methyldopa, thereby increasing the availability of levodopa for uptake into the central nervous system. This mechanism enhances the therapeutic effects of levodopa by ensuring more of it is available to be converted to dopamine in the brain, which is crucial for alleviating the motor symptoms of Parkinson&#x27;s disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A large number of deaths of drug abusers were reported who had purchased and self-administered illicit drugs that contained lethal amounts of fentanyl. One patient who received this fentanyl-laced drug presents in your emergency department, barely alive. Which of the following drugs should you administer first, with the best hope that it can promptly reverse the lethal effects of the fentanyl?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Naloxone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fomepizole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Naloxone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Naloxone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ B. Diazepam&lt;/li&gt;&lt;li&gt;â€¢ B. Diazepam&lt;/li&gt;&lt;li&gt;â€¢ Diazepam is a benzodiazepine used primarily for its anxiolytic, muscle relaxant, and anticonvulsant properties. It does not counteract the effects of opioids like fentanyl and is not suitable for reversing opioid overdose.&lt;/li&gt;&lt;li&gt;â€¢ C. Flumazenil&lt;/li&gt;&lt;li&gt;â€¢ C. Flumazenil&lt;/li&gt;&lt;li&gt;â€¢ Flumazenil is a benzodiazepine antagonist used to reverse the effects of benzodiazepines. It has no effect on opioid receptors and therefore cannot reverse the effects of fentanyl.&lt;/li&gt;&lt;li&gt;â€¢ D. Fomepizole&lt;/li&gt;&lt;li&gt;â€¢ D. Fomepizole&lt;/li&gt;&lt;li&gt;â€¢ Fomepizole is an antidote for methanol and ethylene glycol poisoning. It inhibits the enzyme alcohol dehydrogenase, preventing the formation of toxic metabolites. It does not interact with opioid receptors and is not useful in treating opioid overdose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In cases of opioid overdose, particularly with potent opioids like fentanyl, the first line of treatment is the administration of naloxone. Naloxone is an opioid antagonist that effectively and rapidly reverses the life-threatening effects of opioid overdose, including respiratory depression and sedation. Other drugs such as diazepam, flumazenil, and fomepizole are not effective in treating opioid overdose, as they do not target opioid receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Relative intensities of blocking effect (represented by +) of four drugs on different receptors is Which drug is MOST LIKELY to exacerbate the symptoms of Parkinsonism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Drug A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Drug B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Drug D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture38.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Drug D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Drug A&lt;/li&gt;&lt;li&gt;â€¢ A. Drug A&lt;/li&gt;&lt;li&gt;â€¢ Drug A blocks Î²1 (++) and M1 (+++) receptors, as well as D2 receptors (+++). While it does block D2 receptors, which could exacerbate Parkinsonism, it also blocks M1 receptors. Blocking M1 receptors can help to mitigate some of the cholinergic overactivity, potentially balancing the dopaminergic-cholinergic activity. Thus, Drug A is less likely to exacerbate Parkinsonism compared to Drug D.&lt;/li&gt;&lt;li&gt;â€¢ B. Drug B&lt;/li&gt;&lt;li&gt;â€¢ B. Drug B&lt;/li&gt;&lt;li&gt;â€¢ Drug B primarily affects GABAA receptors (++++) and does not block D2 or M1 receptors. Since it does not interfere with dopaminergic or cholinergic pathways, it is unlikely to impact Parkinsonism symptoms.&lt;/li&gt;&lt;li&gt;â€¢ C. Drug C&lt;/li&gt;&lt;li&gt;â€¢ C. Drug C&lt;/li&gt;&lt;li&gt;â€¢ Drug C has a strong blocking effect on M1 receptors (++++), and a minimal effect on D2 receptors (+). The blockade of M1 receptors can help to reduce cholinergic activity, which is beneficial in managing Parkinsonism. The minimal D2 receptor blockade makes it less likely to exacerbate Parkinsonism compared to Drug D.&lt;/li&gt;&lt;li&gt;â€¢ D. Drug D&lt;/li&gt;&lt;li&gt;â€¢ D. Drug D&lt;/li&gt;&lt;li&gt;â€¢ Drug D primarily blocks D2 receptors with a high intensity (++++), which significantly exacerbates the dopamine deficiency in Parkinsonism, thereby worsening the symptoms. Its minor activities on Î²1 and GABAA receptors do not counteract the strong D2 blockade.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In Parkinsonism, there is a critical balance between dopaminergic and cholinergic activity. The disease is characterized by a deficiency in dopamine, leading to an imbalance favouring cholinergic activity. Drugs that block D2 receptors can exacerbate this dopamine deficiency, worsening parkinsonian symptoms. Conversely, blocking muscarinic (M1) receptors can help reduce cholinergic overactivity, potentially improving symptoms. Therefore, drugs that strongly block D2 receptors, such as Drug D, are more likely to worsen Parkinsonism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Researchers are conducting an experimental study on rats to understand the effects of naloxone, an opioid antagonist, on different opioids. The rats were tested with tail flick test, a model to test analgesic effect of drugs. After giving all opioids, there is increase in duration in tail flick test signifying the analgesic effect. Post-administration, all the rats are given naloxone to assess the extent to which naloxone can reverse the analgesic effects of different opioids. Interestingly, the researchers notice that, in the one group of rats, the analgesic effects are not completely reversed by naloxone. Based on this observation, which of the following opioid is being given to this group?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tramadol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pethidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alfentanil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tramadol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Tramadol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Pethidine (Meperidine)&lt;/li&gt;&lt;li&gt;â€¢ B. Pethidine (Meperidine)&lt;/li&gt;&lt;li&gt;â€¢ Pethidine is a synthetic opioid that acts primarily on opioid receptors. Its analgesic effects are typically reversed by naloxone, as it does not have significant non-opioid mechanisms.&lt;/li&gt;&lt;li&gt;â€¢ C. Morphine&lt;/li&gt;&lt;li&gt;â€¢ C. Morphine&lt;/li&gt;&lt;li&gt;â€¢ Morphine is a pure opioid agonist, and its analgesic effects are fully mediated through opioid receptors. Naloxone effectively reverses the analgesic effects of morphine.&lt;/li&gt;&lt;li&gt;â€¢ D. Alfentanil&lt;/li&gt;&lt;li&gt;â€¢ D. Alfentanil&lt;/li&gt;&lt;li&gt;â€¢ Alfentanil is a potent opioid analgesic that acts primarily through opioid receptors. Naloxone effectively reverses its analgesic effects as well.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Tramadol has a unique dual mechanism of action, functioning as both a weak opioid agonist and an inhibitor of norepinephrine and serotonin reuptake. This means that its analgesic effects are only partially reversed by naloxone, which targets opioid receptors but does not counteract the neurotransmitter reuptake inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug is used for management of treatment resistant depression and is given by intranasal route?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Venlafaxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esketamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Samidorphan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brexanolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Esketamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Esketamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Venlafaxine&lt;/li&gt;&lt;li&gt;â€¢ A. Venlafaxine&lt;/li&gt;&lt;li&gt;â€¢ Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder, generalized anxiety disorder, and panic disorder. It is not administered intranasally and is taken orally.&lt;/li&gt;&lt;li&gt;â€¢ C. Samidorphan&lt;/li&gt;&lt;li&gt;â€¢ C. Samidorphan&lt;/li&gt;&lt;li&gt;â€¢ Samidorphan is an opioid receptor antagonist that is often combined with other medications, such as buprenorphine, to treat certain psychiatric conditions. It is not used intranasally for treatment-resistant depression.&lt;/li&gt;&lt;li&gt;â€¢ D. Brexanolone&lt;/li&gt;&lt;li&gt;â€¢ D. Brexanolone&lt;/li&gt;&lt;li&gt;â€¢ Brexanolone is a neuroactive steroid used for the treatment of postpartum depression. It is administered as an intravenous infusion, not intranasally.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Esketamine, administered via the intranasal route, is an effective treatment for treatment-resistant depression, offering a rapid onset of action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 14-year-old boy is brought to the emergency by her mother, who has observed that he has abruptly experienced frequent impairments of consciousness associated with episodes of staring into space lasting approximately 30s. EEG of the girl reveals 3 spikes per wave pattern. With which of the following drugs should we start treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Valproate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Valproate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Diazepam&lt;/li&gt;&lt;li&gt;â€¢ B. Diazepam&lt;/li&gt;&lt;li&gt;â€¢ Diazepam is a benzodiazepine used primarily for acute seizure management and status epilepticus, not for chronic management of absence seizures.&lt;/li&gt;&lt;li&gt;â€¢ C. Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ C. Carbamazepine&lt;/li&gt;&lt;li&gt;â€¢ Carbamazepine is not effective for absence seizures and may even exacerbate them. It is typically used for focal seizures and generalized tonic-clonic seizures.&lt;/li&gt;&lt;li&gt;â€¢ D. Phenytoin&lt;/li&gt;&lt;li&gt;â€¢ D. Phenytoin&lt;/li&gt;&lt;li&gt;â€¢ Phenytoin is effective for focal and generalized tonic-clonic seizures but is not effective for absence seizures and may exacerbate them.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ The first-line treatment for absence seizures, characterized by frequent episodes of impaired consciousness and a 3 Hz spike-and-wave EEG pattern, is typically valproate or ethosuximide. Valproate is effective in reducing the frequency and severity of absence seizures, making it an appropriate choice for initiating treatment in a patient presenting with these symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about vigabatrin is FALSE:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by inhibiting the enzyme GABA transaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is utilized for treatment of infantile spasms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can cause visual field contraction as an adverse effect.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is a competitive antagonist of GABA-A receptors&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is a competitive antagonist of GABA-A receptors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It is a competitive antagonist of GABA-A receptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Vigabatrin is an anticonvulsant that acts by inhibiting the enzyme GABA transaminase, thereby increasing the levels of GABA in the brain. It is used in the treatment of infantile spasms and can cause visual field contraction as an adverse effect. It is not a competitive antagonist of GABA-A receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year old epileptic female was stabilized on phenytoin therapy since 2 years. Recently she presented with weakness and fatigue. She appears pale and pulse was rapid. Her hemogram reveals: Hb = 4.6 g% TLC = 7000/mm 3 Platelet count = 180000/mm 3 MCV = 76 fl MCH = 24 pg/dl How will you proceed for the management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start folic acid as it is likely to be phenytoin induced megaloblastic anemia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stop phenytoin and start some other antiepileptic drug as it is phenytoin induced agranulocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give vitamin B 12 injections as it is likely to be phenytoin induced megaloblastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Investigate on the line of iron deficiency anemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Investigate on the line of iron deficiency anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Investigateon the line of iron deficiency anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Start folic acid as it is likely to be phenytoin induced megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ A. Start folic acid as it is likely to be phenytoin induced megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ While phenytoin can cause folic acid deficiency leading to megaloblastic anemia, the patient&#x27;s laboratory findings suggest microcytic hypochromic anemia (low MCV and low MCH), which is not consistent with megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ B. Stop phenytoin and start some other antiepileptic drug as it is phenytoin induced agranulocytosis.&lt;/li&gt;&lt;li&gt;â€¢ B. Stop phenytoin and start some other antiepileptic drug as it is phenytoin induced agranulocytosis.&lt;/li&gt;&lt;li&gt;â€¢ Agranulocytosis would present with a significantly low total leukocyte count (TLC), but the patient&#x27;s TLC is within normal limits (7000/mm3). Therefore, this diagnosis is not supported by the lab results.&lt;/li&gt;&lt;li&gt;â€¢ C. Give vitamin B12 injections as it is likely to be phenytoin induced megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ C. Give vitamin B12 injections as it is likely to be phenytoin induced megaloblastic anemia.&lt;/li&gt;&lt;li&gt;â€¢ Vitamin B12 deficiency also typically results in macrocytic anemia, not microcytic hypochromic anemia, which is indicated by the patient&#x27;s MCV and MCH values.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ When evaluating a patient with anemia, it is crucial to interpret laboratory findings such as hemoglobin, MCV, and MCH to determine the type of anemia. Microcytic hypochromic anemia, indicated by low MCV and MCH, typically points towards iron deficiency anemia. Treatment should be directed based on the specific type of anemia diagnosed through these lab values.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statement regarding effect of opioids on pupil is CORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eye drops of a lipid soluble opioid like fentanyl can produce miosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tolerance occurs commonly to opioid induced miosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Systemic overdose of morphine can produce pin point pupil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Systemic overdose of morphine can produce pin point pupil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Systemic overdose of morphine can produce pin point pupil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Eye drops of a lipid soluble opioid like fentanyl can produce miosis.&lt;/li&gt;&lt;li&gt;â€¢ A. Eye drops of a lipid soluble opioid like fentanyl can produce miosis.&lt;/li&gt;&lt;li&gt;â€¢ While systemic administration of opioids causes miosis, the use of eye drops of even a highly lipid-soluble opioid like fentanyl is unlikely to produce miosis. The central action on the Edinger-Westphal nucleus is crucial for this effect, which is not typically achieved through topical application.&lt;/li&gt;&lt;li&gt;â€¢ B. Tolerance occurs commonly to opioid induced miosis.&lt;/li&gt;&lt;li&gt;â€¢ B. Tolerance occurs commonly to opioid induced miosis.&lt;/li&gt;&lt;li&gt;â€¢ Tolerance to the miotic effect of opioids is rare. Unlike other effects of opioids, such as analgesia and euphoria, the miotic effect remains consistent even with chronic use. This is because the central stimulation of the Edinger-Westphal nucleus does not exhibit tolerance as other opioid effects do.&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect because statements A and B are not accurate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Opioids cause miosis by stimulating the Edinger-Westphal nucleus in the brainstem, leading to increased parasympathetic activity and pupil constriction. This central mechanism is responsible for the pinpoint pupils seen in opioid overdose. Unlike other opioid effects, tolerance to this miotic effect is uncommon.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following limitations of typical tricyclic antidepressants have been overcome by selective serotonin reuptake inhibitors EXCEPT :&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anticholinergic, sedative and hypotensive adverse effects&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Delayed response&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High risk of cardiac arrhythmias and seizures in overdose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Risk of weight gain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Delayed response&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Delayed response&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Anticholinergic, sedative and hypotensive adverse effects&lt;/li&gt;&lt;li&gt;â€¢ A. Anticholinergic, sedative and hypotensive adverse effects&lt;/li&gt;&lt;li&gt;â€¢ SSRIs generally have fewer anticholinergic, sedative, and hypotensive adverse effects compared to TCAs. This is because SSRIs specifically target serotonin reuptake without significantly affecting other neurotransmitter systems like acetylcholine, histamine, and norepinephrine.&lt;/li&gt;&lt;li&gt;â€¢ C. High risk of cardiac arrhythmias and seizures in overdose&lt;/li&gt;&lt;li&gt;â€¢ C. High risk of cardiac arrhythmias and seizures in overdose&lt;/li&gt;&lt;li&gt;â€¢ SSRIs have a much lower risk of causing cardiac arrhythmias and seizures in overdose compared to TCAs. TCAs can be particularly dangerous in overdose due to their effects on cardiac ion channels, which can lead to life-threatening arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ D. Risk of weight gain&lt;/li&gt;&lt;li&gt;â€¢ D. Risk of weight gain&lt;/li&gt;&lt;li&gt;â€¢ SSRIs are less likely to cause weight gain compared to TCAs. While some patients on SSRIs may still experience weight changes, the risk is generally lower than with TCAs, which often cause significant weight gain due to their antihistaminic and anticholinergic effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Selective serotonin reuptake inhibitors (SSRIs) have improved upon many limitations of tricyclic antidepressants (TCAs) by reducing the risk of anticholinergic, sedative, hypotensive effects, cardiac arrhythmias, and seizures in overdose, as well as decreasing the risk of weight gain. However, both SSRIs and TCAs share the limitation of a delayed therapeutic response, typically requiring several weeks of treatment before significant clinical improvement is observed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young woman is taken to the emergency department by some of her friends. It seems they were out on â€œbar nightâ€ and someone mixed something into her alcoholic beverage She is now extraordinarily drowsy and has little recall of what happened between the time she sipped her drink and now. Which of the following is the likely substance mixed in her drink?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flunitrazepam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flumazenil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fentanyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenobarbitone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Flunitrazepam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Flunitrazepam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ B. Flumazenil&lt;/li&gt;&lt;li&gt;â€¢ B. Flumazenil&lt;/li&gt;&lt;li&gt;â€¢ Flumazenil is a benzodiazepine antagonist used to reverse the effects of benzodiazepines. It is not a sedative or a substance that would be mixed into a drink to cause drowsiness and memory loss.&lt;/li&gt;&lt;li&gt;â€¢ C. Fentanyl&lt;/li&gt;&lt;li&gt;â€¢ C. Fentanyl&lt;/li&gt;&lt;li&gt;â€¢ Fentanyl is a potent opioid analgesic. While it can cause sedation and respiratory depression, it is less commonly associated with drug-facilitated assault due to its primary medical use and risk of severe overdose and death.&lt;/li&gt;&lt;li&gt;â€¢ D. Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ D. Phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ Phenobarbitone (phenobarbital) is a barbiturate that can cause sedation and drowsiness. However, it is less commonly used as a drug to facilitate assault due to its slower onset and prolonged duration of action compared to benzodiazepines like flunitrazepam.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Flunitrazepam, a potent benzodiazepine, is commonly associated with drug-facilitated sexual assault due to its sedative and amnestic effects. Recognizing the symptoms of flunitrazepam ingestion, such as extreme drowsiness and anterograde amnesia, is crucial for timely and appropriate medical intervention in suspected cases of drug-facilitated assault.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient Rajnish having depressive disorder has taken 25 times the normal dose of amitriptyline. Which of the following is not likely to be observed in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coma and shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hot dry skin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pinpoint pupil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pinpoint pupil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Pinpoint pupil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Coma and shock&lt;/li&gt;&lt;li&gt;â€¢ A. Coma and shock&lt;/li&gt;&lt;li&gt;â€¢ These are common findings in TCA overdose. The drug&#x27;s central nervous system depressant effects can lead to coma, and cardiotoxic effects can cause shock.&lt;/li&gt;&lt;li&gt;â€¢ B. Hot dry skin&lt;/li&gt;&lt;li&gt;â€¢ B. Hot dry skin&lt;/li&gt;&lt;li&gt;â€¢ Hot dry skin is a result of the anticholinergic properties of TCAs, which inhibit sweating and cause skin dryness and warmth.&lt;/li&gt;&lt;li&gt;â€¢ D. Hypotension&lt;/li&gt;&lt;li&gt;â€¢ D. Hypotension&lt;/li&gt;&lt;li&gt;â€¢ Hypotension is a common and serious effect of TCA overdose, often due to peripheral vasodilation and direct cardiotoxic effects on the heart.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ In the case of tricyclic antidepressant (TCA) overdose, such as with amitriptyline, patients may present with symptoms due to the drug&#x27;s anticholinergic and cardiotoxic properties, including coma, shock, hot dry skin, and hypotension. However, pinpoint pupils are not characteristic of TCA overdose; instead, dilated pupils are more commonly observed due to the anticholinergic effects. Recognizing these symptoms is crucial for diagnosing and managing TCA overdose effectively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The combination of alcohol and disulfiram results in nausea, vomiting, abdominal pain and hypotension as a result of accumulation of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methanol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetaldehyde&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NADH&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acetaldehyde&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Acetaldehyde&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Acetate&lt;/li&gt;&lt;li&gt;â€¢ A. Acetate&lt;/li&gt;&lt;li&gt;â€¢ Acetate is the product of the metabolism of acetaldehyde by aldehyde dehydrogenase. Since disulfiram inhibits this enzyme, acetate does not accumulate.&lt;/li&gt;&lt;li&gt;â€¢ B. Methanol&lt;/li&gt;&lt;li&gt;â€¢ B. Methanol&lt;/li&gt;&lt;li&gt;â€¢ Methanol is a different type of alcohol and is not related to the metabolic pathway of ethanol or the effects of disulfiram.&lt;/li&gt;&lt;li&gt;â€¢ D. NADH&lt;/li&gt;&lt;li&gt;â€¢ D. NADH&lt;/li&gt;&lt;li&gt;â€¢ NADH is a coenzyme involved in various metabolic processes, including alcohol metabolism, but its accumulation is not the primary cause of the disulfiram-alcohol reaction symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The combination of alcohol and disulfiram leads to the accumulation of acetaldehyde due to the inhibition of aldehyde dehydrogenase. This accumulation causes adverse reactions like nausea, vomiting, abdominal pain, and hypotension, which are meant to deter alcohol consumption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding sedative hypnotic drugs is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Benzodiazepines exhibit a steeper dose response relationship as compared to barbiturates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Barbiturates may increase the half-lives of drugs metabolized by the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alkalization of the urine will accelerate the elimination of phenobarbitone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory depression caused by barbiturate overdosage can be reversed by flumazenil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alkalization of the urine will accelerate the elimination of phenobarbitone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alkalizatoin of the urine will accelerate the elimination of phenobarbitone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of All Options:&lt;/li&gt;&lt;li&gt;â€¢ a. Benzodiazepines exhibit a steeper dose response relationship as compared to barbiturates&lt;/li&gt;&lt;li&gt;â€¢ a. Benzodiazepines exhibit a steeper dose response relationship as compared to barbiturates&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Barbiturates exhibit a steeper dose-response curve compared to benzodiazepines. This means that small increases in the dose of barbiturates can lead to significant increases in their effect, which can quickly progress from sedation to hypnosis to anesthesia and, eventually, to fatal respiratory depression. In contrast, benzodiazepines have a flatter dose-response curve, making them safer because they have a higher therapeutic index and a ceiling effect on CNS depression.&lt;/li&gt;&lt;li&gt;â€¢ b. Barbiturates may increase the half-lives of drugs metabolized by the liver&lt;/li&gt;&lt;li&gt;â€¢ b. Barbiturates may increase the half-lives of drugs metabolized by the liver&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Barbiturates are known to induce hepatic enzymes, which can lead to increased metabolism of drugs processed by the liver. This enzyme induction typically decreases the half-lives of these drugs, not increases them. The increased enzyme activity enhances the breakdown and clearance of the drugs.&lt;/li&gt;&lt;li&gt;â€¢ c. Alkalization of the urine will accelerate the elimination of phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ c. Alkalization of the urine will accelerate the elimination of phenobarbitone&lt;/li&gt;&lt;li&gt;â€¢ This statement is correct. Phenobarbital (phenobarbitone) is a weak acid, and its elimination can be enhanced by alkalinizing the urine. This process increases the ionization of phenobarbital, reducing its reabsorption in the renal tubules and thereby increasing its excretion.&lt;/li&gt;&lt;li&gt;â€¢ d. Respiratory depression caused by barbiturate overdosage can be reversed by flumazenil&lt;/li&gt;&lt;li&gt;â€¢ d. Respiratory depression caused by barbiturate overdosage can be reversed by flumazenil&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Flumazenil is a benzodiazepine receptor antagonist and is used to reverse the effects of benzodiazepines. It does not have any effect on barbiturates and cannot reverse barbiturate-induced respiratory depression. Treatment of barbiturate overdose typically involves supportive care, including mechanical ventilation if necessary, and measures to enhance drug elimination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the pharmacokinetics and pharmacodynamics of sedative-hypnotic drugs, including differences in dose-response relationships, the impact of hepatic enzyme induction, and methods to enhance drug elimination, is crucial for safe and effective management of these medications. It is important to remember that barbiturates have a steeper dose-response curve compared to benzodiazepines and induce hepatic enzymes, decreasing the half-lives of other drugs. Alkalization of urine accelerates the elimination of acidic drugs like phenobarbitone. Flumazenil reverses benzodiazepine, not barbiturate, overdose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Therapeutic plasma concentration of phenytoin should be maintained between 10-20 mcg/dl. A patient on anti-epileptic drug therapy has plasma phenytoin level of 36 mcg/dl. Which of the following adverse effect is likely to be seen at this high plasma drug concentration of phenytoin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hirsutism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gum hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ataxia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ataxia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ B. Hirsutism&lt;/li&gt;&lt;li&gt;â€¢ B. Hirsutism&lt;/li&gt;&lt;li&gt;â€¢ Hirsutism is a potential side effect of phenytoin, but it typically develops with long-term use rather than from acute high plasma concentrations.&lt;/li&gt;&lt;li&gt;â€¢ C. Gum hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ C. Gum hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ Gum hyperplasia is another well-known side effect of long-term phenytoin therapy, but it is not specifically related to acute high plasma levels.&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;li&gt;â€¢ This option is incorrect because, while hirsutism and gum hyperplasia can occur with phenytoin use, they are associated with chronic use and not specifically with acutely high plasma levels like ataxia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that acute high plasma concentrations of phenytoin can lead to cardiac side effects like arrhthmias and neurological side effects such as ataxia, while other adverse effects like hirsutism and gum hyperplasia are more commonly associated with long-term therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Use of morphine should be avoided in all of the following patients EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ischemic heart disease patients&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchial asthma patients&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patients with head injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biliary colic patients&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ischemic heart disease patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ischemic heart disease patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Bronchial asthma patients&lt;/li&gt;&lt;li&gt;â€¢ B. Bronchial asthma patients&lt;/li&gt;&lt;li&gt;â€¢ Morphine should be avoided in patients with bronchial asthma because it can cause histamine release, leading to bronchoconstriction and exacerbation of asthma symptoms.&lt;/li&gt;&lt;li&gt;â€¢ C. Patients with head injury&lt;/li&gt;&lt;li&gt;â€¢ C. Patients with head injury&lt;/li&gt;&lt;li&gt;â€¢ Morphine is contraindicated in patients with head injury because it can increase intracranial pressure, which can worsen the patient&#x27;s condition and obscure the clinical assessment of neurological status.&lt;/li&gt;&lt;li&gt;â€¢ D. Biliary colic patients&lt;/li&gt;&lt;li&gt;â€¢ D. Biliary colic patients&lt;/li&gt;&lt;li&gt;â€¢ Morphine should be avoided in patients with biliary colic as it can cause spasm of the sphincter of Oddi, worsening the pain and potentially complicating the condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Morphine is a potent opioid analgesic used for pain management. It is particularly beneficial in ischemic heart disease patients due to its analgesic and anxiolytic properties, which help reduce myocardial oxygen demand. However, it should be avoided in patients with bronchial asthma due to the risk of bronchoconstriction, in head injury patients due to the potential increase in intracranial pressure, and in biliary colic patients due to the risk of spasm of the sphincter of Oddi.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test21" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 6 (Endocrine)   24 07 2023   2023 07 24&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 6 (Endocrine)   24 07 2023   2023 07 24&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A young married couple has been trying to have a child for four years, but without success despite not using any contraceptives. The husband&#x27;s sperm count is within the normal range. The doctor advised the wife to undergo treatment to enhance fertility. Among the options below, which drug can either stimulate or inhibit ovulation, depending solely on how it&#x27;s scheduled to be taken?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Letrozole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clomiphene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leuprolide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Human chorionic gonadotropin (hCG)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Leuprolide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Leuprolide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old individual named Suresh, who has been diagnosed with insulin-dependent diabetes mellitus, has been prescribed insulin therapy. The discomfort from the injections has become unbearable for him, leading him to attempt consuming the insulin orally from the vial that was initially intended for subcutaneous injection. What is the most likely consequence of his action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrointestinal upset&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic high blood sugar levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kidney failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chronic high blood sugar levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Chronic high blood sugar levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Anil, a 63-year-old male with diabetes, currently on sitagliptin, presents to OPD of GTB hospital with complaints of recurring instances of sinusitis and a sore throat. His fasting blood glucose level is 96 mg/dL. What is the most plausible explanation for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypersensitivity to environmental allergens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acid reflux from the stomach&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Side effect related to his medication&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nasal polyp&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Side effect related to his medication&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Side effect related to his medication&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman, diagnosed with osteoporosis, is visiting her doctor for a standard check-up. She is currently taking risedronate. What is the mechanism of action of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of osteocyte activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibition of enzymes involved in mevalonate pathway of cholesterol biosynthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stimulation of osteoblasts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of apoptosis of osteoclasts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inhibition of enzymes involved in mevalonate pathway of cholesterol biosynthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/whatsapp-image-2023-07-22-at-51729-pm.jpeg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inhibition of enzymes involved in mevalonate pathway of cholesterol biosynthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Considering the standard roles of triiodothyronine (T3) and thyroxine (T4) in a young female presenting with hypothyroidism, which of the following assertions is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The absorption of T3 is reduced by food consumption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The hormones are broken down through the microsomal P450 system&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenytoin slows down the metabolism of thyroid hormones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampin slows down the metabolism of thyroid hormones&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The hormones are broken down through the microsomal P450 system&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. The hormones are broken down through the microsomal P450 system&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old boy sustains a shoulder injury in a road side accident. Despite using the NSAIDs, he&#x27;s still struggling with pain and swelling. When he enquires about glucocorticoid injections, his doctor begins discussing the wide range of glucocorticoid effects on the body. In what ways could glucocorticoids potentially assist this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reducing the activity of phospholipase A2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enhancing healing through increased collagen production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increasing blood flow via vasodilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Reducing the activity of phospholipase A2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Reducing the activity of phospholipase A2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Raju, a 50-year-old male is experiencing rapid heart rate, intolerance to heat, tremors, and unexpected weight loss. Her thyroid-stimulating hormone (TSH) levels are significantly elevated. He was prescribed a medication to block the release of TSH. Which medication is this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Levothyroxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methimazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Octreotide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Octreotide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Metformin is least likely to reduce blood sugar in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obese diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-diabetics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 2 diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetics not responding to sulfonylureas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-diabetics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Non-diabetics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Obese diabetics&lt;/li&gt;&lt;li&gt;â€¢ A. Obese diabetics&lt;/li&gt;&lt;li&gt;â€¢ Metformin is particularly effective in obese diabetics because it helps reduce insulin resistance and can aid in weight management, both of which are beneficial in managing type 2 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ C. Type 2 diabetics&lt;/li&gt;&lt;li&gt;â€¢ C. Type 2 diabetics&lt;/li&gt;&lt;li&gt;â€¢ Metformin is a first-line treatment for type 2 diabetes and is effective in reducing blood sugar levels in these patients by addressing the underlying pathophysiological mechanisms of the disease.&lt;/li&gt;&lt;li&gt;â€¢ D. Diabetics not responding to sulfonylureas&lt;/li&gt;&lt;li&gt;â€¢ D. Diabetics not responding to sulfonylureas&lt;/li&gt;&lt;li&gt;â€¢ Metformin can be effective in diabetics who do not respond to sulfonylureas. It works through different mechanisms, so it can be beneficial as monotherapy or in combination with other antidiabetic medications, including when sulfonylureas alone are insufficient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Metformin is a widely used antihyperglycemic agent for managing type 2 diabetes, particularly effective in patients with insulin resistance, such as obese diabetics. It works by decreasing hepatic glucose production and improving insulin sensitivity. However, in non-diabetic individuals, metformin is least likely to reduce blood sugar levels significantly, as their glucose metabolism is generally normal.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not an indication of oxytocin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Treatment of breast engorgement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Induction of labour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Post partum hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperprolactinemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hyperprolactinemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Hyperprolactinemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Oxytocin is primarily used for the induction or augmentation of labor and the management of postpartum hemorrhage due to its ability to stimulate uterine contractions. It is not indicated for the treatment of hyperprolactinemia, which is managed with dopamine agonists.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old postmenopausal woman presents to your clinic with persistent lower back pain for the last three months. She reports the pain is gradually increasing in intensity. The pain is non-radiating and does not change with position or activity. She denies trauma or any other symptoms. Her medical history is notable for hypertension and type 2 diabetes. Her only medications are lisinopril and metformin. Her BMI is 28. A dual-energy x-ray absorptiometry (DEXA) scan reveals a T-score of -2.7 at the lumbar spine. Laboratory tests show normal calcium, phosphate, and vitamin D levels. You start her treatment with the drug of choice for this condition. Which of the following is the most likely side effect of this drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteonecrosis of the jaw&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peptic ulcer disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Osteonecrosis of the jaw&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Osteonecrosis of the jaw&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug can decrease bone resorption as well as increase bone formation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Denosumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Romosozumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Teriparatide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cinacalcet&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Romosozumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Romosozumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Denosumab&lt;/li&gt;&lt;li&gt;â€¢ A. Denosumab&lt;/li&gt;&lt;li&gt;â€¢ Denosumab is a monoclonal antibody that inhibits RANKL (receptor activator of nuclear factor kappa-Î’ ligand), leading to decreased bone resorption. It does not significantly increase bone formation. Denosumab is used primarily to prevent bone loss in conditions like osteoporosis and certain cancers.&lt;/li&gt;&lt;li&gt;â€¢ C. Teriparatide&lt;/li&gt;&lt;li&gt;â€¢ C. Teriparatide&lt;/li&gt;&lt;li&gt;â€¢ Teriparatide is a recombinant form of parathyroid hormone (PTH) that primarily stimulates bone formation. It is used to treat osteoporosis by increasing bone formation but does not significantly decrease bone resorption. Teriparatide is typically reserved for patients with severe osteoporosis or those who have not responded to other treatments.&lt;/li&gt;&lt;li&gt;â€¢ D. Cinacalcet&lt;/li&gt;&lt;li&gt;â€¢ D. Cinacalcet&lt;/li&gt;&lt;li&gt;â€¢ Cinacalcet is a calcimimetic agent used to treat secondary hyperparathyroidism in patients with chronic kidney disease and hypercalcemia in patients with parathyroid carcinoma. It lowers parathyroid hormone (PTH) levels by increasing the sensitivity of calcium-sensing receptors in the parathyroid gland. Cinacalcet does not directly affect bone resorption or formation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Romosozumab uniquely decreases bone resorption and increases bone formation by inhibiting sclerostin. In contrast, denosumab decreases bone resorption by inhibiting RANKL, teriparatide increases bone formation as a recombinant PTH, and cinacalcet lowers PTH levels without directly affecting bone metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman, Seema was a resident of Nubra Valley in Leh Ladakh. She underwent a kidney transplant at AIIMS, Delhi. After transplant she was started several immunosuppressant drugs, including daily prednisone. She had returned to her home at Nubra Valley and is taking prednisone for the past two months since her transplant. However, she is trapped in her house due to heavy snow and may soon run out of prednisone. What health risk is she most likely to face if she does not get her prednisone in time?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoporosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Higher susceptibility to infections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiovascular collapse&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sleep disturbances or insomnia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiovascular collapse&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cardiovascular collapse&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old sexually active female approaches her family doctor seeking a contraceptive. She is a chronic smoker consuming around a pack of cigarettes daily. She also consumes few alcoholic drinks per week. She has no personal or family history of breast, ovarian, or endometrial cancer. What could be the reason for her physician to advise against using a contraceptive containing estrogen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased risk of disulfiram-like reactions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The potential for estrogen to disrupt the patient&#x27;s lipid profile like increasing LDL cholesterol, leading to an elevated risk of cardiovascular disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High risk of developing endometrial cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased risk of thromboembolism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased risk of thromboembolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Increased risk of thromboembolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman with a medical history of diabetes, hypertension, rheumatoid arthritis and gastroesophageal reflux disease (GERD) has been feeling tired for the past 2 weeks. Her current medication regimen includes glipizide, prednisone, telmisartan, and pantoprazole. Her complete blood count shows an elevated white blood cell count with predominant neutrophilia. Which of her medications could potentially be the reason for her increased TLC and neutrophilia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glipizide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Telmisartan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pantoprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Prednisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young couple is having trouble conceiving after nine months of unprotected intercourse. The wife&#x27;s levels of thyroid-stimulating hormone (TSH) and follicle-stimulating hormone (FSH) are normal, and her pelvic exam shows no abnormalities. They agree to a trial of letrozole in hopes of increasing their chances of conception. How does letrozole work?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It inhibits aromatase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It increases sperm production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It blocks estrogen receptors in the hypothalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It suppresses prolactin secretion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It inhibits aromatase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. It inhibits aromatase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the given diagram, identify the site of action of sodium iodide as antithyroid drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/whatsapp-image-2023-07-22-at-51729-pm-1.jpeg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/untitled-1151_MR1Sz6P.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man has insulin-dependent diabetes. He desires to take insulin glargine because of its efficacy and ease of dosing. This would be represented as which of the following labels on the above diagram?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. D&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/whatsapp-image-2023-07-22-at-51728-pm.jpeg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/22/untitled-1152.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. D&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about dapagliflozin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Its major mode of action in diabetes mellitus is to cause glucosuria when serum glucose is above 180 mg/dL.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It acts by inhibiting SGLT2 present in collecting tubules of the nephron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urinary tract infections are common with its use&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Urinary tract infections are common with its use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Urinary tract infections are common with its use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about elagolix is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a gonadotropin release hormone antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is not effective orally&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is approved for treatment of pain due to endometriosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can cause hot flashes as adverse effect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is not effective orally&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It is not effective orally&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Elagolix is an orally active gonadotropin-releasing hormone (GnRH) antagonist approved for the treatment of moderate to severe pain associated with endometriosis. It effectively reduces the production of gonadotropins and estrogen, which can alleviate endometriosis-related pain. However, its estrogen-lowering effect can lead to side effects such as hot flashes. Understanding the pharmacokinetics, therapeutic indications, and potential adverse effects of elagolix is crucial for its appropriate use in clinical practice.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drug acts as Selective Estrogen Receptor Downregulator?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fulvestrant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Raloxifene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mifepristone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fulvestrant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Fulvestrant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Selective Estrogen Receptor Downregulators (SERDs) like fulvestrant are used in the treatment of hormone receptor-positive metastatic breast cancer by promoting the degradation of estrogen receptors and reducing estrogen-mediated signaling. Raloxifene, a Selective Estrogen Receptor Modulator (SERM), and mifepristone, a progesterone receptor antagonist, have different mechanisms of action and therapeutic uses.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test22" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 7 (Hematology &amp;amp; Git)   07 08 2023   2023 08 07&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 7 (Hematology &amp;amp; Git)   07 08 2023   2023 08 07&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Despite their short half lives, proton pump inhibitors cause a prolonged suppression of acid secretion (up to 48 h) because?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are pro-drugs and undergo activation gradually&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;From stomach, these quickly reach the parietal cells and enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are irreversible inhibit the proton pump molecule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are available as enteric coated capsules, from which drug is gradually released&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. They are irreversible inhibit the proton pump molecule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. They are irreversible inhibit the proton pump molecule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Proton pump inhibitors (PPIs) irreversibly inhibit the H+/K+ ATPase enzyme (proton pump) in the stomach&#x27;s parietal cells, leading to prolonged suppression of gastric acid secretion. This irreversible inhibition means that the acid secretion remains suppressed until new proton pumps are synthesized, which typically takes about 48 hours.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following drugs reversibly binds the site labelled as B in the given figure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ticagrelor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ticlopidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ticagrelor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/07/whatsapp-image-2023-06-12-at-190121011010202.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Ticagrelor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Site A&lt;/li&gt;&lt;li&gt;â€¢ Site A&lt;/li&gt;&lt;li&gt;â€¢ The site labeled \&quot;A\&quot; in the figure corresponds to the COX-1 enzyme. COX-1 is responsible for the production of thromboxane A2, a potent promoter of platelet aggregation. The primary drug that targets this site is aspirin , which irreversibly inhibits COX-1, leading to a decrease in thromboxane A2 production and thus reduced platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ aspirin&lt;/li&gt;&lt;li&gt;â€¢ Site C&lt;/li&gt;&lt;li&gt;â€¢ Site C&lt;/li&gt;&lt;li&gt;â€¢ The site labeled \&quot;C\&quot; in the figure corresponds to the GPIIb/IIIa receptor. This receptor is crucial for platelet aggregation because it binds fibrinogen, which links platelets together. Drugs that target this receptor, known as GPIIb/IIIa inhibitors, include abciximab , eptifibatide , and tirofiban . These drugs prevent fibrinogen binding to the GPIIb/IIIa receptor, thereby inhibiting platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ abciximab&lt;/li&gt;&lt;li&gt;â€¢ eptifibatide&lt;/li&gt;&lt;li&gt;â€¢ tirofiban&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Understanding the mechanisms of action of antiplatelet drugs is crucial for their effective use in preventing thrombotic events. Ticagrelor is a reversible P2Y12 receptor antagonist, which distinguishes it from other P2Y12 inhibitors like clopidogrel, prasugrel, and ticlopidine, which bind irreversibly. Aspirin targets the COX-1 enzyme, reducing thromboxane A2 production, while GPIIb/IIIa inhibitors prevent platelet aggregation by blocking fibrinogen binding.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is not a characteristic feature of treatment of iron deficiency anemia with oral iron supplements?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;If 200-300 mg elemental iron is consumed, about 40-50 mg is absorbed.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The proportion of iron absorbed reduces as hemoglobin improves.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The reticulocyte count should begin to increase in two weeks and peak in four weeks - this suggests a good response to treatment.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The treatment should be discontinued immediately once hemoglobin normalizes to prevent side effects of iron.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The treatment should be discontinued immediately once hemoglobin normalizes to prevent side effects of iron.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. The treatment should be discontinued immediately once hemoglobin normalizes to prevent side effects of iron.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ When treating iron deficiency anemia with oral iron supplements, it is crucial to continue the treatment for 3-6 months after hemoglobin levels normalize to ensure complete replenishment of iron stores and prevent recurrence of anemia. Discontinuing treatment immediately after normalization of hemoglobin is not recommended.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old chronic alcoholic man is brought to the emergency department due to an altered mental status. Blood tests show normal creatinine levels but indicate hyperammonemia. After administering lactulose, his blood ammonia levels soon drop to a more appropriate range. Which organ is the primary site of action for lactulose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kidney&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Colon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Colon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Lactulose is used to treat hyperammonemia, particularly in hepatic encephalopathy, by acting in the colon. It is metabolized by colonic bacteria to lower the pH, converting ammonia to ammonium, which is less absorbable and thus reduces blood ammonia levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about warfarin group of oral anticoagulants is false ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They interfere with an early step in the synthesis of clotting factors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Their dose is adjusted by repeated measurement of INR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are contraindicated during first trimester of pregnancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They interfere with an early step in the synthesis of clotting factors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. They interfere with an early step in the synthesis of clotting factors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ B. Irrespective of the dose administered, their anticoagulant effect has a latency of onset of 4-5 days&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin has a delayed onset of action because it does not affect clotting factors that have already been synthesized and are present in the bloodstream. It takes several days for these existing clotting factors to degrade and for the anticoagulant effect to become apparent.&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ C. Their dose is adjusted by repeated measurement of INR&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. The dose of warfarin is adjusted based on the International Normalized Ratio (INR) to ensure that the patient&#x27;s blood is maintained within the therapeutic range, which minimizes the risk of bleeding and thromboembolism.&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ D. They are contraindicated during first trimester of pregnancy&lt;/li&gt;&lt;li&gt;â€¢ This statement is true. Warfarin is contraindicated during pregnancy, especially in the first trimester, due to its teratogenic effects. It can cause fetal warfarin syndrome, characterized by nasal hypoplasia and stippled epiphyses, among other congenital abnormalities.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Warfarin is an oral anticoagulant that inhibits the enzyme vitamin K epoxide reductase, affecting the carboxylation and activation of certain clotting factors. It has a delayed onset of action, typically taking 4-5 days, and its dose is adjusted based on INR measurements. Warfarin is contraindicated during pregnancy due to its teratogenic potential, especially in the first trimester.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67 years old female was given rivaroxaban to prevent thromboembolism after total knee replacement surgery. She took overdose of the above drug. Which of the following drug can be used to reverse the effect of the anticoagulant taken by her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idarucizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Andexanet alpha&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin K&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Protamine sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Andexanet alpha&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Andexanet alpha&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Idarucizumab&lt;/li&gt;&lt;li&gt;â€¢ A. Idarucizumab&lt;/li&gt;&lt;li&gt;â€¢ Idarucizumab is a monoclonal antibody fragment designed specifically to reverse the anticoagulant effects of dabigatran, a direct thrombin inhibitor. It is not effective for reversing the effects of rivaroxaban.&lt;/li&gt;&lt;li&gt;â€¢ C. Vitamin K&lt;/li&gt;&lt;li&gt;â€¢ C. Vitamin K&lt;/li&gt;&lt;li&gt;â€¢ Vitamin K is used to reverse the effects of vitamin K antagonists, such as warfarin. It is not effective for reversing the effects of direct Factor Xa inhibitors like rivaroxaban.&lt;/li&gt;&lt;li&gt;â€¢ D. Protamine sulphate&lt;/li&gt;&lt;li&gt;â€¢ D. Protamine sulphate&lt;/li&gt;&lt;li&gt;â€¢ Protamine sulphate is used to reverse the effects of heparin and low molecular weight heparins. It is not effective for reversing the effects of direct oral anticoagulants like rivaroxaban.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ In cases of overdose with direct Factor Xa inhibitors like rivaroxaban, Andexanet alpha is the appropriate reversal agent. It acts as a decoy protein, binding to the Factor Xa inhibitors and thereby neutralizing their anticoagulant effects.&lt;/li&gt;&lt;li&gt;âž¤ Anticoagulant&lt;/li&gt;&lt;li&gt;âž¤ Anticoagulant&lt;/li&gt;&lt;li&gt;âž¤ Class&lt;/li&gt;&lt;li&gt;âž¤ Class&lt;/li&gt;&lt;li&gt;âž¤ Antidote&lt;/li&gt;&lt;li&gt;âž¤ Antidote&lt;/li&gt;&lt;li&gt;âž¤ Warfarin&lt;/li&gt;&lt;li&gt;âž¤ Warfarin&lt;/li&gt;&lt;li&gt;âž¤ Vitamin K Antagonist&lt;/li&gt;&lt;li&gt;âž¤ Vitamin K, Fresh Frozen Plasma (FFP), Prothrombin Complex Concentrate (PCC)&lt;/li&gt;&lt;li&gt;âž¤ Heparin&lt;/li&gt;&lt;li&gt;âž¤ Heparin&lt;/li&gt;&lt;li&gt;âž¤ Unfractionated Heparin&lt;/li&gt;&lt;li&gt;âž¤ Protamine Sulphate&lt;/li&gt;&lt;li&gt;âž¤ Low Molecular Weight Heparins&lt;/li&gt;&lt;li&gt;âž¤ Low Molecular Weight Heparins&lt;/li&gt;&lt;li&gt;âž¤ (e.g., Enoxaparin)&lt;/li&gt;&lt;li&gt;âž¤ Protamine Sulphate (partial reversal)&lt;/li&gt;&lt;li&gt;âž¤ Dabigatran&lt;/li&gt;&lt;li&gt;âž¤ Dabigatran&lt;/li&gt;&lt;li&gt;âž¤ Direct Thrombin Inhibitor&lt;/li&gt;&lt;li&gt;âž¤ Idarucizumab&lt;/li&gt;&lt;li&gt;âž¤ Rivaroxaban&lt;/li&gt;&lt;li&gt;âž¤ Rivaroxaban&lt;/li&gt;&lt;li&gt;âž¤ Direct Factor Xa Inhibitor&lt;/li&gt;&lt;li&gt;âž¤ Andexanet Alpha&lt;/li&gt;&lt;li&gt;âž¤ Apixaban&lt;/li&gt;&lt;li&gt;âž¤ Apixaban&lt;/li&gt;&lt;li&gt;âž¤ Direct Factor Xa Inhibitor&lt;/li&gt;&lt;li&gt;âž¤ Andexanet Alpha&lt;/li&gt;&lt;li&gt;âž¤ Edoxaban&lt;/li&gt;&lt;li&gt;âž¤ Edoxaban&lt;/li&gt;&lt;li&gt;âž¤ Direct Factor Xa Inhibitor&lt;/li&gt;&lt;li&gt;âž¤ Andexanet Alpha (off-label)&lt;/li&gt;&lt;li&gt;âž¤ Fondaparinux&lt;/li&gt;&lt;li&gt;âž¤ Fondaparinux&lt;/li&gt;&lt;li&gt;âž¤ Factor Xa Inhibitor&lt;/li&gt;&lt;li&gt;âž¤ No specific antidote, supportive care and activated charcoal if early ingestion&lt;/li&gt;&lt;li&gt;âž¤ Argatroban&lt;/li&gt;&lt;li&gt;âž¤ Argatroban&lt;/li&gt;&lt;li&gt;âž¤ Direct Thrombin Inhibitor&lt;/li&gt;&lt;li&gt;âž¤ No specific antidote, supportive care&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;As compared to unfractionated heparin, low molecular weight heparins?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Are absorbed more uniformly when given subcutaÂ­neously&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Require more frequent laboratory monitoring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Can be given to patients with heparin induced thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Predispose to a higher risk of osteopenia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Are absorbed more uniformly when given subcutaÂ­neously&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Low molecular weight heparins (LMWHs) offer several advantages over unfractionated heparin (UFH), including more uniform and predictable absorption when given subcutaneously, reduced need for laboratory monitoring, and a lower risk of side effects such as osteopenia. However, LMWHs should not be used in patients with heparin-induced thrombocytopenia (HIT).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about heparin is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It acts by inhibiting anti-thrombin III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin is preferred over warfarin for long-term treatment of DVT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Heparin has fewer drug interactions as compared to warfarin because it is metabolized by non-microsomal enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An old woman is required to receive 4 cycles of cancer chemotherapy. After her first cycle, she developed chemotherapy induced thrombocytopenia. Then in the next cycle, it would be appropriate to give this patient:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Darbopoietin alpha&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Filgrastim&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron dextran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oprelvekin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Oprelvekin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Darbepoetin alpha&lt;/li&gt;&lt;li&gt;â€¢ A. Darbepoetin alpha&lt;/li&gt;&lt;li&gt;â€¢ Darbepoetin alpha is an erythropoiesis-stimulating agent used to treat anemia, particularly in patients with chronic kidney disease or chemotherapy-induced anemia. It is not effective for treating thrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ B. Filgrastim&lt;/li&gt;&lt;li&gt;â€¢ B. Filgrastim&lt;/li&gt;&lt;li&gt;â€¢ Filgrastim (G-CSF) is used to stimulate the production of white blood cells and is effective for preventing and treating chemotherapy-induced neutropenia. It does not address thrombocytopenia.&lt;/li&gt;&lt;li&gt;â€¢ C. Iron dextran&lt;/li&gt;&lt;li&gt;â€¢ C. Iron dextran&lt;/li&gt;&lt;li&gt;â€¢ Iron dextran is used to treat iron deficiency anemia. It does not affect platelet counts and is not used to manage chemotherapy-induced thrombocytopenia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ In cases of chemotherapy-induced thrombocytopenia, the appropriate treatment is to use a thrombopoietic agent such as oprelvekin (interleukin-11) to stimulate platelet production.&lt;/li&gt;&lt;li&gt;âž¤ Growth Factor&lt;/li&gt;&lt;li&gt;âž¤ Growth Factor&lt;/li&gt;&lt;li&gt;âž¤ Drug&lt;/li&gt;&lt;li&gt;âž¤ Drug&lt;/li&gt;&lt;li&gt;âž¤ Indications&lt;/li&gt;&lt;li&gt;âž¤ Indications&lt;/li&gt;&lt;li&gt;âž¤ Erythropoietin (EPO)&lt;/li&gt;&lt;li&gt;âž¤ Erythropoietin (EPO)&lt;/li&gt;&lt;li&gt;âž¤ Epoetin alfa, Darbepoetin alfa&lt;/li&gt;&lt;li&gt;âž¤ Anemia of chronic kidney disease, chemotherapy-induced anemia&lt;/li&gt;&lt;li&gt;âž¤ Granulocyte Colony-Stimulating Factor (G-CSF)&lt;/li&gt;&lt;li&gt;âž¤ Granulocyte Colony-Stimulating Factor (G-CSF)&lt;/li&gt;&lt;li&gt;âž¤ Filgrastim, Pegfilgrastim&lt;/li&gt;&lt;li&gt;âž¤ Chemotherapy-induced neutropenia, bone marrow transplantation, mobilization of peripheral blood progenitor cells&lt;/li&gt;&lt;li&gt;âž¤ Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)&lt;/li&gt;&lt;li&gt;âž¤ Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)&lt;/li&gt;&lt;li&gt;âž¤ Sargramostim&lt;/li&gt;&lt;li&gt;âž¤ Neutropenia, bone marrow transplantation, mobilization of peripheral blood progenitor cells&lt;/li&gt;&lt;li&gt;âž¤ Interleukin-11 (IL-11)&lt;/li&gt;&lt;li&gt;âž¤ Interleukin-11 (IL-11)&lt;/li&gt;&lt;li&gt;âž¤ Oprelvekin&lt;/li&gt;&lt;li&gt;âž¤ Chemotherapy-induced thrombocytopenia&lt;/li&gt;&lt;li&gt;âž¤ Thrombopoietin (TPO)&lt;/li&gt;&lt;li&gt;âž¤ Thrombopoietin (TPO)&lt;/li&gt;&lt;li&gt;âž¤ Romiplostim, Eltrombopag&lt;/li&gt;&lt;li&gt;âž¤ Chronic immune thrombocytopenia (ITP), aplastic anemia, thrombocytopenia due to hepatitis C treatment&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on cisplatin therapy develops intractable vomiting on the third day of treatment. Agent of choice for controlling this vomiting is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rolapitant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prochlorperazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rolapitant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ In patients experiencing delayed chemotherapy-induced nausea and vomiting (CINV), particularly those receiving cisplatin, NK1 receptor antagonists such as rolapitant are the agents of choice. These drugs are specifically designed to address the delayed phase of CINV, providing effective control when other antiemetics like 5-HT3 antagonists (e.g., ondansetron) are less effective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Stimulant purgatives are contraindicated in the following condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bed ridden patients&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Before abdominal radiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute intestinal obstruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Functional constipation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Subacute intestinal obstruction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Stimulant purgatives are contraindicated in conditions like subacute intestinal obstruction due to the risk of exacerbating the obstruction and causing severe complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Choose the correct statement about the use of opioid anti-motility drugs in the management of diarrhea:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are used to control diarrhea irrespective of its etiology&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are used as adjuvant to antimicrobial therapy of diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are the drug of choice in Travellerâ€™s diarrhea&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. They should be used only as a short term measure after ensuring that enteroinvasive organisms are not involved&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Opioid anti-motility drugs should be used cautiously in the management of diarrhea. They are most appropriate for short-term use after confirming that the diarrhea is not caused by enteroinvasive organisms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old woman has had several episodes of transient ischemic attacks (TIAs). Aspirin would be a preferred treatment, but she has a history of severe â€œaspirin sensitivityâ€ manifest as intense bronchoconstriction and urticaria. Which of the following would you consider to be the best alternative to the aspirin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptokinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Clopidogrel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Clopidogrel&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ A. Heparin&lt;/li&gt;&lt;li&gt;â€¢ A. Heparin&lt;/li&gt;&lt;li&gt;â€¢ Heparin is an anticoagulant that works by inhibiting thrombin and factor Xa. It is primarily used for the acute treatment of thromboembolic disorders such as deep vein thrombosis and pulmonary embolism. However, heparin is not ideal for long-term management of TIAs because it requires parenteral administration and carries a higher risk of bleeding complications compared to oral antiplatelet agents.&lt;/li&gt;&lt;li&gt;â€¢ C. Warfarin&lt;/li&gt;&lt;li&gt;â€¢ C. Warfarin&lt;/li&gt;&lt;li&gt;â€¢ Warfarin is a vitamin K antagonist that inhibits the synthesis of clotting factors II, VII, IX, and X. It is used to prevent thromboembolism in conditions like atrial fibrillation and in patients with mechanical heart valves. However, warfarin is less preferred for the management of TIAs due to the need for regular INR monitoring and dietary restrictions, making it less convenient and potentially more hazardous than antiplatelet agents like clopidogrel.&lt;/li&gt;&lt;li&gt;â€¢ D. Streptokinase&lt;/li&gt;&lt;li&gt;â€¢ D. Streptokinase&lt;/li&gt;&lt;li&gt;â€¢ Streptokinase is a fibrinolytic agent that converts plasminogen to plasmin, leading to the dissolution of clots. It is used in acute settings for the treatment of myocardial infarction and pulmonary embolism. Streptokinase is not suitable for the long-term prevention of TIAs because it is designed for acute thrombolytic therapy and carries a high risk of severe bleeding. It is not indicated for chronic use in preventing recurrent ischemic events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with a history of transient ischemic attacks (TIAs) who have severe aspirin sensitivity, clopidogrel is the best alternative due to its antiplatelet properties and lack of bronchoconstrictive or urticarial side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old male patient presents to the emergency department with complaints of sudden-onset shortness of breath and palpitations. His medical history reveals a recent deep vein thrombosis. As part of his evaluation and potential treatment plan, the physician discusses long-term anticoagulation therapy options. The patient, having done some prior reading, mentions a few medications he came across. Which of the following medications on his list is NOT an oral anticoagulant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Edoxaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dabigatran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dicumarol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prasugrel&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prasugrel&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ A. Edoxaban&lt;/li&gt;&lt;li&gt;â€¢ A. Edoxaban&lt;/li&gt;&lt;li&gt;â€¢ Edoxaban is an oral anticoagulant that belongs to the class of direct factor Xa inhibitors. It is used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).&lt;/li&gt;&lt;li&gt;â€¢ B. Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ B. Dabigatran&lt;/li&gt;&lt;li&gt;â€¢ Dabigatran is an oral anticoagulant that works as a direct thrombin inhibitor. It is used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for the treatment and prevention of DVT and PE.&lt;/li&gt;&lt;li&gt;â€¢ C. Dicumarol&lt;/li&gt;&lt;li&gt;â€¢ C. Dicumarol&lt;/li&gt;&lt;li&gt;â€¢ Dicumarol is an oral anticoagulant and a coumarin derivative, similar in mechanism to warfarin. It inhibits the synthesis of vitamin K-dependent clotting factors. Although it is not commonly used today, it historically served as an anticoagulant.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ In evaluating long-term anticoagulation therapy options, it is essential to differentiate between anticoagulants and antiplatelet agents. Anticoagulants, such as Edoxaban, Dabigatran, and Dicumarol, are used to prevent and treat conditions like DVT and PE by affecting the coagulation cascade. In contrast, antiplatelet agents like Prasugrel inhibit platelet aggregation and are primarily used in the context of arterial thrombosis prevention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following clinical conditions, use of warfarin provide maximum benefit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prevention of recurrence of myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients with prolonged immobilization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebrovascular accident&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retinal artery thrombosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Patients with prolonged immobilization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ A. Prevention of recurrence of myocardial infarction&lt;/li&gt;&lt;li&gt;â€¢ A. Prevention of recurrence of myocardial infarction&lt;/li&gt;&lt;li&gt;â€¢ While warfarin can be used in some cases to prevent thromboembolic events, it is not the primary choice for the prevention of recurrent myocardial infarction. Antiplatelet agents like aspirin and P2Y12 inhibitors (e.g., clopidogrel) are more commonly used for this purpose due to their efficacy in preventing arterial thrombosis.&lt;/li&gt;&lt;li&gt;â€¢ C. Cerebrovascular accident&lt;/li&gt;&lt;li&gt;â€¢ C. Cerebrovascular accident&lt;/li&gt;&lt;li&gt;â€¢ In stroke (cerebrovascular accident) prevention, antiplatelet drugs like aspirin are preferred as the thrombus is in the arterial circulation.&lt;/li&gt;&lt;li&gt;â€¢ D. Retinal artery thrombosis&lt;/li&gt;&lt;li&gt;â€¢ D. Retinal artery thrombosis&lt;/li&gt;&lt;li&gt;â€¢ Retinal artery thrombosis is primarily an arterial event, and anticoagulants like warfarin are not the first-line treatment. Management often involves addressing underlying cardiovascular risk factors and using antiplatelet therapy to prevent further arterial events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Warfarin provides maximum benefit in patients with prolonged immobilization due to its efficacy in preventing venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). In other conditions, such as the prevention of recurrent myocardial infarction or retinal artery thrombosis, antiplatelet drugs are more effective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with severe abdominal pain and a â€œburningâ€ sensation in the upper abdomen. Endoscopy reveals several benign ulcers in the antral mucosa of the stomach. Which of the following drugs is most likely to provide the fastest relief of the discomfort with just a single dose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antacids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cimetidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Misoprostol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lansoprazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Antacids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Cimetidine&lt;/li&gt;&lt;li&gt;â€¢ Cimetidine&lt;/li&gt;&lt;li&gt;â€¢ Cimetidine is an H2 receptor antagonist that reduces stomach acid production. While it is effective in reducing acid and promoting ulcer healing, it does not act as quickly as antacids. Cimetidine typically takes about 30 minutes to start working, so it may not provide immediate relief with a single dose.&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol&lt;/li&gt;&lt;li&gt;â€¢ Misoprostol is a prostaglandin analog that protects the stomach lining by increasing mucus and bicarbonate secretion. It is used for the prevention of NSAID-induced ulcers but is not typically used for immediate symptom relief. Misoprostol also has slower onset of action compared to antacids.&lt;/li&gt;&lt;li&gt;â€¢ Lansoprazole&lt;/li&gt;&lt;li&gt;â€¢ Lansoprazole&lt;/li&gt;&lt;li&gt;â€¢ Lansoprazole is a proton pump inhibitor (PPI) that effectively reduces stomach acid production by inhibiting the proton pumps in the gastric parietal cells. While PPIs are highly effective for long-term management of ulcers, they do not provide immediate relief as their onset of action is slower, usually taking several hours to become effective.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For immediate relief of discomfort from benign ulcers in the stomach, antacids are the most effective option due to their rapid action in neutralizing stomach acid. Other medications such as H2 receptor antagonists, prostaglandin analogs, and proton pump inhibitors are effective for longer-term management but do not provide the same rapid relief with a single dose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Oral rehydration solution is indicated in all of the following conditions except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A patient with very severe dehydration due to excessive diarrhea and vomiting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Traveller&#x27;s diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heat stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;While shifting from total parenteral nutrition to enteral nutrition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A patient with very severe dehydration due to excessive diarrhea and vomiting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of options&lt;/li&gt;&lt;li&gt;â€¢ a. Heat stroke&lt;/li&gt;&lt;li&gt;â€¢ a. Heat stroke&lt;/li&gt;&lt;li&gt;â€¢ Oral rehydration solution (ORS) can be used for rehydration in heat stroke, although severe cases might require intravenous fluids.&lt;/li&gt;&lt;li&gt;â€¢ b. A patient with very severe dehydration due to excessive diarrhea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ b. A patient with very severe dehydration due to excessive diarrhea and vomiting&lt;/li&gt;&lt;li&gt;â€¢ In cases of very severe dehydration, intravenous rehydration is preferred over oral rehydration solutions to rapidly restore fluid and electrolyte balance. ORS is more suitable for mild to moderate dehydration.&lt;/li&gt;&lt;li&gt;â€¢ c. Traveller&#x27;s diarrhea&lt;/li&gt;&lt;li&gt;â€¢ c. Traveller&#x27;s diarrhea&lt;/li&gt;&lt;li&gt;â€¢ Patients with any type of diarrhea including Traveller&#x27;s diarrhea may require ORS to prevent dehydration.&lt;/li&gt;&lt;li&gt;â€¢ d. While shifting from total parenteral nutrition to enteral nutrition&lt;/li&gt;&lt;li&gt;â€¢ d. While shifting from total parenteral nutrition to enteral nutrition&lt;/li&gt;&lt;li&gt;â€¢ ORS can be helpful to maintain hydration and electrolyte balance during the transition from total parenteral nutrition to enteral nutrition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oral rehydration solution (ORS) is indicated for mild to moderate dehydration and during transitions from parenteral to enteral nutrition. However, in cases of very severe dehydration, especially due to diarrhea and vomiting, intravenous fluids are preferred.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A small amount of atropine is added to diphenoxylate in order to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Suppress associated vomiting of gastroenteritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Augment the anti-motility action of diphenoxylate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Block side effects of diphenoxylate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Discourage overdose and abuse of diphenoxylate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Discourage overdose and abuse of diphenoxylate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ A. Suppress associated vomiting of gastroenteritis&lt;/li&gt;&lt;li&gt;â€¢ A. Suppress associated vomiting of gastroenteritis&lt;/li&gt;&lt;li&gt;â€¢ While atropine has antiemetic properties due to its anticholinergic effects, this is not the primary reason for its inclusion in the combination with diphenoxylate. The main purpose is to prevent abuse, not to suppress vomiting.&lt;/li&gt;&lt;li&gt;â€¢ B. Augment the anti-motility action of diphenoxylate&lt;/li&gt;&lt;li&gt;â€¢ B. Augment the anti-motility action of diphenoxylate&lt;/li&gt;&lt;li&gt;â€¢ Diphenoxylate itself is a potent anti-motility agent that works by slowing down gut movement through its opioid effects. Atropine does have some antispasmodic properties but is not primarily included to enhance the anti-motility action of diphenoxylate.&lt;/li&gt;&lt;li&gt;â€¢ C. Block side effects of diphenoxylate&lt;/li&gt;&lt;li&gt;â€¢ C. Block side effects of diphenoxylate&lt;/li&gt;&lt;li&gt;â€¢ Atropine does not block the side effects of diphenoxylate. In fact, the side effects of atropine (anticholinergic effects) are used to deter abuse. The combination is intended to prevent misuse rather than to mitigate the side effects of diphenoxylate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atropine is added to diphenoxylate to discourage overdose and abuse of the medication. This combination leverages the unpleasant side effects of atropine at higher doses to act as a deterrent, preventing misuse of diphenoxylate, which is an opioid with potential for abuse.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which antiemetic drug selectively blocks levodopa induced vomiting without blocking its anti-Parkinsonian action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cisapride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Domperidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ondansetron&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Domperidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ A. Metoclopramide&lt;/li&gt;&lt;li&gt;â€¢ A. Metoclopramide&lt;/li&gt;&lt;li&gt;â€¢ Metoclopramide is a dopamine antagonist that crosses the blood-brain barrier and can block dopamine receptors both peripherally and centrally. While it can be effective in controlling nausea and vomiting, it can also interfere with the anti-Parkinsonian effects of levodopa by blocking central dopamine receptors, potentially worsening Parkinson&#x27;s symptoms.&lt;/li&gt;&lt;li&gt;â€¢ B. Cisapride&lt;/li&gt;&lt;li&gt;â€¢ B. Cisapride&lt;/li&gt;&lt;li&gt;â€¢ Cisapride is a prokinetic agent that enhances gastrointestinal motility by increasing the release of acetylcholine at the myenteric plexus. It is not specifically used to block levodopa-induced vomiting and does not have a selective dopamine antagonist effect at the CTZ.&lt;/li&gt;&lt;li&gt;â€¢ D. Ondansetron&lt;/li&gt;&lt;li&gt;â€¢ D. Ondansetron&lt;/li&gt;&lt;li&gt;â€¢ Ondansetron is a selective serotonin 5-HT3 receptor antagonist used primarily to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It does not have the specific action needed to selectively block levodopa-induced vomiting without affecting its anti-Parkinsonian action.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Domperidone selectively blocks levodopa-induced vomiting without interfering with its anti-Parkinsonian action, making it the preferred antiemetic for patients with Parkinson&#x27;s disease experiencing nausea and vomiting from levodopa therapy. Other antiemetics, such as metoclopramide, can block central dopamine receptors and potentially worsen Parkinson&#x27;s symptoms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The plasma half-life of aspirin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Is independent of dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Is longer for anti-inflammatory doses compared to that for anti-platelet dose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Is shorter for anti-inflammatory doses compared to that for anti-platelet dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Can be increased by alkalinizing the urine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Is longer for anti-inflammatory doses compared to that for anti-platelet dose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.B. Is longer for anti-inflammatory doses compared to that for anti-platelet dose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options:&lt;/li&gt;&lt;li&gt;â€¢ A. Is independent of dose&lt;/li&gt;&lt;li&gt;â€¢ A. Is independent of dose&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect because the half-life of aspirin is dose-dependent. At low doses, aspirin exhibits first-order kinetics, but at higher doses, it shifts to zero-order kinetics due to the saturation of metabolic pathways.&lt;/li&gt;&lt;li&gt;â€¢ C. Is shorter for anti-inflammatory doses compared to that for anti-platelet dose&lt;/li&gt;&lt;li&gt;â€¢ C. Is shorter for anti-inflammatory doses compared to that for anti-platelet dose&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. At higher doses used for anti-inflammatory purposes, the half-life of aspirin is longer due to the saturation of metabolic pathways, which causes a shift to zero-order kinetics.&lt;/li&gt;&lt;li&gt;â€¢ D. Can be increased by alkalinizing the urine&lt;/li&gt;&lt;li&gt;â€¢ D. Can be increased by alkalinizing the urine&lt;/li&gt;&lt;li&gt;â€¢ This statement is incorrect. Alkalinizing the urine enhances the excretion of salicylate, decreasing its half-life. This approach is used to increase the elimination of salicylates in cases of overdose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The plasma half-life of aspirin is dose-dependent, demonstrating first-order kinetics at low, anti-platelet doses and zero-order kinetics at higher, anti-inflammatory doses. At low doses, aspirin is metabolized proportionally to its concentration, resulting in a shorter half-life. However, at higher doses, metabolic pathways become saturated, leading to a constant rate of metabolism and a longer half-life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test23" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 8 (Antimicrobials 1)   21 08 2023   2023 08 21&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 8 (Antimicrobials 1)   21 08 2023   2023 08 21&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A patient is admitted with H. influenza meningitis. Cefotaxime is preferred over ampicillin in this patient because:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefotaxime is effective orally whereas ampicillin is not&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefotaxime is more effective against H. influenza having altered penicillin binding proteins.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cefotaxime is cidal drug whereas ampicillin is static&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefotaxime is more active against beta lactamase producing strains of H. influenza.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cefotaxime is more active against beta lactamase producing strains of H. influenza.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Cefotaxime is more active against beta-lactamase producing strains of H. influenzae.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ One of the main reasons cefotaxime is preferred over ampicillin in the treatment of H. influenzae meningitis is due to its activity against beta-lactamase producing strains. Many strains of H. influenzae produce beta-lactamase, an enzyme that hydrolyzes the beta-lactam ring of ampicillin, rendering it ineffective. Cefotaxime, being a third-generation cephalosporin, is resistant to this enzyme and can effectively treat beta-lactamase producing strains of H. influenzae. Cefotaxime is primarily given intravenously or intramuscularly, not orally. Ampicillin can be given both orally and parenterally. Both cefotaxime and ampicillin target penicillin-binding proteins (PBPs). However, the resistance of H. influenzae to ampicillin is primarily due to the production of beta-lactamase, not the alteration of PBPs. Both cefotaxime and ampicillin are bactericidal agents. They kill bacteria by inhibiting the synthesis of the bacterial cell wall.&lt;/li&gt;&lt;li&gt;â€¢ One of the main reasons cefotaxime is preferred over ampicillin in the treatment of H. influenzae meningitis is due to its activity against beta-lactamase producing strains. Many strains of H. influenzae produce beta-lactamase, an enzyme that hydrolyzes the beta-lactam ring of ampicillin, rendering it ineffective. Cefotaxime, being a third-generation cephalosporin, is resistant to this enzyme and can effectively treat beta-lactamase producing strains of H. influenzae.&lt;/li&gt;&lt;li&gt;â€¢ Cefotaxime is primarily given intravenously or intramuscularly, not orally. Ampicillin can be given both orally and parenterally.&lt;/li&gt;&lt;li&gt;â€¢ Both cefotaxime and ampicillin target penicillin-binding proteins (PBPs). However, the resistance of H. influenzae to ampicillin is primarily due to the production of beta-lactamase, not the alteration of PBPs.&lt;/li&gt;&lt;li&gt;â€¢ Both cefotaxime and ampicillin are bactericidal agents. They kill bacteria by inhibiting the synthesis of the bacterial cell wall.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;35-year-old patient presents to the clinic with a swollen, painful abscess on the forehead that is discharging pus. The clinical findings strongly suggest a pus-forming gram-positive bacterial infection. Which of the following antibiotics is LEAST likely to be effective for treating this infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxycillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cloxacillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cotrimoxazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cephalexin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cotrimoxazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cotrimoxazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Amoxycillin: An aminopenicillin effective against many gram-positive bacteria, often utilized for skin infections. Cloxacillin: An isoxazolyl penicillin designed to counter gram-positive bacteria, especially strains of Staphylococcus aureus. Cotrimoxazole (Trimethoprim-sulfamethoxazole): Although it has broad-spectrum activity, Cotrimoxazole is not the preferred choice for purulent (pus-forming) gram-positive skin infections. Its efficacy can be reduced in the presence of pus, and it&#x27;s not the primary choice for such infections. Cephalexin: A first-generation cephalosporin that effectively targets gram-positive cocci and is often employed for skin and soft tissue infections.&lt;/li&gt;&lt;li&gt;â€¢ Amoxycillin: An aminopenicillin effective against many gram-positive bacteria, often utilized for skin infections.&lt;/li&gt;&lt;li&gt;â€¢ Cloxacillin: An isoxazolyl penicillin designed to counter gram-positive bacteria, especially strains of Staphylococcus aureus.&lt;/li&gt;&lt;li&gt;â€¢ Cotrimoxazole (Trimethoprim-sulfamethoxazole): Although it has broad-spectrum activity, Cotrimoxazole is not the preferred choice for purulent (pus-forming) gram-positive skin infections. Its efficacy can be reduced in the presence of pus, and it&#x27;s not the primary choice for such infections.&lt;/li&gt;&lt;li&gt;â€¢ Cephalexin: A first-generation cephalosporin that effectively targets gram-positive cocci and is often employed for skin and soft tissue infections.&lt;/li&gt;&lt;li&gt;â€¢ In the context of a purulent skin infection, Cotrimoxazole is less likely to be effective compared to the other options presented.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;TRUE statement regarding vancomycin is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is bacteriostatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has the advantage of high oral bioavailability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Staphylococcal enterocolits occurs commonly with its use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is not susceptible to penicillinases&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It is not susceptible to penicillinases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It is not susceptible to penicillinases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ It is bacteriostatic: Vancomycin is primarily bactericidal. This means it actively kills bacteria rather than merely inhibiting their growth. It has the advantage of high oral bioavailability: Vancomycin has poor oral bioavailability. When given orally, it doesn&#x27;t absorb well from the gastrointestinal tract, so its oral form is mainly used to treat C. difficile colitis. For systemic infections, it&#x27;s typically given intravenously. Staphylococcal enterocolitis occurs commonly with its use: Staphylococcal enterocolitis isn&#x27;t a common association with vancomycin use. However, antibiotics, including vancomycin, can be associated with antibiotic-induced diarrhea or colitis, most famously caused by Clostridium difficile. It is not susceptible to penicillinases: This is true. Vancomycin&#x27;s action is distinct from beta-lactams. It binds to the D-Ala-D-Ala terminus of the cell wall precursor units, preventing cell wall synthesis. As a result, penicillinases, which break down the beta-lactam ring in penicillins, don&#x27;t affect vancomycin.&lt;/li&gt;&lt;li&gt;â€¢ It is bacteriostatic: Vancomycin is primarily bactericidal. This means it actively kills bacteria rather than merely inhibiting their growth.&lt;/li&gt;&lt;li&gt;â€¢ It is bacteriostatic:&lt;/li&gt;&lt;li&gt;â€¢ It has the advantage of high oral bioavailability: Vancomycin has poor oral bioavailability. When given orally, it doesn&#x27;t absorb well from the gastrointestinal tract, so its oral form is mainly used to treat C. difficile colitis. For systemic infections, it&#x27;s typically given intravenously.&lt;/li&gt;&lt;li&gt;â€¢ It has the advantage of high oral bioavailability:&lt;/li&gt;&lt;li&gt;â€¢ Staphylococcal enterocolitis occurs commonly with its use: Staphylococcal enterocolitis isn&#x27;t a common association with vancomycin use. However, antibiotics, including vancomycin, can be associated with antibiotic-induced diarrhea or colitis, most famously caused by Clostridium difficile.&lt;/li&gt;&lt;li&gt;â€¢ Staphylococcal enterocolitis occurs commonly with its use:&lt;/li&gt;&lt;li&gt;â€¢ It is not susceptible to penicillinases: This is true. Vancomycin&#x27;s action is distinct from beta-lactams. It binds to the D-Ala-D-Ala terminus of the cell wall precursor units, preventing cell wall synthesis. As a result, penicillinases, which break down the beta-lactam ring in penicillins, don&#x27;t affect vancomycin.&lt;/li&gt;&lt;li&gt;â€¢ It is not susceptible to penicillinases:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old male with a history of chronic kidney disease is being considered for treatment with a broad-spectrum antibiotic. The clinician is considering imipenem. Which of the following statements about imipenem is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The drug has a narrow spectrum of antibacterial action&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is used in fixed dose combination with sulbactum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;In renal dysfunction, dosage reductions are necessary to avoid seizures&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Imipenem is active against methicillin-resistant staphylococci&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. In renal dysfunction, dosage reductions are necessary to avoid seizures&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. In renal dysfunction, dosage reductions are necessary to avoid seizures&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The drug has a narrow spectrum of antibacterial action: Imipenem is a broad-spectrum carbapenem antibiotic effective against both gram-positive and gram-negative bacteria, including many that are resistant to other antibiotics. It is used in fixed dose combination with sulbactum: Imipenem is commonly combined with cilastatin, not sulbactum. Cilastatin inhibits the renal enzyme that metabolizes imipenem, thereby prolonging its action. In renal dysfunction, dosage reductions are necessary to avoid seizures: This statement is accurate. Imipenem, when used in high doses or in patients with renal dysfunction, can lead to neurotoxic effects, including seizures. Thus, dose adjustments are required in patients with kidney impairment to minimize this risk. Imipenem is active against methicillin-resistant staphylococci: While imipenem has a broad spectrum of activity, most strains of methicillin-resistant Staphylococcus aureus (MRSA) are resistant to it.&lt;/li&gt;&lt;li&gt;â€¢ The drug has a narrow spectrum of antibacterial action: Imipenem is a broad-spectrum carbapenem antibiotic effective against both gram-positive and gram-negative bacteria, including many that are resistant to other antibiotics.&lt;/li&gt;&lt;li&gt;â€¢ The drug has a narrow spectrum of antibacterial action:&lt;/li&gt;&lt;li&gt;â€¢ It is used in fixed dose combination with sulbactum: Imipenem is commonly combined with cilastatin, not sulbactum. Cilastatin inhibits the renal enzyme that metabolizes imipenem, thereby prolonging its action.&lt;/li&gt;&lt;li&gt;â€¢ It is used in fixed dose combination with sulbactum:&lt;/li&gt;&lt;li&gt;â€¢ In renal dysfunction, dosage reductions are necessary to avoid seizures: This statement is accurate. Imipenem, when used in high doses or in patients with renal dysfunction, can lead to neurotoxic effects, including seizures. Thus, dose adjustments are required in patients with kidney impairment to minimize this risk.&lt;/li&gt;&lt;li&gt;â€¢ In renal dysfunction, dosage reductions are necessary to avoid seizures:&lt;/li&gt;&lt;li&gt;â€¢ Imipenem is active against methicillin-resistant staphylococci: While imipenem has a broad spectrum of activity, most strains of methicillin-resistant Staphylococcus aureus (MRSA) are resistant to it.&lt;/li&gt;&lt;li&gt;â€¢ Imipenem is active against methicillin-resistant staphylococci:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Chemical structure of a drug is shown in the figure below. It is drug of choice for:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enteric fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Scrub typhus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRSA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gonorrhea&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Scrub typhus&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/untitled-13582.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Scrub typhus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Biochemical mechanisms of drug resistance are shown in the given below figure. Most important mode of resistance in MRSA is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/untitled-13583.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/21/untitled-13584.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Regarding the antibacterial action of tobramycin, which of the following statements is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibacterial activity is often reduced by the presence of an inhibitor of cell wall synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It continues to exert antibacterial effects even after plasma levels decrease below detectable range&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Efficacy is directly proportionate to the time that the plasma level of the drug is greater than the minimal inhibitory concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It has strong antibacterial activity against Salmonella&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It continues to exert antibacterial effects even after plasma levels decrease below detectable range&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. It continues to exert antibacterial effects even after plasma levels decrease below detectable range&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Aminoglycosides like tobramycin can actually act synergistically with cell wall synthesis inhibitors like beta-lactams in certain gram-positive infections. This is because the destruction of the cell wall can facilitate the uptake of the aminoglycoside into the bacterial cell. This phenomenon is known as the \&quot;post-antibiotic effect\&quot; (PAE). It refers to the continued suppression of bacterial growth after brief exposure of organisms to antibiotics and even after levels of the antibiotic are below the minimum inhibitory concentration (MIC). Aminoglycosides, like tobramycin, exhibit this effect against many bacteria. The efficacy of aminoglycosides is more closely related to their peak plasma concentrations (peak/MIC ratio) rather than the time their plasma concentration remains above the MIC. This is referred to as concentration-dependent killing. While aminoglycosides have activity against many gram-negative bacteria, Salmonella strains are often resistant to aminoglycosides, so they are not the first choice for treating Salmonella infections.&lt;/li&gt;&lt;li&gt;â€¢ Aminoglycosides like tobramycin can actually act synergistically with cell wall synthesis inhibitors like beta-lactams in certain gram-positive infections. This is because the destruction of the cell wall can facilitate the uptake of the aminoglycoside into the bacterial cell.&lt;/li&gt;&lt;li&gt;â€¢ This phenomenon is known as the \&quot;post-antibiotic effect\&quot; (PAE). It refers to the continued suppression of bacterial growth after brief exposure of organisms to antibiotics and even after levels of the antibiotic are below the minimum inhibitory concentration (MIC). Aminoglycosides, like tobramycin, exhibit this effect against many bacteria.&lt;/li&gt;&lt;li&gt;â€¢ The efficacy of aminoglycosides is more closely related to their peak plasma concentrations (peak/MIC ratio) rather than the time their plasma concentration remains above the MIC. This is referred to as concentration-dependent killing.&lt;/li&gt;&lt;li&gt;â€¢ While aminoglycosides have activity against many gram-negative bacteria, Salmonella strains are often resistant to aminoglycosides, so they are not the first choice for treating Salmonella infections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about tigecycline are false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is effective against tetracycline resistant organisms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has wide spectrum of activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is effective against most of the Pseudomonas infections&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It does not require dose adjustment in renal failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is effective against most of the Pseudomonas infections&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is effective against most of the Pseudomonas infections&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true about pseudomembranous colitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous vancomycin can be used as an alternative in patients not responding to fidaxomicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bezlotoxumab is a highly effective monoclonal antibody that can kill most of Clostridium difficile bacteria responsible for the infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clostridium difficile is the common organism implicated in the causation of Pseudomembranous colitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Clostridium difficile is the common organism implicated in the causation of Pseudomembranous colitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Clostridium difficile is the common organism implicated in the causation of Pseudomembranous colitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Intravenous vancomycin is not typically used for pseudomembranous colitis. Instead, oral vancomycin is used because it achieves high concentrations in the colon, where the infection is located. Intravenous administration doesn&#x27;t reach effective concentrations in the colon. Now, the drug of choice for pseudomembranous colitis is fidaxomicin. Bezlotoxumab is a monoclonal antibody against toxin B of Clostridium difficile. While it can reduce the recurrence of Clostridium difficile infection (CDI) in patients who are at high risk for CDI recurrence, it does not \&quot;kill\&quot; the bacteria. Instead, it neutralizes one of the toxins produced by the bacteria. Clostridium difficile is indeed the common organism implicated in the causation of Pseudomembranous colitis. The disease arises from the toxin production of this bacterium, typically after antibiotic therapy has disrupted the normal gut flora.&lt;/li&gt;&lt;li&gt;â€¢ Intravenous vancomycin is not typically used for pseudomembranous colitis. Instead, oral vancomycin is used because it achieves high concentrations in the colon, where the infection is located. Intravenous administration doesn&#x27;t reach effective concentrations in the colon. Now, the drug of choice for pseudomembranous colitis is fidaxomicin.&lt;/li&gt;&lt;li&gt;â€¢ Bezlotoxumab is a monoclonal antibody against toxin B of Clostridium difficile. While it can reduce the recurrence of Clostridium difficile infection (CDI) in patients who are at high risk for CDI recurrence, it does not \&quot;kill\&quot; the bacteria. Instead, it neutralizes one of the toxins produced by the bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Clostridium difficile is indeed the common organism implicated in the causation of Pseudomembranous colitis. The disease arises from the toxin production of this bacterium, typically after antibiotic therapy has disrupted the normal gut flora.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 86-year-old man complains of cough and blood in his sputum for the past 2 days. On admission, his temperature is 103á´¼F. Physical examination reveals rales in his right lung, and X-ray examination shows increased density in the right middle lobe. A sputum smear shows many gram-positive cocci, confirmed by sputum culture as penicillinase-producing Staphylococcus aureus . Which of the following antibiotics would be best to administer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxacillin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ampicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbenicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ticarcillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oxacillin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Oxacillin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ When treating infections caused by penicillinase-producing Staphylococcus aureus, it is crucial to choose antibiotics that are resistant to penicillinase.&lt;/li&gt;&lt;li&gt;âž¤ Penicillinase resistant penicillins include:&lt;/li&gt;&lt;li&gt;âž¤ Penicillinase resistant penicillins include:&lt;/li&gt;&lt;li&gt;âž¤ C: Cloxacillin&lt;/li&gt;&lt;li&gt;âž¤ O: Oxacillin&lt;/li&gt;&lt;li&gt;âž¤ N: Nafcillin&lt;/li&gt;&lt;li&gt;âž¤ D: Dicloxacillin&lt;/li&gt;&lt;li&gt;âž¤ O:&lt;/li&gt;&lt;li&gt;âž¤ M: Methicillin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Irfan, a 5-year-old female was brought to the emergency with fever, headache and confusion. A provisional diagnosis of bacterial meningitis was made. The baby developed a severe allergic reaction to penicillin around six months back. She was admitted and intravenous antibiotics were started. Few days later her investigations revealed as: Hemoglobin 6.0 g/L Erythrocyte count 1.2 Ã— 10 6 /mm 3 Platelets 60000/mm 3 Leukocyte count 1500/mm 3 Which of the following is the most likely drug responsible for the above findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gentamicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloramphenicol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chloramphenicol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Chloramphenicol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The presented laboratory findings indicate bone marrow suppression, which can manifest as anemia (decreased hemoglobin and erythrocyte count), thrombocytopenia (decreased platelets), and leukopenia (decreased leukocyte count)&lt;/li&gt;&lt;li&gt;â€¢ Gentamicin is an aminoglycoside antibiotic. Its main side effects are nephrotoxicity and ototoxicity. Chloramphenicol is known to cause bone marrow suppression. It can lead to a dose-dependent, reversible bone marrow suppression or a dose-independent idiosyncratic aplastic anemia, which is irreversible and can be fatal. Doxycycline is a tetracycline antibiotic. It is not commonly associated with bone marrow suppression as a side effect. Vancomycin is used primarily for Gram-positive infections. Its main side effects include nephrotoxicity, ototoxicity, and \&quot;red man syndrome\&quot; (flushing and rash due to histamine release).&lt;/li&gt;&lt;li&gt;â€¢ Gentamicin is an aminoglycoside antibiotic. Its main side effects are nephrotoxicity and ototoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Chloramphenicol is known to cause bone marrow suppression. It can lead to a dose-dependent, reversible bone marrow suppression or a dose-independent idiosyncratic aplastic anemia, which is irreversible and can be fatal.&lt;/li&gt;&lt;li&gt;â€¢ Doxycycline is a tetracycline antibiotic. It is not commonly associated with bone marrow suppression as a side effect.&lt;/li&gt;&lt;li&gt;â€¢ Vancomycin is used primarily for Gram-positive infections. Its main side effects include nephrotoxicity, ototoxicity, and \&quot;red man syndrome\&quot; (flushing and rash due to histamine release).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male patient presents to the hospital with a 6-week history of progressive dyspnea, fatigue, and a productive cough with greenish sputum. He has a past medical history of chronic obstructive pulmonary disease (COPD) and has been treated multiple times for respiratory infections, though he mentions that they were never this prolonged or severe. On physical examination, you notice decreased breath sounds and crackles in the right lower lobe. A sputum culture identifies Pseudomonas aeruginosa. Which of the following antimicrobial agents is NOT effective against this organism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pseudomonas aeruginosa is a gram-negative bacterium, and as such, it is inherently resistant to many antibiotics including vancomycin.&lt;/li&gt;&lt;li&gt;â€¢ Among the options provided:&lt;/li&gt;&lt;li&gt;â€¢ Among the options provided:&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin can have activity against a variety of pathogens including gram positive bacteria like MRSA and gram negative bacteria like Pseudomonas. Vancomycin is primarily effective against gram-positive organisms and lacks efficacy against Pseudomonas aeruginosa. Ceftazidime, a third-generation cephalosporin, has good activity against Pseudomonas aeruginosa. Ciprofloxacin, a member of the fluoroquinolones, is effective against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin can have activity against a variety of pathogens including gram positive bacteria like MRSA and gram negative bacteria like Pseudomonas.&lt;/li&gt;&lt;li&gt;â€¢ Vancomycin is primarily effective against gram-positive organisms and lacks efficacy against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Ceftazidime, a third-generation cephalosporin, has good activity against Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;â€¢ Ciprofloxacin, a member of the fluoroquinolones, is effective against Pseudomonas aeruginosa.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36 years old woman recently treated for leukemia is admitted to the hospital with malaise, chills and high fever. Gram stain of blood reveals the presence of gram negative bacilli. The initial diagnosis is bacteremia and parenteral antibiotics are indicated. The record of the patient reveals that she had severe urticarial rash, hypotension and respiratory difficulty after oral pencillin V about 6 months ago. The most appropriate drug should be:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin plus sulbactum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefazolin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aztreonam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Imipenem plus cilastatin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aztreonam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Aztreonam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A severe urticarial rash, hypotension, and respiratory difficulty after penicillin V intake are indicative of a severe penicillin allergy, possibly anaphylaxis. In patients with a history of severe penicillin allergy, cross-reactivity with other beta-lactam antibiotics (e.g., cephalosporins, carbapenems) is a concern.&lt;/li&gt;&lt;li&gt;â€¢ Breaking down the options:&lt;/li&gt;&lt;li&gt;â€¢ Ampicillin plus sulbactam: This combination is a beta-lactam/beta-lactamase inhibitor. Given her history of severe reaction to penicillin, it would not be an appropriate choice due to the risk of cross-reactivity. Cefazolin: A first-generation cephalosporin, which is also a beta-lactam antibiotic. While the risk of cross-reactivity between penicillins and first-generation cephalosporins is lower than with other cephalosporins, it&#x27;s still present. Thus, it may not be the safest choice. Aztreonam: This is a monobactam antibiotic that is specifically formulated to treat gram-negative bacterial infections. Importantly, it does not have cross-reactivity with other beta-lactam antibiotics, making it safe for those with penicillin allergies. Imipenem plus cilastatin: Imipenem is a carbapenem, another class of beta-lactam antibiotics. There&#x27;s a potential (though small) risk of cross-reactivity with penicillins.&lt;/li&gt;&lt;li&gt;â€¢ Ampicillin plus sulbactam: This combination is a beta-lactam/beta-lactamase inhibitor. Given her history of severe reaction to penicillin, it would not be an appropriate choice due to the risk of cross-reactivity.&lt;/li&gt;&lt;li&gt;â€¢ Cefazolin: A first-generation cephalosporin, which is also a beta-lactam antibiotic. While the risk of cross-reactivity between penicillins and first-generation cephalosporins is lower than with other cephalosporins, it&#x27;s still present. Thus, it may not be the safest choice.&lt;/li&gt;&lt;li&gt;â€¢ Aztreonam: This is a monobactam antibiotic that is specifically formulated to treat gram-negative bacterial infections. Importantly, it does not have cross-reactivity with other beta-lactam antibiotics, making it safe for those with penicillin allergies.&lt;/li&gt;&lt;li&gt;â€¢ Imipenem plus cilastatin: Imipenem is a carbapenem, another class of beta-lactam antibiotics. There&#x27;s a potential (though small) risk of cross-reactivity with penicillins.&lt;/li&gt;&lt;li&gt;â€¢ Considering the patient&#x27;s severe reaction to penicillin, it&#x27;s essential to avoid any drug that has even a slight potential for cross-reactivity. Aztreonam would be the most appropriate choice in this context.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with a recent surgical history presents with signs of abdominal sepsis. She is empirically started on intravenous ampicillin and gentamicin. Which of the following statements regarding her treatment is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A drug active against anaerobe should be included in the antibiotic regimen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Combination of ampicillin and gentamicin provides good coverage for all likely pathogens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;If the patient is severely allergic to ampicillin, then ceftriaxone should be used&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A drug active against anaerobe should be included in the antibiotic regimen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. A drug active against anaerobe should be included in the antibiotic regimen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin: While third-generation cephalosporins are often used for abdominal infections because of their broad-spectrum coverage, it&#x27;s not accurate to say they should \&quot;always\&quot; be included. A drug active against anaerobe should be included in the antibiotic regimen: This is accurate. Abdominal sepsis often involves a mixture of aerobic and anaerobic organisms, especially if the source is intra-abdominal. Thus, anaerobic coverage is important. Combination of ampicillin and gentamicin provides good coverage for all likely pathogens: This combination can be effective against many pathogens; however, it might lack sufficient anaerobic coverage for abdominal sepsis, which often involves anaerobic bacteria. If the patient is severely allergic to ampicillin, then ceftriaxone should be used: While ceftriaxone can be an alternative in many infections, if a patient is severely allergic to a penicillin like ampicillin, there&#x27;s a risk of cross-reactivity with cephalosporins like ceftriaxone. In such cases, it would be crucial to select an antibiotic considering the allergy history.&lt;/li&gt;&lt;li&gt;â€¢ Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin: While third-generation cephalosporins are often used for abdominal infections because of their broad-spectrum coverage, it&#x27;s not accurate to say they should \&quot;always\&quot; be included.&lt;/li&gt;&lt;li&gt;â€¢ Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin:&lt;/li&gt;&lt;li&gt;â€¢ A drug active against anaerobe should be included in the antibiotic regimen: This is accurate. Abdominal sepsis often involves a mixture of aerobic and anaerobic organisms, especially if the source is intra-abdominal. Thus, anaerobic coverage is important.&lt;/li&gt;&lt;li&gt;â€¢ A drug active against anaerobe should be included in the antibiotic regimen:&lt;/li&gt;&lt;li&gt;â€¢ Combination of ampicillin and gentamicin provides good coverage for all likely pathogens: This combination can be effective against many pathogens; however, it might lack sufficient anaerobic coverage for abdominal sepsis, which often involves anaerobic bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Combination of ampicillin and gentamicin provides good coverage for all likely pathogens:&lt;/li&gt;&lt;li&gt;â€¢ If the patient is severely allergic to ampicillin, then ceftriaxone should be used: While ceftriaxone can be an alternative in many infections, if a patient is severely allergic to a penicillin like ampicillin, there&#x27;s a risk of cross-reactivity with cephalosporins like ceftriaxone. In such cases, it would be crucial to select an antibiotic considering the allergy history.&lt;/li&gt;&lt;li&gt;â€¢ If the patient is severely allergic to ampicillin, then ceftriaxone should be used:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old male with a history of chronic kidney disease (CKD) presents with a severe respiratory tract infection. Given his renal impairment, the treating physician wants to select a cephalosporin that does not necessitate dose adjustment in patients with any degree of renal insufficiency. Which of the following cephalosporins would be the most appropriate choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefuroxime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefoperazone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftazidime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefotaxime&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cefoperazone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Cefoperazone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Cefuroxime&lt;/li&gt;&lt;li&gt;â€¢ A. Cefuroxime&lt;/li&gt;&lt;li&gt;â€¢ Cefuroxime is primarily excreted by the kidneys, and its dosage needs to be adjusted in patients with renal impairment to prevent accumulation and toxicity.&lt;/li&gt;&lt;li&gt;â€¢ C. Ceftazidime&lt;/li&gt;&lt;li&gt;â€¢ C. Ceftazidime&lt;/li&gt;&lt;li&gt;â€¢ Ceftazidime is also primarily excreted by the kidneys, necessitating dose adjustments in patients with renal insufficiency to avoid adverse effects.&lt;/li&gt;&lt;li&gt;â€¢ D. Cefotaxime&lt;/li&gt;&lt;li&gt;â€¢ D. Cefotaxime&lt;/li&gt;&lt;li&gt;â€¢ Cefotaxime, like many other cephalosporins, is predominantly eliminated by the kidneys, and dose adjustment is required in patients with renal impairment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ When selecting antibiotics for patients with chronic kidney disease, it is important to choose agents that do not require renal dose adjustments to avoid toxicity. Cefoperazone is a cephalosporin that is excreted mainly through the biliary system and does not necessitate dose adjustments in patients with renal insufficiency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the fluoroquinolones is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonococcal resistance to fluoroquinolones may involve changes in DNA gyrase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Modification of ciprofloxacin dosage is required in patients if creatinine clearance is less than 50 mL/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Norfloxacin is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7 year-old girl&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fluoroquinolones inhibit relaxation of positively supercoiled DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Norfloxacin is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7 year-old girl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Norfloxacin is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7 year-old girl&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A post operative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotics treatment, the review of the charts was done. It was found that that the resident doctor had started the combination of antibiotics which was mutually antagonistic in action. Which of the following is the most likely combination that was given?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vancomycin and Amikacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ampicillin and Chloramphenicol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cephalexin and Gentamicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin and Piperacillin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ampicillin and Chloramphenicol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Ampicillin and Chloramphenicol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Mostly two bactericidal or two bacteriostatic drugs can be combined together to produce synergistic or additive effect. However, in most cases, a bactericidal and a bacteriostatic drug combination is antagonistic.&lt;/li&gt;&lt;li&gt;â€¢ Ampicillin and Chloramphenicol: These two antibiotics can be antagonistic when used together. Ampicillin is a bactericidal agent that inhibits cell wall synthesis, while chloramphenicol is bacteriostatic and inhibits protein synthesis. When a bacteriostatic antibiotic (like chloramphenicol) is used in combination with a bactericidal antibiotic (like ampicillin), it can inhibit the action of the bactericidal drug, as bactericidal agents generally require actively dividing bacteria to be effective. Vancomycin and Amikacin: Both are bactericidal, and they act on different targets. Vancomycin acts on the bacterial cell wall, while amikacin acts on the 30S ribosomal subunit. They are not known to be antagonistic. Cephalexin and Gentamicin: Cephalexin acts on the bacterial cell wall, while gentamicin targets the 30S ribosomal subunit. They are both bactericidal and are not known to have an antagonistic relationship. Ciprofloxacin and Piperacillin: Ciprofloxacin is a fluoroquinolone that inhibits DNA gyrase, while piperacillin is a penicillin derivative that disrupts cell wall synthesis. They are not known to be antagonistic and can be used in combination.&lt;/li&gt;&lt;li&gt;â€¢ Ampicillin and Chloramphenicol: These two antibiotics can be antagonistic when used together. Ampicillin is a bactericidal agent that inhibits cell wall synthesis, while chloramphenicol is bacteriostatic and inhibits protein synthesis. When a bacteriostatic antibiotic (like chloramphenicol) is used in combination with a bactericidal antibiotic (like ampicillin), it can inhibit the action of the bactericidal drug, as bactericidal agents generally require actively dividing bacteria to be effective.&lt;/li&gt;&lt;li&gt;â€¢ Vancomycin and Amikacin: Both are bactericidal, and they act on different targets. Vancomycin acts on the bacterial cell wall, while amikacin acts on the 30S ribosomal subunit. They are not known to be antagonistic.&lt;/li&gt;&lt;li&gt;â€¢ Cephalexin and Gentamicin: Cephalexin acts on the bacterial cell wall, while gentamicin targets the 30S ribosomal subunit. They are both bactericidal and are not known to have an antagonistic relationship.&lt;/li&gt;&lt;li&gt;â€¢ Ciprofloxacin and Piperacillin: Ciprofloxacin is a fluoroquinolone that inhibits DNA gyrase, while piperacillin is a penicillin derivative that disrupts cell wall synthesis. They are not known to be antagonistic and can be used in combination.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old female with a history of rheumatoid arthritis on immunosuppressive therapy presented with a 5-day history of worsening pain and redness around a surgical wound in her left knee. She had undergone knee replacement surgery three weeks prior. The wound appeared inflamed with purulent discharge. A wound swab was taken, and culture results identified Pseudomonas aeruginosa. Subsequent testing demonstrated that the isolated strain was producing extended-spectrum beta-lactamases (ESBLs). Given her worsening clinical status, the decision to start empiric antimicrobial therapy was made. Which of the following antimicrobials would be effective against the ESBL-producing Pseudomonas isolated from her wound?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxicillin plus clavulanic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefpirome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Piperacillin-tazobactam&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of these&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Piperacillin-tazobactam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Piperacillin-tazobactam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Amoxicillin plus clavulanic acid: This combination mainly targets gram-positive and some gram-negative organisms. Pseudomonas is intrinsically resistant to amoxycillin. Cefpirome: A fourth-generation cephalosporin, it has broad-spectrum activity. However, most strains of ESBL-producing Pseudomonas aeruginosa are resistant to beta lactam antimicrobials including cefpirome. Piperacillin-tazobactam: This combination is more effective against ESBL-producing organisms, including some strains of Pseudomonas aeruginosa, as tazobactam acts as a beta-lactamase inhibitor to extend the antibiotic&#x27;s spectrum of activity.&lt;/li&gt;&lt;li&gt;â€¢ Amoxicillin plus clavulanic acid: This combination mainly targets gram-positive and some gram-negative organisms. Pseudomonas is intrinsically resistant to amoxycillin.&lt;/li&gt;&lt;li&gt;â€¢ Cefpirome: A fourth-generation cephalosporin, it has broad-spectrum activity. However, most strains of ESBL-producing Pseudomonas aeruginosa are resistant to beta lactam antimicrobials including cefpirome.&lt;/li&gt;&lt;li&gt;â€¢ Piperacillin-tazobactam: This combination is more effective against ESBL-producing organisms, including some strains of Pseudomonas aeruginosa, as tazobactam acts as a beta-lactamase inhibitor to extend the antibiotic&#x27;s spectrum of activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents to his primary care physician with complaints of a persistent sore throat, fever, and swollen glands for the past week. On examination, the physician observes inflamed tonsils with a white exudate. The doctor is considering using a cephalosporin. She is debating which generation to use and recalls a drug she learned about during her medical training. Which of the following cephalosporins, that the doctor is considering, is a second-generation cephalosporin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefprozil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefadroxil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftizoxime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ceftobiprole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cefprozil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Cefprozil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cefprozil is a second-generation cephalosporin. These are often used for respiratory tract infections. Cefadroxil is a first-generation cephalosporin. Ceftizoxime is a third-generation cephalosporin. Ceftobiprole is a fifth-generation cephalosporin.&lt;/li&gt;&lt;li&gt;â€¢ Cefprozil is a second-generation cephalosporin. These are often used for respiratory tract infections.&lt;/li&gt;&lt;li&gt;â€¢ Cefprozil is a second-generation cephalosporin. These are often used for respiratory tract infections.&lt;/li&gt;&lt;li&gt;â€¢ Cefadroxil is a first-generation cephalosporin.&lt;/li&gt;&lt;li&gt;â€¢ Cefadroxil is a first-generation cephalosporin.&lt;/li&gt;&lt;li&gt;â€¢ Ceftizoxime is a third-generation cephalosporin.&lt;/li&gt;&lt;li&gt;â€¢ Ceftizoxime is a third-generation cephalosporin.&lt;/li&gt;&lt;li&gt;â€¢ Ceftobiprole is a fifth-generation cephalosporin.&lt;/li&gt;&lt;li&gt;â€¢ Ceftobiprole is a fifth-generation cephalosporin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents to the pediatric clinic with a 2-week history of an evolving cough. The mother reports that the child initially had a mild cough with cold-like symptoms that has progressed to episodes of severe coughing followed by a high-pitched \&quot;whoop\&quot; sound during inhalation. The episodes are often followed by vomiting. The child is afebrile and has not received all of his scheduled immunizations. Based on the clinical presentation, which is the preferred antibiotic for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amoxicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Azithromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Azithromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Azithromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of pertussis, commonly known as whooping cough. Pertussis is a highly contagious bacterial disease caused by Bordetella pertussis. The preferred treatment for children and adults with pertussis is azithromycin. Azithromycin is often preferred because of its shorter treatment course and better side-effect profile.&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of pertussis, commonly known as whooping cough.&lt;/li&gt;&lt;li&gt;â€¢ Pertussis is a highly contagious bacterial disease caused by Bordetella pertussis.&lt;/li&gt;&lt;li&gt;â€¢ The preferred treatment for children and adults with pertussis is azithromycin.&lt;/li&gt;&lt;li&gt;â€¢ Azithromycin is often preferred because of its shorter treatment course and better side-effect profile.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test24" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;T 20 Pharmacology Test 9 (Antimicrobials 2)   04 09 2023   2023 09 04&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;T 20 Pharmacology Test 9 (Antimicrobials 2)   04 09 2023   2023 09 04&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                20 Questions | 80 Total Marks | 30 min Duration | ~90.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 34-year-old woman presents to the clinic with a 3-month history of a persistent cough, unintentional weight loss, and night sweats. A chest X-ray reveals findings consistent with pulmonary tuberculosis. After confirming the diagnosis, the physician prescribes a multi-drug therapy (MDT) regimen. What is the most important reason for using MDT in her treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To enhance the speed of clinical recovery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To reduce the duration of treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To prevent the emergence of drug-resistant strains&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To reduce the adverse side effects of anti-tubercular drugs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. To prevent the emergence of drug-resistant strains&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. To prevent the emergence of drug-resistant strains&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. To enhance the speed of clinical recovery&lt;/li&gt;&lt;li&gt;â€¢ A. To enhance the speed of clinical recovery&lt;/li&gt;&lt;li&gt;â€¢ While MDT can help in effective treatment and clinical recovery, this is not the primary reason for its use. The main goal is to prevent drug resistance.&lt;/li&gt;&lt;li&gt;â€¢ B. To reduce the duration of treatment&lt;/li&gt;&lt;li&gt;â€¢ B. To reduce the duration of treatment&lt;/li&gt;&lt;li&gt;â€¢ Although MDT can help to reduce the overall duration of treatment compared to monotherapy, this is not the primary reason for its use. The main objective remains the prevention of drug-resistant TB strains.&lt;/li&gt;&lt;li&gt;â€¢ D. To reduce the adverse side effects of anti-tubercular drugs&lt;/li&gt;&lt;li&gt;â€¢ D. To reduce the adverse side effects of anti-tubercular drugs&lt;/li&gt;&lt;li&gt;â€¢ Each anti-tubercular drug can have side effects. By using multiple drugs, it&#x27;s possible to give each drug at a lower dose than if used alone, potentially reducing the severity of side effects. However, this is not the primary reason for using MDT. The main rationale behind MDT is the prevention of drug resistance, not the minimization of side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ The most important reason for using multi-drug therapy (MDT) in the treatment of tuberculosis (TB) is to prevent the emergence of drug-resistant strains. TB bacteria can develop resistance to drugs when they are exposed to a single drug for an extended period. Using a combination of drugs ensures that even if some bacteria are resistant to one drug, they will be killed by the other drugs in the regimen, thus preventing the development and spread of drug-resistant TB strains.&lt;/li&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Multi-drug therapy (MDT) is crucial in the treatment of tuberculosis to prevent the emergence of drug-resistant strains of Mycobacterium tuberculosis. While MDT can also reduce the overall treatment duration, its primary purpose is to ensure that the bacteria are effectively eradicated by using a combination of drugs, thereby minimizing the risk of developing resistance to any single drug.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the clinic with recurrent oral herpes outbreaks. He mentions that his outbreaks were previously well controlled with acyclovir, but recently, the medication seems less effective. The physician suspects the herpes simplex virus (HSV) causing his symptoms might have developed resistance to acyclovir. Resistance to acyclovir is most commonly due to mutation in a viral gene that encodes a protein that:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Converts viral RNA into DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transports acyclovir into the cell&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphorylates acyclovir&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transports acyclovir out of the cell&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phosphorylates acyclovir&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Phosphorylates acyclovir&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Converts viral RNA into DNA&lt;/li&gt;&lt;li&gt;â€¢ A. Converts viral RNA into DNA&lt;/li&gt;&lt;li&gt;â€¢ This description matches the function of reverse transcriptase, which is not relevant to the herpes simplex virus (HSV) as HSV is a DNA virus, not an RNA virus.&lt;/li&gt;&lt;li&gt;â€¢ B. Transports acyclovir into the cell&lt;/li&gt;&lt;li&gt;â€¢ B. Transports acyclovir into the cell&lt;/li&gt;&lt;li&gt;â€¢ The transport of acyclovir into the cell is not the primary mechanism of resistance. Acyclovir enters the cell via diffusion and not through a specific transport protein.&lt;/li&gt;&lt;li&gt;â€¢ D. Transports acyclovir out of the cell&lt;/li&gt;&lt;li&gt;â€¢ D. Transports acyclovir out of the cell&lt;/li&gt;&lt;li&gt;â€¢ There is no significant evidence that resistance to acyclovir is due to the transport of the drug out of the cell.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Resistance to acyclovir in herpes simplex virus (HSV) is primarily due to mutations in the viral thymidine kinase gene. Thymidine kinase is crucial for the initial phosphorylation of acyclovir to its active form. Mutations in this enzyme reduce the ability of the virus to phosphorylate acyclovir, leading to decreased drug efficacy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old male diagnosed with HIV seeks guidance from his primary care doctor for appropriate treatment. Given the significant drop in his CD4 counts, initiation of HAART (Highly Active Antiretroviral Therapy) is being contemplated. Concerning the role of ritonavir for this patient, which statement holds true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;This agent is associated with resistance when used in combination with another protease inhibitor.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is used primarily for its inhibitory effect on CYP3A4.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;This is an excellent single agent for use in HAART therapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is used primarily for its inhibitory effect on CYP3A4.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. It is used primarily for its inhibitory effect on CYP3A4.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.&lt;/li&gt;&lt;li&gt;â€¢ A. Ritonavir is commonly used to inhibit the HIV protease enzyme along with other drugs in HAART regimen.&lt;/li&gt;&lt;li&gt;â€¢ While ritonavir does have protease inhibitory activity, its primary role in HAART regimens is as a pharmacokinetic enhancer of other protease inhibitors rather than as the main protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ B. This agent is associated with resistance when used in combination with another protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ B. This agent is associated with resistance when used in combination with another protease inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Ritonavir, when used in low doses as a booster, does not contribute significantly to resistance. Its role is to increase the effectiveness of other protease inhibitors without leading to increased resistance.&lt;/li&gt;&lt;li&gt;â€¢ D. This is an excellent single agent for use in HAART therapy.&lt;/li&gt;&lt;li&gt;â€¢ D. This is an excellent single agent for use in HAART therapy.&lt;/li&gt;&lt;li&gt;â€¢ Ritonavir is not used as a single agent in HAART therapy due to its side effect profile and the development of resistance when used alone. It is always used in combination with other antiretroviral drugs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Ritonavir is primarily used in HAART regimens for its strong inhibitory effect on the cytochrome P450 enzyme CYP3A4. This inhibition enhances the pharmacokinetics of other protease inhibitors, increasing their plasma levels and efficacy, which allows for lower dosages and reduced side effects.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old female discovered she was HIV-positive four weeks ago. Upon receiving her diagnosis, she initiated a HAART (Highly Active Antiretroviral Therapy) protocol. Currently, she&#x27;s experiencing symptoms of nausea, episodes of vomiting, and stomach pain. Lab tests indicate a heightened serum amylase level. If these symptoms are a result of her medication, which antiretroviral drug is most likely the culprit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Efavirenz&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Didanosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Raltegravir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nevirapine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Didanosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Didanosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation of Other Options&lt;/li&gt;&lt;li&gt;â€¢ A. Efavirenz&lt;/li&gt;&lt;li&gt;â€¢ A. Efavirenz&lt;/li&gt;&lt;li&gt;â€¢ Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is more commonly associated with central nervous system side effects such as dizziness, insomnia, and vivid dreams rather than gastrointestinal side effects and pancreatitis.&lt;/li&gt;&lt;li&gt;â€¢ C. Raltegravir&lt;/li&gt;&lt;li&gt;â€¢ C. Raltegravir&lt;/li&gt;&lt;li&gt;â€¢ Raltegravir is an integrase strand transfer inhibitor (INSTI) and is not typically associated with pancreatitis. Its common side effects include elevated creatine kinase, muscle pain, and insomnia.&lt;/li&gt;&lt;li&gt;â€¢ D. Nevirapine&lt;/li&gt;&lt;li&gt;â€¢ D. Nevirapine&lt;/li&gt;&lt;li&gt;â€¢ Nevirapine is another NNRTI that is primarily associated with hepatotoxicity and skin rash, including severe reactions like Stevens-Johnson syndrome, rather than pancreatitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Didanosine, an NRTI used in HAART regimens, is associated with gastrointestinal side effects, including pancreatitis. Elevated serum amylase levels, along with symptoms such as nausea, vomiting, and stomach pain, are indicative of pancreatitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old girl comes to the medical office complaining of a severely pruritic skin condition that started 3 days ago. Three other children from her school have been diagnosed with similar skin complaints. On examination, the girl has itchy red bumps and clear linear tracks, particularly on her finger webs of hand and feet and on ankles. They somewhat resemble the marks left by tiny insects. What would be the best course of action for treating this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Topical agents like miconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral ivermectin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topical permethrin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skin creams containing steroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Topical permethrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Topical permethrin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old male patient with a history of type 2 diabetes and hypertension is admitted with a 7-day history of fever, cough, and increasing shortness of breath. A PCR test confirms a diagnosis of COVID-19. Chest X-ray demonstrates bilateral infiltrates indicative of pneumonia, and his oxygen saturation on room air registers at 88%. Considering the current understanding of COVID-19 treatments, which therapeutic approach is most suitable to enhance this patient&#x27;s clinical outcome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of remdesivir.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Combination of high-flow oxygen and dexamethasone therapy.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous administration of tocilizumab.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment with monoclonal antibodies against SARS-CoV-2.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Combination of high-flow oxygen and dexamethasone therapy.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Combination of high-flow oxygen and dexamethasone therapy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-tubercular drugs is safe in hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethionamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Streptomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Streptomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with a single hypoesthetic patch on the skin, suggestive of paucibacillary leprosy. According to current guidelines, what is the treatment of choice for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rifampicin + Ofloxacin + Minocycline as a single dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampicin + Clofazimine + Dapsone for one year&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rifampicin + Dapsone + Clofazimine for six months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin + Dapsone for 6 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rifampicin + Dapsone + Clofazimine for six months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Rifampicin + Dapsone + Clofazimine for six months&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents to the clinic with symptoms of fever, weight loss, and splenomegaly. She has recently returned from a trip to a region known for endemic visceral leishmaniasis, also known as Kala-azar. Which of the following medications is suitable for single-dose treatment of Kala-azar?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pentamidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liposomal Amphotericin B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium stibogluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Miltefosine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liposomal Amphotericin B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Liposomal Amphotericin B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents to the clinic for a routine check-up. Blood tests reveal elevated liver enzymes, and subsequent tests confirm a diagnosis of chronic hepatitis C. She has no significant medical history and wishes to begin antiviral therapy to minimize the risk of progression to liver cirrhosis or hepatocellular carcinoma. Which of the following oral medications is recommended as a first-line treatment for hepatitis C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ribavirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tenofovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sofosbuvir&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sofosbuvir&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Sofosbuvir&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following combination of drug and its indication is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pretomanid: MDR tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fostemsavir: Treatment of HIV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Remdesivir: Moderate to severe COVID-19 pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tafenoquine: Single dose treatment of P. falciparum malaria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Tafenoquine: Single dose treatment of P. falciparum malaria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Understanding the specific indications for various drugs is crucial for their appropriate use. Pretomanid is used for MDR tuberculosis, fostemsavir for HIV treatment, and remdesivir for moderate to severe COVID-19 pneumonia. Tafenoquine, however, is primarily indicated for the radical cure of P. vivax malaria and not as a single-dose treatment for P. falciparum malaria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about fluconazole is most accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is the drug of choice for the treatment of aspergillosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It does not penetrate the blood-brain barrier&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Its oral bioavailability is less than that of ketoconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It inhibits demethylation of lanosterol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It inhibits demethylation of lanosterol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. It inhibits demethylation of lanosterol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old Indian man, pursuing his post-graduation, recently returned from Africa where he completed an academic research project. A few weeks after his return, he visits the hospital after testing positive for Plasmodium vivax malaria. The doctor recommends primaquine for the radical cure of his P. vivax infection. Shortly after beginning the regimen, the patient exhibits yellowing of the eyes. What could be the most probable reason for this symptom?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Primaquine merely stains the tears yellow; this isn&#x27;t genuine yellowing of the eyes.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interaction with another medication.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deficiency of a specific enzyme.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primaquine&#x27;s liver-damaging effects.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deficiency of a specific enzyme.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Deficiency of a specific enzyme.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old sexually active, HIV-negative male visits his healthcare provider with a painless sore on his inner lip and a non-itchy rash on the soles of his feet. He recalls having a non-tender ulcer on his scrotum about a month and a half ago, which resolved on its own. He receives an intramuscular injection of benzathine penicillin G and is discharged. How might the treatment approach for this patient have been modified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The choice of antibiotic was not appropriate, and another class should have been selected.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The correct treatment would involve a different form of penicillin G, rather than benzathine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;There is no need for changes; the treatment administered is correct.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;After the initial injection, a follow-up dose should be given after 7 days.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. There is no need for changes; the treatment administered is correct.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/04/screenshot-2023-09-04-125631.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. There is no need for changes; the treatment administered is correct.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents to the clinic with recurrent vaginal itching and discharge. She reports that over-the-counter antifungal creams have provided only temporary relief. Given her history, the physician decides to initiate a prescription antifungal regimen. Based on the mechanisms of action of various antifungal medications, which of the following statements is incorrectly matched?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azoles - Inhibit ergosterol synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flucytosine - Inhibit microtubule&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echinocandins - Inhibit glycan synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphotericin B - Create artificial pores in the membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Flucytosine - Inhibit microtubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Flucytosine - Inhibit microtubule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Flucytosine does not inhibit microtubules; rather, it works by interfering with fungal DNA and RNA synthesis. It is converted to 5-fluorouracil within the fungal cell, which then inhibits thymidylate synthase, thereby disrupting DNA and RNA synthesis.&lt;/li&gt;&lt;li&gt;âž¤ A. Azoles - Inhibit ergosterol synthesis&lt;/li&gt;&lt;li&gt;âž¤ A. Azoles - Inhibit ergosterol synthesis&lt;/li&gt;&lt;li&gt;âž¤ This statement is correct. Azoles inhibit the enzyme lanosterol 14Î±-demethylase, which is crucial for the synthesis of ergosterol, an essential component of the fungal cell membrane.&lt;/li&gt;&lt;li&gt;âž¤ C. Echinocandins - Inhibit glycan synthesis&lt;/li&gt;&lt;li&gt;âž¤ C. Echinocandins - Inhibit glycan synthesis&lt;/li&gt;&lt;li&gt;âž¤ This statement is correct. Echinocandins inhibit the enzyme Î²-(1,3)-D-glucan synthase, which is essential for the synthesis of Î²-(1,3)-D-glucan, an important component of the fungal cell wall.&lt;/li&gt;&lt;li&gt;âž¤ D. Amphotericin B - Create artificial pores in the membrane&lt;/li&gt;&lt;li&gt;âž¤ D. Amphotericin B - Create artificial pores in the membrane&lt;/li&gt;&lt;li&gt;âž¤ This statement is correct. Amphotericin B binds to ergosterol in the fungal cell membrane, creating pores that increase membrane permeability and lead to cell death.&lt;/li&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Understanding the mechanisms of action of antifungal medications is essential for effective treatment. Azoles inhibit ergosterol synthesis, echinocandins inhibit glycan synthesis, and amphotericin B creates artificial pores in the fungal cell membrane. Flucytosine, however, works by interfering with fungal DNA and RNA synthesis, not by inhibiting microtubules.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man is diagnosed with both HIV and chronic hepatitis B infection. His physician is considering a treatment regimen that can effectively address both conditions. Which of the following antiretroviral medications would also have activity against hepatitis B virus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indinavir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Didanosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Efavirenz&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lamivudine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Lamivudine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ganciclovir is preferred over acyclovir in the following condition:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Herpes simplex keratitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytomegalovirus retinitis in AIDS patients&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Herpes zoster&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chickenpox&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cytomegalovirus retinitis in AIDS patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Cytomegalovirus retinitis in AIDS patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents to the emergency room with seizures. A CT scan of his head reveals a space-occupying lesion, suggesting a diagnosis of neurocysticercosis. Which of the following medications is NOT recommended for treating this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamazepine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Di-Ethyl-Carbamezine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Albendazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Di-Ethyl-Carbamezine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Di-Ethyl-Carbamezine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the clinic with complaints of severe headaches, disturbances in sleep, and intermittent fever for the past few weeks. He recently returned from a trip to Central Africa. Lumbar puncture results reveal trypanosomes in the cerebrospinal fluid, suggesting a late-stage African trypanosomiasis with CNS involvement. Which drug would be most effective in treating both the blood and CNS stages of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Emetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Melarsoprol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nifurtimox&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suramin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Melarsoprol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Melarsoprol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents to her gynecologist with complaints of vaginal discharge and a fishy odor. After taking a history and performing a pelvic exam, a wet mount preparation shows a \&quot;clue cell\&quot; pattern. The pH of the vaginal fluid is found to be above 4.5. The diagnosis of bacterial vaginosis is made. Which of the following is the recommended first-line treatment for bacterial vaginosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluconazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metronidazole&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Metronidazole&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Metronidazole&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Metronidazole is the recommended first-line treatment for bacterial vaginosis (BV). It is effective against the anaerobic bacteria associated with BV, such as Gardnerella vaginalis. Metronidazole can be administered either orally or intravaginally and is known for its efficacy in treating this condition.&lt;/li&gt;&lt;li&gt;âž¤ A. Fluconazole&lt;/li&gt;&lt;li&gt;âž¤ A. Fluconazole&lt;/li&gt;&lt;li&gt;âž¤ Fluconazole is an antifungal medication used primarily to treat yeast infections, such as vaginal candidiasis. It is not effective against the bacteria that cause BV.&lt;/li&gt;&lt;li&gt;âž¤ B. Clindamycin&lt;/li&gt;&lt;li&gt;âž¤ B. Clindamycin&lt;/li&gt;&lt;li&gt;âž¤ Clindamycin is another effective treatment for BV and can be used as an alternative to metronidazole. However, it is not the first-line treatment.&lt;/li&gt;&lt;li&gt;âž¤ D. Ciprofloxacin&lt;/li&gt;&lt;li&gt;âž¤ D. Ciprofloxacin&lt;/li&gt;&lt;li&gt;âž¤ Ciprofloxacin is an antibiotic used to treat various bacterial infections, but it is not recommended for the treatment of BV. It is more commonly used for urinary tract infections and certain types of bacterial diarrhea.&lt;/li&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Bacterial vaginosis is commonly treated with metronidazole, which is effective against the anaerobic bacteria associated with the condition. It can be administered orally or intravaginally. Understanding the appropriate treatment options for BV ensures effective management and resolution of symptoms, such as vaginal discharge and odor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 30 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

</body>
</html>
